Citrus Sinensis ID: 001778
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1014 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.910 | 0.926 | 0.408 | 0.0 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.907 | 0.920 | 0.423 | 0.0 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.890 | 0.909 | 0.401 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.899 | 0.876 | 0.367 | 1e-159 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.929 | 0.930 | 0.359 | 1e-155 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.894 | 0.904 | 0.373 | 1e-155 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.903 | 0.831 | 0.353 | 1e-154 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.896 | 0.883 | 0.375 | 1e-153 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.911 | 0.931 | 0.358 | 1e-151 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.937 | 0.949 | 0.362 | 1e-151 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/961 (40%), Positives = 572/961 (59%), Gaps = 38/961 (3%)
Query: 31 DREHAVLLKLKQHWQNPPP-ISHWATTNSSHCTWPEIACTD--GSVTELHLTNMNMNGTF 87
+++ +L ++K +P +S W + ++S C W ++C SVT + L++ N+ G F
Sbjct: 17 NQDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPF 76
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKF 147
P IC L NL L L N I S P + C L+ LDLSQN G +P+ + + L
Sbjct: 77 PSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVH 136
Query: 148 LYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPS 207
L LT NN SG IPAS G+ L L+LV N +G+IP +GN+ L+ L L+YN FSPS
Sbjct: 137 LDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP-FSPS 195
Query: 208 SLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNL 267
+P F L L+ +W+ +L+G+IP+++G + L LDL++N+ G IP S+ L N+
Sbjct: 196 RIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNV 255
Query: 268 SKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSG 326
++ LY+NSL+GEIP + +L +L+++D S N LTG IP++ ++ L +L+L N L G
Sbjct: 256 VQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEG 314
Query: 327 EIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKL 386
E+P I L P+L ++R+F N L+G LP D G SPL + +VS N +G LP LCA G+L
Sbjct: 315 ELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGEL 374
Query: 387 AGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTG 446
+ N+ SG +PESL +C SL +++ N F+G++P G W +++++ + +N F+G
Sbjct: 375 EELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSG 434
Query: 447 ELPDKMSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSL 504
E+ + G NLS L +SNN F+G +P + S NL AS N F+G++P L +L L
Sbjct: 435 EISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGEL 494
Query: 505 TTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
TL L NQ SG L I SWK L LNL+ N+ +G+IP++IG L VL LDLS N FSG
Sbjct: 495 GTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSG 554
Query: 565 KIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVP 624
KIP + L L LNLS NRL+G++P Y +SF+ NPGLC + C
Sbjct: 555 KIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGL----CGSEN 610
Query: 625 RKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQK-RKDELTSTETTSFHRLNFRDS 683
++G + I V V L + F++ R ++K R E + SFH+L F +
Sbjct: 611 EAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEH 670
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN---------DRKLDQK---HE 731
+IL L E NVIG+G SGKVY+V + + E VAVK++W D + K +
Sbjct: 671 EILESLDEDNVIGAGASGKVYKVVLTN-GETVAVKRLWTGSVKETGDCDPEKGYKPGVQD 729
Query: 732 KEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR 791
+ F AEV+ L IRH NIVKL CC S+ + KLLVYEYM SL LH ++
Sbjct: 730 EAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHS---------SK 780
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
+L W+ R +I + AA+GL Y+HHD P IVHRD+KS+NIL+D ++ A++ADFGVAK +
Sbjct: 781 GGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAV 840
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD-EHT 910
+MS + GSCGYIAPEYA T +VNEK+DIYSFGV++LE+ T K + +
Sbjct: 841 DLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK 900
Query: 911 CLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQI 970
L +W + + K I +D ++D CF EE+ ++ +G++CTS LP RP+MR V+++
Sbjct: 901 DLVKWVCSTLDQ-KGIEHVIDPKLDS-CFKEEISKILNVGLLCTSPLPINRPSMRRVVKM 958
Query: 971 L 971
L
Sbjct: 959 L 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/964 (42%), Positives = 575/964 (59%), Gaps = 44/964 (4%)
Query: 31 DREHAVLLKLKQHWQNPP-PISHWATTNS-SHCTWPEIACTDGS-VTELHLTNMNMNGTF 87
+++ +L + K +P +S W+ N + C W ++C S V + L++ + G F
Sbjct: 22 NQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDLSSFMLVGPF 81
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYN-CSKLEYLDLSQNYFIGPIPEDID-RLSRL 145
P +C L +L L L N I ++ C L LDLS+N +G IP+ + L L
Sbjct: 82 PSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNL 141
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
KFL ++ NN+S IP+S G +L LNL N +G+IPA +GN+ L+ L+LAYN FS
Sbjct: 142 KFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNL-FS 200
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLK 265
PS +PS L +L+ LW+A NL+G IP ++ + +L LDL+ N TGSIPS + +LK
Sbjct: 201 PSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLK 260
Query: 266 NLSKVYLYSNSLSGEIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
+ ++ L++NS SGE+P+++ ++ LK D S N LTG IP D L NL +L+L N L
Sbjct: 261 TVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIP-DNLNLLNLESLNLFENML 319
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
G +PE I +L +++LFNN L+G LP G SPL+Y ++S N +G +P ++C G
Sbjct: 320 EGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEG 379
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
KL + DN+ SGE+ +LG C SL V++ NN +G IP G W LS++ +SDN F
Sbjct: 380 KLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSF 439
Query: 445 TGELPDKMSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALP 502
TG +P + G NLS L IS NRFSG IP + S ++ + N F+G IP L L
Sbjct: 440 TGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLK 499
Query: 503 SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
L+ L L +NQLSG +P ++ WK+L LNL+ N LSGEIP+++G LPVL LDLS NQF
Sbjct: 500 QLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQF 559
Query: 563 SGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFF 622
SG+IP ++ L L LNLS N L+G+IP + N+ YA F+ NPGLC + C
Sbjct: 560 SGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGL----CRK 615
Query: 623 VPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDE-LTSTETTSFHRLNFR 681
+ R G + I + VF+V ++ F R + K L +++ SFH+L+F
Sbjct: 616 ITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWRSFHKLHFS 675
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK-------LDQKHEKEF 734
+ +I L E NVIG G SGKVY+V + EVVAVKK+ K D + F
Sbjct: 676 EHEIADCLDEKNVIGFGSSGKVYKVEL-RGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVF 734
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV 794
AEV+ L TIRH +IV+L CC SS + KLLVYEYM SL LH + + V
Sbjct: 735 AAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGV-------V 787
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-LIK 853
L W R++IA+ AA+GL Y+HHDC P IVHRD+KSSNILLD ++ AK+ADFG+AK+ +
Sbjct: 788 LGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMS 847
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANN---GDEHT 910
AMS + GSCGYIAPEY T +VNEK+DIYSFGV+LLEL TGK+ + GD+
Sbjct: 848 GSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDKD- 906
Query: 911 CLAQWAWRHIQEG--KPIVD-ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMV 967
+A+W + + +P++D LD + F EE+ +V +G++CTS LP RP+MR V
Sbjct: 907 -MAKWVCTALDKCGLEPVIDPKLDLK-----FKEEISKVIHIGLLCTSPLPLNRPSMRKV 960
Query: 968 LQIL 971
+ +L
Sbjct: 961 VIML 964
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 637 bits (1644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/960 (40%), Positives = 560/960 (58%), Gaps = 57/960 (5%)
Query: 50 ISHWATT--NSSHCTWPEIAC-----TDGSVTELHLTNMNMNGTFPPFICDLR---NLTI 99
+ W T N S C W I C + +VT + L+ N++G FP C +R N+T+
Sbjct: 46 LQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFCRIRTLINITL 105
Query: 100 LDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKI 159
N I P L CSKL+ L L+QN F G +PE +L+ L L +N +G+I
Sbjct: 106 SQNNLNGTIDSAPLSL--CSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEI 163
Query: 160 PASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKL 219
P S GRLT L+ LNL N +G +PA +G L L L+LAY F PS +PS L L
Sbjct: 164 PQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAY-ISFDPSPIPSTLGNLSNL 222
Query: 220 KKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSG 279
L + +NL+GEIP++I +++ LE LDL++N+ TG IP S+ +L+++ ++ LY N LSG
Sbjct: 223 TDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSG 282
Query: 280 EIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
++P+++ +L L+ D+S NNLTG +P L+ L++ +L N +G +P+ + L P+L
Sbjct: 283 KLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDNFFTGGLPDVVALNPNL 341
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ ++FNN +G LP + G++S + F+VS N +G LP +LC KL I N LSG
Sbjct: 342 VEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSG 401
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NL 456
E+PES G+C SL +++ +N +G +PA W + L ++N G +P +S +L
Sbjct: 402 EIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHL 461
Query: 457 SRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSG 516
S+LEIS N FSG IP + ++L V S N F G+IP + L +L + + +N L G
Sbjct: 462 SQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDG 521
Query: 517 SLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLT 576
+P + S LT LNLS N+L G IP ++G LPVL LDLS NQ +G+IP ++ RL L
Sbjct: 522 EIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLN 581
Query: 577 SLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQHVA 636
N+S N+L G+IPS F+ + SFL NP LCA + + ++ C R R+ ++++
Sbjct: 582 QFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDP-IRPC----RSKRE--TRYIL 634
Query: 637 VIIVSVIAVFLVALLSFFYMIRIYQKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIG 696
I + I AL+ F + KRK + T+ + T F R+ F + DI P+LTE N+IG
Sbjct: 635 PISILCIVALTGALVWLFIKTKPLFKRKPKRTN-KITIFQRVGFTEEDIYPQLTEDNIIG 693
Query: 697 SGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI 756
SGGSG VYRV + + + +AVKK+W + + E F +EV+ L +RH NIVKLL C
Sbjct: 694 SGGSGLVYRVKL-KSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCC 752
Query: 757 SSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH 815
+ E + LVYE+ME SL LH +K ++S L W R IAVGAAQGL Y+H
Sbjct: 753 NGEEFRFLVYEFMENGSLGDVLHSEKEHRAVS------PLDWTTRFSIAVGAAQGLSYLH 806
Query: 816 HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF---AAMSTVVGSCGYIA 872
HD P IVHRD+KS+NILLD+ ++ADFG+AK L +E+ + +MS V GS GYIA
Sbjct: 807 HDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIA 866
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD--EHTCLAQWAWR--------HIQE 922
PEY T KVNEK+D+YSFGV+LLEL TGK N+ E+ + ++A ++
Sbjct: 867 PEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAED 926
Query: 923 GKPIVDA------LDKEIDEPCFL-----EEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
G D+ L K +D L EE+ +V + ++CTS P RP MR V+++L
Sbjct: 927 GAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKVVELL 986
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 562 bits (1448), Expect = e-159, Method: Compositional matrix adjust.
Identities = 354/962 (36%), Positives = 520/962 (54%), Gaps = 50/962 (5%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTD--GSVTELHLTNMNMNGTFPPFICDLRNLTI 99
Q W+ P ++ C+W + C + V L L++ N++G P I L +L
Sbjct: 54 QDWKVPVN----GQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLLY 109
Query: 100 LDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKI 159
L+L N + FP +++ +KL LD+S+N F P I +L LK +NN G +
Sbjct: 110 LNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGLL 169
Query: 160 PASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKL 219
P+ + RL L +LN + F G IPA G LQ L+ + LA N LP L +L
Sbjct: 170 PSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNV--LGGKLPPRLGLLTEL 227
Query: 220 KKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSG 279
+ + + + G IP + L++ D+S + +GS+P + L NL ++L+ N +G
Sbjct: 228 QHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287
Query: 280 EIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
EIP++ +L +LK++D S+N L+G+IP+ F L+NL LSL+ N LSGE+PEGIG LP L
Sbjct: 288 EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ L+NN +G LP G LE +VS N+ TG++P LC G KL + N G
Sbjct: 348 TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGN--L 456
ELP+SL C SL + NN G IP G + NL+ V +S+N FT ++P + L
Sbjct: 408 ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVL 467
Query: 457 SRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSG 516
L +S N F K+P + + NL +F AS + G IP S + L N L+G
Sbjct: 468 QYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIP-NYVGCKSFYRIELQGNSLNG 526
Query: 517 SLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIG-RLML 575
++P DI + L LNLS+N L+G IP +I LP + D+DLS N +G IP G +
Sbjct: 527 TIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTI 586
Query: 576 TSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCA-------SSSNVNLKSCFFVPRKSR 628
T+ N+S N+L G IPS S F +N GLC +S N +
Sbjct: 587 TTFNVSYNQLIGPIPSGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKE 646
Query: 629 KGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQK----RKDELTST-------ETTSFHR 677
+ + I+ + A V R +QK R D + T+F R
Sbjct: 647 ERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQR 706
Query: 678 LNFRDSDILPKLTES-NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE--- 733
LNF D++ L+++ N++G G +G VY+ + + E++AVKK+W K + K +
Sbjct: 707 LNFTADDVVECLSKTDNILGMGSTGTVYKAEMPN-GEIIAVKKLWGKNKENGKIRRRKSG 765
Query: 734 FLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDE 793
LAEV +L +RH NIV+LL C ++ + +L+YEYM SLD LH +++ +
Sbjct: 766 VLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTA------ 819
Query: 794 VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK 853
W QIA+G AQG+CY+HHDC P IVHRDLK SNILLD +F A++ADFGVAK++
Sbjct: 820 AAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQT 879
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD--EHTC 911
+E +MS V GS GYIAPEYA T +V++K+DIYS+GVILLE+ TGK + + E
Sbjct: 880 DE----SMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNS 935
Query: 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFL--EEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ W ++ + + + LDK + C L EEM ++ ++ ++CTS PT+RP MR VL
Sbjct: 936 IVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLL 995
Query: 970 IL 971
IL
Sbjct: 996 IL 997
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1419), Expect = e-155, Method: Compositional matrix adjust.
Identities = 357/993 (35%), Positives = 546/993 (54%), Gaps = 50/993 (5%)
Query: 10 LQILLSTLLLFFFGRANSQLYD----REHAVLLKLKQHWQNPPP-ISHWATTNSS-HCTW 63
++I++ L + G +S L E +VLL +K +P + W +++S HC W
Sbjct: 3 MKIIVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNW 62
Query: 64 PEIAC-TDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLE 122
+ C ++G+V +L L MN+ G I L +L ++ N S P+ + L+
Sbjct: 63 TGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSI---PPLK 119
Query: 123 YLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGS 182
+D+SQN F G + + L L + NN+SG + +G L L L+L N F GS
Sbjct: 120 SIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGS 179
Query: 183 IPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA 242
+P+ NLQ L L L+ N LPS QL L+ + G IP G++ +
Sbjct: 180 LPSSFKNLQKLRFLGLSGNNL--TGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINS 237
Query: 243 LEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLN-LKVIDLSANNLT 301
L++LDL+I +G IPS + KLK+L + LY N+ +G IP+ + S+ LKV+D S N LT
Sbjct: 238 LKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALT 297
Query: 302 GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
G IP + KL+NL L+LM N+LSG IP I L L+ + L+NN LSG LP D G+ SP
Sbjct: 298 GEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSP 357
Query: 362 LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT 421
L++ +VS N+ +G +P LC G L + +N +G++P +L C SL+ V++ NN
Sbjct: 358 LQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLN 417
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGVSSSKN 479
G+IP G L + ++ N +G +P +S +LS ++ S N+ +P+ + S N
Sbjct: 418 GSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHN 477
Query: 480 LVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLS 539
L F ++N +G +P + PSL+ L L N L+G++P I S + L +LNL N L+
Sbjct: 478 LQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLT 537
Query: 540 GEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIP-SQFENRA 597
GEIP +I + L LDLS N +G +P IG L LN+S N+LTG +P + F
Sbjct: 538 GEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTI 597
Query: 598 YASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQH----VAVIIVSVIAVFLVALLSF 653
N GLC L C R + SS H VA ++ + +V + +L+
Sbjct: 598 NPDDLRGNSGLCGGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTI 653
Query: 654 FYMIRIYQKRKDELTSTETTS----------FHRLNFRDSDILPKLTESNVIGSGGSGKV 703
+ + ET S FHRL F SDIL + ESN+IG G +G V
Sbjct: 654 VTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIV 713
Query: 704 YRVPINHTAEVVAVKKIWND-RKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762
Y+ ++ ++ V+AVKK+W ++ +F+ EV +L +RH NIV+LL + ++
Sbjct: 714 YKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNM 773
Query: 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTI 822
++VYE+M +L +H KN +GR ++ W R IA+G A GL Y+HHDC P +
Sbjct: 774 MIVYEFMLNGNLGDAIHGKNA---AGRL---LVDWVSRYNIALGVAHGLAYLHHDCHPPV 827
Query: 823 VHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN 882
+HRD+KS+NILLD N +A+IADFG+A+++ +++ +S V GS GYIAPEY T KV+
Sbjct: 828 IHRDIKSNNILLDANLDARIADFGLARMMARKK---ETVSMVAGSYGYIAPEYGYTLKVD 884
Query: 883 EKTDIYSFGVILLELTTGK---EANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCF 939
EK DIYS+GV+LLEL TG+ E G E + +W R I++ + +ALD + +
Sbjct: 885 EKIDIYSYGVVLLELLTGRRPLEPEFG-ESVDIVEWVRRKIRDNISLEEALDPNVGNCRY 943
Query: 940 L-EEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ EEM+ V ++ ++CT+ LP +RP+MR V+ +L
Sbjct: 944 VQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 549 bits (1414), Expect = e-155, Method: Compositional matrix adjust.
Identities = 358/958 (37%), Positives = 512/958 (53%), Gaps = 51/958 (5%)
Query: 49 PISHWATTNSSHCTWPEIAC--TDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNY 106
P+S W + +S CTW + C + VT L L+ +N++GT P + LR L L L N
Sbjct: 46 PLSSWKVS-TSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENL 104
Query: 107 IISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDR-LSRLKFLYLTANNMSGKIPASIGR 165
I P + + S L +L+LS N F G P++I L L+ L + NN++G +P S+
Sbjct: 105 ISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTN 164
Query: 166 LTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMA 225
LT+LR L+L N F G IP G+ +E L ++ N +P L L++L++
Sbjct: 165 LTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVG--KIPPEIGNLTTLRELYIG 222
Query: 226 STNLIGE-IPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQA 284
N + +P IG++ L D + TG IP + KL+ L ++L N SG +
Sbjct: 223 YYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWE 282
Query: 285 VESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRL 343
+ +L+ LK +DLS N TG IP F +L+NL L+L N+L GEIPE IG LP L+ ++L
Sbjct: 283 LGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQL 342
Query: 344 FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPES 403
+ N +G++P G L ++S N LTG+LP ++C+G KL + N L G +P+S
Sbjct: 343 WENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDS 402
Query: 404 LGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELP--DKMSGNLSRLEI 461
LG C SL +++ N G+IP GL+ L+ V + DN +GELP +S NL ++ +
Sbjct: 403 LGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISL 462
Query: 462 SNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLD 521
SNN+ SG +P + + + N F G IP E+ L L+ + N SG + +
Sbjct: 463 SNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPE 522
Query: 522 IISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNL 580
I K LT ++LSRN+LSGEIP +I + +L L+LS N G IP I + LTSL+
Sbjct: 523 ISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDF 582
Query: 581 SSNRLTGEIP--SQFENRAYASSFLNNPGLCA------------SSSNVNLKSCFFVPRK 626
S N L+G +P QF Y +SFL NP LC + K K
Sbjct: 583 SYNNLSGLVPGTGQFSYFNY-TSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMK 641
Query: 627 SRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDELTSTETTSFHRLNFRDSDIL 686
V I +V+A+ L K+ E + T+F RL+F D+L
Sbjct: 642 LLLVLGLLVCSIAFAVVAIIKARSL----------KKASESRAWRLTAFQRLDFTCDDVL 691
Query: 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH 746
L E N+IG GG+G VY+ + ++VAVK++ + H+ F AE+Q L IRH
Sbjct: 692 DSLKEDNIIGKGGAGIVYK-GVMPNGDLVAVKRLAAMSR-GSSHDHGFNAEIQTLGRIRH 749
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
+IV+LL S+ LLVYEYM SL + LH K + L W R +IA+
Sbjct: 750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK---------KGGHLHWDTRYKIALE 800
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
AA+GLCY+HHDCSP IVHRD+KS+NILLD NF A +ADFG+AK L ++ G MS + G
Sbjct: 801 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL-QDSGTSECMSAIAG 859
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG-KEANNGDEHTCLAQWAWRHIQEGK- 924
S GYIAPEYA T KV+EK+D+YSFGV+LLEL TG K + + QW + K
Sbjct: 860 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKD 919
Query: 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982
++ LD + + E+ VF + ++C ERP MR V+QIL P P K+
Sbjct: 920 SVLKVLDPRLSS-IPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKD 976
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 547 bits (1409), Expect = e-154, Method: Compositional matrix adjust.
Identities = 379/1073 (35%), Positives = 541/1073 (50%), Gaps = 157/1073 (14%)
Query: 31 DREHAVLLKLKQHWQNPPP-ISHWATTNSSHCTWPEIACTD-GSVTELHLTNMNMNGTFP 88
+ E VLL+ K + ++ W +S+ C W IACT +VT + L MN++GT
Sbjct: 25 NEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGTLS 84
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS--------------------- 127
P IC L L L++ N+I P+ L C LE LDL
Sbjct: 85 PLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKL 144
Query: 128 ---QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIP 184
+NY G IP I LS L+ L + +NN++G IP S+ +L +LR + N F+G IP
Sbjct: 145 YLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIP 204
Query: 185 AEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALE 244
+EI ++L+ L LA N SLP +L+ L L + L GEIP ++G++ LE
Sbjct: 205 SEISGCESLKVLGLAEN--LLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLE 262
Query: 245 FLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGA 303
L L N FTGSIP + KL + ++YLY+N L+GEIP+ + +L + ID S N LTG
Sbjct: 263 VLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGF 322
Query: 304 IPNDFGKL---------ENLL---------------NLSLMFNQLSGEIPEGIGLLPSLK 339
IP +FG + EN+L L L N+L+G IP+ + LP L
Sbjct: 323 IPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLV 382
Query: 340 DVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGE 399
D++LF+N L G +PP G YS ++S N+L+G +P H C L ++ N LSG
Sbjct: 383 DLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGN 442
Query: 400 LPESLGNCSSLLMVKIYNNSFTGNIPAGL--------------WTGFNLSMVL------- 438
+P L C SL + + +N TG++P L W N+S L
Sbjct: 443 IPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLE 502
Query: 439 ---ISDNLFTGELPDKMSGNLS---------------------------RLEISNNRFSG 468
+++N FTGE+P ++ GNL+ RL++S N+FSG
Sbjct: 503 RLRLANNNFTGEIPPEI-GNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSL 528
I + L + + S+N G IP L L L L N LS ++P+++ SL
Sbjct: 562 YIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSL 621
Query: 529 -TALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLT 586
+LN+S N LSG IP+ +G L +L+ L L++N+ SG+IP IG LM L N+S+N L
Sbjct: 622 QISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLV 681
Query: 587 GEIP-SQFENRAYASSFLNNPGLCASSSNVNLKSCF-FVPRKSRK-----GSSQHVAVII 639
G +P + R +S+F N GLC S + C VP K SQ ++
Sbjct: 682 GTVPDTAVFQRMDSSNFAGNHGLCNSQRS----HCQPLVPHSDSKLNWLINGSQRQKILT 737
Query: 640 VSVIAVFLVALLSFFYMIRIYQKRKDELTSTETTSFHRLNFRDSDILPK----------- 688
++ I + V L++F + ++R+ + E + + + DS PK
Sbjct: 738 ITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQT--KPDVMDSYYFPKKGFTYQGLVDA 795
Query: 689 ---LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
+E V+G G G VY+ ++ EV+AVKK+ N R + F AE+ L IR
Sbjct: 796 TRNFSEDVVLGRGACGTVYKAEMS-GGEVIAVKKL-NSRGEGASSDNSFRAEISTLGKIR 853
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H NIVKL +N LL+YEYM K SL + L + ++ L L W R +IA+
Sbjct: 854 HRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL--------LDWNARYRIAL 905
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
GAA+GLCY+HHDC P IVHRD+KS+NILLD F A + DFG+AK++ + +MS V
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI--DLSYSKSMSAVA 963
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE-----ANNGDEHTCLAQWAWRHI 920
GS GYIAPEYA T KV EK DIYSFGV+LLEL TGK GD L W R I
Sbjct: 964 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD----LVNWVRRSI 1019
Query: 921 QEGKPIVDALDKEID--EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ P ++ D +D + + EM V K+ + CTS P RP MR V+ ++
Sbjct: 1020 RNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 543 bits (1399), Expect = e-153, Method: Compositional matrix adjust.
Identities = 365/973 (37%), Positives = 538/973 (55%), Gaps = 64/973 (6%)
Query: 42 QHWQNPPPISHWATTNSS--HCTWPEIAC-TDGSVTELHLTNMNMNGTFPPFICDLRNLT 98
Q W+ P ATT S HC W + C +G V +L L+NMN++G I +L
Sbjct: 49 QDWKRP----ENATTFSELVHCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQ 104
Query: 99 ILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGK 158
LDL N S P+ L N + L+ +D+S N F G P + + L + ++NN SG
Sbjct: 105 ALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGF 164
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKK 218
+P +G T L L+ F GS+P+ NL+NL+ L L+ N F +P +L
Sbjct: 165 LPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNN-FG-GKVPKVIGELSS 222
Query: 219 LKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS 278
L+ + + +GEIPE G + L++LDL++ N TG IPSS+ +LK L+ VYLY N L+
Sbjct: 223 LETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLT 282
Query: 279 GEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPS 337
G++P+ + + +L +DLS N +TG IP + G+L+NL L+LM NQL+G IP I LP+
Sbjct: 283 GKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPN 342
Query: 338 LKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLS 397
L+ + L+ N L G+LP G+ SPL++ +VS N L+G +P LC L + +N+ S
Sbjct: 343 LEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFS 402
Query: 398 GELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPD--KMSGN 455
G++PE + +C +L+ V+I N +G+IPAG L + ++ N TG++PD +S +
Sbjct: 403 GQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTS 462
Query: 456 LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLS 515
LS ++IS N S + + SS NL F AS+N F G IP ++ PSL+ L L N S
Sbjct: 463 LSFIDISFNHLSSLS-SSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFS 521
Query: 516 GSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-M 574
G +P I S++ L +LNL NQL GEIP+ + + +L LDLS N +G IP +G
Sbjct: 522 GGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPT 581
Query: 575 LTSLNLSSNRLTGEIPSQFENRAYAS----SFLNNPGLCASSSNVNLKSCFFVPRKSRKG 630
L LN+S N+L G IPS N +A+ + N GLC KS + K R
Sbjct: 582 LEMLNVSFNKLDGPIPS---NMLFAAIDPKDLVGNNGLCGGVLPPCSKS-LALSAKGRNP 637
Query: 631 SSQHV----------AVIIVSVIAVFLVA--------LLSFFYMIRIYQKRKDELTSTET 672
HV +IV++ +FL L S F I+ K+ E
Sbjct: 638 GRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRL 697
Query: 673 TSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPI-NHTAEVVAVKKIW------ND-- 723
+F RL F DIL + ESN+IG G G VY+ + VAVKK+W ND
Sbjct: 698 VAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIE 757
Query: 724 -RKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKN 782
++ E + L EV +L +RH NIVK+L + +E ++VYEYM +L LH K+
Sbjct: 758 DHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKD 817
Query: 783 RSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842
L RD W R +AVG QGL Y+H+DC P I+HRD+KS+NILLD N A+I
Sbjct: 818 EKFL---LRD----WLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARI 870
Query: 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902
ADFG+AK+++ + +S V GS GYIAPEY T K++EK+DIYS GV+LLEL TGK
Sbjct: 871 ADFGLAKMMLHKN---ETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKM 927
Query: 903 ANNG--DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPC--FLEEMIRVFKLGVICTSMLP 958
+ ++ + +W R +++ + + + +D I C +EEM+ ++ ++CT+ LP
Sbjct: 928 PIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLP 987
Query: 959 TERPNMRMVLQIL 971
+RP++R V+ +L
Sbjct: 988 KDRPSIRDVITML 1000
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 538 bits (1385), Expect = e-151, Method: Compositional matrix adjust.
Identities = 347/967 (35%), Positives = 539/967 (55%), Gaps = 43/967 (4%)
Query: 32 REHAVLLKLKQHWQN-PPPISHWATTN-SSHCTWPEIACTD--GSVTELHLTNMNMNGTF 87
R+ VL+ LKQ + + P + W N +S C+W ++C + S+T L L+N+N++GT
Sbjct: 33 RQANVLISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTI 92
Query: 88 PPFICDLR-NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIP-EDIDRLSRL 145
P I L +L LD+ N + P+ +Y S LE L++S N F G + ++++L
Sbjct: 93 SPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQL 152
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
L N+ +G +P S+ LT L L+L N F+G IP G+ +L+ L L+ N
Sbjct: 153 VTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGND--L 210
Query: 206 PSSLPSNFTQLKKLKKLWMASTN-LIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKL 264
+P+ + L +L++ N G IP G ++ L LDL+ + GSIP+ + L
Sbjct: 211 RGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNL 270
Query: 265 KNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
KNL ++L +N L+G +P+ + ++ +LK +DLS N L G IP + L+ L +L FN+
Sbjct: 271 KNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNR 330
Query: 324 LSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
L GEIPE + LP L+ ++L++N +G +P G L ++S N LTG +PE LC G
Sbjct: 331 LHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFG 390
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
+L + +N L G LPE LG C L ++ N T +P GL NLS++ + +N
Sbjct: 391 RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNF 450
Query: 444 FTGELPDKMSGN-----LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEL 498
TGE+P++ +GN L+++ +SNNR SG IP + + ++L + N +G IPGE+
Sbjct: 451 LTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEI 510
Query: 499 TALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558
+L SL + + +N SG P + SLT L+LS NQ+SG+IP +I + +L L++S
Sbjct: 511 GSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVS 570
Query: 559 ENQFSGKIPPQIGRLM-LTSLNLSSNRLTGEIPSQFENRAYA-SSFLNNPGLCASSSNV- 615
N F+ +P ++G + LTS + S N +G +P+ + + +SFL NP LC SSN
Sbjct: 571 WNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPC 630
Query: 616 -----NLKSCFFVPRKSR-KGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDELTS 669
+S +R +G + + + + +++ + RK+
Sbjct: 631 NGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNL 690
Query: 670 TETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK 729
+ F +L FR IL + E++VIG GG G VY+ + E VAVKK+ K
Sbjct: 691 WKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYK-GVMPNGEEVAVKKLLTITK-GSS 748
Query: 730 HEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR 789
H+ AE+Q L IRH NIV+LL S++++ LLVYEYM SL + LH K
Sbjct: 749 HDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGK-------- 800
Query: 790 ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
L W R+QIA+ AA+GLCY+HHDCSP I+HRD+KS+NILL F A +ADFG+AK
Sbjct: 801 -AGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAK 859
Query: 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA--NNGD 907
++++ G MS++ GS GYIAPEYA T +++EK+D+YSFGV+LLEL TG++ N G+
Sbjct: 860 FMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGE 919
Query: 908 EHTCLAQWAWRHIQEG---KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM 964
E + QW+ IQ + +V +D+ + L E + +F + ++C ERP M
Sbjct: 920 EGIDIVQWS--KIQTNCNRQGVVKIIDQRLSN-IPLAEAMELFFVAMLCVQEHSVERPTM 976
Query: 965 RMVLQIL 971
R V+Q++
Sbjct: 977 REVVQMI 983
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 537 bits (1383), Expect = e-151, Method: Compositional matrix adjust.
Identities = 361/995 (36%), Positives = 531/995 (53%), Gaps = 44/995 (4%)
Query: 33 EHAVLLKLKQHW---QNPPPISHWATTNSSHCTWPEIACTDG--SVTELHLTNMNMNGTF 87
E LL LK + ++ P ++ W +++ C+W + C VT L L+ +N++GT
Sbjct: 27 ELHALLSLKSSFTIDEHSPLLTSW-NLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTL 85
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDR-LSRLK 146
+ L L L L N I P + N +L +L+LS N F G P+++ L L+
Sbjct: 86 SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR 145
Query: 147 FLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSP 206
L L NN++G +P S+ LT+LR L+L N F+G IPA G LE L ++ N E +
Sbjct: 146 VLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGN-ELT- 203
Query: 207 SSLPSNFTQLKKLKKLWMASTNLI-GEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLK 265
+P L L++L++ N +P IG++ L D + TG IP + KL+
Sbjct: 204 GKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQ 263
Query: 266 NLSKVYLYSNSLSGEIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
L ++L N+ +G I Q + ++ LK +DLS N TG IP F +L+NL L+L N+L
Sbjct: 264 KLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKL 323
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
G IPE IG +P L+ ++L+ N +G++P G L ++S N LTG+LP ++C+G
Sbjct: 324 YGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGN 383
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
+L + N L G +P+SLG C SL +++ N G+IP L+ LS V + DN
Sbjct: 384 RLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYL 443
Query: 445 TGELP---DKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTAL 501
TGELP +SG+L ++ +SNN+ SG +P + + + N F+G+IP E+ L
Sbjct: 444 TGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRL 503
Query: 502 PSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQ 561
L+ L N SG + +I K LT ++LSRN+LSG+IP ++ + +L L+LS N
Sbjct: 504 QQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNH 563
Query: 562 FSGKIPPQIGRLM-LTSLNLSSNRLTGEIPS--QFENRAYASSFLNNPGLCASSSNVNLK 618
G IP I + LTS++ S N L+G +PS QF Y +SF+ N LC L
Sbjct: 564 LVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNY-TSFVGNSHLCGPY----LG 618
Query: 619 SCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKR-KDELTSTETTSFHR 677
C +S +++ + +F + + +I+ R E + T+F R
Sbjct: 619 PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQR 678
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE 737
L+F D+L L E N+IG GG+G VY+ + ++VAVK++ H+ F AE
Sbjct: 679 LDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMP-KGDLVAVKRLATMSH-GSSHDHGFNAE 736
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
+Q L IRH +IV+LL S+ LLVYEYM SL + LH K + L W
Sbjct: 737 IQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK---------KGGHLHW 787
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
R +IA+ AA+GLCY+HHDCSP IVHRD+KS+NILLD NF A +ADFG+AK L ++ G
Sbjct: 788 NTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL-QDSGT 846
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE-ANNGDEHTCLAQWA 916
MS + GS GYIAPEYA T KV+EK+D+YSFGV+LLEL TGK+ + + QW
Sbjct: 847 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWV 906
Query: 917 WRHIQEGKPIVDALDKEID---EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973
K D + K ID + E+ VF + ++C ERP MR V+QIL
Sbjct: 907 RSMTDSNK---DCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTE 963
Query: 974 NPIFPTEKNGGRKYD--HVTPLLTDSKREKMSESD 1006
P P K + D P + +S + S D
Sbjct: 964 IPKIPLSKQQAAESDVTEKAPAINESSPDSGSPPD 998
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1014 | ||||||
| 225445082 | 1021 | PREDICTED: receptor-like protein kinase | 0.995 | 0.988 | 0.619 | 0.0 | |
| 224142219 | 963 | predicted protein [Populus trichocarpa] | 0.932 | 0.982 | 0.649 | 0.0 | |
| 224142213 | 982 | predicted protein [Populus trichocarpa] | 0.945 | 0.976 | 0.640 | 0.0 | |
| 224142217 | 930 | predicted protein [Populus trichocarpa] | 0.890 | 0.970 | 0.649 | 0.0 | |
| 449485899 | 1267 | PREDICTED: receptor-like protein kinase | 0.945 | 0.756 | 0.597 | 0.0 | |
| 356495853 | 1003 | PREDICTED: receptor-like protein kinase | 0.960 | 0.971 | 0.597 | 0.0 | |
| 255550970 | 1026 | serine-threonine protein kinase, plant-t | 0.962 | 0.951 | 0.573 | 0.0 | |
| 356497583 | 1010 | PREDICTED: receptor-like protein kinase | 0.981 | 0.985 | 0.578 | 0.0 | |
| 224143344 | 1014 | predicted protein [Populus trichocarpa] | 0.951 | 0.951 | 0.572 | 0.0 | |
| 356561798 | 1009 | PREDICTED: receptor-like protein kinase | 0.961 | 0.966 | 0.578 | 0.0 |
| >gi|225445082|ref|XP_002280395.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1227 bits (3175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/1026 (61%), Positives = 769/1026 (74%), Gaps = 17/1026 (1%)
Query: 1 MSKTAPTTSLQILLSTLLLFFFG---RANSQLYDREHAVLLKLKQHWQNPPPISHWATTN 57
MSKT P S+QI TL + F NSQ D+E ++LLKLKQHW NPP I HW ++N
Sbjct: 1 MSKTPPP-SVQIHFYTLSILLFSLTFYGNSQASDQELSILLKLKQHWHNPPAIDHWTSSN 59
Query: 58 SSHCTWPEIACT-DGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLY 116
SS+CTWPEI C DGSVT + L N+N+ PPFICDL+N+T +DLQ NYI FP LY
Sbjct: 60 SSYCTWPEIECAEDGSVTGISLVNINITNEIPPFICDLKNITTIDLQLNYIPGGFPTGLY 119
Query: 117 NCSKLEYLDLSQNYFIGPIPEDIDRLS-RLKFLYLTANNMSGKIPASIGRLTELRQLNLV 175
NC+KLEYLDLSQNYF+GPIP D+DRLS RL L+L NN SG IPA+IGRL ELR L L
Sbjct: 120 NCTKLEYLDLSQNYFVGPIPADVDRLSPRLYLLFLVGNNFSGDIPAAIGRLPELRFLRLT 179
Query: 176 VNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE 235
NQFNGS P EIGNL LE L +AYN +F PS +P NFT+LK LK LWMA +NLIGEIPE
Sbjct: 180 QNQFNGSFPPEIGNLSKLEHLGMAYN-DFRPSEIPLNFTKLKNLKYLWMAQSNLIGEIPE 238
Query: 236 TIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDL 295
IG+M AL++LDLS NN +G IPSS+F LKNL+++YL N SGEI +E++NL IDL
Sbjct: 239 MIGEMTALQYLDLSSNNLSGKIPSSLFLLKNLTELYLQVNQFSGEIGPTIEAINLLRIDL 298
Query: 296 SANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD 355
S NNL+G IP DFG+L L L L NQ +GEIPE IG L +L+DVRLF+N LSG LPPD
Sbjct: 299 SKNNLSGTIPEDFGRLSKLEVLVLYSNQFTGEIPESIGNLTALRDVRLFSNNLSGILPPD 358
Query: 356 FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKI 415
FGRYS LE FEV+ N+ TG LPE+LCAGGKL G+ A DN LSGELPESLGNC +L V +
Sbjct: 359 FGRYSMLEAFEVASNSFTGRLPENLCAGGKLEGLVAFDNKLSGELPESLGNCRNLKTVMV 418
Query: 416 YNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS 475
YNNS +GN+P+GLWT N+S +++S N FTGELPD++ NLSRLEI +N F G IP GV+
Sbjct: 419 YNNSLSGNVPSGLWTLVNISRLMLSHNSFTGELPDELGWNLSRLEIRDNMFYGNIPAGVA 478
Query: 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSR 535
S KNLVVF A NN +G IP ELTALPSLTTL LD+N G LP I+SWKSL LNLSR
Sbjct: 479 SWKNLVVFDARNNQLSGPIPSELTALPSLTTLFLDRNLFDGHLPSKIVSWKSLNFLNLSR 538
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
NQ+SG IP +IG+LP L +LDLSENQ SG+IPP+IG L T LNLSSN LTG+IP++FEN
Sbjct: 539 NQISGMIPAEIGYLPDLSELDLSENQLSGEIPPEIGLLTFTFLNLSSNHLTGKIPTKFEN 598
Query: 596 RAYASSFLNNPGLCASSS--NVNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSF 653
+AY SSFLNNPGLC S+ + C RK K SS+ +A+I++ A ++AL
Sbjct: 599 KAYDSSFLNNPGLCTSNPFLGTGFQLCHSETRKKSKISSESLALILIVAAAAAVLALSFS 658
Query: 654 FYMIRIYQKRKDELTST-ETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTA 712
F + R+Y+++ T + TSF RLNF +++IL L E+NVIGSGGSGKVY VP+NH
Sbjct: 659 FIVFRVYRRKTHRFDPTWKLTSFQRLNFTEANILSSLAENNVIGSGGSGKVYCVPVNHLG 718
Query: 713 EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772
EVVAVK+IW R LD K EKEFLAEV+IL IRH NI+KLLCC+SSE+ KLLVYEYME+R
Sbjct: 719 EVVAVKRIWTHRNLDHKLEKEFLAEVEILGAIRHSNIIKLLCCVSSEDSKLLVYEYMERR 778
Query: 773 SLDQWLHKKNRSSL-SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831
SLD+WLH+K R + SG VL+W +R++IAV AQGLCYMHHDCSP IVHRD+KSSN
Sbjct: 779 SLDRWLHRKRRPMIASGLVHHFVLAWPQRLKIAVDIAQGLCYMHHDCSPPIVHRDVKSSN 838
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFG 891
ILLD FNAK+ADFG+AK+LIK GE MSTV GS GY+APE A T +V+EKTD+YSFG
Sbjct: 839 ILLDSEFNAKLADFGLAKMLIK-PGELNTMSTVAGSVGYMAPESAHTARVSEKTDVYSFG 897
Query: 892 VILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGV 951
VILLEL TG+EA++GDEHTCL +WAW+HIQEGK DALDKEI EPC+L+EM VFKLG+
Sbjct: 898 VILLELVTGREASDGDEHTCLVEWAWQHIQEGKHTADALDKEIKEPCYLDEMSSVFKLGI 957
Query: 952 ICTSMLPTERPNMRMVLQILL--NNPI-FPTEKNGGRKYDHVTPLLTDSKREKMSESDDA 1008
ICT LP+ RP+MR VL+ILL +NP+ +N GR+YD PLL D+K ++SE++ +
Sbjct: 958 ICTGTLPSTRPSMRKVLKILLQYSNPLEVYGGENTGREYD-AAPLL-DTKPARISENNGS 1015
Query: 1009 CLVSLV 1014
S V
Sbjct: 1016 NFASNV 1021
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142219|ref|XP_002324456.1| predicted protein [Populus trichocarpa] gi|222865890|gb|EEF03021.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1207 bits (3123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 618/951 (64%), Positives = 747/951 (78%), Gaps = 5/951 (0%)
Query: 24 RANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNM 83
AN QL+D+E A+LL+LKQ+WQNP + W ++SSHCTWP +AC + S+T+L L N ++
Sbjct: 16 HANPQLHDQEQAILLRLKQYWQNPSSLDRWTPSSSSHCTWPGVACANNSITQLLLDNKDI 75
Query: 84 NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLS 143
GT PPFI DL+NL +L+ N II +FP +YN SKLE LDLSQNYF+G IP+DID LS
Sbjct: 76 TGTIPPFISDLKNLKVLNFSNNSIIGKFPVAVYNFSKLEILDLSQNYFVGTIPDDIDSLS 135
Query: 144 RLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTE 203
RL +L L ANN +G IPA+IGR+ ELR L L N FNG+ PAEIGNL LE L +++N
Sbjct: 136 RLSYLNLCANNFTGNIPAAIGRIPELRTLYLHDNLFNGTFPAEIGNLSKLEELYMSHNG- 194
Query: 204 FSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK 263
F PS LPS+FTQLKKL++LW+ NLIGEIP+ IG+M+ALE LDLS N TGSIP+ +F
Sbjct: 195 FLPSKLPSSFTQLKKLRELWIFEANLIGEIPQMIGEMVALEHLDLSKNELTGSIPNGLFM 254
Query: 264 LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
LKNL ++LY N LSGEIPQ VE+LN VIDLS NNL G IP DFGKL+ L LSL FNQ
Sbjct: 255 LKNLKFLFLYKNLLSGEIPQVVEALNSIVIDLSWNNLNGTIPVDFGKLDKLSGLSLSFNQ 314
Query: 324 LSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
LSGEIPE IG LP+LKD LF+N LSG +PPD GRYS L+ F+V+ N LTG+LPE+LC G
Sbjct: 315 LSGEIPESIGRLPALKDFALFSNNLSGPIPPDLGRYSALDGFQVASNRLTGNLPEYLCHG 374
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
G L G+ A DN L GELP+SL NCSSLL V+I NN+F GNIP GLWT NL ++I+DNL
Sbjct: 375 GSLTGVVAFDNKLGGELPKSLENCSSLLTVRISNNAFFGNIPVGLWTALNLQQLMINDNL 434
Query: 444 FTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPS 503
FTGELP+++S +LSRLEISNN+FSG I +S +NLVVF ASNN F GTIP ELTALP+
Sbjct: 435 FTGELPNEVSTSLSRLEISNNKFSGSISIEGNSWRNLVVFNASNNQFTGTIPLELTALPN 494
Query: 504 LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFS 563
LT LLLD+NQL+G+LP DIISWKSLT LNLS+NQLSG+IPE+I LP L +LDLS+NQFS
Sbjct: 495 LTVLLLDKNQLTGALPSDIISWKSLTTLNLSQNQLSGQIPEEIAILPHLLELDLSDNQFS 554
Query: 564 GKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFV 623
G+IPPQ+G L LT LNLSSN L G+IP+++EN AY+SSFLNNPG+CAS ++ LK C
Sbjct: 555 GQIPPQLGLLRLTYLNLSSNHLVGKIPAEYENAAYSSSFLNNPGICASRPSLYLKVCISR 614
Query: 624 PRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDELTST-ETTSFHRLNFRD 682
P+KS K S+Q +A+I+ +I FL+ALL F +IR++ KR S + +FHRLNF +
Sbjct: 615 PQKSSKTSTQLLALILSVLITAFLLALLFAFIIIRVHWKRNHRSDSEWKFINFHRLNFTE 674
Query: 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
S+IL LTESN+IGSGGSGKVYRV N ++ VVAVK+IWN+R L++K EKEFLAEV+ILS
Sbjct: 675 SNILSGLTESNLIGSGGSGKVYRVAANGSS-VVAVKRIWNNRPLEKKLEKEFLAEVEILS 733
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS-SLSGRARDEVLSWRRRM 801
TIRHLNIVKLLCCI ++N KLLVYEY+ SLDQWLH RS S S VL W +R+
Sbjct: 734 TIRHLNIVKLLCCIVNDNSKLLVYEYLVNHSLDQWLHTARRSNSASTSVNHVVLDWPKRL 793
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
QIAVGAAQGLCY+HHDCSP IVHRD+KSSNILLD FNAKIADFG+AK+LIK+E E A +
Sbjct: 794 QIAVGAAQGLCYLHHDCSPPIVHRDVKSSNILLDSEFNAKIADFGLAKMLIKQE-ELATV 852
Query: 862 STVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921
S V GS GYIAPEYA+T +VNEKTD+YSFGV+LLELTTGK AN GDEHT LA+WA RH+Q
Sbjct: 853 SAVAGSFGYIAPEYAQTVRVNEKTDVYSFGVVLLELTTGKAANYGDEHTGLAKWALRHMQ 912
Query: 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972
EGK IVDALD EI EPC+++EM VF LGV CTS +P+ RP+M+ VLQILL
Sbjct: 913 EGKTIVDALDDEIKEPCYVDEMSNVFLLGVFCTSEVPSARPHMKEVLQILL 963
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142213|ref|XP_002324453.1| predicted protein [Populus trichocarpa] gi|222865887|gb|EEF03018.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/968 (64%), Positives = 752/968 (77%), Gaps = 9/968 (0%)
Query: 8 TSLQILLSTLLLFFFGRANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIA 67
T + +L+ L LF F ANSQ +D+ AVLL++KQHWQNP + W +NSSHCTWP +
Sbjct: 5 TPIVLLIHFLTLFLFLHANSQFHDQ--AVLLRMKQHWQNPLSLEQWTPSNSSHCTWPGVV 62
Query: 68 CTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
CTD +T+L L N N++GT PPF+ DL+NLT L+ N II +FP ++N SKLE LDLS
Sbjct: 63 CTDNYITQLILDNKNISGTIPPFLSDLKNLTFLNFSNNNIIGKFPVAVHNLSKLEILDLS 122
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI 187
QNY +G IP+DID L+RL +L L NN +G IPA+IGR+ ELR L L N F+G+ P EI
Sbjct: 123 QNYIVGTIPDDIDCLARLSYLNLCVNNFTGSIPAAIGRIPELRTLYLHDNLFDGTFPPEI 182
Query: 188 GNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLD 247
GNL LE L +A+N FSPS L S+FTQLKKLK LW++ NLIGEIP+ IG+M+ALE LD
Sbjct: 183 GNLSKLEELYMAHNG-FSPSRLHSSFTQLKKLKMLWISGANLIGEIPQMIGEMVALEHLD 241
Query: 248 LSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPND 307
LS N TG+IP S+F L NL ++LY N LSGEIP+AVE+LNL +DLS NNLTG IP D
Sbjct: 242 LSSNKLTGNIPGSLFMLMNLRVLWLYKNKLSGEIPRAVEALNLTSVDLSENNLTGTIPVD 301
Query: 308 FGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEV 367
FGKL+ L LSL NQLSGEIPEGIG LP+LKD +LF+N LSG++PPD GRYS LE FEV
Sbjct: 302 FGKLDKLSGLSLFSNQLSGEIPEGIGRLPALKDFKLFSNNLSGSIPPDLGRYSALERFEV 361
Query: 368 SVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAG 427
N LTG+LPE+LC GG L G+ A DN L GELP+SL NCSSL++V I NN+F GNIP G
Sbjct: 362 CSNRLTGNLPEYLCHGGSLRGVVAFDNKLGGELPKSLENCSSLVIVSISNNAFFGNIPVG 421
Query: 428 LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASN 487
LWT NL +++ISDNLFTGELP+++S +LSRLEISNN+FSG I SS +NLVVF ASN
Sbjct: 422 LWTALNLQLLMISDNLFTGELPNEVSTSLSRLEISNNKFSGSISIQGSSWRNLVVFNASN 481
Query: 488 NLFNGTIPGEL-TALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI 546
N F GTIP EL TALP+LT LLLD+N L+G+LP +IISWKSL LNLS+NQLSG+IPEK
Sbjct: 482 NQFTGTIPLELITALPNLTVLLLDKNHLTGALPPNIISWKSLNILNLSQNQLSGQIPEKF 541
Query: 547 GFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNP 606
GFL L LDLS+NQFSGKIPPQ+G L L LNLSSN LTG+IP++ EN AYA+SFLNNP
Sbjct: 542 GFLTNLVKLDLSDNQFSGKIPPQLGSLRLVFLNLSSNNLTGQIPTENENVAYATSFLNNP 601
Query: 607 GLCASSSNVNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDE 666
GLC SS + LK C P KS K S+Q +A+I+ ++ FL+ALL F IR++ KR
Sbjct: 602 GLCTRSS-LYLKVCNSRPHKSSKTSTQFLALILSTLFGAFLLALLFAFITIRVHWKRNHR 660
Query: 667 LTST-ETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK 725
L S + +FH+LNF +S+I+ L ESN+IGSGGSGKVYRV N + VAVK+I N+R
Sbjct: 661 LDSEWKFINFHKLNFTESNIVSGLKESNLIGSGGSGKVYRVVANGFGD-VAVKRISNNRN 719
Query: 726 LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSS 785
DQK EKEFLAE++IL TIRHLNIVKLLCCIS++N KLLVYEYMEKR LDQWLH + ++
Sbjct: 720 SDQKFEKEFLAEIEILGTIRHLNIVKLLCCISNDNSKLLVYEYMEKRGLDQWLHSERKAK 779
Query: 786 LSGRARDEV-LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
+ + + V + W +R+QIAVGAAQGLCYMHHDCSP IVHRD+KSSNILLD FNAKIAD
Sbjct: 780 GASASVNHVAVDWSKRLQIAVGAAQGLCYMHHDCSPPIVHRDVKSSNILLDSEFNAKIAD 839
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEAN 904
FG+A++L++ +GE A +S V GS GYIAPEYART +VNEK D+YSFGV+LLELTTGK AN
Sbjct: 840 FGLARMLVR-QGELATVSAVAGSLGYIAPEYARTVRVNEKIDVYSFGVVLLELTTGKAAN 898
Query: 905 NGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM 964
GDE TCLA+WAWRH+QEGKPIVD LD+EI EPC+++EM VFKLGV CTSMLP+ERPNM
Sbjct: 899 YGDEDTCLAEWAWRHMQEGKPIVDVLDEEIKEPCYVDEMRDVFKLGVFCTSMLPSERPNM 958
Query: 965 RMVLQILL 972
+ V+QILL
Sbjct: 959 KDVVQILL 966
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142217|ref|XP_002324455.1| predicted protein [Populus trichocarpa] gi|222865889|gb|EEF03020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1169 bits (3023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/908 (64%), Positives = 712/908 (78%), Gaps = 5/908 (0%)
Query: 67 ACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDL 126
CTD +T+L L N N++GT PPF+ DL+NLT L+ N II +FP + N SKLE LDL
Sbjct: 10 VCTDNYITQLILDNKNISGTIPPFLSDLKNLTFLNFSNNNIIGKFPVAVPNLSKLEILDL 69
Query: 127 SQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAE 186
SQNY +G IP+DID L+RL +L L ANN SG IPA+IG L ELR L L NQFNG+ P E
Sbjct: 70 SQNYIVGTIPDDIDCLARLSYLNLYANNFSGNIPAAIGLLPELRTLRLYDNQFNGTFPPE 129
Query: 187 IGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFL 246
IGNL LE L +A+N FSPS L S+FTQLKKLK LW++ NLIGEIP+ IG+M+ALE L
Sbjct: 130 IGNLSKLEELSMAHNG-FSPSRLHSSFTQLKKLKMLWISGANLIGEIPQMIGEMVALEHL 188
Query: 247 DLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPN 306
DLS N TG+IP S+F L NL +YL+ N LS EIP+ VE+LNL +DLS NNLTG IP
Sbjct: 189 DLSSNKLTGNIPGSLFMLLNLRVLYLHKNKLSEEIPRVVEALNLTSVDLSVNNLTGTIPF 248
Query: 307 DFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFE 366
DFGKL+ L LSL NQLSGEIPEGIG LP+LKD +LF+N LSG++PPD GRYS LE FE
Sbjct: 249 DFGKLDKLSGLSLFSNQLSGEIPEGIGRLPALKDFKLFSNNLSGSIPPDLGRYSALERFE 308
Query: 367 VSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPA 426
V N LTG+LPE+LC GG L G+ A DN L GELP+SL NCSSLL+V++ NN+F GNIP
Sbjct: 309 VCSNRLTGNLPEYLCHGGSLRGVVAFDNKLGGELPKSLENCSSLLVVRMSNNAFFGNIPV 368
Query: 427 GLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQAS 486
GLWT NL ++ISDNLFTGELP+++S +LSRLEISNN+FSG + SS +NLVVF AS
Sbjct: 369 GLWTALNLQQLMISDNLFTGELPNEVSTSLSRLEISNNKFSGSVSIEGSSWRNLVVFNAS 428
Query: 487 NNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI 546
NN F GTIP ELTALP+LT LLLD+NQL+G+LP +IISWKSL LNLS+N LSG+IPEK
Sbjct: 429 NNQFTGTIPLELTALPNLTVLLLDKNQLTGALPPNIISWKSLNILNLSQNHLSGQIPEKF 488
Query: 547 GFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNP 606
GFL L LDLS+NQFSGKIPPQ+G L L LNLSSN L G+IP+++E+ AYA+SFLNNP
Sbjct: 489 GFLTDLVKLDLSDNQFSGKIPPQLGSLRLVFLNLSSNNLMGKIPTEYEDVAYATSFLNNP 548
Query: 607 GLCASSSNVNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDE 666
GLC S++ LK C P+KS K S+Q +A+I+ ++ A FL+A+L F MIR+++KR
Sbjct: 549 GLCTRRSSLYLKVCNSRPQKSSKTSTQFLALILSTLFAAFLLAMLFAFIMIRVHRKRNHR 608
Query: 667 LTST-ETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK 725
L S + +FH+LNF +S+I+ L ESN+IGSGGSGKVYRV N + VAVK+I N+R
Sbjct: 609 LDSEWKFINFHKLNFTESNIVSGLKESNLIGSGGSGKVYRVAANGFGD-VAVKRISNNRN 667
Query: 726 LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS- 784
DQK EKEFLAE++IL TIRHLNIVKLLCCIS++N KLLVYEYMEKRSLDQWLH + ++
Sbjct: 668 SDQKLEKEFLAEIEILGTIRHLNIVKLLCCISNDNSKLLVYEYMEKRSLDQWLHSERKAK 727
Query: 785 SLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
S S L W +R+QIAVGAAQGLCYMHHDCSP IVHRD+KSSNILLD FNAKIAD
Sbjct: 728 SASASVNHVALDWSKRLQIAVGAAQGLCYMHHDCSPPIVHRDVKSSNILLDSEFNAKIAD 787
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEAN 904
FG+A++L+K +GE A +S V GS GYIAPEYA+T +VNEK D+YSFGV+LLELTTGK AN
Sbjct: 788 FGLARMLVK-QGELATVSAVAGSLGYIAPEYAQTVRVNEKIDVYSFGVVLLELTTGKAAN 846
Query: 905 NGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM 964
GDE TCLA+WAWRH+QEGKPIVD LD+E+ EPC+++EM VFKLGV CTSMLP+ERPNM
Sbjct: 847 YGDEDTCLAKWAWRHMQEGKPIVDVLDEEVKEPCYVDEMRDVFKLGVFCTSMLPSERPNM 906
Query: 965 RMVLQILL 972
+ V+QILL
Sbjct: 907 KEVVQILL 914
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485899|ref|XP_004157305.1| PREDICTED: receptor-like protein kinase 5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1142 bits (2954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/968 (59%), Positives = 726/968 (75%), Gaps = 9/968 (0%)
Query: 25 ANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMN 84
A S LY +EH+VLL+L Q W+N PI+HW ++N SHC+WPE+ CT+ SVT L + N+N
Sbjct: 300 ALSNLYQQEHSVLLRLNQFWKNQAPITHWLSSNVSHCSWPEVQCTNNSVTALFFPSYNLN 359
Query: 85 GTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSR 144
GT P FI DL+NLT L+ Q NY FP LY C L YLDLSQN GPIP+D+DRLSR
Sbjct: 360 GTIPSFISDLKNLTYLNFQVNYFTGGFPTTLYTCLNLNYLDLSQNLLTGPIPDDVDRLSR 419
Query: 145 LKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEF 204
L+FL L NN SG+IP SI RL+ELR L+L VNQFNG+ P+EIGNL NLE L LAYN++
Sbjct: 420 LQFLSLGGNNFSGEIPVSISRLSELRFLHLYVNQFNGTYPSEIGNLLNLEELLLAYNSKL 479
Query: 205 SPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKL 264
P+ LPS+F QL KL LWM+ +N+IGEIPE IG++ AL LDLS NN G IP+S+F L
Sbjct: 480 EPAELPSSFAQLSKLTYLWMSGSNVIGEIPEWIGNLTALVQLDLSRNNLIGKIPNSLFTL 539
Query: 265 KNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
KNLS VYL+ N LSGEIPQ ++S + DLS NNLTG IP G L+NL L L N+L
Sbjct: 540 KNLSFVYLFKNKLSGEIPQRIDSKAITEYDLSENNLTGRIPAAIGDLQNLTALLLFTNRL 599
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
GEIPE IG LP L DVRLF+N L+G +PPDFGR L F+V+ N LTGSLPEHLC+GG
Sbjct: 600 HGEIPESIGRLPLLTDVRLFDNNLNGTIPPDFGRNLILRGFQVNSNKLTGSLPEHLCSGG 659
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
+L G+ A NNLSGELP+SLGNC SL++V ++ N+ +G IPAGLWT NL+ ++S+N F
Sbjct: 660 QLLGLIAYQNNLSGELPKSLGNCDSLVIVDVHENNISGEIPAGLWTALNLTYAVMSNNSF 719
Query: 445 TGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSL 504
TG+ P +S NL+RLEISNN+ SG+IP+ +SS NL F+ASNNL G IP ELTAL L
Sbjct: 720 TGDFPQTVSKNLARLEISNNKISGEIPSELSSFWNLTEFEASNNLLTGNIPEELTALSKL 779
Query: 505 TTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
LLLD+NQ++G LP IISWKSL L L+RN+LSGEIP++ G+LP L DLDLSENQ SG
Sbjct: 780 NNLLLDENQINGELPKKIISWKSLQRLKLNRNRLSGEIPDEFGYLPNLNDLDLSENQLSG 839
Query: 565 KIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVP 624
IP +G+L L L+LSSN L+G IPS FEN +A SFLNNP LC++++ +NL C
Sbjct: 840 SIPLSLGKLSLNFLDLSSNFLSGVIPSAFENSIFARSFLNNPNLCSNNAVLNLDGCSLRT 899
Query: 625 RKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQK---RKDELTSTETTSFHRLNFR 681
+ SRK SSQH+A+I+ + V ++ ++S ++I+IY++ R D + TSF RLNF
Sbjct: 900 QNSRKISSQHLALIVSLGVIVVILFVVSALFIIKIYRRNGYRAD--VEWKLTSFQRLNFS 957
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL 741
++++L L+E+NVIGSGGSGKVYR+P+N E VAVKKIWN+RK D K EK+F+AEV+IL
Sbjct: 958 EANLLSGLSENNVIGSGGSGKVYRIPVNSLGETVAVKKIWNNRKSDHKLEKQFMAEVKIL 1017
Query: 742 STIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKN---RSSLSGRARDEVLSWR 798
S+IRH NI+KLLCC+S + KLLVYEYMEK+SLD+WLHKKN R + S L+W
Sbjct: 1018 SSIRHNNIIKLLCCVSCDTSKLLVYEYMEKQSLDKWLHKKNSPPRITGSEPISGVALNWP 1077
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
R QIAVGAAQGLCYMHHDCSP ++HRDLKSSNILLD +FNAKIADFG+AK+LIK +GE
Sbjct: 1078 TRFQIAVGAAQGLCYMHHDCSPPVIHRDLKSSNILLDSDFNAKIADFGLAKLLIK-QGEP 1136
Query: 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918
A++S V GS GYIAPEYA+T ++NEK D++SFGVILLEL TGKEA +GD + LA+WAW
Sbjct: 1137 ASVSAVAGSFGYIAPEYAQTPRINEKIDVFSFGVILLELATGKEALDGDADSSLAEWAWE 1196
Query: 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978
+I++GKPIVDALD+++ EP +L+EM VFKLGVICTS LPT RPNM LQIL+ +
Sbjct: 1197 YIKKGKPIVDALDEDVKEPQYLDEMCSVFKLGVICTSGLPTHRPNMNQALQILIGSRTSA 1256
Query: 979 TEKNGGRK 986
+ +G +K
Sbjct: 1257 PQNHGDKK 1264
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495853|ref|XP_003516786.1| PREDICTED: receptor-like protein kinase HSL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1140 bits (2950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/996 (59%), Positives = 743/996 (74%), Gaps = 22/996 (2%)
Query: 25 ANSQ-----LYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLT 79
ANSQ LYD+EHAVLL++KQH QNPP ++HW +NSSHCTWPEI+CT+GSVT L +
Sbjct: 16 ANSQSQYSLLYDQEHAVLLRIKQHLQNPPFLNHWTPSNSSHCTWPEISCTNGSVTSLTMI 75
Query: 80 NMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI 139
N N+ T PPF+CDL NLT +D Q+N+I +FP+ LYNCSKLEYLDLSQNYF+G IP+DI
Sbjct: 76 NTNITQTLPPFLCDLTNLTHVDFQWNFIPGEFPKYLYNCSKLEYLDLSQNYFVGKIPDDI 135
Query: 140 DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELA 199
D L+ L FL L NN SG IPASIGRL ELR L L NG+ PAEIGNL NLE+L +
Sbjct: 136 DHLASLSFLSLGGNNFSGDIPASIGRLKELRSLQLYQCLLNGTFPAEIGNLSNLESLYVF 195
Query: 200 YNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPS 259
N P+ LPS+ TQL KLK M ++L+GEIPE IG M+ALE LDLS N+ +G IP+
Sbjct: 196 SNHMLPPTKLPSSLTQLNKLKVFHMYESSLVGEIPEAIGHMVALEELDLSKNDLSGQIPN 255
Query: 260 SVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSL 319
+F LKNLS +YLY NSLSGEIP VE+ +L +DLS N L+G IP+D G+L NL L+L
Sbjct: 256 DLFMLKNLSILYLYRNSLSGEIPGVVEAFHLTDLDLSENKLSGKIPDDLGRLNNLKYLNL 315
Query: 320 MFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEH 379
NQLSG++PE I L +L D +F N LSG LP DFG +S LE F+V+ N+ TG LPE+
Sbjct: 316 YSNQLSGKVPESIARLRALTDFVVFINNLSGTLPLDFGLFSKLETFQVASNSFTGRLPEN 375
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLI 439
LC G L G+ A DNNLSGELPESLG+CSSL ++++ NN+ +GNIP+GLWT NL+ ++I
Sbjct: 376 LCYHGSLVGLTAYDNNLSGELPESLGSCSSLQILRVENNNLSGNIPSGLWTSMNLTKIMI 435
Query: 440 SDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELT 499
++N FTG+LP++ NLS L IS N+FSG+IP GVSS KN+V+F ASNNLFNG+IP ELT
Sbjct: 436 NENKFTGQLPERFHCNLSVLSISYNQFSGRIPLGVSSLKNVVIFNASNNLFNGSIPLELT 495
Query: 500 ALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSE 559
+LP LTTLLLD NQL+G LP DIISWKSL L+L NQLSG IP+ I LP L LDLSE
Sbjct: 496 SLPRLTTLLLDHNQLTGPLPSDIISWKSLITLDLCHNQLSGVIPDAIAQLPGLNILDLSE 555
Query: 560 NQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKS 619
N+ SG+IP Q+ LT+LNLSSN LTG IPS+ EN AYA+SFLNN GLCA S +NL
Sbjct: 556 NKISGQIPLQLALKRLTNLNLSSNLLTGRIPSELENLAYATSFLNNSGLCADSKVLNLTL 615
Query: 620 CFFVPRKSR--KGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDELT-STETTSFH 676
C P+++R + S+ H A+II V+A L+ALLS F MIR+Y+KRK EL S + TSF
Sbjct: 616 CNSRPQRARIERRSASH-AIIISLVVAASLLALLSSFLMIRVYRKRKQELKRSWKLTSFQ 674
Query: 677 RLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA 736
RL+F +I+ ++E N+IGSGG G VYRV ++ VAVKKIW+ R L++K FLA
Sbjct: 675 RLSFTKKNIVSSMSEHNIIGSGGYGAVYRVAVD-DLNYVAVKKIWSSRMLEEKLVSSFLA 733
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNR-SSLSGRARDEVL 795
EV+ILS IRH NIVKLLCCIS E+ LLVYEY+E SLD+WL KK++ +++SG VL
Sbjct: 734 EVEILSNIRHNNIVKLLCCISKEDSLLLVYEYLENHSLDRWLQKKSKPAAVSG----SVL 789
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
W +R+ IA+GAAQGLCYMHHDC P +VHRD+K+SNILLD FNAK+ADFG+AK+L+K E
Sbjct: 790 DWPKRLHIAIGAAQGLCYMHHDCLPPVVHRDVKTSNILLDSQFNAKVADFGLAKMLMKPE 849
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915
E A MS V G+ GYIAPEYA+T +VNEK D+YSFGV+LLELTTGKEAN GDE++CLA+W
Sbjct: 850 -ELATMSAVAGTFGYIAPEYAQTTRVNEKIDVYSFGVVLLELTTGKEANRGDEYSCLAEW 908
Query: 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL--N 973
AWRHIQ G + D LD+EI E C++EE+ +F+LGV+CT+ LP RP+M+ VL+ILL +
Sbjct: 909 AWRHIQIGTDVEDILDEEIKEACYMEEICNIFRLGVMCTATLPASRPSMKEVLKILLTCS 968
Query: 974 NPIFPTEKNGGRKYDHVTPLLTDSKREKMSE--SDD 1007
N + EKN G YD + PLL +SK E E +DD
Sbjct: 969 NLLTNGEKNAGF-YDSI-PLLKNSKWENQVEYYTDD 1002
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550970|ref|XP_002516533.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223544353|gb|EEF45874.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1122 bits (2903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 569/993 (57%), Positives = 728/993 (73%), Gaps = 17/993 (1%)
Query: 32 REHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTD-GSVTELHLTNMNMNGTFPPF 90
+E ++LL +KQ NPP + W TT++S CTWPEI+C+D GSVT L L + N+ P
Sbjct: 35 QEQSILLNIKQQLGNPPSLQSW-TTSTSPCTWPEISCSDDGSVTALGLRDKNITVAIPAR 93
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
ICDL+NLT+LDL +NYI FP LYNCS LE LDLSQNYF+G +P+DIDRLS LK + L
Sbjct: 94 ICDLKNLTVLDLAYNYIPGGFPTFLYNCSSLERLDLSQNYFVGTVPDDIDRLSNLKSIDL 153
Query: 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLP 210
+ANN SG IP +IG L EL+ L L N+FNG+ P EIGNL NLE L LA+N F PS +P
Sbjct: 154 SANNFSGDIPPAIGNLRELQTLFLHQNEFNGTFPKEIGNLANLEQLRLAFNG-FVPSRIP 212
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKV 270
F L KL LW+ NLIG IPE++ ++ +LE LDLSIN GSIP +F LKNL+ +
Sbjct: 213 VEFGNLTKLTFLWIRDANLIGSIPESLANLSSLETLDLSINKLEGSIPDGLFLLKNLTYL 272
Query: 271 YLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPE 330
YL+ N LSG++P+ VE+LNL +DL NNL G+I DFGKL+NL L L NQLSGE+P+
Sbjct: 273 YLFHNQLSGDMPKKVEALNLVEVDLGINNLIGSISEDFGKLKNLERLHLYSNQLSGELPQ 332
Query: 331 GIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIA 390
IGLLP+LK R+F N LSG LP + G +S L+YFEVS N+ +G LPE+LCAGG L G+
Sbjct: 333 TIGLLPALKSFRVFTNNLSGVLPTEIGLHSKLQYFEVSTNHFSGKLPENLCAGGVLEGVV 392
Query: 391 AQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPD 450
A NNL+GE+P+SLG C+SL V++YNN F+G IP+G+WT N++ +++S+N F+G+LP
Sbjct: 393 AFSNNLTGEVPQSLGKCNSLKTVQLYNNRFSGEIPSGIWTVINMTYLMLSNNSFSGKLPS 452
Query: 451 KMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLD 510
++ NLSRLE+SNN+FSG IPTG+SS NLVVF+ASNNL +G IP E+T+L L TLLLD
Sbjct: 453 SLAWNLSRLELSNNKFSGPIPTGISSWVNLVVFEASNNLLSGEIPVEVTSLSHLNTLLLD 512
Query: 511 QNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQI 570
NQL G LP IISWK+L LNLSRN LSG+IP IG LP L LDLS+N SG+IP +
Sbjct: 513 GNQLLGQLPSKIISWKTLNTLNLSRNALSGQIPAAIGSLPDLLYLDLSQNHLSGQIPSEF 572
Query: 571 GRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRKG 630
G+L L SLNLSSN+ +G+IP +F+N AY +SFLNN LCA + ++L +C+ R S K
Sbjct: 573 GQLNLISLNLSSNQFSGQIPDKFDNLAYENSFLNNSNLCAVNPILDLPNCYTRSRNSDKL 632
Query: 631 SSQHVAVIIVSVIAVFLVALLSFFYMIRIY--QKRKDELTSTETTSFHRLNFRDSDILPK 688
SS+ +A+I++ + F++ ++ + +R Y +K K EL + + TSF R++F ++IL
Sbjct: 633 SSKFLAMILIFTVTAFIITIVLTLFAVRDYLRKKHKRELAAWKLTSFQRVDFTQANILAS 692
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
LTESN+IGSGGSGKVYRV +N E+VAVK+IW +R+ D+K EKEFLAEV+IL IRH N
Sbjct: 693 LTESNLIGSGGSGKVYRVAVNRAGELVAVKRIWTNRQFDEKLEKEFLAEVEILGAIRHSN 752
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNR-SSLSG--RARDEVLSWRRRMQIAV 805
IVKLLCCISSE KLLVYEYME +SLD+WLH K R SSL+G +D VL+W RR+QIAV
Sbjct: 753 IVKLLCCISSEESKLLVYEYMENQSLDRWLHGKKRNSSLAGTNSVQDIVLNWPRRLQIAV 812
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
GAAQGLCYMHHDCSP I+HRD+KSSNILLD F A+IADFG+AKIL+K EGE MS V
Sbjct: 813 GAAQGLCYMHHDCSPPIIHRDVKSSNILLDSEFKARIADFGLAKILVK-EGEARTMSAVA 871
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925
GS GYIAPEYA T KVNEK D+YSFGV+LLEL TG+E NNGDE++ LA+WAWR EG P
Sbjct: 872 GSFGYIAPEYAYTIKVNEKIDVYSFGVVLLELVTGREPNNGDENSSLAEWAWRQNAEGTP 931
Query: 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGR 985
I+D D+EI +PC+LEEM VF LG+ CTS +P +RP+M+ VLQ+L ++N G
Sbjct: 932 IIDCFDEEIRQPCYLEEMTAVFNLGLFCTSNMPNQRPSMKDVLQVLRRYSPTSYKENMGS 991
Query: 986 KYDHVTPLLTDS-------KREKMSESDDACLV 1011
++D V PLL + +++S+ D LV
Sbjct: 992 EFD-VAPLLASATYLSSYKHSKRVSDEYDCSLV 1023
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497583|ref|XP_003517639.1| PREDICTED: receptor-like protein kinase HSL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/1009 (57%), Positives = 746/1009 (73%), Gaps = 14/1009 (1%)
Query: 7 TTSLQILLSTLLLFF--FGRANSQ--LYDREHAVLLKLKQHWQNPPPISHWATTNSSHCT 62
++ L+ L +L++ F F ANSQ L+D+E A LLK+K++ +NP +SHW ++SSHC+
Sbjct: 6 SSCLKFLFHSLVILFVLFNHANSQSQLHDQERATLLKIKEYLENPEFLSHWTPSSSSHCS 65
Query: 63 WPEIACT-DGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKL 121
WPEI CT DGSVT L L+N ++ T P FICDL+NLT++D NYI +FP LYNCSKL
Sbjct: 66 WPEIKCTSDGSVTGLTLSNSSITQTIPSFICDLKNLTVVDFYNNYIPGEFPTTLYNCSKL 125
Query: 122 EYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNG 181
EYLDLSQN F+G IP DIDRLS L++L L N SG IPASIGRL ELR L + NG
Sbjct: 126 EYLDLSQNNFVGSIPHDIDRLSNLQYLSLGYTNFSGDIPASIGRLKELRNLQFQNSLLNG 185
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML 241
+ PAEIGNL NL+ L+L+ N PS L ++T+L KLK +M +NL+GEIPETI +M+
Sbjct: 186 TFPAEIGNLSNLDTLDLSSNNMLPPSRLHDDWTRLNKLKFFFMFQSNLVGEIPETIVNMV 245
Query: 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT 301
ALE LDLS NN +G IP +F L+NLS ++L N+LSGEIP VE+LNL +IDL+ N ++
Sbjct: 246 ALERLDLSQNNLSGPIPGGLFMLENLSIMFLSRNNLSGEIPDVVEALNLTIIDLTRNFIS 305
Query: 302 GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
G IP+ FGKL+ L L+L N L GEIP IGLLPSL D ++F N LSG LPPDFGRYS
Sbjct: 306 GKIPDGFGKLQKLTGLALSINNLEGEIPASIGLLPSLVDFKVFFNNLSGILPPDFGRYSK 365
Query: 362 LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT 421
LE F V+ N+ +G LPE+LC G L I+ +N LSGELP+SLGNCSSL+ +KIY+N F+
Sbjct: 366 LETFLVANNSFSGKLPENLCYNGHLLNISVYENYLSGELPQSLGNCSSLMELKIYSNEFS 425
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLV 481
G+IP+GLWT NLS ++S N FTGELP+++S ++SRLEI N+FSG+IPTGVSS N+V
Sbjct: 426 GSIPSGLWT-LNLSNFMVSHNKFTGELPERLSSSISRLEIDYNQFSGRIPTGVSSWTNVV 484
Query: 482 VFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGE 541
VF+AS N NG+IP ELTALP L LLLDQNQL+GSLP DIISW+SL LNLS+NQLSG
Sbjct: 485 VFKASENYLNGSIPKELTALPKLNILLLDQNQLTGSLPSDIISWQSLVTLNLSQNQLSGH 544
Query: 542 IPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASS 601
IP+ IG LPVL LDLSENQ SG +P + R LT+LNLSSN LTG +PS+F+N AY +S
Sbjct: 545 IPDSIGLLPVLTILDLSENQLSGDVPSILPR--LTNLNLSSNYLTGRVPSEFDNPAYDTS 602
Query: 602 FLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQ 661
FL+N GLCA + ++L+ C P+ K SS A+II V L+ALL+ +IR Y+
Sbjct: 603 FLDNSGLCADTPALSLRLCNSSPQSQSKDSSWSPALIISLVAVACLLALLTSLLIIRFYR 662
Query: 662 KRKDELT-STETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
KRK L S + SF RL+F +S+I+ LTE+N+IGSGG G VYRV ++ +AVKKI
Sbjct: 663 KRKQVLDRSWKLISFQRLSFTESNIVSSLTENNIIGSGGYGAVYRVAVDGLG-YIAVKKI 721
Query: 721 WNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHK 780
W ++KLD+ E F EV+ILS IRH NIVKL+CCIS+E+ LLVYEY+E RSLD+WLH+
Sbjct: 722 WENKKLDKNLESSFHTEVKILSNIRHRNIVKLMCCISNEDSMLLVYEYVENRSLDRWLHR 781
Query: 781 KNRSS-LSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839
KN+SS +SG VL W +R+ IA+GAAQGL YMHHDCSP IVHRD+K+SNILLD FN
Sbjct: 782 KNKSSAVSGSVHHVVLDWPKRLHIAIGAAQGLSYMHHDCSPPIVHRDVKTSNILLDSQFN 841
Query: 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
AK+ADFG+A++L+K GE A MS+V+GS GYIAPEYA+T +V+EK D++SFGVILLELTT
Sbjct: 842 AKVADFGLARMLMK-PGELATMSSVIGSFGYIAPEYAKTTRVSEKIDVFSFGVILLELTT 900
Query: 900 GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPT 959
GKEAN GDEH+ LA+WAWRH Q G I + LDK++ E +L+ M +VFKLG++C++ LP+
Sbjct: 901 GKEANYGDEHSSLAEWAWRHQQLGSNIEELLDKDVMETSYLDGMCKVFKLGIMCSATLPS 960
Query: 960 ERPNMRMVLQILLN-NPIFPTEKNGGRKYDHVTPLLTDSKREKMSESDD 1007
RP+M+ VLQILL+ F ++ YD V PLL +SKRE + D+
Sbjct: 961 SRPSMKEVLQILLSCEDSFSKGESIIGHYDDV-PLLKNSKREHKLDIDN 1008
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143344|ref|XP_002336031.1| predicted protein [Populus trichocarpa] gi|222838987|gb|EEE77338.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1110 bits (2872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/979 (57%), Positives = 716/979 (73%), Gaps = 14/979 (1%)
Query: 24 RANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACT-DGSVTELHLTNMN 82
R SQ + E +LLKL+Q NP I W T+SS C W + C DGSV+ELHL + N
Sbjct: 26 RVISQDANTEKTILLKLRQQLGNPSSIQSW-NTSSSPCNWTGVTCGGDGSVSELHLGDKN 84
Query: 83 MNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRL 142
+ T P +CDL+NLT LD+ FNYI FP+VLY+C+KL++LDLSQN+F+GPIP+DID+L
Sbjct: 85 ITETIPATVCDLKNLTFLDMNFNYIPGGFPKVLYSCTKLQHLDLSQNFFVGPIPDDIDKL 144
Query: 143 SRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNT 202
S L+++ L NN +G IP IG LTEL+ L+L NQFNG+ P EI L NLE L LA+N
Sbjct: 145 SGLRYINLGGNNFTGNIPPQIGNLTELQTLHLFQNQFNGTFPKEISKLSNLEVLGLAFN- 203
Query: 203 EFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVF 262
EF PSS+P F QLKKL LWM +NLIGEIPE++ ++ +LE LDL+IN G IP +F
Sbjct: 204 EFVPSSIPVEFGQLKKLWFLWMRQSNLIGEIPESLTNLSSLEHLDLAINALEGKIPDGLF 263
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322
LKNL+ +YL+ N+LSGEIPQ VE+LNL IDL+ N L G+IP DFGKL+ L LSL+ N
Sbjct: 264 SLKNLTNLYLFQNNLSGEIPQRVETLNLVEIDLAMNQLNGSIPKDFGKLKKLQFLSLLDN 323
Query: 323 QLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCA 382
LSGE+P IGLLP+L ++F+N LSGALPP G S L F+V+ N +G LPE+LCA
Sbjct: 324 HLSGEVPPSIGLLPALTTFKVFSNNLSGALPPKMGLSSKLVEFDVAANQFSGQLPENLCA 383
Query: 383 GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442
GG L G A +NNLSG +P+SLGNC+SL +++Y+NSF+G IPAG+WT N++ +++SDN
Sbjct: 384 GGVLLGAVAFENNLSGRVPQSLGNCNSLHTIQLYSNSFSGEIPAGVWTASNMTYLMLSDN 443
Query: 443 LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALP 502
F+G LP K++ NLSRLE+ NNRFSG IP G+SS NLV F+ASNNL +G IP E+T+LP
Sbjct: 444 SFSGGLPSKLAWNLSRLELGNNRFSGPIPPGISSWVNLVDFKASNNLLSGEIPVEITSLP 503
Query: 503 SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
L+ LLLD N SG LP IISWKSLT+LNLSRN LSG+IP++IG LP L LDLS+N F
Sbjct: 504 HLSNLLLDGNLFSGQLPSQIISWKSLTSLNLSRNALSGQIPKEIGSLPDLLYLDLSQNHF 563
Query: 563 SGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFF 622
SG+IP + +L L SLNLSSN L+G+IP QF+N AY +SFLNN LCA + +N +C+
Sbjct: 564 SGEIPLEFDQLKLVSLNLSSNHLSGKIPDQFDNHAYDNSFLNNSNLCAVNPILNFPNCYA 623
Query: 623 VPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKR--KDELTSTETTSFHRLNF 680
R S+K S+ +A+I+ + +FLV + +M+R YQ++ K +L + + TSF RL+F
Sbjct: 624 KLRDSKKMPSKTLALILALTVTIFLVTTIVTLFMVRDYQRKKAKRDLAAWKLTSFQRLDF 683
Query: 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
++++L LTE+N+IGSGGSGKVYRV IN + VAVK+IWN+ K+D EKEFLAEVQI
Sbjct: 684 TEANVLASLTENNLIGSGGSGKVYRVAINRAGDYVAVKRIWNNEKMDHNLEKEFLAEVQI 743
Query: 741 LSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRA--RDEVLSWR 798
L TIRH NIVKLLCCISSE+ KLLVYE+ME +SLD+WLH + RSS G + + VL W
Sbjct: 744 LGTIRHANIVKLLCCISSESSKLLVYEFMENQSLDRWLHGRKRSSSMGTSSVHNSVLDWP 803
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
R QIA+GAA+GL YMHHDCS I+HRD+KSSNILLD A+IADFG+A+IL K +GE
Sbjct: 804 TRFQIAIGAARGLSYMHHDCSTPIIHRDVKSSNILLDSELKARIADFGLARILAK-QGEV 862
Query: 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918
MS V GS GY+APEYA T +VNEK D+YSFGV+LLEL TG+E N+GDEHT LA+WAW+
Sbjct: 863 HTMSVVAGSFGYMAPEYAYTTRVNEKIDVYSFGVVLLELATGREPNSGDEHTSLAEWAWQ 922
Query: 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978
+GKP+VD LD+EI EPCFL+EM VF LG+ICT P+ RP+M+ VL+IL
Sbjct: 923 QFGQGKPVVDCLDQEIKEPCFLQEMTTVFNLGLICTHSSPSTRPSMKEVLEILRR---VS 979
Query: 979 TEKNGGRKYD---HVTPLL 994
+ NG +K V PLL
Sbjct: 980 ADSNGEKKTGAELDVVPLL 998
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356561798|ref|XP_003549165.1| PREDICTED: receptor-like protein kinase HSL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1092 bits (2823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 573/990 (57%), Positives = 714/990 (72%), Gaps = 15/990 (1%)
Query: 17 LLLFFFGRANSQ-LYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTE 75
+L F G +SQ LYD+EHAVLL +KQ+ Q+PP +S+W +T+SSHC+WPEI CT SVT
Sbjct: 19 VLFFLLGHTSSQSLYDQEHAVLLNIKQYLQDPPFLSNWTSTSSSHCSWPEIICTTNSVTS 78
Query: 76 LHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPI 135
L L+ N+N T P FIC L NLT LD FN+I FP LYNCSKLEYLDLS N F G +
Sbjct: 79 LTLSQSNINRTIPSFICGLTNLTHLDFSFNFIPGGFPTPLYNCSKLEYLDLSGNNFDGKV 138
Query: 136 PEDIDRLS-RLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
P DID+LS L++L L + N G +P+SI +L +LRQ+ L NGS+ EI +L NLE
Sbjct: 139 PHDIDQLSANLQYLNLGSTNFHGDVPSSIAKLKQLRQIKLQYCLLNGSVAGEIDDLSNLE 198
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
L+L+ N F LP N T+ KLK + TNL+GEIPE IGDM+AL+ LD+S N+
Sbjct: 199 YLDLSSNFMFPEWKLPWNLTKFNKLKVFNLYGTNLVGEIPENIGDMVALDMLDMSNNSLA 258
Query: 255 GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENL 314
G IPS +F LKNL+ + LY+NSLSGEIP VE+LNL +DL+ NNLTG IP+ FGKL+ L
Sbjct: 259 GGIPSGLFLLKNLTSLRLYANSLSGEIPSVVEALNLANLDLARNNLTGKIPDIFGKLQQL 318
Query: 315 LNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTG 374
LSL N LSG IPE G LP+LKD R+F N LSG LPPDFGRYS LE F ++ N+ TG
Sbjct: 319 SWLSLSLNGLSGVIPESFGNLPALKDFRVFFNNLSGTLPPDFGRYSKLETFMIASNSFTG 378
Query: 375 SLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNL 434
LP++LC G L ++ DNNLSGELPESLGNCS LL +K++NN F+GNIP+GLWT FNL
Sbjct: 379 KLPDNLCYHGMLLSLSVYDNNLSGELPESLGNCSGLLDLKVHNNEFSGNIPSGLWTSFNL 438
Query: 435 SMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTI 494
+ ++S N FTG LP+++S N+SR EIS N+FSG IP+GVSS NLVVF AS N FNG+I
Sbjct: 439 TNFMVSHNKFTGVLPERLSWNISRFEISYNQFSGGIPSGVSSWTNLVVFDASKNNFNGSI 498
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQD 554
P +LTALP LTTLLLDQNQL+G LP DIISWKSL ALNLS+NQL G+IP IG LP L
Sbjct: 499 PRQLTALPKLTTLLLDQNQLTGELPSDIISWKSLVALNLSQNQLYGQIPHAIGQLPALSQ 558
Query: 555 LDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSN 614
LDLSEN+FSG++P R LT+LNLSSN LTG IPS+FEN +ASSFL N GLCA +
Sbjct: 559 LDLSENEFSGQVPSLPPR--LTNLNLSSNHLTGRIPSEFENSVFASSFLGNSGLCADTPA 616
Query: 615 VNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFFYMIRIYQKRKDELT-STETT 673
+NL C ++ KGSS V ++I VI L+ LL IR +KRK L S +
Sbjct: 617 LNLTLCNSGLQRKNKGSSWSVGLVISLVIVALLLILLLSLLFIRFNRKRKHGLVNSWKLI 676
Query: 674 SFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE 733
SF RLNF +S I+ +TE N+IGSGG G VYR+ + + VAVKKIWN+RKL++K E
Sbjct: 677 SFERLNFTESSIVSSMTEQNIIGSGGYGIVYRIDVG--SGYVAVKKIWNNRKLEKKLENS 734
Query: 734 FLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDE 793
F AEV+ILS IRH NIV+L+CCIS+E+ LLVYEY+E SLD+WLHKK + SG
Sbjct: 735 FRAEVRILSNIRHTNIVRLMCCISNEDSMLLVYEYLENHSLDKWLHKKVK---SGSVSKV 791
Query: 794 VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK 853
VL W +R++IA+G AQGL YMHHDCSP +VHRD+K+SNILLD FNAK+ADFG+AK+LIK
Sbjct: 792 VLDWPKRLKIAIGIAQGLSYMHHDCSPPVVHRDIKTSNILLDTQFNAKVADFGLAKMLIK 851
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLA 913
GE MS V+GS GYIAPEY +T +V+EK D++SFGV+LLELTTGKEAN GD+H+ L+
Sbjct: 852 -PGELNTMSAVIGSFGYIAPEYVQTTRVSEKIDVFSFGVVLLELTTGKEANYGDQHSSLS 910
Query: 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL-- 971
+WAWRH+ G + + LDK++ E + +EM VFKLGV+CT+ LP RP+MR LQIL
Sbjct: 911 EWAWRHVLIGGNVEELLDKDVMEAIYSDEMCTVFKLGVLCTATLPASRPSMREALQILQS 970
Query: 972 LNNPI-FPTEKNGGRKYDHVTPLLTDSKRE 1000
L P + +KN G YD + PLL S++E
Sbjct: 971 LGEPFAYGDQKNFGHYYDAI-PLLKSSEKE 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1014 | ||||||
| TAIR|locus:2180617 | 1005 | AT5G25930 [Arabidopsis thalian | 0.952 | 0.961 | 0.515 | 8.1e-266 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.908 | 0.921 | 0.402 | 4e-177 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.905 | 0.921 | 0.393 | 1.8e-174 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.891 | 0.910 | 0.388 | 1.2e-161 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.561 | 0.546 | 0.356 | 3.6e-150 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.553 | 0.545 | 0.364 | 6.7e-147 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.908 | 0.909 | 0.349 | 2e-143 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.910 | 0.930 | 0.352 | 2.6e-143 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.902 | 0.912 | 0.369 | 1.4e-142 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.933 | 0.945 | 0.358 | 1.9e-140 |
| TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2557 (905.2 bits), Expect = 8.1e-266, P = 8.1e-266
Identities = 508/986 (51%), Positives = 662/986 (67%)
Query: 27 SQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGT 86
SQ D+ + LL LK+ +PP + W T SS C W EI CT G+VT ++ N N GT
Sbjct: 22 SQFNDQ--STLLNLKRDLGDPPSLRLWNNT-SSPCNWSEITCTAGNVTGINFKNQNFTGT 78
Query: 87 FPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLS-RL 145
P ICDL NL LDL FNY +FP VLYNC+KL+YLDLSQN G +P DIDRLS L
Sbjct: 79 VPTTICDLSNLNFLDLSFNYFAGEFPTVLYNCTKLQYLDLSQNLLNGSLPVDIDRLSPEL 138
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
+L L AN SG IP S+GR+++L+ LNL ++++G+ P+EIG+L LE L LA N +F+
Sbjct: 139 DYLDLAANGFSGDIPKSLGRISKLKVLNLYQSEYDGTFPSEIGDLSELEELRLALNDKFT 198
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEI-PETIGDMLALEFLDLSINNFTGSIPSSVFKL 264
P+ +P F +LKKLK +W+ NLIGEI P +M LE +DLS+NN TG IP +F L
Sbjct: 199 PAKIPIEFGKLKKLKYMWLEEMNLIGEISPVVFENMTDLEHVDLSVNNLTGRIPDVLFGL 258
Query: 265 KNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
KNL++ YL++N L+GEIP+++ + NL +DLSANNLTG+IP G L L L+L N+L
Sbjct: 259 KNLTEFYLFANGLTGEIPKSISATNLVFLDLSANNLTGSIPVSIGNLTKLQVLNLFNNKL 318
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
+GEIP IG LP LK+ ++FNN L+G +P + G +S LE FEVS N LTG LPE+LC GG
Sbjct: 319 TGEIPPVIGKLPGLKEFKIFNNKLTGEIPAEIGVHSKLERFEVSENQLTGKLPENLCKGG 378
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
KL G+ NNL+GE+PESLG+C +LL V++ NN F+G P+ +W ++ + +S+N F
Sbjct: 379 KLQGVVVYSNNLTGEIPESLGDCGTLLTVQLQNNDFSGKFPSRIWNASSMYSLQVSNNSF 438
Query: 445 TGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXX 504
TGELP+ ++ N+SR+EI NNRFSG+IP + + +LV F+A NN F+G P E
Sbjct: 439 TGELPENVAWNMSRIEIDNNRFSGEIPKKIGTWSSLVEFKAGNNQFSGEFPKELTSLSNL 498
Query: 505 XXXXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
D+N L+G LP +IISWKSL L+LS+N+LSGEIP +G LP L +LDLSENQFSG
Sbjct: 499 ISIFLDENDLTGELPDEIISWKSLITLSLSKNKLSGEIPRALGLLPRLLNLDLSENQFSG 558
Query: 565 KIPPQIGXXXXXXXXXXXXXXXGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVP 624
IPP+IG G IP Q +N AY SFLNN LCA + ++L C
Sbjct: 559 GIPPEIGSLKLTTFNVSSNRLTGGIPEQLDNLAYERSFLNNSNLCADNPVLSLPDC---- 614
Query: 625 RKSRKGS----SQHXXXXXXXXXXXXXXXXXXXXYMIRIY--QKRKDELTSTETTSFHRL 678
RK R+GS + +++R Y ++R+ L + + TSFHR+
Sbjct: 615 RKQRRGSRGFPGKILAMILVIAVLLLTITLFVTFFVVRDYTRKQRRRGLETWKLTSFHRV 674
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEV 738
+F +SDI+ L E VIGSGGSGKVY++ + + + VAVK+IW+ +KLDQK EKEF+AEV
Sbjct: 675 DFAESDIVSNLMEHYVIGSGGSGKVYKIFVESSGQCVAVKRIWDSKKLDQKLEKEFIAEV 734
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+IL TIRH NIVKLLCCIS E+ KLLVYEY+EKRSLDQWLH K + G L+W
Sbjct: 735 EILGTIRHSNIVKLLCCISREDSKLLVYEYLEKRSLDQWLHGKKKG---GTVEANNLTWS 791
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
+R+ IAVGAAQGLCYMHHDC+P I+HRD+KSSNILLD FNAKIADFG+AK+LIK+ E
Sbjct: 792 QRLNIAVGAAQGLCYMHHDCTPAIIHRDVKSSNILLDSEFNAKIADFGLAKLLIKQNQEP 851
Query: 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918
MS V GS GYIAPEYA T KV+EK D+YSFGV+LLEL TG+E NNGDEHT LA W+W+
Sbjct: 852 HTMSAVAGSFGYIAPEYAYTSKVDEKIDVYSFGVVLLELVTGREGNNGDEHTNLADWSWK 911
Query: 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978
H Q GKP +A D++I E E M VFKLG++CT+ LP+ RP+M+ VL +L +
Sbjct: 912 HYQSGKPTAEAFDEDIKEASTTEAMTTVFKLGLMCTNTLPSHRPSMKEVLYVLRQQGLEA 971
Query: 979 TEKNGGRKYDHVTPLLTDSKREKMSE 1004
T+K Y+ PLL + S+
Sbjct: 972 TKKTATEAYE--APLLVSLSGRRTSK 995
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 388/963 (40%), Positives = 554/963 (57%)
Query: 31 DREHAVLLKLKQHWQNPPP-ISHWATTNS-SHCTWPEIAC-TDGSVTELHLTNMNMNGTF 87
+++ +L + K +P +S W+ N + C W ++C +V + L++ + G F
Sbjct: 22 NQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDLSSFMLVGPF 81
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYN-CSKLEYLDLSQNYFIGPIPEDID-RLSRL 145
P +C L +L L L N I ++ C L LDLS+N +G IP+ + L L
Sbjct: 82 PSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNL 141
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
KFL ++ NN+S IP+S G +L LNL N +G+IPA +GN+ L+ L+LAYN FS
Sbjct: 142 KFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNL-FS 200
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLK 265
PS +PS L +L+ LW+A NL+G IP ++ + +L LDL+ N TGSIPS + +LK
Sbjct: 201 PSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLK 260
Query: 266 NLSKVYLYSNSLSGEIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
+ ++ L++NS SGE+P+++ ++ LK D S N LTG IP++ L NL +L+L N L
Sbjct: 261 TVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLL-NLESLNLFENML 319
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
G +PE I +L +++LFNN L+G LP G SPL+Y ++S N +G +P ++C G
Sbjct: 320 EGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEG 379
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
KL + DN+ SGE+ +LG C SL V++ NN +G IP G W LS++ +SDN F
Sbjct: 380 KLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSF 439
Query: 445 TGELPDKMSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXX 502
TG +P + G NLS L IS NRFSG IP + S ++ + N F+G IP
Sbjct: 440 TGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLK 499
Query: 503 XXXXXXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
+NQLSG +P ++ WK+L LNL+ N LSGEIP+++G LPVL LDLS NQF
Sbjct: 500 QLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQF 559
Query: 563 SGKIPPQIGXXXXXXXXXXXXXXXGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFF 622
SG+IP ++ G+IP + N+ YA F+ NPGLC + C
Sbjct: 560 SGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGL----CRK 615
Query: 623 VPRKSRKGSSQHXXXXXXXXXXXXXXXXXXXXYMIRIYQKRKDE-LTSTETTSFHRLNFR 681
+ R G R + K L +++ SFH+L+F
Sbjct: 616 ITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWRSFHKLHFS 675
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-DQKHEKE------F 734
+ +I L E NVIG G SGKVY+V + EVVAVKK+ K D ++ + F
Sbjct: 676 EHEIADCLDEKNVIGFGSSGKVYKVELRG-GEVVAVKKLNKSVKGGDDEYSSDSLNRDVF 734
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV 794
AEV+ L TIRH +IV+L CC SS + KLLVYEYM SL LH + + V
Sbjct: 735 AAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGV-------V 787
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-LIK 853
L W R++IA+ AA+GL Y+HHDC P IVHRD+KSSNILLD ++ AK+ADFG+AK+ +
Sbjct: 788 LGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMS 847
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANN---GDEHT 910
AMS + GSCGYIAPEY T +VNEK+DIYSFGV+LLEL TGK+ + GD+
Sbjct: 848 GSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDKD- 906
Query: 911 CLAQWAWRHIQE-G-KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968
+A+W + + G +P++D ++D F EE+ +V +G++CTS LP RP+MR V+
Sbjct: 907 -MAKWVCTALDKCGLEPVIDP---KLDLK-FKEEISKVIHIGLLCTSPLPLNRPSMRKVV 961
Query: 969 QIL 971
+L
Sbjct: 962 IML 964
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1695 (601.7 bits), Expect = 1.8e-174, P = 1.8e-174
Identities = 376/956 (39%), Positives = 545/956 (57%)
Query: 36 VLLKLKQHWQNPPP-ISHWATTNSSHCTWPEIACTD--GSVTELHLTNMNMNGTFPPFIC 92
+L ++K +P +S W + ++S C W ++C SVT + L++ N+ G FP IC
Sbjct: 22 ILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVIC 81
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
L NL L L N I S P + C L+ LDLSQN G +P+ + + L L LT
Sbjct: 82 RLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTG 141
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN 212
NN SG IPAS G+ L L+LV N +G+IP +GN+ L+ L L+YN FSPS +P
Sbjct: 142 NNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP-FSPSRIPPE 200
Query: 213 FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYL 272
F L L+ +W+ +L+G+IP+++G + L LDL++N+ G IP S+ L N+ ++ L
Sbjct: 201 FGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIEL 260
Query: 273 YSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEG 331
Y+NSL+GEIP + +L +L+++D S N LTG IP++ ++ L +L+L N L GE+P
Sbjct: 261 YNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGELPAS 319
Query: 332 IGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAA 391
I L P+L ++R+F N L+G LP D G SPL + +VS N +G LP LCA G+L +
Sbjct: 320 IALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLI 379
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
N+ SG +PESL +C SL +++ N F+G++P G W +++++ + +N F+GE+
Sbjct: 380 IHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKS 439
Query: 452 MSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXXXXXXX 509
+ G NLS L +SNN F+G +P + S NL AS N F+G++P
Sbjct: 440 IGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDL 499
Query: 510 DQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQ 569
NQ SG L I SWK L LNL+ N+ +G+IP++IG L VL LDLS N FSGKIP
Sbjct: 500 HGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVS 559
Query: 570 IGXXXXXXXXXXXXXXXGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRK 629
+ G++P Y +SF+ NPGLC + C ++
Sbjct: 560 LQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGL----CGSENEAKKR 615
Query: 630 GSSQHXXXXXXXXXXXXXXXXXXXXYMIRIYQK-RKDELTSTETTSFHRLNFRDSDILPK 688
G + R ++K R E + SFH+L F + +IL
Sbjct: 616 GYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILES 675
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN---------DRKLDQK---HEKEFLA 736
L E NVIG+G SGKVY+V + + E VAVK++W D + K ++ F A
Sbjct: 676 LDEDNVIGAGASGKVYKVVLTN-GETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEA 734
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
EV+ L IRH NIVKL CC S+ + KLLVYEYM SL LH SS G +L
Sbjct: 735 EVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLH----SSKGG-----MLG 785
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
W+ R +I + AA+GL Y+HHD P IVHRD+KS+NIL+D ++ A++ADFGVAK +
Sbjct: 786 WQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGK 845
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD-EHTCLAQW 915
+MS + GSCGYIAPEYA T +VNEK+DIYSFGV++LE+ T K + + L +W
Sbjct: 846 APKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEKDLVKW 905
Query: 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + K I +D ++D CF EE+ ++ +G++CTS LP RP+MR V+++L
Sbjct: 906 VCSTLDQ-KGIEHVIDPKLDS-CFKEEISKILNVGLLCTSPLPINRPSMRRVVKML 959
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1574 (559.1 bits), Expect = 1.2e-161, P = 1.2e-161
Identities = 373/959 (38%), Positives = 535/959 (55%)
Query: 50 ISHWATT--NSSHCTWPEIAC--TDGS---VTELHLTNMNMNGTFPPFICDLR---NLTI 99
+ W T N S C W I C GS VT + L+ N++G FP C +R N+T+
Sbjct: 46 LQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFCRIRTLINITL 105
Query: 100 LDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKI 159
N I P L CSKL+ L L+QN F G +PE +L+ L L +N +G+I
Sbjct: 106 SQNNLNGTIDSAPLSL--CSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEI 163
Query: 160 PASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKL 219
P S GRLT L+ LNL N +G +PA +G L L L+LAY F PS +PS L L
Sbjct: 164 PQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAY-ISFDPSPIPSTLGNLSNL 222
Query: 220 KKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSG 279
L + +NL+GEIP++I +++ LE LDL++N+ TG IP S+ +L+++ ++ LY N LSG
Sbjct: 223 TDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSG 282
Query: 280 EIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
++P+++ +L L+ D+S NNLTG +P L+ L++ +L N +G +P+ + L P+L
Sbjct: 283 KLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDNFFTGGLPDVVALNPNL 341
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ ++FNN +G LP + G++S + F+VS N +G LP +LC KL I N LSG
Sbjct: 342 VEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSG 401
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NL 456
E+PES G+C SL +++ +N +G +PA W + L ++N G +P +S +L
Sbjct: 402 EIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHL 461
Query: 457 SRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXXXXXXXDQNQLSG 516
S+LEIS N FSG IP + ++L V S N F G+IP +N L G
Sbjct: 462 SQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDG 521
Query: 517 SLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGXXXXX 576
+P + S LT LNLS N+L G IP ++G LPVL LDLS NQ +G+IP ++
Sbjct: 522 EIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLN 581
Query: 577 XXXXXXXXXXGEIPSQFENRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQHXX 636
G+IPS F+ + SFL NP LCA + + ++ C R R+ +++
Sbjct: 582 QFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDP-IRPC----RSKRE--TRYIL 634
Query: 637 XXXXXXXXXXXXXXXXXXYMIRIYQKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIG 696
+ KRK + T+ + T F R+ F + DI P+LTE N+IG
Sbjct: 635 PISILCIVALTGALVWLFIKTKPLFKRKPKRTN-KITIFQRVGFTEEDIYPQLTEDNIIG 693
Query: 697 SGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI 756
SGGSG VYRV + + + +AVKK+W + + E F +EV+ L +RH NIVKLL C
Sbjct: 694 SGGSGLVYRVKLK-SGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCC 752
Query: 757 SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHH 816
+ E + LVYE+ME SL LH + RA L W R IAVGAAQGL Y+HH
Sbjct: 753 NGEEFRFLVYEFMENGSLGDVLHSEKEH----RAVSP-LDWTTRFSIAVGAAQGLSYLHH 807
Query: 817 DCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA---MSTVVGSCGYIAP 873
D P IVHRD+KS+NILLD+ ++ADFG+AK L +E+ + + MS V GS GYIAP
Sbjct: 808 DSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAP 867
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGD--EHTCLAQWAWR--------HIQEG 923
EY T KVNEK+D+YSFGV+LLEL TGK N+ E+ + ++A ++G
Sbjct: 868 EYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDG 927
Query: 924 KPIVDAL------DKEIDEPCFL-----EEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
D+L K +D L EE+ +V + ++CTS P RP MR V+++L
Sbjct: 928 AMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKVVELL 986
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 3.6e-150, Sum P(2) = 3.6e-150
Identities = 209/586 (35%), Positives = 299/586 (51%)
Query: 37 LLKLKQHWQNPPP-ISHWAT-TNSSH----CTWPEIACTD--GSVTELHLTNMNMNGTFP 88
LL LK PP W N + C+W + C + V L L++ N++G P
Sbjct: 39 LLSLKTSLSGPPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIP 98
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFL 148
I L +L L+L N + FP +++ +KL LD+S+N F P I +L LK
Sbjct: 99 IQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVF 158
Query: 149 YLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSS 208
+NN G +P+ + RL L +LN + F G IPA G LQ L+ + LA N
Sbjct: 159 NAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNV--LGGK 216
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
LP L +L+ + + + G IP + L++ D+S + +GS+P + L NL
Sbjct: 217 LPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLE 276
Query: 269 KVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGE 327
++L+ N +GEIP++ +L +LK++D S+N L+G+IP+ F L+NL LSL+ N LSGE
Sbjct: 277 TLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGE 336
Query: 328 IPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
+PEGIG LP L + L+NN +G LP G LE +VS N+ TG++P LC G KL
Sbjct: 337 VPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLY 396
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGE 447
+ N GELP+SL C SL + NN G IP G + NL+ V +S+N FT +
Sbjct: 397 KLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQ 456
Query: 448 LPDKMSGN--LSRLEISNNRFSGKIPTGVSSSKNLVVFQAS-NNLFNGTIPGEXXXXXXX 504
+P + L L +S N F K+P + + NL +F AS +NL G IP
Sbjct: 457 IPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLI-GEIPN-YVGCKSF 514
Query: 505 XXXXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
N L+G++P DI + L LNLS+N L+G IP +I LP + D+DLS N +G
Sbjct: 515 YRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTG 574
Query: 565 KIPPQIGXXXXXXXXXXXXXXX-GEIPSQFENRAYASSFLNNPGLC 609
IP G G IPS S F +N GLC
Sbjct: 575 TIPSDFGSSKTITTFNVSYNQLIGPIPSGSFAHLNPSFFSSNEGLC 620
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 6.7e-147, Sum P(2) = 6.7e-147
Identities = 210/576 (36%), Positives = 312/576 (54%)
Query: 42 QHWQNPPPISHWATTNSS--HCTWPEIAC-TDGSVTELHLTNMNMNGTFPPFICDLRNLT 98
Q W+ P ATT S HC W + C +G V +L L+NMN++G I +L
Sbjct: 49 QDWKRPEN----ATTFSELVHCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQ 104
Query: 99 ILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGK 158
LDL N S P+ L N + L+ +D+S N F G P + + L + ++NN SG
Sbjct: 105 ALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGF 164
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKK 218
+P +G T L L+ F GS+P+ NL+NL+ L L+ N F +P +L
Sbjct: 165 LPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNN-FG-GKVPKVIGELSS 222
Query: 219 LKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS 278
L+ + + +GEIPE G + L++LDL++ N TG IPSS+ +LK L+ VYLY N L+
Sbjct: 223 LETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLT 282
Query: 279 GEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPS 337
G++P+ + + +L +DLS N +TG IP + G+L+NL L+LM NQL+G IP I LP+
Sbjct: 283 GKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPN 342
Query: 338 LKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLS 397
L+ + L+ N L G+LP G+ SPL++ +VS N L+G +P LC L + +N+ S
Sbjct: 343 LEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFS 402
Query: 398 GELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK--MSGN 455
G++PE + +C +L+ V+I N +G+IPAG L + ++ N TG++PD +S +
Sbjct: 403 GQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTS 462
Query: 456 LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXXXXXXXDQNQLS 515
LS ++IS N S + + + SS NL F AS+N F G IP + N S
Sbjct: 463 LSFIDISFNHLSS-LSSSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFS 521
Query: 516 GSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGXX-X 574
G +P I S++ L +LNL NQL GEIP+ + + +L LDLS N +G IP +G
Sbjct: 522 GGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPT 581
Query: 575 XXXXXXXXXXXXGEIPSQFENRAY-ASSFLNNPGLC 609
G IPS A + N GLC
Sbjct: 582 LEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLC 617
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1402 (498.6 bits), Expect = 2.0e-143, P = 2.0e-143
Identities = 337/965 (34%), Positives = 512/965 (53%)
Query: 33 EHAVLLKLKQHWQNPPP-ISHWATTNSS-HCTWPEIAC-TDGSVTELHLTNMNMNGTFPP 89
E +VLL +K +P + W +++S HC W + C ++G+V +L L MN+ G
Sbjct: 30 ELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCNSNGNVEKLDLAGMNLTGKISD 89
Query: 90 FICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLY 149
I L +L ++ N S P+ + L+ +D+SQN F G + + L L
Sbjct: 90 SISQLSSLVSFNISCNGFESLLPKSI---PPLKSIDISQNSFSGSLFLFSNESLGLVHLN 146
Query: 150 LTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSL 209
+ NN+SG + +G L L L+L N F GS+P+ NLQ L L L+ N L
Sbjct: 147 ASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN--LTGEL 204
Query: 210 PSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSK 269
PS QL L+ + G IP G++ +L++LDL+I +G IPS + KLK+L
Sbjct: 205 PSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLET 264
Query: 270 VYLYSNSLSGEIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ LY N+ +G IP+ + S+ LKV+D S N LTG IP + KL+NL L+LM N+LSG I
Sbjct: 265 LLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSI 324
Query: 329 PEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAG 388
P I L L+ + L+NN LSG LP D G+ SPL++ +VS N+ +G +P LC G L
Sbjct: 325 PPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTK 384
Query: 389 IAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGEL 448
+ +N +G++P +L C SL+ V++ NN G+IP G L + ++ N +G +
Sbjct: 385 LILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGI 444
Query: 449 PDKMSGN--LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXXXX 506
P +S + LS ++ S N+ +P+ + S NL F ++N +G +P +
Sbjct: 445 PGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSN 504
Query: 507 XXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKI 566
N L+G++P I S + L +LNL N L+GEIP +I + L LDLS N +G +
Sbjct: 505 LDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVL 564
Query: 567 PPQIGXX-XXXXXXXXXXXXXGEIP-SQFENRAYASSFLNNPGLCASSSNVNLKSCFFVP 624
P IG G +P + F N GLC L C
Sbjct: 565 PESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV----LPPCSKFQ 620
Query: 625 RKSRKGSSQHXXXXXXXXXXXXXXXXXXXXYMI---RIYQK-RKDELTSTETTS------ 674
R + SS H I +Y+K + ET S
Sbjct: 621 RATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPW 680
Query: 675 ----FHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK-LDQK 729
FHRL F SDIL + ESN+IG G +G VY+ ++ ++ V+AVKK+W ++
Sbjct: 681 RLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDG 740
Query: 730 HEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR 789
+F+ EV +L +RH NIV+LL + ++ ++VYE+M +L +H KN + GR
Sbjct: 741 TTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAA---GR 797
Query: 790 ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
++ W R IA+G A GL Y+HHDC P ++HRD+KS+NILLD N +A+IADFG+A+
Sbjct: 798 L---LVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLAR 854
Query: 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD-- 907
++ +++ +S V GS GYIAPEY T KV+EK DIYS+GV+LLEL TG+ +
Sbjct: 855 MMARKK---ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG 911
Query: 908 EHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFL-EEMIRVFKLGVICTSMLPTERPNMRM 966
E + +W R I++ + +ALD + ++ EEM+ V ++ ++CT+ LP +RP+MR
Sbjct: 912 ESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971
Query: 967 VLQIL 971
V+ +L
Sbjct: 972 VISML 976
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1401 (498.2 bits), Expect = 2.6e-143, P = 2.6e-143
Identities = 341/968 (35%), Positives = 523/968 (54%)
Query: 32 REHAVLLKLKQHWQN-PPPISHWATTN-SSHCTWPEIACTD--GSVTELHLTNMNMNGTF 87
R+ VL+ LKQ + + P + W N +S C+W ++C + S+T L L+N+N++GT
Sbjct: 33 RQANVLISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTI 92
Query: 88 PPFICDLR-NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIP-EDIDRLSRL 145
P I L +L LD+ N + P+ +Y S LE L++S N F G + ++++L
Sbjct: 93 SPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQL 152
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
L N+ +G +P S+ LT L L+L N F+G IP G+ +L+ L L+ N
Sbjct: 153 VTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGND--L 210
Query: 206 PSSLPSNFTQLKKLKKLWMASTN-LIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKL 264
+P+ + L +L++ N G IP G ++ L LDL+ + GSIP+ + L
Sbjct: 211 RGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNL 270
Query: 265 KNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
KNL ++L +N L+G +P+ + ++ +LK +DLS N L G IP + L+ L +L FN+
Sbjct: 271 KNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNR 330
Query: 324 LSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
L GEIPE + LP L+ ++L++N +G +P G L ++S N LTG +PE LC G
Sbjct: 331 LHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFG 390
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
+L + +N L G LPE LG C L ++ N T +P GL NLS++ + +N
Sbjct: 391 RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNF 450
Query: 444 FTGELPDKMSGN-----LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEX 498
TGE+P++ +GN L+++ +SNNR SG IP + + ++L + N +G IPGE
Sbjct: 451 LTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEI 510
Query: 499 XXXXXXXXXXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558
+N SG P + SLT L+LS NQ+SG+IP +I + +L L++S
Sbjct: 511 GSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVS 570
Query: 559 ENQFSGKIPPQIGXXXXXXXXXXXXXX-XGEIPSQFENRAYAS-SFLNNPGLCASSSNV- 615
N F+ +P ++G G +P+ + + + SFL NP LC SSN
Sbjct: 571 WNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPC 630
Query: 616 -----NLKSCFFVPRKSR-KGSSQHXXXXXXXXXXXXXXXXXXXXYMIRIYQKRKDELTS 669
+S +R +G +++ + RK+
Sbjct: 631 NGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNL 690
Query: 670 TETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK 729
+ F +L FR IL + E++VIG GG G VY+ + E VAVKK+ K
Sbjct: 691 WKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYK-GVMPNGEEVAVKKLLTITK-GSS 748
Query: 730 HEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR 789
H+ AE+Q L IRH NIV+LL S++++ LLVYEYM SL + LH G+
Sbjct: 749 HDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLH--------GK 800
Query: 790 ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
A L W R+QIA+ AA+GLCY+HHDCSP I+HRD+KS+NILL F A +ADFG+AK
Sbjct: 801 A-GVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAK 859
Query: 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA--NNGD 907
++++ G MS++ GS GYIAPEYA T +++EK+D+YSFGV+LLEL TG++ N G+
Sbjct: 860 FMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGE 919
Query: 908 EHTCLAQWAWRHIQEG---KPIVDALDKEIDE-PCFLEEMIRVFKLGVICTSMLPTERPN 963
E + QW+ IQ + +V +D+ + P L E + +F + ++C ERP
Sbjct: 920 EGIDIVQWS--KIQTNCNRQGVVKIIDQRLSNIP--LAEAMELFFVAMLCVQEHSVERPT 975
Query: 964 MRMVLQIL 971
MR V+Q++
Sbjct: 976 MREVVQMI 983
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1394 (495.8 bits), Expect = 1.4e-142, P = 1.4e-142
Identities = 351/950 (36%), Positives = 496/950 (52%)
Query: 49 PISHWATTNSSHCTWPEIACTDGS---VTELHLTNMNMNGTFPPFICDLRNLTILDLQFN 105
P+S W + +S CTW + C D S VT L L+ +N++GT P + LR L L L N
Sbjct: 46 PLSSWKVS-TSFCTWIGVTC-DVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAEN 103
Query: 106 YIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDR-LSRLKFLYLTANNMSGKIPASIG 164
I P + + S L +L+LS N F G P++I L L+ L + NN++G +P S+
Sbjct: 104 LISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVT 163
Query: 165 RLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWM 224
LT+LR L+L N F G IP G+ +E L ++ N E +P L L++L++
Sbjct: 164 NLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGN-ELV-GKIPPEIGNLTTLRELYI 221
Query: 225 ASTNLIGE-IPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQ 283
N + +P IG++ L D + TG IP + KL+ L ++L N SG +
Sbjct: 222 GYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTW 281
Query: 284 AVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVR 342
+ +L+ LK +DLS N TG IP F +L+NL L+L N+L GEIPE IG LP L+ ++
Sbjct: 282 ELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQ 341
Query: 343 LFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPE 402
L+ N +G++P G L ++S N LTG+LP ++C+G KL + N L G +P+
Sbjct: 342 LWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPD 401
Query: 403 SLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELP--DKMSGNLSRLE 460
SLG C SL +++ N G+IP GL+ L+ V + DN +GELP +S NL ++
Sbjct: 402 SLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQIS 461
Query: 461 ISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXXXXXXXXXXDQNQLSGSLPL 520
+SNN+ SG +P + + + N F G IP E N SG +
Sbjct: 462 LSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAP 521
Query: 521 DIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGXXXXXXXXX 580
+I K LT ++LSRN+LSGEIP +I + +L L+LS N G IP I
Sbjct: 522 EISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLD 581
Query: 581 XXXXX-XGEIPS--QFENRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSR-KGSSQHXX 636
G +P QF Y +SFL NP LC +S KG
Sbjct: 582 FSYNNLSGLVPGTGQFSYFNY-TSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASM 640
Query: 637 XXXXXXXXXXXXXXXXXXYMIRIYQ-KRKDELTSTETTSFHRLNFRDSDILPKLTESNVI 695
+I+ K+ E + T+F RL+F D+L L E N+I
Sbjct: 641 KLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNII 700
Query: 696 GSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCC 755
G GG+G VY+ + ++VAVK++ + H+ F AE+Q L IRH +IV+LL
Sbjct: 701 GKGGAGIVYK-GVMPNGDLVAVKRLAAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGF 758
Query: 756 ISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH 815
S+ LLVYEYM SL + LH K G L W R +IA+ AA+GLCY+H
Sbjct: 759 CSNHETNLLVYEYMPNGSLGEVLHGKK----GGH-----LHWDTRYKIALEAAKGLCYLH 809
Query: 816 HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEY 875
HDCSP IVHRD+KS+NILLD NF A +ADFG+AK L ++ G MS + GS GYIAPEY
Sbjct: 810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIAPEY 868
Query: 876 ARTRKVNEKTDIYSFGVILLELTTG-KEANNGDEHTCLAQWAWRHIQEGKP-IVDALDKE 933
A T KV+EK+D+YSFGV+LLEL TG K + + QW + K ++ LD
Sbjct: 869 AYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPR 928
Query: 934 IDE-PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982
+ P + E+ VF + ++C ERP MR V+QIL P P K+
Sbjct: 929 LSSIP--IHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKD 976
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1374 (488.7 bits), Expect = 1.9e-140, P = 1.9e-140
Identities = 357/996 (35%), Positives = 515/996 (51%)
Query: 34 HAVLLKLKQHW---QNPPPISHWATTNSSHCTWPEIACTDGS---VTELHLTNMNMNGTF 87
HA LL LK + ++ P ++ W +++ C+W + C D S VT L L+ +N++GT
Sbjct: 29 HA-LLSLKSSFTIDEHSPLLTSW-NLSTTFCSWTGVTC-DVSLRHVTSLDLSGLNLSGTL 85
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDR-LSRLK 146
+ L L L L N I P + N +L +L+LS N F G P+++ L L+
Sbjct: 86 SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR 145
Query: 147 FLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSP 206
L L NN++G +P S+ LT+LR L+L N F+G IPA G LE L ++ N E +
Sbjct: 146 VLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGN-ELT- 203
Query: 207 SSLPSNFTQLKKLKKLWMASTNLIGE-IPETIGDMLALEFLDLSINNFTGSIPSSVFKLK 265
+P L L++L++ N +P IG++ L D + TG IP + KL+
Sbjct: 204 GKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQ 263
Query: 266 NLSKVYLYSNSLSGEIPQAVESLN-LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
L ++L N+ +G I Q + ++ LK +DLS N TG IP F +L+NL L+L N+L
Sbjct: 264 KLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKL 323
Query: 325 SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
G IPE IG +P L+ ++L+ N +G++P G L ++S N LTG+LP ++C+G
Sbjct: 324 YGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGN 383
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
+L + N L G +P+SLG C SL +++ N G+IP L+ LS V + DN
Sbjct: 384 RLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYL 443
Query: 445 TGELPDK---MSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEXXXX 501
TGELP +SG+L ++ +SNN+ SG +P + + + N F+G+IP E
Sbjct: 444 TGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRL 503
Query: 502 XXXXXXXXDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQ 561
N SG + +I K LT ++LSRN+LSG+IP ++ + +L L+LS N
Sbjct: 504 QQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNH 563
Query: 562 FSGKIPPQIGXXXXXXXXXXXXXX-XGEIPS--QFENRAYASSFLNNPGLCASSSNVNLK 618
G IP I G +PS QF Y +SF+ N LC L
Sbjct: 564 LVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNY-TSFVGNSHLCGPY----LG 618
Query: 619 SCFFVPRKSRKGSSQHXXXXXXXXXXXXXXXXXXXXYMIRIYQKRK-DELTSTETTSFHR 677
C +S +I+ R E + T+F R
Sbjct: 619 PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQR 678
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE 737
L+F D+L L E N+IG GG+G VY+ + ++VAVK++ H+ F AE
Sbjct: 679 LDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPK-GDLVAVKRLAT-MSHGSSHDHGFNAE 736
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
+Q L IRH +IV+LL S+ LLVYEYM SL + LH K G L W
Sbjct: 737 IQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK----GGH-----LHW 787
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
R +IA+ AA+GLCY+HHDCSP IVHRD+KS+NILLD NF A +ADFG+AK L ++ G
Sbjct: 788 NTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL-QDSGT 846
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE--ANNGDEHTCLAQW 915
MS + GS GYIAPEYA T KV+EK+D+YSFGV+LLEL TGK+ GD + QW
Sbjct: 847 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VDIVQW 905
Query: 916 AWRHIQEGKP-IVDALDKEIDE-PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973
K ++ +D + P + E+ VF + ++C ERP MR V+QIL
Sbjct: 906 VRSMTDSNKDCVLKVIDLRLSSVP--VHEVTHVFYVALLCVEEQAVERPTMREVVQILTE 963
Query: 974 NPIFPTEKNGGRKYDHVT---PLLTDSKREKMSESD 1006
P P K + D VT P + +S + S D
Sbjct: 964 IPKIPLSKQQAAESD-VTEKAPAINESSPDSGSPPD 998
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1014 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-156 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 485 bits (1250), Expect = e-156
Identities = 333/1005 (33%), Positives = 478/1005 (47%), Gaps = 112/1005 (11%)
Query: 12 ILLSTLLLFFFGRANSQLYDREHAVLLKLKQHWQNPPP-ISHWATTNSSHCTWPEIACTD 70
L+ L F S L+ E +LL K +P +S+W ++ C W I C +
Sbjct: 11 YLIFMLFFLFLN--FSMLHAEELELLLSFKSSINDPLKYLSNWNSSADV-CLWQGITCNN 67
Query: 71 GS-VTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPR-VLYNCSKLEYL---- 124
S V + L+ N++G I L + ++L N + P + S L YL
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 125 ------------------DLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRL 166
DLS N G IP DI S LK L L N + GKIP S+ L
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 167 TELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMAS 226
T L L L NQ G IP E+G +++L+ + L YN
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN------------------------- 222
Query: 227 TNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVE 286
NL GEIP IG + +L LDL NN TG IPSS+ LKNL ++LY N LSG IP ++
Sbjct: 223 -NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 287 SL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFN 345
SL L +DLS N+L+G IP +L+NL L L N +G+IP + LP L+ ++L++
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 346 NMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLG 405
N SG +P + G+++ L ++S NNLTG +PE LC+ G L + N+L GE+P+SLG
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
Query: 406 NCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVL-ISDNLFTGELPDKM--SGNLSRLEIS 462
C SL V++ +NSF+G +P+ +T L L IS+N G + + +L L ++
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460
Query: 463 NNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDI 522
N+F G +P SK L S N F+G +P +L +L L L L +N+LSG +P ++
Sbjct: 461 RNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 523 ISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLS 581
S K L +L+LS NQLSG+IP +PVL LDLS+NQ SG+IP +G + L +N+S
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 582 SNRLTGEIPSQFENRAY-ASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQHVAVIIV 640
N L G +PS A AS+ N LC + L C ++ RK S I
Sbjct: 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC----KRVRKTPSWW--FYIT 633
Query: 641 SVIAVFLVALLSFFYMIRIYQKRKDELTSTET------TSFHRLNFRDS----DILPKLT 690
+ FLV L F + I + EL E F S DIL L
Sbjct: 634 CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK 693
Query: 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
E NVI G G Y+ VK+I +E+ + ++H NIV
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI-------NDVNSIPSSEIADMGKLQHPNIV 746
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
KL+ SE L++EY+E ++L + L LSW RR +IA+G A+
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------------LSWERRRKIAIGIAKA 792
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L ++H CSP +V +L I++D + + G + S Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKD--------EPHLRLSLPGLLCTDTKCFISSAY 844
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE--HTCLAQWAWRHIQEGKPIVD 928
+APE T+ + EK+DIY FG+IL+EL TGK + + H + +WA R+ +
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA-RYCYSDCHLDM 903
Query: 929 ALDKEI--DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+D I D E++ V L + CT+ PT RP VL+ L
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 77/205 (37%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG G VY T + VA+K I ++ +E L E++IL + H NIVKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
EN LV EY E SL L + LS ++I + +GL Y+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEG----------KLSEDEILRILLQILEGLEYL 108
Query: 815 HHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H S I+HRDLK NILLD N K+ADFG++K+L ++ + T+VG+ Y+AP
Sbjct: 109 H---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL---LKTIVGTPAYMAP 162
Query: 874 EYARTR-KVNEKTDIYSFGVILLEL 897
E + +EK+DI+S GVIL EL
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 94/280 (33%), Positives = 132/280 (47%), Gaps = 37/280 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G GKVY T ++VA+K I +K +K + L E++IL ++H NIV+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
E+ LV EY E L L K+ R S DE + R QI L
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-----DEARFYLR--QIL----SALE 111
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S IVHRDLK NILLD + + K+ADFG+A+ L E ++T VG+ Y+A
Sbjct: 112 YLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPEYMA 164
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE + + DI+S GVIL EL TGK GD+ ++ I + KP +
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEW 221
Query: 933 EIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
+I ++IR +L P +R LQ
Sbjct: 222 DISPEAK--DLIR---------KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 90/285 (31%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 694 VIGSGGSGKVYRVPINH-TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+GSG G VY+ + T ++VAVK + + +K ++ E++IL + H NIV+L
Sbjct: 6 KLGSGSFGTVYKA-KHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRL 63
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ ++ LV EY E L +L + LS +IA+ +GL
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-----------LSEDEAKKIALQILRGLE 112
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S I+HRDLK NILLD N KIADFG+AK L+K ++T VG+ Y+A
Sbjct: 113 YLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS---LTTFVGTPWYMA 166
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGK----EANNGDEHTCLAQWAWRHIQEGKPIV 927
PE K D++S GVIL EL TGK N D+ + + I
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR-----ILGPPLEF 221
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
D E EE + L P++RP +LQ
Sbjct: 222 D----EPKWSSGSEEAKD------LIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 64/302 (21%)
Query: 689 LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
LT +G G G+VY+ VAVK + D ++ +EFL E +I+ +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL 58
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H N+VKLL C E L +V EYME L +L R LS +
Sbjct: 59 DHPNVVKLLGVCTEEEPL-YIVMEYMEGGDLLSYL----------RKNRPKLSLSDLLSF 107
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
A+ A+G+ Y+ +HRDL + N L+ N KI+DFG +S
Sbjct: 108 ALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFG--------------LSR 150
Query: 864 VVGSCGYI------------APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE--H 909
+ Y APE + K K+D++SFGV+L E+ T G++
Sbjct: 151 DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT-----LGEQPYP 205
Query: 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ +++ G L + + P E+ + C + P +RP +++
Sbjct: 206 GMSNEEVLEYLKNGY----RLPQPPNCP---PELYDLMLQ---CWAEDPEDRPTFSELVE 255
Query: 970 IL 971
IL
Sbjct: 256 IL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 82/281 (29%), Positives = 134/281 (47%), Gaps = 34/281 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G GKVY V ++ +K+I + + +K ++ L EV+IL + H NI+K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ +V EY + L Q + K+ + +++L W Q+ + L
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFV--QLCLA----LK 117
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S I+HRD+K NI L N K+ DFG++K+L + A TVVG+ Y++
Sbjct: 118 YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLA--KTVVGTPYYLS 171
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE + + N K+DI+S G +L EL T K G+ L + A + I +G+
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALK-ILKGQY------P 221
Query: 933 EIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQI 970
I + E+ + +S+L P ERP++ +LQ
Sbjct: 222 PI-PSQYSSELRN------LVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 49/295 (16%)
Query: 689 LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
LT +G G G+VY+ + VAVK + D ++ +EFL E +I+ +
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL 58
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H NIVKLL C E L ++V EYM L +L K R + LS +
Sbjct: 59 DHPNIVKLLGVCTEEEPL-MIVMEYMPGGDLLDYLRKN---------RPKELSLSDLLSF 108
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
A+ A+G+ Y+ +HRDL + N L+ N KI+DFG+++ L ++
Sbjct: 109 ALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-------Y 158
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE--HTCLAQWA 916
G + APE + K K+D++SFGV+L E+ T G+E
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEV 213
Query: 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++++G L K + P E+ ++ C + P +RP +++IL
Sbjct: 214 LEYLKKGY----RLPKPPNCP---PELYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 36/288 (12%)
Query: 693 NVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G G G+VY+ + VAVK + D +++ K+FL E +++ + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 750 VKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
V+LL C E L LV EYME L +L K S LS + + A+ A
Sbjct: 59 VRLLGVCTEEEPL-YLVLEYMEGGDLLDYLRKSRPVFPSP--EKSTLSLKDLLSFAIQIA 115
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+G+ Y+ S VHRDL + N L+ + KI+DFG+++ + ++ +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL--- 169
Query: 869 GYI---APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE--HTCLAQWAWRHIQEG 923
I APE + K+D++SFGV+L E+ T G + ++++G
Sbjct: 170 -PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT-----LGATPYPGLSNEEVLEYLRKG 223
Query: 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
L K P +E+ + C + P +RP +++ L
Sbjct: 224 Y----RLPKPEYCP---DELYELMLS---CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 689 LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
L +G G G+VY+ T VAVK + ++ +EFL E I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL 58
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H NIV+LL C E L +V EYM L +L K L+ + +Q+
Sbjct: 59 SHPNIVRLLGVCTQGEPL-YIVTEYMPGGDLLDFLRKHGEK----------LTLKDLLQM 107
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
A+ A+G+ Y+ S VHRDL + N L+ N KI+DFG+++ + +++
Sbjct: 108 ALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD------YY 158
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTTG 900
G + APE + K K+D++SFGV+L E+ T
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG GG G+VY+ T + VA+K I ++ +++ + E+QIL +H NIVK
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI-KLES--KEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GAAQG 810
++ +V E+ SL L N++ E QIA +G
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL------TES-------QIAYVCKELLKG 110
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+H S I+HRD+K++NILL + K+ DFG++ L + +T+VG+ +
Sbjct: 111 LEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR----NTMVGTPYW 163
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+APE + + K DI+S G+ +EL GK
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+ T ++G G G VY T E++AVK + ++ + E++ILS+++H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 748 NIVKLL-CCISSENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIA 804
NIV+ E L ++ EY+ SL L K G+ + V+ R+ QI
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF------GKLPEPVI--RKYTRQIL 111
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+GL Y+H S IVHRD+K +NIL+D + K+ADFG AK + + +V
Sbjct: 112 ----EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSV 163
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
G+ ++APE R + DI+S G ++E+ TGK
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
++IG G G VY+ T + VA+K+I + K+ ++ K + E+ +L ++H NIVK
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNR--SSLSGRARDEVLSWRRRMQIAVGAAQ 809
+ I + + ++ EY E SL Q + K SL +VL Q
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------------Q 110
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL Y+H ++HRD+K++NIL + K+ADFGVA L + A +VVG+
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA---SVVGTPY 164
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
++APE + +DI+S G ++EL TG
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 28/211 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G SG+VY+ T + VA+KK+ +L +++++ + E+ I+ +H NIV
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 754 CCISSENLKLLVYEYMEKRSL----DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
+ +V EYM+ SL Q + N ++ R EVL Q
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVL-------------Q 127
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL Y+H S ++HRD+KS NILL + + K+ADFG A L KE+ + ++VVG+
Sbjct: 128 GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK---RNSVVGTPY 181
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
++APE + + K DI+S G++ +E+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 72/216 (33%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
N IG G G V++V V A+K+I + K++++ +E + E ++L+ + I++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ +V EY E L + L + L E WR +QI +G L
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP-----EDQVWRFFIQILLG----LA 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H S I+HRD+KS N+ LD N KI D GVAK+L + FA +T+VG+ Y++
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFA--NTIVGTPYYLS 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK---EANN 905
PE + NEK+D+++ GV+L E TGK +ANN
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 3e-29
Identities = 84/297 (28%), Positives = 122/297 (41%), Gaps = 24/297 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL-NIVKL 752
+G G G+VY VA+K + + K + FL E+QIL+++ H NIVKL
Sbjct: 7 KLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
E LV EY++ SL+ L K R LS + I L
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--------PLSESEALFILAQILSALE 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKILIKEEGEF---AAMSTVVGSC 868
Y+H I+HRD+K NILLD + K+ DFG+AK+L A ST VG+
Sbjct: 116 YLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 869 GYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925
GY+APE + +DI+S G+ L EL TG G++++ + I E
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982
A P + + L + P R + L L + E +
Sbjct: 233 PSLASPLSPSNPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G GKV V T ++ A+K + + + +K + L E ILS I H IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 755 CISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLS-GRAR---DEVLSWRRRMQIAVGAAQ 809
+E KL LV EY L + H S RAR E++
Sbjct: 61 AFQTEE-KLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAEIVL------------- 104
Query: 810 GLCYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L Y+H I++RDLK NILLD + + K+ DFG+AK L E + +T G+
Sbjct: 105 ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTP 157
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE + + D +S GV+L E+ TGK
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G SG VY+V T ++ A+KKI D D++ K+ L E++ L + +VK
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
E +V EYM+ SL L KK G+ + VL IA +GL Y
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLAD-LLKKV-----GKIPEPVL-----AYIARQILKGLDY 114
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H I+HRD+K SN+L++ KIADFG++K+L E +T VG+ Y++P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E + + DI+S G+ LLE GK
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 19/236 (8%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G V +V +++ K+I + + +K +++ ++EV IL ++H NIV+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 753 LC-CISSENLKL-LVYEYMEKRSLDQWLHK--KNRSSLSGRARDEVLSWRRRMQIAVGAA 808
I N L +V EY E L Q + K K R + +E WR Q+ + A
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-----EEEFIWRILTQLLL--A 117
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
C+ D T++HRDLK +NI LD N N K+ DFG+AKIL A T VG+
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFA-KTYVGTP 174
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
Y++PE +EK+DI+S G ++ EL LA I+EGK
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS----KIKEGK 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
+G G G VY+ T E+VA+KKI +LD + E L E+ +L ++H NIVK
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
LL I +E LV+EY + L ++L K LS + S Q+ +GL
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPN---LIKSIMY--QLL----RGL 111
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL---IKEEGEFAAMSTVVGSC 868
Y H S I+HRDLK NIL++ + K+ADFG+A+ ++ + V +
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR------TYTHEVVTL 162
Query: 869 GYIAPE-YARTRKVNEKTDIYSFGVILLELTTGK 901
Y APE ++ + DI+S G I E+ TGK
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G G VY+ T +VVA+K + + L +E + E+ IL IVK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPYIVKYY 64
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GAAQG 810
+V EY S+ + + ++ L+ +IA +G
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM----------KITNKTLTEE---EIAAILYQTLKG 111
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+H S +HRD+K+ NILL+ AK+ADFGV+ L A +TV+G+ +
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTVIGTPFW 165
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+APE + N K DI+S G+ +E+ GK
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 46/223 (20%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF----LAEVQILSTIRHLNIV 750
IG G G+VY+ T E+VA+KKI +++ + E F + E+++L +RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI----RMENEKE-GFPITAIREIKLLQKLRHPNIV 61
Query: 751 KLLCCISSENLK--LLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+L ++S+ +V+EYM+ LD + + + S ++ + +++
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVKFTES-----QIKCYMKQL---- 109
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+GL Y+H + I+HRD+K SNIL++ + K+ADFG+A+ K A + V
Sbjct: 110 --LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADYTNRV 162
Query: 866 GSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ Y PE Y + D++S G IL EL GK
Sbjct: 163 ITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 28/211 (13%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
L IG G G V ++ + VAVK + +D Q FLAE +++T+RH N
Sbjct: 8 LKLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA----FLAEASVMTTLRHPN 61
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V+LL + N +V EYM K SL +L RS GRA V++ +++ A+
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYL----RS--RGRA---VITLAQQLGFALDVC 112
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK--ILIKEEGEFAAMSTVVG 866
+G+ Y+ VHRDL + N+L+ + AK++DFG+AK ++ G+ T
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--- 166
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
APE R +K + K+D++SFG++L E+
Sbjct: 167 -----APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE--KEFLAEVQILSTIRHLNIV 750
VIG G + VY E VA+K+I L++ E EVQ +S H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GA 807
K + LV Y+ SL +SS DE + IA
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAI-------IATVLKEV 111
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG-EFAAMSTVVG 866
+GL Y+H S +HRD+K+ NILL + + KIADFGV+ L T VG
Sbjct: 112 LKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 867 SCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGK 901
+ ++APE + K DI+SFG+ +EL TG
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 70/226 (30%), Positives = 109/226 (48%), Gaps = 39/226 (17%)
Query: 689 LTESNVIGSGGSGKV----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
L +G G GKV Y ++T E VAVK + + +++H +F E++IL T+
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTL 63
Query: 745 RHLNIVKL--LCCISSENLKLLVYEYMEKRSLDQWLHK-KNRSSLSGRARDEVLSWRRRM 801
H NIVK +C L+ EY+ SL +L + +++ +L R +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK-----------RLL 112
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL--------IK 853
+ +G+ Y+ S +HRDL + NIL++ KI+DFG+AK+L +K
Sbjct: 113 LFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
E GE + APE RT K + +D++SFGV L EL T
Sbjct: 170 EPGESPIF--------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVK--KIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+GSG G VY + AVK + +D + Q+ K+ E+ +LS ++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 753 LCCISSENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L E+ L ++ E + SL + L K G + V+ R QI +G L
Sbjct: 68 LGTEREED-NLYIFLELVPGGSLAKLLKK------YGSFPEPVIRLYTR-QILLG----L 115
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H VHRD+K +NIL+D N K+ADFG+AK ++ EF+ + GS ++
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV----EFSFAKSFKGSPYWM 168
Query: 872 APEY-ARTRKVNEKTDIYSFGVILLELTTGK 901
APE A+ DI+S G +LE+ TGK
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G+G SG V +V T +++AVK I ++++ +K+ L E+ IL IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ + EYM+ SLD+ L + GR + +L +IAV +GL
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILG-----KIAVAVLKGLT 114
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I+HRD+K SNIL++ K+ DFGV+ L+ A T VG+ Y+A
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAK-TFVGTSSYMA 167
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE + + K+DI+S G+ L+EL TG+
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
N IG G GKVY T E++AVK+I + D K KE E+++L ++H N+VK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 752 LLCCISSENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
+ K+ ++ EY +L++ L GR DE + +Q+ G
Sbjct: 64 YYG-VEVHREKVYIFMEYCSGGTLEELLE-------HGRILDEHVIRVYTLQLLEG---- 111
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG--EFAAMSTVVGSC 868
L Y+H S IVHRD+K +NI LD+N K+ DFG A +K + ++ G+
Sbjct: 112 LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLAGTP 167
Query: 869 GYIAPEYARTRKVNEK---TDIYSFGVILLELTTGK 901
Y+APE K DI+S G ++LE+ TGK
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILS-TIRHLNIVK 751
+IG G V T + A+K I + R+L +K K E ++L+ H I+K
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIK-ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ-- 809
L E V EY L Q++ K SL ++ + AA+
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLD----EKCTRFY--------AAEIL 112
Query: 810 -GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL----------------- 851
L Y+H S I+HRDLK NILLD + + KI DFG AK+L
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ E ++ VG+ Y++PE + + +D+++ G I+ ++ TGK
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G V+ ++V +K+I ++ + E Q+L + H NI++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ ++V EY +L +++ K+ S L D +L + ++ +A
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD---EDTILHFFVQILLA--------- 113
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+HH + I+HRDLK+ NILLD + KI DFG++KIL + TVVG+ YI+
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYIS 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEA 903
PE + N+K+DI++ G +L EL + K A
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 30/225 (13%)
Query: 685 ILPKLTE---SNVIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAE 737
+ K TE V+GSG G VY+ +P ++ VA+K + + K KE L E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDE 59
Query: 738 VQILSTIRHLNIVKLLC-CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
+++++ H ++V+LL C+SS+ L+ + M L ++ + ++ ++ + +L+
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQ--VQLITQLMPLGCLLDYV-RNHKDNIGSQY---LLN 113
Query: 797 WRRRMQIAVGAAQGLCY--MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
W QIA +G+ Y +VHRDL + N+L+ + KI DFG+AK+L +
Sbjct: 114 WCV--QIA----KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
E E+ A V ++A E R K+D++S+GV + EL T
Sbjct: 163 EKEYHAEGGKV-PIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
K+ E + +G G G V + + +T + A+K I D D + K+ L E++I + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSP 59
Query: 748 NIVKLLCCI---SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
IVK SS ++ + + EY E SLD ++KK + GR ++VL +IA
Sbjct: 60 YIVKYYGAFLDESSSSIGIAM-EYCEGGSLDS-IYKKVKK-RGGRIGEKVLG-----KIA 111
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF--AAMS 862
+GL Y+H S I+HRD+K SNILL K+ DFGV+ GE +
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAG 161
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
T G+ Y+APE + + + +D++S G+ LLE+ +
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/247 (28%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 694 VIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
+G G GKV+ H E+VAVK + + + K+F E ++L+ +H N
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDAR-KDFEREAELLTNFQHEN 69
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKN---RSSLSGRARDEVLSWRRRMQIAV 805
IVK + + ++V+EYME L+++L S + L+ + +QIAV
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A G+ Y+ S VHRDL + N L+ Y+ KI DFG MS V
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFG--------------MSRDV 172
Query: 866 GSCGY-------------IAPEYARTRKVNEKTDIYSFGVILLEL-TTGK----EANNGD 907
+ Y + PE RK ++D++SFGV+L E+ T GK +N +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 908 EHTCLAQ 914
C+ Q
Sbjct: 233 VIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 78/280 (27%), Positives = 123/280 (43%), Gaps = 40/280 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G VY+V + A+K++ + + QK ++ + E++IL+++ H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
N +V EY L + + K + E WR +Q+ +GL +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLL----RGLQAL 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H I+HRDLKS+NILL N KI D G++K+L K T +G+ Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPE 171
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK--PIVDALDK 932
+ R + K+DI+S G +L E+ T L +Q GK PI
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY----KVQRGKYPPI------ 221
Query: 933 EIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
P + +++ SML P RPN +L
Sbjct: 222 ---PPIYSQDLQN------FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 82/281 (29%), Positives = 123/281 (43%), Gaps = 48/281 (17%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G V +V T V+A K + K K+ L E+QI+ R IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+EN + E+M+ SLD+ K G E+L +IAV +GL Y+
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKK------GGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 815 ---HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
H I+HRD+K SNIL++ K+ DFGV+ LI + T VG+ Y+
Sbjct: 120 YNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-----SIADTFVGTSTYM 169
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDEHTCLAQWAWRHIQEGKPIVD 928
+PE + K K+D++S G+ ++EL GK +N D+ I+D
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG---------ILD 220
Query: 929 ALDKEIDEPC-------FLEEMIRVFKLGVICTSMLPTERP 962
L + + EP F E++ C PTERP
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+GSG G+V+ + V A+K + +D L +++F EVQ L +RH +++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRV-AIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFA 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
S ++ E MEK SL +L +VL + +A A+G+ Y+
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFL---------RSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+HRDL + NIL+ + K+ADFG+A++ IKE+ ++ + + APE
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKI--PYKWTAPE 174
Query: 875 YARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
A + K+D++SFG++L E+ T G+ G + I G +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITAGYRM------- 223
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTERPNMR 965
PC + ++K+ + C + P +RP+ +
Sbjct: 224 ---PCPAKCPQEIYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
VIG G G+V R + + VA+K + Q+ +FL E I+ H NI
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNI 67
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
++L ++ +++ EYME SLD++L R D + + + + G A
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFL----------RENDGKFTVGQLVGMLRGIAS 117
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ Y+ VHRDL + NIL++ N K++DFG+++ L E + G
Sbjct: 118 GMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG------G 168
Query: 870 YI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
I APE RK +D++SFG+++ E+ +
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ N+T V AVK + K K+FLAE QI+ +RH +++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ E +V E M+ SL ++L +GRA L + + +A A G+ Y+
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGG-----AGRA----LKLPQLIDMAAQVASGMAYL 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+ +HRDL + N+L+ N K+ADFG+A++ IKE+ + A + APE
Sbjct: 120 E---AQNYIHRDLAARNVLVGENNICKVADFGLARV-IKED-IYEAREGAKFPIKWTAPE 174
Query: 875 YARTRKVNEKTDIYSFGVILLELTT 899
A + + K+D++SFG++L E+ T
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE-KEFLAEVQILSTIRHLNIVK 751
VIG G GKV V T ++ A+K + N +K +K + L E +IL + H +V
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L E LV + + L L +K + S + + L
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVK----------FWICEIVLAL 113
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H S I+HRD+K NILLD + I DF +A + + + G+ GY+
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT----STSGTPGYM 166
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGK 901
APE + + D +S GV E GK
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 72/216 (33%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G GK+Y +E +K+I + K+ K ++ EV +L+ ++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEI-DLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+V EY + L + ++++ S D++LSW +QI++G
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS---EDQILSWF--VQISLG------- 113
Query: 814 MHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ H I+HRD+KS NI L N AK+ DFG+A+ L + E A T VG+ Y++
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELA--YTCVGTPYYLS 170
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK---EANN 905
PE + R N KTDI+S G +L EL T K E NN
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ N T +V AVK + K + FL E QI+ +RH +V+L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
S E +V EYM K SL +L G+ L + + +A A+G+ Y+
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSG-----EGKK----LRLPQLVDMAAQIAEGMAYL 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
S +HRDL + NIL+ N KIADFG+A+++ E+ E+ A + APE
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPE 174
Query: 875 YARTRKVNEKTDIYSFGVILLELTT 899
A + K+D++SFG++L E+ T
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVK 751
IGSG G VY+ T E+VA+K I KL+ + E + E+ +L RH NIV
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA---VGAA 808
+ +V EY SL Q +++ R LS +QIA
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLS------------ELQIAYVCRETL 111
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+GL Y+H +HRD+K +NILL + + K+ADFGV+ L A + +G+
Sbjct: 112 KGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA---TIAKRKSFIGTP 165
Query: 869 GYIAPEYA---RTRKVNEKTDIYSFGVILLEL 897
++APE A R + K DI++ G+ +EL
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G VY+ T E+VA+KKI R + K L E+++L + H NI+KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ LV+E+M+ L + + + R L QGL +
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLI----------KDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H S I+HRDLK N+L++ K+ADFG+A+ + V + Y APE
Sbjct: 115 H---SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPE 168
Query: 875 -YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + DI+S G I EL + +
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIW--NDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G G+VY T +AVK++ D +K E+Q+L ++H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 753 LCCISSENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
C+ ++ L ++ EYM S+ L K +L+ E ++ + QI +G+
Sbjct: 70 YGCLR-DDETLSIFMEYMPGGSVKDQL--KAYGALT-----ETVTRKYTRQIL----EGV 117
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL--IKEEGEFAAMSTVVGSCG 869
Y+H S IVHRD+K +NIL D N K+ DFG +K L I G M +V G+
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG--MKSVTGTPY 172
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+++PE K D++S G ++E+ T K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G+G G+V V + + A+K + + + K + L E +IL +IRH +V L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ---G 810
++ LV EY+ L L K R AAQ
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP--------------VARFYAAQVVLA 113
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+H IV+RDLK N+LLD + KI DFG AK + + + T+ G+ Y
Sbjct: 114 LEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTY----TLCGTPEY 164
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTG 900
+APE ++ + D ++ G+++ E+ G
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 35/269 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G+V+ N T V A+K + K + FL E Q++ +RH +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+S E + +V EYM K SL +L K + L + + +A A G+ Y+
Sbjct: 69 VVSEEPI-YIVTEYMSKGSLLDFL--KGEMG-------KYLRLPQLVDMAAQIASGMAYV 118
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
VHRDL+++NIL+ N K+ADFG+A+++ E+ E+ A + APE
Sbjct: 119 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPE 173
Query: 875 YARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
A + K+D++SFG++L ELTT G+ G + ++D +++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------------MVNREVLDQVERG 219
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTERP 962
PC E + L C P ERP
Sbjct: 220 YRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 34/206 (16%)
Query: 709 NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKL-LVY 766
++T EVVAVKK+ + +H ++F E++IL +++H NIVK C S+ L LV
Sbjct: 30 DNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86
Query: 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRD 826
EY+ SL +L +K+R L R + + A +G+ Y+ S VHRD
Sbjct: 87 EYLPYGSLRDYL-QKHRERLDHR---------KLLLYASQICKGMEYLG---SKRYVHRD 133
Query: 827 LKSSNILLDYNFNAKIADFGVAKIL--------IKEEGEFAAMSTVVGSCGYIAPEYART 878
L + NIL++ KI DFG+ K+L ++E GE S + + APE
Sbjct: 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE----SPIF----WYAPESLTE 185
Query: 879 RKVNEKTDIYSFGVILLELTTGKEAN 904
K + +D++SFGV+L EL T + +
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL-------AEVQILSTIRH 746
+IG G G+VY T E++AVK++ + +H+ +E++ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
LNIV+ L ++E + EY+ S+ L GR ++++ + +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT------YGRFEEQLVRFFTEQVL--- 118
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
+GL Y+H S I+HRDLK+ N+L+D + KI+DFG++K MS + G
Sbjct: 119 --EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQG 172
Query: 867 SCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGK 901
S ++APE + + + K DI+S G ++LE+ G+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 86/298 (28%), Positives = 134/298 (44%), Gaps = 40/298 (13%)
Query: 689 LTESNVIGSGGSGKV--YRV-PINH-TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
L + V+G G GKV Y P N T E+VAVK + R+ Q++ + E+ IL T+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL 63
Query: 745 RHLNIVKLLCCISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
H NIVK C S + K L+ EY+ SL +L K L+ + +
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------------LNLAQLLL 111
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL--------IKE 854
A +G+ Y+H S +HRDL + N+LLD + KI DFG+AK + ++E
Sbjct: 112 FAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+G+ S V + A E + K + +D++SFGV L EL T ++
Sbjct: 169 DGD----SPVF----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220
Query: 915 WAWRHIQEGK-PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ Q +++ L++ + PC V+ L C RP R ++ IL
Sbjct: 221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE 737
LN ++ L IG G G V + ++ VAVK I ND + FLAE
Sbjct: 3 LNMKE------LKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAE 49
Query: 738 VQILSTIRHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
+++ +RH N+V+LL I E L +V EYM K SL +L + RS L G
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD------- 102
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
++ ++ + + Y+ + VHRDL + N+L+ + AK++DFG L KE
Sbjct: 103 --CLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEAS 153
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ T + APE R +K + K+D++SFG++L E+
Sbjct: 154 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 22/219 (10%)
Query: 689 LTESNVIGSGGSGKVYR--VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
+T+ VIG+G G+V+R + + EV VA+K + +K ++FL+E I+
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQFS 64
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H NI++L ++ +++ EYME +LD++L R D S + + +
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL----------RDHDGEFSSYQLVGMLR 114
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
G A G+ Y+ VHRDL + NIL++ N K++DFG++++L E+ +T
Sbjct: 115 GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSG 169
Query: 866 GSCG--YIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902
G + APE RK +D++SFG+++ E+ + E
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
I G G+V+ T ++ A+K I + + + L E ILS + +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ LV EY+ L L + DE ++ +I + L Y+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVG-------SLDEDVARIYIAEIVL----ALEYL 109
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-----LIKEEGEFAAMSTVVGSCG 869
H S I+HRDLK NIL+D N + K+ DFG++K+ I + +VG+
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
YIAPE + ++ D +S G IL E G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 79/269 (29%), Positives = 127/269 (47%), Gaps = 35/269 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ N +V AVK + K + FL E QI+ +RH +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+S E + +V EYM K SL +L GRA L + +A A G+ Y+
Sbjct: 69 VVSEEPI-YIVTEYMSKGSLLDFLKDGE-----GRA----LKLPNLVDMAAQVAAGMAYI 118
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+HRDL+S+NIL+ KIADFG+A+++ E+ E+ A + APE
Sbjct: 119 ER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPE 173
Query: 875 YARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
A + K+D++SFG++L EL T G+ G + +++ +++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPG--------------MNNREVLEQVERG 219
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTERP 962
PC + I + +L + C P ERP
Sbjct: 220 YRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G VY T EVVA+KK+ K + ++ + EV+ L +RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 755 CISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C E+ LV EY + D +HKK E+ + I GA QGL Y
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKK------PLQEVEIAA------ICHGALQGLAY 130
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +HRD+K+ NILL K+ADFG A ++ + ++ VG+ ++AP
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV-------SPANSFVGTPYWMAP 180
Query: 874 EYARTR---KVNEKTDIYSFGVILLELTTGK 901
E + + K D++S G+ +EL K
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKL 752
IG G G+VY+ T +VVA+K I + D E E + E+Q LS R I K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED---EIEDIQQEIQFLSQCRSPYITKY 64
Query: 753 LCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR-RRMQIAVGAAQ- 809
+ KL ++ EY G D + + IA +
Sbjct: 65 YGSFL-KGSKLWIIMEYCG----------------GGSCLDLLKPGKLDETYIAFILREV 107
Query: 810 --GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
GL Y+H + +HRD+K++NILL + K+ADFGV+ L + +T VG+
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGT 161
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
++APE + +EK DI+S G+ +EL G+
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 44/220 (20%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL- 753
IG G G V++ T E VA+KK+ R+L+ + L E++ L +H +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 754 ------CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV-----LSWRRRMQ 802
+ LV EYM S LS RDE + M+
Sbjct: 67 VFPHGSGFV-------LVMEYMP-------------SDLSEVLRDEERPLPEAQVKSYMR 106
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+ + G+ YMH + I+HRDLK +N+L+ + KIADFG+A++ +EE S
Sbjct: 107 MLLK---GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR--LYS 158
Query: 863 TVVGSCGYIAPE--YARTRKVNEKTDIYSFGVILLELTTG 900
V + Y APE Y RK + D+++ G I EL G
Sbjct: 159 HQVATRWYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
L KLT +IG G G V + +T + VAVK I D + FL E +++ +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLH 57
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H N+V+LL I L + V E M K +L +L + R+ ++S + +Q ++
Sbjct: 58 HKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRA---------LVSVIQLLQFSL 107
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A+G+ Y+ S +VHRDL + NIL+ + AK++DFG+A++ +
Sbjct: 108 DVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV------GSMGVDNSK 158
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ APE + +K + K+D++S+GV+L E+
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G VY+ VVA+KK+ +D K ++ L E+ +L + H N++K L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWL-HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
N +V E + L + + H K + R E W+ +Q+ L +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQ----KRLIPERTIWKYFVQLC----SALEH 121
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
MH S I+HRD+K +N+ + K+ D G+ + + AA S +VG+ Y++P
Sbjct: 122 MH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHS-LVGTPYYMSP 175
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
E N K+DI+S G +L E+ + GD+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-----EV 738
D+ P+ + IG G G V T VA+KKI E + E+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREI 54
Query: 739 QILSTIRHLNIVKLLCCISSENLK-----LLVYEYMEKRSLDQWLHKKNRS-SLSGRARD 792
+IL +H NI+ +L I + + +V E ME L+K ++ LS D
Sbjct: 55 KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSN---D 106
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
+ + QI +GL Y+H S ++HRDLK SN+LL+ N + KI DFG+A+I
Sbjct: 107 HIQYFL--YQIL----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKT-DIYSFGVILLELTTGK 901
E ++ V + Y APE K K DI+S G IL E+ + +
Sbjct: 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK--EFLAEVQILSTIRHLNIVKL 752
IG G G VY +HT EVVAVKK+ K Q +EK + + EV+ L ++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 753 LCCISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
C E+ LV EY + D +HKK + A I GA QGL
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------ITHGALQGL 134
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H ++HRD+K+ NILL K+ADFG A + ++ VG+ ++
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS-------SPANSFVGTPYWM 184
Query: 872 APEYARTR---KVNEKTDIYSFGVILLELTTGKEA 903
APE + + K D++S G+ +EL K
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 71/225 (31%), Positives = 115/225 (51%), Gaps = 36/225 (16%)
Query: 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
L +L N IGSG G VY+V T + A+K I+ + + ++ E++IL +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN 130
Query: 746 HLNIVKLLCCISSEN---LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
H N+VK C ++ +++L+ E+M+ SL+ H + L+ AR ++LS
Sbjct: 131 HPNVVK--CHDMFDHNGEIQVLL-EFMDGGSLEG-THIADEQFLADVAR-QILS------ 179
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
G+ Y+H IVHRD+K SN+L++ N KIADFGV++IL + +
Sbjct: 180 -------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ---TMDPCN 226
Query: 863 TVVGSCGYIAPEYARTRKVNEKT------DIYSFGVILLELTTGK 901
+ VG+ Y++PE T +N DI+S GV +LE G+
Sbjct: 227 SSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G GK V + +K+I N K+ K +E EV +LS ++H NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+V +Y E L + ++ + D++L W +QI + +
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWF--VQICLA-------L 114
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H I+HRD+KS NI L + K+ DFG+A++L E A T +G+ Y++PE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELA--RTCIGTPYYLSPE 171
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGKEA 903
R N K+DI++ G +L E+ T K A
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL- 753
IG G G VY+ + EV AVK + D K ++FL E +IL H NIVKL+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIG 59
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C+ + + +V E + SL +L KK R L+ ++ +Q+++ AA G+ Y
Sbjct: 60 VCVQKQPI-YIVMELVPGGSLLTFLRKK-----KNR-----LTVKKLLQMSLDAAAGMEY 108
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI-- 871
+ +HRDL + N L+ N KI+DFG+++ +EEG + TV I
Sbjct: 109 LESKNC---IHRDLAARNCLVGENNVLKISDFGMSR---EEEG---GIYTVSDGLKQIPI 159
Query: 872 ---APEYARTRKVNEKTDIYSFGVILLELTTG 900
APE + ++D++S+G++L E +
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 7e-19
Identities = 76/224 (33%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IGSG G V T VA+KKI N D K L E+++L +RH NI+ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGL 64
Query: 753 LCCI---SSENLK--LLVYEYMEKRSLDQWLHK--KNRSSLSGRARDEVLSWRRRMQ-IA 804
L + S E+ +V E ME D LHK K+ L+ D+ +Q
Sbjct: 65 LDILRPPSPEDFNDVYIVTELME---TD--LHKVIKSPQPLT----DD------HIQYFL 109
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+GL Y+H S ++HRDLK SNIL++ N + KI DFG+A+ + +E E ++
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 865 VGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
V + Y APE Y + DI+S G I EL T K
Sbjct: 167 VVTRWYRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 72/221 (32%), Positives = 103/221 (46%), Gaps = 32/221 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
IG G G VY+ T E+VA+KKI +L+ + E + E+ +L + H NIV+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
LL + SEN LV+E+ LD L KK S D L Q+ QG+
Sbjct: 63 LLDVVHSENKLYLVFEF-----LDLDL-KKYMDSSPLTGLDPPLIKSYLYQLL----QGI 112
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AMSTVVGS 867
Y H S ++HRDLK N+L+D K+ADFG+A+ F + V +
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARA-------FGVPVRTYTHEVVT 162
Query: 868 CGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907
Y APE +R+ + DI+S G I E+ + GD
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+DI K + +G G G+VY + VAVK + K D +EFL E ++
Sbjct: 6 TDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMK 57
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
I+H N+V+LL + E ++ E+M +L +L + NR ++ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV---------LLY 108
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+A + + Y+ +HRDL + N L+ N K+ADFG+++++ + A +
Sbjct: 109 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHA 163
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE K + K+D+++FGV+L E+ T
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE---FLAEVQILSTIRHLNIVK 751
+G G GKVY+ T A K I + E+E F+ E+ ILS +H NIV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII------QIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L EN ++ E+ + +LD + + R G ++ R+M + L
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELER----GLTEPQIRYVCRQM------LEAL 116
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
++H S ++HRDLK+ NILL + + K+ADFGV+ + T +G+ ++
Sbjct: 117 NFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK---RDTFIGTPYWM 170
Query: 872 APEYA-----RTRKVNEKTDIYSFGVILLELTTGKEANN 905
APE + + K DI+S G+ L+EL + ++
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 693 NVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
VIG G G VY + + AVK + +R D + ++FL E I+ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 750 VKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ LL C+ SE L+V YM+ L ++ + + + + + + A
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP----------TVKDLIGFGLQVA 108
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK-ILIKEEGEFAAMSTVVGS 867
+G+ Y+ S VHRDL + N +LD +F K+ADFG+A+ I KE +
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
++A E +T+K K+D++SFGV+L EL T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 47/284 (16%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G+V+ N T +V A+K + K + FL E QI+ +RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+S E + +V E+M K SL +L + + + L + + +A A G+ Y+
Sbjct: 69 VVSEEPI-YIVTEFMGKGSLLDFLKEGD---------GKYLKLPQLVDMAAQIADGMAYI 118
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+HRDL+++NIL+ N KIADFG+A+++ E+ E+ A + APE
Sbjct: 119 ER---MNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPE 173
Query: 875 YARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
A + K+D++SFG++L EL T G+ G + +++ +++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPG--------------MVNREVLEQVERG 219
Query: 934 IDEPC------FLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
PC L E+++ +C P ERP + L
Sbjct: 220 YRMPCPQGCPESLHELMK------LCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIW---NDRKLDQKHEKEFLAEVQILSTIRH 746
T+ V+G G G VY + + +++AVK++ ++ +K ++ EV +L +++H
Sbjct: 3 TKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
+NIV+ L +N + E++ S+ L NR E + + QI
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFG----PLPEPVFCKYTKQIL-- 112
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL--IKEEGEFAAM-ST 863
G+ Y+H++C +VHRD+K +N++L N K+ DFG A+ L + G + M +
Sbjct: 113 --DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ G+ ++APE K+DI+S G + E+ TGK
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVKL 752
V+G G GKV + T E A+K + D L+ + + E ++L+ H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQ 809
C ++ V EY+ L + R + RAR E++
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIIC------------- 107
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL ++H I++RDLK N+LLD + + KIADFG+ K + EG+ ST G+
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPD 161
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
YIAPE + +K NE D +SFGV+L E+ G+ +G++
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 69/214 (32%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL 753
+G G G VY T E+VA+KK+ +K E L EV+ L + H NIVKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 754 CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLS-GRARDEVLSWRRRMQIAVGAAQGL 811
EN +L V+EYME +L Q + + S R + QI QGL
Sbjct: 65 EVFR-ENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIY------QIL----QGL 112
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS---TVVGSC 868
++H HRDLK N+L+ KIADFG+A+ E + V +
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTR 162
Query: 869 GYIAPE-YARTRKVNEKTDIYSFGVILLELTTGK 901
Y APE R+ + DI++ G I+ EL T +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 30/218 (13%)
Query: 694 VIGSGGSGKVY--RVPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
VIG+G G+V R+ + E+ VA+K + +K ++FL+E I+ H NI+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS----SLSGRARDEVLSWRRRMQIAVG 806
L ++ ++V EYME SLD +L K + L G R G
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR--------------G 114
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
A G+ Y+ D VHRDL + NIL++ N K++DFG++++L E+ AA +T G
Sbjct: 115 IASGMKYL-SDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGG 169
Query: 867 SCG--YIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902
+ APE RK +D++S+G+++ E+ + E
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK---EFLAEVQILSTIRH 746
+ +G+G Y+ T ++AVK++ R + E+ E+++++ + H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
+I+++L ++ L E+M S+ L K A E + Q+
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-------AFKEAVIINYTEQLL-- 113
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKIL---IKEEGEFAAMS 862
+GL Y+H + I+HRD+K +N+L+D +IADFG A L GEF
Sbjct: 114 --RGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ- 167
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922
++G+ ++APE R + D++S G +++E+ T K N ++H+ H+
Sbjct: 168 -LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-------NHLAL 219
Query: 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
I A P L +R L C + P +RP R LL +P+F
Sbjct: 220 IFKIASATTAP-SIPEHLSPGLRDVTLR--CLELQPEDRPPSRE----LLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 688 KLTESNVIGSGGSGKVY-----RVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
K+T +G G G VY V VA+K + + + ++ EFL E ++
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMK 64
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
++V+LL +S+ L+V E M K L +L + + + + ++ +Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG-PPTLQKFIQ 123
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL-----IKEEGE 857
+A A G+ Y+ + VHRDL + N ++ + KI DFG+ + + ++ G+
Sbjct: 124 MAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ V ++APE + K+D++SFGV+L E+ T
Sbjct: 181 --GLLPV----RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-18
Identities = 75/233 (32%), Positives = 114/233 (48%), Gaps = 37/233 (15%)
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL 741
D IL K +G G G V++ T EVVA+KKI++ + ++ F E+ L
Sbjct: 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFL 60
Query: 742 STIR-HLNIVKLLCCISSENLK--LLVYEYME-------KRSLDQWLHKKNRSSLSGRAR 791
+ H NIVKLL I +EN K LV+EYME + ++ + +HK+
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR---------- 110
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
I + L Y+H S ++HRDLK SNILL+ + K+ADFG+A+ L
Sbjct: 111 ----------YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
Query: 852 --IKEEGEFAAMSTVVGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGK 901
++E E ++ V + Y APE + + + D++S G IL E+ GK
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 694 VIGSG--GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
V+G G G +YR +V K++ N +L +K ++ L E+ ILS ++H NI+
Sbjct: 7 VLGKGAFGEATLYRR--TEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+N L+ EY +L + ++ +E++ W QI +
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE----EEMVLWYL-FQIVSAVS--- 115
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H I+HRD+K+ NI L K+ DFG++KIL E++ TVVG+ Y+
Sbjct: 116 -YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYM 168
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907
+PE + K N K+DI++ G +L EL T K +
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-18
Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE 737
L F++ D T+ IG G G VY T EVVA+KK+ K + ++ + E
Sbjct: 17 LFFKE-DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLS 796
V+ L I+H N ++ C E+ LV EY + D +HKK + A
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------ 129
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
I GA QGL Y+H S ++HRD+K+ NILL K+ADFG A I
Sbjct: 130 ------ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA----- 175
Query: 857 EFAAMSTVVGSCGYIAPEYARTR---KVNEKTDIYSFGVILLELTTGK 901
+ ++ VG+ ++APE + + K D++S G+ +EL K
Sbjct: 176 --SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-18
Identities = 60/206 (29%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 711 TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL-VYEYM 769
T VA+K + D ++ F E + + + H NIV LL + L V+EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA--AQGLCYMHHDCSPTIVHRDL 827
R+L + L A D L G Q L + + IVHRDL
Sbjct: 62 PGRTLREVL-----------AADGALP-----AGETGRLMLQVLDALACAHNQGIVHRDL 105
Query: 828 KSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMST----VVGSCGYIAPEYARTRK 880
K NI++ +AK+ DFG+ +L A T V+G+ Y APE R
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165
Query: 881 VNEKTDIYSFGVILLELTTGKEANNG 906
V +D+Y++G+I LE TG+ G
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 76/276 (27%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G GKV + T E+ AVK + D L + + E ++L+ +H + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C +++ V EY+ L + + R RAR A GL
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RAR----------FYAAEIVLGLQ 110
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG--EFAAMSTVVGSCGY 870
++H I++RDLK N+LLD + KIADFG+ K EG ST G+ Y
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDY 162
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDAL 930
IAPE + D ++ GV+L E+ G+ GD+ L Q L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-------------SIL 209
Query: 931 DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM 966
+ E+ P +L + + I S L T+ P R+
Sbjct: 210 EDEVRYPRWLSK-----EAKSILKSFL-TKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
VIG G GKVY+ T ++VA+K + + + E+E E IL H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM----DIIEDEEEEIKEEYNILRKYSNHPNIATF 68
Query: 753 LCCISSENLKL------LVYEYMEKRS---LDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
+N LV E S L + L KK + R ++E +++ I
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-----RLKEEWIAY-----I 118
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+GL Y+H ++HRD+K NILL N K+ DFGV+ L G +T
Sbjct: 119 LRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG---RRNT 172
Query: 864 VVGSCGYIAPE-----YARTRKVNEKTDIYSFGVILLELTTGK 901
+G+ ++APE + ++D++S G+ +EL GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 73/221 (33%), Positives = 109/221 (49%), Gaps = 31/221 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
IG G G VY+ T E +A+KKI +L+Q+ E + E+ +L ++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L + SE LV+EY++ LD KK+ S A++ L QI +G+
Sbjct: 66 LQDVVHSEKRLYLVFEYLD---LDL---KKHMDSSPDFAKNPRLIKTYLYQI----LRGI 115
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAK---ILIKEEGEFAAMSTVVGS 867
Y H S ++HRDLK N+L+D NA K+ADFG+A+ I ++ + V +
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR------TFTHEVVT 166
Query: 868 CGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907
Y APE +R + DI+S G I E+ K GD
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDR---KLDQKHEKEFLA---EVQILSTIRHL 747
+IGSG G VY + E++AVK++ + A E+ +L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NIV+ L + + EY+ S+ L+ A +E L QI
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-------AFEETLVRNFVRQIL--- 116
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL---IKEEGEFAAMSTV 864
+GL Y+H + I+HRD+K +NIL+D KI+DFG++K L A ++
Sbjct: 117 -KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
GS ++APE + K DI+S G +++E+ TGK
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 57/193 (29%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 709 NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC-CISSENLKLLVYE 767
+ +VAVK + D + + +FL E++I+S +++ NI++LL C+S + L ++ E
Sbjct: 41 DGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-CMITE 97
Query: 768 YMEKRSLDQWLHKKN-RSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRD 826
YME L+Q+L ++ S+ + +S + +AV A G+ Y+ S VHRD
Sbjct: 98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRD 154
Query: 827 LKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTD 886
L + N L+ ++ KIADFG+++ L + + V ++A E K +D
Sbjct: 155 LATRNCLVGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASD 213
Query: 887 IYSFGVILLELTT 899
+++FGV L E+ T
Sbjct: 214 VWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQILSTIRHL 747
N IG G G VYR + E+VA+KK+ D E++ L E+ +L +RH
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDN------ERDGIPISSLREITLLLNLRHP 66
Query: 748 NIVKLLCCISSENLK--LLVYEYMEK---RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
NIV+L + ++L LV EY E+ LD N + ++ + L +Q
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD------NMPTPFSESQVKCLM----LQ 116
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+ +GL Y+H + I+HRDLK SN+LL KIADFG+A+ M+
Sbjct: 117 LL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMT 166
Query: 863 TVVGSCGYIAPEYA-RTRKVNEKTDIYSFGVILLELTTGK 901
V + Y APE D+++ G IL EL K
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 45/107 (42%), Positives = 62/107 (57%), Gaps = 4/107 (3%)
Query: 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKI 566
L LD L G +P DI + L ++NLS N + G IP +G + L+ LDLS N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 567 PPQIGRL-MLTSLNLSSNRLTGEIPSQFENRAY--AS-SFLNNPGLC 609
P +G+L L LNL+ N L+G +P+ R AS +F +N GLC
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 74/222 (33%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
IG G G VY+ T EVVA+KKI +LD + E + E+ +L + H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHK-KNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
LL I +EN LV+E+ L Q L K + S LSG + S+ ++ QG
Sbjct: 64 LLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQL------LQG 112
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AMSTVVG 866
L + H S ++HRDLK N+L++ K+ADFG+A+ F + V
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-------AFGVPVRTYTHEVV 162
Query: 867 SCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907
+ Y APE + + DI+S G I E+ T + GD
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G+V V + +KK+ N R ++ K E Q+LS ++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 754 CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
E+ L +V + E L L ++ + ++L + ++ V A L
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQ---------KGKLLPENQVVEWFVQIAMALQ 116
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I+HRDLK+ N+ L K+ D G+A++L E + ST++G+ Y++
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLIGTPYYMS 170
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK--PIVDAL 930
PE + N K+D+++ G + E+ T K A N + L I EGK P+
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY----RIIEGKLPPMPKDY 226
Query: 931 DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
E L E+I S P +RP+++ +L+
Sbjct: 227 SPE------LGELIATM------LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 695 IGSGGSGKV----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+G G G V Y + EV AVK + + K KEFL E +++ + H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIV 59
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
+L+ E L +LV E L ++L K+ +S ++ Q+A+G
Sbjct: 60 RLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-----DLKELA--HQVAMG---- 107
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
M + S VHRDL + N+LL AKI+DFG+++ L + A + +
Sbjct: 108 ---MAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLE 896
APE K + K+D++S+GV L E
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 685 ILPKLTESNVIGSGGSGKVYRVPI-----NHTAEVVAVKKIWNDRKLDQKHE----KEFL 735
L + +G G GKVY+ + +A VA+K L + E +EF
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT------LKENAEPKVQQEFR 56
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRA 790
E +++S ++H NIV LL + E +++EY+ L ++L H +
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 791 RDEVLSWRRRMQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848
L + IA+ A G+ Y+ HH VHRDL + N L+ KI+DFG++
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ I + S + ++ PE K ++DI+SFGV+L E+
Sbjct: 172 R-DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
++G G G VY+ T ++AVK I D ++ +K+ ++E++IL I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL--QKQIMSELEILYKCDSPYIIGF 64
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
EN + E+M+ SLD + + + VL +IAV +GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY----------RKIPEHVLG-----RIAVAVVKGLT 109
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+ S I+HRD+K SN+L++ K+ DFGV+ L+ + T VG+ Y+A
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SIAKTYVGTNAYMA 161
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE + +D++S G+ +EL G+
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE--KEFLAEVQIL 741
D KL E +G+G G V +V + ++A K I L+ K + + E+++L
Sbjct: 1 DDFEKLGE---LGAGNGGVVTKVLHRPSGLIMARKLI----HLEIKPAIRNQIIRELKVL 53
Query: 742 STIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
IV S+ + E+M+ SLDQ L K +GR + +L
Sbjct: 54 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK------AGRIPENILG----- 102
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
+I++ +GL Y+ I+HRD+K SNIL++ K+ DFGV+ LI +
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMA 155
Query: 862 STVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
++ VG+ Y++PE + ++DI+S G+ L+E+ G+
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
VIG+G G+V R + + VA+K + +K ++FL+E I+ H NI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
L ++ +++ E+ME +LD +L R D + + + + G A G
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL----------RQNDGQFTVIQLVGMLRGIAAG 118
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG- 869
+ Y+ VHRDL + NIL++ N K++DFG+++ L + + S++ G
Sbjct: 119 MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 870 -YIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902
+ APE RK +D++S+G+++ E+ + E
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ-ILSTIRHL 747
L + IG G G V ++ + ++AVK+I +D+K +K L ++ ++ +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
IVK + E + E M+ SLD+ +K L +E+L +IAV
Sbjct: 64 YIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILG-----KIAVAT 116
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ L Y+ + I+HRD+K SNILLD N N K+ DFG++ L+ + A + G
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV----DSIAKTRDAGC 170
Query: 868 CGYIAPEY---ARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE + + ++D++S G+ L E+ TGK
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G VY+ T +VA+KKI + + K F A E+++L ++H NI+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHK--KNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
L ++ LV+E+ME D L K K++S + A ++ S+ M + + +G
Sbjct: 68 LDVFGHKSNINLVFEFMET---D--LEKVIKDKSIVLTPA--DIKSY---MLMTL---RG 114
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA----MSTVVG 866
L Y+H S I+HRDLK +N+L+ + K+ADFG+A+ F + M+ V
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS-------FGSPNRKMTHQVV 164
Query: 867 SCGYIAPE-YARTRKVNEKTDIYSFGVILLEL 897
+ Y APE R D++S G I EL
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 74/225 (32%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWN--DRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G V + T E VA+KKI N D ++D K L E+++L + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVIAI 69
Query: 753 LCCI---SSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+ E +VYE M D LH+ RSS + LS
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSS-------QTLSDDHCQYFLYQL 117
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+GL Y+H S ++HRDLK SN+LL+ N + KI DFG+A+ E+G+F M+ V +
Sbjct: 118 LRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDF--MTEYVVT 171
Query: 868 CGYIAPEYARTRKVNEKT---DIYSFGVILLELTTGKEANNGDEH 909
Y APE +E T D++S G I EL K G ++
Sbjct: 172 RWYRAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 48/280 (17%)
Query: 695 IGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+G G G V R V AVK + +D+ D +FL E I+ ++ H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENLI 59
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS--WRRRMQIAVGAA 808
+L + + L + V E SL L K +S +QIA
Sbjct: 60 RLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFL-------ISTLCDYAVQIA---- 107
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
G+ Y+ S +HRDL + NILL + KI DFG+ + L + E + +
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
+ APE RTR + +D++ FGV L E+ T G+E W + G I+
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE-------------PWAGLS-GSQIL 210
Query: 928 DALDKEID-----EPCFLEEMIRVFKLGVICTSMLPTERP 962
+DKE + E C + ++ + + C + P +RP
Sbjct: 211 KKIDKEGERLERPEACPQD----IYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G VY +EVVA+KK+ K + ++ + EV+ L +RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 755 CISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C E+ LV EY + D +HKK + A + GA QGL Y
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHGALQGLAY 130
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S ++HRD+K+ NILL K+ DFG A I+ A + VG+ ++AP
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWMAP 180
Query: 874 EYARTR---KVNEKTDIYSFGVILLELTTGK 901
E + + K D++S G+ +EL K
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL---NIV 750
+IG G G VYR T VVA+K I D D + + EV +LS +R NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ--REVALLSQLRQSQPPNIT 65
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
K ++ EY E S+ R+ + E + I
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAE----KYISVIIREVLVA 113
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+H ++HRD+K++NIL+ N K+ DFGVA +L + + ST VG+ +
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RSTFVGTPYW 167
Query: 871 IAPEYART-RKVNEKTDIYSFGVILLELTTG 900
+APE + + K DI+S G+ + E+ TG
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G V + T E+VA+KK + + + D+ +K L EV++L +RH NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV--LSWRRRMQIAVGAAQGL 811
+ LV+EY+E+ L+ + + L D V W Q+ Q +
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELL--EASPGGLP---PDAVRSYIW----QLL----QAI 113
Query: 812 CYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
Y H H+ I+HRD+K NIL+ + K+ DFG A+ L + ++ V + Y
Sbjct: 114 AYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYVATRWY 167
Query: 871 IAPE-------YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT 910
APE Y + D+++ G I+ EL G+ GD
Sbjct: 168 RAPELLVGDTNYGKP------VDVWAIGCIMAELLDGEPLFPGDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ N++ +V AVK + K + FL E ++ T++H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
++ E ++ EYM K SL +L +S G+ + + + + A+G+ Y+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFL----KSDEGGK-----VLLPKLIDFSAQIAEGMAYI 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+HRDL+++N+L+ + KIADFG+A+++ E+ E+ A + APE
Sbjct: 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE 174
Query: 875 YARTRKVNEKTDIYSFGVILLELTT 899
K+D++SFG++L E+ T
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 21/234 (8%)
Query: 695 IGSGGSGKVYRVPINHTAE-----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G G GKV+ ++ +VAVK + ++ + ++F E ++L+ ++H +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWL--HKKNRSSLSGRARDEV--LSWRRRMQIAV 805
V+ + L+V+EYM L+++L H + L+G L+ + + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A G+ Y+ S VHRDL + N L+ KI DFG+++ + + T++
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEA----NNGDEHTCLAQ 914
++ PE RK ++DI+SFGV+L E+ T GK+ +N + C+ Q
Sbjct: 187 -PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 63/215 (29%), Positives = 112/215 (52%), Gaps = 19/215 (8%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+L V+GSG G VY+ VP T ++ KI N+ K EF+ E I++++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASM 66
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H ++V+LL S ++L V + M L ++H+ ++ ++ + +L+W
Sbjct: 67 DHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHE-HKDNIGSQL---LLNW------C 115
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
V A+G+ Y+ +VHRDL + N+L+ + KI DFG+A++L +E E+ A
Sbjct: 116 VQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ ++A E RK ++D++S+GV + EL T
Sbjct: 173 M-PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ N +V A+K + K + FLAE ++ ++H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKV-AIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
++ E + ++ EYME SL +L L+ + + +A A+G+ ++
Sbjct: 69 VVTQEPI-YIITEYMENGSLVDFLKTPEGIKLT---------INKLIDMAAQIAEGMAFI 118
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+HRDL+++NIL+ KIADFG+A+++ E+ E+ A + APE
Sbjct: 119 ERK---NYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE 173
Query: 875 YARTRKVNEKTDIYSFGVILLELTT 899
K+D++SFG++L E+ T
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 66/240 (27%), Positives = 96/240 (40%), Gaps = 54/240 (22%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD---QKHEKEFLAEVQILSTIRHLNIV 750
VIG G G+V+ V T +V A+K + RK D + AE IL+ IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR----RMQIAVG 806
KL E LV EYM L L +K+ E R + +A+
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF-------PE--ETARFYIAELVLALD 115
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS---- 862
+ L + +HRD+K NIL+D + + K+ADFG+ K + K + ++
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 863 ----------------------TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
+ VG+ YIAPE R + D +S GVIL E+ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQILSTIRHL 747
IG G G+VY+ T E+VA+KK+ +LD +EKE + E++IL + H
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV----RLD--NEKEGFPITAIREIKILRQLNHR 66
Query: 748 NIVKLLCCISSENLKL----------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
NIV L ++ + L LV+EYM D L S L + D + S+
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
+++ +GL Y H +HRD+K SNILL+ K+ADFG+A++ EE
Sbjct: 122 MKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 858 FAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ V + Y PE + D++S G IL EL T K ++ LAQ
Sbjct: 173 --PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 63/227 (27%), Positives = 111/227 (48%), Gaps = 25/227 (11%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEV--VAVKKIWNDRKLDQKHEKE---FLAEVQ 739
+LT +G G G+V + V +++ E VAVK + +D EK+ ++E++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKDLSDLVSEME 67
Query: 740 ILSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNR------SSLSGRARD 792
++ I +H NI+ LL + E +V EY +L +L + R S R +
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
E L+ + + A A+G+ ++ S +HRDL + N+L+ + KIADFG+A+ I
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD-I 182
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ + ++APE R ++D++SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 695 IGSGGSGKV-----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G G GKV Y + +VAVK + D L + K+F E ++L+ ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 750 VKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL---SGRARDE--VLSWRRRMQI 803
VK C + L ++V+EYM+ L+++L ++ G+ R L + + I
Sbjct: 70 VKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
A A G+ Y+ S VHRDL + N L+ N KI DFG+++ + + T
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKE 902
++ ++ PE RK ++D++SFGVIL E+ T GK+
Sbjct: 186 ML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 57/187 (30%), Positives = 100/187 (53%), Gaps = 8/187 (4%)
Query: 714 VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC-CISSENLKLLVYEYMEKR 772
+VAVK + D ++ +FL E++I+S ++ NI++LL CI+S+ L ++ EYME
Sbjct: 48 LVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-CMITEYMENG 104
Query: 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNI 832
L+Q+L + + +A +S+ + +A A G+ Y+ S VHRDL + N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC 161
Query: 833 LLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGV 892
L+ N+ KIADFG+++ L + + V +++ E K +D+++FGV
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 893 ILLELTT 899
L E+ T
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 695 IGSGGSGKVYRV-PINHTAEVVAVKKIW----NDRKLDQKHEKEF---LAEVQIL-STIR 745
+GSG G VY+V N+ ++A+K+I K ++ +K ++EV I+ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 746 HLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H NIV+ EN +L +V + +E L + H + R +E + W +Q+
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERI-WNIFVQMV 123
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ L Y+H + IVHRDL +NI+L + I DFG+A K++ + +++V
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA----KQKQPESKLTSV 173
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
VG+ Y PE + EK D+++FG IL ++ T
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 75/232 (32%), Positives = 107/232 (46%), Gaps = 60/232 (25%)
Query: 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI-LSTIR---- 745
E IG G G VY+ +T VA+KK+ + L+E I LST+R
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV-----------RVPLSEEGIPLSTLREIAL 51
Query: 746 --------HLNIVKLL--C--CISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSG-RAR 791
H NIV+LL C + LKL LV+E+++ + L +L K + L +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIK 110
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
D L Q+ +G+ ++H S IVHRDLK NIL+ + KIADFG+A+I
Sbjct: 111 D--LMR----QL----LRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
Query: 852 IKEEGEFAAMSTVVGSCGYIAPE------YARTRKVNEKTDIYSFGVILLEL 897
A+++VV + Y APE YA D++S G I EL
Sbjct: 158 ----SFEMALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 695 IGSGGSGKVYR--VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+GSG G V + + + + VAVK + ND D + E L E ++ + + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRM 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ +E+ +LV E E L+++L +KN+ ++ + ++ + G+
Sbjct: 62 IGICEAESW-MLVMELAELGPLNKFL-QKNKH----------VTEKNITELVHQVSMGMK 109
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+ VHRDL + N+LL AKI+DFG++K L +E + A + + A
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 873 PEYARTRKVNEKTDIYSFGVILLE 896
PE K + K+D++SFGV++ E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE---FLAEVQILSTIRHLNIVK 751
+G G GKVY+ T + A K I + K E+E ++ E++IL+T H IVK
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
LL + ++ E+ ++D + + +R G ++ R+M + L
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVICRQM------LEAL 123
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H S I+HRDLK+ N+LL + + K+ADFGV+ K + +G+ ++
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWM 177
Query: 872 APEYARTRKVNE-----KTDIYSFGVILLEL 897
APE + + K DI+S G+ L+E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 695 IGSGGSGKVYRVPIN-HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G+G G+V+ N HT VAVK + K + FLAE ++ T++H +VKL
Sbjct: 14 LGAGQFGEVWMATYNKHTK--VAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
++ E + ++ E+M K SL +L ++ L + + + A+G+
Sbjct: 68 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLP-----------KLIDFSAQIAEGM 115
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
++ +HRDL+++NIL+ + KIADFG+A+++ E+ E+ A +
Sbjct: 116 AFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT 170
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTT 899
APE K+D++SFG++L+E+ T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA---EVQILSTIRHLNIV 750
++G G G+VY T +AVK++ D Q+ KE A E+Q+L +RH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 751 KLLCCISS-ENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ C+ E KL ++ EYM S+ L K +L+ E ++ R QI
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALT-----ENVTRRYTRQIL---- 116
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
QG+ Y+H S IVHRD+K +NIL D N K+ DFG +K + + +V G+
Sbjct: 117 QGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+++PE K D++S ++E+ T K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-FLAEVQILSTIRHLNIVKL 752
V+G G G+ V ++ + A+K+I R E E +L+ ++H NIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
++ +V EY + L Q + K R L D +L W +M + V
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLF--PEDTILQWFVQMCLGV------- 113
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
H ++HRD+KS NI L N K+ DFG A++L G +A T VG+ Y+
Sbjct: 114 --QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGAYAC--TYVGTPYYVP 168
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE N K+DI+S G IL EL T K
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 18/222 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
++G G GKV+ + T + A+K + D L + + E ++LS H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C ++ V EY+ L + ++ L R A GL
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----------RATFYAAEIICGLQ 110
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H S IV+RDLK NILLD + + KIADFG+ K + + A T G+ YIA
Sbjct: 111 FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIA 164
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
PE +K N D +SFGV+L E+ G+ +G + L Q
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G GKVY+ T + A K I D K +++ E +++ E+ IL++ H NIVKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELE-DYMVEIDILASCDHPNIVKLLD 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
EN ++ E+ ++D + + R + R + + L Y+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR----------VVCKQTLEALNYL 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H + I+HRDLK+ NIL + + K+ADFGV+ K + +G+ ++APE
Sbjct: 120 HEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPE 173
Query: 875 Y-----ARTRKVNEKTDIYSFGVILLEL 897
++ R + K D++S G+ L+E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 689 LTESN---VIGSGGSGKVYRVPINHTAEVVAVKKI--WNDRKLDQKHEKEFLAEVQILST 743
E+ V+G G G VY T +A+K+I + R + HE E+ + S
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-----EIALHSY 61
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
++H NIV+ L S + E + SL L RS +E QI
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQI 117
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD-YNFNAKIADFGVAKILIKEEGEFAAMS 862
+GL Y+H + IVHRD+K N+L++ Y+ KI+DFG +K L G
Sbjct: 118 ----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---AGINPCTE 167
Query: 863 TVVGSCGYIAPEYAR--TRKVNEKTDIYSFGVILLELTTGK 901
T G+ Y+APE R DI+S G ++E+ TGK
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE-KEFLAEVQILSTIRHLNIVKLL 753
+G GG G+V+ T E+VA+K L + +E + L E IL+T + +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 754 CCISSENLKLLVYEYM---EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
+ L EY+ + R+L N LS D + M AV A
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTL-----LNNLGVLS---EDHARFYMAEMFEAVDALHE 119
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+H RDLK N L+D + + K+ DFG++K G ++VVGS Y
Sbjct: 120 LGYIH---------RDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDY 164
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTG 900
+APE R + + D +S G +L E G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIV 750
V+G G GKV T E+ A+K + + + + + E +I T RH +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
L C +E+ V EY L +H +V S R + A G
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHT------------DVFSEPRAVFYAACVVLG 113
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE-GEFAAMSTVVGSCG 869
L Y+H + IV+RDLK N+LLD KIADFG L KE G ST G+
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGFGDRTSTFCGTPE 166
Query: 870 YIAPEY----ARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
++APE + TR V D + GV++ E+ G+ GD+
Sbjct: 167 FLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G+G G+V T E A+K + L K + E IL + H IV +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+C EN + E++ L L K +GR ++V + +
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRK------AGRFPNDVAKFYHAELVL-----AFE 132
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S I++RDLK N+LLD + K+ DFG AK + + F T+ G+ Y+A
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRTF----TLCGTPEYLA 183
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTG 900
PE +++ + D ++ GV+L E G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 75/296 (25%), Positives = 136/296 (45%), Gaps = 41/296 (13%)
Query: 695 IGSGGSGKVYR------VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
IG G G+V++ +P +VAVK + + D + +F E +++ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPN 69
Query: 749 IVKLL-CCISSENLKLLVYEYMEKRSLDQ--------WLHKKNRSSLSGRARDE---VLS 796
IVKLL C + + LL +EYM L++ + S+ S R LS
Sbjct: 70 IVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
++ IA A G+ Y+ VHRDL + N L+ N KIADFG+++ + +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEANNGDEHTCLAQW 915
A+ + + ++ PE + ++D++++GV+L E+ + G + G H +
Sbjct: 186 YKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----EE 240
Query: 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++++G + + C LE ++ L +C S LP++RP+ + +IL
Sbjct: 241 VIYYVRDGNVL------SCPDNCPLE----LYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG G+V V + A+K + ++ ++ +E +IL H IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ ++ EY L L + + R IA Y+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----------EYTARFYIA-CVVLAFEYL 109
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H+ I++RDLK N+LLD N K+ DFG AK L + + T G+ Y+APE
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPE 162
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
+ + D +S G++L EL TG+ D+
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKL 752
V+G G GKV + + + AVK + D L + + E +ILS R H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRAR---DEVLSWRRRMQIAVGAA 808
CC + + V E++ L H +K+R RAR E+ S
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITS------------ 107
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L ++H I++RDLK N+LLD+ + K+ADFG+ K I ST G+
Sbjct: 108 -ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTP 160
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDE 908
YIAPE + D ++ GV+L E+ G EA N D+
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
IG G G VY+ T ++VA+KKI +L+ + E + E+ +L ++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L + E+ L++E++ S+D L K S G+ D L QI QG+
Sbjct: 64 LQDVLMQESRLYLIFEFL---SMD--LKKYLDSLPKGQYMDAELVKSYLYQIL----QGI 114
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK---ILIKEEGEFAAMSTVVGSC 868
+ H S ++HRDLK N+L+D K+ADFG+A+ I ++ + V +
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR------VYTHEVVTL 165
Query: 869 GYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGD 907
Y APE + + + DI+S G I E+ T K +GD
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-15
Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG GG G+VY + VA+KKI D + +K FL E +I + + H IV +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA------- 807
S + Y+E +L +S L + E LS + +VGA
Sbjct: 70 ICSDGDPVYYTMPYIEGYTL--------KSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 808 -AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA------ 860
+ Y+H S ++HRDLK NILL I D+G A EE +
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 861 ---------MSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+VG+ Y+APE +E TDIY+ GVIL ++ T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF----LAEVQILSTIRHLN 748
N I G G VYR T E+VA+KK+ K++++ E F L E+ IL ++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEG-FPITSLREINILLKLQHPN 65
Query: 749 IVKLLCCISSENLK--LLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
IV + + NL +V EY+E K ++ K S EV ++
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLME---TMKQPFLQS-----EVKCLMLQL-- 115
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
G+ ++H + I+HRDLK+SN+LL+ KI DFG+A+ + +
Sbjct: 116 ----LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQ 165
Query: 864 VVGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGK 901
+V + Y APE ++ + D++S G I EL T K
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G VY+ T E+VA+K+I LD + A E+ ++ ++H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 753 LCCISSENLKLLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
I +EN +LV+EYM+ K+ +D + A D Q+ +
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVR--------GALDPNTVKSFTYQL----LK 111
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ + H + ++HRDLK N+L++ K+ADFG+A+ F S V +
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLW 165
Query: 870 YIAPEYAR-TRKVNEKTDIYSFGVILLELTTGK 901
Y AP+ +R + DI+S G I+ E+ TG+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNIVK 751
IG G G V++ T E+VA+K++ +LD E L E+ +L ++H NIV+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAVGAAQG 810
L + S+ LV+EY DQ L KK S +G E++ + M Q+ G A
Sbjct: 64 LYDVLHSDKKLTLVFEY-----CDQDL-KKYFDSCNGDIDPEIV--KSFMFQLLKGLA-- 113
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK---ILIKEEGEFAAMSTVVGS 867
C+ H+ ++HRDLK N+L++ N K+ADFG+A+ I ++ S V +
Sbjct: 114 FCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR------CYSAEVVT 162
Query: 868 CGYIAPEYARTRKV-NEKTDIYSFGVILLELTTG 900
Y P+ K+ + D++S G I EL
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
+I + + +G G G V T + VA+KKI ++ + E+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKH 65
Query: 744 IRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
+RH NI+ L IS V E + D LH R S + + +
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL---GTD--LH---RLLTSRPLEKQFIQY----- 112
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+GL Y+H S +VHRDLK SNIL++ N + KI DFG+A+I + M+
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMT 163
Query: 863 TVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
V + Y APE T +K + + DI+S G I E+ GK G +H
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+LT IGSG G V+ +V A+K I + E++F+ E Q++ + H
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTI----REGAMSEEDFIEEAQVMMKLSHP 59
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+V+L + + LV+E+ME L +L RA+ S + + +
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYL----------RAQRGKFSQETLLGMCLDV 109
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+G+ Y+ ++HRDL + N L+ N K++DFG+ + ++ + ++ + +
Sbjct: 110 CEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFP 164
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ +PE K + K+D++SFGV++ E+
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V + T ++ A K++ R +K E L E QIL + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+++ LV M L H N + G + L + AA+ LC
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHIYNMGN-PGFEEERALFY---------AAEILCG 114
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA-KILIKEEGEFAAMSTVVGSCGYIA 872
+ V+RDLK NILLD + +I+D G+A KI EGE ++ VG+ GY+A
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGE--SIRGRVGTVGYMA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE ++ D + G ++ E+ G+ G + + R + E +
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--------TE 221
Query: 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM 966
E+ F EE IC ML T+ P R+
Sbjct: 222 EVYSAKFSEEA------KSIC-KMLLTKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 9e-15
Identities = 65/234 (27%), Positives = 114/234 (48%), Gaps = 23/234 (9%)
Query: 695 IGSGGSGKV-----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G G GKV Y + +VAVK + + K+F E ++L+ ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 69
Query: 750 VKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL---SGRARDEVLSWRRRMQIAV 805
VK C+ + L ++V+EYM+ L+++L ++ G E L+ + + IA
Sbjct: 70 VKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIAQ 127
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A G+ Y+ S VHRDL + N L+ N KI DFG+++ + + T++
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEA----NNGDEHTCLAQ 914
++ PE RK ++D++S GV+L E+ T GK+ +N + C+ Q
Sbjct: 185 -PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G V + T E+VA+KK + D + +++ ++ L E+++L T++ NIV+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
LV+EY+EK L+ N G ++V S+ ++ A+
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAI-------- 113
Query: 814 MHHDCSPT-IVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
H C IVHRD+K N+L+ +N K+ DFG A+ L EG A + V + Y +
Sbjct: 114 --HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRS 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE + D++S G IL EL+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 695 IGSGGSGKV----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+G G GKV Y ++T E VAVK + + H + E++IL + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIV 69
Query: 751 KL--LCCISSENLKLLVYEYMEKRSLDQWLHK-KNRSSLSGRARDEVLSWRRRMQIAVGA 807
K +C N L+ E++ SL ++L + KN+ +L +++++ AV
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL-----------KQQLKYAVQI 118
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+G+ Y+ S VHRDL + N+L++ KI DFG+ K + ++ + +
Sbjct: 119 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE K +D++SFGV L EL T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 695 IGSGGSGKVYRVPINHTA---EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
+G G G VY V + A E + V K +L+ + E Q+LS + H IVK
Sbjct: 8 LGKGSFGTVYLV-KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLH--KKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
+ ++ EY E R LD L K +LS ++V W ++ +
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS---ENQVCEWFIQLLL------ 117
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ YMH I+HRDLK+ NI L N KI DFGV+++L+ G +T G+
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM---GSCDLATTFTGTPY 170
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLEL 897
Y++PE + + + K+DI+S G IL E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA---EVQILSTIRHLNIV 750
++G G G+VY T +A K++ D + + KE A E+Q+L ++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSALECEIQLLKNLQHERIV 67
Query: 751 KLLCCISSENLKLLV--YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ C+ K L EYM S+ L K +L+ E ++ + QI
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALT-----ESVTRKYTRQIL---- 116
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+G+ Y+H S IVHRD+K +NIL D N K+ DFG +K L + +V G+
Sbjct: 117 EGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+++PE K D++S G ++E+ T K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 69/282 (24%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 695 IGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+G GK+Y+ +P A++VA+K + + + + EF E +++ + H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIV 70
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDE------VLSWRRRMQIA 804
LL ++ E +++EY+ + L ++L ++ S G + DE L + IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ A G+ Y+ S VH+DL + NIL+ + KI+D G+++ + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YYRVQPKS 186
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEANNGDEHTCLAQWAWRHIQEG 923
+ ++ PE K + +DI+SFGV+L E+ + G + G + QE
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----------QE- 234
Query: 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR 965
+++ + K PC + R++ L C P+ RP +
Sbjct: 235 --VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 72/252 (28%), Positives = 108/252 (42%), Gaps = 46/252 (18%)
Query: 675 FHR--LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-DQKHE 731
F+R LN ++ + + +GSG G+V T VA+KK+ R H
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHA 58
Query: 732 KEFLAEVQILSTIRHLNIVKLLCCI----SSENLK--LLVYEYMEKRSLDQWLHKKNRSS 785
K E+++L + H N++ LL S E+ + LV M +
Sbjct: 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-------------AD 105
Query: 786 LSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845
L+ + + LS + +GL Y+H S I+HRDLK SNI ++ + KI DF
Sbjct: 106 LNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF 162
Query: 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELT 898
G+A+ E M+ V + Y APE Y N+ DI+S G I+ EL
Sbjct: 163 GLARHTDDE------MTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELL 210
Query: 899 TGKEANNGDEHT 910
TGK G +H
Sbjct: 211 TGKTLFPGSDHI 222
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G+V+ V + A+K + + K E+ E ++L + H I++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNR-SSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ ++ EY+ L +L R S+ +G A++ +C
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL---------------FYASEIVCA 113
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+ + S IV+RDLK NILLD + K+ DFG AK L T+ G+ Y+AP
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAP 167
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E +++ N+ D ++ G+++ E+ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRH 746
K T IG G SG VY T + VA+K++ L Q+ +KE + E+ ++ +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEILVMRENKH 75
Query: 747 LNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQI 803
NIV L + + L +V EY+ SL + + + ++ R E L
Sbjct: 76 PNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-ECL-------- 125
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
Q L ++H S ++HRD+KS NILL + + K+ DFG + E+ + ST
Sbjct: 126 -----QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RST 174
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+VG+ ++APE + K DI+S G++ +E+ G+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G +VYR VA+KK+ +D K + + E+ +L + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWLH--KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+N +V E + L + + KK + R E W+ +Q+ L
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQK-----RLIPEKTVWKYFVQL----CSALE 120
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+MH S ++HRD+K +N+ + K+ D G+ + + A ++VG+ Y++
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMS 174
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
PE N K+DI+S G +L E+ + GD+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 68/283 (24%), Positives = 122/283 (43%), Gaps = 38/283 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G +VYR + VA+KK+ +D K ++ + E+ +L + H N++K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 755 CISSENLKLLVYEYMEKRSLDQWLH--KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+N +V E + L Q + KK + R E W+ +Q+ +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQL----CSAVE 120
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+MH S ++HRD+K +N+ + K+ D G+ + + A ++VG+ Y++
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMS 174
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE N K+DI+S G +L E+ + GD+ +L +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----------------SLCQ 218
Query: 933 EIDE----PCFLEEMIRVFK-LGVICTSMLPTERPNMRMVLQI 970
+I++ P E + L +C P +RP++ V QI
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKLL 753
+GSG G VY+ HT E+ AVK I KL+ + + E+ ++ +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
S + EY SL H ++G + +++ R + QGL Y
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETL-----QGLAY 121
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +HRD+K +NILL N + K+ADFGVA K A + +G+ ++AP
Sbjct: 122 LH---SKGKMHRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAP 175
Query: 874 EYARTRK---VNEKTDIYSFGVILLEL 897
E A K N+ DI++ G+ +EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
K+T S +G G G VY V + VA+K + + + EFL E ++
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMK 64
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
++V+LL +S L++ E M + L +L + R + S ++ +Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQ 123
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+A A G+ Y++ + VHRDL + N ++ +F KI DFG+ + I E +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGG 179
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921
+ +++PE + +D++SFGV+L E+ T ++ G + + R +
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRFVM 235
Query: 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN 963
EG LDK + P L E++R +C P RP+
Sbjct: 236 EG----GLLDKPDNCPDMLFELMR------MCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE-KEFLAEVQILSTIRHL-NIVKL 752
IGSG G+VY++ T V+AVK++ R+ K E K L ++ ++ IVK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+++ + E M LD+ L + + G +++L ++ V + L
Sbjct: 80 YGYFITDSDVFICMELMST-CLDKLLKR-----IQGPIPEDILG-----KMTVAIVKALH 128
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+ ++HRD+K SNILLD + N K+ DFG++ L+ + A + G Y+A
Sbjct: 129 YLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV----DSKAKTRSAGCAAYMA 182
Query: 873 PEYARTRKVNEKTDI----YSFGVILLELTTGK--EANNGDEHTCLAQWAWRHIQEGKPI 926
PE N K DI +S G+ L+EL TG+ N E L + +QE P
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT----KILQEEPPS 238
Query: 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ F + L C + +RP R +LQ
Sbjct: 239 LPP------NEGFSPDFCSFVDL---CLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 89/306 (29%), Positives = 135/306 (44%), Gaps = 62/306 (20%)
Query: 693 NVIGSGGSGKVYR---VPINHTAE---VVAVKKIWNDRKLDQKHEK-EFLAEVQILSTIR 745
N +GSG G+VY I VAVK + RK EK EFL E ++S
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 746 HLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H NIVKLL C+ +E +++ E ME L +L +L+ + + I
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGP----PLLTLKELLDIC 112
Query: 805 VGAAQGLCY---MHHDCSPTIVHRDLKSSNILL-----DYNFNAKIADFGVAKILIK--- 853
+ A+G Y MH +HRDL + N L+ D + KI DFG+A+ + K
Sbjct: 113 LDVAKGCVYLEQMH------FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 854 --EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLE-LTTGKE---ANNGD 907
+EGE + V ++APE K ++D++SFGV++ E LT G++ A N
Sbjct: 167 YRKEGE--GLLPV----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 908 EHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMV 967
E +H+ G + +P + I +L C + P+ERP +
Sbjct: 221 E-------VLQHVTAG--------GRLQKPENCPDKIY--QLMTNCWAQDPSERPTFDRI 263
Query: 968 LQILLN 973
+IL N
Sbjct: 264 QEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 90/311 (28%), Positives = 134/311 (43%), Gaps = 74/311 (23%)
Query: 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL---AEVQILSTIRHLN 748
S V+GSG +G V E AVK + ++ E + AEV L +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVV----DMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 749 IVKLLCC---------ISSENLKL--LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
IVK C + EN+ + LV +Y L Q + K+R+ + R
Sbjct: 93 IVK---CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI--KSRAK-TNRTF------ 140
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
R + + Q L +HH S ++HRD+KS+NILL N K+ DFG +K+
Sbjct: 141 -REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA----- 194
Query: 858 FAAMSTVVGS--CG---YIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE---- 908
A +S VG CG Y+APE R + ++K D++S GV+L EL T K +G+
Sbjct: 195 -ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
Query: 909 -HTCLAQWAWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR 965
H LA G+ P+ ++ E+ E I T++L ++ P R
Sbjct: 254 MHKTLA---------GRYDPLPPSISPEMQE---------------IVTALLSSD-PKRR 288
Query: 966 MVLQILLNNPI 976
LLN PI
Sbjct: 289 PSSSKLLNMPI 299
|
Length = 496 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 16/193 (8%)
Query: 714 VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKLLVYEYMEKR 772
+VAVK + D + +++ FL EV+ILS ++ NI++LL C+ + L ++ EYME
Sbjct: 48 LVAVKILRPDANKNARND--FLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENG 104
Query: 773 SLDQWLHKKNRSSLSGRARDE--------VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVH 824
L+Q+L + D +S+ + +A+ A G+ Y+ S VH
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVH 161
Query: 825 RDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEK 884
RDL + N L+ N KIADFG+++ L + + V ++A E K
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 885 TDIYSFGVILLEL 897
+D+++FGV L E+
Sbjct: 221 SDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-14
Identities = 30/77 (38%), Positives = 53/77 (68%)
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
+P++ ++L+ L+ + ++ ++ G IP ++G + +LE LDLS N+F GSIP S+ +L +L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 269 KVYLYSNSLSGEIPQAV 285
+ L NSLSG +P A+
Sbjct: 494 ILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKL 752
V+G G GKV + T EV A+K + D L + E +IL+ H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
CC +++ V EY+ L + +++R R+R A L
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSR----------FYAAEVTLALM 110
Query: 813 YMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
++H H +++RDLK NILLD + K+ADFG+ K I +T G+ YI
Sbjct: 111 FLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYI 163
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDE 908
APE + + D ++ GV++ E+ G+ EA+N D+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V + T ++ A KK+ R +K E L E QIL + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL-SGRARDEVLSWRRRMQIAVGAAQGLC 812
+++ LV M L ++ + GRA AA+ C
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA-------------VFYAAEICC 113
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ IV+RDLK NILLD + + +I+D G+A + EG+ + VG+ GY+A
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQ--TIKGRVGTVGYMA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE + + D ++ G +L E+ G+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
D K++E +G+G G V++V + ++A K I + K +++ + E+Q+L
Sbjct: 5 DDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHE 59
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
IV S+ + E+M+ SLDQ L K +GR +++L ++
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK------AGRIPEQILG-----KV 108
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
++ +GL Y+ I+HRD+K SNIL++ K+ DFGV+ LI + ++
Sbjct: 109 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANS 161
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
VG+ Y++PE + + ++DI+S G+ L+E+ G+
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G G+V++ + V AVK D L Q+ + +FL+E +IL H NIVKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +V E + +L KK +DE L ++ ++ A+ AA G+ Y
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKK---------KDE-LKTKQLVKFALDAAAGMAY 108
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+ S +HRDL + N L+ N KI+DFG+++ +++G +++ + AP
Sbjct: 109 LE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAP 163
Query: 874 EYARTRKVNEKTDIYSFGVILLE 896
E + + ++D++S+G++L E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 689 LTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
+T +G G G+VY + VAVK + ++ E +FL E I+S
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSK 65
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H NIV+L+ + ++ E M L +L ++NR R L+ + +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPE---RPSSLTMKDLLFC 121
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN---AKIADFGVAKILIKEE----- 855
A A+G Y+ +HRD+ + N LL AKIADFG+A+ + +
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
G AM + ++ PE KTD++SFGV+L E+
Sbjct: 179 GR--AMLPI----KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ--KHEKEFLAEVQILSTIRHLNIVK 751
++G G G+VY T +AVK++ D + + K E+Q+L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 752 LLCCISSENLKLL--VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
C+ + L E+M S+ L K+ +L+ E ++ + QI +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALT-----ENVTRKYTRQIL----E 117
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ Y+H S IVHRD+K +NIL D N K+ DFG +K L M +V G+
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+++PE K DI+S G ++E+ T K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
T+ IG G G+VY+ N T EVVA+K I D + + ++ E+ +LS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 749 IVKLLCCISSENLKLLVYEYMEKRS-LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
I + ++ EY+ S LD + E+L
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL------------ 111
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+GL Y+H S +HRD+K++N+LL + K+ADFGVA L + +T VG+
Sbjct: 112 -KGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGT 164
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
++APE + + K DI+S G+ +EL G E N D H
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG+G GKV + V VK++ D+ + FL EVQ + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE--QLLFLQEVQPYRELNHPNVLQC 60
Query: 753 LC-CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L CI S LLV E+ L +L + NR ++ A+ +VL +RM A A GL
Sbjct: 61 LGQCIESIPY-LLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVL---QRM--ACEVASGL 113
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
++H +H DL N L + + KI D+G+A E+ V ++
Sbjct: 114 LWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWL 169
Query: 872 APEYA-------RTRKVNEKTDIYSFGVILLELTT 899
APE + +K++I+S GV + EL T
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG G+V + T ++ A KK+ R +K E+ L E +IL + IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-GRARDEVLSWRRRMQIAVGAAQGLCY 813
+++ LV M L ++ RA AAQ +C
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI-------------FYAAQIICG 107
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV---VGSCGY 870
+ H IV+RDLK N+LLD + N +I+D G+A E + G+ GY
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV-------ELKGGKKIKGRAGTPGY 160
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+APE + + D ++ G L E+ G+
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTA-----EVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
L +G G GKV + VAVK + ++ L+E +L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLK 58
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK------------NRSSLSGRA 790
+ H +++KL S + LL+ EY + SL +L + NR+S
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 791 RDE-VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
DE L+ + A ++G+ Y+ +VHRDL + N+L+ KI+DFG+++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ EE + S ++A E ++D++SFGV+L E+ T
Sbjct: 176 D-VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRH 746
K T IG G SG VY T + VA+K++ L Q+ +KE + E+ ++ ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM----NLQQQPKKELIINEILVMRENKN 75
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQIA 804
NIV L + +V EY+ SL + + + ++ R+
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE------------ 123
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
Q L ++H S ++HRD+KS NILL + + K+ DFG + E+ + ST+
Sbjct: 124 --CLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTM 175
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
VG+ ++APE + K DI+S G++ +E+ G+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 75/255 (29%), Positives = 108/255 (42%), Gaps = 32/255 (12%)
Query: 669 STETTSFHRLNFRDSD--ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL 726
S E + F+ + DS +L + + IGSG G V VAVKK+ +
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ- 59
Query: 727 DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL------KLLVYEYMEKRSLDQWLHK 780
+Q H K E+ +L + H NI+ LL + + LV E M+ +L Q +H
Sbjct: 60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM 118
Query: 781 KNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840
+ RM + Q LC + H S I+HRDLK SNI++ +
Sbjct: 119 ELD--------------HERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162
Query: 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
KI DFG+A+ M+ V + Y APE E DI+S G I+ EL G
Sbjct: 163 KILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
Query: 901 KEANNGDEHTCLAQW 915
G +H + QW
Sbjct: 219 SVIFQGTDH--IDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 67/210 (31%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 709 NHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKLLVY 766
N A V VAVK + D ++FL EV+ILS + NI +LL C L ++
Sbjct: 42 NADAPVLVAVKVLRPD--ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-CMIM 98
Query: 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRD 826
EYME L+Q+L K + + LS+ + +A A G M + S VHRD
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG---MRYLESLNFVHRD 155
Query: 827 LKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY-------------IAP 873
L + N L+ N+ KIADFG MS + S Y +A
Sbjct: 156 LATRNCLVGKNYTIKIADFG--------------MSRNLYSSDYYRVQGRAPLPIRWMAW 201
Query: 874 EYARTRKVNEKTDIYSFGVILLE-LTTGKE 902
E K K+D+++FGV L E LT +E
Sbjct: 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI-LSTIRHLNIVKLL 753
+G G G V ++ T ++AVK+I ++ + +K L ++ I + ++ V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ E + E M SLD++ K L +++L +IAV + L Y
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGL--TIPEDILG-----KIAVSIVKALEY 118
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S ++HRD+K SN+L++ N K+ DFG++ L+ A + G Y+AP
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYMAP 172
Query: 874 EY----ARTRKVNEKTDIYSFGVILLELTTGK 901
E + + K+D++S G+ ++EL TG+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKL 752
VIG G GKV AVK + L +K + +AE +L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ V +Y+ L + H ++ R L RAR A A +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRAR----------FYAAEVASAI 109
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H S I++RDLK NILLD + + DFG+ K ++ E ST G+ Y+
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTFCGTPEYL 163
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTG 900
APE R + D + G +L E+ G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 41/296 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF-LAEVQILSTIRHLNIVKL 752
++G G G V + T ++VA+KK D K K+ + E+++L +RH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ + LV+E+++ LD N DE + QI G C
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-------GLDESRVRKYLFQILRGI--EFC 116
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ H+ I+HRD+K NIL+ + K+ DFG A+ L GE + V + Y A
Sbjct: 117 HSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGE--VYTDYVATRWYRA 168
Query: 873 PEY-ARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT--------CLAQWAWRH---I 920
PE K DI++ G ++ E+ TG+ GD CL RH
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVI-------CTSMLPTERPNMRMVLQ 969
Q+ E+ E LE+ R KL + C + P +RP+ +L
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEK--RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 58/218 (26%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEV-VAVKKI--WNDRKLDQKHEKEFLAEVQIL 741
+L + ++GSG G V++ +P + ++ VA+K I + R+ Q+ LA +
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA----M 63
Query: 742 STIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
++ H IV+LL +L+L V + SL + +++R SL + +L+W
Sbjct: 64 GSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQ---RLLNW---- 114
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
V A+G+ Y+ +VHR+L + NILL + +IADFGVA +L ++ ++
Sbjct: 115 --CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY-FY 168
Query: 862 STVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
S ++A E + ++D++S+GV + E+ +
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVKL 752
V+G G GKV + E AVK + D L + + E ++L+ + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C ++ V E++ L + K R L R A GL
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY-----------RATFYAAEIVCGLQ 110
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H S I++RDLK N++LD + + KIADFG+ K + + ST G+ YIA
Sbjct: 111 FLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIA 164
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
PE + K D +SFGV+L E+ G+ +GD+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G GKV +V T + A+K I + + LAE +L+ + IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
S LV ++ L L ++ R LS RAR A+ LC +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RAR-------------FYTAELLCAL 106
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+ +++RDLK NILLDY + + DFG+ K+ +K++ + +T G+ Y+APE
Sbjct: 107 ENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPE 163
Query: 875 YARTRKVNEKTDIYSFGVILLELTTG 900
+ D ++ GV+L E+ TG
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G V HT E VA+KKI ND L E+++L +RH +IV++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 754 CCI---SSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ S K +V+E ME L Q + +A D+ L+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMES-DLHQVI----------KANDD-LTPEHHQFFLYQLL 113
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+ L Y+H + + HRDLK NIL + + KI DFG+A++ + + V +
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 869 GYIAPEYART--RKVNEKTDIYSFGVILLELTTGK 901
Y APE + K DI+S G I E+ TGK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 78/286 (27%), Positives = 122/286 (42%), Gaps = 44/286 (15%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
T+ IG G G+V++ N T +VVA+K I D + + ++ E+ +LS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 749 IVKLLCCISSENLKLLVYEYMEKRS-LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+ K ++ EY+ S LD L DE QIA
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDL---------LRAGPFDE-------FQIATML 107
Query: 808 AQ---GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ GL Y+H S +HRD+K++N+LL + K+ADFGVA L + +T
Sbjct: 108 KEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTF 161
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
VG+ ++APE + + K DI+S G+ +EL G E N D H + I +
Sbjct: 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-EPPNSDMHPMRVLF---LIPKNN 217
Query: 925 PIVDALDKEIDEPCFLEEMIRVFKLGV-ICTSMLPTERPNMRMVLQ 969
P P E + FK + C + P+ RP + +L+
Sbjct: 218 P-----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
L IG G +G V T VAVKK+ D + Q+ E F EV I+ +H
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLF-NEVVIMRDYQHP 76
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIA-- 804
NIV++ + +V E++E +L D H R +E QIA
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--------TRMNEE--------QIATV 120
Query: 805 -VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ + L ++H + ++HRD+KS +ILL + K++DFG + K E +
Sbjct: 121 CLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EVPRRKS 174
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+VG+ ++APE + DI+S G++++E+ G+
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-13
Identities = 91/266 (34%), Positives = 124/266 (46%), Gaps = 15/266 (5%)
Query: 92 CDLRNLTILDLQFNYIISQF--PRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLY 149
L L LDL IS L N L LDL+ N I E + L+ L L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLD 122
Query: 150 LTANNMSGKIPASIGRLT-ELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSS 208
L NN++ IP IG L L++L+L N+ S+P+ + NL NL+ L+L++N S
Sbjct: 123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFN---DLSD 177
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
LP + L L L + S N I ++P I + ALE LDLS NN + SS+ LKNLS
Sbjct: 178 LPKLLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLS 235
Query: 269 KVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ L +N L NL+ +DLS N ++ + G L NL L L N LS +
Sbjct: 236 GLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNAL 293
Query: 329 PEGIGLLPSLKDVRLFNNMLSGALPP 354
P L L L N +L+
Sbjct: 294 PLIALL--LLLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINH----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
KLT +G G G+V + I+ A VAVK + +D +K + ++E+++
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 73
Query: 741 LSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-----GRARDEV 794
+ I +H NI+ LL + + ++ EY K +L ++L + + R DE
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
++++ + A+G+ Y+ S +HRDL + N+L+ N KIADFG+A+ +
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-VNN 189
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ + ++APE R ++D++SFGV++ E+ T
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G VY+V T +A+K+I +LD+ + + E+ IL IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
E + EYM+ SLD+ + ++VL +I +GL ++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLY---AGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
+ + I+HRD+K +N+L++ N K+ DFGV+ L+ + T +G Y+APE
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-----SLAKTNIGCQSYMAPE 171
Query: 875 YARTRKVNE------KTDIYSFGVILLELTTGK 901
++ N+ ++D++S G+ +LE+ G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRH 746
K T IG G SG V+ T + VA+K+I L ++ +KE + E+ ++ +++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI----NLQKQPKKELIINEILVMKELKN 75
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQIA 804
NIV L + +V EY+ SL + + + + ++ R+
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE------------ 123
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
Q L ++H + ++HRD+KS N+LL + + K+ DFG + E+ + ST+
Sbjct: 124 --CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTM 175
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
VG+ ++APE + K DI+S G++ +E+ G+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 58/211 (27%), Positives = 110/211 (52%), Gaps = 23/211 (10%)
Query: 694 VIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
V+GSG G VY+ +P ++ VA+K++ K KE L E +++++ + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPHV 71
Query: 750 VKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+LL C++S L+ + M L ++ ++++ ++ + +L+W V A
Sbjct: 72 CRLLGICLTST--VQLITQLMPFGCLLDYV-REHKDNIGSQ---YLLNW------CVQIA 119
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+G+ Y+ +VHRDL + N+L+ + KI DFG+AK+L +E E+ A V
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PI 175
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
++A E R ++D++S+GV + EL T
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 65/237 (27%), Positives = 112/237 (47%), Gaps = 37/237 (15%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-F--- 734
F D + K + IG G G+V++ T ++VA+KK+ + EKE F
Sbjct: 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN------EKEGFPIT 57
Query: 735 -LAEVQILSTIRHLNIVKLLCCISSENLK--------LLVYEYMEKRSLDQWLHKKN-RS 784
L E++IL ++H N+V L+ ++ LV+E+ E L L KN +
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKF 116
Query: 785 SLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
+LS E+ ++ M++ + GL Y+H I+HRD+K++NIL+ + K+AD
Sbjct: 117 TLS-----EI---KKVMKMLL---NGLYYIH---RNKILHRDMKAANILITKDGILKLAD 162
Query: 845 FGVAK-ILIKEEGEFAAMSTVVGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTT 899
FG+A+ + + + + V + Y PE R D++ G I+ E+ T
Sbjct: 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G+G G V +V + ++A K I + K +++ + E+Q+L IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYG 70
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
S+ + E+M+ SLDQ L + R +E+L ++++ +GL Y+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIP------EEILG-----KVSIAVLRGLAYL 119
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
I+HRD+K SNIL++ K+ DFGV+ LI + ++ VG+ Y++PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPE 172
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + ++DI+S G+ L+EL G+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTA-EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RH 746
+ +VIG G G+V R I ++ A K+ + + H ++F E+++L + H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLGHH 62
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKN-RSSLSGRARDE----VLSWRRRM 801
NI+ LL + + EY +L +L K + A++ L+ ++ +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
Q A A G M + +HRDL + N+L+ N +KIADFG+++ GE +
Sbjct: 123 QFASDVATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYV 173
Query: 862 STVVGS--CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+G ++A E K+D++SFGV+L E+ +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL- 753
IG G +G V H+ VAVK + D + Q+ E F EV I+ +H N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLF-NEVVIMRDYQHQNVVEMYK 85
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR--RMQIAV---GAA 808
+ E L +L+ E+ L G A +++S R QIA
Sbjct: 86 SYLVGEELWVLM-EF-----------------LQGGALTDIVSQTRLNEEQIATVCESVL 127
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
Q LCY+H S ++HRD+KS +ILL + K++DFG + K + ++VG+
Sbjct: 128 QALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKSLVGTP 181
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
++APE + DI+S G++++E+ G+
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V + T ++ A KK+ R +K E L E QIL + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+++ LV M L ++ ++ DE R AA+ C
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY-----NMGNPGFDE-----ERAVFY--AAEITCG 114
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+ IV+RDLK NILLD + +I+D G+A + I EGE + VG+ GY+AP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIP-EGE--TIRGRVGTVGYMAP 170
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E + + D + G ++ E+ GK
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILST 743
+L + V+GSG G VY+ +P ++ VA+K + + K KE L E +++
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAG 65
Query: 744 IRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
+ + +LL C++S LV + M L ++ ++N+ + + ++L+W
Sbjct: 66 VGSPYVCRLLGICLTST--VQLVTQLMPYGCLLDYV-RENKDRIGSQ---DLLNW----- 114
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
V A+G+ Y+ +VHRDL + N+L+ + KI DFG+A++L +E E+ A
Sbjct: 115 -CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921
V ++A E R+ ++D++S+GV + EL T G + +G
Sbjct: 171 GKV-PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------I 215
Query: 922 EGKPIVDALDK--EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR 965
+ I D L+K + +P I V+ + V C + RP R
Sbjct: 216 PAREIPDLLEKGERLPQPPIC--TIDVYMIMVKCWMIDSECRPRFR 259
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 60/251 (23%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF---- 734
RD +IL KL G G G+VY+ T VVA+KKI +EK+
Sbjct: 6 KLRDYEILGKL------GEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPIT 53
Query: 735 -LAEVQILSTIRHLNIVKLLCCI-----SSENLKLLVY---EYMEKRSLDQWLHKKNRSS 785
L E++IL ++H N+V L+ S+ + VY YM+
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-------------HD 100
Query: 786 LSG-----RARDEVLSWRRRM-QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839
LSG + + M Q+ +G+ Y+H I+HRD+K++NIL+D
Sbjct: 101 LSGLLENPSVKLTESQIKCYMLQLL----EGINYLH---ENHILHRDIKAANILIDNQGI 153
Query: 840 AKIADFGVAKIL---IKEEGEFAAMST-----VVGSCGYIAPEY-ARTRKVNEKTDIYSF 890
KIADFG+A+ T +V + Y PE R+ DI+
Sbjct: 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213
Query: 891 GVILLELTTGK 901
G + E+ T +
Sbjct: 214 GCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 48/220 (21%)
Query: 695 IGSGGSGKV----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+GSG G V +R I+ VA+K I + E +F+ E +++ + H N+V
Sbjct: 12 LGSGQFGVVHLGKWRGKID-----VAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
+L + + +V EYM L +L R R L + +
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYL----------RERKGKL----GTEWLLDMCSD 108
Query: 811 LC----YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
+C Y+ + +HRDL + N L+ + K++DFG+A+ ++ ++
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--------YTS 157
Query: 867 SCG------YIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
S G + PE + + K+D++SFGV++ E+ +
Sbjct: 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 70/284 (24%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G +G V HT + VAVKK+ D + Q+ E F EV I+ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLF-NEVVIMRDYHHENVVDMYN 86
Query: 755 CISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +V E++E +L D H R +E ++ + + + L Y
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIA-----TVCLSVLRALSY 133
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H + ++HRD+KS +ILL + K++DFG + K E ++VG+ ++AP
Sbjct: 134 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRKSLVGTPYWMAP 187
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
E + DI+S G++++E+ G+ + +Q + I D L
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----------PLQAMRRIRDNLPPR 237
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
+ + + ++R F ++ P+ R Q LL +P
Sbjct: 238 VKDSHKVSSVLRGF------LDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G +G V + + ++VAVKK+ D + Q+ E F EV I+ +H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLF-NEVVIMRDYQHENVVEMYN 84
Query: 755 CISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +V E++E +L D H R +E ++ + + + L
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIA-----AVCLAVLKALSV 131
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H + ++HRD+KS +ILL ++ K++DFG + K E ++VG+ ++AP
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---EVPRRKSLVGTPYWMAP 185
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E + DI+S G++++E+ G+
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 73/245 (29%), Positives = 105/245 (42%), Gaps = 30/245 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILSTIRHLNIVKL 752
IGSG G V T + VA+KK+ R + H K E+ ++ + H NI+ L
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 753 LCCISSENLKLL-----VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
L + + K L VY ME +D L + + L RM +
Sbjct: 81 LNVFTPQ--KSLEEFQDVYLVME--LMDANLCQVIQMDLD----------HERMSYLL-- 124
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
Q LC + H S I+HRDLK SNI++ + KI DFG+A+ G M+ V +
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVT 180
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
Y APE E DI+S G I+ E+ G G +H + QW Q G P
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSD 238
Query: 928 DALDK 932
+ + +
Sbjct: 239 EFMSR 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRH 746
K T IG G SG VY T + VA++++ L Q+ +KE + E+ ++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKN 76
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQIA 804
NIV L + +V EY+ SL + + + ++ R+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE------------ 124
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
Q L ++H S ++HRD+KS NILL + + K+ DFG + E+ + + M
Sbjct: 125 --CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--- 176
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
VG+ ++APE + K DI+S G++ +E+ G+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 693 NVIGSGGSGKVYRVPINHTA-EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIV 750
+VIG G G+V + I + A K + H ++F E+++L + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 59
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKN-RSSLSGRARDE----VLSWRRRMQIAV 805
LL L EY +L +L K + A LS ++ + A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A+G+ Y+ +HRDL + NIL+ N+ AKIADFG+++ G+ + +
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTM 170
Query: 866 GS--CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
G ++A E +D++S+GV+L E+ +
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 14/219 (6%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAE-----VVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
L E +G G G+V+ E +V VK + K D+ + EF E+ +
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTK-DENLQSEFRRELDMFRK 64
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
+ H N+V+LL ++ EY + L Q+L + S + + LS ++++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL--RATKSKDEKLKPPPLSTKQKVAL 122
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
A G M H + VHRDL + N L+ K++ ++K + E + +
Sbjct: 123 CTQIALG---MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE--YYKLRN 177
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902
+ ++APE + + K+D++SFGV++ E+ T E
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 695 IGSGGSGKVYRV--PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G+VY+ + A+KK D++ + E+ +L ++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 753 L-CCISSENLKL-LVYEYMEKRSLDQW----LHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
+ + + + L+++Y E D W H++ + + + L W QI
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLW----QIL-- 118
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA----KIADFGVAKILIKEEGEFAAMS 862
G+ Y+H S ++HRDLK +NIL+ KI D G+A++ A +
Sbjct: 119 --NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 863 TVVGSCGYIAPEY---AR--TRKVNEKTDIYSFGVILLELTT------GKEA 903
VV + Y APE AR T+ + DI++ G I EL T G+EA
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 694 VIGSGGSGKVYRVP---INHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHL 747
+G+G GKV ++ + V VAVK + ++ + ++E++I+S + H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHE 99
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NIV LL + L++ EY L +L +K R+ L+ + +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK---------RESFLTLEDLLSFSYQV 150
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
A+G+ ++ S +HRDL + N+LL + KI DFG+A+ I + +
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARLP 206
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
++APE ++D++S+G++L E+
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKL 752
VIG G GKV + AVK + L +K +K +AE +L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ + V +Y+ L + H ++ RS RAR A A L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRAR----------FYAAEIASAL 109
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H S I++RDLK NILLD + + DFG+ K I+ ST G+ Y+
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTFCGTPEYL 163
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTG 900
APE R + + D + G +L E+ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 51/281 (18%)
Query: 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE-KEFLAEVQIL 741
D+ + + +G G +G V+ + + VAVKKI L K L E++I+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV----LTDPQSVKHALREIKII 56
Query: 742 STIRHLNIVKLLCCISSENLKL--------------LVYEYME---KRSLDQWLHKKNRS 784
+ H NIVK+ + L +V EYME L+Q + +
Sbjct: 57 RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA 116
Query: 785 SLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIA 843
L +GL Y+H S ++HRDLK +N+ ++ + KI
Sbjct: 117 RL----------------FMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157
Query: 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYA-RTRKVNEKTDIYSFGVILLELTTGKE 902
DFG+A+I+ +S + + Y +P + D+++ G I E+ TGK
Sbjct: 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 903 ANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEM 943
G Q I E P+V E D L +
Sbjct: 218 LFAGAHELEQMQL----ILESVPVVR----EEDRNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 78/299 (26%), Positives = 134/299 (44%), Gaps = 29/299 (9%)
Query: 688 KLTESNVIGSGGSGKVY----RVPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILS 742
K+T +G G G VY R I AE VAVK + L ++ EFL E ++
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMK 64
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
++V+LL +S L+V E M L +L + + R + + +Q
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQ 123
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+A A G+ Y++ + VHRDL + N ++ ++F KI DFG+ + I E +
Sbjct: 124 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGG 179
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922
+ ++APE + +D++SFGV+L E+T+ LA+ ++ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------LAEQPYQGLSN 227
Query: 923 GKPIVDALD-KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN--PIFP 978
+ + +D +D+P E RV L +C P RP ++ +L ++ P FP
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V + T ++ A KK+ R +K E L E +IL + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+++ LV M L H N + DE Q A+ A LC
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHIYN---MGNPGFDE--------QRAIFYAAELCC 113
Query: 814 MHHDCS-PTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
D IV+RDLK NILLD + +I+D G+A + EGE + VG+ GY+A
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGE--TVRGRVGTVGYMA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE K D + G ++ E+ G+
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 12/191 (6%)
Query: 715 VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRS 773
VAVK + +D +K + ++E++++ I +H NI+ LL + + ++ EY K +
Sbjct: 53 VAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 774 LDQWLHKKNRSSLS-----GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLK 828
L ++L + + + +E LS++ + A A+G+ Y+ S +HRDL
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 829 SSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIY 888
+ N+L+ + KIADFG+A+ I + + ++APE R ++D++
Sbjct: 168 ARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226
Query: 889 SFGVILLELTT 899
SFGV+L E+ T
Sbjct: 227 SFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKL 752
VIG G GKV + AVK + L +K EK ++E +L ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ + V +Y+ L L ++ R L RAR A A L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRAR----------FYAAEIASALG 110
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S IV+RDLK NILLD + + DFG+ K I+ G ST G+ Y+A
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGTPEYLA 164
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTG 900
PE + + D + G +L E+ G
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 34/227 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLN-IV 750
IG G GKVY+ +T ++VA+KK +L+ E L E+ +L + IV
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT----RLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 751 KLLCCISSEN-----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+LL E LV+EY++ L +++ R GR Q+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGP--GRPLPAKTIKSFMYQLLK 121
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAK---ILIKEEGEFAAM 861
G A C+ H ++HRDLK N+L+D KIAD G+ + I +K +
Sbjct: 122 GVAH--CHKH-----GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK------SY 168
Query: 862 STVVGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907
+ + + Y APE + + DI+S G I E++ + GD
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G GKV V + + A+K + + + + L E ++L RH + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+++ V EY+ L + H +R+ V S R L Y
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFH---------LSRERVFSEDRTRFYGAEIVSALDY 110
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S IV+RDLK N++LD + + KI DFG+ K I + A M T G+ Y+AP
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATMKTFCGTPEYLAP 164
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E D + GV++ E+ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-12
Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 1/92 (1%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAI 304
L L G IP+ + KL++L + L NS+ G IP ++ S+ +L+V+DLS N+ G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGIGLLP 336
P G+L +L L+L N LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG G+V V + +T ++ A KK+ R + EK L E +IL + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
S+ LV M L ++ L + V+ + +AQ C +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE---MERVIHY---------SAQITCGI 108
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H S IV+RD+K N+LLD N +++D G+A E + ++ G+ GY+APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPE 164
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + D ++ G + E+ G+
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 41/284 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G+V+ + VAVK D K +FL E +IL H NIV+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ + +V E ++ +L R L + +Q+ AA G+ Y+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL----------RTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA---MSTVVGSCGYI 871
+HRDL + N L+ KI+DFG+++ +E+G +A+ M + +
Sbjct: 111 ESKHC---IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQI--PVKWT 163
Query: 872 APEYARTRKVNEKTDIYSFGVILLE---LTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
APE + + ++D++SFG++L E L AN ++ T +
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------RE 207
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972
A+++ + PC V++L C P +RP+ V Q L
Sbjct: 208 AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G GKV V T A+K + + + + L E ++L RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ + V EY L + H +R+ V S R L Y
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL--FFH---------LSRERVFSEDRARFYGAEIVSALDY 110
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H + +V+RDLK N++LD + + KI DFG+ K IK+ A M T G+ Y+AP
Sbjct: 111 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAP 165
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E D + GV++ E+ G+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 1/138 (0%)
Query: 27 SQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGT 86
S L + ++ L L+ W P + + + C + + L L N + G
Sbjct: 375 SALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTK-GKWFIDGLGLDNQGLRGF 433
Query: 87 FPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLK 146
P I LR+L ++L N I P L + + LE LDLS N F G IPE + +L+ L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 147 FLYLTANNMSGKIPASIG 164
L L N++SG++PA++G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL--------DQKHEKEF---LA 736
+L +G G G+V R AE + K D+ + D +K+ ++
Sbjct: 13 RLVLGKPLGEGCFGQVVR------AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS 66
Query: 737 EVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-----GRA 790
E++++ I +H NI+ LL + E ++ EY K +L ++L + +
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 791 RDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850
+E LS++ + A A+G+ Y+ S +HRDL + N+L+ + KIADFG+A+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 851 LIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ + + S ++APE R ++D++SFG+++ E+ T
Sbjct: 184 -VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 33/215 (15%)
Query: 695 IGSGGSGKVYRV-PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL------ 747
IG G GKV++ + + VA+K++ ++ E L+ ++ ++ +RHL
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 748 NIVKL--LCCISS---ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
N+V+L +C +S E LV+E++++ L +L K + +++ Q
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM-----FQ 118
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+ +GL ++H S +VHRDLK NIL+ + K+ADFG+A+I + A++
Sbjct: 119 LL----RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALT 167
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+VV + Y APE D++S G I E+
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 689 LTESNVIGSGGSGKVYR-VPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
+T IG G G VY+ V ++ E VAVK N + EK FL E I+
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EK-FLQEAYIMRQFD 65
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H +IVKL+ I+ EN +V E L +L + N+ SL + +
Sbjct: 66 HPHIVKLIGVIT-ENPVWIVMELAPLGELRSYL-QVNKYSLD---------LASLILYSY 114
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ L Y+ S VHRD+ + N+L+ K+ DFG+++ L E+ + S
Sbjct: 115 QLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGK 169
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
++APE R+ +D++ FGV + E+
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKLL 753
IGSG G VY+ +T E+ A+K I KL+ + + E+ ++ +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI----KLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ + E+ SL H ++G + +++ R + QGL Y
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYH------VTGPLSESQIAYVSRETL-----QGLYY 121
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +HRD+K +NILL N + K+ADFGV+ + A + +G+ ++AP
Sbjct: 122 LH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAP 175
Query: 874 EYA---RTRKVNEKTDIYSFGVILLEL 897
E A R N+ DI++ G+ +EL
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIW---NDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
IG G G VY+ H+ VA+K + N+ L +E +A ++ L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 752 LL-CCISS----ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
L+ C +S E LV+E++++ L +L K L + + M+ +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLP------AETIKDLMRQFL- 118
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
+GL ++H +C IVHRDLK NIL+ K+ADFG+A+I + A++ VV
Sbjct: 119 --RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVV 169
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ Y APE D++S G I E+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 715 VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774
VA+K I K E EF+ E +++ + H +V+L + + +V EYM L
Sbjct: 31 VAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834
+L R ++L ++ +G+ Y+ S +HRDL + N L+
Sbjct: 87 LNYL----REHGKRFQPSQLL------EMCKDVCEGMAYLE---SKQFIHRDLAARNCLV 133
Query: 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS---CGYIAPEYARTRKVNEKTDIYSFG 891
D K++DFG+++ ++ +E ++ VGS + PE K + K+D+++FG
Sbjct: 134 DDQGCVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188
Query: 892 VILLEL-TTGK 901
V++ E+ + GK
Sbjct: 189 VLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 74/267 (27%), Positives = 113/267 (42%), Gaps = 22/267 (8%)
Query: 669 STETTSFHRLNFRDSD--ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL 726
S +F+ + DS +L + IGSG G V VA+KK+ +
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ- 62
Query: 727 DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE-NLKLLVYEYMEKRSLDQWLHKKNRSS 785
+Q H K E+ ++ + H NI+ LL + + +L+ Y+ +D L + +
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 786 LSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845
L RM + Q LC + H S I+HRDLK SNI++ + KI DF
Sbjct: 123 LD----------HERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANN 905
G+A+ G M+ V + Y APE E DI+S G I+ E+ G
Sbjct: 171 GLART----AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 906 GDEHTCLAQWAWRHIQEGKPIVDALDK 932
G +H + QW Q G P + + K
Sbjct: 227 GTDH--IDQWNKVIEQLGTPCPEFMKK 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 49/195 (25%), Positives = 95/195 (48%), Gaps = 34/195 (17%)
Query: 715 VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKLLVYEYMEKRS 773
VA+K I N+ + E++F+ E +++ + H +V+L C + L +V E+ME
Sbjct: 31 VAIKAI-NEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL-YIVTEFMENGC 85
Query: 774 LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833
L +L ++ G+ ++L + + +G+ Y+ + + +HRDL + N L
Sbjct: 86 LLNYLRQRQ-----GKLSKDML-----LSMCQDVCEGMEYLERN---SFIHRDLAARNCL 132
Query: 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG------YIAPEYARTRKVNEKTDI 887
+ K++DFG+ + ++ +E S G + PE K + K+D+
Sbjct: 133 VSSTGVVKVSDFGMTRYVLDDE--------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 888 YSFGVILLEL-TTGK 901
+SFGV++ E+ T GK
Sbjct: 185 WSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 33/82 (40%), Positives = 47/82 (57%), Gaps = 1/82 (1%)
Query: 277 LSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLL 335
L G IP + L +L+ I+LS N++ G IP G + +L L L +N +G IPE +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 336 PSLKDVRLFNNMLSGALPPDFG 357
SL+ + L N LSG +P G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 687 PKLTESNVIGSGGSGKVYRVPINH----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
++T S+++ G G+++ + E V VK + + Q L E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLY 63
Query: 743 TIRHLNIVKLLC-CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
+ H NI+ +L CI ++Y YM +L +L + L + LS ++ +
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ---CRLGEANNPQALSTQQLV 120
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
+A+ A G+ Y+H ++H+D+ + N ++D KI D +++ L F
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL------FPMD 171
Query: 862 STVVGS-----CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+G ++A E ++ + +D++SFGV+L EL T
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G V++ T ++VA+KK + + + D +K L E+++L ++H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ LV+EY + L++ L K R E L + Q Q + +
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNE-LEKNPRGV------PEHLIKKIIWQTL----QAVNFC 116
Query: 815 H-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H H+C +HRD+K NIL+ K+ DFG A+IL ++ + V + Y AP
Sbjct: 117 HKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAP 169
Query: 874 EY-ARTRKVNEKTDIYSFGVILLELTTG 900
E + D+++ G + EL TG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 14/192 (7%)
Query: 715 VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL-CCISSENLKLLVYEYMEKR 772
VAVK + +D K + ++E++++ I +H NI+ LL C L +LV EY K
Sbjct: 47 VAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103
Query: 773 SLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL 827
+L ++L + + + + +E L+++ + A A+G+ Y+ S +HRDL
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 828 KSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDI 887
+ N+L+ + KIADFG+A+ + + + ++APE R ++D+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARD-VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 888 YSFGVILLELTT 899
+SFGV+L E+ T
Sbjct: 220 WSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G GKV V T A+K + + + + + E ++L RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ + V EY L + H +R+ V + R L Y
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL--FFH---------LSRERVFTEERARFYGAEIVSALEY 110
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +V+RD+K N++LD + + KI DFG+ K I + A M T G+ Y+AP
Sbjct: 111 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAP 164
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E D + GV++ E+ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 55/306 (17%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEV---VAVKKIWNDRKLD---QKHEKEFLAEVQILS 742
L ++G G G V ++ VAVK + KLD +EFL+E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMK 56
Query: 743 TIRHLNIVKLL-CCISSENLK-----LLVYEYMEKRSLDQWLHKKNRSSLSGRARD--EV 794
H N++KL+ C + +L+ +++ +M+ L +L L R E
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL-------LYSRLGGLPEK 109
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
L + ++ V A G+ Y+ + +HRDL + N +L + +ADFG++K +
Sbjct: 110 LPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG 166
Query: 855 ----EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLE-LTTGKEANNGDEH 909
+G A M +IA E R K+D+++FGV + E T G+ G E+
Sbjct: 167 DYYRQGRIAKMPV-----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
Query: 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN---MRM 966
+ + RH K D LD+ ++ L C P +RP +R
Sbjct: 222 HEIYDYL-RHGNRLKQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLRE 267
Query: 967 VLQILL 972
VL+ +L
Sbjct: 268 VLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 24/208 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL-NIVKLL 753
I G G VY T + A+K + + + AE I+ + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
S++ LV EY+ + L G D W + Q G+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKT-----LGGLPED----WAK--QYIAEVVLGVED 112
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-LIKEEGEFAAMSTVVGSCGYIA 872
+H I+HRD+K N+L+D + K+ DFG+++ L ++ VG+ Y+A
Sbjct: 113 LHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTPDYLA 161
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTG 900
PE ++ +D +S G ++ E G
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
T+ IG G G+V++ N T +VVA+K I D + + ++ E+ +LS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK--NRSSLSGRARDEVLSWRRRMQIAVG 806
+ K + ++ EY+ S L + + ++ R E+L
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-EIL----------- 111
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
+GL Y+H S +HRD+K++N+LL + K+ADFGVA L + +T VG
Sbjct: 112 --KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVG 163
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ ++APE + + K DI+S G+ +EL G+
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKL 752
VIG G GKV + AVK + L++K +K +AE +L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ V +++ L + H ++ RS RAR A A L
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRAR----------FYAAEIASAL 109
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+H S IV+RDLK NILLD + + DFG+ K I + +T G+ Y+
Sbjct: 110 GYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYL 163
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTG 900
APE R + + D + G +L E+ G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 18/222 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G GKV T E+ A+K + D + + + E ++L+ + + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C + + V EY+ L + + G+ ++ + A A GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVF-----YAAEIAIGLF 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H S I++RDLK N++LD + KIADFG+ K I T G+ YIA
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDYIA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
PE + + D ++FGV+L E+ G+ +G++ L Q
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 33/78 (42%), Positives = 44/78 (56%)
Query: 124 LDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSI 183
L L G IP DI +L L+ + L+ N++ G IP S+G +T L L+L N FNGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 184 PAEIGNLQNLEALELAYN 201
P +G L +L L L N
Sbjct: 483 PESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 695 IGSGGSG----KVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
+GSG G VY++ + V K N++ + E + E +I+ + + IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV----RDEMMREAEIMHQLDNPYIV 58
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
+++ +E L +LV E L+++L K +DE+ + +++ + G
Sbjct: 59 RMIGVCEAEAL-MLVMEMASGGPLNKFLSGK---------KDEI-TVSNVVELMHQVSMG 107
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
+ Y+ VHRDL + N+LL AKI+DFG++K L ++ + A S +
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLE 896
APE RK + ++D++S+G+ + E
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 33/244 (13%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPI-NHTAEVVAVKK 719
K+KD ++ E +++ + D + + L G+G G+V N VA+K+
Sbjct: 10 HKKKDSDSTKEPKRKNKMKYEDFNFIRTL------GTGSFGRVILATYKNEDFPPVAIKR 63
Query: 720 IWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLH 779
+ + QK +E +IL+ I H V L E+ LV E++ +L
Sbjct: 64 FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 780 KKNRSSLSGRARDEVLSWRRRMQIAVG---AAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836
+ +R VG AAQ + + S IV+RDLK N+LLD
Sbjct: 124 RN-----------------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK 166
Query: 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLE 896
+ K+ DFG AK++ T+ G+ YIAPE + D ++ G+ + E
Sbjct: 167 DGFIKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 897 LTTG 900
+ G
Sbjct: 221 ILVG 224
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-HEKEFLAEVQILSTIRHLNIVKLL 753
+GSG G V T VAVKK+ R H K E+++L ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR----RMQIAV-GAA 808
+ RSL+++ + L G + ++ ++ +Q +
Sbjct: 83 DVFTP------------ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 130
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+GL Y+H S I+HRDLK SN+ ++ + KI DFG+A+ E M+ V +
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATR 181
Query: 869 GYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
Y APE N+ DI+S G I+ EL TG+ G +H
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVK 751
+G G VY+ T ++VA+K+I +L+ + F A E +L ++H NIV
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L I ++ LV+EY++ L Q++ R + R GL
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR----------GL 116
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
Y H ++HRDLK N+L+ K+ADFG+A+
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVKL 752
V+G G GKV T E+ A+K + D + + + E ++L+ + + + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C + + V EY+ L + + GR ++ + A A GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEP-----HAVFYAAEIAIGLF 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H S I++RDLK N++LD + KIADFG+ K + + T G+ YIA
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919
PE + + D ++FGV+L E+ G+ G++ L Q H
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G GKV V T + A+K + + + + L E ++L RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLH-KKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQ 809
+ + V EY L + H + R RAR E++S
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVS------------- 106
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA-MSTVVGSC 868
L Y+H S +V+RDLK N++LD + + KI DFG L KE A M T G+
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFCGTP 159
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE D + GV++ E+ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG G+V + T ++ A KK+ R +K + + E +IL+ + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
++ LV M L ++ + + G + AQ + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFY---------TAQIISGL 110
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H I++RDLK N+LLD + N +I+D G+A L + + + G+ G++APE
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---GTPGFMAPE 167
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + + D ++ GV L E+ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 822 IVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART--R 879
I++RD+K NILLD + + DFG++K + EE E A + G+ Y+APE R
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA--YSFCGTIEYMAPEVIRGGSG 183
Query: 880 KVNEKTDIYSFGVILLELTTG 900
++ D +S GV+ EL TG
Sbjct: 184 GHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 729 KHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSG 788
K + FLAE L H NIV+L I+ N ++V EYM +LD +L
Sbjct: 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---------- 97
Query: 789 RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848
R + L + M + G A G+ Y+ VH+ L + +L++ + KI+ F
Sbjct: 98 RKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-- 152
Query: 849 KILIKEEGEFAAMSTVVGSCG--YIAPEYARTRKVNEKTDIYSFGVILLEL 897
++E+ A +T+ G + APE + + +D++SFG+++ E+
Sbjct: 153 --RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+GSG G V T VA+KK++ + + ++ + E+++L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81
Query: 755 CISS-ENLK-----LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ +L LV +M + L + E LS R +
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMG-------------TDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+GL Y+H + I+HRDLK N+ ++ + KI DFG+A+ E M+ V +
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTGYVVTR 179
Query: 869 GYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
Y APE + DI+S G I+ E+ TGK G +H
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 694 VIGSGGSGKVYRVPINH---TAEVVAVK-----KIWNDRKLDQKHEKEFLAEVQILSTIR 745
V+G GG GKV++V T ++ A+K I ++K D H K AE IL ++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK-DTAHTK---AERNILEAVK 58
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H IV L+ + L+ EY+ L L ++ D + + +A+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF-----MEDTACFYLSEISLAL 113
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
++H I++RDLK NILLD + K+ DFG+ K I EG T
Sbjct: 114 E------HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI-HEGTVT--HTFC 161
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
G+ Y+APE + D +S G ++ ++ TG
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IGSG G V + + VA+KKI + + K L E++IL +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL-AKRTLRELKILRHFKHDNIIAIR 70
Query: 754 CCI-SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS---WRRRM-QIAVGAA 808
+ VY M+ D LH S D+ L+ R + Q+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESD--LHHIIHS-------DQPLTEEHIRYFLYQLL---- 117
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA-MSTVVGS 867
+GL Y+H S ++HRDLK SN+L++ + +I DFG+A+ L E M+ V +
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 868 CGYIAPEYARTRKVNEKT---DIYSFGVILLEL 897
Y APE + + E T D++S G I E+
Sbjct: 175 RWYRAPELLLS--LPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 34/104 (32%), Positives = 48/104 (46%), Gaps = 2/104 (1%)
Query: 450 DKMSGN--LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTL 507
D G + L + N G IP +S ++L S N G IP L ++ SL L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471
Query: 508 LLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV 551
L N +GS+P + SL LNL+ N LSG +P +G +
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 11/173 (6%)
Query: 727 DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL 786
D++ +E+ L+ H IVK S++ LL+ EY L++ + ++ + L
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164
Query: 787 SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846
+ + L + QI + L +H ++HRDLKS+NI L K+ DFG
Sbjct: 165 PFQEYEVGLLF---YQIVLA----LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFG 214
Query: 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+K + S+ G+ Y+APE ++ ++K D++S GVIL EL T
Sbjct: 215 FSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 694 VIGSGGSGKVY--RVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
V+G G GKV+ R A + K+ L + E IL+ + H IVK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA-AQG 810
L +E L+ +++ R D L R EV+ ++ + A
Sbjct: 63 LHYAFQTEGKLYLILDFL--RGGD----------LFTRLSKEVMFTEEDVKFYLAELALA 110
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L ++H S I++RDLK NILLD + K+ DFG++K I E + + G+ Y
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 164
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLELTTG 900
+APE R + D +SFGV++ E+ TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 72/261 (27%), Positives = 111/261 (42%), Gaps = 22/261 (8%)
Query: 675 FHRLNFRDSD--ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK 732
F+ + DS +L + IGSG G V VA+KK+ + +Q H K
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAK 61
Query: 733 EFLAEVQILSTIRHLNIVKLLCCISSE-NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR 791
E+ ++ + H NI+ LL + + +L+ Y+ +D L + + L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---- 117
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
RM + Q LC + H S I+HRDLK SNI++ + KI DFG+A+
Sbjct: 118 ------HERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART- 168
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911
G M+ V + Y APE E DI+S G I+ E+ K G ++
Sbjct: 169 ---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-- 223
Query: 912 LAQWAWRHIQEGKPIVDALDK 932
+ QW Q G P + + K
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKK 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+I +G G VY V T + A+KKI + + ++ E IL+ + +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C ++ +V EY+E L KN +L RM A L Y
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMA--------RMYFA-ETVLALEY 116
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-------------LIKEEGEFAA 860
+H + IVHRDLK N+L+ + K+ DFG++KI + K+ EF
Sbjct: 117 LH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 861 MSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
V G+ YIAPE + + D ++ G+IL E G
Sbjct: 174 -KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G GKV T E+ A+K + D + + + E ++L+ + + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C + + V EY+ L + + G+ ++ + + A + GL
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEP-----QAVFYAAEISVGLF 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H I++RDLK N++LD + KIADFG+ K + + T G+ YIA
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919
PE + + D +++GV+L E+ G+ +G++ L Q H
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G+VY+V T + A+K + +KE +A+ ++ TI NI L+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL---------SKKEIVAKKEVAHTIGERNI--LVR 49
Query: 755 CISSEN-----LKL---------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
+ E+ LK LV +YM L L K+ R S RA+ +
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFYI------ 102
Query: 801 MQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA 860
A+ + + H IV+RDLK NILLD + + DFG++K + +
Sbjct: 103 -------AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KT 152
Query: 861 MSTVVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTG 900
+T G+ Y+APE K + D +S GV++ E+ G
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 695 IGSGGSGKVYRVPINHTA-----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G GKVY+ + TA + VA+K + + K + +EF E + S ++H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD--KAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDE-----VLSWRRRMQIA 804
V LL ++ E +++ Y L ++L ++ S G D+ L + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 805 VGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
A G+ ++ HH +VH+DL + N+L+ N KI+D G+ + + + + M
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD-YYKLMG 184
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ +++PE K + +DI+S+GV+L E+
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVV--AVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNI 749
+VIG G G+V + I + A+K++ + ++F E+++L + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKK-----NRSSLSGRARDEVLSWRRRMQIA 804
+ LL L EY +L +L K + + + LS ++ + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
A+G+ Y+ +HRDL + NIL+ N+ AKIADFG+++ G+ +
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKT 181
Query: 865 VGS--CGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921
+G ++A E +D++S+GV+L E+ + G G TC +
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTC------AELY 233
Query: 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968
E P L+K ++ C E V+ L C P ERP+ +L
Sbjct: 234 EKLPQGYRLEKPLN--CDDE----VYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-10
Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL- 753
IG+G G+V+ V T E K I + R L ++ + + + EV ++ ++H NIV+ +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAI-SYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 754 CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
++ N KL ++ E+ + L + + K + + G+ + + + I L
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAI-----VDITRQLLHALA 132
Query: 813 YMHH----DCSPTIVHRDLKSSNILLDY-------------NFN----AKIADFGVAKIL 851
Y H+ ++HRDLK NI L N N AKI DFG++K +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYA--RTRKVNEKTDIYSFGVILLELTTGK----EANN 905
G + + VG+ Y +PE T+ ++K+D+++ G I+ EL +GK +ANN
Sbjct: 193 ----GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 695 IGSGGSGKVYR-VPINHTAE--VVAVKKIWNDRK-LDQKHEK--EFLAEVQILSTIRHLN 748
+G G +Y+ V + V +++ K L H F ++S + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 749 IVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+VKL C+ EN+ +V EY++ LD +LH + ++++S W ++ +A
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLH-REKNNVSL-------HW--KLDVAKQL 110
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILL-------DYNFNAKIADFGVAK-ILIKEEGEFA 859
A L Y+ +VH ++ NIL+ Y K++D G+ +L +EE
Sbjct: 111 ASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 860 AMSTVVGSCGYIAPEYAR--TRKVNEKTDIYSFGVILLEL 897
+IAPE R + D +SFG LLE+
Sbjct: 168 I--------PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 53/293 (18%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKE-FLAEVQILSTIR 745
L +G G G V +N + VAVK + + + E E FL+E +
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM--KIAICTRSEMEDFLSEAVCMKEFD 58
Query: 746 HLNIVKLL--CCISSEN----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
H N+++L+ C + E+ +++ +M+ L +L L R D
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-------LYSRLGDCPQYLPT 111
Query: 800 RMQIAVGA--AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK---- 853
+M + A G+ Y+ S + +HRDL + N +L+ N N +ADFG++K +
Sbjct: 112 QMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912
+G A M +IA E R K+D++SFGV + E+ T G+ G E++ +
Sbjct: 169 RQGRIAKMPV-----KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
Query: 913 AQWAWRHIQEG---KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP 962
+ ++++G K D LD M C + P +RP
Sbjct: 224 ----YDYLRQGNRLKQPPDCLD------GLYSLMSS-------CWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 65/246 (26%), Positives = 100/246 (40%), Gaps = 57/246 (23%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ----ILSTIRHLNI 749
VIG G G+V V T + A+KK+ RK + EKE +A V+ IL+ + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEM-LEKEQVAHVRAERDILAEADNPWV 63
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
VKL EN L+ EY+ + L KK+ + +E + +A+ +
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT-----EEETRFYIAETILAIDSIH 118
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV------------------AKIL 851
L Y +HRD+K N+LLD + K++DFG+ A
Sbjct: 119 KLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 852 IKEEGEFAAMS-----------------TVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ MS + VG+ YIAPE N++ D +S GVI+
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 895 LELTTG 900
E+ G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL 753
IG G GKVY+V + AVK + +D++ E AE IL ++ H N+VK
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE----AEYNILQSLPNHPNVVKFY 85
Query: 754 CCISSENLKL-----LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ + LV E S+ + + K R + ++S+ I GA
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISY-----ILYGAL 138
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
GL ++H++ I+HRD+K +NILL K+ DFGV+ L +T VG+
Sbjct: 139 LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTP 192
Query: 869 GYIAPEYARTRK-----VNEKTDIYSFGVILLELTTG 900
++APE + + + D++S G+ +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 65/234 (27%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-----EVQILS 742
+ T +GSG G V T E VA+KK L + + E A E+ +L
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK------LSRPFQSEIFAKRAYRELTLLK 69
Query: 743 TIRHLNIVKLLCCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
++H N++ LL +S LV YM ++ L + LS
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-------------QTDLQ-KIMGHPLS 115
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
+ + GL Y+H S I+HRDLK N+ ++ + KI DFG+A+
Sbjct: 116 EDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR------H 166
Query: 857 EFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
A M+ V + Y APE N+ DI+S G I+ E+ TGK G ++
Sbjct: 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 69/265 (26%), Positives = 104/265 (39%), Gaps = 58/265 (21%)
Query: 688 KLTESNVIGSGGSGKVYRVPI-----NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L V+G G GKV + VAVK + K ++E++IL
Sbjct: 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILI 65
Query: 743 TI-RHLNIVKLLCCISSENLKLLV-YEYMEKRSLDQWLHKK--------NRS-SLSGRAR 791
I HLN+V LL + N L+V E+ + +L +L K +S GR R
Sbjct: 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFR 125
Query: 792 DEVLSWRRRMQIAVGAAQGL--------------------------------CY------ 813
V R +I G A L CY
Sbjct: 126 AMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVAR 185
Query: 814 -MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
M S +HRDL + NILL N KI DFG+A+ + K+ ++ + ++A
Sbjct: 186 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSARLPLKWMA 244
Query: 873 PEYARTRKVNEKTDIYSFGVILLEL 897
PE + ++D++SFGV+L E+
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 29/79 (36%), Positives = 45/79 (56%)
Query: 110 QFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTEL 169
P + L+ ++LS N G IP + ++ L+ L L+ N+ +G IP S+G+LT L
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 170 RQLNLVVNQFNGSIPAEIG 188
R LNL N +G +PA +G
Sbjct: 493 RILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-----RHLN 748
VIG G KV V + T + A+K I K + ++ E + VQ + H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI----KKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V L C +E+ V E++ D H + + L + + + +A
Sbjct: 58 LVGLHSCFQTESRLFFVIEFV--SGGDLMFHMQRQRKLP---EEHARFYSAEISLA---- 108
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L ++H I++RDLK N+LLD + K+ D+G+ K I+ G+ ST G+
Sbjct: 109 --LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGD--TTSTFCGTP 160
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE-------ANNGDEHT 910
YIAPE R D ++ GV++ E+ G+ ++N D++T
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 694 VIGSGGSGKVY--RVPINHTAEVVAVKKIWNDRKLDQKHE--KEFLAEVQILSTIRHLN- 748
V+G+G GKV+ R H + + K+ + QK + + E Q+L IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V L ++ L+ +Y+ L L ++ R + +QI G
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK------------EQEVQIYSG-- 112
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+ + + H I++RD+K NILLD N + + DFG++K ++E E A + G+
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA--YSFCGTI 170
Query: 869 GYIAPEYARTRKV--NEKTDIYSFGVILLELTTG 900
Y+AP+ R ++ D +S GV++ EL TG
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN----- 748
VIG G KV V + ++ A+K + K + H+ E + VQ T +H+
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVV----KKELVHDDEDIDWVQ---TEKHVFEQASS 54
Query: 749 ---IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+V L C + + LV EY+ D H + + L + + + IA
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGG--DLMFHMQRQRKLP---EEHARFYAAEICIA- 108
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
L ++H I++RDLK N+LLD + + K+ D+G+ K + G ST
Sbjct: 109 -----LNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL---GPGDTTSTFC 157
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
G+ YIAPE R + D ++ GV++ E+ G+
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+IG GG G+VY T ++ A+K + D+K + + E LA LN +L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLA----------LNERIML 48
Query: 754 CCISSENLKLLV---YEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQ 809
+S+ + +V Y + L L N L ++ V S A
Sbjct: 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL +MH+ +V+RDLK +NILLD + + +I+D G+A K++ + VG+ G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160
Query: 870 YIAPE-YARTRKVNEKTDIYSFGVILLELTTG----KEANNGDEHTC 911
Y+APE + + D +S G +L +L G ++ D+H
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 33/232 (14%)
Query: 676 HRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL 735
R+ D D++ VIG G G+V V + +V A+K + + + F
Sbjct: 38 LRMKAEDFDVI------KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 736 AEVQILSTIRHLN---IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
E I++ H N IV+L + +V EYM L + +S
Sbjct: 92 EERDIMA---HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDIP 140
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
E W R V A L +H S +HRD+K N+LLD + + K+ADFG + +
Sbjct: 141 E--KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKM 192
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVN----EKTDIYSFGVILLELTTG 900
G T VG+ YI+PE +++ + + D +S GV L E+ G
Sbjct: 193 DANGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 292 VID-LSANN--LTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
ID L +N L G IPND KL +L +++L N + G IP +G + SL+ + L N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKL 386
+G++P G+ + L ++ N+L+G +P L GG+L
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL--GGRL 514
|
Length = 623 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 44/235 (18%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKI-WNDRKLDQKHEKEF----------LAEVQIL 741
+G G GKV + T ++VA+KK+ + D +++ L E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 742 STIRHLNIVKLLCCISSENLKLLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+ I+H NI+ L+ + LV + M K+ +D + L+ +L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKCILL-- 126
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK--------- 849
QI GL +H +HRDL +NI ++ KIADFG+A+
Sbjct: 127 ---QIL----NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 850 ILIKEEGEFAA--MSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGK 901
L K+E M++ V + Y APE K + D++S G I EL TGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-HEKEFLAEVQILSTIRHLNIVKLL 753
+GSG G V + VAVKK+ R H + E+++L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKL--SRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 754 ------CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
I + N LV M + L+ + + LS +
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMG-------------ADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+GL Y+H S I+HRDLK SN+ ++ + +I DFG+A+ E M+ V +
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVAT 178
Query: 868 CGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
Y APE N+ DI+S G I+ EL GK G+++
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 63/263 (23%)
Query: 694 VIGSGGSGKVYR---VPINHTA--EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHL 747
+G G GKV + I +A VAVK + + ++ K + E++IL I HL
Sbjct: 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEY-KALMTELKILIHIGHHL 71
Query: 748 NIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
N+V LL C +++ EY + +L +L K R + R M+ G
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRK---REMKQKEG 128
Query: 807 AAQGL-------------------------------------------CY-------MHH 816
Q L Y M
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 817 DCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYA 876
S +HRDL + NILL N KI DFG+A+ + K+ ++ ++APE
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPESI 247
Query: 877 RTRKVNEKTDIYSFGVILLELTT 899
+ ++D++SFGV+L E+ +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
VIG G KV V + T + A+K + + D + E + H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C +E+ V EY+ D H + + L + + + +A L
Sbjct: 62 HSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLP---EEHARFYSAEISLA------LN 110
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I++RDLK N+LLD + K+ D+G+ K ++ G+ ST G+ YIA
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGD--TTSTFCGTPNYIA 164
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK-------EANNGDEHT 910
PE R D ++ GV++ E+ G+ ++N D++T
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G+V V + +V A+K + + + F E I++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C + +V EYM L + D W + V A L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSN----------YDVPEKWAKFYTAEVVLA--LDA 157
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S ++HRD+K N+LLD + + K+ADFG + +E T VG+ YI+P
Sbjct: 158 IH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISP 212
Query: 874 EYARTRK----VNEKTDIYSFGVILLELTTG 900
E +++ + D +S GV L E+ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+++G G G+V V T ++ A+K + L Q+ F E ILS I +L
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA--VGAAQG 810
++ LV EY L SL R D+ + +A V A
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDL---------LSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
+ M + VHRD+K N+L+D + K+ADFG A L + + + VG+ Y
Sbjct: 118 VHQMGY------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDY 169
Query: 871 IAPEYARTRKVNEKT------DIYSFGVILLELTTGK 901
IAPE T + K D +S GVI E+ G+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G G V+ V + VA+KK+ N + + K E+++L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRS--SLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ ++ Y+ + LHK S LS D V + QI +GL
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS---DHVKVFL--YQIL----RGLK 117
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H S I+HRD+K N+L++ N KI DFG+A+ ++E E M+ V + Y A
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDESKHMTQEVVTQYYRA 172
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGK 901
PE +R DI+S G I EL +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G V++ T +VA+K+I +L+ + A EV +L ++H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI----RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
I +E LV+EY++ L Q+L N +L ++ ++ +GL
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQ--------LLRGLS 117
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y H I+HRDLK N+L++ K+ADFG+A+ + S V + Y
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRP 171
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGK 901
P+ + + + D++ G IL E+ TG+
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 18/163 (11%)
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV 794
L E +L + H +++++ + S + +V + L +L K++R
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP---------- 153
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
L + + I +GL Y+H + I+HRD+K+ NI ++ I D G A+ +
Sbjct: 154 LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
TV + APE K N K DI+S G++L E+
Sbjct: 211 PAFLGLAGTVETN----APEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 67/237 (28%), Positives = 100/237 (42%), Gaps = 46/237 (19%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK--EFLAEVQILSTIRHLNIVK 751
++G G G+V+ V + T ++ A+K + D+K K K L E +IL+T+ H +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVL--DKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA-VGAAQG 810
L +E LV +Y L + L ++ LS +EV R A V A
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS----EEVA----RFYAAEVLLA-- 115
Query: 811 LCYMHHDCSPTIVHRDLKSSNILL-----------DYNFNAKIADFGVAKILIK------ 853
L Y+H IV+RDLK NILL D + + + V+K L K
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 854 ----------EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
EE F + S VG+ YIAPE D ++ G++L E+ G
Sbjct: 173 VNSIPSETFSEEPSFRSNS-FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 695 IGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
IG+G GKV +N A+VV + + +Q FL E Q +++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLLQ 59
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ-IAVGAAQG 810
L + LLV E+ L +L S R + + +Q +A A G
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLR-------SCRKAELMTPDPTTLQRMACEIALG 112
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L ++H + +H DL N LL + KI D+G++ KE+ V +
Sbjct: 113 LLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-PLRW 168
Query: 871 IAPEYARTRKVN-------EKTDIYSFGVILLEL 897
IAPE N ++++++S GV + EL
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 29/225 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+IG GG G+VY T ++ A+K + D+K + + E LA LN +L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLA----------LNERIML 48
Query: 754 CCISSENLKLLV---YEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQ 809
+S+ + +V Y + L L N L ++ V S + A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL 108
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL +MH+ +V+RDLK +NILLD + + +I+D G+A K++ + VG+ G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160
Query: 870 YIAPE-YARTRKVNEKTDIYSFGVILLELTTG----KEANNGDEH 909
Y+APE + + D +S G +L +L G ++ D+H
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-FLAEVQILSTIRHLNIVKL 752
VIG G G+V V + HT + A+K I N ++ ++ E F E +L I L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMK-ILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
EN LV +Y L L K AR + M +A+ + L
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----AEMVLAIHSIHQLH 122
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y VHRD+K N+LLD N + ++ADFG + + + ++G + S VG+ YI+
Sbjct: 123 Y---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQS-SVAVGTPDYIS 171
Query: 873 PEYARTR-----KVNEKTDIYSFGVILLELTTGK 901
PE + K + D +S GV + E+ G+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G VY+ T +VA+K+I +L+ + A EV +L ++H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
I +E LV+EY++K L Q+L S + + R GL
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLR----------GLN 118
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y H ++HRDLK N+L++ K+ADFG+A+ + S V + Y
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRP 172
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGK 901
P+ + + + D++ G I E++TG+
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 694 VIGSGGSGKVY--RVPINHTAEVVAVKKIWNDRKLDQK-----HEKEFLAEVQILSTIRH 746
V+G+G GKV+ R H + K+ L QK H + E +L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR---TERNVLEHVRQ 63
Query: 747 LN-IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+V L +E L+ +Y+ + L++++ S DEV + + +A
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEIILA- 117
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ H IV+RD+K NILLD + + DFG++K + EE E +
Sbjct: 118 --------LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFC 167
Query: 866 GSCGYIAPEYARTRKVNEK-TDIYSFGVILLELTTG 900
G+ Y+APE R + + K D +S G+++ EL TG
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G+V V + + +V A+K + L + F E +L + I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
EN LV +Y L L K AR + M IA+ + L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQLHY 123
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
VHRD+K NIL+D N + ++ADFG L+ E+G + S VG+ YI+P
Sbjct: 124 ---------VHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQS-SVAVGTPDYISP 172
Query: 874 EYARTR-----KVNEKTDIYSFGVILLELTTGK 901
E + K + D +S GV + E+ G+
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 55/233 (23%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
RD + +L E V+G+G G+VY+ T ++ A+K + + + E+E E+
Sbjct: 11 LRDPAGIFELVE--VVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTEDEEEEIKLEIN 64
Query: 740 ILSTI-RHLNIVKLLCCI------SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
+L H NI ++ LV E+ S+ + ++L ++
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL----KE 120
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
+ +++ I +GL ++H + ++HRD+K N+LL N K+ DFGV+ L
Sbjct: 121 DWIAY-----ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRK-----VNEKTDIYSFGVILLELTTG 900
+ G +T +G+ ++APE + + ++DI+S G+ +E+ G
Sbjct: 173 RTVGR---RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 74/239 (30%), Positives = 113/239 (47%), Gaps = 11/239 (4%)
Query: 64 PEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEY 123
P I ++ EL L + N + P + +L NL LDL FN +S P++L N S L
Sbjct: 133 PLIGLLKSNLKELDL-SDNKIESLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNN 190
Query: 124 LDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSI 183
LDLS N I +P +I+ LS L+ L L +NN ++ +S+ L L L L N+ +
Sbjct: 191 LDLSGNK-ISDLPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLE-DL 247
Query: 184 PAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML-- 241
P IGNL NLE L+L+ N S SSL S L L++L ++ +L +P +L
Sbjct: 248 PESIGNLSNLETLDLSNNQISSISSLGS----LTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNL 300
L L +S+ N+ S+ + I +++ +L L +NL
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNL 362
|
Length = 394 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 69/222 (31%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 695 IGSGGSGKVYRVPINHT--AEVVAVKKIWN--DRKLDQKHEKEFLAEVQILSTIR-HLNI 749
+G G G V T E VA+KKI N +K+ K L E+++L R H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA---LRELKLLRHFRGHKNI 64
Query: 750 VKL--LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-GRARDEVLSWRRRMQIAVG 806
L + + N +Y Y E D LH+ RS A + + QI G
Sbjct: 65 TCLYDMDIVFPGNFNE-LYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIY----QILCG 117
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK---ILIKEEGEFAAMST 863
L Y+H S ++HRDLK N+L++ + KI DFG+A+ E F M+
Sbjct: 118 ----LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--MTE 168
Query: 864 VVGSCGYIAPE----YARTRKVNEKTDIYSFGVILLELTTGK 901
V + Y APE + K D++S G IL EL K
Sbjct: 169 YVATRWYRAPEIMLSFQSYTK---AIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G+V V T +V A+K + + + F E I++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +V EYM L + D W R V A L
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSN----------YDVPEKWARFYTAEVVLA--LDA 157
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +HRD+K N+LLD + + K+ADFG + KE T VG+ YI+P
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYISP 212
Query: 874 EYARTRK----VNEKTDIYSFGVILLELTTG 900
E +++ + D +S GV L E+ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
N+IG+G G VY T+E VA+KK+ D + + E+ I+ + H+NI+ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFL 124
Query: 753 LCCISSENLKL--------LVYEYMEKRSLDQWLHKKNRS-SLSGRARDEVLSWRRRMQI 803
+E K +V E+ + Q +HK + + + A L Q+
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAKILIKEEGEFAAMS 862
+ L Y+H S I HRDLK N+L+D N + K+ DFG AK L+ A
Sbjct: 180 C----RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL------AGQR 226
Query: 863 TVVGSCG--YIAPEYAR-TRKVNEKTDIYSFGVILLELTTG 900
+V C Y APE D++S G I+ E+ G
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/233 (24%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
RD + +L E ++G+G G+VY+ T ++ A+K + D D+ E+E E+
Sbjct: 1 LRDPAGIFELVE--LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEIN 54
Query: 740 ILSTI-RHLNIVKLLCCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
+L H NI +N LV E+ S+ + ++L ++
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KE 110
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
E +++ I +GL ++H ++HRD+K N+LL N K+ DFGV+ L
Sbjct: 111 EWIAY-----ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRK-----VNEKTDIYSFGVILLELTTG 900
+ G +T +G+ ++APE + + K+D++S G+ +E+ G
Sbjct: 163 RTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
E+ IL TI H I+ L+ ++ +V M K D + + L ++ ++
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLP---LEQAIT 189
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
+RR+ A L Y+H I+HRD+K+ NI LD NA + DFG A L
Sbjct: 190 IQRRLLEA------LAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL----D 236
Query: 857 EFAAMSTVVGSCGYI---APEYARTRKVNEKTDIYSFGVILLEL 897
G G + +PE KTDI+S G++L E+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE--KEFLA 736
+F D ++ E+ IG G GKV++V AVK LD H+ +E A
Sbjct: 12 SFPDPSDTWEIIET--IGKGTYGKVFKVLNKKNGSKAAVKI------LDPIHDIDEEIEA 63
Query: 737 EVQILSTIR-HLNIVKLLCCISSENLKLLVYEYMEKRSLDQ-WLHKK--NRSSLSGRARD 792
E IL + H N+VK +Y + ++ DQ WL + N S++ +
Sbjct: 64 EYNILKALSDHPNVVKFYG----------MYYKKDVKNGDQLWLVLELCNGGSVTDLVKG 113
Query: 793 EVLSWRRRMQIAVG-----AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847
+ R + + A GL ++H + +HRD+K +NILL K+ DFGV
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-----VNEKTDIYSFGVILLELTTG 900
+ L +T VG+ ++APE + + + D++S G+ +EL G
Sbjct: 171 SAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G V++ T +VA+K+I +L+ + A EV +L ++H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ ++ LV+EY++K L Q++ ++S +GL
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCG----------NIMSMHNVKIFLYQILRGLA 118
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y H ++HRDLK N+L++ K+ADFG+A+ + S V + Y
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRP 172
Query: 873 PEYAR-TRKVNEKTDIYSFGVILLELTTGK 901
P+ + + + + D++ G I E+ +G+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-07
Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 2/99 (2%)
Query: 367 VSVNN--LTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNI 424
+ ++N L G +P + L I N++ G +P SLG+ +SL ++ + NSF G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 425 PAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISN 463
P L +L ++ ++ N +G +P + G L N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521
|
Length = 623 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 720 IWNDRKLDQKHEKEF--------------LAEVQILSTIRHLNIVKLL-CCISSENLKL- 763
++ ++ D K EKE+ E+ +L ++H N++ L +S + K+
Sbjct: 17 VYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76
Query: 764 LVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRM--QIAVGAAQGLCYMHHDCSP 820
L+++Y E D W + K +R+S +A + + R M + G+ Y+H +
Sbjct: 77 LLFDYAEH---DLWHIIKFHRAS---KANKKPMQLPRSMVKSLLYQILDGIHYLHANW-- 128
Query: 821 TIVHRDLKSSNILL----DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYA 876
++HRDLK +NIL+ KIAD G A++ A + VV + Y APE
Sbjct: 129 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 877 R-TRKVNEKTDIYSFGVILLELTTGK 901
R + DI++ G I EL T +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 26/62 (41%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 530 ALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLTGE 588
L L L G IP I L LQ ++LS N G IPP +G + L L+LS N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 589 IP 590
IP
Sbjct: 482 IP 483
|
Length = 623 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 46/239 (19%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G+V V T + A+K + L+++ AE IL +VK+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ L+ E++ + L KK+ S + + +A+ A L +
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS-----EEATQFYIAETVLAIDAIHQLGF 122
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK---------------EEGEF 858
+HRD+K N+LLD + K++DFG+ L K + F
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 859 AAMST-----------------VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
M++ VG+ YIAPE N+ D +S GVI+ E+ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 46/239 (19%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
VIG G G+V V T V A+K + L+++ AE IL L +VK+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ L+ E++ + L KK+ + +E + +A+ + L +
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT-----EEETQFYIAETVLAIDSIHQLGF 122
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK---------------EEGEF 858
+HRD+K N+LLD + K++DFG+ L K + F
Sbjct: 123 ---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 859 AAMST-----------------VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
M++ VG+ YIAPE N+ D +S GVI+ E+ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 33/217 (15%)
Query: 696 GSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL---AEVQILSTIRHLNIVKL 752
+ + T +VAVKKI LD +++ E+ ++H NI+
Sbjct: 11 EDLMIVHLAKH--KPTNTLVAVKKI----NLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ ++ +V M S + L L E+ I L
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAI----AFILKDVLNALD 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE-------FAAMSTVV 865
Y+H +HR +K+S+ILL + ++ + +IK G+ F S
Sbjct: 116 YIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSVKN 171
Query: 866 GSCGYIAPE--YARTRKVNEKTDIYSFGVILLELTTG 900
+++PE + NEK+DIYS G+ EL G
Sbjct: 172 --LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--EVQILSTIRHLNIVKL 752
+G G VY+ ++VA+K I + + F A E +L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
I ++ V+EYM L Q++ + R + R GL
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLR----------GLA 117
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I+HRDLK N+L+ Y K+ADFG+A+ + S+ V + Y
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRP 171
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGKEANNG 906
P+ + DI+ G I +E+ G+ A G
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 63/237 (26%), Positives = 93/237 (39%), Gaps = 47/237 (19%)
Query: 718 KKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQW 777
K++ + + E E LA L + H NI+K+ E L+ YM
Sbjct: 198 KRVKAGSRAAIQLENEILA----LGRLNHENILKI-----EEILRSEANTYM-------- 240
Query: 778 LHKKNRSSLSGRARDEVLSWRRR---MQIAVGAAQGLC---YMHHDCSPTIVHRDLKSSN 831
+ +K L DE W+ R Q Q LC Y+H ++HRD+K N
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFG 891
I L+ + + DFG A KE F VG+ +PE E TDI+S G
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFD--YGWVGTVATNSPEILAGDGYCEITDIWSCG 355
Query: 892 VILLELTTGK----EANNGDEHTCLAQWAWRHIQEGKPIVDAL---DKEI-DEPCFL 940
+ILL++ + G ++ I+D+L D+E D PC L
Sbjct: 356 LILLDMLSHDFCPIGDGGGKPG-----------KQLLKIIDSLSVCDEEFPDPPCKL 401
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA--E 737
F +D KL + +G G VY+ ++VA+K I +L ++ F A E
Sbjct: 1 FGKADSYEKLEK---LGEGSYATVYKGKSKVNGKLVALKVI----RLQEEEGTPFTAIRE 53
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
+L ++H NIV L I ++ LV+EY+ L Q++ K G + V +
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHP----GGLHPENVKLF 108
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849
++ +GL Y+H I+HRDLK N+L+ K+ADFG+A+
Sbjct: 109 LFQL------LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 20/59 (33%), Positives = 24/59 (40%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
NL LDL N + L+ LDLS N PE L L+ L L+ NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 71/296 (23%), Positives = 116/296 (39%), Gaps = 79/296 (26%)
Query: 695 IGSGGSGKV-----YRVPINHTAEVVAVKKIWNDRKLDQKHE--KEFLAEVQILSTI-RH 746
+G G G+V + + T VAVK + K H + ++E++IL I H
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMSELKILIHIGHH 70
Query: 747 LNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRS-----SLSGRAR-------DE 793
LN+V LL C +++ E+ + +L +L K + R R D
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130
Query: 794 VLSWRRRMQIAVGAAQG-----------------------------------LCY----- 813
+RR+ ++ ++Q +CY
Sbjct: 131 SEDLKRRLD-SITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVA 189
Query: 814 --MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
M S +HRDL + NILL N KI DFG+A+ + K+ ++ ++
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWM 248
Query: 872 APEYARTRKVNEKTDIYSFGVILLEL-TTGKEANNG---DEHTCLAQWAWRHIQEG 923
APE R ++D++SFGV+L E+ + G G DE C R ++EG
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEG 298
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 737 EVQILSTIRHLNIVKLL-CCISSENLKL-LVYEYMEKRSLDQW-LHKKNRSSLSGRARDE 793
E+ +L ++H N++ L +S + K+ L+++Y E D W + K +R+S + +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANK---- 100
Query: 794 VLSWRRRMQIAVGAAQGLCY-----MHHDCSPTIVHRDLKSSNILL----DYNFNAKIAD 844
+ +Q+ G + L Y +H+ + ++HRDLK +NIL+ KIAD
Sbjct: 101 -----KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGK 901
G A++ A + VV + Y APE R + DI++ G I EL T +
Sbjct: 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 13/219 (5%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
++ + N L + +N ++P+ L NL + +S N + +LP
Sbjct: 127 NITDIPPLIGLLKSNLKELD---LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKL 181
Query: 452 MSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLL 509
+S NL+ L++S N+ S +P + L SNN + L+ L +L+ L L
Sbjct: 182 LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL 239
Query: 510 DQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQ 569
N+L LP I + +L L+LS NQ+S +G L L++LDLS N S P
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS-NALPL 295
Query: 570 IGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGL 608
I L+L L + LT + N ++ + + G
Sbjct: 296 IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 49/161 (30%), Positives = 64/161 (39%), Gaps = 34/161 (21%)
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
N+V L I SE+ LV ++ E L W H S + V W M +A+ A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHI---SKFLNIPEECVKRWAAEMVVALDA 100
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+H + IV RDL +NILLD + ++ F S V S
Sbjct: 101 ------LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS-------------RWSEVEDS 138
Query: 868 CG-------YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
C Y APE + E D +S G IL EL TGK
Sbjct: 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-FLAEVQILSTIRHLNIVKL 752
VIG G G+V V + +T +V A+K I N ++ ++ E F E +L I L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMK-ILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
EN LV +Y L L K AR + M +A+ + L
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQLG 122
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y VHRD+K N+LLD N + ++ADFG + + + +G + + VG+ YI+
Sbjct: 123 Y---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQS-NVAVGTPDYIS 171
Query: 873 PEYAR-----TRKVNEKTDIYSFGVILLELTTGK 901
PE + + + D +S GV + E+ G+
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWND-RKLDQKHEKEFLAEVQILSTIR-HLNIVKL 752
IG G +V + T + A+K + + L+Q + L E+Q L + H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 753 LCCI---SSENLKLL-------VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
+ + + L L+ +YE ++ R + L V S+ Q
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGR----------KRPLP---EKRVKSYMY--Q 108
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA-M 861
+ + L +MH + I HRD+K NIL+ + K+ADFG + I + + +
Sbjct: 109 LL----KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRG-IYSKPPYTEYI 159
Query: 862 STVVGSCGYIAPEYARTRKV-NEKTDIYSFGVILLELTT 899
ST Y APE T K DI++ G + E+ +
Sbjct: 160 STR----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 7/199 (3%)
Query: 393 DNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGEL-PDK 451
+N LP SL SL ++ S L L + ++ N +
Sbjct: 55 SSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLL-NLLPLPSLDLNLNRLRSNISELL 113
Query: 452 MSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQ 511
NL+ L++ NN + P NL S+N ++P L LP+L L L
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSF 172
Query: 512 NQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIG 571
N LS LP + + +L L+LS N++S ++P +I L L++LDLS N ++ +
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 572 RLM-LTSLNLSSNRLTGEI 589
L L+ L LS+N+L
Sbjct: 230 NLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 689 LTESNVIGSGGSGKVYRVPI---NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
T ++G G G V + + + + VAVK + D E EFL E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59
Query: 746 HLNIVKLLCCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDE--VLSW 797
H N++KL+ K +++ +M+ L +L L R +E L
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-------LMSRIGEEPFTLPL 112
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
+ ++ + A G+ Y+ S +HRDL + N +L+ N +ADFG++K + G+
Sbjct: 113 QTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGD 167
Query: 858 FAAMSTVVG-SCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ ++A E +D+++FGV + E+ T
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 21/169 (12%)
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
E IL I H +I++L + L+ K L +L K ++ ++L+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAIC-----DILA 186
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA--KILIKE 854
R + + + Y+H + I+HRD+K+ NI +++ + + DFG A + I
Sbjct: 187 IERSV------LRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA 903
+ T+ + APE DI+S G++L E+ T ++
Sbjct: 238 NKYYGWAGTIATN----APELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 41/166 (24%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
AQG+ ++ S +HRD+ + N+LL AKI DFG+A+ I + +
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYVVKGNARLP 277
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLEL-TTGKEANNGDEHTCLAQWAWRHIQEGKPI 926
++APE ++D++S+G++L E+ + GK G + ++ ++ G
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG---ILVNSKFYKMVKRG--- 331
Query: 927 VDALDKEIDEPCF-LEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++ P F E+ + K+ C ++ PTERP + Q++
Sbjct: 332 -----YQMSRPDFAPPEIYSIMKM---CWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 76/280 (27%)
Query: 688 KLTESNVIGSGGSGKV-----YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L+ +G+G GKV Y + + A VAVK + L ++ + ++E+++LS
Sbjct: 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 93
Query: 743 TI-RHLNIVKLL--CCISSENLKLLVY--------------------------------- 766
+ H+NIV LL C + L + Y
Sbjct: 94 YLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKN 153
Query: 767 -------------EYME-KRSLDQWLHKKNRSSLSGRA-----RDEVLSWRRRMQIAVG- 806
EYM+ K + + K S R+ +D ++A+
Sbjct: 154 LLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDT 213
Query: 807 ---------AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
A+G+ ++ S +HRDL + NILL + KI DFG+A+ I+ +
Sbjct: 214 EDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD-IRNDSN 269
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+ ++APE ++D++S+G++L E+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
I G GKVY + +++ AVK + +++ + AE L+ + IV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
+ S N LV EY+ + LH + G DE ++ I+ A L Y+
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH------IYGYF-DEEMA---VKYIS-EVALALDYL 120
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP- 873
H I+HRDLK N+L+ + K+ DFG++K+ + E M ++ + P
Sbjct: 121 HRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN---MMDILTTPSMAKPK 174
Query: 874 -EYART 878
+Y+RT
Sbjct: 175 NDYSRT 180
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 30/106 (28%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 794 VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK 853
LS+ + + A G+ ++ S VHRDL + N+L+ KI DFG+A+ +++
Sbjct: 235 ALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 854 EEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ + ST + ++APE +D++SFG++L E+ T
Sbjct: 292 DSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 1/84 (1%)
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
M S VHRDL + N+LL KI DFG+A+ ++ + + ST + ++AP
Sbjct: 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVKWMAP 308
Query: 874 EYARTRKVNEKTDIYSFGVILLEL 897
E +D++S+G++L E+
Sbjct: 309 ESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 36/158 (22%), Positives = 60/158 (37%), Gaps = 27/158 (17%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV--KL 752
+ G + +VY + V+ KI R+ E+E V IL + + K+
Sbjct: 6 LKGGLTNRVYLLGTKDEDYVL---KINPSREKGADRERE----VAILQLLARKGLPVPKV 58
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L S+ L+ E++E +LD+ +S ++ IA A+ L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE---------VSEEEKE---------DIAEQLAELLA 100
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850
+H + H DL NIL+D I D+ A
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG+G GKV I V V VK++ + K + EFL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQC 60
Query: 753 LC-CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L C+ + LLV+EY E L +L S R+ L +RM + A G+
Sbjct: 61 LGQCVEAIPY-LLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQRMACEIAA--GV 112
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
+MH +H DL N L + K+ D+G+ KE+ ++
Sbjct: 113 THMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWL 168
Query: 872 APEYARTR-------KVNEKTDIYSFGVILLEL 897
APE + + +++++ GV L EL
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-04
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGE 447
G+ + L G +P + L + + NS GNIP L + +L ++ +S N F G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 448 LPDKMSGNLSRLEISN---NRFSGKIPTGVSSSKNLVVFQASNNLFNGT----IPGELTA 500
+P+ + G L+ L I N N SG++P + ++ +AS N + IPG
Sbjct: 482 IPESL-GQLTSLRILNLNGNSLSGRVPAALGG---RLLHRASFNFTDNAGLCGIPGLRAC 537
Query: 501 LPSLT 505
P L+
Sbjct: 538 GPHLS 542
|
Length = 623 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 27/172 (15%)
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKL----LVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
E++ L I NI+K+ I L L+ EY + L + L K+ +D
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---------KD 118
Query: 793 EVLSWRRRMQIAVGAAQGLCYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
LS++ ++ +A+ +GL ++ + P +++L S + L+ N+ KI G+ KIL
Sbjct: 119 --LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGK 901
F ++ +V Y + + + K DIYS GV+L E+ TGK
Sbjct: 174 --SSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 18/60 (30%), Positives = 24/60 (40%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
++ L L+N + L NL +LDL N + S P L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 31/82 (37%), Positives = 35/82 (42%), Gaps = 23/82 (28%)
Query: 243 LEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTG 302
L+ LDLS N T IP F K L NLKV+DLS NNLT
Sbjct: 2 LKSLDLSNNRLT-VIPDGAF--KGLP--------------------NLKVLDLSGNNLTS 38
Query: 303 AIPNDFGKLENLLNLSLMFNQL 324
P F L +L +L L N L
Sbjct: 39 ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 73/295 (24%), Positives = 107/295 (36%), Gaps = 50/295 (16%)
Query: 315 LNLSLMFNQLS-GEIPEGIGLLPSLKDVRLFNNMLSG----ALPPDFGRYSPLEYFEVSV 369
L LSL L E + L L+ +RL N L AL L+ +S+
Sbjct: 1 LQLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSL 60
Query: 370 NNL------TGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNC---SSLLMVKIYNNSF 420
N SL + L G L + DN L + L + SSL +K+ NN
Sbjct: 61 NETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL 120
Query: 421 TGNIPAGLWTGF-----NLSMVLISDNLFTGELPDKMSGNLS------RLEISNNRFSGK 469
L G L +++ N G + ++ L L ++NN
Sbjct: 121 GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180
Query: 470 -IPT---GVSSSKNLVVFQASNNLFN----GTIPGELTALPSLTTLLLDQNQLS--GSLP 519
I G+ ++ NL V +NN + L +L SL L L N L+ G+
Sbjct: 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240
Query: 520 LD---IISWKSLTALNLSRN--------QLSGEIPEKIGFLPVLQDLDLSENQFS 563
L + SL L+LS N L+ + EK L +LDL N+F
Sbjct: 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK----ESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 26/60 (43%), Positives = 30/60 (50%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
NLK +DLS N LT F L NL L L N L+ PE LPSL+ + L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 34/218 (15%)
Query: 115 LYNCSKLEYLDLSQNYFIG---PIPEDIDRLSRLKFLYLTANNMSGKIPASIGR-LTE-- 168
L L+ LDLS N + E + R S L+ L L N + + + + L +
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 169 --LRQLNLVVNQFNGSIPAEIGNL----QNLEALELAYN--TEFSPSSLPSNFTQLKKLK 220
L +L L N+ G+ + ++L+ L LA N + +L L+
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 221 KLWMASTNL----IGEIPETIGDMLALEFLDLSINNFTG--------SIPSSVFKLKNLS 268
L + + L + ET+ + +LE L+L NN T ++ S L LS
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256
Query: 269 KVYLYSNSLSGEIPQAV-----ESLNLKVIDLSANNLT 301
L N ++ + + + E +L +DL N
Sbjct: 257 ---LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 32/167 (19%)
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
HL V +C SEN+ +V E++E LD L K+ GR ++W ++ +A
Sbjct: 77 HLAFVHGVCVRGSENI--MVEEFVEHGPLDVCLRKEK-----GRVP---VAW--KITVAQ 124
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-------KIADFGVA-KILIKEEGE 857
A L Y+ +VH ++ + NILL A K++D GV+ L +EE
Sbjct: 125 QLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER- 180
Query: 858 FAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEA 903
V +IAPE ++ D +SFG LLE+ E
Sbjct: 181 -------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 40/119 (33%)
Query: 823 VHRDLKSSNILLDYNFNAKIADFG------------------------------------ 846
+HRD+K NIL+D + + K+ DFG
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 847 ----VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ K + + ++VG+ YIAPE + D +S GVIL E+ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1014 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.07 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.94 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.93 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.93 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.56 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.54 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.41 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.37 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.35 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-116 Score=1118.45 Aligned_cols=930 Identities=35% Similarity=0.566 Sum_probs=781.6
Q ss_pred CCCCCCchHHHHHHHHHHHHHHhhhccCCCHHHHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCceEeCC-CceeEEee
Q 001778 1 MSKTAPTTSLQILLSTLLLFFFGRANSQLYDREHAVLLKLKQHWQNPP-PISHWATTNSSHCTWPEIACTD-GSVTELHL 78 (1014)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~k~~~~~~~-~~~~w~~~~~~~c~w~gv~c~~-~~v~~L~l 78 (1014)
||+.+|..--. +++++++++... +...+.|+.||++||+++.++. .+.+|+.. .+||.|.||+|++ ++|+.|+|
T Consensus 1 ~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L 76 (968)
T PLN00113 1 MAKKGPQHCPY-LIFMLFFLFLNF--SMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDL 76 (968)
T ss_pred CCCCCCCCCCh-HHHHHHHHHHHc--cCCCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEe
Confidence 77777754433 222333333322 2236689999999999998764 47899754 6899999999974 79999999
Q ss_pred ccccCCccCCCCCCCCCCccEEECccCCCCCCCCcccc-CCCCcceecccccccCCCCCcccccccccceeeecCccCCC
Q 001778 79 TNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLY-NCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSG 157 (1014)
Q Consensus 79 ~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 157 (1014)
++++++|.+++.|..+++|++|+|++|++.+.+|..+. ++++|++|+|++|.+++.+|. +.+++|++|+|++|.+++
T Consensus 77 ~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~ 154 (968)
T PLN00113 77 SGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSG 154 (968)
T ss_pred cCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccc
Confidence 99999999999999999999999999999998888766 999999999999999998885 568999999999999999
Q ss_pred CCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCcccccc
Q 001778 158 KIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETI 237 (1014)
Q Consensus 158 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l 237 (1014)
.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++. +.+|..++++++|++|++++|++.+.+|..+
T Consensus 155 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 232 (968)
T PLN00113 155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV--GQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232 (968)
T ss_pred cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCc--CcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence 99999999999999999999999999999999999999999999753 4688999999999999999999999999999
Q ss_pred ccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccc-cccceeeccccccCCCCCCcccccccccc
Q 001778 238 GDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES-LNLKVIDLSANNLTGAIPNDFGKLENLLN 316 (1014)
Q Consensus 238 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 316 (1014)
+++++|++|++++|++++.+|..+.++++|+.|++++|++.+..|..+.. .+|++|++++|.+.+.+|..+.++++|+.
T Consensus 233 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 312 (968)
T PLN00113 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312 (968)
T ss_pred hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcE
Confidence 99999999999999999999999999999999999999999999887766 48999999999999999999999999999
Q ss_pred cccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEcccccc
Q 001778 317 LSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396 (1014)
Q Consensus 317 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l 396 (1014)
|++++|.+.+.+|..++.+++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..++.+++|+.|++++|.+
T Consensus 313 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l 392 (968)
T PLN00113 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392 (968)
T ss_pred EECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCC--CCCceeccccccccCcCCCcc
Q 001778 397 SGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS--GNLSRLEISNNRFSGKIPTGV 474 (1014)
Q Consensus 397 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~--~~L~~L~Ls~N~l~~~~~~~~ 474 (1014)
.+.+|..+.++++|+.|++++|++++.+|..+..+++|+.+++++|.+++.+|..+. ++|+.|+|++|++.+.+|..+
T Consensus 393 ~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~ 472 (968)
T PLN00113 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472 (968)
T ss_pred cccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc
Confidence 999999999999999999999999999999999999999999999999999987543 689999999999999988866
Q ss_pred cCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccccccccce
Q 001778 475 SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQD 554 (1014)
Q Consensus 475 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 554 (1014)
...+|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++|.+|..|.++++|+.
T Consensus 473 -~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 551 (968)
T PLN00113 473 -GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551 (968)
T ss_pred -ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE
Confidence 4589999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCccccCCchhhhhh-cccccccCCCcccccCChhhhh-hcccccccCCCCCCCCCCCCCcccccccCCCCCCCCC
Q 001778 555 LDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFEN-RAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSS 632 (1014)
Q Consensus 555 L~Ls~N~l~g~ip~~~~~~-~l~~l~ls~N~l~~~~p~~~~~-~~~~~~~~~n~~~c~~~~~~~~~~c~~~p~~~~~~s~ 632 (1014)
|||++|+++|.+|..+..+ .|+.|++++|+++|.+|...+. .+..++|.+|+++||.+......+|... .+..
T Consensus 552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~----~~~~- 626 (968)
T PLN00113 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV----RKTP- 626 (968)
T ss_pred EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc----cccc-
Confidence 9999999999999999988 7999999999999999976443 3556789999999997755544566431 1111
Q ss_pred CcchhhhhHHHHHHHHHHHH-HHHHhhhhhccccccccccccccccc--------cccccccCCCCCCCceeccCCcEEE
Q 001778 633 QHVAVIIVSVIAVFLVALLS-FFYMIRIYQKRKDELTSTETTSFHRL--------NFRDSDILPKLTESNVIGSGGSGKV 703 (1014)
Q Consensus 633 ~~~~~ii~~~i~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~LG~G~~g~V 703 (1014)
.+..++++++++++++++++ ++++++++++.+.+..+.+...+... .+...+....++..++||+|+||.|
T Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V 706 (968)
T PLN00113 627 SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706 (968)
T ss_pred eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeE
Confidence 22222222222222222222 22222222211111111111111100 0111233445777889999999999
Q ss_pred EEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCC
Q 001778 704 YRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNR 783 (1014)
Q Consensus 704 y~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~ 783 (1014)
|+|.+..+++.||||++..... ...+|++++++++|||||+++++|.+++..++||||+++|+|.++++.
T Consensus 707 y~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--- 776 (968)
T PLN00113 707 YKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776 (968)
T ss_pred EEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---
Confidence 9999988999999999843211 123468889999999999999999999999999999999999999953
Q ss_pred CCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccc
Q 001778 784 SSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863 (1014)
Q Consensus 784 ~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 863 (1014)
++|.++.+|+.|+|+|++|||..++++|+|||+||+||+++.++.+++. ||.+..... ...
T Consensus 777 -----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-------~~~ 837 (968)
T PLN00113 777 -----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-------DTK 837 (968)
T ss_pred -----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-------CCC
Confidence 7899999999999999999997777899999999999999999888875 665543211 123
Q ss_pred cccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCC--chhHHHHHHHHHhcCCcchhccccccCC--ccc
Q 001778 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE--HTCLAQWAWRHIQEGKPIVDALDKEIDE--PCF 939 (1014)
Q Consensus 864 ~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 939 (1014)
..+|++|+|||++.+..++.++|||||||++|||+||+.||+... .....+|....... ......+++.+.. +..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCCCcc
Confidence 468899999999999999999999999999999999999996432 23455565443322 2233444544422 234
Q ss_pred HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 940 LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.++..++.+++.+||+.||++||+|+||+++|++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 56677889999999999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=618.85 Aligned_cols=513 Identities=36% Similarity=0.569 Sum_probs=485.0
Q ss_pred CceeEEeeccccCCccCCCCCC-CCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceee
Q 001778 71 GSVTELHLTNMNMNGTFPPFIC-DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLY 149 (1014)
Q Consensus 71 ~~v~~L~l~~~~l~~~~~~~l~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (1014)
.+++.|+|++|++.|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 3789999999999999998765 999999999999999998885 5689999999999999999999999999999999
Q ss_pred ecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccc
Q 001778 150 LTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNL 229 (1014)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l 229 (1014)
|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++. +.+|..++++++|++|++++|++
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l 248 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS--GEIPYEIGGLTSLNHLDLVYNNL 248 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC--CcCChhHhcCCCCCEEECcCcee
Confidence 9999999999999999999999999999999999999999999999999999753 47889999999999999999999
Q ss_pred cCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCcccccc-ccceeeccccccCCCCCCcc
Q 001778 230 IGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDF 308 (1014)
Q Consensus 230 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~ 308 (1014)
.+.+|..++++++|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+... +|+.|++++|.+++.+|..+
T Consensus 249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~ 328 (968)
T PLN00113 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328 (968)
T ss_pred ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence 99999999999999999999999999999999999999999999999999999887764 89999999999999999999
Q ss_pred cccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccE
Q 001778 309 GKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAG 388 (1014)
Q Consensus 309 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~ 388 (1014)
+.+++|+.|+|++|++++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.
T Consensus 329 ~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~ 408 (968)
T PLN00113 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408 (968)
T ss_pred hcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccccccCCCCCcccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCC-CCCceecccccccc
Q 001778 389 IAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS-GNLSRLEISNNRFS 467 (1014)
Q Consensus 389 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~-~~L~~L~Ls~N~l~ 467 (1014)
|++++|++++.+|..|.++++|+.|++++|++++.+|..++.+.+|+.|++++|.+.+.+|..+. .+|+.|+|++|+++
T Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~ 488 (968)
T PLN00113 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFS 488 (968)
T ss_pred EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999998765 68999999999999
Q ss_pred CcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccc
Q 001778 468 GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIG 547 (1014)
Q Consensus 468 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 547 (1014)
+.+|..+.++++|+.|++++|.+.+.+|..++.+++|++|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..+.
T Consensus 489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 568 (968)
T PLN00113 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568 (968)
T ss_pred CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccceeecCCCccccCCchhhhhhcccccccCCCc-ccc
Q 001778 548 FLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNR-LTG 587 (1014)
Q Consensus 548 ~l~~L~~L~Ls~N~l~g~ip~~~~~~~l~~l~ls~N~-l~~ 587 (1014)
+++.|+.|++++|+++|.+|..-.-..+....+.+|+ ++|
T Consensus 569 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG 609 (968)
T ss_pred cCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence 9999999999999999999975222234455567776 444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=384.66 Aligned_cols=264 Identities=30% Similarity=0.444 Sum_probs=222.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-ceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN-LKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lV~ 766 (1014)
.++..+.||+|..|+||++.++.+++.+|+|++.. ..+....+++.+|+++++..+||+||+++|+|..++ ...++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 45667889999999999999999999999999933 345667789999999999999999999999999998 499999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||++|+|.++++..+ ++++...-+|+.+|++||.|||+. ++||||||||+|||++..|.|||||||
T Consensus 158 EYMDgGSLd~~~k~~g-----------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG-----------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred hhcCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 9999999999998753 388999999999999999999962 499999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCC--CchhHHHHHHHHHhcCC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD--EHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~--~~~~~~~~~~~~~~~~~ 924 (1014)
.+..+... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||... ......+....+..+..
T Consensus 225 VS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 225 VSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred ccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 99876542 345789999999999999999999999999999999999999999764 22233344444444333
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGR 985 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~ 985 (1014)
+ .+... ....++..++..|+++||.+||+++|+++ |||+........
T Consensus 300 P-------~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~----Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 300 P-------RLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ----HPFIKKFEDPNV 346 (364)
T ss_pred C-------CCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc----CHHHhhcccccc
Confidence 2 22221 23445677888999999999999988888 999998665433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=390.19 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=220.2
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhH----HhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ----KHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
+.+.|...+.||+|+||.|-+|..+.+|+.||||++.+...... .....+.+|+++|++++||+||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45568889999999999999999999999999999965443331 23455789999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC---
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN--- 837 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~--- 837 (1014)
..|+|+||++||+|.+.+-..+ .+.+.....+++|++.|+.|||+. ||+||||||+|||+..+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 9999999999999999997753 367777889999999999999965 99999999999999765
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCC---CCcCcchhHHHHHHHHhcCCCCCCCCCchh-HH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKV---NEKTDIYSFGVILLELTTGKEANNGDEHTC-LA 913 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~DvwSlGvll~elltg~~p~~~~~~~~-~~ 913 (1014)
..+||+|||+|+..+ ....+.+.+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+..... ..
T Consensus 316 ~llKItDFGlAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~ 391 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK 391 (475)
T ss_pred eEEEecccchhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence 779999999999864 2345678999999999999987543 347899999999999999999998654332 33
Q ss_pred HHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
++ +..+.. .+..+.+.+...+..++|.+||..||++|||++|+++ ||||+...-++
T Consensus 392 eQ----I~~G~y-------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~----hpW~~~~~~~s 447 (475)
T KOG0615|consen 392 EQ----ILKGRY-------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN----HPWFKDAPCLS 447 (475)
T ss_pred HH----HhcCcc-------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc----Chhhhcccccc
Confidence 32 222222 1122345556667889999999999999999999999 99999766544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=406.84 Aligned_cols=279 Identities=44% Similarity=0.734 Sum_probs=236.5
Q ss_pred ccccc-cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEE
Q 001778 678 LNFRD-SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI 756 (1014)
Q Consensus 678 ~~~~~-~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 756 (1014)
+.+.+ ..++++|...++||+|+||.||+|..... ..||||++..... .. ..+|.+|++++.+++|||+|+++|||
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~--~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSG--QG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCC--cc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 44444 45567899999999999999999987654 8899998743221 11 55699999999999999999999999
Q ss_pred EcCC-ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec
Q 001778 757 SSEN-LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835 (1014)
Q Consensus 757 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~ 835 (1014)
.+++ +.+||||||++|+|.++++.... . +++|.+|.+|+.++|+||+|||+.+.++|+||||||+|||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~--------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG--------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC--------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 9988 59999999999999999998532 1 689999999999999999999998888999999999999999
Q ss_pred CCCcEEEeecccccccccccCcccccccc-ccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCC---Cchh
Q 001778 836 YNFNAKIADFGVAKILIKEEGEFAAMSTV-VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD---EHTC 911 (1014)
Q Consensus 836 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~---~~~~ 911 (1014)
+++.+||+|||+|+..... ....... .||.+|+|||+...+..+.++|||||||++.|++||+.+.+.. ....
T Consensus 212 ~~~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~ 288 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS 288 (361)
T ss_pred CCCCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence 9999999999999654320 1111222 8999999999999999999999999999999999999888743 3445
Q ss_pred HHHHHHHHHhcCCcchhccccccC-CcccH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEID-EPCFL-EEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.+|++..+..+ .+.+++|+.+. ..+.. +++.++.+++.+|++.+|.+||+|.||+++|+.
T Consensus 289 l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 289 LVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 889998888877 67999999987 44443 688899999999999999999999999999944
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.70 Aligned_cols=287 Identities=25% Similarity=0.318 Sum_probs=242.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+.|+..++||+|+||+||.++.+.+++.+|+|++.+++.......+...+|..++..++||+||+++..|++++.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45688999999999999999999999999999999888777778889999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+.||.|...+++++. +++..+.-++.+|+.||.|||+. +|||||+||+|||+|.+|+++|+||
T Consensus 104 ld~~~GGeLf~hL~~eg~-----------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR-----------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred EeccCCccHHHHHHhcCC-----------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 999999999999987643 88999999999999999999955 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+++.....+ ......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||.+.+.. .+...+..+..+
T Consensus 170 gL~k~~~~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 170 GLCKEDLKDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---KMYDKILKGKLP 243 (357)
T ss_pred ccchhcccCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---HHHHHHhcCcCC
Confidence 9998643321 2344689999999999999999999999999999999999999999987743 333333333211
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcccccccccchhhhhhcc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKYDHVTPLLTDSKREKMS 1003 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1014)
....... .+..+++...++.||++|....+=.+.+++||||....|..-...+.+|++.+.....++
T Consensus 244 --------~~p~~ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~ 310 (357)
T KOG0598|consen 244 --------LPPGYLS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLED 310 (357)
T ss_pred --------CCCccCC---HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccc
Confidence 0011122 245577889999999999864444556888999999999998888999977766554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.76 Aligned_cols=260 Identities=27% Similarity=0.377 Sum_probs=225.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|...+.||+|||+.||++++..+|+.||+|++.++........+.+.+||++.+.++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999998877778888999999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|+|+.|+|..+++.. .++++.++..++.||+.|+.|||.. +|+|||||..|+|++++.+|||+|||
T Consensus 98 ELC~~~sL~el~Krr-----------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred EecCCccHHHHHHhc-----------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999854 4599999999999999999999955 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|..+..++ .+..+.+|||.|+|||++....++..+||||+|||+|.|+.|++||....-.+ .+..+.....
T Consensus 164 LAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----ty~~Ik~~~Y- 235 (592)
T KOG0575|consen 164 LATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----TYNKIKLNEY- 235 (592)
T ss_pred eeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----HHHHHHhcCc-
Confidence 999875432 24457899999999999999999999999999999999999999998765322 2222222221
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..+.....+..++|..+|+.||.+|||+++|++ |+||.+.-.
T Consensus 236 ----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~----h~Ff~~g~~ 277 (592)
T KOG0575|consen 236 ----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD----HPFFKSGFT 277 (592)
T ss_pred ----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc----CHhhhCCCc
Confidence 011122345668899999999999999999999 999955333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=369.83 Aligned_cols=263 Identities=30% Similarity=0.459 Sum_probs=218.5
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
...++|...+.||+|+||+||+|+++.++..||||.+..++ ..++..+.+..|+.+++.++|||||+++++++.++..|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~-l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK-LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc-cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 34567888889999999999999999999999999995432 26677888999999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC------
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN------ 837 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~------ 837 (1014)
+|||||.||+|.+|++..+ .+++.....++.|+|.||++||+. +||||||||+|||++..
T Consensus 86 lVMEyC~gGDLs~yi~~~~-----------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~ 151 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRG-----------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTS 151 (429)
T ss_pred EEEEeCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCC
Confidence 9999999999999999874 389999999999999999999966 99999999999999764
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
..+||+|||+|+.+... ....+.+|++-|||||+++.+.|+.|+|+||+|+++|+|++|+.||+.....++..
T Consensus 152 ~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~--- 224 (429)
T KOG0595|consen 152 PVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL--- 224 (429)
T ss_pred ceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---
Confidence 56899999999987642 23457899999999999999999999999999999999999999999877655443
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.++.+............ ....+++...++.+|.+|-+..+... |++.....
T Consensus 225 -~~~k~~~~~~~~~~~~s--------~~~~~Ll~~ll~~~~~~~~~~~~~~~----~~~l~~~p 275 (429)
T KOG0595|consen 225 -YIKKGNEIVPVLPAELS--------NPLRELLISLLQRNPKDRISFEDFFD----HPFLAANP 275 (429)
T ss_pred -HHhccccccCchhhhcc--------CchhhhhhHHHhcCccccCchHHhhh----hhhcccCc
Confidence 33333332222222221 12346666778888888888888776 77776655
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=384.88 Aligned_cols=255 Identities=36% Similarity=0.496 Sum_probs=208.9
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-ceEEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN-LKLLVYE 767 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lV~e 767 (1014)
+...+.||+|+||+||+|.|..+. .||||++......... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 445566999999999999887432 2999999654333333 789999999999999999999999999887 7999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEeccCCCCCeeecCCC-cEEEeec
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPT-IVHRDLKSSNILLDYNF-NAKIADF 845 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~-ivH~Dlk~~NIll~~~~-~~kl~Df 845 (1014)
|+++|+|.++++.. ....+++..+.+|+.|||+||.|||.. + ||||||||+|||++.++ ++||+||
T Consensus 121 y~~~GsL~~~l~~~---------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred eCCCCcHHHHHhhc---------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence 99999999999874 124599999999999999999999966 6 99999999999999997 9999999
Q ss_pred ccccccccccCccccccccccCcccccccccc--cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR--TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|+++...... .......||+.|||||++. ...|+.++|||||||++|||+||+.||.+.... +.+...+..+
T Consensus 189 Glsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~ 262 (362)
T KOG0192|consen 189 GLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGG 262 (362)
T ss_pred ccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcC
Confidence 9998754321 2334478999999999999 679999999999999999999999999987652 2222232222
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.. ...+..+...+..++..||+.||++||++.+++..|+.
T Consensus 263 ~R----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 263 LR----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred CC----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 21 11122255667788889999999999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.93 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=215.9
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+...++|+|+||.||+|+++.+|+.||||++... ..++...+-..+|++++++++|||+|.++++|.....+++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 4677888999999999999999999999999999543 334556677899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||+. ++.+-++... ..++.....++++|++.|+.|+|.+ +++||||||+|||++.++.+|+||||
T Consensus 81 E~~dh-TvL~eLe~~p----------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYP----------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred eecch-HHHHHHHhcc----------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence 99987 4444444432 2378889999999999999999955 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH-----
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI----- 920 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~----- 920 (1014)
+|+.+...+. .++..+.|..|+|||.+.+ ..|+.++||||+||++.||++|++.|.+.++.+....+...+
T Consensus 147 FAR~L~~pgd---~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 147 FARTLSAPGD---NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhHhhcCCcc---hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 9998864222 3446788999999999887 789999999999999999999999999887654433332221
Q ss_pred ------hcCCcchhccccccCC-----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 921 ------QEGKPIVDALDKEIDE-----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 921 ------~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.....+....-+.... ..+.....-+++++..|++.||++|++-+|++. |++|+.-
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~----H~yFd~~ 290 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH----HPYFDGF 290 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc----ChHHHHH
Confidence 1111111111121111 122233335779999999999999999888888 9999663
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=352.28 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=213.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEE-EEEcC-CceE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC-CISSE-NLKL 763 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~-~~~~~-~~~~ 763 (1014)
...|++.++||+|.||+||++.+..+|..||.|.+. -...+.+..+....|+.++++++|||||++++ .+.++ +..+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345888999999999999999999999999999986 34456777889999999999999999999998 44444 4489
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeecCCCcEEE
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCS-PTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s-~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
+|||||.+|+|.+.++.... ....+++..+|+++.|++.||.++|.... ..|+||||||.||+++.+|.||+
T Consensus 97 ivmE~c~~GDLsqmIk~~K~-------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKK-------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred HHHHhhcccCHHHHHHHHHh-------ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 99999999999999987532 34569999999999999999999996321 23889999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||+++.+.+.. ......+|||.||+||++.+.+|++++||||+||++|||+.-++||.+++-..+.. . +..
T Consensus 170 GDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~---K-I~q 242 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK---K-IEQ 242 (375)
T ss_pred ccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH---H-HHc
Confidence 9999999885532 33457899999999999999999999999999999999999999999986433332 2 222
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.. +.+....+++ .+.++|..|+.+||+.||+....+..+++
T Consensus 243 gd~------~~~p~~~YS~---~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDY------PPLPDEHYST---DLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCC------CCCcHHHhhh---HHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 211 1122223333 45567778999999999995555554443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=389.04 Aligned_cols=471 Identities=29% Similarity=0.429 Sum_probs=321.2
Q ss_pred ceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeec
Q 001778 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151 (1014)
Q Consensus 72 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (1014)
....+.+++|.+. .+.+.+.+|..|++|++++|++. ..|++++.+..++.|+.++|+++ .+|++++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3566777777776 44556777777777777777774 45667777777777777777777 677777777777777777
Q ss_pred CccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccC
Q 001778 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIG 231 (1014)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~ 231 (1014)
+|.+. .+|+.++.+..|+.|+..+|+++ ..|+.++++.+|..+++.+|+ +.++|...-+++.|++|+..+| +.+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~---l~~l~~~~i~m~~L~~ld~~~N-~L~ 196 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNK---LKALPENHIAMKRLKHLDCNSN-LLE 196 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccc---hhhCCHHHHHHHHHHhcccchh-hhh
Confidence 77777 66677777777777777777776 667777777777777777775 3445555555666666665443 334
Q ss_pred ccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCccccc
Q 001778 232 EIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311 (1014)
Q Consensus 232 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 311 (1014)
.+|+.++.|.+|..|+|.+|++. .+| .|..+..|++|+++.|+|.-.+.+.. .++
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~-----------------------~~L 251 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHL-----------------------KHL 251 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHh-----------------------ccc
Confidence 55556666666666666666665 445 55555555555555555543222222 245
Q ss_pred ccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCC---ccE
Q 001778 312 ENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGK---LAG 388 (1014)
Q Consensus 312 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~---L~~ 388 (1014)
++|..|||.+|+++ +.|+.++-+.+|.+||+++|.|+ .+|.+++++ .|++|-+.+|.+... -..+-..+. |++
T Consensus 252 ~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKy 327 (565)
T KOG0472|consen 252 NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKY 327 (565)
T ss_pred ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHH
Confidence 55555555555554 45555555555555555555555 344455555 555555555554421 111111000 111
Q ss_pred EEc-------ccc--------ccCCCCCcccccCCcccEEEeecceeecCCCcccccccc---cccccccCCcccCCCCC
Q 001778 389 IAA-------QDN--------NLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFN---LSMVLISDNLFTGELPD 450 (1014)
Q Consensus 389 L~l-------~~N--------~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~---L~~l~l~~n~~~~~~p~ 450 (1014)
|.- +.. ............+-+.+.|+++.-+++ .+|..+|.... ...++++.|++. ++|.
T Consensus 328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk 405 (565)
T KOG0472|consen 328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPK 405 (565)
T ss_pred HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhh
Confidence 110 000 000111122344567788888888888 78888887665 788889999888 7777
Q ss_pred cCCC---CCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCccccccccc
Q 001778 451 KMSG---NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKS 527 (1014)
Q Consensus 451 ~~~~---~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 527 (1014)
.+.. -.+.+++++|.++ .+|..++.+++|+.|+|+||.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..
T Consensus 406 ~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~ 482 (565)
T KOG0472|consen 406 RLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQT 482 (565)
T ss_pred hhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHH
Confidence 6652 3556778888877 88999999999999999999998 78999999999999999999998 89998888888
Q ss_pred ccceeccccccccccCcccccccccceeecCCCccccCCchhhhhh-cccccccCCCccc
Q 001778 528 LTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLT 586 (1014)
Q Consensus 528 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~l~~l~ls~N~l~ 586 (1014)
|+.+-.++|++....|+.+.+|.+|.+|||.+|.+. .||+.+|++ .|++|++++|++.
T Consensus 483 lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 483 LETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 999989999998666666999999999999999998 899999999 7999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=378.40 Aligned_cols=252 Identities=30% Similarity=0.452 Sum_probs=215.4
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
++..+.||+|.||+||.|.+..+ ..||+|.++.. ....++|.+|+.+|++++|++||+++++|..++.++|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCC-CcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 45677899999999999998754 35999998442 45567888999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
|+.|+|.++++.. ....+...+.+.++.|||+||+||+.+ ++|||||.++||||+++..|||+|||+|
T Consensus 283 m~~GsLl~yLr~~---------~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 283 MPKGSLLDYLRTR---------EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred cccCcHHHHhhhc---------CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence 9999999999973 234588899999999999999999954 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+... +..+.......-+..|.|||.+..+.++.+||||||||+||||+| |+.||.+....+ +.
T Consensus 351 r~~~--d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~ 414 (468)
T KOG0197|consen 351 RLIG--DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VL 414 (468)
T ss_pred cccC--CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HH
Confidence 9443 334444455566889999999999999999999999999999998 667777665432 24
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.++++.+.+.+..++.++.++|..||+.+|++|||++.+...+++
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 4455666777788888999999999999999999999988877765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.87 Aligned_cols=276 Identities=25% Similarity=0.306 Sum_probs=233.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
..+|+..+.||.|+||+|..++.+.++..+|+|++.+.+....++.+...+|..+++.+.||+++++++.+.+....|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 35688899999999999999999999999999999887777788899999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||++||.|..++++.++ ++...+.-++.||+.|++|||.. +|++||+||+|||+|.+|.+||+||
T Consensus 123 meyv~GGElFS~Lrk~~r-----------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-----------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred EeccCCccHHHHHHhcCC-----------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999998643 89999999999999999999955 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+|+.... ...+.+|||.|+|||++....|..++|.|||||++|||+.|.+||...... .++..+.++..
T Consensus 189 GFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~KI~~~~v 258 (355)
T KOG0616|consen 189 GFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEKILEGKV 258 (355)
T ss_pred cceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHHHHhCcc
Confidence 99987643 234789999999999999999999999999999999999999999987652 22333333322
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCcccccccccch
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-NMRMVLQILLNNPIFPTEKNGGRKYDHVTPLLTD 996 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1014)
. ++.-...++.+++...+++|-.+|- .+..=.+.+.+||||+...|..-...++.++..+
T Consensus 259 ---------~--fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 259 ---------K--FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred ---------c--CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 1 1222223456788899999999993 3333455667799999988886666666665544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=368.27 Aligned_cols=271 Identities=22% Similarity=0.261 Sum_probs=224.5
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+.|...++||+|+||+||.|+.+.+|+.+|+|++++.......+.+.++.|-.+|....+|.||+++..|++.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 45688899999999999999999999999999999888777888899999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||++||++..++...+ .+++..+..++.+++.|+..+|+. |+|||||||+|+|||..|++||+||
T Consensus 220 MEylPGGD~mTLL~~~~-----------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-----------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecCCccHHHHHHhcC-----------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence 99999999999998863 589999999999999999999977 9999999999999999999999999
Q ss_pred cccccccccc--------------------Cccc------------------------cccccccCcccccccccccCCC
Q 001778 846 GVAKILIKEE--------------------GEFA------------------------AMSTVVGSCGYIAPEYARTRKV 881 (1014)
Q Consensus 846 gla~~~~~~~--------------------~~~~------------------------~~~~~~gt~~y~aPE~l~~~~~ 881 (1014)
|++..+.... .+.. .....+|||.|+|||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 9995442200 0000 0012579999999999999999
Q ss_pred CCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCC
Q 001778 882 NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTER 961 (1014)
Q Consensus 882 ~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 961 (1014)
+..+|+||+|||+|||+.|.+||.+++.......+..-. +... -+.......+..++|.+|+. ||++|
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~----------fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLK----------FPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhcc----------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999999999887544333221111 1111 11111122567789999999 99999
Q ss_pred CCHHHHHHHHhcCCCCCCCCCC
Q 001778 962 PNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 962 Pt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. ..=++.+++||||+...|.
T Consensus 434 LG-~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 434 LG-SKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred cC-cccHHHHhcCCccccCCcc
Confidence 98 4445667789999998876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=368.44 Aligned_cols=265 Identities=24% Similarity=0.282 Sum_probs=221.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+|..++.||+|+|++|++|+.+.+++.||||++.+.-...+...+-+..|-.+|.++ .||.|++++..|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 3577788999999999999999999999999999665554555567788899999999 899999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++|+|.+++++.+. |++.....++.+|+.|++|||.+ |||||||||+|||+|+|++++|+||
T Consensus 153 Le~A~nGdll~~i~K~Gs-----------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS-----------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred EEecCCCcHHHHHHHhCc-----------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence 999999999999998753 88888899999999999999955 9999999999999999999999999
Q ss_pred ccccccccccCc----------cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 846 GVAKILIKEEGE----------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 846 gla~~~~~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
|.|+.+.+.... .......+||..|.+||++.+...++.+|+|+||||+|+|+.|.+||.+.++....+.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK 298 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 999988653221 1112458999999999999999999999999999999999999999998776544332
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
+...- - .+. ......+.+|+.+.+..||.+|+|.+++.+ ||||....+..
T Consensus 299 I~~l~---y--------~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----HpFF~~Vdw~n 348 (604)
T KOG0592|consen 299 IQALD---Y--------EFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----HPFFEGVDWEN 348 (604)
T ss_pred HHHhc---c--------cCC----CCCCHHHHHHHHHHHccCccccccHHHHhh----CcccccCChhh
Confidence 22111 1 111 111244567888999999999999876666 99999987764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=367.27 Aligned_cols=273 Identities=27% Similarity=0.345 Sum_probs=221.5
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCC-ceE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSEN-LKL 763 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~-~~~ 763 (1014)
-++|+..+.||.|+||.||+|+.+.+++.||||+++.+ ....++-.=.+|+..++++. ||||+++.+++.+.+ .++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K--f~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK--FYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh--hccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 35788899999999999999999999999999998543 22233444578999999998 999999999998877 999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|||||+. +|.++++.. +..|++..+..|++||++||+|+|++ |+.|||+||+|||+.....+||+
T Consensus 87 fVfE~Md~-NLYqLmK~R----------~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR----------NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred eeHHhhhh-hHHHHHhhc----------CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEec
Confidence 99999976 999999875 35699999999999999999999976 99999999999999988899999
Q ss_pred ecccccccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+|+.+.+.. ..+..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|.|.++.+....+..++
T Consensus 153 DFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL-- 226 (538)
T KOG0661|consen 153 DFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL-- 226 (538)
T ss_pred ccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh--
Confidence 999999876532 345678899999999764 5689999999999999999999999999887643333222222
Q ss_pred CCcchhcccccc------C--C---------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 923 GKPIVDALDKEI------D--E---------PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 923 ~~~~~~~~~~~~------~--~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
|.+..+....+. . . ........+.++++.+|+++||++||||+|+++ ||||+.....+
T Consensus 227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~----~pffq~~~~~~ 301 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ----HPFFQVGRASG 301 (538)
T ss_pred CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc----Ccccccccccc
Confidence 333222222211 0 0 112335557889999999999999999999999 99999876653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.65 Aligned_cols=279 Identities=26% Similarity=0.324 Sum_probs=226.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+.|...++||.|..+.||+|....+++.||||++.-++ .....+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 356888999999999999999999999999999994432 233368899999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|.||.+|++.++++.. ....+.+..+..|++++++||.|||++ |.||||||+.|||++.+|.|||+||
T Consensus 103 mpfMa~GS~ldIik~~---------~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTY---------YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ehhhcCCcHHHHHHHH---------ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence 9999999999999875 223488899999999999999999977 9999999999999999999999999
Q ss_pred ccccccccccCccccc-cccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 846 GVAKILIKEEGEFAAM-STVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|.+..+...+...... ...+||+.|||||+++. ..|+.|+||||||++..|+.+|..||..... .+.....++.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLqn 247 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQN 247 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcC
Confidence 9998776644322222 66799999999999654 4799999999999999999999999976442 2333334444
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKY 987 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~ 987 (1014)
..+... -..+..+........+.+++..|+++||.+|||++++++ |+||+..+-....+
T Consensus 248 ~pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk----h~FFk~~k~~~~~~ 306 (516)
T KOG0582|consen 248 DPPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK----HAFFKKAKSKEYLV 306 (516)
T ss_pred CCCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc----cHHHhhccchhhcc
Confidence 433222 112222222333346778888999999999999998888 99999877554443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=371.47 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=223.2
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+....|+....||+|+.|.||.+....+++.||||++. ...+...+-+.+|+.+|+..+|+|||++++.|..++..
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~---l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMD---LRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEE---eccCCchhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 456677888999999999999999999999999999993 23445567789999999999999999999999988999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
|.|||||++|+|.+++... .+++.++..|++++++||+|||.. +|+|||||.+|||++.+|.+||
T Consensus 346 WVVMEym~ggsLTDvVt~~------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKl 410 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKL 410 (550)
T ss_pred EEEEeecCCCchhhhhhcc------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEE
Confidence 9999999999999999764 489999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||++..+.... .+....+||++|||||+.....|++++||||||++++||+-|++||-.+. ..+.++.+...
T Consensus 411 tDFGFcaqi~~~~---~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~n 484 (550)
T KOG0578|consen 411 TDFGFCAQISEEQ---SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATN 484 (550)
T ss_pred eeeeeeecccccc---CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhc
Confidence 9999998775432 35668899999999999999999999999999999999999999998644 33444555555
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
+.+ +..........+.+++.+||+.||++||++.|+++ |||++
T Consensus 485 g~P---------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~----HpFl~ 527 (550)
T KOG0578|consen 485 GTP---------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE----HPFLK 527 (550)
T ss_pred CCC---------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc----Chhhh
Confidence 554 12223344456778889999999999999999998 99993
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=379.80 Aligned_cols=470 Identities=25% Similarity=0.326 Sum_probs=360.5
Q ss_pred ceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeec
Q 001778 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151 (1014)
Q Consensus 72 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (1014)
.++.|++.++.++ .+|++++.+..++.|+.++|++. .+|.+++.+.+|+.|+.++|.+. .+|+.++.+..|+.|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 5888999999998 78999999999999999999994 67899999999999999999998 789999999999999999
Q ss_pred CccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccC
Q 001778 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIG 231 (1014)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~ 231 (1014)
+|+++ ..|+.+.++.+|..|++.+|++....|+.+ +++.|++|+...|- ++.+|..++.+.+|.-|+|..|.+.
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~---L~tlP~~lg~l~~L~~LyL~~Nki~- 219 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNL---LETLPPELGGLESLELLYLRRNKIR- 219 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhh---hhcCChhhcchhhhHHHHhhhcccc-
Confidence 99999 889999999999999999999995555555 49999999999996 6889999999999999999999887
Q ss_pred ccccccccccccceeecccccccCcCChhhh-CCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccc
Q 001778 232 EIPETIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGK 310 (1014)
Q Consensus 232 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 310 (1014)
.+| .|.+++.|.+|+++.|+|+ .+|.... .+++|..|||..|+++..+.+.+-..+|.+||+|+|.|+ ..|..+++
T Consensus 220 ~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgn 296 (565)
T KOG0472|consen 220 FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGN 296 (565)
T ss_pred cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCccccc
Confidence 456 7999999999999999999 7888776 799999999999999955444444447999999999998 56778888
Q ss_pred cccccccccccceecccCCcccCCCC---CCCcccc--cCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCC
Q 001778 311 LENLLNLSLMFNQLSGEIPEGIGLLP---SLKDVRL--FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGK 385 (1014)
Q Consensus 311 l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~L--~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 385 (1014)
+ .|+.|-+.+|.+.. +-..+-+.. -|++|.= ..-.++.. .-+..+. -++ ..+.. .......+
T Consensus 297 l-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~s---e~~~e~~---~t~----~~~~~-~~~~~~i~ 363 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQS---EGGTETA---MTL----PSESF-PDIYAIIT 363 (565)
T ss_pred c-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCC---ccccccc---CCC----CCCcc-cchhhhhh
Confidence 8 89999999998863 222221111 1333321 00011100 0000000 000 00000 01122233
Q ss_pred ccEEEccccccCCCCCcccccCC--cccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCC--CCCceecc
Q 001778 386 LAGIAAQDNNLSGELPESLGNCS--SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS--GNLSRLEI 461 (1014)
Q Consensus 386 L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~--~~L~~L~L 461 (1014)
.+.|++++-+++....+.|..-. -...++++.|++. .+|..+..+..+....+..|+..+.+|..+. ++|..|+|
T Consensus 364 tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L 442 (565)
T KOG0472|consen 364 TKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDL 442 (565)
T ss_pred hhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeec
Confidence 44444444444422222222221 2455666666665 6777777766666655555555556666554 58999999
Q ss_pred ccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccc
Q 001778 462 SNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGE 541 (1014)
Q Consensus 462 s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 541 (1014)
++|-+. .+|..++.+..|+.||+|+|+|. .+|..+..+..++.+--++|++....|..+.++..|..|||.+|.+. .
T Consensus 443 ~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~ 519 (565)
T KOG0472|consen 443 SNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-Q 519 (565)
T ss_pred ccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-h
Confidence 999888 78999999999999999999998 89999999999999999999998555566999999999999999998 8
Q ss_pred cCcccccccccceeecCCCccccCCchhhhh
Q 001778 542 IPEKIGFLPVLQDLDLSENQFSGKIPPQIGR 572 (1014)
Q Consensus 542 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 572 (1014)
||..+++|++|+.|+|++|.|. .|+....
T Consensus 520 IPp~LgnmtnL~hLeL~gNpfr--~Pr~~iL 548 (565)
T KOG0472|consen 520 IPPILGNMTNLRHLELDGNPFR--QPRHQIL 548 (565)
T ss_pred CChhhccccceeEEEecCCccC--CCHHHHh
Confidence 9999999999999999999997 6665443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=329.25 Aligned_cols=273 Identities=26% Similarity=0.341 Sum_probs=222.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|...+++|+|.||.||+|.+..+|+.||||+++.. ...........+|++.++.++|+||+.++++|...+..-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~-~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLG-NAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecc-ccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 3678889999999999999999999999999999654 223334567899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||+. +|..+++.+ ...++-.++..++.++++|++|+|.. .|+|||+||.|+|++.+|.+||+|||
T Consensus 81 Efm~t-dLe~vIkd~----------~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDK----------NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred Eeccc-cHHHHhccc----------ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence 99986 999999875 34688899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
+|+.+.+.... ....+-|..|+|||++.+ +.|+..+||||.|||+.||+-|.+-|.++++-+....+.+.. |.+
T Consensus 147 LAr~f~~p~~~---~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L--GTP 221 (318)
T KOG0659|consen 147 LARFFGSPNRI---QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL--GTP 221 (318)
T ss_pred chhccCCCCcc---cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc--CCC
Confidence 99998764322 233478999999998887 479999999999999999999999888877644444333332 222
Q ss_pred chhc----------c-----ccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 926 IVDA----------L-----DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 926 ~~~~----------~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
..+. . ........+.......++++..|+..||.+|+|+.|+++ |+||++.+..
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~----~~yf~~~P~p 290 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK----HPYFKSLPLP 290 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc----chhhhcCCCC
Confidence 1111 0 001111234455556789999999999999999999999 9999975543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.98 Aligned_cols=271 Identities=25% Similarity=0.336 Sum_probs=228.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+. ....+..+.+.+|+++++.++|||||.++++|+...+.|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~-gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS-GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc-CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4688889999999999999999999999999998543 345566788999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+.| +|..++... ..++++.+..++.+++.||.|||.. +|.|||+||+|||++.++.+|+||||
T Consensus 81 e~a~g-~L~~il~~d-----------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-----------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred hhhhh-hHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence 99987 999999875 3499999999999999999999955 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+.+.... .......|||.|||||+..++.|+..+|.||+||++||+++|++||...+.. +.+..+..++..
T Consensus 146 ~Ar~m~~~t---~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~~I~~d~v~- 218 (808)
T KOG0597|consen 146 LARAMSTNT---SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVKSILKDPVK- 218 (808)
T ss_pred hhhhcccCc---eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHHHHhcCCCC-
Confidence 999875422 2345678999999999999999999999999999999999999999876643 333344433332
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC---CCCCCCcccccccccc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT---EKNGGRKYDHVTPLLT 995 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~---~~~~~~~~~~~~~~~~ 995 (1014)
.+......+..++...+.+||.+|.+..+++. |||.+. ...+...++..+|+.+
T Consensus 219 -----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~----HpF~k~~~~~~~~~~~~a~~spftn 275 (808)
T KOG0597|consen 219 -----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG----HPFWKGKINIAELPAQVAFDSPFTN 275 (808)
T ss_pred -----------CcccccHHHHHHHHHHhhcChhhcccHHHHhc----ChHHhhhhhhhcccccccccCcccc
Confidence 12244456778888999999999999777776 999887 3444666667777666
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=383.59 Aligned_cols=266 Identities=26% Similarity=0.424 Sum_probs=222.6
Q ss_pred CCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+....+.||+|+||+||+|+... ....||||.++. ..+.+...+|++|+++++.++|||||+++|+|.+++.+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34456789999999999987543 345799999944 34555789999999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCc---ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRA---RDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
++|+|||..|+|.+++............ ...+++-.+.+.||.|||.||.||-.+ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 9999999999999999986544322211 134589999999999999999999955 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 918 (1014)
|||+|||+++..+..+ .+.......-+.+|||||.+..++|+.++|||||||++||+++ |+.||.+...++..+.
T Consensus 642 VKIsDfGLsRdiYssD-YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~--- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSD-YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC--- 717 (774)
T ss_pred EEecccccchhhhhhh-hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH---
Confidence 9999999999988743 3333446677899999999999999999999999999999997 7889988776544333
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
++.+. ..+++.+++.+++.||..||+..|++||+++||-..|+.
T Consensus 718 -i~~g~----------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 718 -IRAGQ----------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred -HHcCC----------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 33332 135677888899999999999999999999999998876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=372.20 Aligned_cols=280 Identities=23% Similarity=0.319 Sum_probs=237.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 765 (1014)
++|...++||+|.||+|+++..+.+++.+|||+++++........+..+.|..|+... +||.++.++++|+..++.|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 4678889999999999999999999999999999998888888899999999999887 599999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+.||++..+.+. ..+++..+.-++..|+.||.|||++ +|||||||.+|||+|.+|.+||+||
T Consensus 448 mey~~Ggdm~~~~~~------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIHT------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred EEecCCCcEEEEEec------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccc
Confidence 999999995444432 3599999999999999999999976 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+++.--. .....++.+||+.|||||++.+..|+.++|+|||||++|||+.|+.||.+++++++.+.+ +....
T Consensus 513 GlcKe~m~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---~~d~~- 585 (694)
T KOG0694|consen 513 GLCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---VNDEV- 585 (694)
T ss_pred ccccccCC---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hcCCC-
Confidence 99986321 223567899999999999999999999999999999999999999999998876554432 22211
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCCcccccccccchhhh
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEKNGGRKYDHVTPLLTDSKR 999 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1014)
.++.....+.+.++.+++..+|++|..+.| =.+.+..||||+...|..-...+++|++.+..+
T Consensus 586 -----------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~ 649 (694)
T KOG0694|consen 586 -----------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIK 649 (694)
T ss_pred -----------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccC
Confidence 233444567788999999999999997721 122334599999999988888888887666544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.21 Aligned_cols=272 Identities=28% Similarity=0.359 Sum_probs=216.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKLL 764 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l 764 (1014)
+.|...++||+|+||.||+|++..+|+.||+|++.-+. .......-..+||.+|++++||||+++.+...+. +.+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35777889999999999999999999999999985432 2344567778999999999999999999998776 78999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|||||+. +|.-++... ...|+..++..++.|++.||+|+|.. ||+|||||.+|||+|.+|.+||+|
T Consensus 196 VFeYMdh-DL~GLl~~p----------~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP----------GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred EEecccc-hhhhhhcCC----------CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecc
Confidence 9999987 888888653 34599999999999999999999955 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||+|+++..... ..++..+-|..|+|||++.+ ..|+.++|+||.|||+.||++|++.|.+..+.+....+.... |
T Consensus 262 FGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc--G 337 (560)
T KOG0600|consen 262 FGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC--G 337 (560)
T ss_pred ccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh--C
Confidence 999998765332 23567888999999998887 479999999999999999999999999877644333333221 2
Q ss_pred Ccchh-----------ccccccCCc-c----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KPIVD-----------ALDKEIDEP-C----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~~~~-----------~~~~~~~~~-~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.+..+ .+.+....+ . +.......++|+..+|..||.+|.|+.++++ ++||..++
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~----seyF~t~p 407 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ----SEYFTTEP 407 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc----CcccccCC
Confidence 21111 111111000 0 1111224678899999999999999999999 99996554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.06 Aligned_cols=264 Identities=28% Similarity=0.351 Sum_probs=210.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC--ceEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN--LKLL 764 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~l 764 (1014)
.++...+.||+|+||+||++....+|+..|||.+... +....+.+.+|+.+|.+++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 3577788999999999999999988999999998432 1122677999999999999999999999855544 6899
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcEEEe
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIA 843 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~kl~ 843 (1014)
+|||+++|+|.+++.+.+ . .+++..+..+..||++||+||| ++|||||||||+|||++. ++.+||+
T Consensus 94 ~mEy~~~GsL~~~~~~~g---------~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG---------G-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeccCCCcHHHHHHHcC---------C-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEec
Confidence 999999999999998863 1 4899999999999999999999 459999999999999999 7999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||++.................||+.|||||++..+ ...+++||||+||++.||+||+.||... .....++......
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~ 238 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRE 238 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhcc
Confidence 999998765311222234467899999999999963 3335999999999999999999999864 1223333333333
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
... +.+ +.....+..+++..|+..||++||||+++++ |||......
T Consensus 239 ~~~------P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~----hpf~~~~~~ 284 (313)
T KOG0198|consen 239 DSL------PEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE----HPFLKQNSI 284 (313)
T ss_pred CCC------CCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhh----Chhhhcccc
Confidence 211 111 1122334567888999999999999999988 999988765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=359.56 Aligned_cols=261 Identities=28% Similarity=0.349 Sum_probs=224.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+-|+.++.||+|+-|.|..|++..+|+.+|||++.+...........+.+|+.+|+.+.||||+++++++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 34578889999999999999999999999999999765555566678899999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
.||+++|.|.+++-.++. +++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+||
T Consensus 91 lEyv~gGELFdylv~kG~-----------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-----------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred EEecCCchhHHHHHhhCC-----------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 999999999999988753 88999999999999999999966 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|+|..-.. .....+.+|++.|.|||++++.+|. .++||||.|||+|.++||+-||++++...+ ...++.|.
T Consensus 157 GMAsLe~~----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L----LlKV~~G~ 228 (786)
T KOG0588|consen 157 GMASLEVP----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL----LLKVQRGV 228 (786)
T ss_pred ceeecccC----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH----HHHHHcCc
Confidence 99986433 2345678999999999999999885 899999999999999999999997664333 33344443
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
- ..+.....+..+|+++|+.+||++|.|++||.+ |||+......
T Consensus 229 f-----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k----HP~l~g~~~~ 272 (786)
T KOG0588|consen 229 F-----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK----HPFLSGYTSL 272 (786)
T ss_pred c-----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh----CchhhcCCCC
Confidence 2 112233345678999999999999999999988 9999886544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=371.68 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=221.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCe---EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
...+.++||.|.||+||+|+.+..++ .||||.++. -..++...+|..|..||.++.||||+++.|+.......++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 35677899999999999999887664 599999944 4567788999999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+|||++|+|+.+++... ..|++.+...|+++||.||.||-++ ++|||||.++|||++.+..+||+|
T Consensus 708 iTEyMENGsLDsFLR~~D----------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND----------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred EhhhhhCCcHHHHHhhcC----------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecc
Confidence 999999999999998863 2389999999999999999999977 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||+++.+.++...........-+.+|.|||.+..++++.++|||||||++||.++ |++||+....++..
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---------- 844 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---------- 844 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------
Confidence 9999987554322222223344689999999999999999999999999999885 88999877654332
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..++++++.+.+.+++..+.+||+.||++|-.+||++++++..|.+
T Consensus 845 ----kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 845 ----KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ----HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 2344455666777888899999999999999999999999999866
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.09 Aligned_cols=275 Identities=24% Similarity=0.302 Sum_probs=218.7
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+++++++.+++..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999999999999999998554333344456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~g~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 82 MNGGDLKFHIYNMG---------NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred cCCCcHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999998886532 12488999999999999999999965 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
....... ......||..|+|||++.+..++.++||||+||++|||++|+.||...........+.........
T Consensus 150 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 222 (285)
T cd05631 150 VQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--- 222 (285)
T ss_pred EEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc---
Confidence 7653211 123457899999999999999999999999999999999999999876543222222222211110
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHHHhcCCCCCCCCCCCCccccccccc
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEKNGGRKYDHVTPLL 994 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~ 994 (1014)
.........+.+++..||+.||++||+ ++|+++ ||||....+..-......|..
T Consensus 223 --------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~----h~~~~~~~~~~~~~~~~~~~~ 281 (285)
T cd05631 223 --------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ----HPIFKNINFKRLEANMLEPPF 281 (285)
T ss_pred --------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc----CHhhcCCCHHHHHhCcCCcCC
Confidence 111112335678899999999999997 677766 999998776655555555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.17 Aligned_cols=261 Identities=30% Similarity=0.353 Sum_probs=215.6
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh-h-HHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCC
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-D-QKHEKEFLAEVQILSTIR-HLNIVKLLCCISSEN 760 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~ 760 (1014)
....+|...+.||+|+||+|+.|.+..+++.||+|++..+... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999976443111 1 134567779999999998 999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-Cc
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FN 839 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~ 839 (1014)
.+++||||+.+|+|.+++...+ ++.+.....+++|++.|++|+|.. ||+||||||+||+++.+ +.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-----------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-----------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-----------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 9999999999999999998853 378899999999999999999955 99999999999999999 99
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCC-CC-CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+..+..... .
T Consensus 160 ~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~---~ 233 (370)
T KOG0583|consen 160 LKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY---R 233 (370)
T ss_pred EEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH---H
Confidence 9999999998763 1223456789999999999999977 86 7899999999999999999999985533222 1
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
.+..... ..+.+.. ..++..++.+|+..||.+|+++.|+++ ||||+.
T Consensus 234 ki~~~~~----------~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~----h~w~~~ 280 (370)
T KOG0583|consen 234 KIRKGEF----------KIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE----HPWFQK 280 (370)
T ss_pred HHhcCCc----------cCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh----Chhhcc
Confidence 2221111 1111111 456678899999999999999999987 999997
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.27 Aligned_cols=271 Identities=23% Similarity=0.249 Sum_probs=225.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..+.||+|.-|+||+++...++..+|+|++.+..........+++.|-+||+.++||.++.+|+.++.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35667889999999999999999999999999977666666777888999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
||+||+|..+.+++. ...+++..+.-++.+|+-||+|||-. |||+|||||+||||.++|++-++||.+
T Consensus 158 yCpGGdL~~LrqkQp---------~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP---------GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred cCCCccHHHHHhhCC---------CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccc
Confidence 999999999998863 45699999999999999999999966 999999999999999999999999999
Q ss_pred ccccccc--------------------------------c-C--------------------ccccccccccCccccccc
Q 001778 848 AKILIKE--------------------------------E-G--------------------EFAAMSTVVGSCGYIAPE 874 (1014)
Q Consensus 848 a~~~~~~--------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE 874 (1014)
+...... . . ........+||-.|.|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 8543100 0 0 001123467999999999
Q ss_pred ccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHcc
Q 001778 875 YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICT 954 (1014)
Q Consensus 875 ~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 954 (1014)
++.+..++.++|+|+|||++|||+.|..||.+.+...- +..++.+.+..+........+.+||++.|
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 99999999999999999999999999999998764322 22222333333333455567889999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 955 SMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 955 ~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+||.+|.....=...+++||||+...|.
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999955555555569999998887
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=326.53 Aligned_cols=273 Identities=26% Similarity=0.306 Sum_probs=219.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKL 763 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~ 763 (1014)
.+.|+..+.|++|+||.||+|+++.+++.||+|+++.++. .....-...+||.++.+.+|||||.+-.+... -+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4568889999999999999999999999999999965442 22334556899999999999999999887754 35689
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|||||+. +|..++.... ++|...++..++.|+++|++|||.. .|+|||+|++|+|+++.|.+||+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~----------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK----------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc----------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEec
Confidence 99999987 9999998753 4689999999999999999999976 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+|+.+... ...+...+-|..|+|||++.+ ..|+.+.||||+|||+.||+++++.|.+..+.+..+.+...+
T Consensus 220 DFGLAR~ygsp---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll-- 294 (419)
T KOG0663|consen 220 DFGLAREYGSP---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL-- 294 (419)
T ss_pred ccchhhhhcCC---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh--
Confidence 99999988653 334567788999999998876 469999999999999999999999999987655444443332
Q ss_pred CCcchhccccccCC----------cccHH----------HHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDE----------PCFLE----------EMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~----------~~~~~----------~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
|.+ .+.+.+++.. +.+.. ....-++++..++.+||.+|.|+.|.++ |.||...+.
T Consensus 295 GtP-te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~----h~~F~e~P~ 369 (419)
T KOG0663|consen 295 GTP-SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK----HEYFRETPL 369 (419)
T ss_pred CCC-ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc----ccccccCCC
Confidence 222 2222222211 00111 1134568888999999999999999999 999998554
Q ss_pred C
Q 001778 983 G 983 (1014)
Q Consensus 983 ~ 983 (1014)
.
T Consensus 370 p 370 (419)
T KOG0663|consen 370 P 370 (419)
T ss_pred C
Confidence 3
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.27 Aligned_cols=267 Identities=26% Similarity=0.289 Sum_probs=212.8
Q ss_pred ccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhH-----------HhHHHHHHHHHHHHcCCCCccc
Q 001778 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ-----------KHEKEFLAEVQILSTIRHLNIV 750 (1014)
Q Consensus 682 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~hpniv 750 (1014)
+.....+|++.+.||+|.||.|.+|.+..+++.||||++.+.+.... ...+.+++||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34556789999999999999999999999999999999955322211 1246899999999999999999
Q ss_pred eEEEEEEcC--CceEEEEEcccCCCHHHHhhhcCCCCCCCCccccc-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC
Q 001778 751 KLLCCISSE--NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV-LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL 827 (1014)
Q Consensus 751 ~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl 827 (1014)
+++++..+. +..|+|+|||..|.+...= .+.+ ++..++++++.++..||+|||.. ||+||||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p------------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP------------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC------------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 999999774 6789999999988775321 2233 89999999999999999999955 9999999
Q ss_pred CCCCeeecCCCcEEEeeccccccccccc--CccccccccccCcccccccccccCC----CCCcCcchhHHHHHHHHhcCC
Q 001778 828 KSSNILLDYNFNAKIADFGVAKILIKEE--GEFAAMSTVVGSCGYIAPEYARTRK----VNEKTDIYSFGVILLELTTGK 901 (1014)
Q Consensus 828 k~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DvwSlGvll~elltg~ 901 (1014)
||+|+|++++|+|||+|||.+....... +........+|||.|+|||.+.++. .+.+.||||+||++|.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 9999999999999999999998763321 1222334589999999999987632 347899999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 902 EANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 902 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.||.++....+.+. + +...+..+...+....+.++|.++|.+||++|.+..||.. |||...+
T Consensus 317 ~PF~~~~~~~l~~K---I----------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~----Hpwvt~~ 378 (576)
T KOG0585|consen 317 LPFFDDFELELFDK---I----------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL----HPWVTRD 378 (576)
T ss_pred CCcccchHHHHHHH---H----------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee----cceeccC
Confidence 99988764433221 1 2222333333445566778999999999999999777776 9999886
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=322.64 Aligned_cols=270 Identities=29% Similarity=0.373 Sum_probs=225.4
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccc-----hhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEE
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDR-----KLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCIS 757 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 757 (1014)
....+|...+.+|.|..+.|.++.++.++..+|+|++.... .....-.++-.+|+.+++++ .||+|+++.+.++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 44567888899999999999999999999999999984211 11223456678899999998 7999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 758 SENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 758 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
.+...++|+|.|+.|.|.+++... ..+++....+|+.|+.+|++|||.. .|||||+||+|||++++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~-----------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK-----------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN 159 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh-----------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc
Confidence 999999999999999999999765 4589999999999999999999966 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCccccccccccc------CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART------RKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
..+||+|||+|+.+.+.. +....+|||+|.|||.+.. ..|+..+|+|+.||++|.++.|.+||+....
T Consensus 160 ~~i~isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-- 233 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-- 233 (411)
T ss_pred cceEEeccceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--
Confidence 999999999999876532 4456899999999998853 4688899999999999999999999986442
Q ss_pred HHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRK 986 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~ 986 (1014)
-.+.+.+.+|.. .+..+.+.+......++|.+|+++||.+|.|++|+++ ||||.+...++..
T Consensus 234 --mlMLR~ImeGky-------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La----Hpff~q~~~~~~r 295 (411)
T KOG0599|consen 234 --MLMLRMIMEGKY-------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA----HPFFIQIAQQQAR 295 (411)
T ss_pred --HHHHHHHHhccc-------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc----ChHHHHHHHhccc
Confidence 223344455543 2344556666677889999999999999999999999 9999776655443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.50 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=217.7
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+.++|+..++||+|+|+.||++.+..+|+.+|+|++..++ ......+++.+|+.+.+.++||||+++.+.+.+.+..|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k-~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhh-hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3457888899999999999999999999999999985433 344477889999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC---CCcEE
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY---NFNAK 841 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~---~~~~k 841 (1014)
|+|+|.||+|..-+-.. ..+++..+-..++||++++.|+|.+ +|||||+||+|+++.. ...+|
T Consensus 88 vFe~m~G~dl~~eIV~R-----------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred EEecccchHHHHHHHHH-----------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCcee
Confidence 99999999998655432 3477788889999999999999966 9999999999999943 34699
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
++|||+|..+.. .......+|||+|||||++...+|+..+|||+.||++|-++.|..||.+++...+.+.+ .
T Consensus 154 L~~FGvAi~l~~----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I----~ 225 (355)
T KOG0033|consen 154 LADFGLAIEVND----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI----K 225 (355)
T ss_pred ecccceEEEeCC----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH----h
Confidence 999999998762 23455789999999999999999999999999999999999999999987765544433 2
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.+.. .+..+++........+++++|+..||++|.|+.|.+. |||+.+.
T Consensus 226 ~g~y-------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~----HpWi~~r 273 (355)
T KOG0033|consen 226 AGAY-------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK----HPWICNR 273 (355)
T ss_pred cccc-------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC----Cchhcch
Confidence 2221 1222333344445667899999999999999999998 9999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.04 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=215.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 57888999999999999999999999999999854333334456778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 82 YVPGGELFSYLRNSG-----------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence 999999999997642 378889999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+...... .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.......+. .......
T Consensus 148 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~-- 216 (291)
T cd05612 148 AKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK---ILAGKLE-- 216 (291)
T ss_pred chhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCcC--
Confidence 9765321 1235689999999999998999999999999999999999999987654332221 1111111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHHHhcCCCCCCCCCCCCcccccccc
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEKNGGRKYDHVTPL 993 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~ 993 (1014)
+. ......+.+++.+||+.||.+||+ ++|+++ ||||+...+.........|.
T Consensus 217 ------~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~----h~~~~~~~~~~~~~~~~~~~ 273 (291)
T cd05612 217 ------FP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN----HRWFKSVDWDDVPQRKLKPP 273 (291)
T ss_pred ------CC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc----CccccCCCHHHHhcCCCCCC
Confidence 11 111235678999999999999995 666665 99998766554333333443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.27 Aligned_cols=283 Identities=25% Similarity=0.361 Sum_probs=211.3
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHc--CCCCccceEEEEEEcCC---
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST--IRHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~--- 760 (1014)
....+..++||+|+||.||+|+.. ++.||||++ ..+..+.|+.|-+|+.. ++|+||++|+++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKif------p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIF------PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEec------CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345677889999999999999665 589999998 34667788888888776 58999999999876655
Q ss_pred -ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEeccCCCCCee
Q 001778 761 -LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD------CSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 761 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~s~~ivH~Dlk~~NIl 833 (1014)
.++||++|.+.|+|.+|++.. .++|....+|+..+++||+|||+. +.++|+|||||++|||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 899999999999999999875 489999999999999999999975 3678999999999999
Q ss_pred ecCCCcEEEeecccccccccccCccccccccccCcccccccccccCC-CC-----CcCcchhHHHHHHHHhcCCCCCCC-
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VN-----EKTDIYSFGVILLELTTGKEANNG- 906 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~~DvwSlGvll~elltg~~p~~~- 906 (1014)
+..|+++.|+|||+|..+....... .....+||.+|||||++.+.. +. .+.||||+|.|+|||+++...++.
T Consensus 349 vK~DlTccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~ 427 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG 427 (534)
T ss_pred EccCCcEEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence 9999999999999999887643332 334589999999999998742 22 478999999999999997754421
Q ss_pred -------------CCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 907 -------------DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 907 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+.... .++..+...+.-.. +...+... ..+.-+.+.+..||+.||+.|.|+.=|.+++.+
T Consensus 428 ~vp~Yqlpfe~evG~hPt~e-~mq~~VV~kK~RP~-~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 428 PVPEYQLPFEAEVGNHPTLE-EMQELVVRKKQRPK-IPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CCCcccCchhHHhcCCCCHH-HHHHHHHhhccCCC-ChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 1111121 12222222221111 11122222 234456688889999999999999999999988
Q ss_pred CCCCCCCCCCCCccccccccc
Q 001778 974 NPIFPTEKNGGRKYDHVTPLL 994 (1014)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~ 994 (1014)
+.=......+.....-++|..
T Consensus 503 l~~~~~~~~~~s~~~~~~~~~ 523 (534)
T KOG3653|consen 503 LMMLWEDSSGESSSSLVTPVD 523 (534)
T ss_pred HhccCCccCCccccccCCCCc
Confidence 754444433333333444443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.50 Aligned_cols=276 Identities=26% Similarity=0.331 Sum_probs=222.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
...|+..+.||+|.||.||+|.+..+++.||+|++.- .......+++++|+.++.+++++||.++++.+..+..+|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L--e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL--EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEech--hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3457777899999999999999999999999999943 34556678899999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
||||.+|++.+.++... .+.+....-|+.++..|+.|||.. +.+|||||+.||++..+|.||++||
T Consensus 90 Mey~~gGsv~~lL~~~~-----------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN-----------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred HHHhcCcchhhhhccCC-----------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEec
Confidence 99999999999998753 235666677899999999999955 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|.+..+... .......+||+.|||||++.+..|+.++||||+|++.+||.+|.+|+........ -..
T Consensus 156 gVa~ql~~~---~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------lfl 222 (467)
T KOG0201|consen 156 GVAGQLTNT---VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------LFL 222 (467)
T ss_pred ceeeeeech---hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------EEe
Confidence 999876442 2334689999999999999999999999999999999999999999976543110 000
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcccccccccchhhhhhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKYDHVTPLLTDSKREKM 1002 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1014)
+...-.+.+.. ....-+.+++..|+++||+.||+|.++++ |+|++..... .-.+....+.++++.
T Consensus 223 Ipk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK----h~FIk~a~k~----s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 223 IPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK----HKFIKRAKKT----SELKELIDRYKRWRV 287 (467)
T ss_pred ccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh----hHHHHhcCCc----hHHHHHHHHHHHHhh
Confidence 11222233333 22234567788999999999999999988 9999984322 334444555555544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=328.64 Aligned_cols=282 Identities=30% Similarity=0.357 Sum_probs=222.3
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-----
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS----- 758 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----- 758 (1014)
....+|...+.||+|+||.|+.+.++.+++.||||++.. ...+....++..+|+.+++.++|+||+.+.+.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556667899999999999999999999999999843 34556678889999999999999999999998755
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
-...|+|+|+|+ -+|.+.++.+ ..++......+++|+++||.|+| |.+|+|||+||.|++++.+.
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~-----------~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQ-----------QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADC 162 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcC-----------ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCC
Confidence 356799999995 5999999875 23888999999999999999999 56999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||+|+...+. .....++..+.|..|+|||++. ...|+.+.||||.|||+.||++|++.|.+.+.....+.+.
T Consensus 163 ~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred CEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 9999999999987543 2333456788999999999875 4689999999999999999999999999877544333333
Q ss_pred HHHhcCCcchhccccccC----------------C---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 918 RHIQEGKPIVDALDKEID----------------E---PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~----------------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
..+ |.+..+.+ ..+. . ..+.......++++.+|+..||.+|+|++|+++ |||+.
T Consensus 242 ~~l--GtP~~e~l-~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~----hPYl~ 314 (359)
T KOG0660|consen 242 ELL--GTPSEEDL-QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA----HPYLA 314 (359)
T ss_pred Hhc--CCCCHHHH-HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc----Chhhh
Confidence 222 11111111 1110 0 011122235678999999999999999999999 99998
Q ss_pred CCCCCCCcccc
Q 001778 979 TEKNGGRKYDH 989 (1014)
Q Consensus 979 ~~~~~~~~~~~ 989 (1014)
.-...++++..
T Consensus 315 ~~hdp~dEP~~ 325 (359)
T KOG0660|consen 315 PYHDPEDEPVC 325 (359)
T ss_pred hhcCCccCCCC
Confidence 86555555433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=356.16 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=207.8
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999996543334455567889999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++...+ .+++..+..++.||+.||+|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 81 ELFFHLSRER-----------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 9999987642 478999999999999999999965 99999999999999999999999999987532
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1014)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+ ......
T Consensus 147 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~------- 213 (323)
T cd05571 147 SDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEEIR------- 213 (323)
T ss_pred cCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH---HcCCCC-------
Confidence 211 1223467999999999999999999999999999999999999999876543332221 111111
Q ss_pred ccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCC
Q 001778 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~ 982 (1014)
+ ......++.+++.+||+.||++|| ++.++++ ||||....+
T Consensus 214 -~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~----h~~f~~~~~ 259 (323)
T cd05571 214 -F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME----HRFFASINW 259 (323)
T ss_pred -C----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc----CCCcCCCCH
Confidence 1 111233567889999999999999 7888777 999987433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.24 Aligned_cols=262 Identities=28% Similarity=0.346 Sum_probs=210.9
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+.+...+.||+|.||+||+|.|.. .||||++..+.. .....+.|++|+.++++-+|.||+-|.|||..+.. .+|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 3456678899999999999999864 499999965443 34478999999999999999999999999998887 999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+.+|+|-+|+.+++.. +..|...+...|++|||+||.|||.. +|||||+|..|||+.++++|||+||
T Consensus 466 TqwCeGsSLY~hlHv~----------etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQ----------ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred ehhccCchhhhhccch----------hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 9999999999999975 24689999999999999999999955 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc---CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART---RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|++..-..-. .........|..-|||||+++. .+|++.+||||||+++|||++|.-||..... .+.++...+.
T Consensus 533 GLatvk~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG 608 (678)
T KOG0193|consen 533 GLATVKTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRG 608 (678)
T ss_pred cceeeeeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEeccc
Confidence 9997643321 1223345668889999999875 4789999999999999999999999984432 2222222211
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
....+.. .....+.+++.+|+..||..+|++||.+.+++..|+.+.-
T Consensus 609 -~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 -YLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1001111 1234455678888999999999999999999998888753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.02 Aligned_cols=262 Identities=24% Similarity=0.290 Sum_probs=211.4
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
..+|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 35688889999999999999999999999999998554333344567789999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+||
T Consensus 97 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-----------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EcCCCCChHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 99999999999997642 378888999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... ..+..+..
T Consensus 163 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~i~~~~~ 232 (329)
T PTZ00263 163 GFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----EKILAGRL 232 (329)
T ss_pred cCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----HHHhcCCc
Confidence 999865331 12357899999999999999999999999999999999999999876533221 12222211
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCH-HHHHHHHhcCCCCCCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM-RMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ev~~~L~~~~~~~~~~~ 982 (1014)
..+ .....++.+++..||+.||.+||+. .+.++.+.+||||....+
T Consensus 233 ---------~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 233 ---------KFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred ---------CCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 000 0112346789999999999999973 223344444999987433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=376.41 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=216.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCe-----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE-----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+.+..+.||+|+||.||.|....... .||||.+ .+..+.+...+|.+|..+|++++|||||+++|.+-+.+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l--~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSL--KRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEec--cccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 45667889999999999998765433 4899988 3455677889999999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++++|||++|+|..|+++.+..... ...++..+...++.|||+|+.||++. ++|||||.++|+|++....|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~----~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQ----PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCC----CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 9999999999999999987654332 44589999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+|+++...+ .+.......-+..|||||.+.++.++.++|||||||++||++| |..||.+.+..+.... +.
T Consensus 844 aDFGlArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~----~~ 918 (1025)
T KOG1095|consen 844 ADFGLARDIYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD----VL 918 (1025)
T ss_pred cccchhHhhhhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----HH
Confidence 9999999776532 2223223355689999999999999999999999999999998 6678877665433221 11
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
++. +.+.+..+...++++|..||+.+|++||++..+++.+.+
T Consensus 919 ~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 919 EGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred hCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 211 234455666778899999999999999999999997755
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.82 Aligned_cols=267 Identities=29% Similarity=0.410 Sum_probs=208.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----ce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN-----LK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~ 762 (1014)
.|...+++|.|+||.||+|...++++.||||++..++... -+|+.+|+.++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 4677889999999999999999999999999986654322 35899999999999999998885432 33
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-CcEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAK 841 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~~k 841 (1014)
.+||||||. +|.++++.... ....++...++-+..|+++||+|||.. +|+||||||.|+|+|.+ |.+|
T Consensus 98 nlVleymP~-tL~~~~r~~~~-------~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTR-------ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhh-------cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEE
Confidence 589999986 99999885311 123467778889999999999999964 99999999999999976 8999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|||||.|+.+.+.+.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+++..+....+....
T Consensus 167 icDFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred eccCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 9999999998765433 244568999999988774 79999999999999999999999999876543333322222
Q ss_pred hcCCcchhccc-----------cccCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 921 QEGKPIVDALD-----------KEIDEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 921 ~~~~~~~~~~~-----------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
|.+..+.+. +.+... .......+.++++.++++++|.+|.++.|++. ||||+.-+.
T Consensus 243 --G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~----h~fFdelr~ 314 (364)
T KOG0658|consen 243 --GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA----HPFFDELRD 314 (364)
T ss_pred --CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc----chhhHHhhC
Confidence 222222221 111111 22334457889999999999999999999999 999998443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.91 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=220.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+.|.+++.||+|-||.||.|+.+.++-.||+|++.+..........++.+|+++-..++||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45688999999999999999999999999999999877766777789999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||.++|++...++..+ ...++......++.|+|.|+.|+|. ++|+||||||+|+|++.++..||+||
T Consensus 101 lEya~~gel~k~L~~~~---------~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR---------MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred EEecCCchHHHHHHhcc---------cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999998653 2347778888999999999999995 49999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|.+..-. ..+....+||..|.+||...+..++..+|+|++|++.||++.|.+||.+....+.-+ ++......
T Consensus 169 GwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk---rI~k~~~~ 240 (281)
T KOG0580|consen 169 GWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK---RIRKVDLK 240 (281)
T ss_pred CceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH---HHHHcccc
Confidence 9987532 235567899999999999999999999999999999999999999998776332221 12211111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.+........++|..|+.++|.+|.+..|+++ |||+.+.
T Consensus 241 ------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~----hpwI~a~ 279 (281)
T KOG0580|consen 241 ------------FPSTISGGAADLISRLLVKNPIERLALTEVMD----HPWIVAN 279 (281)
T ss_pred ------------CCcccChhHHHHHHHHhccCccccccHHHHhh----hHHHHhc
Confidence 11222345678899999999999999999999 9998653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.75 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=204.7
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998544333445567788999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 81 FHHLQREG-----------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred HHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 99997642 378899999999999999999965 9999999999999999999999999999754321
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEI 934 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1014)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ........... +
T Consensus 147 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~~~~~~~~--------~ 212 (312)
T cd05585 147 D---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRKILQEPLR--------F 212 (312)
T ss_pred C---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHHHHcCCCC--------C
Confidence 1 12234679999999999999999999999999999999999999998765332 22222221111 1
Q ss_pred CCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHHhcCCCCCCCC
Q 001778 935 DEPCFLEEMIRVFKLGVICTSMLPTERPN---MRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~~L~~~~~~~~~~ 981 (1014)
.......+.+++.+||+.||++||+ +.|++. ||||....
T Consensus 213 ----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~----hp~~~~~~ 254 (312)
T cd05585 213 ----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN----HPFFSQLS 254 (312)
T ss_pred ----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc----CCCcCCCC
Confidence 1112235678899999999999985 556555 99999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.85 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=214.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 57888999999999999999999999999999954433333456778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~g~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 82 YVPGGDFRTLLNNLG-----------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred CCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 999999999997642 378899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+..... ......||+.|+|||++.+..++.++||||+||++|||++|..||...+.......+.. ......
T Consensus 148 a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~ 218 (333)
T cd05600 148 SKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY---WKETLQ 218 (333)
T ss_pred Cccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh---cccccc
Confidence 976432 22356799999999999999999999999999999999999999987654332222111 110000
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+.... .......++.+++.+|++.+|.+||+++|+++ ||||....+
T Consensus 219 ---~~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~----h~~~~~~~~ 265 (333)
T cd05600 219 ---RPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKN----HPFFKEVDW 265 (333)
T ss_pred ---CCCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHh----CcccCCCCH
Confidence 000000 00122345678889999999999999999888 999997544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.59 Aligned_cols=259 Identities=24% Similarity=0.261 Sum_probs=210.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCC-eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTA-EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
.++|+..+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 346888999999999999999876654 6899999854433344456778899999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
||||+++|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 999999999999997642 378899999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .+..+.
T Consensus 175 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~i~~~~ 244 (340)
T PTZ00426 175 FGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----KILEGI 244 (340)
T ss_pred CCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH----HHhcCC
Confidence 9999765321 224578999999999999889999999999999999999999998765432221 222211
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. .+. +. ....+.+++.+|++.||++|+ +++|+.+ ||||+...+.
T Consensus 245 ~-------~~p-~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~----hp~f~~~~~~ 293 (340)
T PTZ00426 245 I-------YFP-KF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE----HPWFGNIDWV 293 (340)
T ss_pred C-------CCC-CC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc----CCCcCCCCHH
Confidence 1 000 11 123456889999999999995 7777665 9999876544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.57 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=211.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCe---E-EEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE---V-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
+....++||+|+||+||+|..+..+. . ||||..+.+.........++.+|.++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999998876533 3 8999986544566778899999999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|||+|+||+|.+++++.. ..++..++..++.++|.||+|||.. +++||||.++|+|++.++.+||+
T Consensus 238 ivmEl~~gGsL~~~L~k~~----------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK----------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEecCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999863 2489999999999999999999955 99999999999999999999999
Q ss_pred ecccccccccccCcccccc-ccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 844 DFGVAKILIKEEGEFAAMS-TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
|||+++.-. .+.... ...-+.+|+|||.+....|++++|||||||++||+++ |..||.+....+...++. .
T Consensus 305 DFGLs~~~~----~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~ 377 (474)
T KOG0194|consen 305 DFGLSRAGS----QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---K 377 (474)
T ss_pred ccccccCCc----ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---h
Confidence 999987532 122211 3356789999999999999999999999999999998 788999887654444331 2
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+. ..+.+...+..+..++..||..||++||+|.++.+.++.
T Consensus 378 ~~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 378 NGY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred cCc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 111 112222445566778889999999999999999998855
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.34 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=208.0
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999996543334445667788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 81 ELFFHLSRER-----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 9999887642 478999999999999999999965 99999999999999999999999999987532
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1014)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... .......
T Consensus 147 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---~~~~~~~------- 213 (323)
T cd05595 147 SDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---ILMEEIR------- 213 (323)
T ss_pred CCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCCCC-------
Confidence 211 122345789999999999999999999999999999999999999987654332221 1111111
Q ss_pred ccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCC
Q 001778 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+. .....++.+++.+||+.||++|| ++.++++ ||||....+.
T Consensus 214 -~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~----h~~~~~~~~~ 260 (323)
T cd05595 214 -FP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----HRFFLSINWQ 260 (323)
T ss_pred -CC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc----CCCcCCCCHH
Confidence 11 11223566888999999999998 7888877 9999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=341.78 Aligned_cols=269 Identities=24% Similarity=0.292 Sum_probs=214.6
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..++||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 36778999999999999999998999999999854433333445667889999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ...+++..+..++.|++.|+.|||.. +|+||||||+||++++++.++|+|||+
T Consensus 81 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 81 LMNGGDLKFHIYNMG---------NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred ccCCCcHHHHHHhcC---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999998886532 23488999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||.+.........+...+.....
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 222 (285)
T cd05605 149 AVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-- 222 (285)
T ss_pred ceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--
Confidence 97653211 122457899999999999889999999999999999999999999876543332222222221111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCCCCcc
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNGGRKY 987 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~~~~~ 987 (1014)
.........+.+++..||+.||++|| +++++++ ||||....+.+...
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~----~~~~~~~~~~~~~~ 274 (285)
T cd05605 223 ---------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA----HPFFRTANFKRLEA 274 (285)
T ss_pred ---------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc----CcCccCCCHHHHhh
Confidence 11112234567889999999999999 7777766 99998755544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.87 Aligned_cols=274 Identities=23% Similarity=0.333 Sum_probs=215.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||++.+..++..||+|++... ........+.+|+++++.++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 5688899999999999999999999999999998542 23345678999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||
T Consensus 83 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 83 EHMDGGSLDQVLKEAK-----------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred ecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 9999999999997642 378899999999999999999963 269999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+...
T Consensus 150 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 98765331 2234578999999999999899999999999999999999999997655433322211110000000
Q ss_pred -----------------------------hhccc---cccCCc-ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 -----------------------------VDALD---KEIDEP-CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 -----------------------------~~~~~---~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+..+ ...... .......++.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~---- 300 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN---- 300 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc----
Confidence 00000 000000 00012345788999999999999999999998
Q ss_pred CCCCCCCCCCC
Q 001778 974 NPIFPTEKNGG 984 (1014)
Q Consensus 974 ~~~~~~~~~~~ 984 (1014)
||||...+...
T Consensus 301 h~~~~~~~~~~ 311 (331)
T cd06649 301 HTFIKRSEVEE 311 (331)
T ss_pred ChHHhhccccc
Confidence 99998866553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=350.12 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=207.8
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
++||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999996543334455677889999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSRE-----------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999988654 2488999999999999999999965 99999999999999999999999999987532
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1014)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....... .......
T Consensus 147 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---~~~~~~~------- 213 (328)
T cd05593 147 TDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---ILMEDIK------- 213 (328)
T ss_pred Ccc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---hccCCcc-------
Confidence 211 122345799999999999998999999999999999999999999987654322221 1111111
Q ss_pred ccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCC
Q 001778 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+. .....++.+++.+||+.||++|| ++.|+++ ||||....++
T Consensus 214 -~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----h~~~~~~~~~ 260 (328)
T cd05593 214 -FP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR----HSFFTGVNWQ 260 (328)
T ss_pred -CC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc----CCCcCCCCHH
Confidence 11 11223567888999999999997 8888877 9999875443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.39 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=207.1
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||+||++.+..+++.||+|++...........+.+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998544333334456778999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDE-------ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 988865321 224589999999999999999999965 9999999999999999999999999999765432
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEI 934 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1014)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................... .
T Consensus 151 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~ 218 (280)
T cd05608 151 QS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---------V 218 (280)
T ss_pred Cc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------C
Confidence 21 12345789999999999999999999999999999999999999986543222111111111111 0
Q ss_pred CCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCCCC
Q 001778 935 DEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~~~ 983 (1014)
.........+.+++..||+.||++||++++ .++.+.+||||+.-.+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 219 --TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred --CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 111122345678889999999999995444 34455559999875444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.90 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=218.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.-+|.+.+.||+|.||+|-+|.....|+.||||.+++++..+.+....+.+|++||..++||||+.++++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34678889999999999999998889999999999999888999999999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||..+|.|.+|+.+.+ .+++.+...+++||..|+.|+|.+ +++|||+|.+|||+|.++.+||+||
T Consensus 132 MEYaS~GeLYDYiSer~-----------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-----------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred EEecCCccHHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 99999999999998864 389999999999999999999976 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|++-.+... .-.++.+|++-|.+||+..+.+|. +.+|.||+||++|.+..|..||++.+...+..++....-
T Consensus 198 GLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY--- 270 (668)
T KOG0611|consen 198 GLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY--- 270 (668)
T ss_pred chhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---
Confidence 999876542 234578999999999999999885 789999999999999999999999887655544332221
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
..+.. +....-+|++|+-++|++|.|..||..
T Consensus 271 ----------rEP~~---PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 271 ----------REPET---PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ----------cCCCC---CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11111 112345888999999999999999987
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=352.24 Aligned_cols=277 Identities=26% Similarity=0.345 Sum_probs=208.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----Cce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE-----NLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~ 762 (1014)
+|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh-hccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 477889999999999999999999999999998432 12223456788999999999999999999987543 247
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
|+||||++ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 80 ~lv~e~~~-~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN-----------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred EEEEecCC-CCHHHHHHhc-----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEE
Confidence 99999995 6899988654 2388999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
+|||+++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999765332222222335679999999999876 678899999999999999999999998765433222221111
Q ss_pred hcCCc-------------chhccccccCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 921 QEGKP-------------IVDALDKEIDEP---CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 921 ~~~~~-------------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
..... ....+.+....+ .+......+.+++.+||+.||++|||++|+++ ||||.......
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~----hp~f~~~~~~~ 300 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA----DPYFKGLAKVE 300 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc----CchhhhcCccc
Confidence 00000 000000000000 00112235678999999999999999999998 99998865543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=348.20 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=204.8
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999654333444566788899988876 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~~-----------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQR-----------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99998886542 388999999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCC-----chhHHHHHHHHHhcCCcc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE-----HTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~ 926 (1014)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+..........
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 222 (329)
T cd05618 147 LRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred cCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-
Confidence 2211 12234678999999999999999999999999999999999999996311 11122333333322211
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHHHhcCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM------RMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ev~~~L~~~~~~~~~~~ 982 (1014)
.+ +......+.+++.+||+.||++||++ +|++ +||||+...+
T Consensus 223 ------~~----p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~----~hp~f~~~~~ 270 (329)
T cd05618 223 ------RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ----GHPFFRNVDW 270 (329)
T ss_pred ------CC----CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh----cCCCCCCCCH
Confidence 01 11122356788999999999999984 5555 4999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=334.50 Aligned_cols=287 Identities=24% Similarity=0.259 Sum_probs=237.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|..-++||+|+||+||.++.+.+|+.+|.|.+.+++...+..+.-...|-.++.++..+.||.+-.+|+..+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 46677899999999999999999999999999988888888888999999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
.|.||+|.-++...+. ..+++..+..++.+|+.||++||+. +||+||+||+|||+|++|+++|+|+|+
T Consensus 266 lMNGGDLkfHiyn~g~---------~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGN---------PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred eecCCceeEEeeccCC---------CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence 9999999998887642 4589999999999999999999966 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
|..+.... ....++||.+|||||++....|+...|.||+||++|||+.|+.||.......-.+.+...+.+..
T Consensus 334 Avei~~g~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--- 406 (591)
T KOG0986|consen 334 AVEIPEGK----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--- 406 (591)
T ss_pred EEecCCCC----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch---
Confidence 99875532 23356999999999999999999999999999999999999999976443222111222221111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCCcccccccccchhhhhh
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKNGGRKYDHVTPLLTDSKREK 1001 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1014)
..++.....+...+....+.+||.+|..-. +-.+.+++||||+...+.+-......|++.+.....
T Consensus 407 --------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV 473 (591)
T KOG0986|consen 407 --------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV 473 (591)
T ss_pred --------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence 112223333455667789999999998655 334555569999999999888888888877665443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.13 Aligned_cols=269 Identities=24% Similarity=0.298 Sum_probs=207.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6888999999999999999999999999999985432 223445678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++++.+..+.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 81 YVEKNMLELLEEMP-----------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred cCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 99987776554321 2478899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh------
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ------ 921 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~------ 921 (1014)
+........ .......|++.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 147 ARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred ccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 987543211 122345789999999999988899999999999999999999999987654322111111100
Q ss_pred -----cCCcchhccccccCC------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 922 -----EGKPIVDALDKEIDE------PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 922 -----~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
..........+.... .........+.+++.+|++.||++|||++|+++ ||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~----hp~f 287 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN----HPAF 287 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc----CCCC
Confidence 000000000000000 001112345789999999999999999999988 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.29 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=205.3
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
++||+|+||.||+|.+..+++.||+|++...........+.+.+|..++..+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999654333444556788999999988 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 g~L~~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQRQR-----------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99999886542 389999999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCC-----chhHHHHHHHHHhcCCcc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE-----HTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~ 926 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....++..........
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (329)
T cd05588 147 IRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred ccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-
Confidence 2211 12234678999999999999999999999999999999999999996321 11122333333322211
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC------HHHHHHHHhcCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN------MRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+.. .....+.+++..|++.||.+||+ ++|+++ ||||....+
T Consensus 223 ------~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~----hp~~~~~~~ 270 (329)
T cd05588 223 ------RIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS----HPFFRNIDW 270 (329)
T ss_pred ------CCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc----CCCCCCCCH
Confidence 0111 11235678899999999999998 556655 999986443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.14 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=205.8
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||.||+|.++.+++.||||++...........+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998544333344556778888888876 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 g~L~~~i~~~~-----------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKSR-----------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999887642 378899999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....... +..+...
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----i~~~~~~----- 214 (320)
T cd05590 147 IFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVV----- 214 (320)
T ss_pred CcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH----HhcCCCC-----
Confidence 2211 123346799999999999998999999999999999999999999987664332222 2121110
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHH--HHHHhcCCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMV--LQILLNNPIFPTEKNG 983 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev--~~~L~~~~~~~~~~~~ 983 (1014)
. .......+.+++.+|++.||++||++.++ .+.+.+||||....+.
T Consensus 215 --~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 215 --Y----PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred --C----CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 01112356788999999999999998332 2344459999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.74 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=208.8
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||.||++....+++.||+|.+..+..........+..|+++++.++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998543332333445667799999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNVG---------ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99886542 23478999999999999999999965 9999999999999999999999999999765432
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH-HHHHHHHHhcCCcchhccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL-AQWAWRHIQEGKPIVDALDKE 933 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 933 (1014)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ .............
T Consensus 149 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 216 (277)
T cd05607 149 K----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-------- 216 (277)
T ss_pred c----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc--------
Confidence 1 12245689999999999988899999999999999999999999976433211 1111111111110
Q ss_pred cCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 934 IDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.... ....++.+++..||+.||++||+++|+++.+..||||+.-...
T Consensus 217 ~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 217 FEHQ---NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred cccc---cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 0001 1223467889999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.36 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=205.0
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
++||+|+||.||+|.+..+++.||+|++...........+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998554333444556778899988866 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQRSR-----------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999887642 378899999999999999999965 9999999999999999999999999998754
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........+. .......
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---i~~~~~~------ 214 (321)
T cd05591 147 ILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES---ILHDDVL------ 214 (321)
T ss_pred ccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH---HHcCCCC------
Confidence 3211 122345789999999999999999999999999999999999999987764433222 1111111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCC-------CHHHHHHHHhcCCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERP-------NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. .....++.+++..|++.||++|| ++.++++ ||||....+.
T Consensus 215 --~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~----hp~~~~~~~~ 263 (321)
T cd05591 215 --YP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ----HPFFKEIDWV 263 (321)
T ss_pred --CC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc----CCccCCCCHH
Confidence 00 01123567889999999999999 6565655 9999875444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.56 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=207.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 47788899999999999999999999999999965443444556789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 82 YIPGGDMMSLLIRME-----------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred cCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 999999999987642 378888999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCc--------------------------------------------cccccccccCcccccccccccCCCCC
Q 001778 848 AKILIKEEGE--------------------------------------------FAAMSTVVGSCGYIAPEYARTRKVNE 883 (1014)
Q Consensus 848 a~~~~~~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ 883 (1014)
+..+...... ........||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 7643210000 00012357999999999999989999
Q ss_pred cCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhH--ccCCCCCCC
Q 001778 884 KTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVI--CTSMLPTER 961 (1014)
Q Consensus 884 ~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~R 961 (1014)
++||||+||++|||++|+.||.......... ........ ...+.......++.+++.+ |+..+|.+|
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~i~~~~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQL---KVINWENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHH---HHHccccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 9999999999999999999998765432221 11111110 0001111112344556655 566777779
Q ss_pred CCHHHHHHHHhcCCCCCCCCC
Q 001778 962 PNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 962 Pt~~ev~~~L~~~~~~~~~~~ 982 (1014)
|+++|+++ ||||....+
T Consensus 297 ~~~~~~l~----hp~f~~~~~ 313 (381)
T cd05626 297 NGADDIKA----HPFFSEVDF 313 (381)
T ss_pred CCHHHHhc----CcccCCCCh
Confidence 99999888 999987443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.05 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=207.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46888999999999999999999999999999984322 2233456789999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++ +|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 e~~~~-~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 83 EYLDS-DLKQYLDNCG----------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred eCCCc-CHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence 99975 9999886542 2478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC-
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK- 924 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 924 (1014)
+++...... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.......+........
T Consensus 149 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 149 LARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred ceeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 997643221 12234578999999998865 5688999999999999999999999987665433333322221100
Q ss_pred ----------cchhccccccCCcc----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 925 ----------PIVDALDKEIDEPC----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 925 ----------~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+.....+...... ......+..+++..|++.||.+|||++|+++ ||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~----hp~f 288 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR----HSYF 288 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc----CCCC
Confidence 00000001100000 0011235678999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=348.34 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=205.5
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHH-HHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ-ILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||+||+|.+..+++.||+|++.............+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999985433333334455555655 46778999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRER-----------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99999987642 378899999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....+ ........
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~------ 214 (323)
T cd05575 147 IEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD---NILNKPLR------ 214 (323)
T ss_pred ccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH---HHHcCCCC------
Confidence 2211 12234578999999999999999999999999999999999999998765432221 12211111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
+.. .....+.+++.+|++.||++||++.+.++.+.+||||....+
T Consensus 215 --~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 215 --LKP----NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred --CCC----CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 111 113456788999999999999999766667777999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.22 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=204.7
Q ss_pred CCCCCCceeccCCcEEEEEeeec-----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC-
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE- 759 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~- 759 (1014)
++|+..+.||+|+||.||+|.+. .+++.||||++... ......+.+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46888999999999999999752 34567999998532 2234456789999999999 899999999988764
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCC---------------------------------------------------C
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLS---------------------------------------------------G 788 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------~ 788 (1014)
+..++||||+++|+|.+++......... .
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4679999999999999999764211000 0
Q ss_pred CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCc
Q 001778 789 RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868 (1014)
Q Consensus 789 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~ 868 (1014)
......+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... .........++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc-chhcccCCCCCc
Confidence 00124588999999999999999999965 99999999999999999999999999998654321 112223345678
Q ss_pred ccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHH
Q 001778 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVF 947 (1014)
Q Consensus 869 ~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (1014)
.|+|||++.+..++.++|||||||++|||++ |..||.+..... .+......+... .. .......+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~------~~----~~~~~~~l~ 307 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRM------RA----PENATPEIY 307 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCC------CC----CCCCCHHHH
Confidence 9999999999999999999999999999997 999997654321 111222222210 00 112234577
Q ss_pred HHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 948 KLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 948 ~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+++.+||+.||++|||+.|+++.|++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=348.38 Aligned_cols=256 Identities=25% Similarity=0.306 Sum_probs=207.5
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999996543334445567788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++...+ .+++..+..++.|++.||+|||.. .+|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSRER-----------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999886542 488999999999999999999951 399999999999999999999999999987543
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1014)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....... .......
T Consensus 148 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i~~~~~~------- 214 (325)
T cd05594 148 KDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---ILMEEIR------- 214 (325)
T ss_pred CCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---HhcCCCC-------
Confidence 211 122345799999999999999999999999999999999999999987654332222 1111111
Q ss_pred ccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCC
Q 001778 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+. .....++.+++.+|++.||++|+ ++.++++ ||||....+.
T Consensus 215 -~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----h~~~~~~~~~ 261 (325)
T cd05594 215 -FP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ----HKFFAGIVWQ 261 (325)
T ss_pred -CC----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc----CCCcCCCCHH
Confidence 11 11123567889999999999997 8888887 9999875433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.37 Aligned_cols=399 Identities=20% Similarity=0.211 Sum_probs=281.1
Q ss_pred CCCCCCCceEeCCCceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCc
Q 001778 58 SSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPE 137 (1014)
Q Consensus 58 ~~~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 137 (1014)
++.|.-+-..|+...+..++ ...+.|.+|+ +-+.|||++|.+..+.+..|.++++|+.+++..|.++ .||.
T Consensus 49 ~c~c~~~lldcs~~~lea~~--~~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~ 119 (873)
T KOG4194|consen 49 TCPCNTRLLDCSDRELEAID--KSRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPR 119 (873)
T ss_pred cCCCCceeeecCcccccccc--ccccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccc
Confidence 34466666678776666554 3445666653 5567888888888888888888888888888888887 7777
Q ss_pred ccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCccccccc
Q 001778 138 DIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLK 217 (1014)
Q Consensus 138 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~ 217 (1014)
..+...+|+.|+|.+|.|+..-...+..++.|+.|||+.|.|+...-..|..-.++++|+|++|+
T Consensus 120 f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~--------------- 184 (873)
T KOG4194|consen 120 FGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNR--------------- 184 (873)
T ss_pred ccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccc---------------
Confidence 66666678888888888886666777778888888888888874444555555555555555555
Q ss_pred ccceeecccccccCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCcccccc-ccceeecc
Q 001778 218 KLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLS 296 (1014)
Q Consensus 218 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls 296 (1014)
++..-...|.++.+|..|.|++|+++...+..|.+++.|+.|+|..|+|...-.-.|..+ +|+.|.|.
T Consensus 185 -----------It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklq 253 (873)
T KOG4194|consen 185 -----------ITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQ 253 (873)
T ss_pred -----------ccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhh
Confidence 444444456666666666666666664334445556667777776666664434444443 67777777
Q ss_pred ccccCCCCCCcccccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCC
Q 001778 297 ANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSL 376 (1014)
Q Consensus 297 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 376 (1014)
.|.++......|..+.++++|+|+.|+++..--.++.+++.|+.|+|++|.|....+..+...++|+.|+|++|+++...
T Consensus 254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~ 333 (873)
T KOG4194|consen 254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLD 333 (873)
T ss_pred hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCC
Confidence 77777777777888888888888888887666667778888888888888888777888888888888888888888777
Q ss_pred ChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCCCCC
Q 001778 377 PEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNL 456 (1014)
Q Consensus 377 p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L 456 (1014)
+..|..+..|+.|.|++|.+...--..|..+.+|++|||++|.++..|-+.-. +..-.++|
T Consensus 334 ~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~-------------------~f~gl~~L 394 (873)
T KOG4194|consen 334 EGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAV-------------------AFNGLPSL 394 (873)
T ss_pred hhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchh-------------------hhccchhh
Confidence 77888888888888888888877777888888888888888888866554221 11112356
Q ss_pred ceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccc
Q 001778 457 SRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQ 511 (1014)
Q Consensus 457 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 511 (1014)
+.|+|.+|+|..+...+|.++.+|+.|||.+|.|..+.|++|..+ .|++|.++.
T Consensus 395 rkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 395 RKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred hheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 777777777775545567777777777777777776667777666 666665543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=375.38 Aligned_cols=479 Identities=27% Similarity=0.361 Sum_probs=307.9
Q ss_pred eeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeecCccCC
Q 001778 77 HLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMS 156 (1014)
Q Consensus 77 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 156 (1014)
|++.+++. .||..+-+-..++.|+++.|-+....-+.+.+.-+|+.||+++|+++ ..|..+..+.+|+.|+++.|.|.
T Consensus 4 d~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~ 81 (1081)
T KOG0618|consen 4 DASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR 81 (1081)
T ss_pred ccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence 44444444 44444444444555555555544333333344444666666666554 45555555566666666666555
Q ss_pred CCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCccccc
Q 001778 157 GKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPET 236 (1014)
Q Consensus 157 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~ 236 (1014)
..|.+..++.+|++|+|.+|++. ..|..+..+++|++|++++|+ ...+|..+..++.+.++..++|..+...
T Consensus 82 -~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~---f~~~Pl~i~~lt~~~~~~~s~N~~~~~l--- 153 (1081)
T KOG0618|consen 82 -SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH---FGPIPLVIEVLTAEEELAASNNEKIQRL--- 153 (1081)
T ss_pred -hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhc---cCCCchhHHhhhHHHHHhhhcchhhhhh---
Confidence 45555555566666666666555 555566666666666666654 3445555555555555555555222221
Q ss_pred cccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccccc
Q 001778 237 IGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLN 316 (1014)
Q Consensus 237 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 316 (1014)
+.+. ++.+++..|.+.+.++..+..+.. .|+|++|.+. .-..-...+|+.|....|++.... -..++|+.
T Consensus 154 -g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 -GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred -cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh--hhhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 1111 555666666666555555555444 4666666655 111111224555666666555221 12345666
Q ss_pred cccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEcccccc
Q 001778 317 LSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396 (1014)
Q Consensus 317 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l 396 (1014)
|+.++|.++...+. ..-.+|+++++++|+++ .+|.+++.+.+|+.++..+|+++ .+|..+....+|+.|+...|.+
T Consensus 224 L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 66666666522222 12345666667777666 44566666777777777777774 6666666667777777777776
Q ss_pred CCCCCcccccCCcccEEEeecceeecCCCccccccc--ccccccccCCcccCCCCC---cCCCCCceeccccccccCcCC
Q 001778 397 SGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF--NLSMVLISDNLFTGELPD---KMSGNLSRLEISNNRFSGKIP 471 (1014)
Q Consensus 397 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~--~L~~l~l~~n~~~~~~p~---~~~~~L~~L~Ls~N~l~~~~~ 471 (1014)
. .+|.....++.|++|+|..|+|. .+|+.+.... ++..+..+.|.+. ..|. .....|+.|++.+|+++...-
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~ 376 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCF 376 (1081)
T ss_pred h-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccch
Confidence 6 56677777888888888888887 5666544332 3667777777766 3332 122468999999999998877
Q ss_pred CcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccccccc
Q 001778 472 TGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV 551 (1014)
Q Consensus 472 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 551 (1014)
..+.+..+|++|+|++|++.......+.++..|++|+||||+|+ .+|..+..+..|++|...+|++. ..| ++..++.
T Consensus 377 p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q 453 (1081)
T KOG0618|consen 377 PVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ 453 (1081)
T ss_pred hhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence 78889999999999999998655667888999999999999998 89999999999999999999998 788 8999999
Q ss_pred cceeecCCCcccc-CCchhhhhhcccccccCCCcc
Q 001778 552 LQDLDLSENQFSG-KIPPQIGRLMLTSLNLSSNRL 585 (1014)
Q Consensus 552 L~~L~Ls~N~l~g-~ip~~~~~~~l~~l~ls~N~l 585 (1014)
|+.+|+|.|+|+- .+|.......|++|||++|..
T Consensus 454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred ceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999999984 445444334699999999973
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.40 Aligned_cols=254 Identities=28% Similarity=0.388 Sum_probs=201.9
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
++||+|+||.||+|.+..+++.||+|++..+........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999654333334455566677777654 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 g~L~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 81 GDLMFHIQSSG-----------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 99999987642 378889999999999999999965 9999999999999999999999999999754
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... ... ...+
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~---~i~-~~~~------ 213 (316)
T cd05592 147 MNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD---SIL-NDRP------ 213 (316)
T ss_pred CCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-cCCC------
Confidence 3221 22335679999999999999899999999999999999999999998766432222 111 1111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~ 982 (1014)
.+. .....++.+++.+||+.||++||++. ++.+ ||||....+
T Consensus 214 -~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~----h~~~~~~~~ 256 (316)
T cd05592 214 -HFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ----HPFFRGIDW 256 (316)
T ss_pred -CCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHc----CcccCCCCH
Confidence 011 11123456788999999999999875 4444 999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.37 Aligned_cols=255 Identities=26% Similarity=0.338 Sum_probs=206.6
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||+||+|.+..+++.||||++.............+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999654333444566778899999887 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRSG-----------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99999887642 389999999999999999999965 9999999999999999999999999998653
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+....... .......
T Consensus 147 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~---i~~~~~~------ 214 (318)
T cd05570 147 ILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS---ILEDEVR------ 214 (318)
T ss_pred CcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH---HHcCCCC------
Confidence 2211 112245689999999999999999999999999999999999999987654332221 1111111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHHHhcCCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM-----RMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. ......+.+++.+||+.||++||++ .++++ ||||....+.
T Consensus 215 --~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~----~~~~~~~~~~ 261 (318)
T cd05570 215 --YP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG----HPFFREIDWD 261 (318)
T ss_pred --CC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc----CCCcCCCCHH
Confidence 00 1122456789999999999999998 66666 9999886554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.76 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=206.1
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHH---HcCCCCccceEEEEEEcCCceEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL---STIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++ +.++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 55678999999999999999999999999999654333344456677777665 456799999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++|+|..+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~E~~~~~~L~~~~~~~------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EcCCCCCcHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 9999999999887542 389999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|++....... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... ........
T Consensus 146 g~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~---~i~~~~~~ 219 (324)
T cd05589 146 GLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---SIVNDEVR 219 (324)
T ss_pred cCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCC
Confidence 9987532211 12335679999999999999999999999999999999999999998765433222 11111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~ 981 (1014)
. .......+.+++.+||+.||.+||++++ .++.+.+||||....
T Consensus 220 --------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 220 --------Y----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred --------C----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 0 0112244678899999999999996444 355555699998744
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.71 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=210.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 46888899999999999999999999999999985433333344566889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 123 Ey~~gg~L~~~l~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 123 EYMPGGDLVNLMSNY------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred cCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence 999999999998653 267788889999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccC----CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR----KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+...... .....
T Consensus 188 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~~ 262 (370)
T cd05596 188 TCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KIMDH 262 (370)
T ss_pred ceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH---HHHcC
Confidence 997654321 1122356799999999998653 47889999999999999999999998766432211 11111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHHhcCCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTE--RPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
... +..+........+.+++..|++.+|++ ||+++|+++ ||||+...+.
T Consensus 263 ~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~----h~~~~~~~~~ 313 (370)
T cd05596 263 KNS--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS----HPFFKNDQWT 313 (370)
T ss_pred CCc--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc----CcccCCCChh
Confidence 111 000111112345678889999999998 999998888 9999886544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.26 Aligned_cols=278 Identities=24% Similarity=0.304 Sum_probs=216.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCc-cceEEEEEEcCC-----
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN-IVKLLCCISSEN----- 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~----- 760 (1014)
..|...++||+|+||+||+|+.+.+|+.||+|++.-+... +.......+|+.+++.++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4577788899999999999999999999999998543221 335567789999999999999 999999998876
Q ss_pred -ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 761 -LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 761 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
..++||||++. +|.+++....... ..++...+..++.|+++|++|||.+ +|+||||||+||+++++|.
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCc
Confidence 78999999976 9999998764211 2355688999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+||+|||+|+...-.. ......++|..|+|||++.+. .|+...||||+|||++||++++..|.+..+.+...-+..
T Consensus 159 lKlaDFGlAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred EeeeccchHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 9999999999654222 234567889999999999886 799999999999999999999999998876444333333
Q ss_pred HHhcC----Ccchh-c--cc---cccC-Cccc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 919 HIQEG----KPIVD-A--LD---KEID-EPCF----LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 919 ~~~~~----~~~~~-~--~~---~~~~-~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+-.+ ++-.. . .+ +... .... ........+++.+|++.||++|.|++++++ ||||......
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~----h~yf~~~~~~ 311 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT----HPYFSELPEK 311 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc----Chhhcccccc
Confidence 32111 11000 0 00 0000 0001 111135778999999999999999999999 9999987654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.15 Aligned_cols=363 Identities=24% Similarity=0.214 Sum_probs=246.0
Q ss_pred cceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeec
Q 001778 145 LKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWM 224 (1014)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l 224 (1014)
-+.|++++|+++...+..|.++++|+++++..|.++ .+|...+...+|+.|+|.+|.|
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I--------------------- 137 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLI--------------------- 137 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeecccc---------------------
Confidence 344666666666555556666666666666666665 5554444444444444444432
Q ss_pred ccccccCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCcccccc-ccceeeccccccCCC
Q 001778 225 ASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGA 303 (1014)
Q Consensus 225 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~ 303 (1014)
...-.+++..++.|+.||||.|.|+..--..|..-.++++|+|++|+|+......|... +|..|.|++|+++..
T Consensus 138 -----~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 138 -----SSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred -----ccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 22223445556666666666666663333445555667777777777776666666664 577778888888877
Q ss_pred CCCcccccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcC
Q 001778 304 IPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383 (1014)
Q Consensus 304 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 383 (1014)
.+..|.++++|+.|+|..|+|.-.--..|.++++|+.|.|..|.++..-...|-.+.+++.|+|+.|+++..-..++..+
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL 292 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL 292 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence 77788888899999999998873335678888999999999999888778888888888888888888887777777888
Q ss_pred CCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCCCCCceecccc
Q 001778 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISN 463 (1014)
Q Consensus 384 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~ 463 (1014)
+.|+.|+|+.|.|..+.++++..+++|++|+|++|+|+..-+..+..+. .|++|.|++
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~----------------------~Le~LnLs~ 350 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS----------------------QLEELNLSH 350 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH----------------------Hhhhhcccc
Confidence 8888888888888877777777777777777777777743333333333 355555555
Q ss_pred ccccCcCCCcccCCCcceEEEccCCccccccc---cccccccccceecccccccCCCCc-ccccccccccceeccccccc
Q 001778 464 NRFSGKIPTGVSSSKNLVVFQASNNLFNGTIP---GELTALPSLTTLLLDQNQLSGSLP-LDIISWKSLTALNLSRNQLS 539 (1014)
Q Consensus 464 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 539 (1014)
|+++..-...|..+++|+.|||++|.+++.+. ..|.+|++|+.|+|.+|+|. .+| ..|.++.+|+.|||.+|.|.
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcce
Confidence 55554445566667777777777777766553 34666777777777777776 344 56777777777777777777
Q ss_pred cccCcccccccccceeecC
Q 001778 540 GEIPEKIGFLPVLQDLDLS 558 (1014)
Q Consensus 540 ~~~p~~~~~l~~L~~L~Ls 558 (1014)
..-|.+|..+ +|+.|-++
T Consensus 430 SIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 430 SIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred eecccccccc-hhhhhhhc
Confidence 6667777766 66666554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.84 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=205.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++.++...|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 57888999999999999999999999999999955433344455778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 82 FLPGGDMMTLLMKKD-----------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999997642 388999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCc--------------------------------cccccccccCcccccccccccCCCCCcCcchhHHHHHH
Q 001778 848 AKILIKEEGE--------------------------------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILL 895 (1014)
Q Consensus 848 a~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ 895 (1014)
++........ ........||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 9754321100 00012357999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHcc--CCCCCCCCCHHHHHHHHhc
Q 001778 896 ELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICT--SMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 896 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPt~~ev~~~L~~ 973 (1014)
||++|+.||.+......... ........ .+.+.. + ..+ ++.+++.+++ ..++..||+++|+++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~---i~~~~~~~--~~p~~~--~-~s~---~~~~li~~l~~~~~~r~~r~~~~ei~~---- 292 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKK---VMNWKETL--IFPPEV--P-ISE---KAKDLILRFCCEWEHRIGAPGVEEIKT---- 292 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHH---HHcCcCcc--cCCCcC--C-CCH---HHHHHHHHHcCChhhcCCCCCHHHHhC----
Confidence 99999999987654322221 11111100 011111 1 112 2334444433 334445789888877
Q ss_pred CCCCCCCCCC
Q 001778 974 NPIFPTEKNG 983 (1014)
Q Consensus 974 ~~~~~~~~~~ 983 (1014)
||||+...+.
T Consensus 293 hp~f~~~~~~ 302 (363)
T cd05628 293 NPFFEGVDWE 302 (363)
T ss_pred CCCCCCCCHH
Confidence 9999876444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.47 Aligned_cols=269 Identities=25% Similarity=0.287 Sum_probs=214.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-C-----CccceEEEEEEcCCc
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-H-----LNIVKLLCCISSENL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pniv~l~~~~~~~~~ 761 (1014)
+|.+.++||+|+||.|.+|.+..+++.||||++++. +....+...|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 788999999999999999999999999999999553 345666788999999986 4 489999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC--c
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF--N 839 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~--~ 839 (1014)
.|+|+|.++. +|.++++... ...++...+..|+.||+.||.+||+. +|||+||||+|||+.+.. .
T Consensus 263 lciVfELL~~-NLYellK~n~---------f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNK---------FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCc
Confidence 9999999965 9999999864 23489999999999999999999966 999999999999996543 6
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
+||+|||.|+..... ......+..|+|||++.+.+|+.+.||||||||++||++|.+.|.++++.+....+.+.
T Consensus 330 vKVIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred eeEEecccccccCCc------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 999999999875331 11567889999999999999999999999999999999999999988765544433222
Q ss_pred H--------hcCCcchhcccc---------------------------------ccC------Ccc-cHHHHHHHHHHHh
Q 001778 920 I--------QEGKPIVDALDK---------------------------------EID------EPC-FLEEMIRVFKLGV 951 (1014)
Q Consensus 920 ~--------~~~~~~~~~~~~---------------------------------~~~------~~~-~~~~~~~l~~li~ 951 (1014)
. ..+......++. ... ... ...+-..+++++.
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 1 111111111111 000 001 1133346789999
Q ss_pred HccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 952 ICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 952 ~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+|+..||++|+|+.++++ |||++.....
T Consensus 484 ~~L~~dP~~R~tp~qal~----Hpfl~~~~~~ 511 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALN----HPFLTGTSLE 511 (586)
T ss_pred HHhccCchhcCCHHHHhc----Cccccccccc
Confidence 999999999999999999 9999964444
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=342.67 Aligned_cols=275 Identities=23% Similarity=0.339 Sum_probs=213.9
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||++.+..+++.||+|++... ........+.+|+++++.++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 5788999999999999999999999999999988442 23345677899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++.....++.+++.|+.|||+. .+|+|+||||+||+++.++.+||+|||
T Consensus 83 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 83 EHMDGGSLDQVLKKAG-----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred ecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999997642 378888999999999999999953 379999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||................ .+...
T Consensus 150 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 223 (333)
T cd06650 150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV-EGDPA 223 (333)
T ss_pred cchhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc-cCCcc
Confidence 98765321 1224568999999999998889999999999999999999999997654332221111000 00000
Q ss_pred hhc----------------------------cccccC---Ccc-cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 927 VDA----------------------------LDKEID---EPC-FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 927 ~~~----------------------------~~~~~~---~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
... .+.... ... ......++.+++.+||++||++|||++|+++ |
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~----h 299 (333)
T cd06650 224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV----H 299 (333)
T ss_pred ccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh----C
Confidence 000 000000 000 0011235678999999999999999999998 9
Q ss_pred CCCCCCCCCCCc
Q 001778 975 PIFPTEKNGGRK 986 (1014)
Q Consensus 975 ~~~~~~~~~~~~ 986 (1014)
|||+..+.+..+
T Consensus 300 ~~~~~~~~~~~~ 311 (333)
T cd06650 300 AFIKRSEAEEVD 311 (333)
T ss_pred HHHhcCcccccc
Confidence 999987655443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.34 Aligned_cols=263 Identities=23% Similarity=0.287 Sum_probs=209.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC-CccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH-LNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lV~ 766 (1014)
+|+..+.||+|+||.||+|.+..+++.||||++...........+.+..|+.++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 36778899999999999999999999999999855433334456678889999999976 56888999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 E~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred cCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 9999999999987642 378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+ ......
T Consensus 147 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~- 219 (324)
T cd05587 147 MCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI---MEHNVS- 219 (324)
T ss_pred cceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCC-
Confidence 986432211 1223457899999999999999999999999999999999999999876543332221 111111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~ 982 (1014)
+. .....++.+++.+|++.||.+|++.. +..+.+.+||||....+
T Consensus 220 -------~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 220 -------YP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -------CC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11 11223567889999999999999863 34556677999987544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=348.57 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=208.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999999999999999985433333444566889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 123 Ey~~gg~L~~~l~~~------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 123 EYMPGGDLVNLMSNY------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred cCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999998653 267888999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccC----CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR----KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.... .......
T Consensus 188 ~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~~i~~~ 262 (370)
T cd05621 188 TCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YSKIMDH 262 (370)
T ss_pred cceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HHHHHhC
Confidence 998654321 1122356799999999998754 377899999999999999999999987654322 1222211
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHHhcCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTE--RPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
... +..+........+.+++..|++.+|.+ ||+++|+++ ||||+...+
T Consensus 263 ~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~----hp~~~~~~~ 312 (370)
T cd05621 263 KNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ----HPFFKNDQW 312 (370)
T ss_pred Ccc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc----CcccCCCCc
Confidence 111 011111112334567778888765544 889998888 999988654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.17 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=213.7
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
+.++++||+|-||+|..|+... +..||||+++.+ .......+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD--ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred eehhhhhcCcccceeEEEEecC-ceEEEEeecCcc--cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567789999999999998654 688999999654 3344568999999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
|++|+|.+++.....+ ...-....+|+.|||.||+||. +.++||||+.++|+|++.++++||+|||++
T Consensus 617 mEnGDLnqFl~aheap---------t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP---------TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HhcCcHHHHHHhccCc---------ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 9999999999876321 1334456679999999999999 459999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc--CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT--GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+.++.. ..+......+-+.+|||||.+..++++.++|||+||+++||+++ .+.||....++...+........+..
T Consensus 685 R~lysg-~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~- 762 (807)
T KOG1094|consen 685 RNLYSG-DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR- 762 (807)
T ss_pred cccccC-CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-
Confidence 987763 33344455677899999999999999999999999999999865 67799876665555544443333322
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
......+.-+...+++++..||+.|-++||+++++...|++.
T Consensus 763 ------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 ------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111223344556788999999999999999999998877653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.76 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=204.8
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC--CCCccceEEEEEEcC--
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI--RHLNIVKLLCCISSE-- 759 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~hpniv~l~~~~~~~-- 759 (1014)
.+..+.+..+.||+|.||+||+|.|. |+.||||++. ...++.+.+|.++++.+ +|+||+.|+++-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~------srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS------SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEec------ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 45567788899999999999999886 7889999993 35678889999999875 999999999875433
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeccCCCCCe
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD-----CSPTIVHRDLKSSNI 832 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~s~~ivH~Dlk~~NI 832 (1014)
..+|||++|.+.|||.||+... .++-....+++..+|.||+|||.. ..+.|+|||||+.||
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 3579999999999999999874 488899999999999999999953 367899999999999
Q ss_pred eecCCCcEEEeecccccccccccCc-cccccccccCcccccccccccCC----C--CCcCcchhHHHHHHHHhcCC----
Q 001778 833 LLDYNFNAKIADFGVAKILIKEEGE-FAAMSTVVGSCGYIAPEYARTRK----V--NEKTDIYSFGVILLELTTGK---- 901 (1014)
Q Consensus 833 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~----~--~~~~DvwSlGvll~elltg~---- 901 (1014)
||.+++.+.|+|+|+|..+...... ......++||.+|||||++...- + -..+||||||.|+||+..+.
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999887664332 23456789999999999997532 1 14799999999999998643
Q ss_pred ------CCCCCC--CchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 902 ------EANNGD--EHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 902 ------~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.||.+- .++... .+...+-.. .....++..+. ..+.+..+.++|+.||..+|..|.|+--+.+.|.+
T Consensus 428 i~eey~~Pyyd~Vp~DPs~e-eMrkVVCv~-~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFE-EMRKVVCVQ-KLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred EehhhcCCcccCCCCCCCHH-HHhcceeec-ccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 455431 112111 112222111 11222222222 24667789999999999999999999998887766
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.67 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=209.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 57888999999999999999999999999999954333334455678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~g~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 82 YLPGGDMMTLLMKKD-----------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CCCCcHHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999997642 388999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCcc-----------------------------------ccccccccCcccccccccccCCCCCcCcchhHHH
Q 001778 848 AKILIKEEGEF-----------------------------------AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGV 892 (1014)
Q Consensus 848 a~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGv 892 (1014)
+..+....... .......||+.|+|||++.+..++.++||||+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87543211000 0011246999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHH
Q 001778 893 ILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN---MRMVLQ 969 (1014)
Q Consensus 893 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~ 969 (1014)
++|||++|..||.+.+...... ........ +..+........+.+++.+|+. ||.+|++ ++|+++
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~---~i~~~~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYR---KIINWKET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHH---HHHcCCCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999999999998765432222 11111111 0000000112345677788886 9999998 888887
Q ss_pred HHhcCCCCCCCCC
Q 001778 970 ILLNNPIFPTEKN 982 (1014)
Q Consensus 970 ~L~~~~~~~~~~~ 982 (1014)
||||....+
T Consensus 296 ----h~~~~~~~~ 304 (364)
T cd05599 296 ----HPFFKGVDW 304 (364)
T ss_pred ----CCCcCCCCH
Confidence 999987543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.41 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=207.2
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHH-HHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ-ILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||.||+|.+..+++.||+|++.............+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999985543333444556666655 46778999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRE-----------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999888754 2478999999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....+ .... ...
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---~~~~-~~~------ 213 (325)
T cd05604 147 IAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD---NILH-KPL------ 213 (325)
T ss_pred CCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH---HHHc-CCc------
Confidence 2211 12234679999999999999999999999999999999999999998765432221 1111 111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+.. .....+.+++.+|++.||.+||++.+.++.+.+||||....+
T Consensus 214 -~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 214 -VLRP----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -cCCC----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 0111 112346688999999999999999888888888999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=337.84 Aligned_cols=267 Identities=27% Similarity=0.315 Sum_probs=227.3
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCc
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENL 761 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~ 761 (1014)
..+...|+..+.||+|.||.||+|+.+.+|+.+|+|++.+...........+.+|+.+|+++. |||||.+.++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 455667889999999999999999999999999999997766555556789999999999998 9999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC----
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN---- 837 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~---- 837 (1014)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||.. ||+|||+||+|+|+...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred EEEEEEecCCchHHHHHHHc------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCC
Confidence 99999999999999999764 188999999999999999999954 99999999999999543
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+.+|++|||+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........
T Consensus 176 ~~ik~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--- 248 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--- 248 (382)
T ss_pred CcEEEeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---
Confidence 5799999999998654 234567899999999999999999999999999999999999999999877543333
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+..+.. .+..+.+......+.+++..|+..||.+|+|+.++++ |||+......
T Consensus 249 -~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~----HpWi~~~~~~ 302 (382)
T KOG0032|consen 249 -AILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ----HPWIKSIGEA 302 (382)
T ss_pred -HHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc----CccccCCccc
Confidence 2222221 2333444455566778999999999999999999999 9999986433
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=304.92 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=208.9
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----Cc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE-----NL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~ 761 (1014)
++|++.+.+|+|||+.||.++...+++.+|+|++.. ...+..+..++|++..++++||||++++++...+ .+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c---~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC---HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeec---cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 468999999999999999999999999999999843 3356788899999999999999999999876443 35
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.|++++|...|+|.+.+.... .+...+++.+.+.|+.+|++||.+||+. .++++||||||.||++++++.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k-------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK-------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred EEEEeehhccccHHHHHHHHh-------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence 899999999999999998763 2445799999999999999999999987 55699999999999999999999
Q ss_pred EeecccccccccccC------ccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 842 IADFGVAKILIKEEG------EFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~------~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.|||.+....-.-. ..........|..|+|||.+. +...++++|||||||++|+|+.|..||+...
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---- 245 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---- 245 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh----
Confidence 999999976532110 011122345789999999886 3466799999999999999999999996321
Q ss_pred HHHHHHHHhcCCcch-hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 913 AQWAWRHIQEGKPIV-DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.|..+. ......+..+........+.+++..|+++||.+||++.+++..+.+
T Consensus 246 --------~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 246 --------QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --------hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1222222 2222223222223344557788899999999999999999987754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=344.55 Aligned_cols=264 Identities=23% Similarity=0.266 Sum_probs=205.7
Q ss_pred CCCCCceeccCCcEEEEEeeec---CCCeEEEEEEecccchh-hHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 762 (1014)
+|+..+.||+|+||.||++... .+++.||+|++...... .....+.+.+|+.+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3677899999999999998764 46889999998543221 223456788999999999 599999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 9999999999999998764 2378999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...+.
T Consensus 147 ~DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 224 (332)
T cd05614 147 TDFGLSKEFLSEEKE--RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224 (332)
T ss_pred eeCcCCccccccCCC--ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh
Confidence 999999765332211 22245799999999998865 478899999999999999999999975443322222322222
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~ 982 (1014)
...+ .+. ......+.+++.+||+.||++|| +++++++ ||||+...+
T Consensus 225 ~~~~-------~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~----h~~~~~~~~ 275 (332)
T cd05614 225 KCDP-------PFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE----HPFFKGLDW 275 (332)
T ss_pred cCCC-------CCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc----CCCcCCCCH
Confidence 2111 111 11223466889999999999999 6556665 999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.76 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=207.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||+|.+..+++.||||++...........+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 57888999999999999999999999999999855433344556778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 82 FLPGGDLMTMLIKY-----------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999998764 2378888999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCcc----------c----------------------------------cccccccCcccccccccccCCCCC
Q 001778 848 AKILIKEEGEF----------A----------------------------------AMSTVVGSCGYIAPEYARTRKVNE 883 (1014)
Q Consensus 848 a~~~~~~~~~~----------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ 883 (1014)
++.+....... . ......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 96432110000 0 001246999999999999999999
Q ss_pred cCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCC--
Q 001778 884 KTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTER-- 961 (1014)
Q Consensus 884 ~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-- 961 (1014)
++||||+||++|||++|..||.+........ ........ +..+.......++.+++.+|+. +|.+|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~--------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYR---KIINWRET--------LYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHH---HHHccCCc--------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 9999999999999999999998765432211 11111110 0001111112346678888997 66665
Q ss_pred -CCHHHHHHHHhcCCCCCCCC
Q 001778 962 -PNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 962 -Pt~~ev~~~L~~~~~~~~~~ 981 (1014)
+++.|+++ ||||....
T Consensus 296 r~~~~~~l~----hp~~~~~~ 312 (377)
T cd05629 296 RGGAHEIKS----HPFFRGVD 312 (377)
T ss_pred CCCHHHHhc----CCCcCCCC
Confidence 59999888 99998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=342.05 Aligned_cols=255 Identities=27% Similarity=0.342 Sum_probs=202.0
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
++||+|+||.||+|.+..+++.||+|++.............+..|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999998543222233455667788887754 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDKG-----------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 99999987642 378899999999999999999965 9999999999999999999999999998743
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....+. +....+
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~----~~~~~~------ 213 (316)
T cd05620 147 VFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES----IRVDTP------ 213 (316)
T ss_pred ccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCC------
Confidence 2211 123356789999999999999999999999999999999999999987654332222 111111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+.. ....++.+++.+|++.||++||++.+ .+.+||||....+
T Consensus 214 -~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~---~~~~h~~f~~~~~ 256 (316)
T cd05620 214 -HYPR----WITKESKDILEKLFERDPTRRLGVVG---NIRGHPFFKTINW 256 (316)
T ss_pred -CCCC----CCCHHHHHHHHHHccCCHHHcCCChH---HHHcCCCcCCCCH
Confidence 0110 11234667899999999999999742 2445999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.97 Aligned_cols=274 Identities=25% Similarity=0.323 Sum_probs=208.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecC----------------CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH----------------TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv 750 (1014)
.+|+..+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 467888999999999999997532 34479999985432 234467799999999999999999
Q ss_pred eEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCC--------CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001778 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS--------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTI 822 (1014)
Q Consensus 751 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~i 822 (1014)
++++++.+.+..++||||+++|+|.+++......... .......++|..+.+++.|++.||+|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 9999999999999999999999999998764221110 012234588999999999999999999965 99
Q ss_pred EeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc--C
Q 001778 823 VHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT--G 900 (1014)
Q Consensus 823 vH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt--g 900 (1014)
+||||||+||+++.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999986543221 122234456889999999988899999999999999999986 5
Q ss_pred CCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 901 KEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 901 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..||...........+............. .........+.+++.+||+.||++|||+.||.+.|++
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 56777655444433332222111100000 0011223467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.62 Aligned_cols=266 Identities=26% Similarity=0.292 Sum_probs=214.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|...+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 58888999999999999999999999999999955433333556778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 82 YMPGGDLMNLLIRK-----------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 99999999999764 2478899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccC--------------------------ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCC
Q 001778 848 AKILIKEEG--------------------------EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901 (1014)
Q Consensus 848 a~~~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~ 901 (1014)
+........ .........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 986644220 011223467999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHHHhcCCCCCCC
Q 001778 902 EANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-MRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 902 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~~L~~~~~~~~~ 980 (1014)
.||......... ......... ...+........+.+++..|++ ||.+||+ ++|+++ ||||...
T Consensus 228 ~Pf~~~~~~~~~---~~i~~~~~~--------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~----hp~~~~~ 291 (350)
T cd05573 228 PPFYSDTLQETY---NKIINWKES--------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS----HPFFKGI 291 (350)
T ss_pred CCCCCCCHHHHH---HHHhccCCc--------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc----CCCcCCC
Confidence 999876633221 111110010 0011111123456778889997 9999999 999998 9999875
Q ss_pred CCC
Q 001778 981 KNG 983 (1014)
Q Consensus 981 ~~~ 983 (1014)
.+.
T Consensus 292 ~~~ 294 (350)
T cd05573 292 DWE 294 (350)
T ss_pred CHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=340.48 Aligned_cols=254 Identities=28% Similarity=0.369 Sum_probs=202.3
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||+||+|.+..+++.||||++.............+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998543222233445667778888764 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSCH-----------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99999987642 378899999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....+. +....+.
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----i~~~~~~----- 214 (316)
T cd05619 147 MLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPC----- 214 (316)
T ss_pred CCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCC-----
Confidence 2211 122345789999999999998999999999999999999999999987654333222 1111110
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~ 982 (1014)
.. ......+.+++.+||+.||++||++. ++ .+||||+...+
T Consensus 215 --~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l----~~h~~~~~~~~ 256 (316)
T cd05619 215 --YP----RWLTREAKDILVKLFVREPERRLGVKGDI----RQHPFFREIDW 256 (316)
T ss_pred --CC----ccCCHHHHHHHHHHhccCHhhcCCChHHH----HcCcccCCCCH
Confidence 00 01123466888999999999999986 44 45999988543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.21 Aligned_cols=251 Identities=23% Similarity=0.263 Sum_probs=201.7
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc----CCceEEEEE
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS----ENLKLLVYE 767 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lV~e 767 (1014)
...||+|++|.||+|.+ +++.||||++...........+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 35799999999999977 588999999865433334445778899999999999999999999876 346799999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++... ..++|....+++.+++.|++|||.. .+++||||||+||++++++.+||+|||+
T Consensus 103 y~~~g~L~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 103 YCTRGYLREVLDKE-----------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred eCCCCcHHHHHhhC-----------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccch
Confidence 99999999999764 2378999999999999999999963 3788999999999999999999999999
Q ss_pred ccccccccCccccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .....+..
T Consensus 170 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---~i~~~~~~ 240 (283)
T PHA02988 170 EKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---LIINKNNS 240 (283)
T ss_pred Hhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhcCCC
Confidence 9765321 123568899999999976 688999999999999999999999998765432222 22222111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
.... ......+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 241 ------~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 ------LKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------CCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111 1233457789999999999999999999999987643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.85 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=205.4
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHH-HHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ-ILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||+||+|.+..+++.||+|++.............+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999985433222333444555544 56778999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+.+.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQRER-----------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 99999997642 367788888999999999999965 9999999999999999999999999999754
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......+. .......
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~------ 214 (325)
T cd05602 147 IEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---ILNKPLQ------ 214 (325)
T ss_pred ccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---HHhCCcC------
Confidence 3211 122356799999999999999999999999999999999999999987654332222 1111111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.. ......+.+++.+|++.||.+||++.+.+..+.+|+||....+
T Consensus 215 --~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 215 --LK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred --CC----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 11 1112346678889999999999999988888899999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.38 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=209.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+|+..+.||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 367788999999999999999999999999998654333334455677788888777 5899999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||+++++.+||+|||
T Consensus 81 E~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred cCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 9999999999987642 378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+ ......
T Consensus 147 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---~~~~~~- 219 (323)
T cd05616 147 MCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---MEHNVA- 219 (323)
T ss_pred CceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCC-
Confidence 987543211 1223467899999999999999999999999999999999999999876644332222 111111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~~ 983 (1014)
+ +.....++.+++.+|++.||.+|++.. +..+.+..||||....+.
T Consensus 220 -------~----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 220 -------Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred -------C----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 0 111224567889999999999999852 234455669999865433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=350.57 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=204.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..++||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 47788999999999999999999999999999855433344556788999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++.....++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred CCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 999999999987642 378888899999999999999965 999999999999999999999999999
Q ss_pred ccccccccC--------------------------------------------ccccccccccCcccccccccccCCCCC
Q 001778 848 AKILIKEEG--------------------------------------------EFAAMSTVVGSCGYIAPEYARTRKVNE 883 (1014)
Q Consensus 848 a~~~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ 883 (1014)
+..+..... .........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753321000 000012346999999999999999999
Q ss_pred cCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC
Q 001778 884 KTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN 963 (1014)
Q Consensus 884 ~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 963 (1014)
++||||+||++|||++|+.||.+.+..... ......... ...+.......+..+++.+|+ .||.+|++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~~~~--------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQ---MKVINWQTS--------LHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHH---HHHHccCCC--------cCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999999999999999876533221 111111110 000100111223445555554 49999997
Q ss_pred ---HHHHHHHHhcCCCCCCCCC
Q 001778 964 ---MRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 964 ---~~ev~~~L~~~~~~~~~~~ 982 (1014)
++|+++ ||||+...+
T Consensus 296 ~~~~~ei~~----hp~f~~~~~ 313 (382)
T cd05625 296 KNGADEIKA----HPFFKTIDF 313 (382)
T ss_pred CCCHHHHhc----CCCcCCcCh
Confidence 777766 999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.07 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=202.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|+..+.||+|+||.||+|.+..+++.||||++... ........+.+|+++++.++|+||+++++++..++..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4567788999999999999999999999999998432 23344577899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 152 e~~~~~~L~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG 213 (353)
T PLN00034 152 EFMDGGSLEGTH---------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG 213 (353)
T ss_pred ecCCCCcccccc---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence 999999986432 245677889999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
++....... .......||..|+|||++.. ...+.++|||||||++|||++|+.||.................
T Consensus 214 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 290 (353)
T PLN00034 214 VSRILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290 (353)
T ss_pred cceeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc
Confidence 998654321 12234579999999998743 2344689999999999999999999985433222222211111
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.... ........++.+++..||+.||++||++.|+++ ||||....
T Consensus 291 ~~~~-----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~----hp~~~~~~ 335 (353)
T PLN00034 291 SQPP-----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQ----HPFILRAQ 335 (353)
T ss_pred cCCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc----CcccccCC
Confidence 1110 011122345778999999999999999999998 99999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.35 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=205.6
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc--ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 357889999999999999999999999999999985322 222345678899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||++ +++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 82 ~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df 147 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP----------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF 147 (303)
T ss_pred EECCC-cCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence 99996 68888876532 2378888999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCch-hHHHHHHHHHhcC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHT-CLAQWAWRHIQEG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~ 923 (1014)
|++....... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .....+.... +
T Consensus 148 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~ 222 (303)
T cd07869 148 GLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL--G 222 (303)
T ss_pred CcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh--C
Confidence 9987543211 12234568999999998865 45788999999999999999999999865432 1111111111 0
Q ss_pred Ccchhc---------cc-cccC---CcccHH------HHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KPIVDA---------LD-KEID---EPCFLE------EMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~~~~~---------~~-~~~~---~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.+..+. .. .... ...... ....+.+++.+|++.||++|||+.|+++ ||||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~----h~~f~~~~ 295 (303)
T cd07869 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS----HEYFSDLP 295 (303)
T ss_pred CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc----CcccccCC
Confidence 100000 00 0000 000000 1134668999999999999999999988 99998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=342.57 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=210.0
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 767 (1014)
|+..+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+. |++|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566789999999999999999999999999985543333444567788889988885 5778889999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 y~~~g~L~~~i~~~~-----------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 82 YVNGGDLMYHIQQVG-----------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccc
Confidence 999999999987642 388999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......+. .......
T Consensus 148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---i~~~~~~-- 219 (323)
T cd05615 148 CKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS---IMEHNVS-- 219 (323)
T ss_pred ccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCCC--
Confidence 87542211 122345689999999999998999999999999999999999999987664333222 2221111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~~~ 983 (1014)
. .......+.+++.+|++.||.+|++..+ ..+.+.+||||....+.
T Consensus 220 ------~----p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 220 ------Y----PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred ------C----CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 0 0111235678899999999999998643 45666779999986543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.61 Aligned_cols=265 Identities=22% Similarity=0.211 Sum_probs=211.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 57888999999999999999999999999999965433344556778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 82 YQPGGDLLSLLNRYE----------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CCCCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 999999999997641 2488999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccc------cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYAR------TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ......
T Consensus 149 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~~ 223 (330)
T cd05601 149 AARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNNIMN 223 (330)
T ss_pred CeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHHHHc
Confidence 9866432211 222457899999999986 45678899999999999999999999986553322 122211
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.... . ..+........+.+++..|++ ||++||+++++++ ||||....+.
T Consensus 224 ~~~~-~-------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~----h~~~~~~~~~ 272 (330)
T cd05601 224 FQRF-L-------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC----HPFFSKIDWN 272 (330)
T ss_pred CCCc-c-------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC----CCCcCCCCHH
Confidence 1110 0 001111122346678888998 9999999988877 9999875443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=340.83 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=205.9
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999654444445567788999999888 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQRQR-----------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99999887542 389999999999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc---hhHHHHHHHHHhcCCcchh
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH---TCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 928 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....++..........
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 220 (327)
T cd05617 147 LGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--- 220 (327)
T ss_pred cCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---
Confidence 2211 122346799999999999999999999999999999999999999964321 1122233333322211
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH--HHHHHhcCCCCCCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM--VLQILLNNPIFPTEKN 982 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e--v~~~L~~~~~~~~~~~ 982 (1014)
.+. ......+.+++.+|++.||++|+++.+ -++.+.+||||....+
T Consensus 221 ----~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 221 ----RIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ----CCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 011 111234568889999999999998531 1233445999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.59 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=201.5
Q ss_pred ceeccCCcEEEEEeeec---CCCeEEEEEEecccch-hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 693 NVIGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRK-LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
+.||+|+||.||++... .+++.||+|++..... ........+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 4678999999854322 1223456678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++|+|.+++...+ .+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 82 LSGGELFMHLEREG-----------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred CCCchHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999987642 367888889999999999999965 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..... .........
T Consensus 148 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~---~~~~~~~~~--- 218 (323)
T cd05584 148 KESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI---DKILKGKLN--- 218 (323)
T ss_pred eecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCC---
Confidence 7543211 1223457899999999999888999999999999999999999999876543221 112211111
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~ 981 (1014)
+. ......+.+++.+|++.||++|| +++++++ ||||....
T Consensus 219 -----~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~----h~~~~~~~ 263 (323)
T cd05584 219 -----LP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS----HPFFRHVN 263 (323)
T ss_pred -----CC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc----CCCcCCCC
Confidence 11 11123567889999999999999 7666666 99997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.89 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=201.1
Q ss_pred CCCCCceeccCCcEEEEEeeecC-CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC---CCCccceEEEEEE-----c
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIVKLLCCIS-----S 758 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~-----~ 758 (1014)
+|+..+.||+|+||+||+|.+.. +++.||+|++..... .......+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 68889999999999999998854 468899998854322 122234566777777665 6999999999885 3
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
....++|+||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 147 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCC
Confidence 456899999996 69999987642 23478999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||+|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+..
T Consensus 148 ~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 148 QIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred CEEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 9999999999765332 123356789999999999888999999999999999999999999987665443333322
Q ss_pred HHhcCCcchhcccc-------ccC--Ccc-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 919 HIQEGKPIVDALDK-------EID--EPC-----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~-------~~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...... .+.... .+. ... .......+.+++.+|++.||++|||+.|+++ ||||
T Consensus 224 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~----hp~f 290 (290)
T cd07862 224 VIGLPG--EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS----HPYF 290 (290)
T ss_pred HhCCCC--hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc----CCCC
Confidence 211100 000000 000 000 0112234568999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=342.62 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=204.1
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHH-HHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ-ILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
++||+|+||.||+|.+..+++.||+|++.............+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999985433333344455666654 57889999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++... ..+++..+..++.||+.||+|||.. +|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRE-----------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999888654 2377888899999999999999965 9999999999999999999999999998753
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....+ ... ....
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~-~~~~------ 213 (321)
T cd05603 147 VEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD---NIL-HKPL------ 213 (321)
T ss_pred CCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH---HHh-cCCC------
Confidence 2211 12234578999999999999899999999999999999999999998765432222 111 1110
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+. ......+.+++.+|++.||.+||++.+-+..+.+|+||....+
T Consensus 214 -~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 214 -QLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -CCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 011 1122356788999999999999988755566777999976443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.11 Aligned_cols=277 Identities=22% Similarity=0.293 Sum_probs=217.7
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+++++.++|++++++.+++..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999999999999999998544333334456678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++.... ...+++..+..++.|++.||.|||.. +|+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 82 MNGGDLKFHIYNMG---------NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred ccCccHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999887542 23489999999999999999999955 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
....... ......|+..|+|||++.+..++.++|+||+||++|||++|..||...........+...+.....
T Consensus 150 ~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--- 222 (285)
T cd05632 150 VKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--- 222 (285)
T ss_pred eecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc---
Confidence 7643211 123457899999999999889999999999999999999999999876543333333222222211
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCCCccccccc
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMV-LQILLNNPIFPTEKNGGRKYDHVTP 992 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev-~~~L~~~~~~~~~~~~~~~~~~~~~ 992 (1014)
.. .......+.+++..|++.||++||++.|. .+.+..|+||......+....+.+|
T Consensus 223 ----~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05632 223 ----VY----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279 (285)
T ss_pred ----cc----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCC
Confidence 01 11122346788899999999999995543 5555669999987655433334443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=350.96 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=205.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||||++.............+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 58889999999999999999999999999999854333334456778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 82 YIPGGDMMSLLIRLG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred CCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999997642 378888899999999999999965 999999999999999999999999999
Q ss_pred ccccccccC----------------------------------------ccccccccccCcccccccccccCCCCCcCcc
Q 001778 848 AKILIKEEG----------------------------------------EFAAMSTVVGSCGYIAPEYARTRKVNEKTDI 887 (1014)
Q Consensus 848 a~~~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv 887 (1014)
|..+..... .........||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 853311000 0001123479999999999999999999999
Q ss_pred hhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCC---CH
Q 001778 888 YSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP---NM 964 (1014)
Q Consensus 888 wSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~ 964 (1014)
||+||++|||++|+.||.+........ ........ ...+........+.+++.+|+ .+|.+|+ ++
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~---~i~~~~~~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQL---KVINWETT--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHH---HHhccCcc--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 999999999999999998765432211 11111100 000111111233455666665 4999999 88
Q ss_pred HHHHHHHhcCCCCCCC
Q 001778 965 RMVLQILLNNPIFPTE 980 (1014)
Q Consensus 965 ~ev~~~L~~~~~~~~~ 980 (1014)
.|+++ ||||...
T Consensus 296 ~ell~----h~~~~~~ 307 (376)
T cd05598 296 DEIKA----HPFFKGI 307 (376)
T ss_pred HHHhC----CCCcCCC
Confidence 88877 9999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.55 Aligned_cols=241 Identities=29% Similarity=0.443 Sum_probs=200.2
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
+...+-||.|+.|.||+|+.. ++.||||+++. .-..+|+-|++++||||+.|.|+|.....+|+||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 455678999999999999764 68899998721 123467889999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
|..|-|..+++..+ +++-.....|..+||.||.|||.+ .|||||||.-||||+.+..|||+|||.+
T Consensus 194 Ca~GqL~~VLka~~-----------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR-----------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred cccccHHHHHhccC-----------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence 99999999998763 477788889999999999999966 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
+..... ..+....||..|||||++...++++|+||||||||||||+||..||...+... .+| -.+..
T Consensus 260 ~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---IIw---GVGsN--- 326 (904)
T KOG4721|consen 260 KELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---IIW---GVGSN--- 326 (904)
T ss_pred Hhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eEE---eccCC---
Confidence 876442 23346899999999999999999999999999999999999999997544211 111 11111
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
.+..+.+..++.-+.-++..||+.-|..||++.+++..|.
T Consensus 327 ----sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 327 ----SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ----cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 2233455666677778899999999999999999998653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.35 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=209.2
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..++||+|+||.||++.+..+++.||+|.+...........+.+.+|+.+++.++|++++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678899999999999999999999999998544333344456678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 82 ~~g~~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 82 MNGGDLKFHIYHMG---------EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred cCCCcHHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999986532 23488999999999999999999965 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
....... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||....................
T Consensus 150 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---- 221 (285)
T cd05630 150 VHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---- 221 (285)
T ss_pred eecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----
Confidence 7643211 12245789999999999998999999999999999999999999986543221111111111100
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHHHhcCCCCCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~L~~~~~~~~~~ 981 (1014)
.... ......+.+++..||+.||++||| ++|+++ ||||....
T Consensus 222 ---~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~----h~~~~~~~ 268 (285)
T cd05630 222 ---EEYS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE----HPLFKQIN 268 (285)
T ss_pred ---hhcC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc----ChhhhccC
Confidence 0111 112234678899999999999999 778887 99998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.50 Aligned_cols=265 Identities=22% Similarity=0.254 Sum_probs=207.6
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999999999999998543333344456688999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 122 ~Ey~~gg~L~~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 122 MEYMPGGDLVNLMSNY------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred EcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999998653 267788889999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccC----CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR----KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
|++....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.... ......
T Consensus 187 G~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~ 261 (371)
T cd05622 187 GTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMN 261 (371)
T ss_pred CceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---HHHHHc
Confidence 9998654321 1122356799999999998754 378899999999999999999999987654322 122221
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHHhcCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTE--RPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.... .. .+........+.+++..|++.+|.+ ||+++|+++ |+||+...+
T Consensus 262 ~~~~-~~-------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~----h~~~~~~~~ 312 (371)
T cd05622 262 HKNS-LT-------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR----HLFFKNDQW 312 (371)
T ss_pred CCCc-cc-------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc----CcccCCCCh
Confidence 1111 00 0111122334567888899844443 778888877 999988554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.61 Aligned_cols=268 Identities=24% Similarity=0.379 Sum_probs=206.2
Q ss_pred CCCCCCceeccCCcEEEEEeee-----cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPI-----NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~ 760 (1014)
++|+..+.||+|+||.||+|.+ ..++..||||++... ......+.+.+|+.++..+ +||||+++++++..++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--cCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4688899999999999999874 345668999998432 2234456789999999999 8999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCC-----------------------------------------------------
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLS----------------------------------------------------- 787 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------- 787 (1014)
..++||||+++|+|.++++........
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999999764321000
Q ss_pred -----------CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccC
Q 001778 788 -----------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856 (1014)
Q Consensus 788 -----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 856 (1014)
.......++|..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 001123588999999999999999999965 999999999999999999999999999986543221
Q ss_pred ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccccccC
Q 001778 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEID 935 (1014)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1014)
........++..|+|||++.+..++.++|||||||++|||++ |..||....... .....+..+... ..
T Consensus 270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~---~~---- 338 (375)
T cd05104 270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRM---LS---- 338 (375)
T ss_pred -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccC---CC----
Confidence 112223445678999999999999999999999999999998 888887543221 112222222110 00
Q ss_pred CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 936 EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
......++.+++..||+.||++||+++|+++.|++
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01112467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=343.87 Aligned_cols=266 Identities=20% Similarity=0.227 Sum_probs=204.5
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
..+|+..+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 356999999999999999999999999999999752 23467899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+|++. ++|..++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 162 ~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR-----------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EecCC-CCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence 99995 68888886542 378999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCch----hHHHHHHHHHh
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT----CLAQWAWRHIQ 921 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~----~~~~~~~~~~~ 921 (1014)
|+|....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .....+.....
T Consensus 227 G~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred Cccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 9997532211 11223467999999999999989999999999999999999999887543210 00111111110
Q ss_pred -cCCcchh-----------cc---------ccccCC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 922 -EGKPIVD-----------AL---------DKEIDE--PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 922 -~~~~~~~-----------~~---------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.+....+ .. .+.... ........++.+++.+||+.||++|||++|+++ ||||.
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~----hp~f~ 380 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD----FAAFQ 380 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc----Chhhc
Confidence 0000000 00 000000 011123446788999999999999999999998 99998
Q ss_pred CCC
Q 001778 979 TEK 981 (1014)
Q Consensus 979 ~~~ 981 (1014)
...
T Consensus 381 ~~~ 383 (391)
T PHA03212 381 DIP 383 (391)
T ss_pred cCC
Confidence 743
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=334.03 Aligned_cols=257 Identities=29% Similarity=0.403 Sum_probs=215.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..|...+.||+|+||.||-|.+..+.++||||++.-....+.....++..|+..+++++|||++.+-|||-.+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34777888999999999999999999999999996555555666788999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||- |+-.|++.-. .+++.+..+..|+.+++.||+||| |.+.||||||+.|||+++.|.||++|||
T Consensus 106 EYCl-GSAsDlleVh----------kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH----------KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred HHHh-ccHHHHHHHH----------hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecccc
Confidence 9994 6888887654 345888999999999999999999 5599999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
.|....+ ....+|||+|||||++. .+.|+-++||||+|+++.|+.-+++|....+- ....+.+.+..
T Consensus 172 SAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSALYHIAQNe 241 (948)
T KOG0577|consen 172 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNE 241 (948)
T ss_pred chhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHHHHHHHhcC
Confidence 9987654 34689999999999874 47899999999999999999999999876552 23333333333
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.| .+....+.+ .+..++..|+++-|.+|||.+++++ |+|...++
T Consensus 242 sP-------tLqs~eWS~---~F~~Fvd~CLqKipqeRptse~ll~----H~fv~R~R 285 (948)
T KOG0577|consen 242 SP-------TLQSNEWSD---YFRNFVDSCLQKIPQERPTSEELLK----HRFVLRER 285 (948)
T ss_pred CC-------CCCCchhHH---HHHHHHHHHHhhCcccCCcHHHHhh----cchhccCC
Confidence 33 333333444 4556777999999999999999888 99998765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=345.89 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=205.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC-----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~ 760 (1014)
++|+..+.||+|+||.||+|.+... ++.||+|++.... .......+.+|+.+++.+ +||||+++++++..++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4688899999999999999986443 3579999985432 233456788999999999 8999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCC------------------------------------------------------
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSL------------------------------------------------------ 786 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 786 (1014)
..++||||+++|+|.++++.......
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999875421100
Q ss_pred -----CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccc
Q 001778 787 -----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861 (1014)
Q Consensus 787 -----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 861 (1014)
........+++..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeec
Confidence 0001123588999999999999999999965 999999999999999999999999999976543211 1122
Q ss_pred cccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccH
Q 001778 862 STVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFL 940 (1014)
Q Consensus 862 ~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1014)
....++..|+|||++.+..++.++|||||||++|||++ |+.||........ .......+.. .....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~~~~~~----------~~~~~ 338 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMVKRGYQ----------MSRPD 338 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHHHcccC----------ccCCC
Confidence 23345678999999998899999999999999999997 9999976543221 1112221111 00001
Q ss_pred HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 941 EEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
....++.+++.+||+.||++||++.++++.|++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.03 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=216.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc-eEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL-KLLV 765 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-~~lV 765 (1014)
++|...+++|+|+||.++.++++..++.|++|.+.-.+. .....+...+|+.++++++|||||.+.+.|..++. .++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468889999999999999999999999999999865433 34445688999999999999999999999999888 8999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|+|++||++.+.+.+.+ ...++++.+..++.|++.|+.|||+. +|+|||||+.|||++++..|||+||
T Consensus 83 m~Y~eGg~l~~~i~~~k---------~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK---------GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred EeecCCCCHHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecch
Confidence 99999999999999863 34589999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+|+.+.+.. ......+||+.|++||++.+.+|..++||||+||++|||++-+++|.+.+-..+...+....
T Consensus 151 GlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----- 222 (426)
T KOG0589|consen 151 GLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----- 222 (426)
T ss_pred hhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----
Confidence 9999886643 23456899999999999999999999999999999999999999999877544433222211
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQI 970 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 970 (1014)
-.+.+.....++..++..|++.+|..||++.+++..
T Consensus 223 ---------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112233344556678889999999999999999984
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=342.00 Aligned_cols=257 Identities=25% Similarity=0.305 Sum_probs=205.6
Q ss_pred ceeccCCcEEEEEeee---cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcc
Q 001778 693 NVIGSGGSGKVYRVPI---NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
+.||+|+||.||++.+ ..+++.||+|++.... ........+.+|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999876 3568899999985432 12234456788999999999999999999999999999999999
Q ss_pred cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 81 RGGDLFTRLSKE-----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred CCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence 999999998654 2488999999999999999999965 99999999999999999999999999997
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+....... .......
T Consensus 147 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---i~~~~~~---- 216 (318)
T cd05582 147 ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLG---- 216 (318)
T ss_pred ccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH---HHcCCCC----
Confidence 653321 122345789999999999988899999999999999999999999987654322221 1111111
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCCC
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEKN 982 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~~ 982 (1014)
+. ......+.+++..||+.||++||++.+ .++.+.+||||....+
T Consensus 217 ----~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 217 ----MP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred ----CC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 10 111234668899999999999999766 4666777999987543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.02 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=206.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||+|+++++++.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57788999999999999999999999999999954333344456778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 82 FLPGGDMMTLLMKKD-----------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CCCCccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999997642 378899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCc--------------------------------cccccccccCcccccccccccCCCCCcCcchhHHHHHH
Q 001778 848 AKILIKEEGE--------------------------------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILL 895 (1014)
Q Consensus 848 a~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ 895 (1014)
+......... ........||+.|+|||++.+..++.++||||+||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 00011357999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHHh
Q 001778 896 ELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN---MRMVLQILL 972 (1014)
Q Consensus 896 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~~L~ 972 (1014)
||++|+.||.+........ ......... ...+.. + . ..++.+++.+|+ .||.+|++ +.|+.+
T Consensus 228 el~tG~~Pf~~~~~~~~~~---~i~~~~~~~--~~p~~~--~-~---s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--- 292 (360)
T cd05627 228 EMLIGYPPFCSETPQETYR---KVMNWKETL--VFPPEV--P-I---SEKAKDLILRFC-TDSENRIGSNGVEEIKS--- 292 (360)
T ss_pred ecccCCCCCCCCCHHHHHH---HHHcCCCce--ecCCCC--C-C---CHHHHHHHHHhc-cChhhcCCCCCHHHHhc---
Confidence 9999999998765432221 111111100 001110 1 1 123455666665 49999996 555555
Q ss_pred cCCCCCCCCCC
Q 001778 973 NNPIFPTEKNG 983 (1014)
Q Consensus 973 ~~~~~~~~~~~ 983 (1014)
||||+...+.
T Consensus 293 -hp~f~~~~~~ 302 (360)
T cd05627 293 -HPFFEGVDWG 302 (360)
T ss_pred -CCCCCCCCHH
Confidence 9999986544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.12 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=228.8
Q ss_pred ccccccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEE
Q 001778 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCIS 757 (1014)
Q Consensus 678 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 757 (1014)
-...+..+..=|...+.||+|.|+.|-.|++..+|+.||||++.+. ..+......+.+|+..|+.++|||||++|++..
T Consensus 9 g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKT-KlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 9 GHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKT-KLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred ccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccc-ccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 3445667777899999999999999999999999999999999553 345667788999999999999999999999999
Q ss_pred cCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee-cC
Q 001778 758 SENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL-DY 836 (1014)
Q Consensus 758 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll-~~ 836 (1014)
....+|+|+|.-++|+|.+|+.+. +..+.+.-..+++.||+.|+.|+|+. .+||||+||+||.+ .+
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKH----------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEK 154 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKH----------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEK 154 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhh----------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeee
Confidence 999999999999999999999875 34488899999999999999999977 89999999999976 56
Q ss_pred CCcEEEeecccccccccccCccccccccccCcccccccccccCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 837 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
-|-||+.|||++-.+.+. .+....+|+..|-|||++.+..|+ +++||||+|||+|-+.+|+.||+..++.
T Consensus 155 lGlVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----- 225 (864)
T KOG4717|consen 155 LGLVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----- 225 (864)
T ss_pred cCceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----
Confidence 688999999999877653 245678999999999999998887 6899999999999999999999865542
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+.+..++|..+.. +.....++.++|..|+..||++|.+.+||+. ++|.+.....
T Consensus 226 --------ETLTmImDCKYtv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s----~~Wlq~~D~~ 279 (864)
T KOG4717|consen 226 --------ETLTMIMDCKYTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVS----TSWLQAGDRG 279 (864)
T ss_pred --------hhhhhhhcccccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhc----cccccCCCCC
Confidence 1234445555433 3455567889999999999999999887777 9999986544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=341.60 Aligned_cols=256 Identities=25% Similarity=0.297 Sum_probs=200.0
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC---CCCccceEEEEEEcCCceEEEEEcccC
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
||+|+||+||+|++..+++.||||++.............+..|..++... +||||+++++++..+...|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998543333333444556677776655 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 81 g~L~~~l~~~~-----------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKEG-----------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99999987642 378999999999999999999965 9999999999999999999999999998754
Q ss_pred ccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDAL 930 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1014)
.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..... ..+..+..
T Consensus 147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~----- 214 (330)
T cd05586 147 LTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY----RNIAFGKV----- 214 (330)
T ss_pred CCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH----HHHHcCCC-----
Confidence 3211 122346799999999998754 5889999999999999999999999876543221 12221111
Q ss_pred ccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 931 DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.+.... ....+.+++.+||+.||++||++.+.++.+.+||||....
T Consensus 215 --~~~~~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 215 --RFPKNV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --CCCCcc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 011111 1234567889999999999997666566666799998644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=326.52 Aligned_cols=267 Identities=26% Similarity=0.445 Sum_probs=211.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCC-----eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA-----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
++|+..+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 35788899999999999999876554 67999998432 233446678999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~ 836 (1014)
.+++|||+++|+|.+++.......... ......+++.....++.|++.||+|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 999999999999999998653211100 01124588999999999999999999965 9999999999999999
Q ss_pred CCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHH
Q 001778 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQW 915 (1014)
Q Consensus 837 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~ 915 (1014)
++.++|+|||++....... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccc-cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999998654322 1122334566889999999998899999999999999999998 9999987654433322
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+..+.. .........++.+++.+||+.||++||++.||++.|++
T Consensus 239 ----i~~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222211 01112334567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.09 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=218.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.++..++||-|.||+||.|.|+...-.||||.++. +....++|..|..+|+.++|||+|+++|+|..+...|+|+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45667889999999999999999999999999843 45678999999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
||..|+|.+|+++..+ ..++-...+.|+.||+.||+||... ++||||+.++|+|+.++..|||+|||+
T Consensus 344 fM~yGNLLdYLRecnr---------~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR---------SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred cccCccHHHHHHHhch---------hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999998743 3366677889999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++.+.. +.+.......-++.|.|||-+....++.++|||+|||++||+.| |..||.+-+. .++
T Consensus 412 sRlMtg--DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqV---------- 475 (1157)
T KOG4278|consen 412 SRLMTG--DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQV---------- 475 (1157)
T ss_pred hhhhcC--CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHH----------
Confidence 998854 23334444555789999999999999999999999999999997 7778887653 233
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.++.+++.+.+..++..++++|+.||++.|.+||+++|+-+.++.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 33444455566667778889999999999999999999999877755
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.11 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=208.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh--hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL--DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
++|+..+.||+|++|.||+|.+..+++.||+|.+...... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999999889999999998543221 22345678999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|
T Consensus 82 v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999987642 378888999999999999999966 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
||++.................++..|+|||++.+..++.++||||+|+++|||++|+.||...+..... ........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~ 224 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPT 224 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhccCC
Confidence 999976543221111113456788999999999988999999999999999999999999765432211 11111111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. . .........+.+++..||+.||++|||+.|+++ ||||
T Consensus 225 ~------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~----~~~~ 263 (263)
T cd06625 225 N------P----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR----HFFV 263 (263)
T ss_pred C------C----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh----CCCC
Confidence 0 0 111122335678899999999999999999998 9987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=323.95 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=204.1
Q ss_pred CCCCCCceeccCCcEEEEEeeec---CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
.+|+..+.||+|+||.||+|.+. ..+..||+|.+... ......+.+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 35788899999999999999765 34568999998543 22344577899999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++
T Consensus 83 lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~ 149 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE----------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS 149 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEEC
Confidence 9999999999999997642 2488999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||.+....... ........++..|+|||++.+..++.++|||||||++||+++ |+.||........... +..
T Consensus 150 dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~ 223 (266)
T cd05064 150 GFRRLQEDKSEA--IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----VED 223 (266)
T ss_pred CCcccccccccc--hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HHC
Confidence 999876532211 111123345678999999999999999999999999999775 9999987654432222 222
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.. .+........+.+++..||+.+|++||+++++.+.|.+
T Consensus 224 ~~~----------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 224 GFR----------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCC----------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 211 01112233457788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=303.61 Aligned_cols=268 Identities=26% Similarity=0.305 Sum_probs=217.0
Q ss_pred cccccCCCCCCC-ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc
Q 001778 681 RDSDILPKLTES-NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 681 ~~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 758 (1014)
.+-.+.++|++. ++||-|-.|+|-.|.++.+++.+|+|++ ......++|++..-.. .|||||.++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL--------~Ds~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL--------LDSPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHH--------hcCHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 344455666653 6799999999999999999999999998 3345567788876555 79999999998864
Q ss_pred ----CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 001778 759 ----ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 759 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll 834 (1014)
...+.+|||.|+||.|.+.++..+ +..+++.++-+|+.||+.|+.|||.. +|+|||+||+|+|.
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g---------~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLy 194 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRG---------DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLY 194 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcc---------cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheee
Confidence 456789999999999999999864 45699999999999999999999955 99999999999999
Q ss_pred cC---CCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 835 DY---NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 835 ~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
+. +..+|++|||+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+.....
T Consensus 195 t~t~~na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 195 TTTSPNAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred ecCCCCcceEecccccccccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 64 45799999999986432 234556788999999999999999999999999999999999999999876533
Q ss_pred HHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+.-=++..+..+.. .+..+.+........++|+.+++.+|.+|.|+.|++. |||+.+.++-
T Consensus 271 ispgMk~rI~~gqy-------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~----hpwi~~~~~v 331 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQY-------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD----HPWINQYEAV 331 (400)
T ss_pred CChhHHhHhhccCc-------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc----CchhcccccC
Confidence 22222333322221 2334556666667779999999999999999999998 9999987754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.66 Aligned_cols=268 Identities=27% Similarity=0.317 Sum_probs=205.3
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC---
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--- 760 (1014)
...++|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc-ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4567899999999999999999999999999999998432 223345667889999999999999999999986543
Q ss_pred ---ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 761 ---LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 761 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
..++||||+++ ++.+.++.. +++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~ 159 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHME-------------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD 159 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhcc-------------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC
Confidence 46999999975 666665432 67888999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus 160 ~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~ 235 (359)
T cd07876 160 CTLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235 (359)
T ss_pred CCEEEecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999754321 12234578999999999999999999999999999999999999998765432211111
Q ss_pred HHHhcCCcchhcc-----------c--cccCC----------------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 001778 918 RHIQEGKPIVDAL-----------D--KEIDE----------------PCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968 (1014)
Q Consensus 918 ~~~~~~~~~~~~~-----------~--~~~~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 968 (1014)
.. .+.+..+.. . +.... .........+.+++.+|++.||++|||++|++
T Consensus 236 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 236 EQ--LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred Hh--cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 11 111100000 0 00000 00001123567899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 001778 969 QILLNNPIFPT 979 (1014)
Q Consensus 969 ~~L~~~~~~~~ 979 (1014)
+ |||+..
T Consensus 314 ~----hp~~~~ 320 (359)
T cd07876 314 R----HPYITV 320 (359)
T ss_pred c----Cchhhh
Confidence 8 999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=345.44 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=209.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEE-Ec------C
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCI-SS------E 759 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~-~~------~ 759 (1014)
++++.++|.+|||+.||.|++...+..||+|++... ++.....+.+||++|+.++ |+|||.+++.. .. .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456788999999999999999988899999998543 5677888999999999996 99999999932 11 2
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
.+++|.||||++|.|-+++.... ...|++.++++|++|+++|+++||.. .++|||||||-+|||++.++.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl---------q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL---------QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH---------hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCC
Confidence 46789999999999999998752 23499999999999999999999987 888999999999999999999
Q ss_pred EEEeecccccccccccCcc------ccccccccCccccccccc---ccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCch
Q 001778 840 AKIADFGVAKILIKEEGEF------AAMSTVVGSCGYIAPEYA---RTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT 910 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~------~~~~~~~gt~~y~aPE~l---~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~ 910 (1014)
.||||||.|.-........ ...-....|+.|+|||.+ .+...++|+|||++||+||-|+....||+....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~- 263 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK- 263 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence 9999999996543221110 011235689999999976 467889999999999999999999999976431
Q ss_pred hHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 911 CLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
..++...+..+-+......+..||+.||++||.+||++.+|+..+
T Consensus 264 ----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 264 ----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 344555555555667777888999999999999999999988776
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=348.31 Aligned_cols=268 Identities=25% Similarity=0.329 Sum_probs=200.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------ 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------ 759 (1014)
..+|+..++||+|+||.||+|.+..+++.||||++..+ .....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 35688999999999999999999999999999988432 12335799999999999999999876432
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
...++||||+++ ++.+++.... .....+++..+..++.|++.||+|||.. +|+||||||+||+++.+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYA-------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPN 206 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHh-------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCC
Confidence 246789999985 7877775431 1224588999999999999999999965 99999999999999866
Q ss_pred C-cEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 838 F-NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 838 ~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
+ .+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+.........
T Consensus 207 ~~~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 282 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282 (440)
T ss_pred CCceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 5 79999999998654322 1224578999999998865 4689999999999999999999999987654332222
Q ss_pred HHHHHhcCCcchhccc-----------cccC-----CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 916 AWRHIQEGKPIVDALD-----------KEID-----EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~-----------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
+.... +.+..+.+. +... .........++.+++.+||++||.+|||+.|+++ ||||..
T Consensus 283 i~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~----hp~f~~ 356 (440)
T PTZ00036 283 IIQVL--GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA----DPFFDD 356 (440)
T ss_pred HHHHh--CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC----ChhHHh
Confidence 22111 111111000 0000 0001112346789999999999999999999988 999986
Q ss_pred CC
Q 001778 980 EK 981 (1014)
Q Consensus 980 ~~ 981 (1014)
..
T Consensus 357 ~~ 358 (440)
T PTZ00036 357 LR 358 (440)
T ss_pred hh
Confidence 44
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.37 Aligned_cols=265 Identities=22% Similarity=0.243 Sum_probs=205.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..++|++|+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 67888999999999999999999999999999854333334445668899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 y~~~g~L~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 82 YYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred ccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999997632 2478889999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... .......
T Consensus 149 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~~~ 223 (332)
T cd05623 149 CLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNH 223 (332)
T ss_pred heecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH---HHHHhCC
Confidence 875433211 1223457999999999986 34678999999999999999999999987653322 2222221
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHHhcCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTE--RPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.... .+. .........+.+++.+|+..+|++ |++++|+++ ||||....
T Consensus 224 ~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~----h~~f~~~~ 273 (332)
T cd05623 224 KERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ----HPFFTGID 273 (332)
T ss_pred Cccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC----CCCcCCCC
Confidence 1110 000 001112334566777877654444 789888887 99998744
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.34 Aligned_cols=269 Identities=24% Similarity=0.358 Sum_probs=210.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..++..||+|.+..+ ........+.+|+++++.++||||+++++++..++..++|+|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 578889999999999999999999999999998432 223345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.++++..+ .+++..+..++.|+++||+|||+. .+++|+||||+||+++.++.+||+|||+
T Consensus 80 y~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 80 HMDGGSLDQVLKKAG-----------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred ccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCC
Confidence 999999999997642 378899999999999999999952 3899999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc--
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP-- 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 925 (1014)
+...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+......+..........
T Consensus 147 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 147 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred ccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 8754321 123457889999999998888999999999999999999999999765433222221111000000
Q ss_pred -----------------chhcc-------ccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 926 -----------------IVDAL-------DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 -----------------~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
..+.. .+..... ....++.+++.+||+.||++||++.|+++ ||||...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~----~~~~~~~~ 294 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTK----HPFIKRAE 294 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhc----Chhhhhcc
Confidence 00000 0000000 12235778999999999999999999998 99998754
Q ss_pred CC
Q 001778 982 NG 983 (1014)
Q Consensus 982 ~~ 983 (1014)
..
T Consensus 295 ~~ 296 (308)
T cd06615 295 LE 296 (308)
T ss_pred cc
Confidence 44
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.23 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=212.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|+..+.||+|+||.||+|.+..+++.||||.+.............+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999999999999999885444445556678899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 82 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-------QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EecCCCcHHHHHHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 99999999998865321 123478889999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+....... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... ...+.........+
T Consensus 152 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~- 226 (267)
T cd08228 152 LGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQCDYP- 226 (267)
T ss_pred cceeccchh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcCCCC-
Confidence 988754322 1223456889999999999888999999999999999999999999755422 12222211111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
. .........+.+++.+||+.||++||++.+|++.+++.
T Consensus 227 ------~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ------P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 01122335677899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.21 Aligned_cols=272 Identities=25% Similarity=0.358 Sum_probs=217.0
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+...+|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 445568999999999999999999998899999999984322 23356788999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++||||+++++|.+++... .+++.++..++.|++.|++|||.. +|+||||||+||+++.++.+||
T Consensus 93 ~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl 157 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157 (296)
T ss_pred EEeecccCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 9999999999999998653 368889999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||.+....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+... +.......
T Consensus 158 ~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~~~ 231 (296)
T cd06654 158 TDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATN 231 (296)
T ss_pred Cccccchhccccc---cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHhcC
Confidence 9999987653322 11234578899999999998889999999999999999999999997655321 11111111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcccccccccc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKYDHVTPLLT 995 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1014)
+.+ .. .........+.+++.+||++||++||++.|+++ |||+..... ..+.+|..+
T Consensus 232 ~~~-------~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~----~~~~~~~~~----~~~~~~~~~ 287 (296)
T cd06654 232 GTP-------EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ----HQFLKIAKP----LSSLTPLIA 287 (296)
T ss_pred CCC-------CC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh----ChhhhccCC----ccccHHHHH
Confidence 111 00 111122345678899999999999999999998 999987543 334555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.29 Aligned_cols=252 Identities=35% Similarity=0.519 Sum_probs=196.4
Q ss_pred CCceeccCCcEEEEEeeec----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 691 ESNVIGSGGSGKVYRVPIN----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 691 ~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..+.||.|+||.||+|.+. ..+..|+||.+.. .......+.+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 3567999999999999988 4467899999933 234445789999999999999999999999999888899999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.++++.. ....+++..+.+|+.||+.||+|||+. +++|+||+++||++++++.+||+|||
T Consensus 81 e~~~~g~L~~~L~~~---------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~ 148 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK---------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFG 148 (259)
T ss_dssp E--TTEBHHHHHHHT---------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTT
T ss_pred ccccccccccccccc---------ccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 999999999999885 124589999999999999999999966 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++...... ..........+...|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+.++..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~----~~~~~~~ 223 (259)
T PF07714_consen 149 LSRPISEK-SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE----KLKQGQR 223 (259)
T ss_dssp TGEETTTS-SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH----HHHTTEE
T ss_pred cccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc
Confidence 99876321 12223344567889999999999899999999999999999999 678887664433222 2222221
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
.+........+.+++..||+.||++||++.++++.|
T Consensus 224 ----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112234577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=354.67 Aligned_cols=272 Identities=25% Similarity=0.283 Sum_probs=208.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|++..+........+++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999999999999999986543334455678999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.................++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753221111111223467888999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCc---------------cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 847 VAKILIKEEGE---------------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 847 la~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
++......... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866211100 011123579999999999999999999999999999999999999997644321
Q ss_pred HHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHHHhc
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-MRMVLQILLN 973 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~~L~~ 973 (1014)
.... ....... ......+....+.+++.+|++.||++||+ ++++.+.|+.
T Consensus 239 i~~~--~~i~~P~----------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR--DVILSPI----------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh--hhccChh----------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 0000000 00001122345678899999999999975 5556666654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.82 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=209.7
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
-+||+|.||+||.|++..+....|||.+.. ...+..+.+..|+.+.+.++|.|||+++|++.+++..-+.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE---KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc---ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 379999999999999999999999999833 34556678899999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec-CCCcEEEeeccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD-YNFNAKIADFGVAKIL 851 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~ 851 (1014)
+|.++++.+.++- .=.+.+.-.+..||++||.|||+. .|||||||-+|||++ ..|.+||+|||.++++
T Consensus 658 SLSsLLrskWGPl--------KDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPL--------KDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred cHHHHHHhccCCC--------ccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh
Confidence 9999998864311 114566777899999999999977 999999999999995 6789999999999887
Q ss_pred ccccCccccccccccCcccccccccccC--CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
.. -.....+..||..|||||++..+ .|+.++|||||||++.||.||++||..-......-+ ...+-+
T Consensus 727 Ag---inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-kVGmyK------- 795 (1226)
T KOG4279|consen 727 AG---INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-KVGMYK------- 795 (1226)
T ss_pred cc---CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-hhccee-------
Confidence 43 23345578899999999999864 688999999999999999999999975543322111 111111
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
...+.+++...+...+|.+|+.+||.+||++.++++ +||++..
T Consensus 796 ----vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~----DpFlq~~ 838 (1226)
T KOG4279|consen 796 ----VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ----DPFLQHN 838 (1226)
T ss_pred ----cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc----CcccccC
Confidence 112345666677888999999999999999999988 9998876
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.85 Aligned_cols=267 Identities=22% Similarity=0.241 Sum_probs=205.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||+||++.+..+++.||+|++...........+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999999999999999985433334445667889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred ecCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999997531 2478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
++........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ......
T Consensus 148 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---~~~i~~ 222 (331)
T cd05597 148 SCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMN 222 (331)
T ss_pred ceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH---HHHHHc
Confidence 9876543211 11223568999999999863 4578899999999999999999999987653222 122221
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCC--CCCCHHHHHHHHhcCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPT--ERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.... .. +... .......+.+++.+|+..+++ .||++.++++ ||||....+
T Consensus 223 ~~~~-~~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~----hp~~~~~~~ 274 (331)
T cd05597 223 HKEH-FQ-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD----HPFFEGIDW 274 (331)
T ss_pred CCCc-cc-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc----CCCCCCCCH
Confidence 1111 00 0000 011223445666676654443 4889888888 999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=347.90 Aligned_cols=264 Identities=25% Similarity=0.302 Sum_probs=209.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN----- 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----- 760 (1014)
..+|+..+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..++|+|++++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc-CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 458999999999999999999999999999999985432 23455677889999999999999999988765432
Q ss_pred ---ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 761 ---LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 761 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
.+++||||+++|+|.++++.... ....+++..+..++.|++.||+|||.. +|+||||||+||+++.+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-------~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-------TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN 179 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC
Confidence 36899999999999999976421 234588999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... +.
T Consensus 180 ~~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~---~~ 255 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---MH 255 (496)
T ss_pred CCEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HH
Confidence 9999999999986543211 1122356799999999999999999999999999999999999999987653322 22
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
........ +.......++.+++..||+.||++||++.++++ |||++.
T Consensus 256 ~~~~~~~~-----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~----~p~~~~ 302 (496)
T PTZ00283 256 KTLAGRYD-----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN----MPICKL 302 (496)
T ss_pred HHhcCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh----CHHHHH
Confidence 22211110 011122345778899999999999999999987 776654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=308.88 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=215.3
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|.++++||+|+||.||++.++.+|++||+|.+..+ ...+++..|+.+|++.+.|+||++||.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 66788999999999999999999999999998432 3467889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
|..|+..+.++.. ++++.+.++..+++..+.||+|||.. .-+|||||+.|||++.+|.+|++|||.|
T Consensus 110 CGAGSiSDI~R~R----------~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 110 CGAGSISDIMRAR----------RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred cCCCcHHHHHHHh----------cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcccc
Confidence 9999999999864 45799999999999999999999987 7899999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
-.+. ..-.+.....||+.|||||++..-.|..++||||+|++..||..|++||..-..-. .+.. +..
T Consensus 177 GQLT---DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIFM----IPT 243 (502)
T KOG0574|consen 177 GQLT---DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIFM----IPT 243 (502)
T ss_pred chhh---hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeEe----ccC
Confidence 7653 33455678899999999999999999999999999999999999999997533210 0000 000
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.-.+.++ .++....++-++++.|+-+.|++|-|+.++++ |||++..+
T Consensus 244 ~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~----H~FiknA~ 290 (502)
T KOG0574|consen 244 KPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE----HTFIKNAP 290 (502)
T ss_pred CCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh----hhhhcCCC
Confidence 0011121 23444556778999999999999999999888 99998865
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.54 Aligned_cols=272 Identities=20% Similarity=0.291 Sum_probs=208.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|...+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc--cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56888999999999999999999999999999984322 2233456778999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++ ++.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 84 e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 149 (309)
T cd07872 84 EYLDK-DLKQYMDDCG----------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG 149 (309)
T ss_pred eCCCC-CHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 99975 8888876542 2478889999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++....... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.........
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (309)
T cd07872 150 LARAKSVPT---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226 (309)
T ss_pred cceecCCCc---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 997543221 12234567899999998865 46889999999999999999999999876654333332222111100
Q ss_pred -----------chhccccccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 926 -----------IVDALDKEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 -----------~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
....-.+.... ........++.+++.+|++.||.+|||++|+++ ||||+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~----h~~~~~~~ 293 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK----HAYFRSLG 293 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc----Chhhhhcc
Confidence 00000000000 000112335678999999999999999999998 99998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=347.64 Aligned_cols=259 Identities=22% Similarity=0.261 Sum_probs=206.6
Q ss_pred CCCCCceeccCCcEEEEEeeecCC-CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT-AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.|...+.||+|+||.||+|....+ ++.||+|.+..+ .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 378889999999999999988777 778899976332 3344567788999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.++++... .....+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+|||
T Consensus 145 E~~~gg~L~~~l~~~~-------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRL-------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred ECCCCCCHHHHHHHHH-------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence 9999999999886531 1223578899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+++...... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+........ ........
T Consensus 215 la~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---~~~~~~~~- 289 (478)
T PTZ00267 215 FSKQYSDSV-SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---QVLYGKYD- 289 (478)
T ss_pred CceecCCcc-ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCC-
Confidence 998754321 1112335579999999999999999999999999999999999999998765432222 11111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
+........+.+++..||+.||++||++++++. |+|++
T Consensus 290 ----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~----~~~~~ 327 (478)
T PTZ00267 290 ----------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH----TEFLK 327 (478)
T ss_pred ----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh----CHHHH
Confidence 001112245778899999999999999999986 55543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.32 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=205.6
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..+.||+|+||.||+|.+..+++.||+|++..+ ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 467778899999999999999999999999998432 2335678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ...+++..+..++.|+++|++|||.. +++||||||+||++++++.+||+|||.
T Consensus 83 ~~~~~~L~~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 83 FMTYGNLLDYLRECN---------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred eCCCCcHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcc
Confidence 999999999987642 23488999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..... .....+..
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~----~~~~~~~~- 223 (263)
T cd05052 151 SRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----ELLEKGYR- 223 (263)
T ss_pred ccccccce--eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHCCCC-
Confidence 98654321 111222344678999999998899999999999999999998 88999765543222 12221111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.........++.+++.+||+.||++||++.++.+.|+.
T Consensus 224 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 ---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 01111223467789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.40 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=214.3
Q ss_pred CCCCceeccCCcEEEEEeeecCCCe----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
....++||+|+||+||+|.|...++ +||+|++.. ....+..+++.+|+.+|.+++|||+++++++|.... ..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~--~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE--FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec--cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4567899999999999999988876 488888843 345566789999999999999999999999998776 789
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|++||+.|+|.++++..+ ..+.....+.|.+|||+||.|||+. ++|||||.++||||.....+||.|
T Consensus 775 vtq~mP~G~LlDyvr~hr----------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitd 841 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR----------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITD 841 (1177)
T ss_pred HHHhcccchHHHHHHHhh----------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEe
Confidence 999999999999998853 4588889999999999999999966 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||+|+...+++.++.. ....-.+.|||-|.+....|+.++|||||||++||++| |..|+++....++.
T Consensus 842 fgla~ll~~d~~ey~~-~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~---------- 910 (1177)
T KOG1025|consen 842 FGLAKLLAPDEKEYSA-PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP---------- 910 (1177)
T ss_pred cchhhccCcccccccc-cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------
Confidence 9999988776554433 34455789999999999999999999999999999997 88999886644332
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.++.+-+.+.+.-+...++.++.+||-.|++.||+++++...+.+
T Consensus 911 ----dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 911 ----DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ----HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2333333445566667788889999999999999999998887754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.47 Aligned_cols=267 Identities=26% Similarity=0.413 Sum_probs=209.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
.+|...+.||+|+||.||+|.+.. +++.||||++... ......+.+.+|+++++.++||||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 457788999999999999998743 3578999998432 223346789999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCC---CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSG---RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
.++||||+++|+|.+++...+...... ......+++..+..++.|++.|++|||.. +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999998753211100 12334589999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||++....... .........+++.|+|||++.+..++.++||||+||++|||++ |..||...........+.
T Consensus 160 ~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCc-ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999997653321 1111223456789999999999999999999999999999998 999997665543333222
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.. . .........+.+++.+||+.||++||++.||++.|++
T Consensus 239 ----~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGRL-L---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111 0 0011223457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.14 Aligned_cols=268 Identities=26% Similarity=0.317 Sum_probs=200.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC---CCCccceEEEEEEc-----C
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIVKLLCCISS-----E 759 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~-----~ 759 (1014)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 47788999999999999999999999999999854221 122233456677776665 79999999998764 3
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
...++|+||+++ +|.+++.... ...+++..+..++.|++.||.|||.. +|+||||||+||+++.++.
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVP---------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 457999999984 8988887642 23478999999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
+||+|||++....... ......||..|+|||++.+..++.++||||+||++|||++|++||...........+...
T Consensus 147 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 147 VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 9999999998653321 123456899999999999889999999999999999999999999876544332222222
Q ss_pred HhcCCc--chh-------ccccccC---CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 920 IQEGKP--IVD-------ALDKEID---EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 920 ~~~~~~--~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...... ... ...+... .....+....+.+++.+|+++||++|||+.|++. ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~----hp~f 288 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ----HPFF 288 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc----CCCC
Confidence 111000 000 0000000 0001122345678999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.35 Aligned_cols=268 Identities=25% Similarity=0.294 Sum_probs=206.2
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC----
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE---- 759 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~---- 759 (1014)
...++|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc-ccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 3457899999999999999999999999999999998542 22334456788999999999999999999987543
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
...|+||||+++ ++.+++... +++..+..++.|++.||+|||.. +|+||||||+||+++.+
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 162 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQME-------------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD 162 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHhc-------------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCC
Confidence 357999999975 777776532 67888999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+.+||+|||+++..... .......||..|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.
T Consensus 163 ~~~kL~DfG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 163 CTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred CcEEEEeCCCccccCCC----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999764321 12234578999999999999999999999999999999999999998765433222221
Q ss_pred HHHhcCCcchhc-------------------------cccccC----CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 001778 918 RHIQEGKPIVDA-------------------------LDKEID----EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968 (1014)
Q Consensus 918 ~~~~~~~~~~~~-------------------------~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 968 (1014)
... +.+..+. ..+... ..........+.+++.+|++.||.+|||+.|++
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 239 EQL--GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred Hhc--CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 111 1100000 000000 000011123567899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 001778 969 QILLNNPIFPT 979 (1014)
Q Consensus 969 ~~L~~~~~~~~ 979 (1014)
+ ||||..
T Consensus 317 ~----hp~~~~ 323 (364)
T cd07875 317 Q----HPYINV 323 (364)
T ss_pred c----Cccccc
Confidence 8 999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.04 Aligned_cols=269 Identities=24% Similarity=0.359 Sum_probs=207.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCC-----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHT-----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSE 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~ 759 (1014)
..+|++.+.||+|+||.||+|.+... +..||||++... ......+.+.+|+.+++.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45688899999999999999986432 346999998432 23344578999999999995 99999999999999
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCC----------------------------------------------------
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLS---------------------------------------------------- 787 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------- 787 (1014)
+..++||||+++|+|.++++........
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999998764211000
Q ss_pred ---------------------------------CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 001778 788 ---------------------------------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 788 ---------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll 834 (1014)
.......+++..+..++.|++.|++|||.. +|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 000123488999999999999999999965 99999999999999
Q ss_pred cCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHH
Q 001778 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLA 913 (1014)
Q Consensus 835 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~ 913 (1014)
+.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--- 346 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--- 346 (400)
T ss_pred eCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence 9999999999999986543221 122234457789999999998899999999999999999997 88998754321
Q ss_pred HHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.........+... +........+.+++.+||+.||++||++.++.++|++
T Consensus 347 ~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 347 STFYNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1112222222110 1111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=334.15 Aligned_cols=269 Identities=25% Similarity=0.290 Sum_probs=205.1
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
..++|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc-ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 456899999999999999999999989999999998432 22334456788999999999999999999988643
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
...++||||+++ ++.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~-------------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~ 156 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME-------------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc-------------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCC
Confidence 346999999975 677666432 78888999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||+|||+++..... .......||..|+|||++.+..++.++||||+||++|+|++|+.||.+.+..........
T Consensus 157 ~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 157 TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CEEEeeCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999764321 122345789999999999998999999999999999999999999987653322211111
Q ss_pred HHhcCCc---------chhccc---------------cc-c--CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 919 HIQEGKP---------IVDALD---------------KE-I--DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 919 ~~~~~~~---------~~~~~~---------------~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
......+ ....++ .. . ...........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~-- 310 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ-- 310 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc--
Confidence 1100000 000000 00 0 00001112245678999999999999999999998
Q ss_pred hcCCCCCC
Q 001778 972 LNNPIFPT 979 (1014)
Q Consensus 972 ~~~~~~~~ 979 (1014)
||||..
T Consensus 311 --hp~~~~ 316 (355)
T cd07874 311 --HPYINV 316 (355)
T ss_pred --Ccchhc
Confidence 999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.21 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=215.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCC---eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTA---EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+++..+.||+|.||.|++|.|...+ ..||||.+..+.. ....++|.+|+.+|.+++|||++++||...+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--chhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 4556788999999999999997643 3599999965432 2267999999999999999999999999987 66789
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+|.++.|+|.+.+++. ....|-......++.|||.||.||. ++++||||+..+|+++-....|||+|
T Consensus 188 V~ELaplGSLldrLrka---------~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA---------KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred HhhhcccchHHHHHhhc---------cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeec
Confidence 99999999999999883 2345788889999999999999999 55999999999999999988999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||+.+-+...++.+.......-...|+|||.+....++.++|||+|||++|||+| |+.||.+.....+.
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL---------- 325 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL---------- 325 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------
Confidence 9999999887777666666777899999999999999999999999999999998 66799887644332
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
+.+|.+-..+....+...+++++..||...|++|||+..+.+.+
T Consensus 326 ----~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 326 ----KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22333333455567778899999999999999999999997544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=321.94 Aligned_cols=259 Identities=32% Similarity=0.444 Sum_probs=207.0
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|+||+||++.+..+++.||+|++..... .........+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 4567899999999999999999999999999955432 222233445699999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++... ..+++..+..++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+
T Consensus 80 ~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-----------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp ETTEBHHHHHHHH-----------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccc-----------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999843 2479999999999999999999976 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
.... ..........++..|+|||++. +..++.++||||+|+++|+|++|..||.................... .
T Consensus 146 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~ 220 (260)
T PF00069_consen 146 VKLS---ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL--P 220 (260)
T ss_dssp EEST---STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH--H
T ss_pred cccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc--c
Confidence 7541 1122344677899999999998 88899999999999999999999999987632222222222221100 0
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. ... ......++.+++..||+.||++||++.++++ ||||
T Consensus 221 ~~----~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~----~~~~ 260 (260)
T PF00069_consen 221 SS----SQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK----HPWF 260 (260)
T ss_dssp HH----TTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT----SGGG
T ss_pred cc----ccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc----CCCC
Confidence 00 000 0001157888999999999999999999998 9997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.67 Aligned_cols=267 Identities=21% Similarity=0.231 Sum_probs=206.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||+||++++..+++.||+|++.............+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999999999999999985433334445566889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 Ey~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred eCCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999997632 2478889999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.... ......
T Consensus 148 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~~ 222 (331)
T cd05624 148 SCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMN 222 (331)
T ss_pred ceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHHHHc
Confidence 9976543221 12234579999999999875 4678899999999999999999999987653322 222221
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHHhcCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTE--RPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..... .+.. .......++.+++.+|+..++++ |++++++.+ ||||+...+
T Consensus 223 ~~~~~--~~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~----h~~f~~~~~ 274 (331)
T cd05624 223 HEERF--QFPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK----HAFFEGIDW 274 (331)
T ss_pred CCCcc--cCCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc----CCCcCCCCH
Confidence 11110 0011 11112345667888888866554 457766665 999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=338.10 Aligned_cols=270 Identities=22% Similarity=0.250 Sum_probs=206.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeec--CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPIN--HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
..+|...+.||+|+||.||+|... .+++.||+|.+... ....+|+.+++.++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 346889999999999999998754 34578999987332 23467999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+. ++|.+++... ..+++..++.++.|++.||+|||.. +|+||||||+|||++.++.++|+
T Consensus 163 lv~e~~~-~~l~~~l~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS-----------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred EEehhcC-CCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence 9999996 6888888443 2489999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|||++........ ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+................-
T Consensus 228 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 228 DFGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred cCccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 9999976543221 112234679999999999999999999999999999999999999997654332222222221110
Q ss_pred Cc-chhc--------------cccccCCccc-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KP-IVDA--------------LDKEIDEPCF-------LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~-~~~~--------------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.. ..+. .......+.. .....++.+++.+|+..||++|||+.|++. ||||...+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~----~p~f~~~~ 382 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS----LPLFTKEP 382 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh----Cchhhccc
Confidence 00 0000 0000000000 011235668899999999999999999999 99998766
Q ss_pred CC
Q 001778 982 NG 983 (1014)
Q Consensus 982 ~~ 983 (1014)
+.
T Consensus 383 ~~ 384 (392)
T PHA03207 383 IN 384 (392)
T ss_pred hh
Confidence 55
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.51 Aligned_cols=276 Identities=23% Similarity=0.254 Sum_probs=227.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|...++||+|.||+|-.|+-+.+++.+|+|+++++....+.....-..|-++++..+||.+..+-..|+..+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 46778899999999999999999999999999988777777778888999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|..||.|.-++... ..+++.....+-..|..||.|||. .+||+||+|.+|.|+|+||++||.|||+
T Consensus 249 yanGGeLf~HLsre-----------r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 249 YANGGELFFHLSRE-----------RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred EccCceEeeehhhh-----------hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeeccc
Confidence 99999999888765 348888888889999999999995 5999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
++.-.. ........+|||.|.|||++....|+.++|.|.+||++|||++|+.||...+.+.+.+.+. .+.-.
T Consensus 315 CKE~I~---~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---~ed~k-- 386 (516)
T KOG0690|consen 315 CKEEIK---YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---MEDLK-- 386 (516)
T ss_pred chhccc---ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---hhhcc--
Confidence 975432 2235668999999999999999999999999999999999999999999887664443322 11111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCCcccccccccc
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM-RMVLQILLNNPIFPTEKNGGRKYDHVTPLLT 995 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1014)
++.....+...+....+.+||.+|... .+-.+++..|+||....|+....++..|++-
T Consensus 387 ----------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfK 445 (516)
T KOG0690|consen 387 ----------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFK 445 (516)
T ss_pred ----------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCC
Confidence 112222344567778999999999831 1122334449999999988777777776543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.08 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=209.5
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|++|.||+|.+..+++.|++|.+... .......+.+.+|+++++.++|||++++++++..++..++|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh-hCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 66778899999999999999999999999998432 22345677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++.... ...+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 81 AENGDLHKLLKMQR---------GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999998642 23488999999999999999999965 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
........ ......|++.|+|||+..+..++.++|+|||||++|+|++|+.||........... .. .+..
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~--- 218 (256)
T cd08529 149 KLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK---II-RGVF--- 218 (256)
T ss_pred eeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH-cCCC---
Confidence 86644221 12345688999999999998999999999999999999999999987664322221 11 1110
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+........+.+++.+||+.+|++||++.++++ |||+
T Consensus 219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~----~~~~ 256 (256)
T cd08529 219 -------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR----NPSL 256 (256)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh----CCCC
Confidence 0111123346788999999999999999999998 8874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=336.22 Aligned_cols=269 Identities=23% Similarity=0.281 Sum_probs=206.1
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----ceE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN-----LKL 763 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~ 763 (1014)
|+..+.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 67788999999999999999889999999998432 223344567889999999999999999999998776 789
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|+||+. ++|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+
T Consensus 81 lv~e~~~-~~l~~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEec
Confidence 9999997 5788877543 2488999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+++....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+.....
T Consensus 146 Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g- 222 (372)
T cd07853 146 DFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG- 222 (372)
T ss_pred cccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC-
Confidence 9999976533211 122345678999999998774 578999999999999999999999987654332222211110
Q ss_pred CCcchhcc------------ccccCCc-------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 923 GKPIVDAL------------DKEIDEP-------CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 923 ~~~~~~~~------------~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.+..+.+ ......+ .......++.+++.+|++.||++|||+.|+++ ||||...+
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~----hp~~~~~~ 295 (372)
T cd07853 223 -TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA----HPYLDEGR 295 (372)
T ss_pred -CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc----CHhhCCCc
Confidence 0000000 0000000 00112345778999999999999999999988 99998744
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.76 Aligned_cols=275 Identities=24% Similarity=0.388 Sum_probs=212.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
.++|++.+.||+|+||.||+|.++. .+..||+|.+... ........+.+|+.+++.++||||+++++++.++.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3578889999999999999987542 3457999987432 22334456889999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++||||+++|+|.+++........ ........++..+.+++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAE-NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 99999999999999999976432110 111224467888999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 919 (1014)
+++|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+......... .
T Consensus 159 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~---~ 234 (288)
T cd05061 159 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---V 234 (288)
T ss_pred EECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H
Confidence 9999999976543221 111223345778999999998899999999999999999998 7788876554332221 1
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc--CCCCCCCC
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN--NPIFPTEK 981 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~--~~~~~~~~ 981 (1014)
...+.. .........+.+++.+|++.||++||++.|+++.+++ ||+|....
T Consensus 235 ~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 235 MDGGYL-----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 111110 0011123467889999999999999999999999998 89988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=344.35 Aligned_cols=270 Identities=21% Similarity=0.214 Sum_probs=199.9
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC------CCccceEEEEEEcC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR------HLNIVKLLCCISSE 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpniv~l~~~~~~~ 759 (1014)
..+|++.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.++ |++++++++++..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 45789999999999999999999999999999998432 122344556777766664 45688999988764
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
+.+++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||.. .+|+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG-----------PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSD 269 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCC
Confidence 5788999988 678998887642 388999999999999999999951 3999999999999998765
Q ss_pred ----------------cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCC
Q 001778 839 ----------------NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE 902 (1014)
Q Consensus 839 ----------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~ 902 (1014)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 499999998864321 2235679999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHhcCC----------cchhcc------ccccCCc--------c-c--HHHHHHHHHHHhHccC
Q 001778 903 ANNGDEHTCLAQWAWRHIQEGK----------PIVDAL------DKEIDEP--------C-F--LEEMIRVFKLGVICTS 955 (1014)
Q Consensus 903 p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~--------~-~--~~~~~~l~~li~~cl~ 955 (1014)
||.+.+.......+........ ...+.. .+..... . . .-....+.+|+..||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 9987664332222211110000 000000 0000000 0 0 0012346799999999
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 956 MLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 956 ~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.||++|||++|+++ ||||......
T Consensus 424 ~dP~~R~ta~e~L~----Hp~~~~~~~~ 447 (467)
T PTZ00284 424 YDRQKRLNARQMTT----HPYVLKYYPE 447 (467)
T ss_pred cChhhCCCHHHHhc----CccccccCCc
Confidence 99999999999998 9999885443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.85 Aligned_cols=271 Identities=24% Similarity=0.324 Sum_probs=193.6
Q ss_pred CceeccCCcEEEEEeeecC--CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceEEEEE
Q 001778 692 SNVIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKLLVYE 767 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV~e 767 (1014)
.++||+|+||+||+|.+.. +++.||+|.+... .....+.+|+.+++.++||||+++++++.. +...++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4679999999999998653 5688999998432 123457789999999999999999998854 456789999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----cCCCcEEEe
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIA 843 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll----~~~~~~kl~ 843 (1014)
|++ ++|.+++........ ......+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKA--NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred ccC-CCHHHHHHhcccccc--cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 986 588888765322110 11223588999999999999999999965 99999999999999 456789999
Q ss_pred ecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH------HHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL------AQWA 916 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~------~~~~ 916 (1014)
|||+++................||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ....
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 99999876443222223345678999999999876 4588999999999999999999999975432100 0000
Q ss_pred HHHHh-cCCcchh------------ccccccC-----Ccc---cH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 001778 917 WRHIQ-EGKPIVD------------ALDKEID-----EPC---FL-----EEMIRVFKLGVICTSMLPTERPNMRMVLQI 970 (1014)
Q Consensus 917 ~~~~~-~~~~~~~------------~~~~~~~-----~~~---~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 970 (1014)
..... .+.+... ...+... ... .. .....+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~- 313 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ- 313 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc-
Confidence 00000 0000000 0000000 000 00 00124678999999999999999999998
Q ss_pred HhcCCCC
Q 001778 971 LLNNPIF 977 (1014)
Q Consensus 971 L~~~~~~ 977 (1014)
||||
T Consensus 314 ---hp~f 317 (317)
T cd07868 314 ---DPYF 317 (317)
T ss_pred ---CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=336.86 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=202.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.++++++|+||+++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346888899999999999999999999999999642 23356899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+. ++|.+++.... ..++|..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+||
T Consensus 239 ~e~~~-~~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DF 304 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL----------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDF 304 (461)
T ss_pred EEccC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEccc
Confidence 99995 68988886531 2489999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc----hhHHHHHHHHHh
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH----TCLAQWAWRHIQ 921 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~----~~~~~~~~~~~~ 921 (1014)
|+++....... ........||..|+|||++.+..++.++|||||||++|||++|..++..... ......+...+.
T Consensus 305 Gla~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 305 GAACFARGSWS-TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CCceecccccc-cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 99986533211 1112245799999999999999999999999999999999998876543211 111111222222
Q ss_pred cCCcchhccc--------------------cccCCcccH---HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 922 EGKPIVDALD--------------------KEIDEPCFL---EEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 922 ~~~~~~~~~~--------------------~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.......... +....+.+. .....+.+++.+||+.||.+|||+.|+++ ||||+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~----hp~f~ 459 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR----LPLFQ 459 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh----CcccC
Confidence 1110000000 000000011 11225678999999999999999999999 99996
Q ss_pred C
Q 001778 979 T 979 (1014)
Q Consensus 979 ~ 979 (1014)
.
T Consensus 460 ~ 460 (461)
T PHA03211 460 S 460 (461)
T ss_pred C
Confidence 4
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.91 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=203.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeE----EEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEV----VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+|+..+.||+|+||.||+|.+..+++. ||+|++.. .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc--cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3588889999999999999988766654 89999843 22344567789999999999999999999999765 46
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++|+|.+++.... ..+++...+.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl 150 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKI 150 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEE
Confidence 79999999999999998642 2478899999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....... ....
T Consensus 151 ~DfG~a~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~----~~~~ 225 (316)
T cd05108 151 TDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILE 225 (316)
T ss_pred ccccccccccCCCcce-eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHh
Confidence 9999998765422211 1223345678999999999999999999999999999998 99999765533322 2222
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.+... +........+.+++..||+.||++||++.+++..+.+.
T Consensus 226 ~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 226 KGERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22110 00111223567899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.88 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=199.3
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+++++.++||||+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3689999999999999989999999987432 23445678999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 79 ~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 79 DFLTFLRTEG----------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred cHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence 9999987532 2478999999999999999999965 99999999999999999999999999987543
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
... .........++..|+|||.+.+..++.++||||+|+++|||++ |..||......... ........
T Consensus 146 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~----~~~~~~~~------ 214 (252)
T cd05084 146 DGV-YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----EAIEQGVR------ 214 (252)
T ss_pred ccc-ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH----HHHHcCCC------
Confidence 211 1111112233567999999998889999999999999999998 88888654432221 11111111
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.........++.+++.+|++.||++||++.|+.++|+.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 215 ----LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 01111223467789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.56 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=215.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.+-+.+...||.|+||+||+|..+.++-..|.|++ ...+....+++.-||+|+...+||+||++++.|..++.+|++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI---etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI---ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhh---cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 33466777899999999999999988888888988 445667788999999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
.|||.||.+..++-..+ .+++..++.-+++|++.||.||| +..|||||+|+.|||++-+|.++++||
T Consensus 108 iEFC~GGAVDaimlEL~----------r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG----------RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred EeecCCchHhHHHHHhc----------cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecc
Confidence 99999999999887653 35899999999999999999999 459999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|.+... .....+.....|||+|||||+.+ +.+|+.++||||||+++.||..+.+|...-+. ...+..+.
T Consensus 175 GVSAKn---~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKia 248 (1187)
T KOG0579|consen 175 GVSAKN---KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIA 248 (1187)
T ss_pred cccccc---hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHh
Confidence 998643 23344566789999999999874 57899999999999999999999999875542 22222222
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
...+| .+- .+......+-+++..|+.+||..||+++++++ |||+.....
T Consensus 249 KSePP-------TLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~----Hpfv~~~~S 297 (1187)
T KOG0579|consen 249 KSEPP-------TLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK----HPFVQNAPS 297 (1187)
T ss_pred hcCCC-------ccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh----CcccccCCc
Confidence 22221 221 12333445667888999999999999999998 999996543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.42 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=206.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
.++|+..+.||+|+||.||+|.+.. .+..||+|++... .......++.+|+.+++.++||||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3568889999999999999987642 3567999988432 22344567899999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++||||+++|+|.+++...... .........+++..+..++.|++.|++|||+. +++|+||||+||++++++.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPE-MENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCcc-ccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999764321 11111223578899999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 919 (1014)
+|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+........ .
T Consensus 159 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~ 233 (277)
T cd05062 159 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----F 233 (277)
T ss_pred EECCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H
Confidence 9999999876543211 111223455788999999998899999999999999999999 688887655432222 1
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..++.. .. . .......+.+++.+|++.||++||++.|+++.|++
T Consensus 234 ~~~~~~-~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGL-LD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCc-CC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 112111 00 0 11123457789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=318.92 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=205.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..++||+|+||.||+|.+..+++.||+|.+..+ ........+.+|+.++++++||||+++++++..++..++|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 577788999999999999999999999999998432 233445679999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 80 FMDGGSLDVYR---------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred cCCCCChHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99999996542 257788889999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh----HHHHHHHHHhcC
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC----LAQWAWRHIQEG 923 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~----~~~~~~~~~~~~ 923 (1014)
+...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ............
T Consensus 142 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 216 (279)
T cd06619 142 STQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216 (279)
T ss_pred ceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC
Confidence 9765331 2234578999999999999899999999999999999999999997532211 011111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. +..... ....++.+++.+|++.||++||+++|+++ ||||......
T Consensus 217 ~-------~~~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~----~~~~~~~~~~ 262 (279)
T cd06619 217 P-------PVLPVG---QFSEKFVHFITQCMRKQPKERPAPENLMD----HPFIVQYNDG 262 (279)
T ss_pred C-------CCCCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhc----CcccccccCc
Confidence 0 111111 12235678899999999999999999998 9999776444
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=322.79 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=213.5
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+...+|+..+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC---ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 34456899999999999999999999889999999998432 223456788999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++||||+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|
T Consensus 92 ~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l 156 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKL 156 (297)
T ss_pred EEeecccCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999998653 368889999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||.+....... .......+++.|+|||.+.+..++.++|+|||||++|++++|+.||...+..... ......
T Consensus 157 ~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~ 230 (297)
T cd06656 157 TDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATN 230 (297)
T ss_pred CcCccceEccCCc---cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccC
Confidence 9999987653321 1123456889999999999888999999999999999999999999765432111 001111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
+.+ .. .........+.+++.+||+.||++||+++|+++ ||||...+...
T Consensus 231 ~~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~----~~~~~~~~~~~ 279 (297)
T cd06656 231 GTP-------EL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ----HPFLKLAKPLS 279 (297)
T ss_pred CCC-------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc----Cchhccccccc
Confidence 111 00 011122344668889999999999999999999 99999876553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.45 Aligned_cols=274 Identities=24% Similarity=0.366 Sum_probs=207.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecC----------------CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH----------------TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv 750 (1014)
++|+..+.||+|+||.||++.+.. ++..||+|++... ........+.+|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 468889999999999999985432 3456999998432 2344567899999999999999999
Q ss_pred eEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCC
Q 001778 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSS 830 (1014)
Q Consensus 751 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~ 830 (1014)
++++++..++..++||||+++|+|.+++................+++.....++.|++.|++|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999999875432222222334588999999999999999999965 9999999999
Q ss_pred CeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc--CCCCCCCCC
Q 001778 831 NILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT--GKEANNGDE 908 (1014)
Q Consensus 831 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt--g~~p~~~~~ 908 (1014)
||+++.++.++++|||++..+..... ........++..|+|||...+..++.++|||||||++|||++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999986543221 111223345678999999888889999999999999999998 677887554
Q ss_pred chhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
................. ....+........+.+++.+||+.||++||++.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGR-------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 33322221111111000 00001111223567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.32 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=203.3
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE---- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~---- 759 (1014)
..+.|+..+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 345688889999999999999999999999999998432 23456788999999998 799999999998653
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+|+|+||+||+++++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~ 147 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK---------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 147 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCC
Confidence 45799999999999999987632 23488999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.++|+|||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||........
T Consensus 148 ~~~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~ 224 (272)
T cd06637 148 AEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224 (272)
T ss_pred CCEEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 999999999997653211 2233567899999999986 34678899999999999999999999975443211
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
... ..... ....... .....+.+++.+||+.||.+|||++|+++ ||||
T Consensus 225 ~~~---~~~~~-------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~----~~~~ 272 (272)
T cd06637 225 LFL---IPRNP-------APRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK----HPFI 272 (272)
T ss_pred HHH---HhcCC-------CCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh----CCCC
Confidence 111 11110 0011111 12235678999999999999999999998 9997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=316.77 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=211.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|+..+.||+|+||.||+|.+..+++.||||.+............++.+|+.+++.++||||+++++++..++..++|+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999998899999999885544444556678999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||
T Consensus 82 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-------QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EecCCCCHHHHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 99999999999875321 224589999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.... ....... .....
T Consensus 152 ~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~-- 224 (267)
T cd08229 152 LGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-IEQCD-- 224 (267)
T ss_pred hhhccccCC---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhh-hhcCC--
Confidence 987654322 1123456889999999999888999999999999999999999999754322 1111111 11110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+... .......+.+++.+||+.||++|||+.+|++.+++
T Consensus 225 ----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 225 ----YPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred ----CCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 01111 11233467788999999999999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=320.63 Aligned_cols=274 Identities=26% Similarity=0.351 Sum_probs=209.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCC----------------eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA----------------EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv 750 (1014)
.+|+..+.||+|+||.||+|.+...+ ..||+|.+... ......+.+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 46888999999999999998776533 56899998543 2235567899999999999999999
Q ss_pred eEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCC
Q 001778 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSS 830 (1014)
Q Consensus 751 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~ 830 (1014)
++++++..++..++|+||+++++|.+++................+++..++.++.|++.||+|||+. +|+|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 9999999999999999999999999999875321111112233589999999999999999999965 9999999999
Q ss_pred CeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc--CCCCCCCCC
Q 001778 831 NILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT--GKEANNGDE 908 (1014)
Q Consensus 831 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt--g~~p~~~~~ 908 (1014)
||+++.++.++|+|||++....... .........++..|+|||++.+..++.++|||||||++|||++ +..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999997654322 1112234456789999999988889999999999999999998 667886654
Q ss_pred chhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
................. ....+.......++.+++..|++.||++|||+.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 43333222221111110 00001111223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.61 Aligned_cols=271 Identities=23% Similarity=0.265 Sum_probs=216.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788899999999999999998899999999965444334566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ...+++..+..++.|+++||+|||.. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~~~~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 82 YCPGGELFRLLQRQP---------GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred ecCCCCHHHHHHhCC---------CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 999999999987531 23588999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCcc--------------------------ccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCC
Q 001778 848 AKILIKEEGEF--------------------------AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901 (1014)
Q Consensus 848 a~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~ 901 (1014)
+.......... .......|+..|+|||++.+..++.++||||||+++|+|++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 87653221110 0112346889999999999888999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 902 EANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 902 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.||.+.+..... ......... .+........+.+++.+|+..||++||+.+..++.+.+||||....
T Consensus 230 ~pf~~~~~~~~~---~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 230 TPFKGSNRDETF---SNILKKEVT----------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCCCCCchHHHH---HHHhcCCcc----------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 999866543221 111111111 1111113456788999999999999999666666677799998755
Q ss_pred CC
Q 001778 982 NG 983 (1014)
Q Consensus 982 ~~ 983 (1014)
+.
T Consensus 297 ~~ 298 (316)
T cd05574 297 WA 298 (316)
T ss_pred hh
Confidence 44
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.28 Aligned_cols=271 Identities=24% Similarity=0.257 Sum_probs=211.4
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||+||+|.+..+++.||+|.+.............+.+|+++++.++||||+++++++...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998554333344456678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++.... ...+++..+..++.|++.|+.|||.. +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 81 KYHIYNVG---------EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred HHHHHHcC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99997642 13488999999999999999999965 9999999999999999999999999998765331
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEI 934 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1014)
.......++..|+|||++.+..++.++||||+||++|+|++|+.||...........+........ .
T Consensus 149 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~-- 215 (277)
T cd05577 149 ----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA-------V-- 215 (277)
T ss_pred ----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc-------c--
Confidence 122345678899999999888899999999999999999999999976554222221111111100 0
Q ss_pred CCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCCccccccc
Q 001778 935 DEPCFLEEMIRVFKLGVICTSMLPTERPNMRM-VLQILLNNPIFPTEKNGGRKYDHVTP 992 (1014)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~~~~~~~~~~~~~~~~~~~~ 992 (1014)
.........+.+++.+||+.||++||+.+| ..+.+..||||....+.+......+|
T Consensus 216 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~ 272 (277)
T cd05577 216 --EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272 (277)
T ss_pred --cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCC
Confidence 011112345678899999999999996666 56666669999876655444433333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=313.91 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=200.8
Q ss_pred ceeccCCcEEEEEeeecCCC---eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcc
Q 001778 693 NVIGSGGSGKVYRVPINHTA---EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
+.||+|+||.||+|.+...+ ..||+|.+...... ...+.+.+|+.+++.+.||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876554 78999998543322 456789999999999999999999998764 4679999999
Q ss_pred cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
++|+|.+++.... .+++..+..++.|++.|++|||.. +++|+||||+||+++.++.+||+|||.++
T Consensus 78 ~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~ 143 (257)
T cd05060 78 PLGPLLKYLKKRR-----------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR 143 (257)
T ss_pred CCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccc
Confidence 9999999997642 478999999999999999999965 99999999999999999999999999998
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
................++..|+|||.+.+..++.++|||||||++|||++ |..||...+......+ .......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~----~~~~~~~-- 217 (257)
T cd05060 144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM----LESGERL-- 217 (257)
T ss_pred eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HHcCCcC--
Confidence 76543322222222334568999999998899999999999999999998 9999976554333222 2222210
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNP 975 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~ 975 (1014)
+........+.+++.+||+.||++||++.++++.|++++
T Consensus 218 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011112346778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=328.29 Aligned_cols=268 Identities=25% Similarity=0.327 Sum_probs=204.9
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
+.++|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch-hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 346799999999999999999999999999999998432 22233456678999999999999999999887543
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ------------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence 4568999988 77998887542 388999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||++..... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus 156 ~~kl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 156 ELRILDFGLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred CEEEcCCccceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999999986432 1234578999999999876 568899999999999999999999998765432222221
Q ss_pred HHHhcCCcchhcccc-----------cc---CCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 918 RHIQEGKPIVDALDK-----------EI---DEP----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~-----------~~---~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
... +.+..+.... .+ ... ........+.+++.+|++.||++|||+.|+++ ||||..
T Consensus 230 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~----hp~~~~ 303 (343)
T cd07878 230 EVV--GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA----HPYFSQ 303 (343)
T ss_pred HHh--CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc----Ccchhc
Confidence 111 1110110000 00 000 00011124678999999999999999999998 999987
Q ss_pred CC
Q 001778 980 EK 981 (1014)
Q Consensus 980 ~~ 981 (1014)
..
T Consensus 304 ~~ 305 (343)
T cd07878 304 YH 305 (343)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.23 Aligned_cols=269 Identities=25% Similarity=0.271 Sum_probs=214.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.||+|++...........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 57888999999999999999999999999999855444444566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 82 YVPGGELFSHLRKS-----------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999998764 2478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...... ....+..
T Consensus 148 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-- 215 (290)
T cd05580 148 AKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KILEGKV-- 215 (290)
T ss_pred ccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCc--
Confidence 9865432 224568899999999988888999999999999999999999998665322111 1111111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCcccccc
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-NMRMVLQILLNNPIFPTEKNGGRKYDHVT 991 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~~~~~~~~~~~~~~~~~~~ 991 (1014)
.+ .......+.+++.+||+.||.+|| ++.+.++.|.+||||....+..-......
T Consensus 216 -----~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 271 (290)
T cd05580 216 -----RF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271 (290)
T ss_pred -----cC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCC
Confidence 01 111134567889999999999999 22223444445999988665543333333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=325.73 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=202.4
Q ss_pred CCceeccC--CcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 691 ESNVIGSG--GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 691 ~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
..++||+| +|++||++.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 35679999 789999999999999999999844322 233456788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+
T Consensus 81 ~~~~~l~~~~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 81 MAYGSAKDLICTHF---------MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred cCCCcHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999987532 12378999999999999999999965 9999999999999999999999999876
Q ss_pred cccccccCcc----ccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 849 KILIKEEGEF----AAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 849 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
.......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~ 225 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNG 225 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcC
Confidence 4432211110 01123456788999999876 4688999999999999999999999975432211 1111110
Q ss_pred CCcc-----------------hhcccccc-----------------CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 001778 923 GKPI-----------------VDALDKEI-----------------DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968 (1014)
Q Consensus 923 ~~~~-----------------~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 968 (1014)
..+. ....+... ..+........+.+++.+||+.||++|||++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 0000 00000000 0011112234677899999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 001778 969 QILLNNPIFPTE 980 (1014)
Q Consensus 969 ~~L~~~~~~~~~ 980 (1014)
+ ||||++.
T Consensus 306 ~----~p~f~~~ 313 (327)
T cd08227 306 N----HSFFKQI 313 (327)
T ss_pred c----Chhhhhc
Confidence 8 9999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.44 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=198.8
Q ss_pred eeccCCcEEEEEeee--cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 694 VIGSGGSGKVYRVPI--NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
.||+|+||+||+|.+ ..+++.||+|++... .......+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 456788999998533 2334556789999999999999999999998864 467899999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 80 ~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 80 GPLNKFLQKNK-----------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 99999986542 378999999999999999999965 9999999999999999999999999999876
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhcc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDAL 930 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1014)
..............++..|+|||.+....++.++|||||||++|||++ |..||.........+. +..+.. .
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----i~~~~~-~--- 217 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM----IESGER-M--- 217 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCCCC-C---
Confidence 443222222223345679999999988889999999999999999998 9999976554322222 222211 0
Q ss_pred ccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 931 DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.. ......++.+++..||+.||++||++++|++.|++.
T Consensus 218 --~~----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 --EC----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CC----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01 112234577899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=321.94 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=208.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC-----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~ 760 (1014)
.+|+..+.||+|+||.||++.+... ...||+|.+... ........+.+|++++..+ +||||+++++++..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4577888999999999999987643 378999998543 2234456789999999999 8999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~ 835 (1014)
..++||||+++|+|.++++......... ......+++..+++++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999997643211111 12234689999999999999999999965 999999999999999
Q ss_pred CCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHH
Q 001778 836 YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQ 914 (1014)
Q Consensus 836 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~ 914 (1014)
+++.+|++|||.++...... .........++..|+|||++.+..++.++|||||||++||+++ |..||.........+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHID-YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCcccccccccccc-ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999998764322 1112223345678999999998899999999999999999997 888987655333222
Q ss_pred HHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. ...+.. ..........+.+++.+|++.||++|||+.|+++.|++
T Consensus 246 ~----~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 246 L----LKEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred H----HHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1 222111 01111223467789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.21 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=206.1
Q ss_pred CCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+|+..+.||+|+||.||+|.+.. ....||+|.+... ........+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 46778899999999999998653 2356889987432 2234457789999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCC-------------CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCC
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLS-------------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKS 829 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~ 829 (1014)
++|+||+++|+|.+++......... .......+++..++.++.|++.|++|||+. +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 9999999999999998764221100 011223589999999999999999999965 999999999
Q ss_pred CCeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC
Q 001778 830 SNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDE 908 (1014)
Q Consensus 830 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~ 908 (1014)
+||++++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccc-hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999976543221 112233456778999999988889999999999999999998 999997665
Q ss_pred chhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.....+ ....+.. .+.......++.+++..||+.||++||+++|+++.|++
T Consensus 235 ~~~~~~----~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 235 PERLFN----LLKTGYR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HHHHHH----HHhCCCC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 433322 2222111 01111223457789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=315.26 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=206.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC---CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
++|+..+.||+|+||.||+|.+... ...||||.+... ........+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4578889999999999999988654 457999988432 23445677899999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++++
T Consensus 82 iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~ 148 (266)
T cd05033 82 IITEYMENGSLDKFLREND----------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS 148 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEEC
Confidence 9999999999999997642 2488999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||++.......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ..
T Consensus 149 dfg~~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~ 223 (266)
T cd05033 149 DFGLSRRLEDSEATY-TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV----ED 223 (266)
T ss_pred ccchhhcccccccce-eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH----Hc
Confidence 999998765222211 1123345678999999998899999999999999999998 99999765543322222 11
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+... +........+.+++.+||+.||++||++.|+++.|++
T Consensus 224 ~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 224 GYRL----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 0111223457789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=319.42 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=207.6
Q ss_pred CCCCCCceeccCCcEEEEEeeec-----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
.+|...+.||+|+||+||++.+. .++..||+|.+.. ........+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35778899999999999999752 3456799998843 233456779999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCC--CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSL--SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
.++|+||+++++|.+++...+.... ........+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999999976532111 0111223589999999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 918 (1014)
+||+|||++....... .........++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 159 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~--- 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--- 234 (288)
T ss_pred EEeccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 9999999998654321 1122233446788999999998899999999999999999998 8889876654332221
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
...+... . ... .....+.+++.+||+.||.+|||+.|+.+.|++.
T Consensus 235 -i~~~~~~-~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 -ITQGRVL-Q-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred -HHcCCcC-C-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2222110 0 011 1123578899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.97 Aligned_cols=267 Identities=28% Similarity=0.387 Sum_probs=200.6
Q ss_pred CCCCceeccCCcEEEEEee----ecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--Cce
Q 001778 689 LTESNVIGSGGSGKVYRVP----INHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLK 762 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 762 (1014)
|+..+.||+|+||+||++. ...+++.||+|.+... ........+.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc--cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3788999999999998754 3346778999998442 2234567788999999999999999999988653 457
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++||||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|
T Consensus 84 ~lv~e~~~~~~l~~~~~~~------------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH------------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred EEEecCCCCCCHHHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEE
Confidence 8999999999999998653 389999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh--HHHHHHHHH
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC--LAQWAWRHI 920 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~ 920 (1014)
+|||++.................++..|+|||.+.+..++.++||||||+++|||++|..||....... ........
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~- 227 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ- 227 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc-
Confidence 999999866432221111223345678999999988889999999999999999999999986533210 00000000
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.......+.++.....+.......++.+++..||+.||++|||++++++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 00001111111111111222334568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=318.51 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=206.4
Q ss_pred CCCCCCceeccCCcEEEEEeeec----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
..|+..+.||+|+||.||+|.+. ..+..||+|.+... ........+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 34677889999999999999853 35578999998532 2334457789999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCC------CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSG------RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~ 836 (1014)
++||||+++|+|.+++.......... ......+++.+...++.|++.||+|||+. +++||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 99999999999999986543211110 01123578999999999999999999965 9999999999999999
Q ss_pred CCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHH
Q 001778 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQW 915 (1014)
Q Consensus 837 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~ 915 (1014)
++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~- 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE- 237 (283)
T ss_pred CCcEEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence 999999999999876432211 12234456778999999988889999999999999999998 888987655332222
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
........ +.......++.+++.+||+.||++||++.++.+.|.+
T Consensus 238 ---~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22221110 0111223456788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.52 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=201.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccc--hhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDR--KLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKL 763 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~ 763 (1014)
+|+..+.||+|+||.||+|.+..++..||+|++.... ....+....+.+|+.+++.++||||+++++++.. +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5788999999999999999999999999999885322 1223445678999999999999999999998865 35678
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+++||+++++|.+++.... .+++.....++.|++.||+|||.. +|+||||||+||+++.++.+||+
T Consensus 83 l~~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-----------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 9999999999999997642 378889999999999999999955 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|||++.................++..|+|||++.+..++.++||||+||++|||++|+.||...+.. ..+.......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~ 225 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQP 225 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCC
Confidence 9999976532111111222356889999999999888999999999999999999999999765322 1111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
. .+.+ .......+.+++ .||..||++||+++|+++ ||||+
T Consensus 226 ~------~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~----hp~~~ 265 (266)
T cd06651 226 T------NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR----HPFAQ 265 (266)
T ss_pred C------CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc----Ccccc
Confidence 1 1111 111122334454 688899999999999988 99985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=320.70 Aligned_cols=270 Identities=24% Similarity=0.313 Sum_probs=203.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 3677889999999999999999899999999984321 222334678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++ ++|.+++.... ....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 80 ~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 80 FLS-MDLKKYLDSLP--------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred cCC-CCHHHHHhcCC--------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 997 68988886532 123588999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC---
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG--- 923 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 923 (1014)
+....... .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.................
T Consensus 148 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 148 ARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred eeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 97653221 12233467889999998865 457889999999999999999999998755322111111110000
Q ss_pred -----Cc---chhccccccC---CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 -----KP---IVDALDKEID---EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 -----~~---~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. .......... .........++.+++.+||+.||++|||+.++++ ||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~----~~~~ 285 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN----HPYF 285 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc----CCCC
Confidence 00 0000000000 0000112345678999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=318.79 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=209.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.++++++||||+++++++..++..++|+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 578889999999999999999989999999988432 233445778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ....+++..+..++.+++.|+.|||+. .+|+|+||||+||+++.++.+||+|||.
T Consensus 80 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 80 YMDAGSLDKLYAGGV--------ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred ecCCCCHHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999887631 123589999999999999999999952 3899999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccC------CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTR------KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+...... ......++..|+|||++.+. .++.++||||+||++|+|++|+.||.................
T Consensus 150 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 224 (286)
T cd06622 150 SGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224 (286)
T ss_pred cccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence 8765321 12234678899999998654 347899999999999999999999976543322222221111
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+.+ . ........++.+++.+||+.||++||++++++. ||||...+..
T Consensus 225 -~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~----~~~~~~~~~~ 271 (286)
T cd06622 225 -GDP------P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE----HPWLVKYKNA 271 (286)
T ss_pred -cCC------C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc----ChhhhhccCC
Confidence 111 0 111223445678899999999999999998887 9999876644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.99 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=207.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-CCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-ENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lV~ 766 (1014)
.|+..+.||+|++|.||++.+..+++.||+|.+..+ .......+.+.+|++++++++|+|++++++.+.. +...++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR-NASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh-hcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 377889999999999999999988999999998432 2234456678999999999999999999998764 44678999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++.... ...+++.++..++.+++.|+++||+. +++|+||||+||+++.++.++|+|||
T Consensus 80 e~~~~~~l~~~l~~~~---------~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 80 GFCEGGDLYHKLKEQK---------GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred cccCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence 9999999999997632 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+.. ........ +..
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~-~~~- 219 (257)
T cd08223 148 IARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRIIE-GKL- 219 (257)
T ss_pred ceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHh-cCC-
Confidence 997654322 1223456889999999999999999999999999999999999999765532 22222221 111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
+ ........++.+++.+|++.||++||++.++++ ||||
T Consensus 220 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~----~~~~ 257 (257)
T cd08223 220 -----P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR----QPYI 257 (257)
T ss_pred -----C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc----CCCC
Confidence 0 011223346778999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.67 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=212.1
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
...+|+..+.||.|++|.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 345688899999999999999999999999999998432 22345678899999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+||+++++|.+++... .+++.++..++.|++.|++|||.. +++||||||+||+++.++.+||+|
T Consensus 94 v~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~d 158 (296)
T cd06655 94 VMEYLAGGSLTDVVTET------------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTD 158 (296)
T ss_pred EEEecCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999988653 378999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....... ......
T Consensus 159 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~~~~ 232 (296)
T cd06655 159 FGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGT 232 (296)
T ss_pred Cccchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCC
Confidence 999876543221 12345688999999999988899999999999999999999999987654322211 111111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
+. +. ........+.+++.+||..||++||++.+++. ||||.....
T Consensus 233 ~~-------~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~----~~~~~~~~~ 277 (296)
T cd06655 233 PE-------LQ--NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ----HPFLKLAKP 277 (296)
T ss_pred cc-------cC--CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh----ChHhhhccc
Confidence 10 00 11122235678899999999999999999998 999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.79 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=200.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.++. +..+|+|.+... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HcEEeeEecCCcCceEEEEEecc-CceEEEEecccC----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 46677889999999999998764 457999987432 2234678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 80 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 80 FMENGCLLNYLRQRQ----------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred cCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCC
Confidence 999999999987531 2378999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||...........+ ..+...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~~~~ 220 (256)
T cd05114 147 TRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRGFRL 220 (256)
T ss_pred ccccCCCc--eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCCC
Confidence 97653321 111223345678999999988889999999999999999999 88999776543333222 111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
..+. .....+.+++.+||+.||++||+++|+++.|
T Consensus 221 ---~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 ---YRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.50 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=197.5
Q ss_pred eccCCcEEEEEeeec--CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 695 IGSGGSGKVYRVPIN--HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
||+|+||.||+|.+. ..+..||+|++... ......+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 899999999999765 44567999998443 234455779999999999999999999998864 4679999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++.... ..+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 80 ~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 80 PLNKFLSGKK----------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred CHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 9999987532 2488999999999999999999965 99999999999999999999999999997654
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.............++..|+|||.+....++.++|||||||++||+++ |..||......... ..+..+..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~------ 216 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM----SFIEQGKR------ 216 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHHHCCCC------
Confidence 33222222222334678999999988889999999999999999996 99999766543222 22222221
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.+.......++.+++.+||+.||++||++.+|.+.|+..
T Consensus 217 ----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011122335677899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=330.58 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=196.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|+... .....|+.+++.++||||+++++++..+...++|+|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 58889999999999999999999999999998522 123468999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+. ++|.+++.... ..+++..+..++.||+.||.|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 138 ~~~-~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 138 HYS-SDLYTYLTKRS----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred ccC-CcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 995 68888886532 3489999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHH-------HHHHHHH
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLA-------QWAWRHI 920 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~-------~~~~~~~ 920 (1014)
++..... .......||+.|+|||++.+..++.++|||||||++|||+++..++......... ..+....
T Consensus 204 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 204 AQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 9753221 1223456899999999999999999999999999999999876655332211100 1111111
Q ss_pred hc-CC---cch---------hcccc--ccCCccc-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 921 QE-GK---PIV---------DALDK--EIDEPCF-------LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 921 ~~-~~---~~~---------~~~~~--~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.. +. .+. ..++. ....+.. ........+++.+||+.||++|||+.|+++ ||||+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~----hp~f~ 355 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN----YPMFA 355 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc----Cchhc
Confidence 10 00 000 00000 0000000 011123456899999999999999999999 99997
Q ss_pred C
Q 001778 979 T 979 (1014)
Q Consensus 979 ~ 979 (1014)
.
T Consensus 356 ~ 356 (357)
T PHA03209 356 Q 356 (357)
T ss_pred c
Confidence 5
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=326.24 Aligned_cols=268 Identities=25% Similarity=0.387 Sum_probs=204.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc-C
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS-E 759 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-~ 759 (1014)
++|++.+.||+|+||.||+|.+.. +++.||+|++... ......+.+.+|+.++.++ +|+||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--ATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--CCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 468899999999999999996543 3578999998432 2234456788999999999 89999999998764 4
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCC--------------------------------------------------CC
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLS--------------------------------------------------GR 789 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~--------------------------------------------------~~ 789 (1014)
...++++||+++|+|.+++......... ..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998754211000 00
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCcc
Q 001778 790 ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869 (1014)
Q Consensus 790 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~ 869 (1014)
.....++|..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..+..... ........++..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~ 240 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLK 240 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCcc
Confidence 0023689999999999999999999965 999999999999999999999999999987643221 122234456788
Q ss_pred cccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHH
Q 001778 870 YIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFK 948 (1014)
Q Consensus 870 y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 948 (1014)
|+|||++.+..++.++||||+||++|||++ |..||.+..... ........+... . .......++.+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~------~----~~~~~~~~~~~ 307 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRM------R----APEYATPEIYS 307 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCC------C----CCccCCHHHHH
Confidence 999999999999999999999999999997 999997643221 111222222110 0 01112345778
Q ss_pred HHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 949 LGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 949 li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
++.+||+.+|++||++.|+++.|++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.19 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=205.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
++|+..+.||+|++|.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++.+.+.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 468888999999999999999887 6788999987432 234445778999999999999999999999999889
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC---
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF--- 838 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~--- 838 (1014)
.++||||+++|+|.+++...+... .....++|..+.+++.||+.|++|||.. +++||||||+||+++.++
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRP----ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence 999999999999999998764211 1223589999999999999999999965 999999999999998654
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~ 917 (1014)
.+|++|||+++...... ..........+..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 157 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-- 233 (277)
T cd05036 157 VAKIADFGMARDIYRAS-YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-- 233 (277)
T ss_pred ceEeccCccccccCCcc-ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 59999999998763211 1111223334578999999998899999999999999999997 8899987654332221
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
+...... .........+.+++.+|++.||++||++.+|++.|+
T Consensus 234 --~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --VTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111110 011122346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.52 Aligned_cols=273 Identities=26% Similarity=0.352 Sum_probs=206.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC--------------CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT--------------AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l 752 (1014)
.+|...+.||+|+||.||+|.+..+ ...||+|++... ........+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4688899999999999999876542 235899998543 234456679999999999999999999
Q ss_pred EEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCC-CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 001778 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL-SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831 (1014)
Q Consensus 753 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~N 831 (1014)
++++...+..++||||+++++|.+++........ ........+++..+..++.|++.|++|||.. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999975421111 1111123478999999999999999999965 99999999999
Q ss_pred eeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc--CCCCCCCCCc
Q 001778 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT--GKEANNGDEH 909 (1014)
Q Consensus 832 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt--g~~p~~~~~~ 909 (1014)
|++++++.+||+|||++....... .........++..|+|||++....++.++|||||||++|+|++ +..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999997654322 1122233455789999999988889999999999999999998 5667776554
Q ss_pred hhHHHHHHHHHhc-CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 910 TCLAQWAWRHIQE-GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 910 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
............. ....... ........+.+++.+||+.||++||++++|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS--------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCC--------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 3333322211111 1100000 011122468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.24 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=210.3
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
...+.|++.+.||+|+||.||+|++..+++.||+|.+.. ......+.+.+|+.+++.++||||+++++++..++..+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 344678999999999999999999999999999999843 23455677889999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+
T Consensus 86 lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD----------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred EEEecCCCCcHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEc
Confidence 9999999999998876532 2488999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
|||.+....... .......++..|+|||++. ...++.++|||||||++|||++|+.||...+.. .....
T Consensus 153 dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~ 226 (292)
T cd06644 153 DFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLK 226 (292)
T ss_pred cCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHH
Confidence 999987543211 1223456788999999884 345678999999999999999999999765432 11111
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. .... +... .......++.+++.+||+.||++||++.|+++ ||||......
T Consensus 227 ~~-~~~~------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~~~ 278 (292)
T cd06644 227 IA-KSEP------PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE----HPFVSSVTSN 278 (292)
T ss_pred Hh-cCCC------ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc----Cccccccccc
Confidence 11 1111 0000 01122235678899999999999999999988 9999876544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.88 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=211.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|++++++++|++++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888899999999999999999899999999886444444555788999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++..... ....+++.++..++.+++.|++|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 82 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-------QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred ecCCCCCHHHHHHHhcc-------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 99999999999875321 223578999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+... ....+.
T Consensus 152 ~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~-- 224 (267)
T cd08224 152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK-KIEKCD-- 224 (267)
T ss_pred eeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh-hhhcCC--
Confidence 9876533221 122346888999999999888999999999999999999999999654421 111111 111111
Q ss_pred hhccccccCCcccH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 VDALDKEIDEPCFL-EEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... .....+.+++.+||+.+|++||++.+++++|++
T Consensus 225 --------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 225 --------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred --------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 001111 233457789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.09 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=209.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++....+++.||+|.+.... .......++.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh-CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4788899999999999999999999999999984322 233455688999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ...+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 80 YCEGGDLYKKINAQR---------GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred cCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999987642 12478899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+... .+........+
T Consensus 148 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~~~~~~~~-- 219 (256)
T cd08218 148 ARVLNSTV---ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LVLKIIRGSYP-- 219 (256)
T ss_pred eeecCcch---hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HHHHHhcCCCC--
Confidence 97653321 11223468889999999998889999999999999999999999997654332 22222221111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.........+.+++.+||+.||++||++.||++ ||||
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~----~~~~ 256 (256)
T cd08218 220 ---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE----KNFI 256 (256)
T ss_pred ---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh----CcCC
Confidence 011122345778999999999999999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.99 Aligned_cols=274 Identities=22% Similarity=0.318 Sum_probs=208.6
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 356888999999999999999999999999999984322 223345677899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||++ ++|.+++.... ..+++..+..++.|+++||+|||.. +|+|+||||+||+++.++.+||+||
T Consensus 83 ~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG----------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred Eeccc-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcC
Confidence 99997 58998887542 2378899999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|++....... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+........
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 225 (301)
T cd07873 149 GLARAKSIPT---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225 (301)
T ss_pred cchhccCCCC---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9997543211 11223467899999998865 4578899999999999999999999987654333222222111100
Q ss_pred -----------cchhccccccCCccc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 925 -----------PIVDALDKEIDEPCF----LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 925 -----------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.......+....++. ......+.+++.+|++.||.+|||++|+++ ||||..-.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~----h~~f~~~~~ 294 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK----HPYFHCLGE 294 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc----Ccccccccc
Confidence 000000000000000 111235678999999999999999999998 999987553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=355.04 Aligned_cols=483 Identities=28% Similarity=0.322 Sum_probs=385.4
Q ss_pred ceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeec
Q 001778 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151 (1014)
Q Consensus 72 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (1014)
.++.|+++.|-+....-+.+..--+|+.|||++|++ +..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 478888888876643334444555699999999998 567889999999999999999998 788999999999999999
Q ss_pred CccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccC
Q 001778 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIG 231 (1014)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~ 231 (1014)
+|.+. ..|..+..+.+|++|+++.|++. .+|..+..++.++.+..++|. . +.. ++... ++.+++..|.+.+
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~-~-~~~----lg~~~-ik~~~l~~n~l~~ 170 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNE-K-IQR----LGQTS-IKKLDLRLNVLGG 170 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcch-h-hhh----hcccc-chhhhhhhhhccc
Confidence 99998 89999999999999999999998 899999999999999999992 1 122 22222 8889999999999
Q ss_pred ccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCccccc
Q 001778 232 EIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311 (1014)
Q Consensus 232 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 311 (1014)
.++..+..++. .|||++|.+. . ..+..+.+|+.|....|++... .....+++.|+.++|.++...+. .--
T Consensus 171 ~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~~--p~p 240 (1081)
T KOG0618|consen 171 SFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDVH--PVP 240 (1081)
T ss_pred chhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE---EecCcchheeeeccCcceeeccc--ccc
Confidence 99888888776 7999999988 2 2466778888899988888643 23345788899999988843322 223
Q ss_pred ccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEc
Q 001778 312 ENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAA 391 (1014)
Q Consensus 312 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l 391 (1014)
.+|+++++++|+++ .+|++++.+.+|+.|...+|+++ .+|..+...++|++|++.+|.+. -+|+.....+.|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 57888999999998 56788889999999999999986 78888888889999999999888 66777778888999999
Q ss_pred cccccCCCCCcccccCCc-ccEEEeecceeecCCCc-ccccccccccccccCCcccCCCCCcC--CCCCceecccccccc
Q 001778 392 QDNNLSGELPESLGNCSS-LLMVKIYNNSFTGNIPA-GLWTGFNLSMVLISDNLFTGELPDKM--SGNLSRLEISNNRFS 467 (1014)
Q Consensus 392 ~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~-~~~~~~~L~~l~l~~n~~~~~~p~~~--~~~L~~L~Ls~N~l~ 467 (1014)
..|+|....+..|.-+.. |..|+.+.|++. ..|. .=.....|+.|.+.+|.++...-..+ ...|+.|+|++|+|.
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 999988655555555544 788888888887 4442 22244578999999999997543333 368999999999999
Q ss_pred CcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccc-cCccc
Q 001778 468 GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGE-IPEKI 546 (1014)
Q Consensus 468 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~ 546 (1014)
......+.++..|+.|+||+|+++ .+|.++..+..|++|...+|+|. ..| ++..+++|+.+|||.|+|+.. +|...
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 555557889999999999999999 78999999999999999999998 788 899999999999999999853 34333
Q ss_pred ccccccceeecCCCccccCCchhhhhh-cccccccCCC
Q 001778 547 GFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSN 583 (1014)
Q Consensus 547 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~l~~l~ls~N 583 (1014)
- -++|++|||++|.=.-..-..+..+ .+..+++.-|
T Consensus 474 p-~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 474 P-SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred C-CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 2 2899999999997321223344444 4555666555
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.77 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=203.7
Q ss_pred CCCCceeccCCcEEEEEeeecCC---CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc----
Q 001778 689 LTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL---- 761 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~---- 761 (1014)
|+..+.||+|+||.||+|.+..+ +..||+|++..+. ......+.+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 46678999999999999987653 4789999985432 234456789999999999999999999998866544
Q ss_pred --eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 762 --KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 762 --~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
.++|+||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLG-----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMT 151 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhcc-----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCe
Confidence 79999999999999998764321 1224589999999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 918 (1014)
+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+..
T Consensus 152 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-- 228 (273)
T cd05035 152 VCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-- 228 (273)
T ss_pred EEECCccceeecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 99999999987644221 111222345678999999988889999999999999999999 88888765543322221
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... .........+.+++.+||+.||++||++.|+++.|++
T Consensus 229 --~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 229 --RHGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred --HcCCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111110 0111233467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=317.67 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCe----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+|+..+.||+|+||+||+|.+..+++ .|++|.+.. ........++..|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc--ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 357778899999999999999877766 477777632 2223445678888989999999999999998864 456
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl 150 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR----------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQI 150 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEE
Confidence 88999999999999997642 2488999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||.++........ .......++..|+|||++.+..++.++|||||||++||+++ |..||.+.......+. +.
T Consensus 151 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~~ 225 (279)
T cd05111 151 ADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----LE 225 (279)
T ss_pred cCCccceeccCCCcc-cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH
Confidence 999999865432211 12234557789999999998899999999999999999998 9999987654333222 22
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+..... + .. ....+.+++.+||..||++|||+.|+++.|+.
T Consensus 226 ~~~~~~~---~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 226 KGERLAQ---P---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCcCCC---C---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 2221110 0 01 12345678889999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=295.66 Aligned_cols=291 Identities=23% Similarity=0.297 Sum_probs=218.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCC----eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-CC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTA----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-EN 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~ 760 (1014)
...|...+.||+|+||.||+|.-+.+. +.+|+|+++..++ .........+|+.+++.++||||+.+..++-. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 446888899999999999999544432 2689999855433 23345667899999999999999999988876 78
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC---
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN--- 837 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~--- 837 (1014)
..++++||.+. +|.++++-.+.. ....++-..+..|+.||+.|++|||++ -|+|||+||.|||+..+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~------~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRAS------KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccc------hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCc
Confidence 89999999987 999998876432 224688889999999999999999965 89999999999999877
Q ss_pred -CcEEEeecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchh----
Q 001778 838 -FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTC---- 911 (1014)
Q Consensus 838 -~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~---- 911 (1014)
|.|||+|+|+|+.+...-.........+-|..|+|||++.+. .|+.+.|||+.|||+.||+|-++.|.+.+...
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~ 251 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN 251 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence 899999999999886644444445567889999999998875 68999999999999999999999887644211
Q ss_pred --HHHHHHHHH-hcCCcchhccccccC-Cccc------------HH------------HHHHHHHHHhHccCCCCCCCCC
Q 001778 912 --LAQWAWRHI-QEGKPIVDALDKEID-EPCF------------LE------------EMIRVFKLGVICTSMLPTERPN 963 (1014)
Q Consensus 912 --~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~------------~~------------~~~~l~~li~~cl~~dP~~RPt 963 (1014)
-.+++.++. .-|.+ .+..-+.+. .+.+ .+ .....+++..+++++||.+|.|
T Consensus 252 Pfq~dQl~rIf~vLG~P-t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt 330 (438)
T KOG0666|consen 252 PFQHDQLDRIFEVLGTP-TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT 330 (438)
T ss_pred CchHHHHHHHHHHcCCC-ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc
Confidence 111122211 11211 111111110 0000 00 0012578899999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCccccccc
Q 001778 964 MRMVLQILLNNPIFPTEKNGGRKYDHVTP 992 (1014)
Q Consensus 964 ~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 992 (1014)
++++++ |+||+.++....+.++..+
T Consensus 331 a~qAle----h~yF~~d~lpp~pt~~~vn 355 (438)
T KOG0666|consen 331 AEQALE----HPYFTEDPLPPLPTSDNVN 355 (438)
T ss_pred HHHHhc----ccccccCCCCCCcccceee
Confidence 999999 9999999877666655554
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.79 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=206.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|+..+.||+|+||.||+|.+.. ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 458888999999999999999887 888999998432 2334567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||
T Consensus 82 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 82 ELMEKGSLLAFLRSPE---------GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred eecccCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence 9999999999997642 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+. .+..
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~~~ 222 (261)
T cd05148 150 LARLIKEDV---YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----AGYR 222 (261)
T ss_pred chhhcCCcc---ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH----hCCc
Confidence 997653321 11224456778999999988889999999999999999998 888997665433322221 1111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+||+.||++|||++++++.|+.
T Consensus 223 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112223456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.39 Aligned_cols=266 Identities=23% Similarity=0.390 Sum_probs=208.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC-----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
++|+..+.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.++||||+++++++..+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4678889999999999999987643 378999998432 233445678899999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++||||+++|+|.+++........ .......++|..+..++.|++.|+.|||+. +++||||||+||+++.++.+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAE-NNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchh-hccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 9999999999999999976432110 011223578999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||...+........
T Consensus 160 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---- 234 (277)
T cd05032 160 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV---- 234 (277)
T ss_pred ECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH----
Confidence 999999976544221 112234556789999999988889999999999999999998 88898766544333322
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... .. ......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHL------DL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCC------CC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 121110 01 11124567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.83 Aligned_cols=268 Identities=25% Similarity=0.342 Sum_probs=206.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++|||++++++++..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc-cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 6788899999999999999999899999999985332 122334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 81 YCDHTVLNELEKNP-----------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred ccCccHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99998888876543 2379999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP- 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 925 (1014)
+........ ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+....+......-.+
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 147 ARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred ceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 987644221 1223457889999999876 56789999999999999999999999876543322222111100000
Q ss_pred ----------chhccccccCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 ----------IVDALDKEIDEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ----------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
......+..... ........+.+++.+||+.||++||++.|++. ||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~----~~~f 286 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE----HPYF 286 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc----CCCC
Confidence 000000000000 01112346778999999999999999999988 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.50 Aligned_cols=263 Identities=28% Similarity=0.363 Sum_probs=211.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+|+..+.||+|+||+||++.+..+++.||+|++... ......+.+.+|+++++.++||||+++++++......++|+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3577889999999999999999989999999988432 22345678899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++..+..++.+++.|+.|||+. .+++||||||+||+++.++.++|+|||
T Consensus 83 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 83 EFMDCGSLDRIYKKGG-----------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred ecCCCCCHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCC
Confidence 9999999999987642 378999999999999999999962 389999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCch--------hHHHHHHH
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT--------CLAQWAWR 918 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~--------~~~~~~~~ 918 (1014)
++...... ......|+..|+|||++.+..++.++|||||||++|++++|+.||...... ....+...
T Consensus 150 l~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 150 VSGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred cccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 98654221 122457899999999998888999999999999999999999999864432 11122222
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
......+ .+. .......+.+++.+|+++||++||++.|+++ |+||....+.
T Consensus 225 ~~~~~~~-------~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~----~~~~~~~~~~ 275 (284)
T cd06620 225 IVQEPPP-------RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCA----MPPFIQALRA 275 (284)
T ss_pred HhhccCC-------CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhc----Cccccccccc
Confidence 2211111 110 1113346778999999999999999999998 9888665433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.50 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=205.6
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|+||.||+|.+..++..+|+|.+... .....+.+.+|+++++.++|||++++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 56678899999999999999999999999998432 234567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~l~~~~~~~~----------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 84 CAGGAVDAVMLELE----------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred cCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccc
Confidence 99999999876531 2489999999999999999999965 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
....... .......++..|+|||++. +..++.++||||+||++|||++|+.||...+... .........
T Consensus 151 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~~ 224 (282)
T cd06643 151 AKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSE 224 (282)
T ss_pred ccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhhcC
Confidence 7643211 1223456899999999884 3457789999999999999999999997654321 111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.+ ... ........+.+++.+||+.||.+||+++++++ ||||....
T Consensus 225 ~~-------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~ 269 (282)
T cd06643 225 PP-------TLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ----HPFVTVNS 269 (282)
T ss_pred CC-------CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc----CCCEeccC
Confidence 11 000 01112245678899999999999999999888 99988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=314.48 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=204.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+. .+..||+|.+... ....+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 45788899999999999999865 4567999987432 234578899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 81 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 81 EYMAKGSLLDFLKSDE---------GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred ecCCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCc
Confidence 9999999999997642 23478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++....... ........++..|+|||++....++.++|||||||++|+|++ |..||...........+ .....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~ 222 (261)
T cd05072 149 LARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL----QRGYR 222 (261)
T ss_pred cceecCCCc--eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCC
Confidence 998654321 111223446778999999988889999999999999999998 89999765543332222 21111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. +........+.+++.+|++.||++||+++++.+.|++
T Consensus 223 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 M----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0111122457789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.93 Aligned_cols=258 Identities=25% Similarity=0.337 Sum_probs=206.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh------hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL------DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|.+...... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999999888999999988543222 12234678899999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++|+||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-----------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-----------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 999999999999999997642 378889999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCc---cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 842 IADFGVAKILIKEEGE---FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
|+|||.++........ ........|+..|+|||.+.+..++.++|+||+||++|+|++|+.||........ +..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~ 223 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IFK 223 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HHH
Confidence 9999999876432111 1112234588999999999988899999999999999999999999986543211 111
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
... . ..+... ......+.+++.+||+.||++||++.|+++ ||||
T Consensus 224 ~~~-~------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~ 267 (267)
T cd06628 224 IGE-N------ASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK----HPFL 267 (267)
T ss_pred Hhc-c------CCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh----CCCC
Confidence 111 0 011111 122345678899999999999999999998 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.53 Aligned_cols=271 Identities=25% Similarity=0.327 Sum_probs=193.2
Q ss_pred CceeccCCcEEEEEeeecC--CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceEEEEE
Q 001778 692 SNVIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKLLVYE 767 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV~e 767 (1014)
..+||+|+||+||+|.+.. ++..||+|.+... .....+.+|+.+++.++||||+++++++.. +...++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999998654 5578999988432 123457889999999999999999998853 567799999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----cCCCcEEEe
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIA 843 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll----~~~~~~kl~ 843 (1014)
|+++ +|.+++........ ......+++..+..++.|++.||.|||.. +|+||||||+||++ +.++.+||+
T Consensus 81 ~~~~-~l~~~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKA--NKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred eeCC-cHHHHHHhhhcccc--CCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 9874 88888764321110 11223588999999999999999999965 99999999999999 566789999
Q ss_pred ecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH------HHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL------AQWA 916 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~------~~~~ 916 (1014)
|||+++................||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ....
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99999876443222223345678999999999876 4578999999999999999999999975432110 0000
Q ss_pred HHHHh-cCCcchh------------ccc-----cccCCccc--------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 001778 917 WRHIQ-EGKPIVD------------ALD-----KEIDEPCF--------LEEMIRVFKLGVICTSMLPTERPNMRMVLQI 970 (1014)
Q Consensus 917 ~~~~~-~~~~~~~------------~~~-----~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 970 (1014)
..... .+.+..+ ... ........ ......+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~- 313 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ- 313 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc-
Confidence 00000 0000000 000 00000000 011234678999999999999999999998
Q ss_pred HhcCCCC
Q 001778 971 LLNNPIF 977 (1014)
Q Consensus 971 L~~~~~~ 977 (1014)
||||
T Consensus 314 ---hp~f 317 (317)
T cd07867 314 ---DPYF 317 (317)
T ss_pred ---CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=317.01 Aligned_cols=259 Identities=26% Similarity=0.340 Sum_probs=211.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||.|++|.||+|.+..+++.||+|.+..+ ........+.+|+.+++.++|||++++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc--ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 577888999999999999999999999999998432 223445678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||.
T Consensus 80 ~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 80 YCGGGSCLDLLKPG------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred eeCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999998753 478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||...+.... ... +....
T Consensus 145 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~-~~~~~--- 214 (274)
T cd06609 145 SGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFL-IPKNN--- 214 (274)
T ss_pred ceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHH-hhhcC---
Confidence 98764421 122345688899999999988899999999999999999999999976543211 111 11111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+.+.... ....+.+++.+||..||++|||++++++ ||||......
T Consensus 215 ---~~~~~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~----~~~~~~~~~~ 260 (274)
T cd06609 215 ---PPSLEGNK---FSKPFKDFVSLCLNKDPKERPSAKELLK----HKFIKKAKKT 260 (274)
T ss_pred ---CCCCcccc---cCHHHHHHHHHHhhCChhhCcCHHHHhh----ChhhcCCCcc
Confidence 11111110 2234678889999999999999999998 9999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=315.18 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=204.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCe---EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+|+..+.||+|+||.||+|.+..+++ .||+|.+... ......+.+..|+++++.++|||++++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 56778899999999999998876554 7999988432 234456778999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+|++|
T Consensus 84 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 999999999999987642 2478999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||++..................+..|+|||++....++.++|||||||++|||++ |+.||........... +..+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~----i~~~ 226 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA----INDG 226 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----HhcC
Confidence 9999765432211111112233567999999998889999999999999999997 9999976554322222 1111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.. .+........+.+++.+||+.||++||++.+|++.|++
T Consensus 227 ~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 FR----------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11 01111223467899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.89 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=203.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|++|.||+|.+.. ++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 467888999999999999998654 5679999984422 23567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 81 ELMKYGSLLEYLQGGA---------GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred ecccCCcHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence 9999999999997642 23589999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++....... .........+..|+|||++.+..++.++||||||+++|||++ |+.||.+........ .+.....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~~~~ 222 (261)
T cd05068 149 LARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQGYR 222 (261)
T ss_pred eEEEccCCc--ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCC
Confidence 998764211 111112233468999999998899999999999999999999 998997655332222 2211111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+|++.||++||++.++++.|+.
T Consensus 223 ----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ----------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01111223457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.56 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=200.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
..+|+..+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC---ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 34688999999999999999999999999999998432 223345688999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.++++... .+++..+..++.|++.|+.|||+. +|+|||++|+||+++.++.++|+||
T Consensus 85 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcC
Confidence 99999999999987542 378999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|++....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||......... ......
T Consensus 151 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~~~~ 224 (267)
T cd06646 151 GVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMSKS 224 (267)
T ss_pred ccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eeeecC
Confidence 9998653321 1223456889999999874 345778999999999999999999998644321110 000000
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
. ...+.... .......+.+++.+||+.||++||+++++++
T Consensus 225 ~-----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 225 N-----FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred C-----CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 0 00011110 1122346778999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.54 Aligned_cols=254 Identities=27% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|.+... ...+.+.+|+++++.++||||+++++++..+...++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4688889999999999999999988899999998432 12678999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++...+ ..+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.+||+|||
T Consensus 78 e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg 144 (256)
T cd06612 78 EYCGAGSVSDIMKITN----------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG 144 (256)
T ss_pred ecCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence 9999999999987532 3489999999999999999999966 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||........... .....
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-- 215 (256)
T cd06612 145 VSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----IPNKP-- 215 (256)
T ss_pred cchhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----hccCC--
Confidence 9987643221 22345578899999999998999999999999999999999999976543221111 00000
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+.+. .......++.+++.+||+.||++|||+.|+++ ||||
T Consensus 216 ----~~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~----~~~~ 256 (256)
T cd06612 216 ----PPTLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ----HPFI 256 (256)
T ss_pred ----CCCCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc----CCCC
Confidence 01111 11122345778899999999999999999998 9997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.47 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=205.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCC---eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA---EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
.+|+..+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35778899999999999999876444 37999988432 22344678899999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++
T Consensus 82 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~ 148 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD----------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVS 148 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeC
Confidence 9999999999999997642 2478999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||.+.................++..|+|||++.+..++.++|+||||+++||+++ |..||...........+ .+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~----~~ 224 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI----EE 224 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH----hC
Confidence 99999876442221112222334568999999998889999999999999999886 99999765543322221 11
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+.. .+........+.+++.+|++.+|.+||++.++++.|++
T Consensus 225 ~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 225 GYR----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CCc----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 111 01111223456789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.36 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=206.5
Q ss_pred CCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+|...+.||+|+||.||+|.+.. ++..|++|.+.. ......+.+.+|+.+++.++||||+++++++..++..
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46677899999999999997543 345689998843 2334456789999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCC-----CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
++||||+++++|.+++...+.... ........+++..++.++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999976532110 0011223489999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~ 916 (1014)
+.++|+|||++....... .........++..|+|||++.+..++.++|||||||++|||++ |..||.........+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~- 237 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC- 237 (291)
T ss_pred CcEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 999999999997654321 1112234556789999999999899999999999999999999 9999876654332221
Q ss_pred HHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
...+... . ........+.+++.+||+.||++||++.+|+++|++
T Consensus 238 ---~~~~~~~-~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 238 ---ITQGRVL-E---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred ---HhCCCCC-C---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 2221110 0 011123457789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.47 Aligned_cols=266 Identities=23% Similarity=0.375 Sum_probs=205.6
Q ss_pred CCCCCceeccCCcEEEEEeeecCC-----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT-----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+|...+.||+|+||.||+|.+..+ ++.||+|++.... .....+.+.+|+.++..++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 466778899999999999987543 5789999985432 233457789999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCC-----CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
++++||+++++|.+++........ ........+++..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 999999999999999864321110 0111234588999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~ 916 (1014)
+.+||+|||+++....... ........+++.|+|||++.+..++.++||||+||++|||++ |..||.+.......+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-- 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE-- 237 (283)
T ss_pred CceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--
Confidence 9999999999886543221 122234456789999999988889999999999999999998 778887654332222
Q ss_pred HHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. +..+.. .+........+.+++..||+.||++||++++|++.|+.
T Consensus 238 -~-i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 -M-IRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -H-HHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 211111 01112233457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.13 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=203.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4677889999999999999999999999999984322 23456778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ...+++.....++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.
T Consensus 79 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~ 146 (255)
T cd08219 79 YCDGGDLMQKIKLQR---------GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS 146 (255)
T ss_pred eCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCc
Confidence 999999999887532 23478889999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..... .... .+..
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~-~~~~-- 217 (255)
T cd08219 147 ARLLTSPG---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI---LKVC-QGSY-- 217 (255)
T ss_pred ceeecccc---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH---HHHh-cCCC--
Confidence 97654321 1122456889999999999888999999999999999999999999865532221 1111 1111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
..+ .......+.+++.+||+.||++||++.|++.
T Consensus 218 ~~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 218 KPL--------PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCC--------CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 000 1112235678899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.48 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=203.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeE--EEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 763 (1014)
.+|+..+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|++++.++ +||||+++++++..++..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3577788999999999999998777654 57776632 22344567889999999999 8999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
+|+||+++|+|.++++..+...... ......+++.+++.++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 9999999999999998653211100 01123589999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||.+.........
T Consensus 162 ~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-- 235 (303)
T cd05088 162 VAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-- 235 (303)
T ss_pred cEEeCccccCcccch----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH--
Confidence 999999999864211 111112234678999999988889999999999999999998 9999976554322221
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
...+.. ..........+.+++.+||+.||++||+++++++.+++
T Consensus 236 --~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 --LPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred --HhcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 00011122356789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.72 Aligned_cols=258 Identities=26% Similarity=0.308 Sum_probs=201.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+++.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3445556899999999999999888999999988432 2345568899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcEEEeec
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADF 845 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~kl~Df 845 (1014)
||+++++|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+||
T Consensus 85 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 85 EQVPGGSLSALLRSKWG--------PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred ecCCCCCHHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence 99999999999976421 01127788889999999999999965 9999999999999976 678999999
Q ss_pred ccccccccccCccccccccccCcccccccccccC--CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|.+........ ......|+..|+|||++... .++.++||||+|+++|+|++|+.||..........+.......
T Consensus 154 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 229 (268)
T cd06624 154 GTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI- 229 (268)
T ss_pred hhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc-
Confidence 99876533221 12234678999999998654 3788999999999999999999999754332211111100000
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+.+ ......++.+++.+||+.+|++|||+.|+++ ||||
T Consensus 230 -------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~----~~~~ 268 (268)
T cd06624 230 -------HPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ----DPFL 268 (268)
T ss_pred -------CCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh----CCCC
Confidence 0111 1122345678899999999999999999999 9997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.27 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=213.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCC--C--eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT--A--EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
..+..+.||+|-||.||+|..... | -.||||+-+.+ ......+.|..|..+|++++||||++++|.|.+. ..|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 345677899999999999976433 3 35888987443 3445588999999999999999999999999875 479
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|||.++.|.|..|++... ..++......+++||+.||+||| |..+|||||..+|||+.....||++
T Consensus 467 ivmEL~~~GELr~yLq~nk----------~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK----------DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred EEEecccchhHHHHHHhcc----------ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeec
Confidence 9999999999999998753 45888999999999999999999 5699999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+++.+... .+.+.+...-+..|||||.+.-++++.++|||.|||.+||++. |..||.+-...
T Consensus 534 DFGLSR~~ed~--~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------------ 599 (974)
T KOG4257|consen 534 DFGLSRYLEDD--AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------------ 599 (974)
T ss_pred ccchhhhcccc--chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------------
Confidence 99999987553 3334446667889999999999999999999999999999985 88899875432
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+...++.+-+.+++..++..++.++.+||.+||.+||++.|+...|..
T Consensus 600 --DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 600 --DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred --ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 2233445555667888899999999999999999999999999887743
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.30 Aligned_cols=257 Identities=24% Similarity=0.308 Sum_probs=203.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 34688889999999999999999999999999998432 223345678899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++...+ .+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++|+||
T Consensus 85 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-----------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EeccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 99999999999987642 378999999999999999999966 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|.+....... .......|+..|+|||++. ...++.++||||+||++|+|++|+.||........ .......
T Consensus 151 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~ 224 (267)
T cd06645 151 GVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKS 224 (267)
T ss_pred eeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhcc
Confidence 9987653321 1223457899999999874 45688899999999999999999999865442211 1111111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
... .+.... .......+.+++.+|++.||++||+++++++ |||
T Consensus 225 ~~~-----~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~----~~~ 267 (267)
T cd06645 225 NFQ-----PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ----HPF 267 (267)
T ss_pred CCC-----CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc----CCC
Confidence 110 000100 0011234678899999999999999999888 887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=346.42 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=206.8
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCc
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENL 761 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~ 761 (1014)
....+|.+.+.||+|+||+||+|.+..+++.||+|++.... ........+..|+.+++.++||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 44567999999999999999999999999999999985432 234456788999999999999999999998854 456
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEeccCCCCCeeecC-
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDC----SPTIVHRDLKSSNILLDY- 836 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----s~~ivH~Dlk~~NIll~~- 836 (1014)
+|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~-------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK-------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 8999999999999999976321 1235899999999999999999999642 146999999999999964
Q ss_pred ----------------CCcEEEeecccccccccccCccccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHh
Q 001778 837 ----------------NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELT 898 (1014)
Q Consensus 837 ----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~ell 898 (1014)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2348999999998653321 2234578999999999854 45889999999999999999
Q ss_pred cCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 899 TGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 899 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
+|+.||...... . .+...+..... +... .....+.+++..||+.||.+||++.|++. |+|+.
T Consensus 238 TGk~PF~~~~~~--~-qli~~lk~~p~--------lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~----h~~ik 299 (1021)
T PTZ00266 238 SGKTPFHKANNF--S-QLISELKRGPD--------LPIK---GKSKELNILIKNLLNLSAKERPSALQCLG----YQIIK 299 (1021)
T ss_pred HCCCCCCcCCcH--H-HHHHHHhcCCC--------CCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc----cHHHh
Confidence 999999754432 1 12222222111 1001 11245778999999999999999999987 78876
Q ss_pred C
Q 001778 979 T 979 (1014)
Q Consensus 979 ~ 979 (1014)
.
T Consensus 300 ~ 300 (1021)
T PTZ00266 300 N 300 (1021)
T ss_pred h
Confidence 4
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=319.44 Aligned_cols=269 Identities=25% Similarity=0.392 Sum_probs=205.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 357888999999999999999988899999998754322 2234567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||++++++.++.... ..+++..+..++.|++.|++|||+. +++|+|++|+||++++++.++|+|||
T Consensus 80 e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 80 EFVDHTVLDDLEKYP-----------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred ecCCccHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence 999999888876543 2378999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc---
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE--- 922 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--- 922 (1014)
++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..................
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07846 146 FARTLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222 (286)
T ss_pred eeeeccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence 987654322 12234567899999998875 45778999999999999999999999765432211111110000
Q ss_pred -------CCcch-hccccccCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 923 -------GKPIV-DALDKEIDEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 923 -------~~~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
..++. ....+..... ........+.+++.+||+.||++||++.++++ ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~----~~~~ 286 (286)
T cd07846 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH----HEFF 286 (286)
T ss_pred hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc----CCCC
Confidence 00000 0000000000 01122345788999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.59 Aligned_cols=263 Identities=27% Similarity=0.348 Sum_probs=210.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||+||+|.+..++..||+|++..+.. ....+.+.+|+.+++.++|+|++++++.+..++..++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 68889999999999999999988899999999844322 2256789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.++++.... ...+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 80 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred ccCCCcHHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999976421 23478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCcc-ccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 848 AKILIKEEGEF-AAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 848 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
+..+....... .......|+..|+|||++... .++.++|+|||||++|+|++|+.||....... ..........+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~ 225 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQNDPP 225 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcCCCC
Confidence 97765432221 122345688999999998876 78899999999999999999999997654321 11112221111
Q ss_pred chhccccccCCc-ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 IVDALDKEIDEP-CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+... ........+.+++..|++.||++||++.|+++ ||||
T Consensus 226 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~----~p~~ 267 (267)
T cd06610 226 -------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK----HKFF 267 (267)
T ss_pred -------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh----CCCC
Confidence 11110 01223356778999999999999999999998 9997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.62 Aligned_cols=259 Identities=23% Similarity=0.389 Sum_probs=204.4
Q ss_pred CCCCCCceeccCCcEEEEEeee-----cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPI-----NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~ 760 (1014)
.+|...+.||+|+||.||++.+ ...+..||||++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3577888999999999999875 2345679999884322 234457889999999999 7999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++|+||+++|+|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---------ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeE
Confidence 9999999999999999997642 12379999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 919 (1014)
+++|||++........ ........++..|+|||.+.+..++.++||||+||++|||++ |..||........ ....
T Consensus 181 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~ 256 (302)
T cd05055 181 KICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKL 256 (302)
T ss_pred EECCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHH
Confidence 9999999986543221 112223456788999999998899999999999999999998 8999876543211 1122
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
...+.. .........++.+++.+|++.||++||++.|+++.|++
T Consensus 257 ~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 257 IKEGYR----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HHcCCc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 222211 00111122467789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.27 Aligned_cols=265 Identities=28% Similarity=0.398 Sum_probs=199.7
Q ss_pred CCCCCceeccCCcEEEEEeee----cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCc
Q 001778 688 KLTESNVIGSGGSGKVYRVPI----NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~ 761 (1014)
.|+..+.||+|+||.||+|.. ..+++.||+|.+... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 577788999999999999873 456789999998432 34456788999999999999999999998754 346
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++|+||+++|+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR----------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 899999999999999997542 2478999999999999999999966 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
|+|||++.................++..|+|||++.+..++.++|||||||++|||++|..++...... + .....
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~-~~~~~ 223 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----F-MRMMG 223 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----h-hhhcc
Confidence 999999987644222111112223455699999999888999999999999999999988776433211 0 00000
Q ss_pred cCCc-------chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKP-------IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.... +.+.+......+.......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred cccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0000 001111111111112233467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.56 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=208.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 47888999999999999999988899999999855432 24567889999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... .+++..+..++.+++.|++|||+. +++|+||+|+||++++++.+||+|||.
T Consensus 80 ~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 80 YCSGGTLEELLEHGR-----------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred cCCCCcHHHHHhhcC-----------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence 999999999987642 368889999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCcccc-ccccccCcccccccccccCC---CCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 848 AKILIKEEGEFAA-MSTVVGSCGYIAPEYARTRK---VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 848 a~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~---~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
+............ .....++..|+|||++.+.. ++.++||||||+++|++++|+.||...+... ..........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 223 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGAGH 223 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhcCC
Confidence 9876543222111 22356789999999998766 8899999999999999999999997654221 1111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+ .+ +........+.+++.+||+.||.+||++.|++. |||+
T Consensus 224 ~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~----~~~~ 264 (264)
T cd06626 224 KP-------PI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ----HPFV 264 (264)
T ss_pred CC-------CC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc----CCCC
Confidence 10 01 111112345668899999999999999999988 9985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.89 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=208.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh---hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL---DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|++...... .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999999899999999998543211 12346789999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-cEEEe
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NAKIA 843 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-~~kl~ 843 (1014)
|+||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|+
T Consensus 81 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999999987642 378899999999999999999965 999999999999998775 59999
Q ss_pred ecccccccccccCcc-ccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEF-AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||.+.......... .......++..|+|||++.+..++.++||||+|+++|+|++|..||..................
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc
Confidence 999997764421111 1122346889999999998888999999999999999999999999755433222222211111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.. ...........+.+++.+|++.||++||++.|++. ||||+
T Consensus 227 ~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~----~~~~~ 268 (268)
T cd06630 227 TT----------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK----HPVFR 268 (268)
T ss_pred CC----------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc----CcccC
Confidence 11 01111223356778999999999999999999988 99985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.41 Aligned_cols=270 Identities=27% Similarity=0.367 Sum_probs=209.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc-ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4778889999999999999999899999999985432 223445778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++++|||.
T Consensus 80 ~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 80 YM-PSDLSEVLRDEE----------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred cc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 99 999999987642 3489999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP- 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 925 (1014)
+........ .......|+..|+|||.+.+. .++.++||||+|+++|||++|.++|.+.........+.........
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07832 146 ARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223 (286)
T ss_pred cccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence 987644221 122345789999999988654 4689999999999999999998888766543333322222111100
Q ss_pred ----chh-----ccc-cccC----CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 926 ----IVD-----ALD-KEID----EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 926 ----~~~-----~~~-~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
..+ .+. +.-. .....+....+.+++.+|++.||++||+++++++ ||||.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~----h~~~~ 286 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR----HPYFT 286 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh----CcCcC
Confidence 000 000 0000 0001122367789999999999999999999999 99984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.35 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=209.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.|.....||+|+||.||++.+..+++.||||.+.. ......+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec---chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 345556779999999999999988899999999833 23345667899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.++|+|||
T Consensus 99 e~~~~~~L~~~~~~~------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 99 EFLEGGALTDIVTHT------------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred eCCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence 999999999988542 378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...+.......+. .
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~---- 232 (292)
T cd06658 164 FCAQVSKEV---PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR----D---- 232 (292)
T ss_pred chhhccccc---ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h----
Confidence 987653321 12234568899999999988889999999999999999999999998655432221111 1
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
......... ......+.+++..|+..||++|||++|+++ ||||......+
T Consensus 233 --~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~----~~~~~~~~~~~ 282 (292)
T cd06658 233 --NLPPRVKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQ----HPFLKLAGPPS 282 (292)
T ss_pred --cCCCccccc--cccCHHHHHHHHHHccCChhHCcCHHHHhh----ChhhhccCCcc
Confidence 011111110 112234667888999999999999999998 99999776554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.95 Aligned_cols=261 Identities=29% Similarity=0.414 Sum_probs=210.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||++.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++..+...++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4677889999999999999999999999999985432 23556788999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ..+++....+++.|++.|++|||. ..+++|+||||+||++++++.++|+|||.
T Consensus 80 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 80 YMDGGSLDKILKEVQ----------GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred ecCCCcHHHHHHHcc----------CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999987641 347889999999999999999995 14999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc--hhHHHHHHHHHhcCCc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH--TCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~ 925 (1014)
+....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+. ....+..........+
T Consensus 148 ~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd06605 148 SGQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222 (265)
T ss_pred chhhHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC
Confidence 87653321 1126788999999999998999999999999999999999999975431 1122222222221111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.... .....++.+++..||..||++|||+.|++. ||||+..+
T Consensus 223 -------~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~----~~~~~~~~ 264 (265)
T cd06605 223 -------RLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE----HPFIKKYE 264 (265)
T ss_pred -------CCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh----Cchhhccc
Confidence 1100 013345778999999999999999999998 99997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.83 Aligned_cols=261 Identities=24% Similarity=0.228 Sum_probs=199.5
Q ss_pred eeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHc---CCCCccceEEEEEEcCCceEEEEEccc
Q 001778 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST---IRHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~---l~hpniv~l~~~~~~~~~~~lV~e~~~ 770 (1014)
+||+|+||.||++.+..+++.||+|.+.............+.+|..+++. .+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999855433223333444455544443 479999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~ 850 (1014)
+|+|.+++... ..+++..+..++.|++.|++|||.. +|+|+||||+||++++++.++++|||++..
T Consensus 81 ~~~L~~~i~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 81 GGDLHYHLSQH-----------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999988754 2489999999999999999999965 999999999999999999999999999875
Q ss_pred cccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 851 LIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 851 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
.... ......|+..|+|||.+.+ ..++.++||||+||++|||++|..||........... .......
T Consensus 147 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~------ 214 (279)
T cd05633 147 FSKK-----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTV------ 214 (279)
T ss_pred cccc-----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHHhhcC------
Confidence 4321 1123468999999998864 5688999999999999999999999976543322211 1111100
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCCCCcccc
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNGGRKYDH 989 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~~~~~~~ 989 (1014)
...+ ......++.+++.+|++.||++|| +++|+++ ||||+..........+
T Consensus 215 -~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~----h~~~~~~~~~~~~~~~ 270 (279)
T cd05633 215 -NVEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE----HVFFKGIDWQQVYLQK 270 (279)
T ss_pred -CcCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh----CccccCCCHhHHhcCC
Confidence 0011 112234567888999999999999 5877777 9999986655444333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.18 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=204.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccch--hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--Cce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK--LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 762 (1014)
.+|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 467888999999999999999999999999998743221 1234457889999999999999999999998763 467
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEE
Confidence 89999999999999987542 367888999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||.+.................|+..|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~ 224 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---IFKIATQ 224 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---HHHHhcC
Confidence 9999998654321111122345688999999999888899999999999999999999999976532211 1111111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.. ...........+.+++.+|+. +|++||+++|+++ |||+.
T Consensus 225 ~~----------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~----~~~~~ 265 (265)
T cd06652 225 PT----------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR----HTFVH 265 (265)
T ss_pred CC----------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc----CcccC
Confidence 10 011122333456778888985 9999999999988 99974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=306.65 Aligned_cols=256 Identities=27% Similarity=0.364 Sum_probs=209.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..++||+|+||.||.++...+++.|++|.+.... ......+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 4778899999999999999999999999999984332 234556778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.
T Consensus 80 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 80 YANGGTLYDKIVRQK---------GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred ecCCCcHHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcc
Confidence 999999999997641 23478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+........ ......+++.|+|||++.+..++.++||||+|+++|||++|..||........ ...... +.. .
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~~~~~-~~~-~ 219 (256)
T cd08221 148 SKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VVKIVQ-GNY-T 219 (256)
T ss_pred eEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHc-CCC-C
Confidence 986543221 22345789999999999888889999999999999999999999976543322 222221 111 0
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. .......++.+++.+||+.||++||++.|+++ |+|+
T Consensus 220 ~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~----~~~l 256 (256)
T cd08221 220 P---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLD----QPLL 256 (256)
T ss_pred C---------CccccCHHHHHHHHHHcccCcccCCCHHHHhh----CcCC
Confidence 0 01122345778899999999999999999998 7774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.08 Aligned_cols=257 Identities=24% Similarity=0.312 Sum_probs=210.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 477788899999999999999988999999998432 223456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++... .+++.....++.|++.|++|||+. +++|+||+|+||+++.++.++++|||+
T Consensus 83 ~~~~~~L~~~i~~~------------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 83 YLGGGSALDLLRAG------------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred cCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccc
Confidence 99999999998643 267888999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......++..|+|||++.+..++.++|+|||||++|||++|..||.......... ......
T Consensus 148 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~--- 217 (277)
T cd06640 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKNN--- 217 (277)
T ss_pred ceeccCCc---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcCC---
Confidence 97654322 11223467889999999988889999999999999999999999997654322111 111111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
...........+.+++.+||+.||++||++.|+++ |+||.....
T Consensus 218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~~ 261 (277)
T cd06640 218 -------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK----HKFIVKNAK 261 (277)
T ss_pred -------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh----ChHhhhcch
Confidence 11122334556788999999999999999999998 999976554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.98 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=200.8
Q ss_pred CCCceeccCCcEEEEEeeecCCCe--EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------Cc
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAE--VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------NL 761 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~ 761 (1014)
...+.||+|+||.||+|.+..+++ .||+|.+... .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456889999999999999877765 5899987442 22344567889999999999999999999987432 24
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++|+||+++|+|.+++...+.. .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc-----CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEE
Confidence 68999999999999988543211 1123589999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|+|||++........ ........+++.|+|||+..+..++.++||||||+++|||++ |+.||.+...... ....
T Consensus 153 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~ 227 (272)
T cd05075 153 VADFGLSKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYL 227 (272)
T ss_pred ECCCCcccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH
Confidence 999999987643221 111223356778999999999899999999999999999999 7888876544322 2222
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+.... . .......+.+++.+||+.||++|||+.|+++.|++
T Consensus 228 ~~~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 228 RQGNRLK------Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HcCCCCC------C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 2222100 0 11122346789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.31 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=204.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccch---hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK---LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+|+..+.||+|+||+||+|.. .+++.+|+|.+..+.. ........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 477889999999999999976 4678899998854321 223445678999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|
T Consensus 80 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 80 FMEFVPGGSISSILNRFG-----------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred EEecCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 999999999999997642 378899999999999999999965 999999999999999999999999
Q ss_pred cccccccccccC---ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 845 FGVAKILIKEEG---EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 845 fgla~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
||.+........ .........|+..|+|||++.+..++.++||||+||++|+|++|+.||...+...... ....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~ 222 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGA 222 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---Hhhh
Confidence 999876532111 1111224568999999999999889999999999999999999999997654321111 1111
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.... . +.... .....+.+++.+||+.||++||++.|+++ ||||
T Consensus 223 ~~~~-~----~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~----~~~~ 265 (265)
T cd06631 223 HRGL-M----PRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR----HDFL 265 (265)
T ss_pred ccCC-C----CCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc----CCCC
Confidence 1011 0 11111 12345678899999999999999999988 9997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.09 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=209.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ......+.+.+|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI---ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 4568889999999999999999988899999999843 2344557788999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+||
T Consensus 81 ~e~~~~~~L~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~ 147 (280)
T cd06611 81 IEFCDGGALDSIMLELE----------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADF 147 (280)
T ss_pred eeccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccC
Confidence 99999999999987642 2488999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|.+....... .......+++.|+|||++. ...++.++||||+|+++|||++|+.||...+.... .. ..
T Consensus 148 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---~~-~~ 220 (280)
T cd06611 148 GVSAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---LL-KI 220 (280)
T ss_pred ccchhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---HH-HH
Confidence 9987543221 1223456899999999875 34567899999999999999999999976543221 11 11
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
..... +.+.. .......+.+++..||+.||.+||++.++++ |||+....
T Consensus 221 ~~~~~------~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~----~~~~~~~~ 269 (280)
T cd06611 221 LKSEP------PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK----HPFVSDQS 269 (280)
T ss_pred hcCCC------CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhc----Chhhcccc
Confidence 11111 01100 1112235678899999999999999999988 99998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.39 Aligned_cols=258 Identities=25% Similarity=0.297 Sum_probs=210.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||.|+||.||+|.+..+++.||+|++...........+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999998999999999965443344567889999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 81 LLLGGDLRYHLSQK-----------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred CCCCCCHHHHHHhc-----------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999998764 2478899999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... ......|+..|+|||++.+..++.++|+||+|+++|+|++|..||........... .........
T Consensus 147 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-- 219 (258)
T cd05578 147 ATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-RAKQETADV-- 219 (258)
T ss_pred ccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH-HHHhccccc--
Confidence 98654321 22345688899999999988899999999999999999999999987664322222 211111110
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.........+.+++.+||+.||.+||++. ++.+.+||||
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 220 ---------LYPATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred ---------cCcccCcHHHHHHHHHHccCChhHcCCcc--HHHHhcCCCC
Confidence 11112235677899999999999999994 3444559997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.52 Aligned_cols=267 Identities=25% Similarity=0.429 Sum_probs=206.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
.+|+..+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457888899999999999998743 5678999998432 233445779999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCC-----------CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCC
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLS-----------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSS 830 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~ 830 (1014)
.++|+||+++|+|.+++......... .......+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 99999999999999999864221110 011223478999999999999999999965 9999999999
Q ss_pred CeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCc
Q 001778 831 NILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEH 909 (1014)
Q Consensus 831 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~ 909 (1014)
||+++.++.++|+|||.+........ .........+..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999876543221 111223345678999999998899999999999999999997 8788876554
Q ss_pred hhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..... ....+... +.......++.+++.+|++.||++|||+.|+++.|++
T Consensus 239 ~~~~~----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIY----YVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH----HHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 32222 12111110 0111223567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.43 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=199.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+.. +..+|+|++... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREG----AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccC----CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 57788999999999999998764 567999998432 1234568889999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 80 ~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 80 YMANGCLLNYLRERK----------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred cCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccc
Confidence 999999999997642 2478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~~~~~ 220 (256)
T cd05059 147 ARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVSAGYRL 220 (256)
T ss_pred ceeccccc--ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHHcCCcC
Confidence 97653311 111112234568999999998899999999999999999999 788887654432222 12111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
........++.+++.+||+.+|++|||+.|+++.|
T Consensus 221 ----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 ----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111234678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.19 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=202.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCe----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+|+..++||+|+||.||+|.+..+++ .||+|++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 357788999999999999999877766 4899988432 2344567789999999999999999999998764 46
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++++||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL 150 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK----------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKI 150 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEE
Confidence 79999999999999987631 2488999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+++........ .......++..|+|||...+..++.++|||||||++|||++ |..||..........++ .
T Consensus 151 ~dfG~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~ 225 (279)
T cd05109 151 TDFGLARLLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL----E 225 (279)
T ss_pred CCCCceeecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----H
Confidence 999999876432211 11223345678999999998899999999999999999998 88898765543333222 2
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+... +.......++.+++.+||+.||++||++.|+++.++.
T Consensus 226 ~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 226 KGERL----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred CCCcC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 21110 0011223457789999999999999999999988755
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=317.84 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=206.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.|+..+.||+|+||.||+|.+..+++.||+|.+... ......+.+.+|+.+++.++||||+++++++..+...++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc--cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 3466778899999999999999888999999998432 22344578999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||
T Consensus 82 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06642 82 EYLGGGSALDLLKPG------------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EccCCCcHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence 999999999988542 378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......++..|+|||++.+..++.++|||||||++|||++|+.||..........+ ...+.
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~-- 217 (277)
T cd06642 147 VAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPKNS-- 217 (277)
T ss_pred ccccccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhcCC--
Confidence 997654321 122234678999999999998899999999999999999999999875433221111 11111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
.+.+. ......+.+++.+||+.+|++||++.|+++ |||+..
T Consensus 218 ----~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~~~ 258 (277)
T cd06642 218 ----PPTLE----GQYSKPFKEFVEACLNKDPRFRPTAKELLK----HKFITR 258 (277)
T ss_pred ----CCCCC----cccCHHHHHHHHHHccCCcccCcCHHHHHH----hHHHHH
Confidence 11111 122345778999999999999999999999 888754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.20 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=205.5
Q ss_pred CCCCCCceeccCCcEEEEEeeec-----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~ 760 (1014)
++|...+.||+|+||.||+|.+. ..++.||+|++.... .....+.+.+|+.++..+. ||||+++++++...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 45777899999999999999864 345689999995432 2333457889999999997 999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCC------------------------------------------------------
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSL------------------------------------------------------ 786 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 786 (1014)
..++|+||+++|+|.++++..+....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999986532100
Q ss_pred ---------------------------------CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 787 ---------------------------------SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 787 ---------------------------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
........+++.....++.|++.||+|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 0001123578899999999999999999955 9999999999999
Q ss_pred ecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhH
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~ 912 (1014)
+++++.+|++|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999865332211 11223457889999999998889999999999999999998 888987543221
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.....+..+... ........++.+++.+||+.||.+||+++|+++.|++
T Consensus 350 --~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 --QFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred --HHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111222222110 0111123467788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.91 Aligned_cols=269 Identities=24% Similarity=0.265 Sum_probs=208.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999999999999999999855433334456788899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.
T Consensus 82 ~~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 82 YVEGGDCATLLKNIG-----------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999997642 378899999999999999999965 999999999999999999999999998
Q ss_pred ccccccccC------------ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 848 AKILIKEEG------------EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 848 a~~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
++....... .........++..|+|||++.+..++.++|+|||||++|||++|..||.+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~--- 224 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--- 224 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 864211000 00011134578899999999888899999999999999999999999986553322
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.......... .+... . .....+.+++.+||+.||++||++.++.+ +.+||||....+.
T Consensus 225 ~~~~~~~~~~-----~~~~~-~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~-ll~~~~~~~~~~~ 282 (305)
T cd05609 225 FGQVISDDIE-----WPEGD-E---ALPADAQDLISRLLRQNPLERLGTGGAFE-VKQHRFFLGLDWN 282 (305)
T ss_pred HHHHHhcccC-----CCCcc-c---cCCHHHHHHHHHHhccChhhccCccCHHH-HHhCccccCCCHH
Confidence 1111111111 00000 0 12334678999999999999998544433 3338999775554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.89 Aligned_cols=267 Identities=25% Similarity=0.396 Sum_probs=206.9
Q ss_pred CCCCCCceeccCCcEEEEEeeec-------CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-------HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 758 (1014)
++|++.+.||+|+||.||+|.+. ..+..||+|.+... ......+.+.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 45778899999999999999753 23457999988432 2334567889999999999 89999999999999
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
....++||||+++|+|.+++.......... ......+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999998753221100 11234689999999999999999999965 9999999999999
Q ss_pred ecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhH
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~ 912 (1014)
++.++.+||+|||.++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||.+......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999987643221 112223456778999999998889999999999999999998 7788876543322
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+ ....+... .........+.+++.+||+.+|++||++.|+++.|++
T Consensus 249 ~~----~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 249 FK----LLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred HH----HHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 22 22222210 0111233567789999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.55 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=204.8
Q ss_pred CCCCCCceeccCCcEEEEEeeec-----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
.+|...+.||+|+||.||++... .++..||+|.+.. ......+.+.+|+++++.++|+||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc---CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 35677889999999999998642 3466899998743 234556789999999999999999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCC----CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSL----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
.++|+||+++|+|.+++........ ........+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999986432100 0011123589999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~ 916 (1014)
+.+||+|||++....... .........+++.|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 159 ~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 999999999997653321 1111223445788999999998899999999999999999998 88898765443322211
Q ss_pred HHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... .. .......+.+++.+||+.||++||+++||.+.|+.
T Consensus 238 ----~~~~~~------~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ----TQGREL------ER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HcCccC------CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111110 00 01122346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.22 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=204.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh-------hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-------DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
+|...+.||+|+||.||+|....+++.||+|.+...... .....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999999888999999987432111 1123457889999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++|+||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 999999999999999998764 2378889999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCC--CCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK--VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+++|||++........ ........|+..|+|||++.... ++.++|+||+|+++|++++|..||...+... ....
T Consensus 148 ~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~ 223 (272)
T cd06629 148 KISDFGISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFK 223 (272)
T ss_pred EEeecccccccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHH
Confidence 9999999976432111 11223456889999999987654 7899999999999999999999996543221 1111
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...... ...+.... .......+.+++..|+++||++||+++||++ |||+
T Consensus 224 ~~~~~~--~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~----~~~~ 272 (272)
T cd06629 224 LGNKRS--APPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ----HPFI 272 (272)
T ss_pred hhcccc--CCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh----CCCC
Confidence 111100 01111111 1122356778899999999999999999999 9986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.79 Aligned_cols=275 Identities=25% Similarity=0.333 Sum_probs=210.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchh--hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL--DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|.+...... .......+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467778999999999999999988999999998543322 123456678899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||.. +|+|+||+|+||+++.++.++|+||
T Consensus 81 ~e~~-~~~L~~~i~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred Eccc-CCCHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 9999 899999997642 2489999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|....................
T Consensus 147 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 147 GLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred eeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 99987644221 2223456788999998854 4678999999999999999999888876554322222111110000
Q ss_pred c--------chhccccccCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 925 P--------IVDALDKEIDEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 925 ~--------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. ...........+ ........+.+++.+||+.||++|||++|+++ |+||+.....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~----~~~~~~~~~~ 291 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE----HPYFSNDPAP 291 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh----CccccCCCCC
Confidence 0 000000000000 11223456789999999999999999999999 9999996644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.30 Aligned_cols=260 Identities=23% Similarity=0.251 Sum_probs=207.7
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||.|++|.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999999655444455678899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDRG-----------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99997642 378899999999999999999965 9999999999999999999999999999876432
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEI 934 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1014)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..+...........
T Consensus 147 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------- 212 (262)
T cd05572 147 Q----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGK--------- 212 (262)
T ss_pred c----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCC---------
Confidence 1 122356889999999998888999999999999999999999999866531 12222222210100
Q ss_pred CCcccHHHHHHHHHHHhHccCCCCCCCCCH-HHHHHHHhcCCCCCCCCCC
Q 001778 935 DEPCFLEEMIRVFKLGVICTSMLPTERPNM-RMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ev~~~L~~~~~~~~~~~~ 983 (1014)
..........+.+++.+||+.||++||++ ...++.+.+||||....+.
T Consensus 213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 01111114567889999999999999992 2234445559999876543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.25 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=201.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4777889999999999999999999999999985432 222334667889999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++ ++|.+++...+ ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 80 YCD-QDLKKYFDSCN----------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred cCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccch
Confidence 997 58888876532 2488999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCc-hhHHHHHHHHH-----
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEH-TCLAQWAWRHI----- 920 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~-~~~~~~~~~~~----- 920 (1014)
+....... .......++..|+|||++.+. .++.++||||+||++|||++|+.|+..... ......+....
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07839 146 ARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222 (284)
T ss_pred hhccCCCC---CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 97653321 122345678899999988764 478999999999999999999998653322 21111111110
Q ss_pred ------hcCCcc--hhccccccC-CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 921 ------QEGKPI--VDALDKEID-EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 921 ------~~~~~~--~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...... ......... .........++.+++.+||+.||.+|||++|+++ ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~----h~~f 284 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ----HPYF 284 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc----CCCC
Confidence 000000 000000000 0001112345678999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.45 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++|||++++++.+..++..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc-cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 4778899999999999999999999999999985432 234456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-CcEEEeecc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFG 846 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~~kl~Dfg 846 (1014)
|+++++|.+++.... ...+++..+.+++.+++.|++|||+. +++|+||+|+||+++.+ +.+|++|||
T Consensus 80 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 80 YAPGGTLAEYIQKRC---------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred cCCCCCHHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999997642 23478999999999999999999965 99999999999999855 468999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....... .......
T Consensus 148 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~---~~~~~~~- 219 (256)
T cd08220 148 ISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK---IMSGTFA- 219 (256)
T ss_pred CceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH---HHhcCCC-
Confidence 998654321 12245688999999999988899999999999999999999999977654322221 1111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. + .......+.+++..||+.||++|||+.|+++ |||+
T Consensus 220 -~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~----~p~~ 256 (256)
T cd08220 220 -P-----I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA----QPIC 256 (256)
T ss_pred -C-----C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh----CCCC
Confidence 0 0 1112335678899999999999999999999 9986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=314.26 Aligned_cols=261 Identities=28% Similarity=0.381 Sum_probs=209.1
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+....|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+++++.++||||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34456788999999999999999999888999999998544334445567789999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||++ |++.+++.... ..+++..+..++.|++.||.|||.. +|+||||+|+||++++++.++|
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK----------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEE
Confidence 99999997 57777775431 2478999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
+|||++..... .....+++.|+|||++. ...++.++||||||+++|||++|+.||...+..... ...
T Consensus 157 ~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~~~ 226 (307)
T cd06607 157 ADFGSASLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI 226 (307)
T ss_pred eecCcceecCC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---HHH
Confidence 99999875432 12346788999999874 456888999999999999999999999765533221 111
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.....+ ... .......+.+++.+||+.||++||++.+++. ||||....
T Consensus 227 ~~~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~ 274 (307)
T cd06607 227 AQNDSP-------TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK----HRFVLRER 274 (307)
T ss_pred hcCCCC-------CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhc----ChhhcccC
Confidence 111111 111 1123345788999999999999999999988 99998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=340.96 Aligned_cols=265 Identities=24% Similarity=0.235 Sum_probs=214.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.|.+.++||+|+||+|..++.+.++++||+|++.+-.........-|..|-++|..-+.+-|+.++.+|+++..+|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 46889999999999999999999999999999995544444556778899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||+||+|..++.+.. ++++..+..++..|..||..+|.. |+|||||||+|||+|..|++|++|||
T Consensus 155 dY~pGGDlltLlSk~~-----------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD-----------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ecccCchHHHHHhhcC-----------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999998752 588999999999999999999966 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccc----c-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYAR----T-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
.+-.+..++ .......+|||.|++||++. + +.|++.+|+||+||++|||+.|..||+.+. +..-...++.
T Consensus 221 sClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---lveTY~KIm~ 295 (1317)
T KOG0612|consen 221 SCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---LVETYGKIMN 295 (1317)
T ss_pred hHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---HHHHHHHHhc
Confidence 998775432 23445789999999999985 2 578999999999999999999999999765 3333333333
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHHhcCCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN---MRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.... +..|.-.....+..++|.+.+. +|+.|.. +.|+.. ||||.+..|.
T Consensus 296 hk~~--------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----HpFF~g~~W~ 347 (1317)
T KOG0612|consen 296 HKES--------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----HPFFEGIDWD 347 (1317)
T ss_pred hhhh--------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----CccccCCChh
Confidence 2111 1111111122344456665555 6888887 777666 9999999984
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=314.52 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=202.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCe--EEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAE--VVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 763 (1014)
++|+..++||+|+||.||+|.+..++. .+++|.+.. .......+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 468888999999999999998877664 468887742 22334456789999999999 7999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCC-----CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLS-----GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
+|+||+++|+|.++++........ .......+++..+..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 999999999999999764321110 011123589999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 157 ~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~-- 230 (297)
T cd05089 157 ASKIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-- 230 (297)
T ss_pred eEEECCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 999999999864211 111112233567999999998889999999999999999997 9999976654332221
Q ss_pred HHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
...+.. .+........+.+++.+||+.||.+||+++++++.|++
T Consensus 231 --~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 231 --LPQGYR----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred --HhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 00111123456789999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.66 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=204.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCe---EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
.|+..+.||+|+||.||+|.+..+++ .||||.+... ........+..|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 46778899999999999999877654 5999998442 234456789999999999999999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|
T Consensus 83 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~d 149 (269)
T cd05065 83 ITEFMENGALDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (269)
T ss_pred EEecCCCCcHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECC
Confidence 999999999999987642 2378999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCcccccccc--ccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 845 FGVAKILIKEEGEFAAMSTV--VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
||.+................ ..+..|+|||++.+..++.++||||+||++||+++ |..||...+......++ .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i----~ 225 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI----E 225 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH----H
Confidence 99987654322211111111 12457999999999899999999999999999886 99999776544333322 1
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.... .+...+....+.+++..||+.+|++||++++++..|++
T Consensus 226 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 226 QDYR----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred cCCc----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1111 01111223456788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.57 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=193.1
Q ss_pred ceeccCCcEEEEEeeecC--CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEccc
Q 001778 693 NVIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 770 (1014)
+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 358999999999997653 45679999884432 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~ 850 (1014)
+|+|.+++...... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.+..
T Consensus 79 ~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 79 LGDLKGYLRSCRKA------ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCcHHHHHHHhhhc------ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccc
Confidence 99999999764221 123467788889999999999999965 999999999999999999999999999975
Q ss_pred cccccCccccccccccCcccccccccccC-------CCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhc
Q 001778 851 LIKEEGEFAAMSTVVGSCGYIAPEYARTR-------KVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 851 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
..... .........++..|+|||++.+. .++.++||||||+++|||++ |+.||............ ...
T Consensus 150 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~ 225 (269)
T cd05087 150 KYKED-YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VRE 225 (269)
T ss_pred ccCcc-eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhc
Confidence 43321 11122345678899999988642 35789999999999999996 99999765543322211 111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
.. ....++..... ....+.+++..|| .||++|||++||++.|+
T Consensus 226 ~~--~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQ--LKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cc--CCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 10 11111111111 1224567888898 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.78 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=199.6
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|+..+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 46777889999999999997754 4459999884322 234678999999999999999999999999889999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++|+|.+++.... ..+++..++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 80 ~~~~~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 80 YMSNGCLLNYLREHG----------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred cCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcc
Confidence 999999999987632 2478999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||........... ...+...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~ 220 (256)
T cd05113 147 SRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQGLRL 220 (256)
T ss_pred ceecCCCc--eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HhcCCCC
Confidence 87654321 111223345678999999998889999999999999999998 8899876553322221 1111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
.. .......+.+++..||+.||++||++.++++.|+
T Consensus 221 ------~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ------YR----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 0012346778999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.12 Aligned_cols=257 Identities=26% Similarity=0.307 Sum_probs=207.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+++.+|+|++... .....+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5688889999999999999999888999999998543 2235678899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 80 e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g 146 (262)
T cd06613 80 EYCGGGSLQDIYQVTR----------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFG 146 (262)
T ss_pred eCCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccc
Confidence 9999999999987641 2478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccC---CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR---KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
.+....... .......++..|+|||.+... .++.++||||||+++|||++|+.||.......... ......
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~~~~ 220 (262)
T cd06613 147 VSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSN 220 (262)
T ss_pred cchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcc
Confidence 997654321 122345688899999998776 88899999999999999999999997654322111 111110
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
.. ..... ........+.+++.+||..||.+|||+.+++. |+|
T Consensus 221 ~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~----~~~ 262 (262)
T cd06613 221 FP-----PPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ----HPF 262 (262)
T ss_pred CC-----Ccccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc----CCC
Confidence 00 00011 11223346788999999999999999999988 876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.92 Aligned_cols=253 Identities=30% Similarity=0.438 Sum_probs=200.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+..+ ..||+|++.... ...+.+.+|+.+++.++||||+++++.+.. ...++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 4688899999999999999988655 459999985322 234578999999999999999999998754 4579999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 80 EYMSKGSLLDFLKGEM---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred EcCCCCcHHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCC
Confidence 9999999999997631 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+........ .......++..|+|||+..+..++.++||||||+++|||++ |..||......... .....+..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~----~~~~~~~~ 221 (262)
T cd05071 148 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVERGYR 221 (262)
T ss_pred ceeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH----HHHhcCCC
Confidence 9976543221 11223456778999999988899999999999999999999 77788765433221 11111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+|++.||++||+++++.+.|+.
T Consensus 222 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11122334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=306.77 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=201.8
Q ss_pred ceeccCCcEEEEEeeecC-CC--eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcc
Q 001778 693 NVIGSGGSGKVYRVPINH-TA--EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
+.||+|++|.||+|.+.. .+ ..||+|.+..+... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998865 33 36999998543322 567889999999999999999999999988 8899999999
Q ss_pred cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
++|+|.+++..... ..+++...+.++.|++.||+|||.. +++|+||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~ 145 (257)
T cd05040 78 PLGSLLDRLRKDAL---------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMR 145 (257)
T ss_pred CCCcHHHHHHhccc---------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccc
Confidence 99999999987421 3489999999999999999999965 99999999999999999999999999998
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
................++..|+|||++.+..++.++|||||||++|||++ |+.||............. .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~--- 219 (257)
T cd05040 146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---KEGER--- 219 (257)
T ss_pred cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCc---
Confidence 77543332222234567889999999999899999999999999999998 999997655433222221 11111
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
. .........+.+++.+|++.+|++||+++|+++.|.
T Consensus 220 -----~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -----L--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----C--CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 011122346778999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.94 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=206.2
Q ss_pred CCceeccCCcEEEEEeeecCCCeEEEEEEec-ccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc--eEEEEE
Q 001778 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIW-NDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL--KLLVYE 767 (1014)
Q Consensus 691 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~--~~lV~e 767 (1014)
...+||+|+|-+||+|.+..+|..||=-.+. .+...++...++|..|+.+|+.++||||+++++++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999999888887632221 1222344556899999999999999999999999987654 778999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcEEEeecc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFG 846 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~kl~Dfg 846 (1014)
.+..|+|..|.++.+. +.....+.|++||++||.|||.+ .++|+|||||-+||||+. .|.|||+|+|
T Consensus 124 L~TSGtLr~Y~kk~~~-----------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-----------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred cccCCcHHHHHHHhcc-----------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence 9999999999998643 77889999999999999999987 889999999999999975 5789999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|....... .....|||.|||||... ..|.+.+||||||+.++||.|+.+||..... ..++++.+..|...
T Consensus 192 LAtl~r~s~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 192 LATLLRKSH-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---PAQIYKKVTSGIKP 262 (632)
T ss_pred HHHHhhccc-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---HHHHHHHHHcCCCH
Confidence 999865422 22478999999999988 6899999999999999999999999976543 23344444444431
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
. .+.+. ...++.++|.+|+.. ..+|||+.|++. ||||+.+
T Consensus 263 ~-sl~kV--------~dPevr~fIekCl~~-~~~R~sa~eLL~----d~Ff~~d 302 (632)
T KOG0584|consen 263 A-ALSKV--------KDPEVREFIEKCLAT-KSERLSAKELLK----DPFFDED 302 (632)
T ss_pred H-Hhhcc--------CCHHHHHHHHHHhcC-chhccCHHHHhh----Chhhccc
Confidence 1 11111 123567889999999 999999999988 9999997
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.65 Aligned_cols=253 Identities=30% Similarity=0.447 Sum_probs=200.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.++++++|++++++++++.. ...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT----MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC----CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 46788899999999999999765 45669999985422 234678999999999999999999998854 5578999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 80 EYMSKGSLLDFLKDGE---------GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EecCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCce
Confidence 9999999999997631 23478999999999999999999966 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+.....+.. .....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~ 221 (260)
T cd05070 148 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV----ERGYR 221 (260)
T ss_pred eeeeccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCC
Confidence 9976543211 11123345678999999988889999999999999999999 88888765543322221 11111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+|+++||++|||++++.+.|++
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ----------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111223457789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.15 Aligned_cols=271 Identities=25% Similarity=0.369 Sum_probs=215.3
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
..+|...+.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 46788899999999999999998888899999998332 233456789999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+|+||+||+++.++.++|+||
T Consensus 95 ~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 95 MEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EecCCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999998653 368889999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|++........ ......|++.|+|||.+....++.++||||||+++|++++|+.||........ .......+.+
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~ 233 (293)
T cd06647 160 GFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTP 233 (293)
T ss_pred cceeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcCCCC
Confidence 99876543221 22345688999999999888899999999999999999999999976543211 1111111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcccccccccchh
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKYDHVTPLLTDS 997 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1014)
.. .........+.+++..||+.||++||++.+++. |+||+..+.. .+.+|.....
T Consensus 234 -------~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~----h~~~~~~~~~----~~~~~~~~~~ 288 (293)
T cd06647 234 -------EL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ----HPFLKIAKPL----SSLTPLIAAA 288 (293)
T ss_pred -------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc----CHHHhcCccc----ccccchHHHh
Confidence 00 111122335678899999999999999999998 9999765533 4555554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=312.46 Aligned_cols=262 Identities=25% Similarity=0.300 Sum_probs=204.5
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC---
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE--- 759 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~--- 759 (1014)
+...+|+..+.||+|+||.||+|....+++.||+|++... ......+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4567799999999999999999999999999999998432 12345677899999998 899999999998653
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
+..++|+||+++|+|.++++... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLL-------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhh-------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 35899999999999999887531 1223588999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccccC-----CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-----KVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||...+....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred CCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 9999999999886543221 12235688999999987643 367899999999999999999999976543211
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
... ...... . .+. ...+....+.+++.+||+.||++||++.|+++ ||||.
T Consensus 242 ---~~~-~~~~~~-~-----~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~----~~~~~ 291 (291)
T cd06639 242 ---LFK-IPRNPP-P-----TLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE----HPFIK 291 (291)
T ss_pred ---HHH-HhcCCC-C-----CCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc----CcccC
Confidence 111 111111 0 010 01122345778999999999999999999998 99984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=310.98 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=201.9
Q ss_pred CCCCCceeccCCcEEEEEeee----cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--Cc
Q 001778 688 KLTESNVIGSGGSGKVYRVPI----NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~ 761 (1014)
.|++.+.||+|+||.||.+.. ..+++.||+|.+... ........+.+|+.+++.++|||++++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 467889999999999999874 456788999998432 2344467899999999999999999999998775 56
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence 799999999999999986531 2479999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCch-----------
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT----------- 910 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~----------- 910 (1014)
|+|||++.................++..|+|||++.+..++.++|||||||++|||++++.|+......
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 999999987654332222223455677899999998888999999999999999999987765432110
Q ss_pred hHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 911 CLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
............+.. .+........+.+++.+||+.||++||+++++++.+++
T Consensus 230 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 230 MTVTRLVRVLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred ccHHHHHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 000111111111111 01111233568889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=328.83 Aligned_cols=363 Identities=27% Similarity=0.377 Sum_probs=198.6
Q ss_pred CcceecccccccC-CCCCcccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhc
Q 001778 120 KLEYLDLSQNYFI-GPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALEL 198 (1014)
Q Consensus 120 ~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 198 (1014)
-.+-.|+++|.|+ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-..++.|+.|+.+.+
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3444555555555 234444455555555555555444 44555555555555555555444 33333444444444444
Q ss_pred ccccCCCCCCCCcccccccccceeecccccc-cCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCC
Q 001778 199 AYNTEFSPSSLPSNFTQLKKLKKLWMASTNL-IGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSL 277 (1014)
Q Consensus 199 ~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l-~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 277 (1014)
..| ++ ...||..+..+..|+.||||+|+++ ..|..+...+++-.|+|++|+|
T Consensus 86 R~N--------------------------~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 86 RDN--------------------------NLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred hcc--------------------------ccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 433 43 2345666777777777777777777 5677776666666666666666
Q ss_pred CCCCCcccccc-ccceeeccccccCCCCCCcccccccccccccccceecccCCcccCCCCCCCcccccCCccc-ccCCcc
Q 001778 278 SGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS-GALPPD 355 (1014)
Q Consensus 278 ~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~ 355 (1014)
..++...+..+ .|-.||||+|++. ..|..+..+..|++|+|++|.+.-..-..+..|++|+.|.+++.+=+ ..+|.+
T Consensus 139 etIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts 217 (1255)
T KOG0444|consen 139 ETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS 217 (1255)
T ss_pred ccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCc
Confidence 64443333332 4555555555555 34444555555555555555444222222333444444444443311 133444
Q ss_pred ccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCcccccccccc
Q 001778 356 FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLS 435 (1014)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~ 435 (1014)
+..+.+|..+|+|.|++ . ..|+.+.++.+|+.|+|++|+|+. +-...
T Consensus 218 ld~l~NL~dvDlS~N~L------------------------p-~vPecly~l~~LrrLNLS~N~ite-L~~~~------- 264 (1255)
T KOG0444|consen 218 LDDLHNLRDVDLSENNL------------------------P-IVPECLYKLRNLRRLNLSGNKITE-LNMTE------- 264 (1255)
T ss_pred hhhhhhhhhccccccCC------------------------C-cchHHHhhhhhhheeccCcCceee-eeccH-------
Confidence 44444444444444433 3 445555555555555555555551 11111
Q ss_pred cccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceEEEccCCcccc-ccccccccccccceeccccccc
Q 001778 436 MVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNG-TIPGELTALPSLTTLLLDQNQL 514 (1014)
Q Consensus 436 ~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l 514 (1014)
..-.+|+.|+||.|+++ .+|.+++.++.|+.|.+.+|+++- -+|..++.|.+|+.+..++|+|
T Consensus 265 ---------------~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 265 ---------------GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred ---------------HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence 01125666666666666 667777777777777777777542 3566677777777777777776
Q ss_pred CCCCcccccccccccceeccccccccccCcccccccccceeecCCCccc
Q 001778 515 SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFS 563 (1014)
Q Consensus 515 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 563 (1014)
. .+|+.+..+.+|+.|.|++|++- .+|+++.-|+.|+.|||..|.-.
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 5 66777777777777777777665 56667777777777777666543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.35 Aligned_cols=285 Identities=22% Similarity=0.269 Sum_probs=230.6
Q ss_pred ccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC
Q 001778 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 682 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~ 760 (1014)
+.-....|....+||+|+||+|-.+..+.+.+.+|||+++++........+--+.|-+++..- +-|.++.++.+|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 333445678889999999999999999999999999999776555555555566777777766 6789999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
++|+||||+.||+|.-.++.-+. +.+..+.-++.+||-||-+||. +||++||+|.+|||+|.+|++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~Gk-----------FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGK-----------FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcc-----------cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCce
Confidence 99999999999999999988653 7777888999999999999995 599999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
||+|||+++.-.-. .....+.+|||.|+|||++..++|+..+|+|||||++|||+.|++||++++++++.+.+..
T Consensus 490 Ki~DFGmcKEni~~---~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e-- 564 (683)
T KOG0696|consen 490 KIADFGMCKENIFD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME-- 564 (683)
T ss_pred EeeecccccccccC---CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--
Confidence 99999999753221 1234478999999999999999999999999999999999999999999987665544332
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCCcccccccccchhh
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKNGGRKYDHVTPLLTDSK 998 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1014)
... .++.....+.+.++...+.+.|.+|.... +--+.++.||||+...|.+-+...+.|+..+..
T Consensus 565 -hnv------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 565 -HNV------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred -ccC------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 222 22333445667788889999999998432 223566679999998888777666666665544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=320.64 Aligned_cols=277 Identities=26% Similarity=0.326 Sum_probs=208.1
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
+.++|+..+.||+|+||.||+|.+..+++.||+|++.. .........+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecc--cccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 34678999999999999999999999999999999842 12233456788899999999999999999887544
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
...++|+||+++ ++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~------------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~ 144 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQ------------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCD 144 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCC
Confidence 357999999974 888877543 388999999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+||+|||++.................|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~ 224 (336)
T cd07849 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224 (336)
T ss_pred EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999865432222222234578999999998654 5688999999999999999999999976553322222211
Q ss_pred HHhcCCc--chhccc-----------cccCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 919 HIQEGKP--IVDALD-----------KEIDEP---CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 919 ~~~~~~~--~~~~~~-----------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
....... ...... .....+ .......++.+++.+||+.||++|||+.|+++ ||||..-..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~----hp~~~~~~~ 300 (336)
T cd07849 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA----HPYLEQYHD 300 (336)
T ss_pred HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc----CccccccCC
Confidence 1111000 000000 000000 01112346789999999999999999999998 999987654
Q ss_pred C
Q 001778 983 G 983 (1014)
Q Consensus 983 ~ 983 (1014)
.
T Consensus 301 ~ 301 (336)
T cd07849 301 P 301 (336)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=311.99 Aligned_cols=262 Identities=25% Similarity=0.294 Sum_probs=202.9
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEE----
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCIS---- 757 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~---- 757 (1014)
.+..++|+..+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34567899999999999999999999999999999987332 12245678899999999 7999999999873
Q ss_pred -cCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC
Q 001778 758 -SENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 758 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~ 836 (1014)
.++..++||||+++++|.+++.... .....+++..+..++.|+++|+.|||.. +++||||||+||++++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFL-------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhh-------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 3456899999999999999886431 1123578899999999999999999965 9999999999999999
Q ss_pred CCcEEEeecccccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 837 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
++.+|++|||++....... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred CCCEEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 9999999999987653321 12234568999999998753 457889999999999999999999997654321
Q ss_pred HHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. .. ...... +....+ .....++.+++.+||+.||++||++.|+++ |+||
T Consensus 237 ~~---~~-~~~~~~------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~----~~~~ 286 (286)
T cd06638 237 AL---FK-IPRNPP------PTLHQP--ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ----HVFI 286 (286)
T ss_pred HH---hh-ccccCC------CcccCC--CCcCHHHHHHHHHHccCCcccCCCHHHHhh----cccC
Confidence 11 10 111110 011000 011235778999999999999999999999 9886
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.84 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=205.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC-------CeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-------AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 758 (1014)
++|.+.+.||+|+||.||++.+... ...||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4688899999999999999976432 346999998543 2234456788999999999 79999999999999
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
++..++|+||+++|+|.+++.......... ......+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 999999999999999999998753211100 01234589999999999999999999965 9999999999999
Q ss_pred ecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhH
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~ 912 (1014)
++.++.+||+|||.+........ ........++..|+|||++.+..++.++||||+||++|||++ |..||........
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999876533111 111112234578999999998889999999999999999998 8888876543222
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.. ....+.. .+.......++.+++.+||+.+|++||++.||++.|++
T Consensus 252 ~~----~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 252 FK----LLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HH----HHHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 21 2222211 01111223467789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=314.79 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=205.4
Q ss_pred CCCCCCceeccCCcEEEEEeeec-------CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-------HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 758 (1014)
++|.+.+.||+|+||.||+|.+. .....||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 46788899999999999999753 23457999988532 2334567789999999999 69999999999999
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCC-----CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLS-----GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
++..++|+||+++|+|.+++......... .......+++.++.+++.|++.||.|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 99999999999999999999775321110 011224589999999999999999999965 9999999999999
Q ss_pred ecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhH
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~ 912 (1014)
++.++.+||+|||.++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY-YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EcCCCcEEEcccccccccccccc-ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986543211 111112234568999999998899999999999999999999 8888876553322
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.. ....+... ........++.+++.+||+.||++||++.|+++.|++.
T Consensus 246 ~~----~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FK----LLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH----HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22 22222110 01112233567899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.86 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=198.6
Q ss_pred ceeccCCcEEEEEeeecCCCe--EEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEcc
Q 001778 693 NVIGSGGSGKVYRVPINHTAE--VVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
++||+|+||.||+|.+..++. .+|+|.+.. .......+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc--cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999887765 468888742 22344556889999999999 8999999999999999999999999
Q ss_pred cCCCHHHHhhhcCCCCC-----CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 770 EKRSLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
++|+|.+++........ ........+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 99999999986532110 0011223588999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||++..... .........+..|+|||++....++.++|||||||++|||++ |..||.+.+.....+. ...+
T Consensus 156 fgl~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~ 227 (270)
T cd05047 156 FGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LPQG 227 (270)
T ss_pred CCCccccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----HhCC
Confidence 999863211 111112234667999999988889999999999999999997 9999976553322221 1111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
... +........+.+++.+||+.||.+||++.|+++.|++
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 110 0111123457789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=310.13 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=206.9
Q ss_pred CCCCCCceeccCCcEEEEEeeecC----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-CCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-ENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~ 761 (1014)
++|+..++||+|+||.||+|.+.. .+..||+|++.. .........+.+|+.+++.++||||+++++++.. +..
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999998876 357899998843 2344556788999999999999999999998765 577
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++++||+++|+|.+++....... ......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGE---ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccc---cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 899999999999999997653211 01224589999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|+|||+++.+..... ........++..|+|||++.+..++.++|||||||++||+++ |+.||..........+ .
T Consensus 158 l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~ 232 (280)
T cd05043 158 ITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY----L 232 (280)
T ss_pred ECCCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH----H
Confidence 999999986543221 111223456778999999998889999999999999999999 9999976554332222 1
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... ........++.+++.+||+.||++|||+.|+++.|++
T Consensus 233 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 233 KDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred HcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111110 0011123457789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=299.01 Aligned_cols=276 Identities=24% Similarity=0.282 Sum_probs=217.7
Q ss_pred ccccccccc-CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-C-C----cc
Q 001778 677 RLNFRDSDI-LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-H-L----NI 749 (1014)
Q Consensus 677 ~~~~~~~~~-~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-p----ni 749 (1014)
..-+...+. .++|.+...+|+|+||.|-++.+..++..||||++++ -.+..++.+-|++++.++. + | -+
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 344444333 7889999999999999999999999999999999833 3455677888999999993 2 2 37
Q ss_pred ceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCC
Q 001778 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKS 829 (1014)
Q Consensus 750 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~ 829 (1014)
|.+.+||+..++.++|+|.+ |-|+.+++..++ ..+++...+..|++|+++++++||+. +++|.|+||
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~---------y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKP 220 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENN---------YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKP 220 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCC---------ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCCh
Confidence 78889999999999999988 459999998863 45689999999999999999999966 999999999
Q ss_pred CCeeecC--------------------CCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchh
Q 001778 830 SNILLDY--------------------NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYS 889 (1014)
Q Consensus 830 ~NIll~~--------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwS 889 (1014)
+||++.+ ...++|+|||.|+.... ..+..+.|..|+|||++.+-.++.++||||
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchheeccCcCCccCcee
Confidence 9999831 34589999999986433 224678899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccc----------c---------------C--------C
Q 001778 890 FGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE----------I---------------D--------E 936 (1014)
Q Consensus 890 lGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~---------------~--------~ 936 (1014)
+|||++|++||...|+..+..+-...+..++ .+.| ...+.+. + + .
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMerIl-Gp~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMMERIL-GPIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM 372 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHHHhh-CCCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence 9999999999999999876544332222221 1211 1111111 0 0 0
Q ss_pred cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 937 PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.....+..++++++..|+..||.+|+|+.|++. ||||+.-.
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~----HpFF~~~~ 413 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALS----HPFFARLT 413 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhc----CHHhhcCC
Confidence 122455667999999999999999999999999 99998754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.60 Aligned_cols=268 Identities=26% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||+|.+..+++.||||++..+. ........+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 3677889999999999999999899999999885432 222344678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++ ++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++|||+
T Consensus 80 ~~~-~~l~~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 80 FLH-QDLKKFMDASP---------LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred ccc-cCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 996 68998886542 23488999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCC-CCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP- 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 925 (1014)
+....... .......++..|+|||++.+.. ++.++|||||||++|||+||+.||.+.+.................
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 147 ARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred hhhcccCc---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 87653321 1222345688999999887644 688999999999999999999999876543222111111100000
Q ss_pred --------------chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 --------------IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
+.....+... .........+.+++.+|++.||++|||++|+++ ||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~----~~~f 284 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA----HPFF 284 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc----CCCC
Confidence 0000000000 000111234668999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=284.42 Aligned_cols=265 Identities=23% Similarity=0.367 Sum_probs=207.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.++...-||.|+.|.||+++.+.++...|||.+.. ..+..+.+++...++++..- ..|+||+.+|||..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r--t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR--TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecc--cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34556679999999999999999999999999944 44566678888888887665 4899999999999998899999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|.|.. .+..+++.. ..++++.-.-++.+.+..||.||.+. ++|+|||+||+|||+|+.|.+|+||||
T Consensus 171 elMs~-C~ekLlkri----------k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRI----------KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHH-HHHHHHHHh----------cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccc
Confidence 98854 566666553 23478888889999999999999875 499999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
.+-++... ...+...|.+.|||||.+. ...|+-++||||||+.++|+.||+.||.+.+-+ .+....++.+.
T Consensus 238 IsGrlvdS----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~e 311 (391)
T KOG0983|consen 238 ISGRLVDS----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNEE 311 (391)
T ss_pred ccceeecc----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhcC
Confidence 99876543 2345678999999999886 357889999999999999999999999985432 12222223222
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRK 986 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~ 986 (1014)
.+ .+.... .....+.+++..|+++|+.+||...++++ |||+...+..+.+
T Consensus 312 PP-------~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~----h~Fi~~ye~a~~d 361 (391)
T KOG0983|consen 312 PP-------LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE----HPFIKRYETAEVD 361 (391)
T ss_pred CC-------CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc----Ccceeecchhhcc
Confidence 22 221111 12345667788999999999999887777 9999986655543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=315.10 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=207.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..|.....||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR---KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec---ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 3445566799999999999999888999999998432 2234567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 98 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg 162 (297)
T cd06659 98 EFLQGGALTDIVSQT------------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG 162 (297)
T ss_pred ecCCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence 999999999987542 378999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+....... +......
T Consensus 163 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~ 235 (297)
T cd06659 163 FCAQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPP 235 (297)
T ss_pred hHhhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCC
Confidence 987553321 122345689999999999988899999999999999999999999986553322211 1111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
. .. ........+.+++..|++.||++||+++|+++ ||||.....
T Consensus 236 ~------~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~----~~~~~~~~~ 279 (297)
T cd06659 236 K------LK--NAHKISPVLRDFLERMLTREPQERATAQELLD----HPFLLQTGL 279 (297)
T ss_pred C------cc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh----ChhhccCCC
Confidence 0 00 00111234678899999999999999999998 999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.10 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=207.1
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
-|+..+.||+|+||.||+|.+..+++.||+|.+... ......+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 467788999999999999999888999999987432 223445788999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||+
T Consensus 83 ~~~~~~l~~~i~~~------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~ 147 (277)
T cd06641 83 YLGGGSALDLLEPG------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 147 (277)
T ss_pred eCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccc
Confidence 99999999998642 378999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......++..|+|||++.+..++.++|+|||||++|+|++|..||.......... . +.....
T Consensus 148 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~-~~~~~~-- 218 (277)
T cd06641 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF---L-IPKNNP-- 218 (277)
T ss_pred ceecccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH---H-HhcCCC--
Confidence 87654321 11223567889999999988888999999999999999999999997644321111 1 111111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
+.+. ......+.+++.+|++.||.+||++.++++ ||||...
T Consensus 219 ----~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~----~~~~~~~ 259 (277)
T cd06641 219 ----PTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLK----HKFIVRF 259 (277)
T ss_pred ----CCCC----cccCHHHHHHHHHHccCChhhCcCHHHHHh----CHHHhhh
Confidence 0111 122345678899999999999999999999 9999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=317.36 Aligned_cols=276 Identities=24% Similarity=0.307 Sum_probs=205.0
Q ss_pred CCCCCceeccCCcEEEEEeeecC--CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKL 763 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~ 763 (1014)
+|+..+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.++..++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999999988 7899999998653322233456778899999999999999999999888 8899
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC----CCc
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY----NFN 839 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~----~~~ 839 (1014)
+||||+++ ++.+++..... .....+++..++.++.|++.|++|||.. +|+||||||+||+++. ++.
T Consensus 81 lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQ------AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred EEEeCCCc-CHHHHHHhhcc------CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccce
Confidence 99999975 77777654321 1123588899999999999999999955 9999999999999999 899
Q ss_pred EEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh-------
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTC------- 911 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~------- 911 (1014)
+||+|||++.................++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 999999999876443222223334567899999998766 457899999999999999999999998654432
Q ss_pred --HHHHHHHHHh-----------cCCcchhcc----ccccCCcccH-------HHHHHHHHHHhHccCCCCCCCCCHHHH
Q 001778 912 --LAQWAWRHIQ-----------EGKPIVDAL----DKEIDEPCFL-------EEMIRVFKLGVICTSMLPTERPNMRMV 967 (1014)
Q Consensus 912 --~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~ev 967 (1014)
....+...+. +........ .......... ....++.+++.+|++.||++|||+.|+
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0000000000 000000000 0000000000 223457889999999999999999999
Q ss_pred HHHHhcCCCC
Q 001778 968 LQILLNNPIF 977 (1014)
Q Consensus 968 ~~~L~~~~~~ 977 (1014)
++ ||||
T Consensus 311 l~----~~~f 316 (316)
T cd07842 311 LE----HPYF 316 (316)
T ss_pred hc----CCCC
Confidence 98 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=306.16 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=200.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|...+.||+|++|.||+|.+..+. .||+|.+.... ...+.+.+|+.+++.++|||++++++++.. +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 45777889999999999999876554 58999874322 234678899999999999999999998864 5578999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 80 EFMGKGSLLDFLKEGD---------GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred EcCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCc
Confidence 9999999999997641 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+........ .......++..|+|||+..+..++.++||||||+++|||++ |..||.+........+ ...+..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~ 221 (260)
T cd05069 148 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VERGYR 221 (260)
T ss_pred cceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCC
Confidence 9976533211 11223346778999999998889999999999999999999 8889876554322222 111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+||++||++||+++++++.|++
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112233567789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.34 Aligned_cols=264 Identities=24% Similarity=0.275 Sum_probs=210.0
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEEccc
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~ 770 (1014)
.++||+|+|+.|-.+....++..+|||++.+ .....+.++.+|++++.+. .|+||+.++++|+++...|+|||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidK---q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDK---QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhc---CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4679999999999999999999999999933 3456678899999999988 59999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC---cEEEeeccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF---NAKIADFGV 847 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~---~~kl~Dfgl 847 (1014)
||.|.+.+++.. .+.+.++.++..+|+.||.|||.. ||.|||+||+|||-.+.. -+|||||.+
T Consensus 160 GGplLshI~~~~-----------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 160 GGPLLSHIQKRK-----------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred CchHHHHHHHhh-----------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 999999998763 489999999999999999999965 999999999999997654 489999998
Q ss_pred ccccccccCcc----ccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc-------hh
Q 001778 848 AKILIKEEGEF----AAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEH-------TC 911 (1014)
Q Consensus 848 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~-------~~ 911 (1014)
+.-+.-..... ......+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.-. ..
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 86553322111 1233568899999999763 34688999999999999999999999975321 11
Q ss_pred H----HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 912 L----AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 912 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. .+.....+++|.. ++ ..+.+.....+..+++...+..||..|.++.+++. |||++..+.+
T Consensus 306 ~Cr~CQ~~LFesIQEGkY--eF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln----hPw~~~~~~e 370 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY--EF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN----HPWVQRCAPE 370 (463)
T ss_pred ccHHHHHHHHHHHhccCC--cC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC----Cccccccchh
Confidence 1 1122333444442 11 22223333445667888899999999999999998 9999987655
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=310.80 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=202.0
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS----- 758 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~----- 758 (1014)
....|+..+.||+|+||.||+|.+..+++.||+|++.. .......+..|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec----ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 44678888999999999999999999999999999833 223446688899999998 79999999999853
Q ss_pred -CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 759 -ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 759 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+|+|++|+||+++++
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTK---------GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 457899999999999999987642 23477888999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.++|+|||++....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||........
T Consensus 158 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 999999999987543211 1223467899999999875 34678899999999999999999999975432211
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. . ..... ...... ......+.+++.+||+.||.+||++.|+++ ||||
T Consensus 235 ~~---~-~~~~~------~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~----~~~~ 282 (282)
T cd06636 235 LF---L-IPRNP------PPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK----HPFI 282 (282)
T ss_pred hh---h-HhhCC------CCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc----CCCC
Confidence 11 0 11111 111111 112345778999999999999999999988 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.77 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=205.8
Q ss_pred ceeccCCcEEEEEeeecCC---CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcc
Q 001778 693 NVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
+.||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+++++.++|+|++++++++..+...++|+||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998866 88899999855332 225688999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
++++|.+++....... .......+++..++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+.
T Consensus 79 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 79 EGGDLLDYLRKSRPVF--PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred cCCcHHHHHhhccccc--cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccc
Confidence 9999999998752110 001124589999999999999999999965 99999999999999999999999999998
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
....... ........++..|+|||.+....++.++||||+|+++|||++ |..||.........+. ...+..
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~~--- 225 (262)
T cd00192 154 DVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRKGYR--- 225 (262)
T ss_pred ccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCC---
Confidence 7654322 222335567889999999988889999999999999999999 5889987654333222 221111
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
.........++.+++.+||+.||.+||++.|+++.|+
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122456788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=307.51 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=201.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.|+..++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++|||++++++++. .+..++|+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 46788899999999999999865 46779999984322 23467889999999999999999999875 45689999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 80 EYMENGSLVDFLKTPE---------GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred EcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence 9999999999987642 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
++....... ........++..|+|||++....++.++||||||+++||+++ |+.||.+.+........ ..+..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~ 221 (260)
T cd05067 148 LARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----ERGYR 221 (260)
T ss_pred ceeecCCCC--cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----HcCCC
Confidence 997654211 111223456788999999998889999999999999999999 99999866543332221 11111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.......++.+++.+|++.||++||+++++.+.|+.
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ----------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111223467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.86 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=197.2
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
++||+|+||.||+|... ++..||+|.+... ........+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 5778999987432 23344567899999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++.... ..+++..+..++.|++.|+.|+|.. +++||||||+||+++.++.+|++|||++....
T Consensus 78 ~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 78 DFLSFLRKKK----------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred cHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecc
Confidence 9999986542 2378999999999999999999965 99999999999999999999999999987543
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
... ........++..|+|||++.+..++.++||||||+++|++++ |..||.......... ....+...
T Consensus 145 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~~~~~~----- 213 (250)
T cd05085 145 DGI--YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEKGYRM----- 213 (250)
T ss_pred ccc--cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHHcCCCC-----
Confidence 211 111122344678999999998889999999999999999998 888997665432222 22221110
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
.........+.+++.+|++.+|++||++.|++++|.
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 -----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111122346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.34 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=207.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.|...+.||+|++|.||++.+..+++.||+|++.. ......+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec---cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 46667899999999999999988899999998832 223345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.
T Consensus 97 ~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 97 FLEGGALTDIVTHT------------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred ccCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccccc
Confidence 99999999998652 378899999999999999999965 999999999999999999999999998
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..... ........+
T Consensus 162 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~~~~~~~-- 233 (285)
T cd06648 162 CAQVSKEV---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRIRDNLPP-- 233 (285)
T ss_pred chhhccCC---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHhcCCC--
Confidence 87543321 1223456889999999998888999999999999999999999999765432221 111111110
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
.... .......+.+++.+||+.||++||++.++++ ||||....
T Consensus 234 -----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~----~~~~~~~~ 276 (285)
T cd06648 234 -----KLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN----HPFLAKAG 276 (285)
T ss_pred -----CCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc----CcccccCC
Confidence 1110 0112245788999999999999999999998 99998855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.76 Aligned_cols=255 Identities=26% Similarity=0.330 Sum_probs=205.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccch--hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK--LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|.+..... ..+...+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46778899999999999999988899999998844221 2234567899999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++... ..+++..+..++.|++.|++|||.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred EEecCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999998764 2378899999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCC-CCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|.+....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ...........
T Consensus 147 ~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~ 219 (258)
T cd06632 147 GMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSKE 219 (258)
T ss_pred ccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhccc
Confidence 9987653322 223456889999999987766 889999999999999999999999765421 11111111011
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...+ .......+.+++.+||+.||++||++.++++ |||+
T Consensus 220 --~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~----~~~~ 258 (258)
T cd06632 220 --LPPI--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE----HPFV 258 (258)
T ss_pred --CCCc--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc----CCCC
Confidence 0001 1112245667889999999999999999998 9985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=320.58 Aligned_cols=268 Identities=25% Similarity=0.391 Sum_probs=202.0
Q ss_pred CCCCCCceeccCCcEEEEEeeec-----CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc-C
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS-E 759 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-~ 759 (1014)
++|+..+.||+|+||.||+|.+. .+++.||||++..+. .......+.+|+.++..+ +||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 57899999999999999999743 457789999985422 233456788999999999 68999999998765 4
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCC----------------------------------------------------
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLS---------------------------------------------------- 787 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------- 787 (1014)
...++||||+++|+|.+++...+.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999999764210000
Q ss_pred ----CCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccc
Q 001778 788 ----GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863 (1014)
Q Consensus 788 ----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 863 (1014)
.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 240 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGD 240 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc-chhhcCC
Confidence 000113478999999999999999999965 99999999999999999999999999997653321 1112223
Q ss_pred cccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHH
Q 001778 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEE 942 (1014)
Q Consensus 864 ~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1014)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........+... .. +. ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~------~~--~~--~~ 307 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRM------RA--PD--YT 307 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHHHHhccCCC------CC--CC--CC
Confidence 445678999999988899999999999999999997 888987643221 111222222110 00 00 11
Q ss_pred HHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 943 MIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
...+.+++..||+.||++||++.|+++.|+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2357788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.82 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=200.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC--cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 457888999999999999999999899999999984432 222344677899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||++ +++.+++.... ..+.+..+..++.|++.||+|||.. +|+|+||||+||+++.++.+||+||
T Consensus 82 ~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP----------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred Eeccc-CCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence 99996 67877765431 2367888899999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh-cC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ-EG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-~~ 923 (1014)
|+++....... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .+.....+. .+
T Consensus 148 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~ 222 (291)
T cd07870 148 GLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLG 222 (291)
T ss_pred ccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcC
Confidence 99875432111 1223457899999999875 35788999999999999999999999765431 111111110 00
Q ss_pred Ccchh-------------ccccccCCccc------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPIVD-------------ALDKEIDEPCF------LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~-------------~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+... ........... ......+.+++.+|++.||.+|||++|++. ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~----h~~~ 291 (291)
T cd07870 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL----HPYF 291 (291)
T ss_pred CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc----CCCC
Confidence 00000 00000000000 011235668899999999999999999998 9997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.55 Aligned_cols=261 Identities=28% Similarity=0.378 Sum_probs=209.4
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV 765 (1014)
+|+..+.||.|+||.||++.+..+++.||+|++... .......+.+.+|+++++.++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc-cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 467788999999999999999999999999998543 2234556778999999999999999999998754 4567999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeccCCCCCeeecCCCcEEEe
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDC--SPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||+++++|.+++.... .....+++..++.++.|++.|++|||..+ +.+++|+||+|+||+++.++.+|++
T Consensus 80 ~e~~~~~~L~~~l~~~~-------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 80 MEYCEGGDLAQLIQKCK-------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred ehhccCCCHHHHHHHHh-------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 99999999999997642 12345899999999999999999999432 4499999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.....+. ...+
T Consensus 153 d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~ 225 (265)
T cd08217 153 DFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK----IKEG 225 (265)
T ss_pred cccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH----HhcC
Confidence 9999987644221 12245689999999999988899999999999999999999999987653322221 1111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. ..........+.+++.+|++.||++||++.+|++ |||+
T Consensus 226 ~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~----~~~~ 265 (265)
T cd08217 226 KF----------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ----LPLI 265 (265)
T ss_pred CC----------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh----CCCC
Confidence 11 0111223356778999999999999999999999 9985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.12 Aligned_cols=269 Identities=27% Similarity=0.345 Sum_probs=206.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5788899999999999999999899999999884322 233445788999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++++.+..+.... ..+++..+..++.|++.|++|||+. +++|+|++|+||++++++.+||+|||.
T Consensus 81 ~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 81 YVERTLLELLEASP-----------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred cCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99987776655432 2378999999999999999999966 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc----
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE---- 922 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~---- 922 (1014)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+................
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 147 ARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred ccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 987654321 122345678899999999887 8899999999999999999999999866543222211111100
Q ss_pred -------CCcchhccccccCCc------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 923 -------GKPIVDALDKEIDEP------CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 923 -------~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.........+..... .......++.+++.+||+.||++||+++++++ ||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~----~~~f 288 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ----HPYF 288 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc----CCCC
Confidence 000000000000000 01112456789999999999999999999988 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.96 Aligned_cols=269 Identities=26% Similarity=0.362 Sum_probs=207.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV 765 (1014)
+|...+.||.|++|.||+|.+..+++.||+|.+... ........+.+|+++++.++||||+++++++.. .+..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD--PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC--CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 467788999999999999999989999999998532 223456778999999999999999999998864 3468999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++++|.+++..... ....+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus 80 ~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-------RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEecCCCCHHHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeec
Confidence 999999999998765321 123478889999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc--hhHHHHHHHHHhcC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH--TCLAQWAWRHIQEG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~--~~~~~~~~~~~~~~ 923 (1014)
|++....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ....+.........
T Consensus 150 g~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 150 GVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred cccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 9987543211 1234578899999999998999999999999999999999999986532 11112111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+ . +...... -......+.+++.+||+.||.+|||+.|+++ ||||.....
T Consensus 225 ~~--~-~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~----~~~~~~~~~ 274 (287)
T cd06621 225 NP--E-LKDEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE----HPWIKAQMK 274 (287)
T ss_pred ch--h-hccCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh----Ccccccccc
Confidence 10 0 1111100 0112345778999999999999999999999 999965543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.22 Aligned_cols=261 Identities=24% Similarity=0.230 Sum_probs=200.5
Q ss_pred eeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHH---HHHcCCCCccceEEEEEEcCCceEEEEEccc
Q 001778 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ---ILSTIRHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~---~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 770 (1014)
+||+|+||.||+|.+..+++.||+|.+.............+..|.. .++...||+|+++++++..++..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999899999999985533222222333444443 3444579999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~ 850 (1014)
+|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 81 g~~L~~~l~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 81 GGDLHYHLSQH-----------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999988653 2489999999999999999999965 999999999999999999999999999876
Q ss_pred cccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 851 LIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 851 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
.... ......|+..|+|||++.++ .++.++||||+||++|||++|+.||............. .....
T Consensus 147 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~------ 214 (278)
T cd05606 147 FSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTM------ 214 (278)
T ss_pred cCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hhhcc------
Confidence 5331 12245789999999998754 68899999999999999999999998653322222111 11110
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCCCCcccc
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNGGRKYDH 989 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L~~~~~~~~~~~~~~~~~~ 989 (1014)
...+. .....++.+++.+|++.||.+|| ++.|+++ ||||....+......+
T Consensus 215 -~~~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 215 -AVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----HPFFRSLDWQMVFLQK 270 (278)
T ss_pred -CCCCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----CccccCCCchHhhhcc
Confidence 01111 11234677888999999999999 9888887 9999887766544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.01 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=189.2
Q ss_pred eeccCCcEEEEEeeecC--CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 694 VIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++++......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999986543 3457888877432 2334456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.+++...... .....++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 80 g~L~~~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 80 GDLKNYLRSNRGM------VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred CcHHHHHHhcccc------ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence 9999999775321 112356788899999999999999965 9999999999999999999999999998754
Q ss_pred ccccCccccccccccCccccccccccc-------CCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYART-------RKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
.... .........++..|+|||+... ..++.++||||+||++|||++ |..||......... .....+.
T Consensus 151 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~~~ 226 (269)
T cd05042 151 YPED-YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL---KQVVREQ 226 (269)
T ss_pred ccch-heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---HHHhhcc
Confidence 3321 1111234456778999998743 356789999999999999999 67788655433221 1222221
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
.. ....+.+.. .....+.+++..|| .||++||+++||++.|
T Consensus 227 ~~--~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 227 DI--KLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred Cc--cCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11 111111111 12234456777788 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.08 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=204.7
Q ss_pred CCCCCceeccCCcEEEEEeeecC----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc--CCc
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~ 761 (1014)
.|+..+.||+|+||.||+|.+.. +++.||||.+..... ....+.+.+|+++++.++||||+++++++.. +..
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46777899999999999998653 478899999854322 1456789999999999999999999999887 557
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEE
Confidence 899999999999999997642 2489999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH---------
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL--------- 912 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~--------- 912 (1014)
++|||.+.................++..|+|||.+.+..++.++||||||+++|||++|+.|+........
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 99999998765322222222234456679999999888899999999999999999999999865332110
Q ss_pred --HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 913 --AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..........+. ..+.......++.+++.+||+.||++||++.||+++|++
T Consensus 230 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 230 MIVTRLLELLKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred ccHHHHHHHHHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111111111 111112233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=311.12 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHH-HHcCCCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI-LSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|++.... .......+..|+.. ++..+||||+++++++..++..++|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 5778899999999999999999999999999985432 22233455566665 56678999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||++ |+|.+++..... ....+++..++.++.|++.||+|||+. .+++||||||+||+++.++.+||+|||
T Consensus 80 e~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 80 EVMD-TSLDKFYKKVYD-------KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred hhhc-ccHHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 9997 688888865421 224589999999999999999999952 289999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
.+...... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... .+........
T Consensus 150 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~ 223 (283)
T cd06617 150 ISGYLVDS----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEE 223 (283)
T ss_pred cccccccc----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhc
Confidence 99765321 11223568899999998865 45688999999999999999999999643221 1111111111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. +.+... ....++.+++.+||+.||++||++.++++ ||||......
T Consensus 224 ~~-------~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~~~ 270 (283)
T cd06617 224 PS-------PQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ----HPFFELHLSK 270 (283)
T ss_pred CC-------CCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc----Cchhhhcccc
Confidence 11 111111 12245778999999999999999999988 9999997644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.59 Aligned_cols=268 Identities=24% Similarity=0.380 Sum_probs=206.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCC-------CeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT-------AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE 759 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 759 (1014)
+|++.+.||+|+||.||+|.+... +..||+|.+... ......+.+.+|+.+++++ +||||+++++++..+
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 578889999999999999976432 236899987432 2334567889999999999 899999999999999
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCC-----CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSG-----RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll 834 (1014)
+..++|+||+++|+|.+++.......... ......++|.++..++.|++.||+|||.. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999998653211100 01234589999999999999999999965 99999999999999
Q ss_pred cCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHH
Q 001778 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLA 913 (1014)
Q Consensus 835 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~ 913 (1014)
+.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+.......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999976543211 111222344578999999999999999999999999999998 78888765533222
Q ss_pred HHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCC
Q 001778 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNP 975 (1014)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~ 975 (1014)
. . +..+.. . +.......++.+++.+||+.+|++||++.|+++.|++..
T Consensus 247 ~---~-~~~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 K---L-LKEGHR-M---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred H---H-HHcCCC-C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 2 1 111111 0 011122346778999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.20 Aligned_cols=269 Identities=23% Similarity=0.326 Sum_probs=201.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 3568888999999999999999988899999999854221 12234567899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++ +|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 82 ~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 147 (291)
T cd07844 82 FEYLDT-DLKQYMDDCG----------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADF 147 (291)
T ss_pred EecCCC-CHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcc
Confidence 999985 9999887642 2478999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCch-hHHHHHHHHHhcC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHT-CLAQWAWRHIQEG 923 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~ 923 (1014)
|+++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... ......+......
T Consensus 148 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07844 148 GLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224 (291)
T ss_pred ccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence 99875422111 1123356889999998865 45889999999999999999999999765421 1111111111100
Q ss_pred Ccc--------hhccccccC---Cc----c--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPI--------VDALDKEID---EP----C--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~--------~~~~~~~~~---~~----~--~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+. .+....... .. . .......+.+++.+|++.||++|||+.|+++ ||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~----~~~f 291 (291)
T cd07844 225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK----HPYF 291 (291)
T ss_pred ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc----CCCC
Confidence 000 000000000 00 0 0011145678999999999999999999988 9997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.64 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=202.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.|++.+.||+||.++||++.... ...||+|++.. ...+....+-|..|+..|.++ .|.+||++++|-..++.+|+||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 48899999999999999986543 45677776522 344566788899999999999 5999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||-+ .+|..+++.... ....| .++.+..|++.|+.+.|++ ||||.||||.|.|+-+ |.+||+|||
T Consensus 440 E~Gd-~DL~kiL~k~~~---------~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS---------IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred eccc-ccHHHHHHhccC---------CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeec
Confidence 9864 599999998643 22334 7888999999999999987 9999999999999875 599999999
Q ss_pred cccccccccCccccccccccCcccccccccccC-----------CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-----------KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
.|..+..+. ........+||+.||+||.+... ..++++||||+|||+|+|+.|+.||+.-. ..|
T Consensus 505 IA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~ 579 (677)
T KOG0596|consen 505 IANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQI 579 (677)
T ss_pred hhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHH
Confidence 999877643 33344578999999999988542 25579999999999999999999997421 122
Q ss_pred HHHHHhcCCcchhcccccc--CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 001778 916 AWRHIQEGKPIVDALDKEI--DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
.+- ..+.++.- ..+...+ ..++++++..||..||++||+..|+++ |||++-.+...
T Consensus 580 aKl--------~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq----hpFl~~~~i~~ 637 (677)
T KOG0596|consen 580 AKL--------HAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ----HPFLQIQPIPV 637 (677)
T ss_pred HHH--------HhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc----Ccccccccccc
Confidence 221 22222221 1111111 112788999999999999999988888 99998855443
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.46 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=200.2
Q ss_pred ceeccCCcEEEEEeeecCCC------eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 693 NVIGSGGSGKVYRVPINHTA------EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.||+|+||.||+|++.... +.||+|.+... ........+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876543 67999987432 22344567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-----cEE
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-----NAK 841 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-----~~k 841 (1014)
||+++|+|.+++....... .....+++.++..++.|++.|++|||+. +++|+||||+||+++.+. .++
T Consensus 79 e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~ 151 (269)
T cd05044 79 ELMEGGDLLSYLRDARVER----FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVK 151 (269)
T ss_pred eccCCCcHHHHHHHhhhcc----cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceE
Confidence 9999999999997642211 1233478999999999999999999965 999999999999999877 899
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 920 (1014)
++|||++....... .........++..|+|||++.+..++.++|||||||++|||++ |+.||........... .
T Consensus 152 l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~----~ 226 (269)
T cd05044 152 IGDFGLARDIYKSD-YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH----V 226 (269)
T ss_pred ECCccccccccccc-ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH----H
Confidence 99999997654321 1112223456789999999999999999999999999999998 9999976543322221 1
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+... .........+.+++.+||+.+|++||+++++++.|++
T Consensus 227 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111110 0111223456789999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.70 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=204.2
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCC---
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~--- 760 (1014)
..++|+..+.||+|++|.||+|.+..+++.||+|++... ....+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 346789999999999999999999888999999998432 23456789999999999 7999999999997644
Q ss_pred ---ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 761 ---LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 761 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||.. +++|+||+|+||+++.+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~ 149 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRK-------KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN 149 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccC
Confidence 48999999999999999876421 124588999999999999999999955 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.+|++|||.+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||........
T Consensus 150 ~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 226 (275)
T cd06608 150 AEVKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226 (275)
T ss_pred CeEEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence 999999999987653321 22334568999999998753 3567899999999999999999999975432211
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. .... .... +.+. ........+.+++.+||..||++|||+.|+++ |||+
T Consensus 227 ~---~~~~-~~~~------~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~----~~~~ 275 (275)
T cd06608 227 L---FKIP-RNPP------PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE----HPFI 275 (275)
T ss_pred H---HHhh-ccCC------CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc----CCCC
Confidence 1 1111 1110 0111 11123346778999999999999999999999 9985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.44 Aligned_cols=258 Identities=26% Similarity=0.339 Sum_probs=207.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC---CCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR---HLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~l 764 (1014)
.|+..+.||+|+||.||+|.+..+++.||+|.+..+ ......+.+.+|+.+++.++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 467788999999999999999999999999998432 23344567889999999986 9999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
||||+++++|.+++... .+++.....++.|++.|+.|||+. +|+|+||+|+||++++++.++++|
T Consensus 80 v~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG------------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCD 144 (277)
T ss_pred EEecCCCCcHHHHHHcc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEcc
Confidence 99999999999988642 378999999999999999999966 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||.+....... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ ... ....
T Consensus 145 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~-~~~~ 217 (277)
T cd06917 145 FGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MML-IPKS 217 (277)
T ss_pred CCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhc-cccC
Confidence 99998765432 12234568899999998865 4568899999999999999999999976543211 110 1110
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..+.+... ....++.+++.+||+.||++||++.|+++ |+||+....
T Consensus 218 ------~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~----~~~~~~~~~ 263 (277)
T cd06917 218 ------KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK----SKWIKAHSK 263 (277)
T ss_pred ------CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh----ChHhhcccc
Confidence 01111111 12346778999999999999999999988 999977553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.15 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=204.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||+|.+. .+..||||.+.... ...+.+.+|+.+++.++|||++++++++......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 356888999999999999999875 45779999985322 2346789999999999999999999999998999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++.... ...+++..+..++.+++.|++|||+. +++|+||||+||++++++.+|++||
T Consensus 80 ~e~~~~~~L~~~i~~~~---------~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 80 TEYMSKGSLLDFLKSGE---------GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred EeccCCCCHHHHHhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcc
Confidence 99999999999997642 23489999999999999999999966 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|.+....... ........++..|+|||.+.+..++.++||||+|+++|++++ |+.||.+.......+.. ..+.
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~~~ 221 (261)
T cd05034 148 GLARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----ERGY 221 (261)
T ss_pred ccceeccchh--hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCC
Confidence 9997654311 111223345678999999998889999999999999999998 89999765533222221 1111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. .+.......++.+++.+|++.||++||+++++.+.|+.
T Consensus 222 ~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 R----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 00111123467789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.39 Aligned_cols=267 Identities=26% Similarity=0.297 Sum_probs=205.3
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
+..+|+..+.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc-ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 456799999999999999999999999999999998432 12334456678899999999999999999988643
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
...++|+||++ ++|.+.+... +++..+..++.|++.||+|||.. +|+||||||+||+++.++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-------------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-------------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 155 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCC
Confidence 35699999996 5888877542 78888999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||+|||.+...... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+.......+..
T Consensus 156 ~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 156 TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CEEEccCccceeCCCC----CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999865331 112345678999999999999999999999999999999999999986653222111111
Q ss_pred HHhcCCc--------------------------chhccccccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 001778 919 HIQEGKP--------------------------IVDALDKEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVL 968 (1014)
Q Consensus 919 ~~~~~~~--------------------------~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 968 (1014)
. .+.+ +.+........ ........++.+++.+|++.||++|||+.|++
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 232 Q--LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred h--cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 1 0111 00000000000 00112244567899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 001778 969 QILLNNPIFPT 979 (1014)
Q Consensus 969 ~~L~~~~~~~~ 979 (1014)
+ |||+..
T Consensus 310 ~----~~~~~~ 316 (353)
T cd07850 310 Q----HPYINV 316 (353)
T ss_pred c----ChhHhh
Confidence 8 998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.88 Aligned_cols=256 Identities=28% Similarity=0.392 Sum_probs=206.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++|+||+++++.+..+...++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh-ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4677889999999999999999999999999984421 223455678899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-cEEEeecc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NAKIADFG 846 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-~~kl~Dfg 846 (1014)
|+++++|.+++.... ...+++..+..++.|++.|++|||.. +++|+||||+||++++++ .+|++|||
T Consensus 80 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 80 YCDGGDLMKRINRQR---------GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred cCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999997642 23478999999999999999999965 999999999999999875 46999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+........ ......|++.|+|||+..+..++.++|+||||+++|||++|+.||...... +++.........
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~- 220 (257)
T cd08225 148 IARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLKICQGYFA- 220 (257)
T ss_pred cchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhcccCC-
Confidence 9976543221 122346889999999998888999999999999999999999999765432 223222221110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
... ......+.+++.+|++.+|++|||+.|+++ ||||
T Consensus 221 --~~~--------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~----~~~~ 257 (257)
T cd08225 221 --PIS--------PNFSRDLRSLISQLFKVSPRDRPSITSILK----RPFL 257 (257)
T ss_pred --CCC--------CCCCHHHHHHHHHHhccChhhCcCHHHHhh----CCCC
Confidence 001 112235778899999999999999999998 9996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.91 Aligned_cols=261 Identities=29% Similarity=0.404 Sum_probs=211.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|...+.||+|++|.||+|.+..+++.||+|++..... ......+.+|+.++..++|+|++++++++..++..++|+|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 47778999999999999999999999999999854322 2456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... ..+++..+..++.|+++|++|||.. .+++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 80 YMDGGSLADLLKKV-----------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred ecCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999764 2478999999999999999999950 4999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........+..........+
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 221 (264)
T cd06623 147 SKVLENTLD---QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-- 221 (264)
T ss_pred ceecccCCC---cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC--
Confidence 987643221 112456789999999999989999999999999999999999999776432222222222211111
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
..... .....+.+++..|++.+|++||++.|+++ |||++..
T Consensus 222 -----~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~----~~~~~~~ 262 (264)
T cd06623 222 -----SLPAE---EFSPEFRDFISACLQKDPKKRPSAAELLQ----HPFIKKA 262 (264)
T ss_pred -----CCCcc---cCCHHHHHHHHHHccCChhhCCCHHHHHh----CHHHHhc
Confidence 11111 02346778899999999999999999999 9999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.97 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=202.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||+|... ++.||+|.+.... ...+++.+|+.+++.++|+||+++++++..+...++|+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 45788899999999999999764 7889999984432 25678999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 80 EYMAKGSLVDYLRSRG---------RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EecCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccc
Confidence 9999999999997642 12489999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.++...... .....+..|+|||++.+..++.++||||||+++||+++ |..||.......... ....+..
T Consensus 148 ~~~~~~~~~------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~~~~ 217 (256)
T cd05039 148 LAKEASQGQ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----HVEKGYR 217 (256)
T ss_pred ccccccccc------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHhcCCC
Confidence 998753211 12344678999999988889999999999999999997 999987665433222 2222111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. .........+.+++.+|++.+|++||++.|++++|++
T Consensus 218 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 M----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 0011123567789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.95 Aligned_cols=269 Identities=24% Similarity=0.289 Sum_probs=205.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKLL 764 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l 764 (1014)
++|+..+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468888999999999999999998999999999854322 223345677899999999999999999998877 88999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|+||++ ++|.+++.... ..+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|
T Consensus 84 v~e~~~-~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK----------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred EehhcC-cCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEee
Confidence 999997 49999887642 2489999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||.+....... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||...........+.......
T Consensus 150 ~g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (293)
T cd07843 150 FGLAREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226 (293)
T ss_pred cCceeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99998764421 122345678899999988754 46889999999999999999999998765433222211111000
Q ss_pred -----------C-----cchhccccccCCcccHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 -----------K-----PIVDALDKEIDEPCFLE-EMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 -----------~-----~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. .........+....... ....+.+++..||+.||++|||+.|++. ||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~----~~~f 293 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK----HPYF 293 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc----CCCC
Confidence 0 00000000000000000 2445678999999999999999999999 9997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.68 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=198.0
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEE-EcCCceEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI-SSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~~lV 765 (1014)
++|+..+.||+|+||.||++... +..||+|.+..+ ...+.+.+|+.+++.++|+|++++++++ ..++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 35778899999999999999654 778999988432 2346788999999999999999999975 455678999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++|+|.++++... ...+++..+.+++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 79 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EECCCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 99999999999987642 23478999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|++....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+ ..+.
T Consensus 147 g~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~ 216 (256)
T cd05082 147 GLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGY 216 (256)
T ss_pred ccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCC
Confidence 9987543211 12344678999999998899999999999999999997 89898765433322221 1111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. . .........+.+++.+|++.||++|||+.++++.|+.
T Consensus 217 ~------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 K------M----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C------C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1 0 0111223467788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.98 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=187.1
Q ss_pred ceeccCCcEEEEEeeecCC------------CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 693 NVIGSGGSGKVYRVPINHT------------AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
+.||+|+||.||+|....+ ...||+|.+... .......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999975432 235888987432 2344567888999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc-
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN- 839 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~- 839 (1014)
..++||||+++|+|..++.... ..+++..+.+++.||++|++|||+. +|+||||||+||+++.++.
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS----------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGID 144 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCcc
Confidence 9999999999999999887532 2478999999999999999999955 9999999999999987654
Q ss_pred ------EEEeecccccccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHh-cCCCCCCCCCchh
Q 001778 840 ------AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELT-TGKEANNGDEHTC 911 (1014)
Q Consensus 840 ------~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~ell-tg~~p~~~~~~~~ 911 (1014)
++++|||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCCCceeEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 89999999875432 12346788999999886 467889999999999999998 5777876544222
Q ss_pred HHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
... .. .+.. .... .....+.+++.+||+.||++||++.++++.+
T Consensus 218 ~~~----~~-~~~~-------~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 KER----FY-EGQC-------MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHH----HH-hcCc-------cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 01 1100 0011 1124577899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.58 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=204.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCe----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+|+..+.||+|+||.||+|.+..+++ .||+|..... ........+.+|+.+++.++|||++++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 457788999999999999998876654 5899987443 234456788999999999999999999999987 778
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL 150 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHK----------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKI 150 (279)
T ss_pred EEEEecCCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEE
Confidence 99999999999999997642 2388999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||.++......... ......++..|+|||.+....++.++|+||||+++||+++ |+.||.+.......+.+ .
T Consensus 151 ~dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~ 225 (279)
T cd05057 151 TDFGLAKLLDVDEKEY-HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL----E 225 (279)
T ss_pred CCCcccccccCcccce-ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----h
Confidence 9999998765322211 1122334678999999988889999999999999999998 99999876544333222 2
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
.+... +........+.+++.+||..||++||++.++++.+.+.
T Consensus 226 ~~~~~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 226 KGERL----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22110 00111223567889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.52 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=199.0
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 772 (1014)
++||+|+||.||+|.+.. ++.||+|.+..... ......+.+|++++++++||||+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999877 89999998844322 245678999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 773 SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 773 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
+|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 78 ~l~~~l~~~~----------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 78 SLLTFLRKKK----------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred cHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9999987642 2478899999999999999999965 99999999999999999999999999997653
Q ss_pred cccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
... .........++..|+|||++.+..++.++|+||+||++|||++ |..||...........+ .....
T Consensus 145 ~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~----~~~~~------ 213 (251)
T cd05041 145 GGI-YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI----ESGYR------ 213 (251)
T ss_pred CCc-ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH----hcCCC------
Confidence 211 1111112334667999999998899999999999999999999 78888765543222221 11110
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.......++.+++.+|++.+|++||++.|+++.|++
T Consensus 214 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 214 ----MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 01111223467889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.47 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=191.8
Q ss_pred ceeccCCcEEEEEeeecC---CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEE-cCCceEEEEEc
Q 001778 693 NVIGSGGSGKVYRVPINH---TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCIS-SENLKLLVYEY 768 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~ 768 (1014)
+.||+|+||.||+|.+.. ....||+|.+.. .......+.+.+|+.+++.++||||+++++++. .++..++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc--cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 345799998733 223344678889999999999999999999775 45567999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++|+|.+++.... ....+..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++
T Consensus 79 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~ 145 (262)
T cd05058 79 MKHGDLRNFIRSET----------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLA 145 (262)
T ss_pred CCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccc
Confidence 99999999997642 2257788899999999999999965 9999999999999999999999999999
Q ss_pred cccccccC-ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCC-CCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 849 KILIKEEG-EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK-EANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 849 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+....... .........++..|+|||++.+..++.++|||||||++|||++|+ .||...+....... ...+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~~~~~~ 221 (262)
T cd05058 146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQGRRL 221 (262)
T ss_pred ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HhcCCCC
Confidence 76533111 011112345677899999998889999999999999999999965 45554433222221 1111110
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.........+.+++..||+.||++||++.|+++.|++
T Consensus 222 ----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 ----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0001112357789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.46 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=202.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
.++|+..+.||+|+||.||++.+. .+..||+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 457888999999999999999765 4556999987432 2345678999999999999999999999887 678999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+||
T Consensus 79 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE---------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred EEeCCCCcHHHHHHhCC---------ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCC
Confidence 99999999999997642 23478899999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|.+....... ........++..|+|||++....++.++|+|||||++|++++ |..||...+......+. ..+.
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~ 220 (260)
T cd05073 147 GLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGY 220 (260)
T ss_pred cceeeccCCC--cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hCCC
Confidence 9997653321 112223445678999999998889999999999999999998 88899876544333222 1111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
. .+.......++.+++.+|+++||++||++.++.+.|++
T Consensus 221 ~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 R----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C----------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 01111223457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.89 Aligned_cols=239 Identities=22% Similarity=0.336 Sum_probs=186.4
Q ss_pred eeccCCcEEEEEeeecCC------------------------CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCcc
Q 001778 694 VIGSGGSGKVYRVPINHT------------------------AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpni 749 (1014)
.||+|+||.||+|....+ ...||+|++.. ........+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP---SHRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh---HHHHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999875321 23588998833 223445678889999999999999
Q ss_pred ceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCC
Q 001778 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKS 829 (1014)
Q Consensus 750 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~ 829 (1014)
+++++++..+...++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp 145 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCA 145 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCc
Confidence 999999999999999999999999999986532 2478899999999999999999965 999999999
Q ss_pred CCeeecCCC-------cEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHh-cC
Q 001778 830 SNILLDYNF-------NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELT-TG 900 (1014)
Q Consensus 830 ~NIll~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~ell-tg 900 (1014)
+||++++.+ .+|++|||.+..... .....++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred ccEEEeccCcccCccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999997643 389999998864322 123457888999998865 56889999999999999995 78
Q ss_pred CCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 901 KEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 901 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
+.||............ ..... ...+ ....+.+++.+||+.+|++||++.++++.|
T Consensus 219 ~~p~~~~~~~~~~~~~----~~~~~--------~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 219 EVPLKERTPSEKERFY----EKKHR--------LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCccccChHHHHHHH----HhccC--------CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 8898765443322211 11111 0111 113577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.01 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=203.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.|+..+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.++.++. ||||+++++++..++..++++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566788999999999999999999999999985432 2245677899999999996 999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||++. ++.++...... .....+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||
T Consensus 83 e~~~~-~l~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 83 ELMDI-SLDKFYKYVYE------VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred ecccC-CHHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecc
Confidence 99864 65554322100 0123589999999999999999999952 489999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccC---CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR---KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
++....... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||..... ..+.........
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~ 227 (288)
T cd06616 154 ISGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD 227 (288)
T ss_pred hhHHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC
Confidence 997654321 11234688999999998776 688999999999999999999999975431 112222211111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+ .+..........++.+++.+||+.||++|||++||++ ||||..-..
T Consensus 228 ~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~----~~~~~~~~~ 275 (288)
T cd06616 228 PP-------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE----HPFIKDYEE 275 (288)
T ss_pred CC-------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc----Chhhhchhh
Confidence 11 1111111223446788999999999999999999998 999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.31 Aligned_cols=269 Identities=25% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc--cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4778899999999999999999999999999985432 22334567789999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||.
T Consensus 79 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~ 146 (284)
T cd07836 79 YMDK-DLKKYMDTHGV--------RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL 146 (284)
T ss_pred cCCc-cHHHHHHhcCC--------CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecch
Confidence 9985 89888876421 23589999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP- 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 925 (1014)
+....... .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.................
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 147 ARAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred hhhhcCCc---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 97553311 12234567889999998865 45788999999999999999999999876544332222211110000
Q ss_pred -ch-----hccccccC-------CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 -IV-----DALDKEID-------EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 -~~-----~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. ........ ..........+.+++..|++.||.+||+++|+++ ||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~----~~~f 284 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ----HPWF 284 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc----CCCC
Confidence 00 00000000 0011122346778999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=308.78 Aligned_cols=261 Identities=29% Similarity=0.381 Sum_probs=207.4
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
+....|+..+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.++...+
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 44455788899999999999999998899999999985443334455677899999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|+||++ |++.+.+.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+
T Consensus 102 lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence 9999997 58887775431 3488999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|||++..... .....|+..|+|||++. ...++.++|||||||++|||++|+.||......... ....
T Consensus 168 dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~ 237 (317)
T cd06635 168 DFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIA 237 (317)
T ss_pred cCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHH
Confidence 9999875432 12456888999999874 456889999999999999999999999765432211 1111
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
....+ ... .......+.+++.+||+.||.+||++.++++ |+|+.....
T Consensus 238 ~~~~~-------~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~----~~~~~~~~~ 285 (317)
T cd06635 238 QNESP-------TLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLK----HMFVLRERP 285 (317)
T ss_pred hccCC-------CCC---CccccHHHHHHHHHHccCCcccCcCHHHHHh----ChhhhccCc
Confidence 11111 011 1122235678899999999999999999998 998866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.40 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=202.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCc-----
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENL----- 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~----- 761 (1014)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++ ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5788899999999999999999999999999874321 12223467888999999994 6999999999877665
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNA 840 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~ 840 (1014)
.|+||||+++ ++.+++..... .....+++..++.++.||+.||.|||.. +|+||||||+||+++. ++.+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR------GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeE
Confidence 7999999985 89998876422 1124589999999999999999999965 9999999999999998 8899
Q ss_pred EEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
||+|||.+..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 151 kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 227 (295)
T cd07837 151 KIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227 (295)
T ss_pred EEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999876533211 1223456889999998865 45789999999999999999999999875543221111111
Q ss_pred HhcCCcchhccc-----------cccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 920 IQEGKPIVDALD-----------KEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 920 ~~~~~~~~~~~~-----------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
. +.+...... +.... ........++.+++.+||++||++||+++|++. ||||+
T Consensus 228 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~----~~~~~ 295 (295)
T cd07837 228 L--GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT----HPYFD 295 (295)
T ss_pred h--CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc----CCCcC
Confidence 1 000000000 00000 000122345778999999999999999999998 99985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.84 Aligned_cols=240 Identities=19% Similarity=0.341 Sum_probs=188.2
Q ss_pred ceeccCCcEEEEEeeecCCCe-------EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 693 NVIGSGGSGKVYRVPINHTAE-------VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
+.||+|+||.||+|.+...+. .||+|.+.. ......+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc---hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999998765443 388888732 2334567788999999999999999999999998999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc------
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN------ 839 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~------ 839 (1014)
|||+++|+|.++++..+ ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.
T Consensus 78 ~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK----------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred EecCCCCcHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCC
Confidence 99999999999997642 2478999999999999999999965 9999999999999987765
Q ss_pred --EEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCC-CCCCCCCchhHHHH
Q 001778 840 --AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGK-EANNGDEHTCLAQW 915 (1014)
Q Consensus 840 --~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~-~p~~~~~~~~~~~~ 915 (1014)
++++|||.+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||...+......
T Consensus 145 ~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~- 216 (258)
T cd05078 145 PFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ- 216 (258)
T ss_pred ceEEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-
Confidence 69999999865432 123467889999999986 45789999999999999999995 4554433221111
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
...... .+... ...++.+++.+||+.||++|||++++++.|
T Consensus 217 ---~~~~~~--------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 ---FYEDRH--------QLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---HHHccc--------cCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111111 01111 123577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=309.06 Aligned_cols=275 Identities=23% Similarity=0.302 Sum_probs=205.0
Q ss_pred ccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-
Q 001778 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN- 760 (1014)
Q Consensus 682 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~- 760 (1014)
..+..++|+..+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++||||+++++++...+
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 34455679999999999999999999999999999998844321 2223445678999999999999999999987654
Q ss_pred -------ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 761 -------LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 761 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
..++|+||+++ ++.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil 151 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKN----------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANIL 151 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 34999999964 8888876531 2489999999999999999999966 9999999999999
Q ss_pred ecCCCcEEEeecccccccccccCcc-ccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEF-AAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
++.++.+||+|||.+.......... .......++..|+|||.+.+. .++.++||||||+++|||++|..||.+.+...
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred ECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998664322211 122345678899999988664 47889999999999999999999998765433
Q ss_pred HHHHHHHHHhcCCcchhcccc----------ccCCcc---cH------HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 912 LAQWAWRHIQEGKPIVDALDK----------EIDEPC---FL------EEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~------~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
....+......-. .+.... ...... .. .....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~--- 306 (310)
T cd07865 232 QLTLISQLCGSIT--PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN--- 306 (310)
T ss_pred HHHHHHHHhCCCC--hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc---
Confidence 3222222110000 000000 000000 00 01234568999999999999999999998
Q ss_pred cCCCC
Q 001778 973 NNPIF 977 (1014)
Q Consensus 973 ~~~~~ 977 (1014)
||||
T Consensus 307 -h~~f 310 (310)
T cd07865 307 -HDFF 310 (310)
T ss_pred -CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.30 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=198.4
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHH-HcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999999889999999998543322233334455555544 445899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
++|.+++.... .+++..+..++.|++.||.|||.. +++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 82 GDCASLIKTLG-----------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred CCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 99999997642 378899999999999999999965 9999999999999999999999999998754
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1014)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+..... .....+...
T Consensus 148 ~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~----- 211 (260)
T cd05611 148 LE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF----DNILSRRIN----- 211 (260)
T ss_pred cc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccC-----
Confidence 22 22446788999999998888899999999999999999999999766543221 111111100
Q ss_pred cccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
............+.+++.+||+.||++||++.++.+ +.+||||....+
T Consensus 212 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~-~l~~~~~~~~~~ 259 (260)
T cd05611 212 --WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE-IKSHPFFKSINW 259 (260)
T ss_pred --CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH-HHcChHhhcCCC
Confidence 000011122346778999999999999997754432 455999976554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.39 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=201.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCe----EEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+|+..+.||+|+||.||+|.+..+++ .||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 356778899999999999999877765 4788887432 2334455789999999999999999999998764 46
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL 150 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK----------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKI 150 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEE
Confidence 79999999999999987642 2478899999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.......++ +.
T Consensus 151 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~----~~ 225 (303)
T cd05110 151 TDFGLARLLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----LE 225 (303)
T ss_pred ccccccccccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH
Confidence 999999876432211 11223445779999999998899999999999999999997 8899976553333322 22
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.... ........+.+++..||..||++||+++|+++.++.
T Consensus 226 ~~~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 226 KGERLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred CCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 221110 001122356788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.82 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=213.4
Q ss_pred cccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
.+..+.|+..+.||+|++|.||+|.+..+++.||+|++..... ....+.+|+++++.++|+|++++++++..+...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 3456678888999999999999999988899999999843221 567788999999999999999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||.. +++|+|++|+||+++.++.++|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF----------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEE
Confidence 99999999999999998742 2589999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||.+........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .....
T Consensus 158 ~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---~~~~~ 231 (286)
T cd06614 158 ADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---LITTK 231 (286)
T ss_pred Cccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhc
Confidence 99999876543211 2234457889999999988889999999999999999999999997654332211 11111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
+.+ . .. ........+.+++.+|++.+|.+||++.++++ |+||....
T Consensus 232 ~~~--~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~----~~~~~~~~ 277 (286)
T cd06614 232 GIP--P-----LK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ----HPFLKKAC 277 (286)
T ss_pred CCC--C-----Cc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh----ChHhhccC
Confidence 111 0 00 01112345778899999999999999999998 99999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.57 Aligned_cols=319 Identities=26% Similarity=0.394 Sum_probs=246.0
Q ss_pred CCCCccEEECccCCCC-CCCCccccCCCCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhcccCccce
Q 001778 93 DLRNLTILDLQFNYII-SQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQ 171 (1014)
Q Consensus 93 ~l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (1014)
-|+..+-.|+++|.++ +..|..+..+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-+.+..|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 3556677777777777 457878888888888888888877 78888888888888888888887 66677788888888
Q ss_pred EeccccccC-CCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCccccccccccccceeeccc
Q 001778 172 LNLVVNQFN-GSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSI 250 (1014)
Q Consensus 172 L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~ 250 (1014)
+++..|++. .-+|..+..+..|+.|+||+|+ +.+.|..+..-+++-.|+|++|++..+...-|.+++.|-.||||+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNq---L~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ---LREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhh---hhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 888888875 3467777788888888888887 567788888888888888888887755445577899999999999
Q ss_pred ccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccc-cccceeeccccccC-CCCCCcccccccccccccccceecccC
Q 001778 251 NNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES-LNLKVIDLSANNLT-GAIPNDFGKLENLLNLSLMFNQLSGEI 328 (1014)
Q Consensus 251 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~ 328 (1014)
|++. .+|..+..+..|++|.|++|.+....-..+.. .+|.+|.+++.+-+ .-+|..+..+.+|..+||+.|.+. .+
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 9998 78888999999999999999876433222323 36888888887644 367888999999999999999998 88
Q ss_pred CcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccC-CCCCcccccC
Q 001778 329 PEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLS-GELPESLGNC 407 (1014)
Q Consensus 329 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~-~~~~~~~~~l 407 (1014)
|+.+-++++|+.|+|++|+|+ .+....+...+|++|+||.|+++ .+|..+|.+++|+.|.+.+|+++ .-+|+.++.+
T Consensus 238 Pecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 999999999999999999998 55566677788888999999888 78888888888888777777765 2234444444
Q ss_pred CcccEEEeeccee
Q 001778 408 SSLLMVKIYNNSF 420 (1014)
Q Consensus 408 ~~L~~L~l~~N~l 420 (1014)
.+|+.+..++|.+
T Consensus 316 ~~Levf~aanN~L 328 (1255)
T KOG0444|consen 316 IQLEVFHAANNKL 328 (1255)
T ss_pred hhhHHHHhhcccc
Confidence 4444444333333
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=332.85 Aligned_cols=287 Identities=21% Similarity=0.224 Sum_probs=199.1
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCe-EEEEE--------------EecccchhhHHhHHHHHHHHHHHHcCCCCcc
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAE-VVAVK--------------KIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~-~vavK--------------~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpni 749 (1014)
+..+|++.+.||+|+||+||+|.++.... .++.| .+.+...........+.+|+.+++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45679999999999999999987654322 12222 1111111222345678899999999999999
Q ss_pred ceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCC
Q 001778 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKS 829 (1014)
Q Consensus 750 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~ 829 (1014)
+++++++...+..|+|+|++. +++.+++...... ............++.|++.||+|||.. +|+||||||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD------WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc------ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 999999999999999999985 5787777653210 112234566778999999999999965 999999999
Q ss_pred CCeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc
Q 001778 830 SNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909 (1014)
Q Consensus 830 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~ 909 (1014)
+|||++.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++.....
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 999999999999999999987643221 122246799999999999999999999999999999999999865433222
Q ss_pred hhHHHHHHHHHhcCC-cchh----------cccc-cc--CCcccHH------HHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 910 TCLAQWAWRHIQEGK-PIVD----------ALDK-EI--DEPCFLE------EMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 910 ~~~~~~~~~~~~~~~-~~~~----------~~~~-~~--~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
..........+..-. ...+ .++. .+ ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111122221111100 0000 0000 00 0000000 1124567788999999999999999998
Q ss_pred HHhcCCCCCCCCCCCCcc
Q 001778 970 ILLNNPIFPTEKNGGRKY 987 (1014)
Q Consensus 970 ~L~~~~~~~~~~~~~~~~ 987 (1014)
||||..........
T Consensus 454 ----hp~f~~~~~~~~~~ 467 (501)
T PHA03210 454 ----LPLFSAEEEEEILF 467 (501)
T ss_pred ----ChhhhcCCchHHHH
Confidence 99998866554433
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.89 Aligned_cols=264 Identities=22% Similarity=0.242 Sum_probs=200.1
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcC--CceEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSE--NLKLLV 765 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~~lV 765 (1014)
|+..+.||+|+||.||+|.+..+++.||+|++..... ........+|+.++.++. |+|++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 5567889999999999999999999999999854321 122234457888888885 99999999999887 889999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||++ |++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+||
T Consensus 79 ~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 79 FELMD-MNLYELIKGRK----------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EecCC-ccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 99997 58888876532 2489999999999999999999966 9999999999999999 99999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|.+....... ......++..|+|||++.+ ..++.++||||+||++|||++|..||.+.+..+...+.........
T Consensus 144 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~ 219 (282)
T cd07831 144 GSCRGIYSKP----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219 (282)
T ss_pred ccccccccCC----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC
Confidence 9998654321 1123457889999997654 5578899999999999999999999987665443333322211100
Q ss_pred c----------chhccccccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 925 P----------IVDALDKEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 925 ~----------~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. ......+.... .........+.+++.+||++||++||+++|+++ ||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~----~~~~ 282 (282)
T cd07831 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR----HPYF 282 (282)
T ss_pred HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh----CCCC
Confidence 0 00000000000 001123467889999999999999999999999 9997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=309.65 Aligned_cols=276 Identities=26% Similarity=0.305 Sum_probs=207.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKL 763 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~ 763 (1014)
..+|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++|+|++++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4578899999999999999999999999999999853321 122234567899999999999999999998754 5689
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|+||+++ +|.+++.... ..+++..+..++.|++.|++|||.. +++||||||+||+++.++.+||+
T Consensus 85 lv~e~~~~-~l~~~l~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP----------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred EEEecCCC-CHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 99999974 8888887532 3489999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||.+........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+......
T Consensus 151 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07845 151 DFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227 (309)
T ss_pred ccceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987643221 1223445788999998865 56789999999999999999999999876644333222221110
Q ss_pred CCc-ch---------hccc-cccCCcc----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 923 GKP-IV---------DALD-KEIDEPC----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 923 ~~~-~~---------~~~~-~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
... .. .... ....... .......+.+++.+|++.||++|||+.|+++ ||||......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~----h~~f~~~~~~ 299 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE----SSYFKEKPLP 299 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc----ChhhccCCCC
Confidence 000 00 0000 0000000 0112345678999999999999999999998 9999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=341.42 Aligned_cols=263 Identities=25% Similarity=0.295 Sum_probs=211.2
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+++....||.|.||.||.|....+|+..|+|-+.-.... ......+.+|+.++..++|||+|+++|+-...+..++.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 567788999999999999999999999999987543332 5566778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
||++|+|.+.+...+. .++.....+-.|++.|++|||++ |||||||||+||+++.+|.+|.+|||.
T Consensus 1315 yC~~GsLa~ll~~gri-----------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI-----------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HhccCcHHHHHHhcch-----------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccc
Confidence 9999999999976532 44555566788999999999976 999999999999999999999999999
Q ss_pred ccccccccCc-cccccccccCcccccccccccC---CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 848 AKILIKEEGE-FAAMSTVVGSCGYIAPEYARTR---KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 848 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|..+...... ........||+.|||||++.+. ....++||||+|||+.||+||+.||..-+.. .+.++......
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGH 1458 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccC
Confidence 9887654311 2234567899999999999764 4567899999999999999999999865542 11112222211
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
+ ...+.....+-.+++.+|+..||++|+++.|+++ |.|-+..+.
T Consensus 1459 ~-----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle----~~f~~~~~d 1502 (1509)
T KOG4645|consen 1459 K-----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE----HAFGKSCTD 1502 (1509)
T ss_pred C-----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH----hhccccccc
Confidence 1 1233334455668899999999999999998888 887766543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.48 Aligned_cols=280 Identities=29% Similarity=0.381 Sum_probs=209.3
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC--C
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE--N 760 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~--~ 760 (1014)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc-cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4556789999999999999999999888999999988432 12233445677899999999 999999999998643 4
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++|+||++ ++|.+++... .+.|..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN------------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 6799999997 5998888653 378889999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCc--cccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 841 KIADFGVAKILIKEEGE--FAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
||+|||.+......... ........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+...........
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999876443211 012234568999999998765 467889999999999999999999997655432222111
Q ss_pred HHHhcCCcc------------hhccc---cccC---CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 918 RHIQEGKPI------------VDALD---KEID---EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~------------~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
... +.+. ...++ ..-. .........++.+++.+||+.||++|||+.++++ |||+..
T Consensus 227 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~----~~~~~~ 300 (337)
T cd07852 227 EVI--GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE----HPYVAQ 300 (337)
T ss_pred HHh--CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh----Chhhhh
Confidence 111 0000 00000 0000 0000112346788999999999999999999998 999977
Q ss_pred CCCCCCc
Q 001778 980 EKNGGRK 986 (1014)
Q Consensus 980 ~~~~~~~ 986 (1014)
-....+.
T Consensus 301 ~~~~~~~ 307 (337)
T cd07852 301 FHNPSDE 307 (337)
T ss_pred hccCCCC
Confidence 5444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.26 Aligned_cols=280 Identities=24% Similarity=0.334 Sum_probs=211.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc----CCce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS----ENLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~ 762 (1014)
.+|+..+.||+|+||.||+|.+..+++.||+|++..+. ......+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 56888899999999999999999999999999985432 122345677889999999999999999988753 3567
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 99999996 6898888653 2389999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCcc-ccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 843 ADFGVAKILIKEEGEF-AAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
+|||++.......... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.......+....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence 9999997654322211 11234578899999998765 468899999999999999999999998765432222211111
Q ss_pred hcCCcchhcccc-----------cc--CCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 921 QEGKPIVDALDK-----------EI--DEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 921 ~~~~~~~~~~~~-----------~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
+.+..+..+. .. ..+ ........+.+++..|++.||++||++++++. ||||.....
T Consensus 229 --g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~----~~~~~~~~~ 302 (334)
T cd07855 229 --GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ----HPFLAQYHD 302 (334)
T ss_pred --CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh----ChhhhhccC
Confidence 1111111000 00 000 01123456789999999999999999999998 999987655
Q ss_pred CCCccc
Q 001778 983 GGRKYD 988 (1014)
Q Consensus 983 ~~~~~~ 988 (1014)
......
T Consensus 303 ~~~~~~ 308 (334)
T cd07855 303 PDDEPT 308 (334)
T ss_pred Cccccc
Confidence 544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.07 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=211.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+|...+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788899999999999999999999999999985544444455678899999999998 999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||
T Consensus 82 e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 82 EYAPNGELLQYIRKYG-----------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999997642 489999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCc-----------------cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc
Q 001778 847 VAKILIKEEGE-----------------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909 (1014)
Q Consensus 847 la~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~ 909 (1014)
++......... ........++..|+|||......++.++||||+|+++|++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 99876442211 1222345678999999999888899999999999999999999999986653
Q ss_pred hhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
....+. ....... ........+.+++.+||+.||++||++.+.++.+.+||||
T Consensus 228 ~~~~~~---~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 228 YLTFQK---ILKLEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHH---HHhcCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 222111 1111111 1111234577899999999999999994444555559997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.02 Aligned_cols=266 Identities=27% Similarity=0.353 Sum_probs=202.5
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||.|++|.||+|.+..+++.||+|++..+. ........+.+|+++++.++|||++++++++.+++..++|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 566788999999999999999999999999985432 2223346788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
++ ++|.+++.... ...+++..+.+++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 80 ~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 80 LD-LDLKKYMDSSP---------LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred cC-cCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 95 68999987642 13589999999999999999999965 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
....... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...+.......+.... +.+..
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 221 (283)
T cd07835 147 RAFGVPV---RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL--GTPDE 221 (283)
T ss_pred cccCCCc---cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CCCCh
Confidence 7553221 112234568899999987654 57889999999999999999999998665322111111110 00000
Q ss_pred hc----------cc--cccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DA----------LD--KEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~----------~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. .. +.... .........+.+++.+|++.||++|||++|+++ ||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~----~~~~ 283 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ----HPYF 283 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc----CCCC
Confidence 00 00 00000 001112245778999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.83 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=206.8
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..|....+||+|+||.||++....+++.||+|++.. ........+.+|+.+++.++|+|++++++++..++..++||
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc---cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 345555789999999999999999999999998732 23345677899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 97 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg 161 (292)
T cd06657 97 EFLEGGALTDIVTHT------------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG 161 (292)
T ss_pred ecCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence 999999999987542 378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
.+....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|..||.+.........+. ...+
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~----~~~~- 233 (292)
T cd06657 162 FCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNLP- 233 (292)
T ss_pred cceeccccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hhCC-
Confidence 987653321 11233568899999999988888999999999999999999999998655432222111 1111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
..+.. .......+.+++.+||+.||.+||++.|+++ ||||..-.
T Consensus 234 -----~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~----~~~~~~~~ 277 (292)
T cd06657 234 -----PKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK----HPFLAKAG 277 (292)
T ss_pred -----cccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc----ChHHhccC
Confidence 11100 1112234667889999999999999999888 99998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.51 Aligned_cols=275 Identities=28% Similarity=0.333 Sum_probs=212.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----ce
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN-----LK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~ 762 (1014)
+|+..+.||+|++|.||+|.+..+++.||+|++... .......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc-cccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 477889999999999999999888999999998542 122445677899999999999999999999987765 78
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
|+|+||++ ++|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.++|
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-----------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP-----------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred EEEecchh-hhHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 99999998 4888888654 2489999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||.+.................++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~- 223 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL- 223 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc-
Confidence 9999998765432111123345678899999999887 88999999999999999999999998776433322222211
Q ss_pred cCCcchhccc---------------cccCC---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 922 EGKPIVDALD---------------KEIDE---PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 922 ~~~~~~~~~~---------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+.+..+... ..... .........+.+++.+||+.||++||+++++++ ||||......
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~----~~~~~~~~~~ 298 (330)
T cd07834 224 -GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA----HPYLAQLHDP 298 (330)
T ss_pred -CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh----CccHHhhccc
Confidence 111000000 00000 001112346788999999999999999999998 9999875554
Q ss_pred C
Q 001778 984 G 984 (1014)
Q Consensus 984 ~ 984 (1014)
.
T Consensus 299 ~ 299 (330)
T cd07834 299 E 299 (330)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.37 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=200.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCC---CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 764 (1014)
+|+..+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 477888999999999999987544 3468999884332 244567899999999999999999999998764 5689
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
||||+++|+|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 84 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 999999999999997642 2479999999999999999999965 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcC
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||++....... ........++..|+|||.+....++.++||||||+++||+++ |..||..........+ ...+
T Consensus 151 ~g~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~ 224 (270)
T cd05056 151 FGLSRYLEDES--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENG 224 (270)
T ss_pred Cceeeeccccc--ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcC
Confidence 99997654321 111223345578999999988889999999999999999986 9999976654332222 1111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
... +........+.+++.+|+..+|++|||+.++++.|++
T Consensus 225 ~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 225 ERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 0111223467789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=302.88 Aligned_cols=258 Identities=26% Similarity=0.324 Sum_probs=205.0
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||.||++.+..+++.||+|.+...........+.+.+|+++++.++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999998654444445678899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++...+ .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 81 ASLLENVG-----------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred HHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99997642 478999999999999999999965 9999999999999999999999999998764332
Q ss_pred cCc-----cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 855 EGE-----FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 855 ~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
... ........++..|+|||......++.++||||||+++|++++|..||........... .......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~---- 219 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN---ILNGKIE---- 219 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCCcC----
Confidence 110 1122345678899999999888899999999999999999999999986654322221 1111110
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.+........+.+++.+||+.+|++|||+.++.+ +.+||||...
T Consensus 220 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~-~l~~~~~~~~ 263 (265)
T cd05579 220 ------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE-IKNHPFFKGI 263 (265)
T ss_pred ------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH-HhcCccccCC
Confidence 0001112356678999999999999999933332 3339999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.10 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=199.8
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+++++.++||+++++++++......++|+|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 56778899999999999998754 6679999884322 234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++.... ..+++..+..++.+++.|++|||+. +++|+||||+||+++.++.++|+|||.
T Consensus 80 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 80 FMEHGCLSDYLRAQR----------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred cCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcc
Confidence 999999999987642 2378999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+....... ........++.+|+|||++.+..++.++||||+|+++|||++ |..||.........+. ..++..
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~- 219 (256)
T cd05112 147 TRFVLDDQ--YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET----INAGFR- 219 (256)
T ss_pred eeecccCc--ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HhCCCC-
Confidence 87653321 111123345678999999998889999999999999999998 8899976553322222 111111
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
...+.. ....+.+++.+||+.+|++||++.|+++.|.
T Consensus 220 --~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 --LYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 001111 1246788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=300.48 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=203.7
Q ss_pred CCCCCceeccCCcEEEEEeeecC-CCeEEEEEEecccc-------hhhHHhHHHHHHHHHHHHc-CCCCccceEEEEEEc
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-TAEVVAVKKIWNDR-------KLDQKHEKEFLAEVQILST-IRHLNIVKLLCCISS 758 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~ 758 (1014)
.|+..+.||+|+||.||+|.+.. .++.+|+|.+.... ........++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999887 67889999874321 1223345667788888875 799999999999999
Q ss_pred CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 759 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
++..++||||+++++|.+++.... .....+++..+++++.|++.|+.|||+. .+++|+||+|+||+++.++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCC
Confidence 999999999999999999886531 1223588999999999999999999952 3899999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 152 ~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~--- 224 (269)
T cd08528 152 KVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK--- 224 (269)
T ss_pred cEEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---
Confidence 99999999998654322 23356788999999999988899999999999999999999999976543322211
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.. .+.. .. ... ......+.+++.+||+.||++||++.|+.+++++
T Consensus 225 ~~-~~~~-~~-----~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 IV-EAVY-EP-----LPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred Hh-hccC-Cc-----CCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11 1110 00 000 0122456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=309.60 Aligned_cols=271 Identities=22% Similarity=0.272 Sum_probs=203.9
Q ss_pred ceeccC--CcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEccc
Q 001778 693 NVIGSG--GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 693 ~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 770 (1014)
..||+| +||+||++.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 999999999999999999999854322 23445788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~ 850 (1014)
+|++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..
T Consensus 83 ~~~l~~~l~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 83 YGSANSLLKTYF---------PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCCHHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999987642 12478899999999999999999955 999999999999999999999999986644
Q ss_pred cccccCcc----ccccccccCcccccccccccC--CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 851 LIKEEGEF----AAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 851 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
........ .......++..|+|||++.+. .++.++||||+||++|||++|+.||......... ........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~ 227 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML---LQKLKGPP 227 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH---HHHhcCCC
Confidence 32211110 011123356679999998763 5789999999999999999999999765432111 11110000
Q ss_pred c-------------------------c----------hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 925 P-------------------------I----------VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 925 ~-------------------------~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
. + .......+..+........+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 0000111111222334557889999999999999999999999
Q ss_pred HHhcCCCCCCCCCC
Q 001778 970 ILLNNPIFPTEKNG 983 (1014)
Q Consensus 970 ~L~~~~~~~~~~~~ 983 (1014)
||||...++.
T Consensus 308 ----~~~~~~~~~~ 317 (328)
T cd08226 308 ----HAFFKQVKEQ 317 (328)
T ss_pred ----CHHHHHHHHh
Confidence 9999876554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.48 Aligned_cols=272 Identities=26% Similarity=0.326 Sum_probs=204.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|++|.||+|.+..+++.||+|.+.... ......+.+.+|+++++.++||||+++++++.++...++|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc-ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888899999999999999999899999999884322 12234467889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcEEEeec
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADF 845 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~kl~Df 845 (1014)
||++ +++.+++.... ...+++.....++.||+.||+|||+. +++|+||+|+||+++. ++.+||+||
T Consensus 81 e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 81 EYLD-LDLKKHMDSSP---------DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred eccc-ccHHHHHHhCC---------CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccc
Confidence 9996 58888875532 12357888889999999999999965 9999999999999985 557999999
Q ss_pred ccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|++....... .......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...+............ +.
T Consensus 148 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~--~~ 222 (294)
T PLN00009 148 GLARAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL--GT 222 (294)
T ss_pred ccccccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CC
Confidence 9997643211 11223467889999998866 457899999999999999999999998765432222111111 11
Q ss_pred cchhccc------------cccCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 925 PIVDALD------------KEIDEP----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 925 ~~~~~~~------------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
+...... +..... .......++.+++.+|++.||++||++.++++ ||||....
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~----~~~~~~~~ 291 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE----HEYFKDLG 291 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc----CchHhHHh
Confidence 1010000 000000 00112235678999999999999999999998 99998754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.56 Aligned_cols=267 Identities=27% Similarity=0.314 Sum_probs=202.5
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC---CCCccceEEEEEEcCCc----
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIVKLLCCISSENL---- 761 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~---- 761 (1014)
|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 5667889999999999999988899999999854332 222345566788777666 59999999999988776
Q ss_pred -eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 762 -KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 762 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
.+++|||+++ +|.+++.... ...+++..+..++.|++.||+|||+. +++|+|++|+||+++.++.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~---------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCP---------KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eeEEEehhccc-CHHHHHHHcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCE
Confidence 8999999974 8998887642 12489999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
||+|||.+....... ......++..|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 147 ~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 147 KIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred EEeccCcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 999999997753321 1123457889999999999899999999999999999999999998765433222222111
Q ss_pred hcCCcch---------hccccccC---CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 921 QEGKPIV---------DALDKEID---EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 921 ~~~~~~~---------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
....... ........ .....+....+.+++.+||+.||++||+++|+++ ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~----~~~~ 287 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ----HPYF 287 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc----CcCC
Confidence 1100000 00000000 0111223356778999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.37 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=197.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|+..+.||+|+||.||++. .+++.||+|.+..+ ...+.+.+|+.+++.++|||++++++++..++ .++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEE
Confidence 357888999999999999985 46788999998432 23467889999999999999999999987654 69999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||
T Consensus 78 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 78 ELMSKGNLVNFLRTRG---------RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred ECCCCCCHHHHHHhcC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCc
Confidence 9999999999997642 23478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+...... ......+..|+|||.+.+..++.++|+||+||++|||++ |..||........... ...+..
T Consensus 146 ~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~ 215 (254)
T cd05083 146 LARVGSMG------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC----VEKGYR 215 (254)
T ss_pred cceecccc------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH----HhCCCC
Confidence 98754221 112334678999999988899999999999999999997 8889876654332221 111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+........+.+++.+||+.+|++||+++++++.|++
T Consensus 216 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00011223456789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=297.75 Aligned_cols=250 Identities=30% Similarity=0.330 Sum_probs=205.7
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|+||.||++.+..+++.||+|++...........+.+..|+.+++.++|||++++++.++.++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999998655444445677899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 854 (1014)
.+++.... .+++.....++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKEG-----------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99997642 378999999999999999999965 9999999999999999999999999999875432
Q ss_pred cCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccccc
Q 001778 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEI 934 (1014)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1014)
. .......++..|+|||...+..++.++|+||||+++|++++|..||...+....... .......
T Consensus 147 ~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~--------- 211 (250)
T cd05123 147 G---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK---ILKDPLR--------- 211 (250)
T ss_pred C---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HhcCCCC---------
Confidence 1 123345688899999999888889999999999999999999999976654222221 1111111
Q ss_pred CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 935 DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
........+.+++.+||..||++||++++ ++.+.+||||
T Consensus 212 ---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~~f 250 (250)
T cd05123 212 ---FPEFLSPEARDLISGLLQKDPTKRLGSGG-AEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCCCC
Confidence 11111345678999999999999999966 6667779998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.53 Aligned_cols=258 Identities=28% Similarity=0.361 Sum_probs=210.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV 765 (1014)
+|+..+.||+|++|.||+|.+..+++.|++|++..... .....+.+.+|+.++++++||||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 36778899999999999999998899999999854322 245678899999999999999999999999988 889999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+|++|+||+++.++.++|+||
T Consensus 80 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-----------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred EEecCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccc
Confidence 99999999999987642 489999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|.+......... .......++..|+|||...+..++.++||||||+++|+|++|..||...+.. ....+.... ...
T Consensus 146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~ 221 (260)
T cd06606 146 GCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS-SGE 221 (260)
T ss_pred ccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc-cCC
Confidence 999876543211 1123467889999999998888999999999999999999999999876522 111111111 010
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...........+.+++.+|++.||++||++.|+++ ||||
T Consensus 222 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~----~~~~ 260 (260)
T cd06606 222 ---------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ----HPFL 260 (260)
T ss_pred ---------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh----CCCC
Confidence 00111122456778899999999999999999999 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.54 Aligned_cols=259 Identities=23% Similarity=0.286 Sum_probs=203.1
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccc--hhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--Cce
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDR--KLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLK 762 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 762 (1014)
.+|...+.||+|+||.||+|.+..+++.||+|.+..+. .........+.+|+.+++.++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36788999999999999999999999999999874321 12334567889999999999999999999998764 457
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++++|.+++.... .+++....+++.|++.|+.|||+. +++|+||||+||+++.++.++|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l 147 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKL 147 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 89999999999999987542 378888999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
+|||.++................++..|+|||++.+..++.++|+|||||++|++++|+.||....... .+......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIFKIATQ 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHHHHHcC
Confidence 999999865331111112224568899999999998889999999999999999999999997653221 11122111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
+. ... ........+.+++..|++ +|.+||++.+++. |||.
T Consensus 225 ~~--~~~--------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~----~~~~ 264 (264)
T cd06653 225 PT--KPM--------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR----HPFV 264 (264)
T ss_pred CC--CCC--------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc----CCCC
Confidence 11 011 112223457788889999 5799999998877 9873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.55 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=204.9
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|...+.||+|+||+||+|.+..+++.||+|++.............+.+|+++++.++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999999999999999998544344445567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+. |++.+++.... ..+++.++..++.|++.|++|||.. +++|+||+|+||+++.++.+||+|||++
T Consensus 103 ~~-~~l~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 103 CL-GSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred CC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 96 58888776532 2478999999999999999999965 9999999999999999999999999998
Q ss_pred cccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+...... .......+
T Consensus 169 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~~~~~ 238 (313)
T cd06633 169 SKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNDSP 238 (313)
T ss_pred cccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCC
Confidence 64321 22456889999999874 4568889999999999999999999997765332222 11111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
....+. ....+.+++.+||+.||.+||++.++++ ||||.....
T Consensus 239 -------~~~~~~---~~~~l~~li~~~l~~~P~~Rp~~~~~l~----~~~~~~~~~ 281 (313)
T cd06633 239 -------TLQSNE---WTDSFRGFVDYCLQKIPQERPASAELLR----HDFVRRDRP 281 (313)
T ss_pred -------CCCccc---cCHHHHHHHHHHccCChhhCcCHHHHhc----CcccCCCch
Confidence 011111 1234667889999999999999999998 999997553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=304.43 Aligned_cols=268 Identities=27% Similarity=0.345 Sum_probs=205.0
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC--CceEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE--NLKLLVY 766 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 766 (1014)
|+..+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+++++.++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 566788999999999999999999999999995432 2233456788999999999999999999999887 8899999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++ +|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||
T Consensus 80 e~~~~-~l~~~~~~~~----------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 80 EYMDH-DLTGLLDSPE----------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred ccccc-cHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccc
Confidence 99975 8888876531 3488999999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.+........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 146 LARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred ceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 9987654321 11234466889999997764 46789999999999999999999999876643332222221110000
Q ss_pred ----ch-h-----ccccccCC-----cccHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 ----IV-D-----ALDKEIDE-----PCFLE-EMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ----~~-~-----~~~~~~~~-----~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.. . ........ ..... ....+.+++..||+.||.+||++.++++ ||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~----~~~~ 287 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ----HEYF 287 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh----CcCC
Confidence 00 0 00000000 00011 1456789999999999999999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.59 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=189.2
Q ss_pred ceeccCCcEEEEEeeecCCC----------eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCce
Q 001778 693 NVIGSGGSGKVYRVPINHTA----------EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 762 (1014)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999988766 357888763321 226788999999999999999999999988 778
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC----
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF---- 838 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~---- 838 (1014)
++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~ 142 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK----------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEG 142 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccC
Confidence 99999999999999998642 1478999999999999999999955 999999999999999887
Q ss_pred ---cEEEeecccccccccccCccccccccccCcccccccccccC--CCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhH
Q 001778 839 ---NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 839 ---~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~ 912 (1014)
.+|++|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||........
T Consensus 143 ~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 143 YVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred CceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 799999999986533 1234567789999998876 78899999999999999999 4667765432211
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
..+.. .... ...+. ...+.+++.+||+.||.+||++.|+++.|
T Consensus 216 ~~~~~----~~~~--------~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 ERFYQ----DQHR--------LPMPD----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHh----cCCC--------CCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111 1110 00111 15677899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=310.85 Aligned_cols=277 Identities=25% Similarity=0.298 Sum_probs=208.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----C
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE-----N 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~ 760 (1014)
..+|...+.||+|+||+||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 457888999999999999999999999999999985421 2233456677899999999999999999987644 3
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-----------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 4799999996 6898888654 2388999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+...........
T Consensus 148 kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 224 (337)
T cd07858 148 KICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224 (337)
T ss_pred EECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 999999998654321 12234567889999998765 46889999999999999999999999876533222222111
Q ss_pred HhcCCc----------chhccc---cccCC---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 920 IQEGKP----------IVDALD---KEIDE---PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 920 ~~~~~~----------~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
...... ....+. ..... .........+.+++.+||+.||++|||++|+++ ||||......
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~----h~~~~~~~~~ 300 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA----HPYLASLHDP 300 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc----CcchhhhcCc
Confidence 100000 000000 00000 001123345789999999999999999999998 9999875444
Q ss_pred CC
Q 001778 984 GR 985 (1014)
Q Consensus 984 ~~ 985 (1014)
..
T Consensus 301 ~~ 302 (337)
T cd07858 301 SD 302 (337)
T ss_pred cc
Confidence 33
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=298.42 Aligned_cols=252 Identities=31% Similarity=0.480 Sum_probs=202.1
Q ss_pred CCCceeccCCcEEEEEeeecCCC----eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 690 TESNVIGSGGSGKVYRVPINHTA----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
+..+.||+|+||.||++.+...+ ..||+|++... ......+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 45678999999999999988766 88999998443 2223567899999999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++||
T Consensus 80 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df 147 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF 147 (258)
T ss_pred EeccCCCCHHHHHHhhhh---------ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence 999999999999976421 1279999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|.+......... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.........+.+ ..+.
T Consensus 148 g~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~ 221 (258)
T smart00219 148 GLSRDLYDDDYY--KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL----KKGY 221 (258)
T ss_pred CCceeccccccc--ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCC
Confidence 999876543111 1112347789999999988889999999999999999998 77888765433332221 1111
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
. . ........++.+++.+|++.||++|||+.|+++.|
T Consensus 222 ~-~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 R-L---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C-C---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 0 01111344677899999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.34 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=191.9
Q ss_pred CCCCCcee--ccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEE
Q 001778 688 KLTESNVI--GSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~~L--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 764 (1014)
+|...+.+ |+|+||.||++....+++.+|+|.+..... .. .|+.....+ +|||++++++++..++..++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc---ch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 45555554 999999999999999999999999843211 10 122222222 79999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-cEEEe
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NAKIA 843 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-~~kl~ 843 (1014)
||||+++|+|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+
T Consensus 87 v~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-----------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999997642 489999999999999999999965 999999999999999998 99999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH--HHHHHHHHh
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL--AQWAWRHIQ 921 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~~ 921 (1014)
|||.+...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||........ ..+... ..
T Consensus 153 dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 224 (267)
T PHA03390 153 DYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQ 224 (267)
T ss_pred cCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hc
Confidence 99998765321 234688999999999998999999999999999999999999985543321 111111 11
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHHHhcCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-MRMVLQILLNNPIFPT 979 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~~L~~~~~~~~ 979 (1014)
... .........+.+++.+||+.||.+||+ ++|+++ ||||..
T Consensus 225 ~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~----h~~~~~ 267 (267)
T PHA03390 225 KKL------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK----HPFLKI 267 (267)
T ss_pred ccC------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc----CCcccC
Confidence 100 111123345778889999999999996 588887 999963
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=301.50 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=204.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecC-----CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
++|+..+.||+|+||.||+|+++. ..+.||+|.+... ......+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 457888899999999999998654 3467999987432 223346779999999999999999999999999899
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~k 841 (1014)
.++||||+++|+|.+++........ ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~--~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDE--KLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccc--cccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence 9999999999999999986531110 01122589999999999999999999965 999999999999999999999
Q ss_pred EeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 920 (1014)
++|||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..
T Consensus 158 l~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~----~~ 231 (275)
T cd05046 158 VSLLSLSKDVYNS--EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN----RL 231 (275)
T ss_pred EcccccccccCcc--cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH----HH
Confidence 9999998754321 1122334566788999999988888999999999999999998 777886544332222 11
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+.. .. .. .......+.+++.+||+.||++||++.|+++.|.+
T Consensus 232 ~~~~~-~~----~~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 QAGKL-EL----PV----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HcCCc-CC----CC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111 00 00 11122467789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.32 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=188.5
Q ss_pred eeccCCcEEEEEeeecCCC--eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 694 VIGSGGSGKVYRVPINHTA--EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
.||+|+||+||+|.+...+ ..+++|.+... ......+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999999998754432 34667766332 2234567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.++++.... .....++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~ 149 (268)
T cd05086 80 GDLKSYLSQEQW-------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149 (268)
T ss_pred CcHHHHHHhhhc-------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence 999999986421 122356777889999999999999965 9999999999999999999999999998643
Q ss_pred ccccCccccccccccCccccccccccc-------CCCCCcCcchhHHHHHHHHhcC-CCCCCCCCchhHHHHHHHHHhcC
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYART-------RKVNEKTDIYSFGVILLELTTG-KEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DvwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
... ..........++..|+|||++.. ..++.++|||||||++|||+++ ..||...+...... ....+.
T Consensus 150 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~~~~ 225 (268)
T cd05086 150 YKE-DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN---HVIKDQ 225 (268)
T ss_pred Ccc-hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHhhc
Confidence 221 11112234567899999998753 2457899999999999999975 56776544322222 112111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
. ....++.+..+ +. .++.+++..|| .||++||+++||++.|.
T Consensus 226 ~--~~~~~~~~~~~-~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 Q--VKLFKPQLELP-YS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred c--cccCCCccCCC-Cc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 11222222222 12 34556778899 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.30 Aligned_cols=258 Identities=30% Similarity=0.424 Sum_probs=210.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.||+|++.... ......+.+.+|+++++.++|||++++++.+..++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4677889999999999999999889999999985432 234556778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++..... ....+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 80 YADGGDLSQKIKKQKK-------EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred ecCCCcHHHHHHHhhc-------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999987421 224589999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+....... .......|++.|+|||...+..++.++|+||+|+++|+|++|+.||...+...... ........
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~-- 221 (258)
T cd08215 150 SKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL---KILKGQYP-- 221 (258)
T ss_pred eeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH---HHhcCCCC--
Confidence 98654422 12234578899999999988889999999999999999999999997665332221 11111100
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+ .......+.+++.+||+.+|++||++.|+++ ||||
T Consensus 222 -----~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~----~~~~ 258 (258)
T cd08215 222 -----PI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ----SPFI 258 (258)
T ss_pred -----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc----CCCC
Confidence 01 1122345778899999999999999999998 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.85 Aligned_cols=261 Identities=22% Similarity=0.368 Sum_probs=200.7
Q ss_pred CCCCceeccCCcEEEEEeeecC---CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----
Q 001778 689 LTESNVIGSGGSGKVYRVPINH---TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN----- 760 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----- 760 (1014)
|...++||+|+||.||+|.+.. +++.||||++..+. ......+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 4567889999999999998653 46889999985432 23445677899999999999999999999886532
Q ss_pred -ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 761 -LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 761 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
..++++||+++|+|.+++...... .....+++....+++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~ 151 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIG-----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMT 151 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCC
Confidence 247899999999999987643211 1122478899999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 918 (1014)
+|++|||.++...... .........+++.|++||.+.+..++.++|||||||++|||++ |+.||.+.+......+
T Consensus 152 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~--- 227 (273)
T cd05074 152 VCVADFGLSKKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY--- 227 (273)
T ss_pred EEECcccccccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH---
Confidence 9999999998654322 1112223445678999999998889999999999999999999 8888876554332222
Q ss_pred HHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
........ . .......+.+++.+|++.+|++||++.|+++.|++
T Consensus 228 -~~~~~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 228 -LIKGNRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -HHcCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11211100 0 01223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=312.13 Aligned_cols=272 Identities=23% Similarity=0.300 Sum_probs=200.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------ 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------ 759 (1014)
..+|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 457889999999999999999999999999999984432 24457788999999999999999999776543
Q ss_pred --------CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 001778 760 --------NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831 (1014)
Q Consensus 760 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~N 831 (1014)
...++|+||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~N 144 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQG------------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPAN 144 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence 35789999997 5888887542 378999999999999999999966 99999999999
Q ss_pred eeecC-CCcEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCc
Q 001778 832 ILLDY-NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEH 909 (1014)
Q Consensus 832 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~ 909 (1014)
|+++. ++.+|++|||.+.................++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 145 ili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 224 (342)
T cd07854 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224 (342)
T ss_pred EEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99974 557899999999765332111111223467889999997654 5678899999999999999999999976543
Q ss_pred hhHHHHHHHHHhcCCc-----ch----hccc-cccCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 910 TCLAQWAWRHIQEGKP-----IV----DALD-KEIDEP-----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 910 ~~~~~~~~~~~~~~~~-----~~----~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
................ .. .... ...... .......++.+++..|++.||++|||+.|+++ |
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~----h 300 (342)
T cd07854 225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM----H 300 (342)
T ss_pred HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC----C
Confidence 2222111111000000 00 0000 000000 00112345778999999999999999999988 9
Q ss_pred CCCCCC
Q 001778 975 PIFPTE 980 (1014)
Q Consensus 975 ~~~~~~ 980 (1014)
|||+.-
T Consensus 301 ~~~~~~ 306 (342)
T cd07854 301 PYMSCY 306 (342)
T ss_pred Cccccc
Confidence 999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.76 Aligned_cols=278 Identities=24% Similarity=0.264 Sum_probs=208.7
Q ss_pred cCCCCCC-CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHH-----------hHHHHHHHHHHHHcCCCCccceE
Q 001778 685 ILPKLTE-SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-----------HEKEFLAEVQILSTIRHLNIVKL 752 (1014)
Q Consensus 685 ~~~~~~~-~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~hpniv~l 752 (1014)
+.++|.. .+.||+|+||.||+|.+..+++.||||++......... ....+.+|+++++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4456654 57799999999999999989999999998442211100 12357899999999999999999
Q ss_pred EEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCe
Q 001778 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNI 832 (1014)
Q Consensus 753 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NI 832 (1014)
++++..++..++||||++ |+|.+++... ..+++.....++.|++.||+|||.. +|+|+||+|+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~ni 150 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK-----------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANI 150 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHe
Confidence 999999999999999997 6999988653 2378899999999999999999965 999999999999
Q ss_pred eecCCCcEEEeeccccccccccc-----------CccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcC
Q 001778 833 LLDYNFNAKIADFGVAKILIKEE-----------GEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTG 900 (1014)
Q Consensus 833 ll~~~~~~kl~Dfgla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg 900 (1014)
+++.++.++++|||.+....... ..........++..|+|||.+.+. .++.++||||+||++|||++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999997654110 001112234568899999988764 468899999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhcCCcchhccccc------------cCC---cccHHHHHHHHHHHhHccCCCCCCCCCHH
Q 001778 901 KEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE------------IDE---PCFLEEMIRVFKLGVICTSMLPTERPNMR 965 (1014)
Q Consensus 901 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 965 (1014)
+.||.+.+.......+........ ....... ... ........++.+++..|++.||++||+++
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCc--hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 999987765443333322221111 0000000 000 00111234577899999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCC
Q 001778 966 MVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 966 ev~~~L~~~~~~~~~~~~ 983 (1014)
|++. ||||+.....
T Consensus 309 ~~l~----~~~~~~~~~~ 322 (335)
T PTZ00024 309 EALK----HEYFKSDPLP 322 (335)
T ss_pred HHhc----CcccCCCCCC
Confidence 9998 9999976544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.02 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=206.4
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|++|.||++.+..+++.|++|++..... .....+.+|+++++.++||+++++++++..+...++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 6677899999999999999988899999999854322 4567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++.... ..+++..+..++.|++.|++|||.. +++||||+|+||++++++.++|+|||.+
T Consensus 79 ~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 79 CSGGSLKDLLKSTN----------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred CCCCcHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccc
Confidence 99999999987641 3489999999999999999999965 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+....... ......+
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~--- 215 (253)
T cd05122 146 AQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IATNGPP--- 215 (253)
T ss_pred cccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcCCC---
Confidence 87654221 2356788999999999888899999999999999999999999976543222111 1111110
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
.... ......++.+++.+||+.||++|||+.|+++ |||
T Consensus 216 ----~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~----~~~ 253 (253)
T cd05122 216 ----GLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK----HPF 253 (253)
T ss_pred ----CcCc--ccccCHHHHHHHHHHccCChhhCCCHHHHhc----CCC
Confidence 0100 1111345778999999999999999999998 887
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=309.81 Aligned_cols=270 Identities=26% Similarity=0.317 Sum_probs=203.3
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------ 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------ 759 (1014)
..+|...+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 356888899999999999999998899999999985422 1223345688999999999999999999998654
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
..+++|+||+.. ++.++... .+++..+..++.|++.||+|||.. +++||||||+||+++.++.
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGH-------------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred ceEEEEeccccc-CHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 346999999964 77665421 378899999999999999999965 9999999999999999999
Q ss_pred EEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+|++|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 156 ~kL~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 156 LKILDFGLARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred EEEeeCCCCcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999875422 1223467889999999876 4688999999999999999999999987653222211111
Q ss_pred HHhcCCcchhccc--------------cccCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 919 HIQEGKPIVDALD--------------KEIDEP----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 919 ~~~~~~~~~~~~~--------------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.. +.+..+..+ +..... .+......+.+++.+||+.||++||+++|+++ ||||...
T Consensus 230 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~----h~~f~~~ 303 (342)
T cd07879 230 VT--GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE----HPYFDSF 303 (342)
T ss_pred hc--CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc----Ccchhhc
Confidence 10 000000000 000000 00112345778999999999999999999988 9999987
Q ss_pred CCCCC
Q 001778 981 KNGGR 985 (1014)
Q Consensus 981 ~~~~~ 985 (1014)
+....
T Consensus 304 ~~~~~ 308 (342)
T cd07879 304 RDADE 308 (342)
T ss_pred ccccc
Confidence 65433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=293.27 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=207.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|++++++++|||++++++++.+++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 46778899999999999999998899999999865432 23456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++... ..+++..+..++.|++.|+.|||.. +|+||||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 80 YAENGSLRQIIKKF-----------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred cCCCCcHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccc
Confidence 99999999998764 2488999999999999999999955 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+........ ......++..|+|||...+..++.++||||+|+++|+|++|+.||........ .+.......+
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-- 217 (254)
T cd06627 146 ATKLNDVSK---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFRIVQDDHP-- 217 (254)
T ss_pred ceecCCCcc---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhccCCC--
Confidence 987654322 12345688999999999888889999999999999999999999976542211 1111111110
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+. ......+.+++.+|++.+|++||++.|++. ||||
T Consensus 218 -----~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~----~~~~ 254 (254)
T cd06627 218 -----PLP----EGISPELKDFLMQCFQKDPNLRPTAKQLLK----HPWI 254 (254)
T ss_pred -----CCC----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc----CCCC
Confidence 011 112345678899999999999999999998 9987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.60 Aligned_cols=271 Identities=27% Similarity=0.326 Sum_probs=204.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC-----
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN----- 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----- 760 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecc-cccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457888999999999999999999999999999985432 12233456788999999999999999999987654
Q ss_pred -----ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec
Q 001778 761 -----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835 (1014)
Q Consensus 761 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~ 835 (1014)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG----------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 78999999986 777776543 12489999999999999999999966 999999999999999
Q ss_pred CCCcEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHH
Q 001778 836 YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914 (1014)
Q Consensus 836 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~ 914 (1014)
+++.+||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+......
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred CCCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999986643221 11223456788999998764 457889999999999999999999998765443333
Q ss_pred HHHHHHhcCCcc--hhc--------ccccc-----CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 915 WAWRHIQEGKPI--VDA--------LDKEI-----DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 915 ~~~~~~~~~~~~--~~~--------~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+........+. .+. .++.- ....+......+.+++..||+.||.+||++.++++ ||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~----~~~~ 302 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN----SPWL 302 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc----CCCC
Confidence 333322111100 000 00000 00001112346789999999999999999999998 9996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.21 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=204.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..|+..+.||+|+||.||+|.+..+++.||+|.+............++.+|+++++.++|+|++++++++..+...++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777888999999999999999899999999985433333445567889999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+. |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||
T Consensus 95 e~~~-~~l~~~~~~~~----------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 95 EYCL-GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred EccC-CCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 9996 68888775431 2378899999999999999999965 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccc---cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYAR---TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
++..... .....++..|+|||++. ...++.++|||||||++|+|++|+.||...+... .........
T Consensus 161 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~ 230 (308)
T cd06634 161 SASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNE 230 (308)
T ss_pred cceeecC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcC
Confidence 9876432 12346788999999874 3567889999999999999999999987643221 111111111
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
. +.... ......+.+++.+||+.+|++||++.++++ |||+....
T Consensus 231 ~-------~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~----~~~~~~~~ 274 (308)
T cd06634 231 S-------PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK----HRFVLRER 274 (308)
T ss_pred C-------CCcCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhh----CccccccC
Confidence 1 01111 122345678899999999999999999998 99998854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.07 Aligned_cols=266 Identities=23% Similarity=0.277 Sum_probs=205.8
Q ss_pred CCCCceeccCCcEEEEEeeec---CCCeEEEEEEecccchhh-HHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceE
Q 001778 689 LTESNVIGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRKLD-QKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 763 (1014)
|+..+.||+|++|.||++.+. .+++.||||++....... ....+.+.+|+.++.++ +||+|+++++++..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 667789999999999998764 356789999985432222 23456788999999999 5999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+||||+++|+|.+++... ..+++.....++.|+++||.|||.. +++||||+|+||+++.++.++|+
T Consensus 82 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-----------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred EEEecCCCCcHHHHHhhc-----------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence 999999999999998653 2378899999999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCC--CCCcCcchhHHHHHHHHhcCCCCCCCCCchhH-HHHHHHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK--VNEKTDIYSFGVILLELTTGKEANNGDEHTCL-AQWAWRHI 920 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DvwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~ 920 (1014)
|||++........ .......|+..|+|||...+.. ++.++||||||+++|||++|..||........ ........
T Consensus 148 dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 225 (288)
T cd05583 148 DFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225 (288)
T ss_pred ECccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH
Confidence 9999876543221 1122346889999999987654 78899999999999999999999965432211 11111111
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
....+ ........+.+++.+||+.||++|||+.++.+ +.+||||+...+.
T Consensus 226 ~~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~-~l~~~~~~~~~~~ 275 (288)
T cd05583 226 KSKPP------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADE-IKNHPFFQGIDWD 275 (288)
T ss_pred ccCCC------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHH-HhcCcccccCCHH
Confidence 11111 11112235678899999999999999887765 5679999887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=283.90 Aligned_cols=284 Identities=21% Similarity=0.291 Sum_probs=228.2
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 764 (1014)
...|...++||+|+|++|..++++.+.+.+|+|++++.-..+....+-++.|..+..+. +||.+|.++.+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 34678899999999999999999999999999999776555556677778888888776 79999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
|.||++||+|.-.++.++ .++++.+..+...|..||.|||++ ||++||+|.+|||+|..|++|+.|
T Consensus 329 vieyv~ggdlmfhmqrqr-----------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred EEEEecCcceeeehhhhh-----------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 999999999988887764 389999999999999999999966 999999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCC----CCchhHHHHHHHHH
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNG----DEHTCLAQWAWRHI 920 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~----~~~~~~~~~~~~~~ 920 (1014)
+|+++.--..+ ...++.+|||.|+|||++.+..|...+|+|++||+++||+.|+.||+- +.+..-.++....+
T Consensus 395 ygmcke~l~~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 395 YGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred cchhhcCCCCC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 99997543322 234578999999999999999999999999999999999999999972 22222333333333
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCCCcccccccccchh
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM--RMVLQILLNNPIFPTEKNGGRKYDHVTPLLTDS 997 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1014)
.+.. ++.+. ....+...+...-+++||.+|..- +--.+.++.|+||+...|.-.+++++.|+..+.
T Consensus 472 lekq---------iripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 472 LEKQ---------IRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ 539 (593)
T ss_pred hhhc---------ccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence 2221 12111 111233456667899999998732 224566778999999999988888888876554
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=306.38 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=205.6
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN---- 760 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~---- 760 (1014)
+.++|+..+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 456799999999999999999999999999999998432 223344567889999999999999999999987653
Q ss_pred --ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 761 --LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 761 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
..++|+||+ +++|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~------------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE------------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 458999999 67998887542 378999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.++++|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||...+......
T Consensus 156 ~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~--- 226 (343)
T cd07880 156 ELKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM--- 226 (343)
T ss_pred CEEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 9999999999764321 123467889999998876 458899999999999999999999998655322111
Q ss_pred HHHhcCCcchhccccc---------------cCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 918 RHIQEGKPIVDALDKE---------------IDEP----CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~---------------~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
............+... .... ........+.+++.+|++.||++|||+.++++ ||||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~----~~~~~ 302 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA----HPYFE 302 (343)
T ss_pred HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc----CccHh
Confidence 1111100000000000 0000 00112235778999999999999999999998 99998
Q ss_pred CCCCC
Q 001778 979 TEKNG 983 (1014)
Q Consensus 979 ~~~~~ 983 (1014)
.....
T Consensus 303 ~~~~~ 307 (343)
T cd07880 303 EFHDP 307 (343)
T ss_pred hhcCc
Confidence 85443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=306.76 Aligned_cols=270 Identities=26% Similarity=0.327 Sum_probs=204.2
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
..++|+..+.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 456789999999999999999999889999999998542 12233456788999999999999999999988643
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
...+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 3467888876 77998887542 378999999999999999999965 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||++..... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+.
T Consensus 158 ~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 158 ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CEEEecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999875422 1224567889999998866 567889999999999999999999997654332222111
Q ss_pred HHHhcCCcchhcc---cc-----------ccCCccc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 918 RHIQEGKPIVDAL---DK-----------EIDEPCF----LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~~~~~---~~-----------~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
... +.+..+.. .. ......+ ......+.+++.+|++.||.+||++.++++ ||||.+
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~----h~~f~~ 305 (345)
T cd07877 232 RLV--GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA----HAYFAQ 305 (345)
T ss_pred HHh--CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc----Chhhhh
Confidence 111 10000000 00 0000000 012335778999999999999999999988 999987
Q ss_pred CCCC
Q 001778 980 EKNG 983 (1014)
Q Consensus 980 ~~~~ 983 (1014)
....
T Consensus 306 ~~~~ 309 (345)
T cd07877 306 YHDP 309 (345)
T ss_pred cCCC
Confidence 4443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.74 Aligned_cols=266 Identities=26% Similarity=0.299 Sum_probs=202.4
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 767 (1014)
|+..+.||+|++|+||+|....+++.||+|++.... .........+|+..+++++ |||++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF--YSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc--cchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 566788999999999999998889999999984322 1223344567999999998 9999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+ +|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 79 ~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~ 145 (283)
T cd07830 79 YM-EGNLYQLMKDRK---------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL 145 (283)
T ss_pred cC-CCCHHHHHHhcc---------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccc
Confidence 99 789999887642 23479999999999999999999965 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC---
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG--- 923 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 923 (1014)
+....... ......++..|+|||++. ...++.++|+||||+++|||++|+.||...................
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 146 AREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred ceeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 97654321 122456788999999875 4567899999999999999999999997665433222211111000
Q ss_pred -----CcchhccccccC-------CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 -----KPIVDALDKEID-------EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 -----~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.......+..+. ..........+.+++.+||+.||++||+++|++. ||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~----~~~~ 283 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ----HPYF 283 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh----CCCC
Confidence 000000000000 0001112356789999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.90 Aligned_cols=267 Identities=22% Similarity=0.268 Sum_probs=203.0
Q ss_pred CCCCCceeccCCcEEEEEeeec---CCCeEEEEEEecccchh-hHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGSGGSGKVYRVPIN---HTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 762 (1014)
+|+..+.||+|+||.||+|.+. .+++.||+|++...... .....+.+.+|+.++..+ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3677889999999999999874 46889999998543221 223456788999999999 699999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
++|+||+++++|.+++.... .+++.....++.|++.||.|||+. +++||||+|+||+++.++.+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 99999999999999987642 378888999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccC--CCCCcCcchhHHHHHHHHhcCCCCCCCCCchh-HHHHHHHH
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTTGKEANNGDEHTC-LAQWAWRH 919 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwSlGvll~elltg~~p~~~~~~~~-~~~~~~~~ 919 (1014)
+|||++........ .......|+..|+|||.+... .++.++||||||+++|+|++|+.||....... ........
T Consensus 147 ~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 224 (290)
T cd05613 147 TDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224 (290)
T ss_pred eeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh
Confidence 99999976533211 122245688999999998753 46789999999999999999999997543221 12222211
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCH-HHHHHHHhcCCCCCCCCC
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM-RMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ev~~~L~~~~~~~~~~~ 982 (1014)
.....+ ........+.+++.+|++.||++||+. ...++.+..||||..-.+
T Consensus 225 ~~~~~~------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 225 LKSEPP------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred hccCCC------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 111111 111123456788999999999999832 223444455999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.59 Aligned_cols=267 Identities=26% Similarity=0.327 Sum_probs=206.8
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 456788999999999999998899999999985432 2224467788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++ ++.+++.... ..+++..+..++.|++.|++|||.. +|+|+||||+||++++++.++|+|||.+
T Consensus 80 ~~~-~l~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 80 MDT-DLYKLIKDRQ----------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred cCC-CHHHHHHhhc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 975 8888887642 2488999999999999999999965 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-c
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP-I 926 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 926 (1014)
....... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+........+ .
T Consensus 146 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 146 RSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred EecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 7764432 122235678899999998776 7889999999999999999999999776543322222111111000 0
Q ss_pred hhcccc-------cc------C-CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 927 VDALDK-------EI------D-EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 927 ~~~~~~-------~~------~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
...... .. . .........++.+++..||++||.+||++.+++. ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~----~~~~ 283 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA----HPYF 283 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh----CCCC
Confidence 000000 00 0 0111233457889999999999999999999998 9997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.41 Aligned_cols=256 Identities=28% Similarity=0.369 Sum_probs=208.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|+..+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 46778899999999999999998999999999844222 33456778899999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|+++++|.+++..... ....+++..++.++.|++.|++|||.. +++|+||+|+||+++.++.+|++|||+
T Consensus 80 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 80 YAPFGDLSKAISKRKK-------KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred hcCCCCHHHHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999876321 124589999999999999999999955 999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1014)
+...... ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+.......+ ..+..
T Consensus 150 ~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~-- 218 (256)
T cd08530 150 SKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV----QRGKY-- 218 (256)
T ss_pred hhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCC--
Confidence 9876442 122356788999999999989999999999999999999999999876543222211 11110
Q ss_pred hccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.+.......++.+++.+|++.+|++||++.|+++ ||+.
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~----~p~~ 256 (256)
T cd08530 219 --------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA----SPAV 256 (256)
T ss_pred --------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc----CCCC
Confidence 0111233456788999999999999999999998 8863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=301.95 Aligned_cols=263 Identities=22% Similarity=0.250 Sum_probs=196.7
Q ss_pred CcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHHh
Q 001778 699 GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL 778 (1014)
Q Consensus 699 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 778 (1014)
++|.||.++...+++.||||++... .......+.+.+|+.+++.++||||+++++++..++..+++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecc-ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 4455555556778999999998543 223455678999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccC--
Q 001778 779 HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG-- 856 (1014)
Q Consensus 779 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 856 (1014)
.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 91 ~~~~---------~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 91 KTHF---------PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 8642 12378888999999999999999965 999999999999999999999999999876533211
Q ss_pred --ccccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc-------
Q 001778 857 --EFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP------- 925 (1014)
Q Consensus 857 --~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 925 (1014)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ........+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML---LEKVRGTVPCLLDKST 235 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccCccccccCc
Confidence 1111234557789999999876 35889999999999999999999999865432111 111110000
Q ss_pred -------chh----cccc----ccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 926 -------IVD----ALDK----EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 -------~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
... ..+. ............++.+++..||+.||++|||++++++ ||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~----~p~~~~~~ 302 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN----HSFFKQCK 302 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc----CchHhhhc
Confidence 000 0000 0011111222346778999999999999999999998 99998665
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.86 Aligned_cols=273 Identities=24% Similarity=0.298 Sum_probs=202.1
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------ 759 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------ 759 (1014)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5678999999999999999999999999999998854322 122234667899999999999999999887543
Q ss_pred --CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 760 --NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 760 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
...++|+||+++ ++.+.+... ...+++..+..++.|+++||+|||.. +|+|+||||+||+++++
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~----------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENP----------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQ 151 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 346999999975 677766543 13489999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCcc--------ccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q 001778 838 FNAKIADFGVAKILIKEEGEF--------AAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDE 908 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~ 908 (1014)
+.++|+|||++.......... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997654322111 11123456888999998765 457899999999999999999999998765
Q ss_pred chhHHHHHHHHHhcCCc--------chhcc----ccccCC---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 909 HTCLAQWAWRHIQEGKP--------IVDAL----DKEIDE---PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 909 ~~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.......+........+ ..... ...... ..+......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~---- 307 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE---- 307 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc----
Confidence 54333322222111000 00000 000000 001122246789999999999999999999988
Q ss_pred CCCC
Q 001778 974 NPIF 977 (1014)
Q Consensus 974 ~~~~ 977 (1014)
||||
T Consensus 308 ~~~f 311 (311)
T cd07866 308 HPYF 311 (311)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.13 Aligned_cols=265 Identities=29% Similarity=0.366 Sum_probs=218.7
Q ss_pred cccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 681 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
.+......|.+.+.||+|.|++|..+.+..++..||+|.+.+. ..+....+.+.+|+++|..+.|||||+++.+.+...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt-~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT-QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc-ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3444566788999999999999999999999999999998553 334444566999999999999999999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
.+|+||||+.+|.+.+++...++ .....+..++.|+.+|++|+|.. .|||||||++|||++.+..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr-----------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR-----------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc-----------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 99999999999999999998753 44477888999999999999955 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccccCCCC-CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
||+|||++..+... ......+|++.|.|||++.+..|. +.+|+||+|+++|-|+.|.-||++..-..+.
T Consensus 195 kIaDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------ 264 (596)
T KOG0586|consen 195 KIADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------ 264 (596)
T ss_pred eeeccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------
Confidence 99999999987542 345678999999999999988764 8999999999999999999999976533221
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
...+...++.+++.. .++-+++++++-.+|.+|++++++.+ |+|....-+.
T Consensus 265 -------~rvl~gk~rIp~~ms--~dce~lLrk~lvl~Pskr~~~dqim~----~~W~n~~~~~ 315 (596)
T KOG0586|consen 265 -------PRVLRGKYRIPFYMS--CDCEDLLRKFLVLNPSKRGPCDQIMK----DRWRNDLLEA 315 (596)
T ss_pred -------chheeeeecccceee--chhHHHHHHhhccCccccCCHHHhhh----hcccchhhhh
Confidence 112222233333322 24567888999999999999999988 8888764433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=300.87 Aligned_cols=270 Identities=27% Similarity=0.318 Sum_probs=205.4
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-CCceE
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-ENLKL 763 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~ 763 (1014)
+..+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4567999999999999999999999999999999884322 223345678899999999999999999999865 56789
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+|+||+ +++|.++++.. .+++.....++.|+++||+|||.. +|+||||+|+||++++++.++|+
T Consensus 87 lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR------------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred EEeehh-ccCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence 999998 56898887642 367888889999999999999965 99999999999999999999999
Q ss_pred ecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhc
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||.+..... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...+.............
T Consensus 151 dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~- 223 (328)
T cd07856 151 DFGLARIQDP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG- 223 (328)
T ss_pred ccccccccCC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-
Confidence 9999875422 1123467889999998766 5688999999999999999999999977654222211111110
Q ss_pred CCcchhccc-------------cccCCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 923 GKPIVDALD-------------KEIDEPCFL-----EEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 923 ~~~~~~~~~-------------~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+..+... .....+... .....+.+++.+|++.||++||++++++. |||+......
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~----~~~~~~~~~~ 297 (328)
T cd07856 224 -TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA----HPYLAPYHDP 297 (328)
T ss_pred -CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc----CCccccccCC
Confidence 00000000 000000011 12246778999999999999999999988 9999764433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=307.49 Aligned_cols=271 Identities=27% Similarity=0.341 Sum_probs=207.7
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc--
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL-- 761 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-- 761 (1014)
.+.++|+..+.||+|++|.||+|.+..+++.||+|++... .........+.+|+.+++.++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc-cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3456788999999999999999999999999999998432 2233445667889999999999999999988766554
Q ss_pred ----eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 762 ----KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 762 ----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||.. +|+||||||+||+++.+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~ 154 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQ------------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNED 154 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC
Confidence 89999998 56999988652 389999999999999999999965 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~ 916 (1014)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...........+
T Consensus 155 ~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 155 CELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred CCEEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999865321 224467889999998865 46788999999999999999999999766543222221
Q ss_pred HHHHhcCCcchhcccc--------------ccCCcc----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 917 WRHIQEGKPIVDALDK--------------EIDEPC----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 917 ~~~~~~~~~~~~~~~~--------------~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
.... +.+....... ....+. +......+.+++.+|++.||++|||+.|+++ ||||.
T Consensus 229 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~----h~~~~ 302 (343)
T cd07851 229 MNLV--GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA----HPYLA 302 (343)
T ss_pred HHhc--CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc----CCCcc
Confidence 1111 1110000000 000000 0112456789999999999999999999988 99998
Q ss_pred CCCCC
Q 001778 979 TEKNG 983 (1014)
Q Consensus 979 ~~~~~ 983 (1014)
.....
T Consensus 303 ~~~~~ 307 (343)
T cd07851 303 EYHDP 307 (343)
T ss_pred ccCCC
Confidence 75544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=299.32 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=202.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 764 (1014)
.++|+..+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++... .||||+++++++.++...++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 356888999999999999999999889999999985422 223345666777766666 59999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEee
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~D 844 (1014)
||||++ +++.++..... ..+++..+.+++.|++.|++|||.. .+|+||||+|+||++++++.+||+|
T Consensus 92 v~e~~~-~~l~~l~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ----------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred EeeccC-cCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECc
Confidence 999985 47777765531 2588999999999999999999952 3899999999999999999999999
Q ss_pred cccccccccccCccccccccccCcccccccccccCC----CCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK----VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 845 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
||.+....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......
T Consensus 159 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~ 232 (296)
T cd06618 159 FGISGRLVDSK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKIL 232 (296)
T ss_pred cccchhccCCC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHh
Confidence 99987653321 112345788999999987553 788999999999999999999999753321 11112222
Q ss_pred hcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
....+ ..... .....++.+++.+||+.||++||++.++++ ||||...+..
T Consensus 233 ~~~~~-------~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~----~~~~~~~~~~ 282 (296)
T cd06618 233 QEEPP-------SLPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQ----HPFIRRYETA 282 (296)
T ss_pred cCCCC-------CCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhc----Chhhhccchh
Confidence 22111 01000 012345778899999999999999999998 9999875544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.66 Aligned_cols=267 Identities=28% Similarity=0.356 Sum_probs=206.1
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|+..+.||+|++|.||+|....+++.||+|++.... ......+.+..|+.+++.++|+|++++++++.+.+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 455678999999999999999999999999985432 2233456778899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
++ ++|.+++.... ..+++..+..++.+++.|++|||+. +|+||||+|+||++++++.++|+|||.+
T Consensus 80 ~~-~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 80 CD-MDLKKYLDKRP----------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred cC-cCHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcc
Confidence 98 59999998642 2488999999999999999999966 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc--
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP-- 925 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 925 (1014)
........ ......++..|+|||.+.+. .++.++||||+||++||+++|+.||.+.........+.........
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 146 RAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred cccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 76543221 22234567789999998766 7889999999999999999999999876543332222221110000
Q ss_pred ------c--hhccccccCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 ------I--VDALDKEIDE----PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ------~--~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. .+..-+.... .........+.+++..||+.||++||++.+++. ||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~----~p~~ 282 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK----HPYF 282 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh----CcCC
Confidence 0 0000000000 001112346889999999999999999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.20 Aligned_cols=254 Identities=28% Similarity=0.332 Sum_probs=206.8
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
.++||.|.||+||-|+++.+|+.||||++.+.+. ..+.+..+++|+.|+++++||.||.+...|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF-p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF-PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccC-CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 5789999999999999999999999999966443 445568999999999999999999999999999999999999965
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC---CCcEEEeecccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY---NFNAKIADFGVA 848 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla 848 (1014)
+..+.+-.. +..++++.....++.||+.||.|||.. +|||+|+||+|||+.+ -.++||||||+|
T Consensus 648 -DMLEMILSs---------EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 648 -DMLEMILSS---------EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred -hHHHHHHHh---------hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence 555544432 233588888888999999999999976 9999999999999964 347999999999
Q ss_pred cccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
+++... .-....+||+.|.|||++..+.|...-|+||+|||+|.-++|..||..+++ +.+++... .
T Consensus 715 RiIgEk----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA--------a 780 (888)
T KOG4236|consen 715 RIIGEK----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA--------A 780 (888)
T ss_pred eecchh----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc--------c
Confidence 987542 223367999999999999999999999999999999999999999976543 33322211 1
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
++- ...-+.+...+.+++|...+++.-.+|-+.+.-+. |||++.+
T Consensus 781 FMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls----h~Wlq~y 825 (888)
T KOG4236|consen 781 FMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS----HPWLQDY 825 (888)
T ss_pred ccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc----chhhhcc
Confidence 111 11234455566789999999999999999777766 9999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=279.67 Aligned_cols=282 Identities=23% Similarity=0.330 Sum_probs=213.8
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEc-----
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS----- 758 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----- 758 (1014)
+...+|....+||+|.||+||+|+.+.+++.||+|++.-+. ..........+|+.++..++|+|++.+++.|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 44556788889999999999999999999999998763321 122345667899999999999999999877643
Q ss_pred ---CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec
Q 001778 759 ---ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835 (1014)
Q Consensus 759 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~ 835 (1014)
....|+||++|+. +|.-++... ...++..++.+++.++..||.|+|.. .|+|||+||+|+|++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~----------~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNR----------KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLIT 158 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCc----------cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEc
Confidence 3457999999986 888888653 34589999999999999999999966 999999999999999
Q ss_pred CCCcEEEeeccccccccccc-CccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHH
Q 001778 836 YNFNAKIADFGVAKILIKEE-GEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLA 913 (1014)
Q Consensus 836 ~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~ 913 (1014)
.++.+||+|||+|+.+...+ .....+..++-|..|++||.+.+ ..|+++.|||+.||++.||+||.+.+.++......
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99999999999997765433 22234567788999999998765 67999999999999999999999999987654433
Q ss_pred HHHHHHH----hcCCc------chhccccc-cCCcc---cHHHHH------HHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 914 QWAWRHI----QEGKP------IVDALDKE-IDEPC---FLEEMI------RVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 914 ~~~~~~~----~~~~~------~~~~~~~~-~~~~~---~~~~~~------~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
..+.... .+-+| ....+.-. +.... ..+... +..+++..++..||.+|+++++++.
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln---- 314 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN---- 314 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc----
Confidence 3322211 11111 11111000 11100 111111 5678899999999999999999998
Q ss_pred CCCCCCCCCCC
Q 001778 974 NPIFPTEKNGG 984 (1014)
Q Consensus 974 ~~~~~~~~~~~ 984 (1014)
|.||..++...
T Consensus 315 h~~F~kdp~pq 325 (376)
T KOG0669|consen 315 HDFFWKDPMPQ 325 (376)
T ss_pred hhhhhcCCcch
Confidence 99998887653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=293.35 Aligned_cols=258 Identities=26% Similarity=0.354 Sum_probs=202.5
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccch--hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK--LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
+|...+.||+|+||.||++.+...+..+++|+++.... ........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999999887777777777643221 1223445677899999999999999999999999999999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeec
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Df 845 (1014)
+||+++++|.+++..... ....+++..++.++.|++.|+.|||+. +++|+|++|+||+++. +.++|+||
T Consensus 81 ~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-------TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-------cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 999999999999875321 224589999999999999999999965 9999999999999985 57999999
Q ss_pred ccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|.+........ ......|++.|+|||...+..++.++|+||||+++|+|++|..||...... ...........+
T Consensus 150 g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~ 223 (260)
T cd08222 150 GVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLRIVEGPTP 223 (260)
T ss_pred CceeecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHcCCCC
Confidence 99876543221 222456788999999998888899999999999999999999999754422 111111111111
Q ss_pred chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. ........+.+++.+||+.||++||++.|+++ ||||
T Consensus 224 -------~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~----~~~~ 260 (260)
T cd08222 224 -------S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR----NPFI 260 (260)
T ss_pred -------C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh----CCCC
Confidence 1 11223346778999999999999999999999 9996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.47 Aligned_cols=278 Identities=25% Similarity=0.310 Sum_probs=207.1
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC------Cce
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------NLK 762 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~~ 762 (1014)
+...+.||+|+||.||+++++.+|+.||||.+.. ....+..+...+|++++++++|||||++++.-+.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~--~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNK--ESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhh--hcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3456789999999999999999999999999854 33556788899999999999999999999876554 356
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec--CCC--
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD--YNF-- 838 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~--~~~-- 838 (1014)
.+|||||.+|||..++.+- .....+++.+.+.++.+++.||.|||++ +|+||||||.||++- .+|
T Consensus 93 vlvmEyC~gGsL~~~L~~P--------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSP--------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred eEEEeecCCCcHHHHhcCc--------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCce
Confidence 8999999999999999763 2345699999999999999999999977 999999999999983 333
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccc-cCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh-HHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC-LAQWA 916 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~-~~~~~ 916 (1014)
..||+|||.|+....+. .....+||..|.+||+.. .+.|+..+|.|||||++|+++||..||....... .....
T Consensus 162 IyKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM 237 (732)
T ss_pred EEeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence 48999999999875532 556789999999999998 4889999999999999999999999997543321 11122
Q ss_pred HHHHhc-CCcchhccccccCC------------cccHHHHHHHHHHHhHccCCCCCCCC--CH-------HHHHHHHhcC
Q 001778 917 WRHIQE-GKPIVDALDKEIDE------------PCFLEEMIRVFKLGVICTSMLPTERP--NM-------RMVLQILLNN 974 (1014)
Q Consensus 917 ~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RP--t~-------~ev~~~L~~~ 974 (1014)
|....+ ...+.-...+...+ ........++-+....++..+|.+|. .. ++|++.---|
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvh 317 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVH 317 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeE
Confidence 222222 11111111111111 12233344556677778889999998 33 3334333445
Q ss_pred CCCCCCCCC
Q 001778 975 PIFPTEKNG 983 (1014)
Q Consensus 975 ~~~~~~~~~ 983 (1014)
-|.......
T Consensus 318 iFs~~~~~~ 326 (732)
T KOG4250|consen 318 IFSMVQATS 326 (732)
T ss_pred EEeeccceE
Confidence 555554433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=325.33 Aligned_cols=149 Identities=27% Similarity=0.366 Sum_probs=134.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999999999999999996544444555678899999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
||+++++|.+++...+ .+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 84 Ey~~g~~L~~li~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred eCCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 9999999999997642 378888999999999999999965 99999999999999999999999999
Q ss_pred ccc
Q 001778 847 VAK 849 (1014)
Q Consensus 847 la~ 849 (1014)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=323.72 Aligned_cols=268 Identities=26% Similarity=0.383 Sum_probs=211.2
Q ss_pred CCCCCceeccCCcEEEEEeeecC-------CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcC
Q 001778 688 KLTESNVIGSGGSGKVYRVPINH-------TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE 759 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 759 (1014)
+++..+.+|+|+||.||+|.... ....||||.++... .....+.+..|+++|+.+ +||||+.++|+|..+
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 34556699999999999986431 14569999985433 336788999999999999 699999999999999
Q ss_pred CceEEEEEcccCCCHHHHhhhcC-CCCCCC--Cccc--ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKN-RSSLSG--RARD--EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~--~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll 834 (1014)
+..++|.||++.|+|.++++..+ ...... .... ..++..+.+.++.|||.|++||+.. ++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999999886 111110 1112 3499999999999999999999954 99999999999999
Q ss_pred cCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCC-chhH
Q 001778 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDE-HTCL 912 (1014)
Q Consensus 835 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~-~~~~ 912 (1014)
+++..+||+|||+|+...+.+......+...-+..|||||.+....|+.++|||||||++|||+| |..||.+.. ...+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 99999999999999976553333222222124678999999999999999999999999999998 667876632 1212
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
...+..| .+.+.+..+..+++++|+.||+.+|++||++.|+++.+..|
T Consensus 532 ----~~~l~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 532 ----LEFLKEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHHHhcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2233333 23344445567888999999999999999999999999886
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=301.89 Aligned_cols=274 Identities=26% Similarity=0.288 Sum_probs=202.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCC--CeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc----CC
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHT--AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS----EN 760 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~----~~ 760 (1014)
+|+..+.||+|+||.||++.+..+ +..||+|++.... ......+.+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 367788999999999999999887 8899999984321 2223456788899999999 59999999987532 24
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++++||++ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~ 144 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG-----------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCEL 144 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCE
Confidence 5788899886 6899888653 2488999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccccCc-cccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGE-FAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
||+|||.+......... ........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...+..........
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 99999999865432211 111234578999999998765 5688999999999999999999999986553322222111
Q ss_pred HHhcCCcchhc---------------cccccCC---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 919 HIQEGKPIVDA---------------LDKEIDE---PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 919 ~~~~~~~~~~~---------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
... .+..+. ....-.. .........+.+++.+|++.||++|||+.|+++ |||++.-
T Consensus 225 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~----~~~~~~~ 298 (332)
T cd07857 225 VLG--TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE----HPYLAIW 298 (332)
T ss_pred HhC--CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc----Chhhhhh
Confidence 110 000000 0000000 000111346778999999999999999999887 9999865
Q ss_pred CCC
Q 001778 981 KNG 983 (1014)
Q Consensus 981 ~~~ 983 (1014)
+..
T Consensus 299 ~~~ 301 (332)
T cd07857 299 HDP 301 (332)
T ss_pred cCc
Confidence 544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=250.55 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=206.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+|...++||+|.||+||+|+...+++.||+|.+.-+.. ++.......+|+-+++.++|.|||++++....+...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999999999999999999865432 34456778999999999999999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
||.. +|..+....++ .++...+..++.|+++|+.+.|. +++.|||+||.|.+++.+|..|++|||+
T Consensus 82 ~cdq-dlkkyfdslng----------~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNG----------DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred HhhH-HHHHHHHhcCC----------cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccch
Confidence 9965 88888876532 37888899999999999999995 4999999999999999999999999999
Q ss_pred ccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHhcCCc
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+-++- .....+..+-|..|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..+....+...+ +.+
T Consensus 148 arafgi---pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l--g~p 222 (292)
T KOG0662|consen 148 ARAFGI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTP 222 (292)
T ss_pred hhhcCC---ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh--CCC
Confidence 987643 23345567789999999999875 58899999999999999986 556677666433222222221 222
Q ss_pred chhcccccc-------CCc------ccHHHHH----HHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 926 IVDALDKEI-------DEP------CFLEEMI----RVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 926 ~~~~~~~~~-------~~~------~~~~~~~----~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
..+.. +.+ ..+ .+.+.+. .=.++....+.-+|..|.++++.++ ||+|..
T Consensus 223 ~ed~w-ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq----hpyf~d 288 (292)
T KOG0662|consen 223 TEDQW-PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ----HPYFSD 288 (292)
T ss_pred ccccC-CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc----Cccccc
Confidence 11111 111 000 1112222 2246777788889999999999999 999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=296.57 Aligned_cols=267 Identities=21% Similarity=0.239 Sum_probs=205.8
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|...+.||-|+||+|.++...++...+|.|.+.+.....+.....++.|-+||..-+.+-||+++..|++.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 56678899999999999999999999999999877777777888899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
++||++..++.+.+ .|.+.-+..++.++..|+++.|.. |+|||||||+|||||.+|++||.|||++
T Consensus 711 IPGGDmMSLLIrmg-----------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred cCCccHHHHHHHhc-----------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 99999999998764 377888888999999999999976 9999999999999999999999999999
Q ss_pred ccccccc-------Cc--------------------------------cccccccccCcccccccccccCCCCCcCcchh
Q 001778 849 KILIKEE-------GE--------------------------------FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYS 889 (1014)
Q Consensus 849 ~~~~~~~-------~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwS 889 (1014)
.-+.... +. .......+||+.|+|||++....|+.-+|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 6542110 00 00112357999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHh-HccCCCCCCCCCHHHHH
Q 001778 890 FGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGV-ICTSMLPTERPNMRMVL 968 (1014)
Q Consensus 890 lGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~-~cl~~dP~~RPt~~ev~ 968 (1014)
.|||||||+.|+.||..+....-...+ ......++-........ ++.++|. .|. ++++|..- -..
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv-------~nw~~~l~~~~~~~ls~----e~~~li~kLc~--sad~RLGk-ng~ 922 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKV-------INWRNFLHIPYQGNLSK----EALDLIQKLCC--SADSRLGK-NGA 922 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeee-------eehhhccccccccccCH----HHHHHHHHHhc--Chhhhhcc-cch
Confidence 999999999999999865432211100 00011122222222223 3333333 243 46777742 223
Q ss_pred HHHhcCCCCCCCCCC
Q 001778 969 QILLNNPIFPTEKNG 983 (1014)
Q Consensus 969 ~~L~~~~~~~~~~~~ 983 (1014)
+.++.||||+.....
T Consensus 923 d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 923 DQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhhhcCccccccchH
Confidence 356679999986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=281.63 Aligned_cols=286 Identities=22% Similarity=0.260 Sum_probs=222.1
Q ss_pred cccccccccccccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-----
Q 001778 671 ETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR----- 745 (1014)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----- 745 (1014)
...-+|.+...+.....+|...++||-|.|++||+|.+....+.||+|+.+. .+.-.+....||.++++++
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCC
Confidence 3445666666666555789999999999999999999999999999999833 4456677889999999983
Q ss_pred C---CccceEEEEEEc----CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC
Q 001778 746 H---LNIVKLLCCISS----ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDC 818 (1014)
Q Consensus 746 h---pniv~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 818 (1014)
| .+||++++.|.. +.+.++|+|+. |-+|..+++... ..-++...+.+|++||+.||.|||..|
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~---------YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN---------YRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC---------CCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 2 479999999864 56889999999 568999988752 345899999999999999999999876
Q ss_pred CCCeEeccCCCCCeeecCC-------------------------------------------------------------
Q 001778 819 SPTIVHRDLKSSNILLDYN------------------------------------------------------------- 837 (1014)
Q Consensus 819 s~~ivH~Dlk~~NIll~~~------------------------------------------------------------- 837 (1014)
||||.||||+|||+..+
T Consensus 208 --gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~ 285 (590)
T KOG1290|consen 208 --GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLE 285 (590)
T ss_pred --CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhh
Confidence 99999999999997100
Q ss_pred --------------------------------------------------------------------------------
Q 001778 838 -------------------------------------------------------------------------------- 837 (1014)
Q Consensus 838 -------------------------------------------------------------------------------- 837 (1014)
T Consensus 286 ~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~ 365 (590)
T KOG1290|consen 286 ASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSL 365 (590)
T ss_pred hhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccc
Confidence
Q ss_pred -------------------------CcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHH
Q 001778 838 -------------------------FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGV 892 (1014)
Q Consensus 838 -------------------------~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGv 892 (1014)
.+|||+|||-|++... .......|..|+|||++.+..|++.+||||++|
T Consensus 366 ~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k------hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC 439 (590)
T KOG1290|consen 366 SSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK------HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTAC 439 (590)
T ss_pred cCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh------hhchhhhhhhccCcceeecCCCCCchhHHHHHH
Confidence 0145555555554322 223445789999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCC-------chhHHHH-------HHHHHhcCCcchhccccccCC-------------------ccc
Q 001778 893 ILLELTTGKEANNGDE-------HTCLAQW-------AWRHIQEGKPIVDALDKEIDE-------------------PCF 939 (1014)
Q Consensus 893 ll~elltg~~p~~~~~-------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------------------~~~ 939 (1014)
++|||+||...|+..+ +..+... -+.....|+...+++...-.. ...
T Consensus 440 ~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s 519 (590)
T KOG1290|consen 440 MAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWS 519 (590)
T ss_pred HHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCC
Confidence 9999999999886321 1112211 233445555555555544211 344
Q ss_pred HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 940 LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.++..++.+++.-||+.+|++||||++.++ |||+..-..
T Consensus 520 ~e~A~~fsdFL~PmLef~PeKR~tA~~cl~----hPwLn~~~~ 558 (590)
T KOG1290|consen 520 EEDAQQFSDFLSPMLEFDPEKRPTAAQCLK----HPWLNPVAG 558 (590)
T ss_pred HHHHHHHHHHHHHHHhcCccccccHHHHhc----CccccCCCC
Confidence 778889999999999999999999999998 999997554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=276.22 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=209.9
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+++....||.|+||+|++-.++..|+..|||++... ....+.+++..|.+...+- +.||||+++|++-.++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~--n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN--NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec--cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 455677899999999999999999999999999543 2356677888888875554 7999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|.|+- |+..+-+.-- .-....+++.-.-.|......||.||.+. ..|+|||+||+|||++..|.+|+||||
T Consensus 143 ELMd~-SlDklYk~vy------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVY------SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred HHHhh-hHHHHHHHHH------HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeeccc
Confidence 99964 6665543210 01223477777788888899999999874 599999999999999999999999999
Q ss_pred cccccccccCccccccccccCccccccccccc--CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
.+-.+.. ....+...|...|||||.+.. ..|+-++||||+|+++||+.||..|+...+. ..+++...+....
T Consensus 214 IcGqLv~----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdp 287 (361)
T KOG1006|consen 214 ICGQLVD----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDP 287 (361)
T ss_pred chHhHHH----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCC
Confidence 9876533 123456789999999998863 4588999999999999999999999987654 4455555555444
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRK 986 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~ 986 (1014)
+.... ... ..+....+.+++-.|+.+|-.+||+..++.+ +||++-.+++..+
T Consensus 288 p~l~~---~~~---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~----~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 288 PILLF---DKE---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK----FPFYRMYAVEGPD 339 (361)
T ss_pred CeecC---ccc---ccccCHHHHHHHHHHhhcccccCcchhhhhc----CchhhhhhhcCCc
Confidence 42211 111 1123345778888999999999999776665 9999887766554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=293.77 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=185.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC---CeEEEEEEecccchhhHHh--------HHHHHHHHHHHHcCCCCccceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKH--------EKEFLAEVQILSTIRHLNIVKLLCC 755 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~--------~~~~~~Ei~~l~~l~hpniv~l~~~ 755 (1014)
.+|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999998877 6677777642211110000 1122233445566789999999987
Q ss_pred EEcCC----ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 001778 756 ISSEN----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831 (1014)
Q Consensus 756 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~N 831 (1014)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~N 156 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-----------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPEN 156 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 65543 33677787643 6666665431 246788899999999999999965 99999999999
Q ss_pred eeecCCCcEEEeecccccccccccCcc----ccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCC
Q 001778 832 ILLDYNFNAKIADFGVAKILIKEEGEF----AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907 (1014)
Q Consensus 832 Ill~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~ 907 (1014)
||++.++.++|+|||+|+.+....... .......||+.|+|||+..+..++.++||||+||++|||++|+.||.+.
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999998764322111 1122356999999999999999999999999999999999999999866
Q ss_pred Cc-hhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 001778 908 EH-TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 908 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 971 (1014)
.. ............. ........ .......+.+++..|++.+|++||+++++.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIK-----RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHH-----Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 32 2111111100000 00001111 112235677899999999999999999999865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=318.08 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=194.4
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
....|.+.++||+||||.||+++.+-+|+.||||++.... +......+.+|+.++.+++|||||+++.++.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3456778899999999999999999999999999995532 566778899999999999999999997443110
Q ss_pred --------------------------------------------------------------------------------
Q 001778 760 -------------------------------------------------------------------------------- 759 (1014)
Q Consensus 760 -------------------------------------------------------------------------------- 759 (1014)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHH
Q 001778 760 ----------------------------------NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805 (1014)
Q Consensus 760 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~ 805 (1014)
..+|+-||||+.-.+.++++.+... -.-...+++++
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----------~~~d~~wrLFr 704 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----------SQRDEAWRLFR 704 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----------hhhHHHHHHHH
Confidence 0125667777776666666554210 02456789999
Q ss_pred HHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccc----c-----------ccCccccccccccCccc
Q 001778 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI----K-----------EEGEFAAMSTVVGSCGY 870 (1014)
Q Consensus 806 ~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~----~-----------~~~~~~~~~~~~gt~~y 870 (1014)
+|++||+|+|+. |||||||||.|||++++..|||+|||+|.... . ........+..+||.-|
T Consensus 705 eIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 705 EILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 999999999966 99999999999999999999999999998732 0 01111234567899999
Q ss_pred ccccccccC---CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHH
Q 001778 871 IAPEYARTR---KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVF 947 (1014)
Q Consensus 871 ~aPE~l~~~---~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (1014)
+|||++.+. .|+.|+||||+|||++||+. ||....+ ... +...++.+.. ... + ..+.+....=.
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~-iL~~LR~g~i-P~~--~----~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RAS-ILTNLRKGSI-PEP--A----DFFDPEHPEEA 848 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHH-HHHhcccCCC-CCC--c----ccccccchHHH
Confidence 999999765 49999999999999999994 5654322 111 1122222211 111 1 12233334446
Q ss_pred HHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 948 KLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 948 ~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
++|+++++.||.+||||.|++. +.|++-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~----s~llpp 876 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN----SELLPP 876 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh----ccCCCc
Confidence 8999999999999999999988 777774
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=294.91 Aligned_cols=278 Identities=22% Similarity=0.248 Sum_probs=230.2
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
.+++....||-|+||+|-.+........+|+|++++....+.+..+.+..|-.+|...+.|.||++|..|.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999998777666669999998888889999999999999999999999999999999999999999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|-|-||.++..+.+.+. |+......++..+.+|++|||.. +||+||+||+|.+++.+|-+|+.|||
T Consensus 500 EaClGGElWTiLrdRg~-----------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-----------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred HhhcCchhhhhhhhcCC-----------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 99999999999988643 77788888999999999999954 99999999999999999999999999
Q ss_pred cccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcc
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+.+.... +..+.+|||.|.|||++....++.++|.||+|+++||+++|.+||.+.+....-..+...+..-
T Consensus 566 FAKki~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--- 638 (732)
T KOG0614|consen 566 FAKKIGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--- 638 (732)
T ss_pred hHHHhccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---
Confidence 999886643 4457899999999999999999999999999999999999999999887543333333322211
Q ss_pred hhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCCcccccccccc
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKNGGRKYDHVTPLLT 995 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1014)
..+........+++++..+.+|.+|.... .-+..+++|.||..-.|.+-......|+..
T Consensus 639 ----------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 639 ----------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred ----------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 11223334566788889999999999732 234567779999998887655555555443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.88 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=216.7
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEc----
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS---- 758 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~---- 758 (1014)
+..+.+.+.++||.|.+|.||+++.+.+++.+|+|+... .....+++..|..+++.. .|||++.++|++..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~----~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP----TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC----CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 445678889999999999999999999999999999843 334556777888899888 69999999999853
Q ss_pred -CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC
Q 001778 759 -ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 759 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~ 837 (1014)
++.+|||||||.+||..++++.-. ...+.|..+..|++.++.|+.+||.. .++|||||-.|||++.+
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~---------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK---------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc---------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc
Confidence 678999999999999999998752 45689999999999999999999976 99999999999999999
Q ss_pred CcEEEeecccccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhH
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~ 912 (1014)
+.||++|||.+..+ +.......+..|||.|||||++.. ..|+.++|+||+|++..||.-|.+|+.......
T Consensus 160 ~~VKLvDFGvSaQl---dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr- 235 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQL---DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR- 235 (953)
T ss_pred CcEEEeeeeeeeee---ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-
Confidence 99999999999876 334456678899999999999853 356789999999999999999999987654321
Q ss_pred HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 981 (1014)
... .-...+......+.....++.++|..|+.+|.++||++.++++ |||++...
T Consensus 236 --aLF---------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~----hpFi~e~~ 289 (953)
T KOG0587|consen 236 --ALF---------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK----HPFITEQP 289 (953)
T ss_pred --hhc---------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc----CCcccccc
Confidence 111 1111122223345666678889999999999999999888888 99999433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=285.90 Aligned_cols=233 Identities=24% Similarity=0.194 Sum_probs=184.1
Q ss_pred CCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHH
Q 001778 698 GGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQW 777 (1014)
Q Consensus 698 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 777 (1014)
|.+|+||++.+..+++.||+|.+.... .+.+|...+....|||++++++++...+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999984321 223344445556799999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCc
Q 001778 778 LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857 (1014)
Q Consensus 778 l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 857 (1014)
+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 76 l~~~~-----------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--- 138 (237)
T cd05576 76 ISKFL-----------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--- 138 (237)
T ss_pred HHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---
Confidence 87642 378999999999999999999965 9999999999999999999999999987654331
Q ss_pred cccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCc
Q 001778 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEP 937 (1014)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1014)
.....++..|+|||...+..++.++||||+|+++|||++|..|+...... ..... ...+.
T Consensus 139 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~------~~~~~-- 198 (237)
T cd05576 139 ---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHT------TLNIP-- 198 (237)
T ss_pred ---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------ccccc------ccCCc--
Confidence 12345577899999998888999999999999999999999887532110 00000 00011
Q ss_pred ccHHHHHHHHHHHhHccCCCCCCCCCHHHH-HHHHhcCCCC
Q 001778 938 CFLEEMIRVFKLGVICTSMLPTERPNMRMV-LQILLNNPIF 977 (1014)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ev-~~~L~~~~~~ 977 (1014)
......+.+++.+|++.||++||++.+. ++.+.+||||
T Consensus 199 --~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 --EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred --ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1122356788999999999999997443 6667779997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=299.34 Aligned_cols=244 Identities=24% Similarity=0.227 Sum_probs=197.9
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEE
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 764 (1014)
.+.|.....+|.|+|+.|-.+.+..+++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 44566667799999999999999999999999998332 33445577666555 79999999999999999999
Q ss_pred EEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee-cCCCcEEEe
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL-DYNFNAKIA 843 (1014)
Q Consensus 765 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll-~~~~~~kl~ 843 (1014)
|||++.+|-+.+.+..... +. ..+..|+.+++.|+.|||.. |+||||+||+|||+ +..++++|+
T Consensus 394 v~e~l~g~ell~ri~~~~~-----------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE-----------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred eehhccccHHHHHHHhcch-----------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEE
Confidence 9999999988888776521 23 67778999999999999965 99999999999999 688999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|||.++..... ....+-|..|.|||++....|++++|+||+|+++|+|++|+.||...... ..+...+..+
T Consensus 459 yFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~ 529 (612)
T KOG0603|consen 459 YFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMP 529 (612)
T ss_pred EechhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCC
Confidence 99999876442 23456688999999999999999999999999999999999999865543 1122222222
Q ss_pred CcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
+ ..........+++.+|++.||.+||+|+++.. |||+
T Consensus 530 ~-------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~----h~w~ 566 (612)
T KOG0603|consen 530 K-------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA----HPWF 566 (612)
T ss_pred c-------------cccccCHHHHHHHHHhccCChhhCcChhhhcc----Ccch
Confidence 1 11223345567888999999999999999888 9999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.24 Aligned_cols=262 Identities=19% Similarity=0.274 Sum_probs=210.2
Q ss_pred CCCCceeccCCcEEEEEeeecCCC-----eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEE-EcCCce
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTA-----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI-SSENLK 762 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~ 762 (1014)
++..-++.+|.||+||+|.|.+.+ +.|-||.++. ..++-+...+..|...+..+.|||+..+.+.+ ++.+..
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 444556889999999999887543 3466777632 34455667788999999999999999999887 456677
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl 842 (1014)
+.++.++.-|+|..++...+.. .......++-.+...++.|++.|++|||.+ +|||.||.++|+++|+..++||
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~---~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGD---DPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eEEEeccCcchHHHHHHHhccC---CCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEe
Confidence 9999999999999999965432 123345677888999999999999999965 9999999999999999999999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|=.+++.+.+.+ ...-......+..||+||.+....|+.++|||||||++|||+| |+.|+..-+..+....
T Consensus 438 tDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y------ 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY------ 510 (563)
T ss_pred ccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH------
Confidence 9999999987743 3333345566889999999999999999999999999999997 7888876664433222
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
+..+.+...+.+++.+++.+|.-||..+|++||++++++.-|.+
T Consensus 511 --------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 --------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22233344556677889999999999999999999999988865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=278.07 Aligned_cols=271 Identities=25% Similarity=0.316 Sum_probs=207.5
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHH----hHHHHHHHHHHHHcCCCCccceEEEEEE-cC
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK----HEKEFLAEVQILSTIRHLNIVKLLCCIS-SE 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~ 759 (1014)
..++|-..+.||+|+|++||+|.+....+.||||+-.-.+.+... ..+...+|.+|.+.+.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345677788999999999999999999999999987554444332 3466789999999999999999999996 45
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC---
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY--- 836 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~--- 836 (1014)
+..|-|+|||+|.+|.-|++.. ..+++.++..|+.||+.||.||.+. +++|+|-|+||.|||+-.
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh-----------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH-----------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh-----------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 6778999999999999999875 3488999999999999999999988 899999999999999954
Q ss_pred CCcEEEeecccccccccccCcc----ccccccccCccccccccccc----CCCCCcCcchhHHHHHHHHhcCCCCCCCCC
Q 001778 837 NFNAKIADFGVAKILIKEEGEF----AAMSTVVGSCGYIAPEYART----RKVNEKTDIYSFGVILLELTTGKEANNGDE 908 (1014)
Q Consensus 837 ~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~----~~~~~~~DvwSlGvll~elltg~~p~~~~~ 908 (1014)
-|.+||.|||+++.+....... .-.+...||..|.+||-+.- ...+.++||||+|||+|+++.|+.||..+.
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 4679999999999886543221 12345789999999997643 356789999999999999999999998654
Q ss_pred chhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
... .++++... ....+-.+ +.-+....+...+|++|+++.-++|....+ |..||+|.--
T Consensus 689 sQQ------dILqeNTI-lkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~q----LA~dpyllPh 747 (775)
T KOG1151|consen 689 SQQ------DILQENTI-LKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ----LACDPYLLPH 747 (775)
T ss_pred hHH------HHHhhhch-hcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHH----HccCccccch
Confidence 321 11111111 11111111 111112234557899999999999998554 5559988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=303.65 Aligned_cols=279 Identities=18% Similarity=0.176 Sum_probs=177.9
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCC----CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEE-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHT----AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCC----- 755 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~----- 755 (1014)
..++|...+.||+|+||.||+|.+..+ +..||||++.... ..+....| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 456788999999999999999999888 8899999874321 11111111 1111122222222211
Q ss_pred -EEcCCceEEEEEcccCCCHHHHhhhcCCCCC---------CCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 001778 756 -ISSENLKLLVYEYMEKRSLDQWLHKKNRSSL---------SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHR 825 (1014)
Q Consensus 756 -~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~ 825 (1014)
...+...++|+||+++++|.++++....... .............+..++.|++.||+|||+. +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 2456788999999999999999976421100 0000111122345668999999999999965 99999
Q ss_pred cCCCCCeeecC-CCcEEEeecccccccccccCccccccccccCcccccccccccC----------------------CCC
Q 001778 826 DLKSSNILLDY-NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR----------------------KVN 882 (1014)
Q Consensus 826 Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~ 882 (1014)
||||+|||++. ++.+||+|||+|+.+..... .......+++.|+|||.+... .++
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999999986 57899999999986543211 123356789999999965322 234
Q ss_pred CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcch---hccccccCC------cccHHHHHHHHHHHhHc
Q 001778 883 EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV---DALDKEIDE------PCFLEEMIRVFKLGVIC 953 (1014)
Q Consensus 883 ~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~l~~li~~c 953 (1014)
.++||||+||++|||+++..++... ...........+.... ....+.... +..........+++.+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 5679999999999999976654322 1111111111111000 000000000 00001112345799999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 954 TSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 954 l~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
++.||++|||++|+++ ||||......
T Consensus 434 L~~dP~kR~ta~e~L~----Hpff~~~~~~ 459 (566)
T PLN03225 434 MRFKGRQRISAKAALA----HPYFDREGLL 459 (566)
T ss_pred ccCCcccCCCHHHHhC----CcCcCCCCcc
Confidence 9999999999999998 9999886654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.97 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=199.7
Q ss_pred CCCceeccCCcEE-EEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEEEE
Q 001778 690 TESNVIGSGGSGK-VYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 690 ~~~~~LG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
...+++|.|+.|+ ||+|.. .++.||||++ -....+.+.+|+..++.- +|||||++++.-.++.+.|+..|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrl------l~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRL------LEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHH------hhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3456799999976 789855 5789999988 234566788999999988 69999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC---C--CcEEE
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY---N--FNAKI 842 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~---~--~~~kl 842 (1014)
.|.. +|.++++..+. +.....-...+.++.|++.|+++||. .+|||||+||.||||+. + .+++|
T Consensus 584 LC~~-sL~dlie~~~~-------d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGL-------DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred Hhhh-hHHHHHhcccc-------chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEe
Confidence 9965 99999987411 11111114557889999999999995 49999999999999976 3 46999
Q ss_pred eecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcC-CCCCCCCCchhHHHHHHHHHh
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG-KEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+++.+..............||.+|+|||++....-+.++||||+||++|+.++| .+||+..-.. . ..++
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----~-~NIl- 726 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----Q-ANIL- 726 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----h-hhhh-
Confidence 9999999998777777777889999999999999998888899999999999999997 6788754211 0 0111
Q ss_pred cCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+..-...+.+ ..++ +..++|.+|+++||..||++.+|+. ||||=..+..
T Consensus 727 ~~~~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~----HPlFW~~ekr 776 (903)
T KOG1027|consen 727 TGNYTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN----HPLFWDSEKR 776 (903)
T ss_pred cCccceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC----CCccCChHHH
Confidence 11111111111 1111 5678999999999999999999998 9999765543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=252.86 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=204.3
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcC--Cce
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSE--NLK 762 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~ 762 (1014)
.++|++.+++|+|-|++||.|....+.+.++||+++. ...+.+.+|+.+++.+. ||||+++++...++ ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3579999999999999999999888999999999833 45678999999999996 99999999998764 466
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-CcEE
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAK 841 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~~k 841 (1014)
.+|+||+.+.+...+-.. ++...+...+.+++.||.|+| |.||.|||+||.||++|.. ..++
T Consensus 111 aLiFE~v~n~Dfk~ly~t--------------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT--------------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred hhHhhhhccccHHHHhhh--------------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence 899999999887766543 677888999999999999999 5599999999999999965 4699
Q ss_pred EeecccccccccccCccccccccccCccccccccccc-CCCCCcCcchhHHHHHHHHhcCCCCCCC-CCc-hhHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNG-DEH-TCLAQWAWR 918 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwSlGvll~elltg~~p~~~-~~~-~~~~~~~~~ 918 (1014)
++|||+|.++.+.. ....++.+..|.-||.+.. +.|+..-|+|||||++..|+..+.||.. .+. ..+...+..
T Consensus 174 lIDWGLAEFYHp~~----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred eeecchHhhcCCCc----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 99999999876633 2345678889999998876 5688899999999999999999999853 222 222222111
Q ss_pred H-------------HhcCCcchhccccccCC--------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 919 H-------------IQEGKPIVDALDKEIDE--------PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 919 ~-------------~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
. +.-...+.+++....+. ...--...+.++++...+..|-.+|||++|.++ ||||
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~----HpyF 325 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA----HPYF 325 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc----CchH
Confidence 0 11111111111111100 000001135778899999999999999999999 9999
Q ss_pred CCCCCC
Q 001778 978 PTEKNG 983 (1014)
Q Consensus 978 ~~~~~~ 983 (1014)
....++
T Consensus 326 ~~~~~~ 331 (338)
T KOG0668|consen 326 APVREA 331 (338)
T ss_pred HHHHHH
Confidence 875544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=290.52 Aligned_cols=277 Identities=19% Similarity=0.186 Sum_probs=187.7
Q ss_pred CCCCCCCceeccCCcEEEEEeeec----------------CCCeEEEEEEecccchhh-----------HHhHHHHHHHH
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPIN----------------HTAEVVAVKKIWNDRKLD-----------QKHEKEFLAEV 738 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~-----------~~~~~~~~~Ei 738 (1014)
.++|.+.++||+|+||.||+|.+. ..++.||||++....... ....+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 557899999999999999998642 234679999985432111 01122344577
Q ss_pred HHHHcCCCCcc-----ceEEEEEEc--------CCceEEEEEcccCCCHHHHhhhcCCCC-------------CCCCccc
Q 001778 739 QILSTIRHLNI-----VKLLCCISS--------ENLKLLVYEYMEKRSLDQWLHKKNRSS-------------LSGRARD 792 (1014)
Q Consensus 739 ~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~ 792 (1014)
.++.+++|.++ ++++++|.. .+..|+||||+++|+|.++++...... .......
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 677777653 356799999999999999998642110 0011122
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCccccc
Q 001778 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872 (1014)
Q Consensus 793 ~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a 872 (1014)
..++|..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~a 378 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSP 378 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeC
Confidence 3467889999999999999999965 999999999999999999999999999976543211 11122345789999
Q ss_pred ccccccCC--------------------C--CCcCcchhHHHHHHHHhcCCC-CCCCCCch--hHH-----HHHHHHHhc
Q 001778 873 PEYARTRK--------------------V--NEKTDIYSFGVILLELTTGKE-ANNGDEHT--CLA-----QWAWRHIQE 922 (1014)
Q Consensus 873 PE~l~~~~--------------------~--~~~~DvwSlGvll~elltg~~-p~~~~~~~--~~~-----~~~~~~~~~ 922 (1014)
||.+.... + ..+.||||+||++|+|+++.. ||...... ... ...|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 134799999999999999875 66432110 000 001111111
Q ss_pred CCcchhccccccCCcccHHHHHHHHHHHhHccCCCC---CCCCCHHHHHHHHhcCCCCCCC
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLP---TERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.. ...+..........+++.+++..+| .+|+|++|+++ ||||..+
T Consensus 459 ~~---------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~----Hp~f~~~ 506 (507)
T PLN03224 459 QK---------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS----HRFFLPE 506 (507)
T ss_pred cC---------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC----CCCcCCC
Confidence 11 1111122233456788888998766 68999999999 9999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=267.85 Aligned_cols=243 Identities=34% Similarity=0.431 Sum_probs=197.2
Q ss_pred CcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHHh
Q 001778 699 GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL 778 (1014)
Q Consensus 699 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 778 (1014)
+||.||+|.+..+++.||+|++........ .+.+.+|++.++.++|+|++++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999854322111 688999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCcc
Q 001778 779 HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858 (1014)
Q Consensus 779 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 858 (1014)
.... .+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 79 ~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--- 141 (244)
T smart00220 79 KKRG-----------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--- 141 (244)
T ss_pred Hhcc-----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---
Confidence 7642 178899999999999999999966 99999999999999999999999999998764421
Q ss_pred ccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCC-CCchhHHHHHHHHHhcCCcchhccccccCCc
Q 001778 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNG-DEHTCLAQWAWRHIQEGKPIVDALDKEIDEP 937 (1014)
Q Consensus 859 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1014)
......++..|+|||......++.++||||+|+++|++++|..||.. .+.....+ ....+..... .
T Consensus 142 -~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~----~~~~~~~~~~--------~ 208 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK----KIGKPKPPFP--------P 208 (244)
T ss_pred -ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----HHhccCCCCc--------c
Confidence 23356688899999999888889999999999999999999999976 33222222 1211111000 0
Q ss_pred ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCC
Q 001778 938 CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~ 977 (1014)
.......++.+++.+|+..||++||++.++++ ||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~----~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ----HPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh----CCCC
Confidence 00002346778999999999999999999998 9986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=258.16 Aligned_cols=265 Identities=26% Similarity=0.297 Sum_probs=210.2
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~----- 759 (1014)
...+|...+.+|.|.- .|..+.+.-.++.||+|++... .......++..+|..++..++|+|+++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888889999999 7888888888999999998554 44566778899999999999999999999998654
Q ss_pred -CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 -NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
...|+|||||. ++|.+.+... ++-.+...|.+|++.|+.|||.. ||+|||+||+||++..+.
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~e-------------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~ 155 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILME-------------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDC 155 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHHh-------------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchh
Confidence 35599999996 5999988754 66778889999999999999955 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||.|||+|+.-.. ...++..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+. +.+|.+.
T Consensus 156 ~lKi~dfg~ar~e~~----~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--idQ~~ki 229 (369)
T KOG0665|consen 156 TLKILDFGLARTEDT----DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--IDQWNKI 229 (369)
T ss_pred heeeccchhhcccCc----ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH--HHHHHHH
Confidence 999999999986322 2356678889999999999988899999999999999999999999986553 5566544
Q ss_pred HHhcCCcchhcccccc----------------------CCc-------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 919 HIQEGKPIVDALDKEI----------------------DEP-------CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~----------------------~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
.-.-+.+-.+.+++-. ... ...-......+++.+|+-.||++|.+++++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 4333333221111110 000 00111223567888999999999999999998
Q ss_pred HHhcCCCCC
Q 001778 970 ILLNNPIFP 978 (1014)
Q Consensus 970 ~L~~~~~~~ 978 (1014)
||+++
T Consensus 310 ----HPY~~ 314 (369)
T KOG0665|consen 310 ----HPYIK 314 (369)
T ss_pred ----CCeee
Confidence 99996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=255.28 Aligned_cols=262 Identities=25% Similarity=0.302 Sum_probs=195.3
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcC-----CceE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE-----NLKL 763 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~~ 763 (1014)
.+-.+.||.|+||.||.+.+..+|+.||+|++.+ ...+-...+.+.+|+.++..++|.|++..++..... .+.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4456789999999999999999999999999843 233445678899999999999999999988876543 2456
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
.++|.|.. +|...+-. ...++-..++-+.+||++||.||| +.+|.||||||.|.|++.+...|||
T Consensus 134 V~TELmQS-DLHKIIVS-----------PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-----------PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred HHHHHHHh-hhhheecc-----------CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEec
Confidence 77777753 66655533 234777788889999999999999 5599999999999999999999999
Q ss_pred ecccccccccccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH--
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI-- 920 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-- 920 (1014)
|||+|+.....+ ...+...+-|.+|+|||++++. .|+.+.||||+||++.|++.++-.|.........+.+...+
T Consensus 199 DFGLARvee~d~--~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 199 DFGLARTWDQRD--RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred ccccccccchhh--hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 999998754422 2345566778999999999875 68999999999999999999998888665443333332221
Q ss_pred ---------hcCCcchhccccccCCc---------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 921 ---------QEGKPIVDALDKEIDEP---------CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 921 ---------~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
.+|.. ...+....+.+ .....-.+.+.+...++..||++|.+.++.+.
T Consensus 277 Ps~EaMr~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 277 PSQEAMKYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred CcHHHHHHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11111 11111111111 11122234556777899999999999998877
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.52 Aligned_cols=268 Identities=22% Similarity=0.244 Sum_probs=211.7
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC------CCccceEEEEEEcCC
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR------HLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpniv~l~~~~~~~~ 760 (1014)
.+|.+....|+|-|++|.+|.+...+..||||++.+. ....+.=+.|+++|++++ .-|+++++..|....
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 4677788899999999999999999999999999553 334455678999999994 358999999999999
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-Cc
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FN 839 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~ 839 (1014)
++|||||-+.. +|.+++++.+ ....+....+..+++|+..||..|..+ +|+|.||||+||||.+. ..
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG--------~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYG--------RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhC--------cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999998854 9999999874 345588899999999999999999976 99999999999999865 46
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHH-
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR- 918 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~- 918 (1014)
+||||||.|.......- ....-+..|.|||++.+-+|+...|+||+||.+||++||+..|.+............
T Consensus 576 LKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeccCccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 89999999987654332 223446789999999999999999999999999999999999988665444333221
Q ss_pred -------HHhcCCcchhccccccCC-------------------------------------cccHHHHHHHHHHHhHcc
Q 001778 919 -------HIQEGKPIVDALDKEIDE-------------------------------------PCFLEEMIRVFKLGVICT 954 (1014)
Q Consensus 919 -------~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~l~~li~~cl 954 (1014)
++..+.-....+|..+.. ......+.++.+|+..|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 122222222222222111 111344557889999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 955 SMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 955 ~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
..||++|.|..++++ ||||+.
T Consensus 731 ~LdP~KRit~nqAL~----HpFi~~ 751 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK----HPFITE 751 (752)
T ss_pred ccChhhcCCHHHHhc----CCcccC
Confidence 999999999999999 999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=234.37 Aligned_cols=218 Identities=24% Similarity=0.385 Sum_probs=175.5
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHc-CCCCccceEEEEEEcCCceEEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST-IRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+.....||+|++|.|-+-++..+|...|+|.+.. ....+..++..+|+.+..+ ..+|.+|.++|.....+..|+.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehh--hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445679999999999999999999999999844 3345667788888887655 589999999999999999999999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
.|.. ||..+-++.- .....+++...-+|+..|..||.|||+. ..++|||+||+|||++.+|++|+||||.
T Consensus 126 ~M~t-Sldkfy~~v~-------~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVL-------KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred Hhhh-hHHHHHHHHH-------hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccc
Confidence 9965 8877655421 1234588888899999999999999975 5899999999999999999999999999
Q ss_pred ccccccccCccccccccccCccccccccccc----CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcC
Q 001778 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYART----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 848 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
+-.+... ...+...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.... ..++....+.+.
T Consensus 196 sG~L~dS----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqvVeep 269 (282)
T KOG0984|consen 196 SGYLVDS----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQVVEEP 269 (282)
T ss_pred ceeehhh----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHHhcCC
Confidence 9776432 22334678899999998853 4788999999999999999999999986543 234444444444
Q ss_pred C
Q 001778 924 K 924 (1014)
Q Consensus 924 ~ 924 (1014)
.
T Consensus 270 ~ 270 (282)
T KOG0984|consen 270 S 270 (282)
T ss_pred C
Confidence 3
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=243.80 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=201.9
Q ss_pred ccccccccccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEE
Q 001778 676 HRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLC 754 (1014)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~ 754 (1014)
..++....+..+.|++.+.+|+|.||.+-.++++.+...+++|.+.. .....++|.+|..---.+ .|.||+.-++
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~----p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR----PQTTQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc----chhhHHHHHHHhccceeeccchhhhHHHH
Confidence 34455556777889999999999999999999999999999999844 334567888887654444 5899998774
Q ss_pred -EEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 755 -CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 755 -~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
+|+..+.+++++||++.|+|..-+...+ +.+....+++.|+++|+.||| ++.+||||||.+|||
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~~G------------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiL 153 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEAAG------------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENIL 153 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCccc------------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEE
Confidence 5788889999999999999999887643 788889999999999999999 569999999999999
Q ss_pred ec--CCCcEEEeecccccccccccCccccccccccCccccccccccc-----CCCCCcCcchhHHHHHHHHhcCCCCCCC
Q 001778 834 LD--YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-----RKVNEKTDIYSFGVILLELTTGKEANNG 906 (1014)
Q Consensus 834 l~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwSlGvll~elltg~~p~~~ 906 (1014)
+- +..++|+||||..+..+. ......-+..|.|||+... -...+.+|||.||+++|.++||+.||+.
T Consensus 154 if~~df~rvKlcDFG~t~k~g~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 154 IFDADFYRVKLCDFGLTRKVGT------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred EecCCccEEEeeecccccccCc------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 93 344899999999876432 1223345678999997753 2456789999999999999999999986
Q ss_pred CCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 907 DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
....+-..|.+..+.++... .+. ..+.....+.+++..+-+..+|++|-...++.+
T Consensus 228 a~~~d~~Y~~~~~w~~rk~~--~~P-----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 228 ASIMDKPYWEWEQWLKRKNP--ALP-----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhccCchHHHHHHHhcccCc--cCc-----hhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 66566666777777666542 111 122223345567777899999999944444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=263.24 Aligned_cols=200 Identities=28% Similarity=0.367 Sum_probs=174.0
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhH-----HHHHHHHHHHHcCC---CCccceEEEEEEcC
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE-----KEFLAEVQILSTIR---HLNIVKLLCCISSE 759 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~Ei~~l~~l~---hpniv~l~~~~~~~ 759 (1014)
.|+..+.+|+|+||.|+.|.++.+...|+||.+.+.+....... -.+-.|+.||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 48888999999999999999999999999999976655433222 23567999999997 99999999999999
Q ss_pred CceEEEEEcc-cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC
Q 001778 760 NLKLLVYEYM-EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 760 ~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~ 838 (1014)
+.+|++||-. ++.+|.+++..+ ..+++.+...|+.||+-|+++||.. +|||||||-+||.++.+|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k-----------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK-----------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNG 707 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc-----------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCC
Confidence 9999999975 456999999876 3488999999999999999999954 999999999999999999
Q ss_pred cEEEeecccccccccccCccccccccccCcccccccccccCCCC-CcCcchhHHHHHHHHhcCCCCCCC
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGKEANNG 906 (1014)
Q Consensus 839 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwSlGvll~elltg~~p~~~ 906 (1014)
-+|++|||.|...... .....+||..|.|||++.+..|- ..-|||++|+++|.++..+.||..
T Consensus 708 ~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999876542 34578999999999999998874 678999999999999999999863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=250.35 Aligned_cols=277 Identities=25% Similarity=0.312 Sum_probs=205.8
Q ss_pred CCCCCCCceeccCCcEEEEEeeecC---CCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCc
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINH---TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENL 761 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 761 (1014)
.+.|..+++||+|.|++||++.+.. .++.||+|.+.. ......+.+|+++|..+ .+.||+++.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-----ccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4568889999999999999998887 788999999833 34456799999999999 59999999999999999
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-CcE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNA 840 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~~ 840 (1014)
..+|+||++.....++... ++...+..+++.+..||+++|.. |||||||||.|++++.. +.-
T Consensus 110 v~ivlp~~~H~~f~~l~~~--------------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS--------------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred eEEEecccCccCHHHHHhc--------------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence 9999999999998888765 57888999999999999999965 99999999999999854 578
Q ss_pred EEeeccccccccccc---------------------------------C--------ccccccccccCccccccccccc-
Q 001778 841 KIADFGVAKILIKEE---------------------------------G--------EFAAMSTVVGSCGYIAPEYART- 878 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~---------------------------------~--------~~~~~~~~~gt~~y~aPE~l~~- 878 (1014)
.|.|||+|....... + .......+.||++|.|||++..
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 999999997321000 0 0001124579999999998865
Q ss_pred CCCCCcCcchhHHHHHHHHhcCCCCCCCCC--chhHHHHHHHH---------HhcCC--cc--------------hhccc
Q 001778 879 RKVNEKTDIYSFGVILLELTTGKEANNGDE--HTCLAQWAWRH---------IQEGK--PI--------------VDALD 931 (1014)
Q Consensus 879 ~~~~~~~DvwSlGvll~elltg~~p~~~~~--~~~~~~~~~~~---------~~~~~--~~--------------~~~~~ 931 (1014)
+..++++||||.|||+.-+++++.||.... .+.+.+.+... ...+. .. .+.++
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~ 332 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH 332 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence 567889999999999999999999996322 11222211100 00011 00 00000
Q ss_pred -ccc-C--------CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCccc
Q 001778 932 -KEI-D--------EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGRKYD 988 (1014)
Q Consensus 932 -~~~-~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~ 988 (1014)
..+ . .....-....++++..+|+..||.+|.|++|.++ ||||....+..+...
T Consensus 333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk----HpFF~~~~~~~~~~~ 395 (418)
T KOG1167|consen 333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK----HPFFDEADRTERGLQ 395 (418)
T ss_pred hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc----CcCCcchhhhhhhhH
Confidence 000 0 0000111225789999999999999999999999 999997665555444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-28 Score=264.57 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=207.9
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceE
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 763 (1014)
+..+.|.....+|.|+||.||+++++.+++..|+|+++- .......-++.|+-+++..+||||+.+++.+...+..|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL---ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL---EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec---cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 456678889999999999999999999999999999943 23345567788999999999999999999999999999
Q ss_pred EEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEe
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~ 843 (1014)
+.||||.+|+|++.-+.-+ ++++.++..+++...+|++||| +.+-+|||||-.||++++.+.+|+.
T Consensus 89 icMEycgggslQdiy~~Tg-----------plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred EEEEecCCCcccceeeecc-----------cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeec
Confidence 9999999999999876543 4788888899999999999999 5598999999999999999999999
Q ss_pred ecccccccccccCccccccccccCccccccccc---ccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYA---RTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 844 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|||.+..+ .....+.....||++|||||+. ..+.|...+|||+.|+...|+---++|-...... + +...+
T Consensus 155 Dfgvsaqi---tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r-~l~Lm 227 (829)
T KOG0576|consen 155 DFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---R-ALFLM 227 (829)
T ss_pred ccCchhhh---hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---H-HHHHh
Confidence 99998766 3344556678999999999975 4578999999999999999998888775443321 1 11111
Q ss_pred -hcCCcchhccccccCCc-ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 921 -QEGKPIVDALDKEIDEP-CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 921 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
..+.. .+.++.+ .+.+. +-++++.|+.++|++||+++..++ |||....
T Consensus 228 TkS~~q-----pp~lkDk~kws~~---fh~fvK~altknpKkRptaeklL~----h~fvs~~ 277 (829)
T KOG0576|consen 228 TKSGFQ-----PPTLKDKTKWSEF---FHNFVKGALTKNPKKRPTAEKLLQ----HPFVSQT 277 (829)
T ss_pred hccCCC-----CCcccCCccchHH---HHHHHHHHhcCCCccCCChhhhee----ceeeccc
Confidence 11111 1122222 22333 345677899999999999887766 8888775
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=252.54 Aligned_cols=414 Identities=20% Similarity=0.203 Sum_probs=252.6
Q ss_pred ceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccc-cccCCCCCcccccccccceeee
Q 001778 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQ-NYFIGPIPEDIDRLSRLKFLYL 150 (1014)
Q Consensus 72 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L 150 (1014)
..++|+|..|+|+...+.+|+.+++|+.|||++|+|+.+-|++|.+|.+|..|-+.+ |+|+....+.|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 577888889999877777889999999999999999888899999888888777766 8888666677888889999999
Q ss_pred cCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeeccccccc
Q 001778 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLI 230 (1014)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~ 230 (1014)
.-|++.....+.|..|++|..|.+.+|.+..+--..|..+..++.+.+..|.......+| .+.. ..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~-------wla~-------~~ 213 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP-------WLAD-------DL 213 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc-------hhhh-------HH
Confidence 888888888888888899999999998888333348888888888888888643322222 1111 11
Q ss_pred CccccccccccccceeecccccccCcCChhhhC-CCCCcEEEccCCCCCCCCCcc-ccc-cccceeeccccccCCCCCCc
Q 001778 231 GEIPETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQA-VES-LNLKVIDLSANNLTGAIPND 307 (1014)
Q Consensus 231 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~~-~~~-~~L~~L~Ls~N~l~~~~p~~ 307 (1014)
...|..++...-..-..+.++++....+..|.. +.++..=..+.+...++.|.. |.. .+|++|+|++|+|+++-+.+
T Consensus 214 a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~a 293 (498)
T KOG4237|consen 214 AMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGA 293 (498)
T ss_pred hhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhh
Confidence 122333444444444445555555333333322 112222122233333333332 333 36777777777777777777
Q ss_pred ccccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCC-ChhhhcCCCc
Q 001778 308 FGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSL-PEHLCAGGKL 386 (1014)
Q Consensus 308 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~~L 386 (1014)
|.++..+++|.|..|++...-...|.++..|+.|+|.+|+|+...|..|..+..|..|+|-.|.+.--- -.++.. .
T Consensus 294 Fe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~--W- 370 (498)
T KOG4237|consen 294 FEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE--W- 370 (498)
T ss_pred hcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH--H-
Confidence 777777777777777777555556777777777777777777777777777777777777777654100 000000 0
Q ss_pred cEEEccccccCCCCCcccccCCcccEEEeecceee---cCCCccccc---------ccccccccccCCcccCCCCCcCCC
Q 001778 387 AGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT---GNIPAGLWT---------GFNLSMVLISDNLFTGELPDKMSG 454 (1014)
Q Consensus 387 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~---~~~p~~~~~---------~~~L~~l~l~~n~~~~~~p~~~~~ 454 (1014)
+..+.-.|..| -+.-..++.+.++.+.+. ..-|++... .+-+..+.=..|.....+|..++.
T Consensus 371 ----lr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~ 444 (498)
T KOG4237|consen 371 ----LRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPV 444 (498)
T ss_pred ----HhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCc
Confidence 01111111110 011122333444433332 112222111 112333444445555577777777
Q ss_pred CCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceeccccc
Q 001778 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQN 512 (1014)
Q Consensus 455 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 512 (1014)
...+|++.+|.++ .+|.. .+..| .+|+|+|++...-...|.+++.|.+|-||+|
T Consensus 445 d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 445 DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 7778888888887 45554 45555 6667777666444455556666666655554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=232.30 Aligned_cols=211 Identities=38% Similarity=0.560 Sum_probs=183.1
Q ss_pred eccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCH
Q 001778 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL 774 (1014)
Q Consensus 695 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL 774 (1014)
||+|.+|.||++....+++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999985432211 457899999999999999999999999998999999999999999
Q ss_pred HHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-CCcEEEeeccccccccc
Q 001778 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKILIK 853 (1014)
Q Consensus 775 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~ 853 (1014)
.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 79 ~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 79 KDLLKENE----------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred HHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 99987641 2478999999999999999999965 9999999999999999 89999999999986544
Q ss_pred ccCccccccccccCcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhcccc
Q 001778 854 EEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932 (1014)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1014)
... ......+...|++||..... .++.++|+|++|++++++
T Consensus 146 ~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 146 DKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred Ccc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------
Confidence 221 12345678899999999887 888999999999999999
Q ss_pred ccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
..+.+++..|++.||++||++.++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 45678889999999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-27 Score=244.80 Aligned_cols=429 Identities=24% Similarity=0.254 Sum_probs=240.8
Q ss_pred eEeCCCceeEEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCccccccccc
Q 001778 66 IACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRL 145 (1014)
Q Consensus 66 v~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 145 (1014)
|.|+...+++ +|..+. ..-+.++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.+|.+|
T Consensus 51 VdCr~~GL~e-----------VP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 51 VDCRGKGLTE-----------VPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred EEccCCCccc-----------CcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 6776655553 333332 345788999999999999999999999999999999998889999999988
Q ss_pred ceeeecC-ccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCc-ccccccccceee
Q 001778 146 KFLYLTA-NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPS-NFTQLKKLKKLW 223 (1014)
Q Consensus 146 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~-~~~~l~~L~~L~ 223 (1014)
..|-+-+ |+|+...-+.|++|..|+.|.+.-|++.-...+.|..+++|..|.+..|.+.+ ++. +|..+..++.+.
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~---i~~~tf~~l~~i~tlh 194 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS---ICKGTFQGLAAIKTLH 194 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh---hccccccchhccchHh
Confidence 8876666 88885555688899999999999999887777888888888888888886433 333 566666666666
Q ss_pred cccccccCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCcccccc--ccceeeccccccC
Q 001778 224 MASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL--NLKVIDLSANNLT 301 (1014)
Q Consensus 224 l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~--~L~~L~Ls~N~l~ 301 (1014)
++.|.+.. .++++.+... +. ..|..++...-..-..+.++++..+.+..+... .+..=-.+.....
T Consensus 195 lA~np~ic-----dCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d 262 (498)
T KOG4237|consen 195 LAQNPFIC-----DCNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPD 262 (498)
T ss_pred hhcCcccc-----ccccchhhhH-Hh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcC
Confidence 66554321 2233322211 11 122223333333333444555544444333221 1111111111111
Q ss_pred CCCC-CcccccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhh
Q 001778 302 GAIP-NDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHL 380 (1014)
Q Consensus 302 ~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 380 (1014)
+.-| ..|. .+++|+.|+|++|+|+.+-+.+|..+..++.|.|..|++...-...|
T Consensus 263 ~~cP~~cf~------------------------~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f 318 (498)
T KOG4237|consen 263 SICPAKCFK------------------------KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMF 318 (498)
T ss_pred CcChHHHHh------------------------hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhh
Confidence 1222 2344 44444444455554444444445444555555555555444444445
Q ss_pred hcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCC-cccccccccccccccCCcccCCCCCcCCCCCcee
Q 001778 381 CAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIP-AGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRL 459 (1014)
Q Consensus 381 ~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L 459 (1014)
..+..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|++...-- .|+.. .+..+.-+|..|-.-+..++.+
T Consensus 319 ~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~~~Cq~p~~~~~~ 391 (498)
T KOG4237|consen 319 QGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGNPRCQSPGFVRQI 391 (498)
T ss_pred hccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCCCCCCCCchhccc
Confidence 555555555555555555566666666666666666666653211 11111 1223334445555555667777
Q ss_pred ccccccccCc---CCCcc---------cCCCcceE-EEccCCccccccccccccccccceecccccccCCCCcccccccc
Q 001778 460 EISNNRFSGK---IPTGV---------SSSKNLVV-FQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWK 526 (1014)
Q Consensus 460 ~Ls~N~l~~~---~~~~~---------~~l~~L~~-L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 526 (1014)
+++.+.+... .|+.. ..++-+.. ..-|++.++ .+|..+- ..-++|+|.+|.++ .+|.+ .+.
T Consensus 392 ~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~ 465 (498)
T KOG4237|consen 392 PISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLR 465 (498)
T ss_pred cchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHh
Confidence 7766655421 11110 01111111 223333333 3332211 13456677777776 56655 455
Q ss_pred cccceeccccccccccCcccccccccceeecCCC
Q 001778 527 SLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSEN 560 (1014)
Q Consensus 527 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 560 (1014)
+| .+|||+|+++-.--..|.++++|.+|-||.|
T Consensus 466 ~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 466 SL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 66 6777777766444556666776666666654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=275.41 Aligned_cols=305 Identities=21% Similarity=0.221 Sum_probs=143.6
Q ss_pred cceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCccccccccccccceeec
Q 001778 169 LRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDL 248 (1014)
Q Consensus 169 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L 248 (1014)
|+.|++.+|.+. .+|..| ...+|+.|+|++|+ +..+|..+..+++|+.|+|++++..+.+|. ++.+++|+.|+|
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~---l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L 664 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSK---LEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL 664 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcc---ccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence 444444444443 333333 23444444444443 223333444444444444444443344442 444445555555
Q ss_pred ccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccccccccccceecccC
Q 001778 249 SINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328 (1014)
Q Consensus 249 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 328 (1014)
++|.....+|..+..+++|+.|++++|..-+.+|......+|+.|++++|...+.+|.. ..+|+.|+|++|.+. .+
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~l 740 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EF 740 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cc
Confidence 55443334455555555555555554433233333333334555555554433333322 234555555555554 44
Q ss_pred CcccCCCCCCCcccccCCcccc-------cCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCC
Q 001778 329 PEGIGLLPSLKDVRLFNNMLSG-------ALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELP 401 (1014)
Q Consensus 329 p~~~~~l~~L~~L~L~~N~l~~-------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~ 401 (1014)
|..+ .+++|+.|++.++.... ..+..+...++|+.|+|++|... +.+|
T Consensus 741 P~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l------------------------~~lP 795 (1153)
T PLN03210 741 PSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSL------------------------VELP 795 (1153)
T ss_pred cccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCc------------------------cccC
Confidence 4433 34555555555433210 11111112234444444444444 4444
Q ss_pred cccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcce
Q 001778 402 ESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLV 481 (1014)
Q Consensus 402 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 481 (1014)
.+++++++|+.|++++|...+.+|..+ .+.+|+.|++++|.....+|. ...+|+.|+|++|.|+ .+|..+..+++|+
T Consensus 796 ~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~-~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~ 872 (1153)
T PLN03210 796 SSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD-ISTNISDLNLSRTGIE-EVPWWIEKFSNLS 872 (1153)
T ss_pred hhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc-cccccCEeECCCCCCc-cChHHHhcCCCCC
Confidence 444444444444444443333444433 333444444444333333332 2346777777777776 5666677777777
Q ss_pred EEEccCCc-cccccccccccccccceeccccc
Q 001778 482 VFQASNNL-FNGTIPGELTALPSLTTLLLDQN 512 (1014)
Q Consensus 482 ~L~ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N 512 (1014)
.|++++|. +. .+|..+..+++|+.|++++|
T Consensus 873 ~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 873 FLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred EEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 77777633 44 45666666777777777666
|
syringae 6; Provisional |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=226.39 Aligned_cols=201 Identities=38% Similarity=0.506 Sum_probs=172.8
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
|...+.||+|++|.||++....+++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 45678899999999999999888899999998543221 2567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++..... .+++.....++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+
T Consensus 79 ~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~ 145 (225)
T smart00221 79 CEGGDLFDYLRKKGG----------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLA 145 (225)
T ss_pred cCCCCHHHHHHhccc----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence 999999999986421 168899999999999999999966 9999999999999999999999999999
Q ss_pred cccccccCccccccccccCccccccccc-ccCCCCCcCcchhHHHHHHHHhcCCCCCCC
Q 001778 849 KILIKEEGEFAAMSTVVGSCGYIAPEYA-RTRKVNEKTDIYSFGVILLELTTGKEANNG 906 (1014)
Q Consensus 849 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DvwSlGvll~elltg~~p~~~ 906 (1014)
......... ......++..|++||.. ....++.++|+|+||+++|+|++|+.||..
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 146 RFIHRDLAA--LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eEecCcccc--cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 876543211 22345678899999998 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=274.60 Aligned_cols=338 Identities=21% Similarity=0.221 Sum_probs=220.7
Q ss_pred CCCCCCCCccEEECccCC------CCCCCCccccCCC-CcceecccccccCCCCCcccccccccceeeecCccCCCCCch
Q 001778 89 PFICDLRNLTILDLQFNY------IISQFPRVLYNCS-KLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPA 161 (1014)
Q Consensus 89 ~~l~~l~~L~~L~L~~n~------i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 161 (1014)
.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 457778888888886553 2334666666653 5888888888776 667666 4678888888888877 6777
Q ss_pred hhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCcccccccccc
Q 001778 162 SIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML 241 (1014)
Q Consensus 162 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 241 (1014)
.+..+++|+.|+|+++...+.+|. ++.+++|++|+|++|.. +..+|..++++++|+.|++++|+..+.+|..+ +++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~--L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSS--LVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCC--ccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 777788888888887654445663 67778888888877642 45677777788888888887777667777655 677
Q ss_pred ccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccC-------CCCCCcccccccc
Q 001778 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT-------GAIPNDFGKLENL 314 (1014)
Q Consensus 242 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~-------~~~p~~~~~l~~L 314 (1014)
+|+.|++++|...+.+|.. ..+|+.|++++|.+.. +|..+...+|+.|++.++... ...+..+...++|
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccc
Confidence 7888888777655455532 3567777777777753 444444456677766653321 1112222334567
Q ss_pred cccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEcccc
Q 001778 315 LNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDN 394 (1014)
Q Consensus 315 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N 394 (1014)
+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|++|++++|.....+|.. ..+|+.|++++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 777777776666677777777777777777765444556554 5667777777776555455443 245667777777
Q ss_pred ccCCCCCcccccCCcccEEEeecceeecCCCcccccccccccccccCC
Q 001778 395 NLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442 (1014)
Q Consensus 395 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n 442 (1014)
.++ .+|.++..+++|+.|++++|+--..+|..+..+.+|+.++++++
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 666 45666677777777777664333356665555555555555554
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=215.60 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=192.4
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccC
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 771 (1014)
..+|.+...|+.|+|+|..++ +++|++.. +....+..++|..|.-.++.+.||||+.++++|..+....++..||+.
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd--ivakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND--IVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhccCCCcccccccccCcc--hhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 446888999999999997544 56676632 445566678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|..++++.. ...++-.++.+++.++|+|++|||.. .+-|..--+.+..|++|++.+++|+ .+-+++.
T Consensus 272 gslynvlhe~t---------~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs 340 (448)
T KOG0195|consen 272 GSLYNVLHEQT---------SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS 340 (448)
T ss_pred hHHHHHHhcCc---------cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee
Confidence 99999999863 34577889999999999999999976 4455566789999999999998884 2333322
Q ss_pred ccccCccccccccccCcccccccccccCCCC---CcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchh
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVN---EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
.. ...+.-.+.||+||.++..+.+ .++|+|||++++||+.|++.||..-..- +...++..++
T Consensus 341 fq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---ecgmkialeg----- 405 (448)
T KOG0195|consen 341 FQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---ECGMKIALEG----- 405 (448)
T ss_pred ee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---hhhhhhhhcc-----
Confidence 11 1234557899999999876544 5799999999999999999999865432 1111222222
Q ss_pred ccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcC
Q 001778 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~ 974 (1014)
++...+.....++.+++.-|++.||.+||.++.|+-+|++.
T Consensus 406 -----lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 -----LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -----ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 22233334455677888889999999999999999988864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=270.44 Aligned_cols=203 Identities=18% Similarity=0.172 Sum_probs=143.0
Q ss_pred CCC-CccceEEEEE-------EcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHh
Q 001778 744 IRH-LNIVKLLCCI-------SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH 815 (1014)
Q Consensus 744 l~h-pniv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 815 (1014)
++| +||++++++| ..++..+.++||+ +++|.+++... ...+++.++..++.||++||+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----------~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----------DRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----------cccccHHHHHHHHHHHHHHHHHHH
Confidence 345 5777888877 2334667888987 56999999653 134899999999999999999999
Q ss_pred hcCCCCeEeccCCCCCeeecCC-------------------CcEEEeecccccccccccC-------c------cccccc
Q 001778 816 HDCSPTIVHRDLKSSNILLDYN-------------------FNAKIADFGVAKILIKEEG-------E------FAAMST 863 (1014)
Q Consensus 816 ~~~s~~ivH~Dlk~~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~-------~------~~~~~~ 863 (1014)
+. +|+||||||+|||++.. +.+|++|||+++....... . ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 55 99999999999999654 4456666666653211000 0 000112
Q ss_pred cccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHH
Q 001778 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEM 943 (1014)
Q Consensus 864 ~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1014)
..||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..... .... ..+ ......
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~-~~~~-----~~~-----~~~~~~ 238 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSL-RHRV-----LPP-----QILLNW 238 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHH-HHhh-----cCh-----hhhhcC
Confidence 4688999999999999999999999999999999998887653211 11111 1000 000 111122
Q ss_pred HHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 001778 944 IRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 944 ~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 980 (1014)
.+...++.+||++||.+||++.|+++ ||||...
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~----h~~~~~~ 271 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ----SEFINEP 271 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh----chhhhhh
Confidence 33457788999999999999999998 9999764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=247.80 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=134.4
Q ss_pred cceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccccccccccc
Q 001778 243 LEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322 (1014)
Q Consensus 243 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 322 (1014)
-..|+|+.|.|+ .+|..+. ++|+.|++.+|+++.. |.. ..+|++|+|++|+|+. +|.. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PAL--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CCC--CCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence 445666666666 4555544 2566666666666542 221 2356666666666653 3322 235556666666
Q ss_pred eecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCc
Q 001778 323 QLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPE 402 (1014)
Q Consensus 323 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~ 402 (1014)
+++ .+|.. .++|+.|++++|+++ .+|.. .++|++|+|++|++++ +|.. ..+|+.|++++|++++ +|.
T Consensus 273 ~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 273 PLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred chh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-ccc
Confidence 655 33332 234555566666655 23321 2445555555555553 2221 1123334444444432 221
Q ss_pred ccccCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceE
Q 001778 403 SLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVV 482 (1014)
Q Consensus 403 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 482 (1014)
. ..+|+.|+|++|+|+ .+|. .+.+|+.|++++|+|++ +|... .+|+.
T Consensus 340 l---p~~Lq~LdLS~N~Ls-------------------------~LP~-lp~~L~~L~Ls~N~L~~-LP~l~---~~L~~ 386 (788)
T PRK15387 340 L---PSGLQELSVSDNQLA-------------------------SLPT-LPSELYKLWAYNNRLTS-LPALP---SGLKE 386 (788)
T ss_pred c---ccccceEecCCCccC-------------------------CCCC-CCcccceehhhcccccc-Ccccc---cccce
Confidence 0 123333444433333 1222 22355666666666663 44322 34666
Q ss_pred EEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccccccccceeecCCCcc
Q 001778 483 FQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562 (1014)
Q Consensus 483 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 562 (1014)
|++++|.|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+++++.|+.|+|++|+|
T Consensus 387 LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 387 LIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred EEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 6666666663 3432 235666666666666 355432 35566666666666 5666666666666666666666
Q ss_pred ccCCchhhh
Q 001778 563 SGKIPPQIG 571 (1014)
Q Consensus 563 ~g~ip~~~~ 571 (1014)
+|.+|..+.
T Consensus 458 s~~~~~~L~ 466 (788)
T PRK15387 458 SERTLQALR 466 (788)
T ss_pred CchHHHHHH
Confidence 666665553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=248.35 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=171.3
Q ss_pred CcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccccccccccceecccCCcccCCCCCCCcccccCC
Q 001778 267 LSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNN 346 (1014)
Q Consensus 267 L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 346 (1014)
-..|+|++|.++. +|..+. .+|+.|++++|+|+. +|.. .++|++|+|++|+|+ .+|.. .++|+.|++++|
T Consensus 203 ~~~LdLs~~~Lts-LP~~l~-~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLTT-LPDCLP-AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCCc-CCcchh-cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCC
Confidence 4456666666663 333222 245666666666653 3321 345555555555555 23321 234555555555
Q ss_pred cccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCc
Q 001778 347 MLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPA 426 (1014)
Q Consensus 347 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 426 (1014)
.++ .+|..+ .+|+.|++++|+++. +|. ..++|+.|++++|++++ +|.
T Consensus 273 ~L~-~Lp~lp---------------------------~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~ 319 (788)
T PRK15387 273 PLT-HLPALP---------------------------SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPA 319 (788)
T ss_pred chh-hhhhch---------------------------hhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCC
Confidence 554 222211 234444445554442 222 12456666666666653 343
Q ss_pred ccccccccccccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccce
Q 001778 427 GLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506 (1014)
Q Consensus 427 ~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 506 (1014)
. ..+|..|++++|.+++ +|. ++.+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.
T Consensus 320 l---p~~L~~L~Ls~N~L~~-LP~-lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~ 386 (788)
T PRK15387 320 L---PSELCKLWAYNNQLTS-LPT-LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKE 386 (788)
T ss_pred C---cccccccccccCcccc-ccc-cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccce
Confidence 1 1245566666666663 553 44689999999999995 5653 3578889999999994 6654 357999
Q ss_pred ecccccccCCCCcccccccccccceeccccccccccCcccccccccceeecCCCccccCCchhhhhh-cccccccCCCcc
Q 001778 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRL 585 (1014)
Q Consensus 507 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~l~~l~ls~N~l 585 (1014)
|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|..++.+ .|+.|+|++|+|
T Consensus 387 LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 387 LIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred EEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 999999999 477543 57999999999998 47764 356889999999998 899999888 799999999999
Q ss_pred cccCChhhhh
Q 001778 586 TGEIPSQFEN 595 (1014)
Q Consensus 586 ~~~~p~~~~~ 595 (1014)
+|.+|+.+..
T Consensus 458 s~~~~~~L~~ 467 (788)
T PRK15387 458 SERTLQALRE 467 (788)
T ss_pred CchHHHHHHH
Confidence 9999987644
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=204.85 Aligned_cols=162 Identities=22% Similarity=0.261 Sum_probs=121.8
Q ss_pred CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccc
Q 001778 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 772 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|+|.++++..+ ..+++.+++.++.|++.||+|||+. + ||+||+++.++.+|+ ||.+...
T Consensus 1 GsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRG----------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEee
Confidence 68899987632 3489999999999999999999965 4 999999999999999 9998765
Q ss_pred ccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCch-hHHHHHHHHHhcCCcchhcc
Q 001778 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT-CLAQWAWRHIQEGKPIVDAL 930 (1014)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 930 (1014)
... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........+
T Consensus 60 ~~~--------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 126 (176)
T smart00750 60 TPE--------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----- 126 (176)
T ss_pred ccc--------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----
Confidence 331 226889999999999999999999999999999999999999754321 111111111111100
Q ss_pred ccccCCcccHHHH--HHHHHHHhHccCCCCCCCCCHHHHHHH
Q 001778 931 DKEIDEPCFLEEM--IRVFKLGVICTSMLPTERPNMRMVLQI 970 (1014)
Q Consensus 931 ~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPt~~ev~~~ 970 (1014)
... ....... .++.+++.+||+.||++||++.|+++.
T Consensus 127 -~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 127 -RDR--SNLESVSAARSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred -ccc--ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence 000 0111111 258899999999999999999999983
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-23 Score=243.08 Aligned_cols=354 Identities=23% Similarity=0.296 Sum_probs=202.2
Q ss_pred cCCCHHHHHHHHHHHHhcCCCCCCCC----CCCCCCCCCCCCc----------------eEeCCCceeEEeeccccCCcc
Q 001778 27 SQLYDREHAVLLKLKQHWQNPPPISH----WATTNSSHCTWPE----------------IACTDGSVTELHLTNMNMNGT 86 (1014)
Q Consensus 27 ~~~~~~~~~~ll~~k~~~~~~~~~~~----w~~~~~~~c~w~g----------------v~c~~~~v~~L~l~~~~l~~~ 86 (1014)
......|.+.+++..+.+.-|+...+ |+.. +++|--.. |.|..+.||.+...+......
T Consensus 58 ~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCHHHHHHHHHHHHHhcCCchhhccccccCCC-CcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 34567899999999999988876666 8765 78885332 889888999988776333222
Q ss_pred CCCCCCCCCCccEEECc----cCCCCCCC---Cccc-----cCCCCcceecccccccCCCCCcccccccccceeeecCcc
Q 001778 87 FPPFICDLRNLTILDLQ----FNYIISQF---PRVL-----YNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154 (1014)
Q Consensus 87 ~~~~l~~l~~L~~L~L~----~n~i~~~~---p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (1014)
...+-.. -.+.... .+.-.+.. -.++ +-..+...|+++++.++ .+|..+. +.|+.|+|++|+
T Consensus 137 ~~~~~~~---~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~ 210 (754)
T PRK15370 137 ASGSKDA---VNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNE 210 (754)
T ss_pred CCCCCCh---hhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCC
Confidence 1111000 0000000 01110000 0111 11134567777777776 4565443 367777777777
Q ss_pred CCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCccc
Q 001778 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP 234 (1014)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p 234 (1014)
++ .+|..+. ++|++|++++|+|+ .+|..+. .+|+.|+|++| ++. .+|
T Consensus 211 Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N--------------------------~L~-~LP 257 (754)
T PRK15370 211 LK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN--------------------------RIT-ELP 257 (754)
T ss_pred CC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC--------------------------ccC-cCC
Confidence 77 4555443 46777777777776 4454332 24555555555 333 333
Q ss_pred cccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccc
Q 001778 235 ETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENL 314 (1014)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 314 (1014)
..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+|++.+ ..+. .+|+.|++++|+++. +|..+. ++|
T Consensus 258 ~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP-~~lp-~sL~~L~Ls~N~Lt~-LP~~l~--~sL 327 (754)
T PRK15370 258 ERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLP-AHLP-SGITHLNVQSNSLTA-LPETLP--PGL 327 (754)
T ss_pred hhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCc-ccch-hhHHHHHhcCCcccc-CCcccc--ccc
Confidence 3332 24566666666665 3454443 35666666666665432 2211 256666777777663 343332 467
Q ss_pred cccccccceecccCCcccCCCCCCCcccccCCcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEcccc
Q 001778 315 LNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDN 394 (1014)
Q Consensus 315 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N 394 (1014)
+.|++++|.+++ +|..+. ++|+.|++++|+++ .+|..+. ++|++|+|++|+++ .+|..+. ..|+.|++++|
T Consensus 328 ~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N 398 (754)
T PRK15370 328 KTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRN 398 (754)
T ss_pred eeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccC
Confidence 777777777763 555443 57777777777776 4555443 46777777777777 4555443 25777777777
Q ss_pred ccCCCCCcc----cccCCcccEEEeecceeecCCCcccccccccccccccCCcccCC
Q 001778 395 NLSGELPES----LGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGE 447 (1014)
Q Consensus 395 ~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~ 447 (1014)
++. .+|.. +..++++..|++.+|+++. ..+.+|+.+ ++.+++.|.
T Consensus 399 ~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 399 NLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGP 447 (754)
T ss_pred Ccc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCC
Confidence 776 34443 3445778888888888872 344455555 445555543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=214.73 Aligned_cols=170 Identities=19% Similarity=0.198 Sum_probs=130.1
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecC-CCeEEEEEEecccch--hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCc
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINH-TAEVVAVKKIWNDRK--LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 761 (1014)
...+|+..+.||+|+||+||+|.+.. +++.||||++..... ......+.+.+|+++++.++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 34579999999999999999998876 678889998742211 123345679999999999999999853322 245
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC-CCCCeeecCCCcE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL-KSSNILLDYNFNA 840 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl-k~~NIll~~~~~~ 840 (1014)
.|+||||+++++|... ... . ...++.++++||+|||+. ||+|||| ||+|||++.++.+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~--------------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH--------------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc--------------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 7999999999999632 110 0 136788999999999965 9999999 9999999999999
Q ss_pred EEeecccccccccccCccc-----cccccccCccccccccccc
Q 001778 841 KIADFGVAKILIKEEGEFA-----AMSTVVGSCGYIAPEYART 878 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~ 878 (1014)
||+|||+|+.+........ ......+++.|+|||++.-
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999997755321111 1135678889999998863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=235.55 Aligned_cols=268 Identities=21% Similarity=0.186 Sum_probs=198.2
Q ss_pred CCCceeccCCcEEEEEeeecCCCeEEEEEEecc---cchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN---DRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
...+++|.|++|.|+.+......+.++.|.+.. ...........+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888877666666666665431 11112222333777888888899999988877777666666669
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|||++ +|..++... ..+...++..++.|+..|+.|+|.. ||.|||+|++|++++.++.+||+|||
T Consensus 401 E~~~~-Dlf~~~~~~-----------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred hcccH-HHHHHHhcc-----------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 99999 999998764 2377788889999999999999966 99999999999999999999999999
Q ss_pred cccccccccC-ccccccccccCcccccccccccCCCCC-cCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCC
Q 001778 847 VAKILIKEEG-EFAAMSTVVGSCGYIAPEYARTRKVNE-KTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 847 la~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
.+..+.-... ........+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+-.. ... ....
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~-~~~~ 542 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTN-NYSD 542 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhh-cccc
Confidence 9987654322 223456789999999999999999875 6899999999999999999997544321110 000 0000
Q ss_pred cchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..-...-..........+...++.+++++||.+|.|+++|++ .+||++.+.
T Consensus 543 ---~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~----d~W~~~i~~ 593 (601)
T KOG0590|consen 543 ---QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN----DEWIRSIEC 593 (601)
T ss_pred ---ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh----ChHhhhcce
Confidence 000000011223444556778999999999999999999998 999988653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=231.38 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=142.2
Q ss_pred CCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccccccccccccceecccCCcccCCCCCCCcccccC
Q 001778 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFN 345 (1014)
Q Consensus 266 ~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 345 (1014)
+.+.|+++++.++.. |..+. .+|+.|+|++|+|+. +|..+. .+|+.|++++|+++ .+|..+. ++|+.|+|++
T Consensus 179 ~~~~L~L~~~~LtsL-P~~Ip-~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLTTI-PACIP-EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcCcC-Ccccc-cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 456677777776643 32221 256666666666663 343332 35666666666655 3444332 2455555555
Q ss_pred CcccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCC
Q 001778 346 NMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIP 425 (1014)
Q Consensus 346 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 425 (1014)
|++. .+|..+. ++|++| ++++|+++ .+|..+. ++|+.|++++|+|+ .+|
T Consensus 251 N~L~-~LP~~l~--s~L~~L------------------------~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP 299 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSL------------------------DLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLP 299 (754)
T ss_pred CccC-cCChhHh--CCCCEE------------------------ECcCCccC-ccccccC--CCCcEEECCCCccc-cCc
Confidence 5554 3343332 234444 44444444 2333332 35666666666665 344
Q ss_pred cccccccccccccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccc
Q 001778 426 AGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT 505 (1014)
Q Consensus 426 ~~~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 505 (1014)
..+. .+|+.|++++|.++ .+|..++.+|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+
T Consensus 300 ~~lp--~sL~~L~Ls~N~Lt-~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~ 370 (754)
T PRK15370 300 AHLP--SGITHLNVQSNSLT-ALPETLPPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTIT 370 (754)
T ss_pred ccch--hhHHHHHhcCCccc-cCCccccccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcC
Confidence 4332 35666666666666 3555555677777777777774 555443 57777777777776 4555442 5777
Q ss_pred eecccccccCCCCcccccccccccceeccccccccccCcc----cccccccceeecCCCccc
Q 001778 506 TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEK----IGFLPVLQDLDLSENQFS 563 (1014)
Q Consensus 506 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 563 (1014)
.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|.. ++.++.+..|+|.+|.++
T Consensus 371 ~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 371 TLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred EEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 7888888877 5666554 36777888888876 45543 334567777777777776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-20 Score=205.31 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=191.7
Q ss_pred CCCCCceeccCCcEEEEEeeecCCC-eEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC----CccceEEEEE-EcCCc
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTA-EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH----LNIVKLLCCI-SSENL 761 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----pniv~l~~~~-~~~~~ 761 (1014)
+|.+.+.||+|+||.||.|.+..++ +.+|+|...... ......+..|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~---~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL---GSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc---cCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7899999999999999999987764 678888873321 1112267888888888863 6899999998 57778
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC----
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN---- 837 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~---- 837 (1014)
.|+||+.+ |.+|.++..... ...++..+..+|+.|++.+|.++|+. |++||||||.|+++...
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~---------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP---------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC---------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 89999987 679999886642 34589999999999999999999965 99999999999999865
Q ss_pred -CcEEEeeccccc--ccccccCc---cc-c-ccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCc
Q 001778 838 -FNAKIADFGVAK--ILIKEEGE---FA-A-MSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909 (1014)
Q Consensus 838 -~~~kl~Dfgla~--~~~~~~~~---~~-~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~ 909 (1014)
..+++.|||+|+ .+...... .. . .....||..|+++....+...+.+.|+||++.++.|+..|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998 33222221 11 1 2346699999999999999999999999999999999999999976553
Q ss_pred hhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
......+........ ... .......+ +.++...+-..+..++|....+...+++
T Consensus 243 ~~~~~~~~~~~~~~~-----~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 243 TDLKSKFEKDPRKLL-----TDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred cchHHHHHHHhhhhc-----ccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 322221111111110 000 11122233 3344444555899999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-19 Score=197.98 Aligned_cols=263 Identities=31% Similarity=0.385 Sum_probs=199.7
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCC-ccceEEEEEEcCCceEEEEE
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL-NIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-niv~l~~~~~~~~~~~lV~e 767 (1014)
|...+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566778999999999999876 77899998554433334578899999999999988 79999999987777899999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-cEEEeecc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NAKIADFG 846 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-~~kl~Dfg 846 (1014)
|+.++++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||
T Consensus 79 ~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred cCCCCcHHHHHHhcccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 99999999777654210 2578889999999999999999966 899999999999999988 79999999
Q ss_pred cccccccccCcc---ccccccccCccccccccccc---CCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHH
Q 001778 847 VAKILIKEEGEF---AAMSTVVGSCGYIAPEYART---RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 847 la~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
.+.......... .......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...............+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 227 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence 998554432221 13457889999999999987 578899999999999999999999977655310111122222
Q ss_pred hcCC-c-chhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 921 QEGK-P-IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 921 ~~~~-~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
.... + .......... ......+.+++..|+..+|..|.++.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 228 LELPTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HhcCCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1111 1 0111111100 222345678888999999999999998776
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-21 Score=213.32 Aligned_cols=256 Identities=23% Similarity=0.223 Sum_probs=199.5
Q ss_pred eeccCCcEEEEEeee---cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEEEcc
Q 001778 694 VIGSGGSGKVYRVPI---NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 769 (1014)
++|+|+||.|+.+.. ...+..+|+|+.++......... ....|..++..++ ||.++++..+++.+...+++.+|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999986532 34467799998866544333333 5667778888886 999999999999999999999999
Q ss_pred cCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
.+|.+...+... ..+...........++-+++++|.. +|+|||+|++||+++.+|++++.|||+++
T Consensus 80 rgg~lft~l~~~-----------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-----------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred ccchhhhccccC-----------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhh
Confidence 999999888764 2366777777888899999999966 99999999999999999999999999998
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhc
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
.....+ ..+||..|||||++. .+..++|.||||++++||+||..||.+ +....+.....
T Consensus 146 e~v~~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~----- 204 (612)
T KOG0603|consen 146 EAVKEK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAEL----- 204 (612)
T ss_pred HhHhhh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhcc-----
Confidence 764422 228999999999998 577899999999999999999999987 11222222111
Q ss_pred cccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCCccccccc
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEKNGGRKYDHVTP 992 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~L~~~~~~~~~~~~~~~~~~~~~ 992 (1014)
..+.+.......++..+...+|..|.... +++..+.+|+||....+.+-....+.+
T Consensus 205 -------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~ 261 (612)
T KOG0603|consen 205 -------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPP 261 (612)
T ss_pred -------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCC
Confidence 22334444556778889999999999775 778888889999997777433333333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=190.63 Aligned_cols=240 Identities=19% Similarity=0.218 Sum_probs=157.7
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC----------CccceEEEEE--
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH----------LNIVKLLCCI-- 756 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------pniv~l~~~~-- 756 (1014)
+...+.||.|+++.||.+++.++++.+|||++...........+++++|.-....+.+ -.++.-++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4567889999999999999999999999999876665566677888888766655432 1111111111
Q ss_pred -------EcC---C-----ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 001778 757 -------SSE---N-----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPT 821 (1014)
Q Consensus 757 -------~~~---~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ 821 (1014)
... . ..+++|+-+. ++|.+++..-.... .....+....+..+..|+++.+++||.. |
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~----~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRA----QTHSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHT----TTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcc----cccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 111 1 2367788774 58888865421100 0122355667778889999999999966 9
Q ss_pred eEeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCccccccccccc--------CCCCCcCcchhHHHH
Q 001778 822 IVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART--------RKVNEKTDIYSFGVI 893 (1014)
Q Consensus 822 ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DvwSlGvl 893 (1014)
+||+||+|+|++++.+|.++++||+.....+.. .. ....+..|.+||.... ..++.+.|.|++|++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCce----ee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999999999999999999999988764331 11 1345578999997644 257889999999999
Q ss_pred HHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCC
Q 001778 894 LLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTER 961 (1014)
Q Consensus 894 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 961 (1014)
+|.|+++..||..........| .+. .|. +.+..+..+|..+++.||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~-----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW-----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG-----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc-----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543322111 111 233 555667789999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=173.02 Aligned_cols=209 Identities=19% Similarity=0.273 Sum_probs=171.0
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC-CccceEEEEEEcCCce
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH-LNIVKLLCCISSENLK 762 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~ 762 (1014)
-...+|..++.||.|+||.+|.|.....|+.||||.-.+ .....++..|..+++.+++ ..|..+..+..+...-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-----~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-----KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-----cCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 445689999999999999999999999999999998622 2334567789999999975 5566667777788888
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC---Cc
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN---FN 839 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~---~~ 839 (1014)
.+|||.. |.+|.++..-.. ..++..+++-.+-|++.-++|+|.. +.+||||||+|.|..-+ ..
T Consensus 87 vlVMdLL-GPsLEdLfnfC~----------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCS----------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred eeeeecc-CccHHHHHHHHh----------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence 9999988 679988877653 2489999999999999999999966 99999999999999643 46
Q ss_pred EEEeecccccccccccC----ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 840 AKIADFGVAKILIKEEG----EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
+.++|||+|+.+.+... .+.......||.+|.+--...+...+.+.|+=|+|.++.++--|.-||++-....
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 89999999988754322 1223446789999999887777778889999999999999999999999865443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=175.93 Aligned_cols=206 Identities=18% Similarity=0.250 Sum_probs=172.4
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCceEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 765 (1014)
..|.++++||+|.||+++.|...-+++.||||.-..+ ...-++..|...++.+ ..+.|...+.+...+.+-.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 4688999999999999999999999999999985221 2345567788888887 578888888888888888999
Q ss_pred EEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC-----cE
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-----NA 840 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~-----~~ 840 (1014)
+|.. |.||.|+..-.+ ..|+..++..||.|++.-++|+|++ .+|+|||||+|.||...+ .+
T Consensus 103 idLL-GPSLEDLFD~Cg----------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG----------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred hhhh-CcCHHHHHHHhc----------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceE
Confidence 9998 668888877653 3499999999999999999999965 999999999999997543 48
Q ss_pred EEeecccccccccccC----ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchh
Q 001778 841 KIADFGVAKILIKEEG----EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~ 911 (1014)
.++|||+|+.+.+... .+.......||.+||+--...+.+.+.+.|.=|+|-++.+.+-|.-||.+-.-..
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 9999999998765432 1223445789999999999999999999999999999999999999999865443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=179.86 Aligned_cols=174 Identities=15% Similarity=0.153 Sum_probs=132.8
Q ss_pred cCCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHH------HHHHHHHHHcCCCCccceEEEEEEc
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE------FLAEVQILSTIRHLNIVKLLCCISS 758 (1014)
Q Consensus 685 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~hpniv~l~~~~~~ 758 (1014)
...+|...+++|.|+||.||.+.. ++..+|+|.+.......+..... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 456799999999999999999655 36679999996544333333333 6899999999999999999888653
Q ss_pred C--------CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCC
Q 001778 759 E--------NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSS 830 (1014)
Q Consensus 759 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~ 830 (1014)
. +..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~ 164 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKG 164 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChH
Confidence 3 35789999999999988731 121 2456899999999966 9999999999
Q ss_pred CeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHh
Q 001778 831 NILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELT 898 (1014)
Q Consensus 831 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ell 898 (1014)
||+++.++ ++++|||........... ..+.....+..++|+|+||+++....
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988 999999988654221100 11344456678999999999877655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=176.08 Aligned_cols=142 Identities=18% Similarity=0.122 Sum_probs=106.6
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHH-----------------------hHHHHHHHHHHHHcCCCCc
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-----------------------HEKEFLAEVQILSTIRHLN 748 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~hpn 748 (1014)
.+.||+|+||.||+|.+. +|+.||||+++........ .......|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999886 7999999999653211100 0123345999999998777
Q ss_pred cceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeccC
Q 001778 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM-HHDCSPTIVHRDL 827 (1014)
Q Consensus 749 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~s~~ivH~Dl 827 (1014)
+.....+... ..++||||++++++....... ..+++....+++.|++.+|.|+ |.. +|+||||
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----------APLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 6433322222 238999999988776543221 2378889999999999999999 544 9999999
Q ss_pred CCCCeeecCCCcEEEeeccccccc
Q 001778 828 KSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 828 k~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
||+||+++ ++.++++|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-20 Score=172.35 Aligned_cols=183 Identities=28% Similarity=0.470 Sum_probs=146.7
Q ss_pred cCCcccEEEeecceeecCCCcccccccccccccccCCcccCCCCCcCC--CCCceeccccccccCcCCCcccCCCcceEE
Q 001778 406 NCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS--GNLSRLEISNNRFSGKIPTGVSSSKNLVVF 483 (1014)
Q Consensus 406 ~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~n~~~~~~p~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 483 (1014)
++.+++.|.|++|+++ .+|+.+..+.+|+.|++++|+++ ++|..++ +.|+.|+++-|++. ..|.+|++++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3444555555555555 55555555555555555555555 4455444 46788888888888 889999999999999
Q ss_pred EccCCcccc-ccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccccccccceeecCCCcc
Q 001778 484 QASNNLFNG-TIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562 (1014)
Q Consensus 484 ~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 562 (1014)
||.+|.+.. ..|+.|..++.|+.|+|+.|.+. .+|.+++++++|+.|.+..|.+- ..|.+++.+++|+.|.+.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 999999864 67999999999999999999998 89999999999999999999997 7999999999999999999999
Q ss_pred ccCCchhhhhhc----ccccccCCCcccccCChhhh
Q 001778 563 SGKIPPQIGRLM----LTSLNLSSNRLTGEIPSQFE 594 (1014)
Q Consensus 563 ~g~ip~~~~~~~----l~~l~ls~N~l~~~~p~~~~ 594 (1014)
+ .+|++++.+. -+.+.+.+|++..+|..+|+
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf~ 220 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQFL 220 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHHHH
Confidence 8 8899998873 46788889999888877664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=168.36 Aligned_cols=193 Identities=15% Similarity=0.069 Sum_probs=140.8
Q ss_pred CCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHH-hHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEEEEE
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-HEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 767 (1014)
.....|++|+||+||.+.. .+..++.+.+....-+... ....+.+|+++|+++. |+++.+++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997643 5677877766333222221 2235889999999995 5889999886 34699999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC-CCCCeeecCCCcEEEeecc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL-KSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl-k~~NIll~~~~~~kl~Dfg 846 (1014)
|++|.+|.+.... ....++.|+++++.++|.. ||+|||| ||+||+++.++.++|+|||
T Consensus 79 yI~G~~L~~~~~~------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 79 YLAGAAMYQRPPR------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred eecCccHHhhhhh------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 9999888654311 1134678899999999966 9999999 7999999999999999999
Q ss_pred cccccccccCc---cc-------cccccccCcccccccccccC-CCC-CcCcchhHHHHHHHHhcCCCCCCCCCc
Q 001778 847 VAKILIKEEGE---FA-------AMSTVVGSCGYIAPEYARTR-KVN-EKTDIYSFGVILLELTTGKEANNGDEH 909 (1014)
Q Consensus 847 la~~~~~~~~~---~~-------~~~~~~gt~~y~aPE~l~~~-~~~-~~~DvwSlGvll~elltg~~p~~~~~~ 909 (1014)
+|......... .. .......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.++.++.+
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 99865432210 00 01234467788888744321 222 578999999999999999999877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-19 Score=181.29 Aligned_cols=203 Identities=20% Similarity=0.195 Sum_probs=142.0
Q ss_pred CCCccceEEEEEEc---------------------------CCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCH
Q 001778 745 RHLNIVKLLCCISS---------------------------ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797 (1014)
Q Consensus 745 ~hpniv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~ 797 (1014)
+|||||++.++|.+ +..+|+||.-.+. +|.+++.... .+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------------~s~ 340 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------------RSY 340 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------------Cch
Confidence 59999999877643 2455899987765 8999987753 455
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeec--CCC--cEEEeeccccccccccc---CccccccccccCccc
Q 001778 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD--YNF--NAKIADFGVAKILIKEE---GEFAAMSTVVGSCGY 870 (1014)
Q Consensus 798 ~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~--~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~~~gt~~y 870 (1014)
....-|+.|+++|..|||++ ||.|||+|++|||+. +|. ..+|+|||++---...+ ..........|....
T Consensus 341 r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l 417 (598)
T KOG4158|consen 341 RTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL 417 (598)
T ss_pred HHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence 56677899999999999976 999999999999994 333 57899999885321100 111222345677889
Q ss_pred ccccccccCCC------CCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHH
Q 001778 871 IAPEYARTRKV------NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMI 944 (1014)
Q Consensus 871 ~aPE~l~~~~~------~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1014)
||||+....+- -.++|.|+.|.+.||+++...||.+..+..+..- ...+..-+ +.+.....
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---------~Yqe~qLP----alp~~vpp 484 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---------TYQESQLP----ALPSRVPP 484 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---------hhhhhhCC----CCcccCCh
Confidence 99998865321 2589999999999999999999987443222111 11111112 22334445
Q ss_pred HHHHHHhHccCCCCCCCCCHHHHHHHHhcCCC
Q 001778 945 RVFKLGVICTSMLPTERPNMRMVLQILLNNPI 976 (1014)
Q Consensus 945 ~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~ 976 (1014)
.+.+++...++.||.+|+++.-....|+=.-|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 56788889999999999998776666543333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=191.19 Aligned_cols=215 Identities=26% Similarity=0.363 Sum_probs=160.1
Q ss_pred HHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 001778 741 LSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSP 820 (1014)
Q Consensus 741 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~ 820 (1014)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.....++++|+.||+|+|.. +
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----------~~~~d~~F~~s~~rdi~~Gl~ylh~s--~ 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----------DIKLDYFFILSFIRDISKGLAYLHNS--P 68 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----------ccCccHHHHHHHHHHHHHHHHHHhcC--c
Confidence 35678999999999999999999999999999999999873 34589999999999999999999974 3
Q ss_pred CeEeccCCCCCeeecCCCcEEEeecccccccccccCccccccccccCcccccccccccC-------CCCCcCcchhHHHH
Q 001778 821 TIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-------KVNEKTDIYSFGVI 893 (1014)
Q Consensus 821 ~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DvwSlGvl 893 (1014)
..+|+.+++.|++++....+|++|||+...... ...........-..-|.|||.+... ..+.++||||||++
T Consensus 69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred ceeeeeeccccceeeeeEEEEechhhhcccccc-cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 349999999999999999999999999987643 1111122223345678999998763 14678999999999
Q ss_pred HHHHhcCCCCCCCCCchhH-HHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 001778 894 LLELTTGKEANNGDEHTCL-AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 894 l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 972 (1014)
++|+++.+.||+....... .+.+......+. ....+.+.... +...++..++..||..+|++||+++.|-..++
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~---~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDPDEIILRVKKGGS---NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred HHHHHhccCccccccccCChHHHHHHHHhcCC---CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 9999999999986332222 222222222111 11122221111 22225778899999999999999999987665
Q ss_pred c
Q 001778 973 N 973 (1014)
Q Consensus 973 ~ 973 (1014)
.
T Consensus 223 ~ 223 (484)
T KOG1023|consen 223 T 223 (484)
T ss_pred h
Confidence 4
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=169.66 Aligned_cols=142 Identities=18% Similarity=0.119 Sum_probs=109.4
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhh-----------------------HHhHHHHHHHHHHHHcCCCCc
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD-----------------------QKHEKEFLAEVQILSTIRHLN 748 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~Ei~~l~~l~hpn 748 (1014)
.+.||+|++|.||+|.+. +|+.||||++....... ......+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999887 89999999986532110 001233468899999999998
Q ss_pred cceEEEEEEcCCceEEEEEcccCCCHHHH-hhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecc
Q 001778 749 IVKLLCCISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHH-DCSPTIVHRD 826 (1014)
Q Consensus 749 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~s~~ivH~D 826 (1014)
+.....+.... .++||||++++++... +.. ..++.....+++.+++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD------------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh------------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 75544433332 4899999998855443 322 125677889999999999999997 5 999999
Q ss_pred CCCCCeeecCCCcEEEeecccccccc
Q 001778 827 LKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 827 lk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
|||+||+++ ++.++|+|||+|....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=203.07 Aligned_cols=254 Identities=21% Similarity=0.180 Sum_probs=179.3
Q ss_pred CCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccc-hhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDR-KLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 688 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++...+.+|.+.|=+|.+|++.+ |. |+||++.+.. ..+-....+-..|++ ...++|||++++.-+.+.+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67778899999999999997653 44 8899985433 222233333344444 55569999999988877788888999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
+|... +|.|.+... ..+...+.+-|+.|++.|+..+|+. ||+|||||.+|||++.=.-+.|+||.
T Consensus 101 qyvkh-nLyDRlSTR-----------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTR-----------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHhh-hhhhhhccc-----------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 99865 899888654 4577778888999999999999966 99999999999999998899999998
Q ss_pred cccccccccCcccc----ccccccCcccccccccccC-----------CCCCcCcchhHHHHHHHHhcC-CCCCCCCCch
Q 001778 847 VAKILIKEEGEFAA----MSTVVGSCGYIAPEYARTR-----------KVNEKTDIYSFGVILLELTTG-KEANNGDEHT 910 (1014)
Q Consensus 847 la~~~~~~~~~~~~----~~~~~gt~~y~aPE~l~~~-----------~~~~~~DvwSlGvll~elltg-~~p~~~~~~~ 910 (1014)
.-+..+-..+.... ..+...-..|.|||.+... ..+++-||||+||++.|+++. +++|.-
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---- 241 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---- 241 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----
Confidence 76554322222111 2233344589999987541 256788999999999999985 666641
Q ss_pred hHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 911 CLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.+.......+....+.+-..++.. .+..++..|++.||++|.++++.++.=.+
T Consensus 242 ---SQL~aYr~~~~~~~e~~Le~Ied~-------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 242 ---SQLLAYRSGNADDPEQLLEKIEDV-------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ---HHHHhHhccCccCHHHHHHhCcCc-------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111111111122222222222221 35578889999999999999999886433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-18 Score=197.72 Aligned_cols=230 Identities=23% Similarity=0.217 Sum_probs=162.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
..|...+.|..|+||.||.++++.+.+.+|+|+= ++. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~--------lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN--------LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccc--------hhhhc--cccccCCccee----------------
Confidence 3577788999999999999999999999999543 111 01110 23333444443
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
|+-...++..+. ++. +.+.+++|+|.. ||+|||+||+|.+|+.-|++|+.|||
T Consensus 136 -----gDc~tllk~~g~-----------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfg 188 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP-----------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFG 188 (1205)
T ss_pred -----chhhhhcccCCC-----------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchh
Confidence 444445544321 221 126889999954 99999999999999999999999999
Q ss_pred cccccccccC------------ccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHH
Q 001778 847 VAKILIKEEG------------EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914 (1014)
Q Consensus 847 la~~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~ 914 (1014)
+++....... ........+||+.|+|||++..+.|+..+|+|++|+|+||.+-|++||.++..+++..
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 9865422110 0112234689999999999999999999999999999999999999999997776655
Q ss_pred HHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.+.....+-. +. + .....+..+++...++++|..|--....+ .+..|+||..-.+.
T Consensus 269 ~visd~i~wp---E~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~-evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 269 QVISDDIEWP---EE-D--------EALPPEAQDLIEQLLRQNPLCRLGTGGAL-EVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhhcccc---cc-C--------cCCCHHHHHHHHHHHHhChHhhcccchhh-hhhhccceeecccc
Confidence 5443322211 11 1 11223456778899999999998666444 57779999876555
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-19 Score=202.65 Aligned_cols=273 Identities=24% Similarity=0.262 Sum_probs=154.1
Q ss_pred eeccccccC-CCCCCcccccccccccccccceecc----cCCcccCCCCCCCcccccCCcccc------cCCccccCCCC
Q 001778 293 IDLSANNLT-GAIPNDFGKLENLLNLSLMFNQLSG----EIPEGIGLLPSLKDVRLFNNMLSG------ALPPDFGRYSP 361 (1014)
Q Consensus 293 L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~ 361 (1014)
|+|..+.++ ......|..+.+|+.|+++++.++. .++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 344444443 1222333444445555555555432 133334445555555555555441 22334555666
Q ss_pred CceeeccccccccCCChhhhcCCC---ccEEEccccccCC----CCCcccccC-CcccEEEeecceeecCCCcccccccc
Q 001778 362 LEYFEVSVNNLTGSLPEHLCAGGK---LAGIAAQDNNLSG----ELPESLGNC-SSLLMVKIYNNSFTGNIPAGLWTGFN 433 (1014)
Q Consensus 362 L~~L~Ls~N~l~~~~p~~~~~~~~---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~~~~ 433 (1014)
|++|++++|.+.+..+..+..+.+ |+.|++++|.+++ .+...+..+ ++|+.|++++|.+++..+..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~---- 158 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA---- 158 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH----
Confidence 666666666666555555544444 6666666665552 222334444 5666666666666532211110
Q ss_pred cccccccCCcccCCCCCcCC--CCCceeccccccccCc----CCCcccCCCcceEEEccCCccccc----cccccccccc
Q 001778 434 LSMVLISDNLFTGELPDKMS--GNLSRLEISNNRFSGK----IPTGVSSSKNLVVFQASNNLFNGT----IPGELTALPS 503 (1014)
Q Consensus 434 L~~l~l~~n~~~~~~p~~~~--~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~ 503 (1014)
..+. .+|+.|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++
T Consensus 159 ----------------~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~ 222 (319)
T cd00116 159 ----------------KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222 (319)
T ss_pred ----------------HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence 0111 2466666666666632 223344456788888888877643 3345666778
Q ss_pred cceecccccccCCCCcccccc-----cccccceeccccccc----cccCcccccccccceeecCCCccccC----Cchhh
Q 001778 504 LTTLLLDQNQLSGSLPLDIIS-----WKSLTALNLSRNQLS----GEIPEKIGFLPVLQDLDLSENQFSGK----IPPQI 570 (1014)
Q Consensus 504 L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~ 570 (1014)
|+.|++++|.+++..+..+.. .+.|+.|++++|.++ ..+...+..+++|+.+|+++|.++.. +...+
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 888888888887533333332 368899999999886 23445566678899999999999855 33333
Q ss_pred hhh--cccccccCCCcc
Q 001778 571 GRL--MLTSLNLSSNRL 585 (1014)
Q Consensus 571 ~~~--~l~~l~ls~N~l 585 (1014)
... .++.+|+.+|++
T Consensus 303 ~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 303 LEPGNELESLWVKDDSF 319 (319)
T ss_pred hhcCCchhhcccCCCCC
Confidence 322 478888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-19 Score=162.52 Aligned_cols=154 Identities=32% Similarity=0.576 Sum_probs=70.7
Q ss_pred CCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhc
Q 001778 119 SKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALEL 198 (1014)
Q Consensus 119 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 198 (1014)
++.+.|.||+|+++ .+|+.+..|.+|+.|++++|+++ .+|.+++.++.|+.|+++-|++. ..|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 33444444444444 33444444444444444444444 44444444444444444444444 44444444444444444
Q ss_pred ccccCCCCCCCCcccccccccceeecccccccCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCC
Q 001778 199 AYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS 278 (1014)
Q Consensus 199 ~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 278 (1014)
++|.+ +-..+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+.+|+++
T Consensus 110 tynnl-~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 110 TYNNL-NENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccc-ccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 44432 12344444444444444444444332 33444555555555555555544 44555555555555555555554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=198.21 Aligned_cols=198 Identities=19% Similarity=0.165 Sum_probs=155.6
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
++|.+.+.||+|+||+||+|.... |+.||+|+-.....+.---..+++..+. .+ --+-|..+..++.-.+.-++|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcceeee
Confidence 357778899999999999998877 9999999875544443333333333332 00 1234455555555666778999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-------CCc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-------NFN 839 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~-------~~~ 839 (1014)
||.+.|+|.+++... ...+|.-++.++.|+++.+++||.. +||||||||+|.|+.. ...
T Consensus 774 ey~~~Gtlld~~N~~-----------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTN-----------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred eccccccHHHhhccC-----------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 999999999999743 3478899999999999999999976 9999999999999942 345
Q ss_pred EEEeecccccccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCC
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA 903 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p 903 (1014)
++|+|||.+.++.--.. .......++|-.|-.+|...++.++..+|-|.++.+++-|+.|++.
T Consensus 840 l~lIDfG~siDm~lfp~-~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPD-GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCC-CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 89999999987754222 2345578899999999999999999999999999999999999853
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-19 Score=202.57 Aligned_cols=275 Identities=23% Similarity=0.227 Sum_probs=138.3
Q ss_pred EeeccccCC-ccCCCCCCCCCCccEEECccCCCCCC----CCccccCCCCcceecccccccCC------CCCcccccccc
Q 001778 76 LHLTNMNMN-GTFPPFICDLRNLTILDLQFNYIISQ----FPRVLYNCSKLEYLDLSQNYFIG------PIPEDIDRLSR 144 (1014)
Q Consensus 76 L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~ 144 (1014)
|+|..++++ +.....+..+..|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 445555554 22333344455566666666655332 33444455556666666655541 12234444555
Q ss_pred cceeeecCccCCCCCchhhcccCc---cceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccc-cccc
Q 001778 145 LKFLYLTANNMSGKIPASIGRLTE---LRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQL-KKLK 220 (1014)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l-~~L~ 220 (1014)
|++|+|++|.+.+..+..+..+.+ |++|++++|++++.... .+...+..+ ++|+
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~----------------------~l~~~l~~~~~~L~ 140 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR----------------------LLAKGLKDLPPALE 140 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH----------------------HHHHHHHhCCCCce
Confidence 666666666555444444444444 66666665555421110 011122223 4445
Q ss_pred eeecccccccCc----cccccccccccceeecccccccCc----CChhhhCCCCCcEEEccCCCCCCCCCccc----c-c
Q 001778 221 KLWMASTNLIGE----IPETIGDMLALEFLDLSINNFTGS----IPSSVFKLKNLSKVYLYSNSLSGEIPQAV----E-S 287 (1014)
Q Consensus 221 ~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~----~-~ 287 (1014)
+|++++|++++. ++..+..+.+|++|++++|.+++. ++..+..+++|+.|++++|.+++.....+ . .
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 555555554422 222344445566666666655531 22233344566666666666553322211 1 1
Q ss_pred cccceeeccccccCCCCCCcccc-----cccccccccccceecc----cCCcccCCCCCCCcccccCCccccc----CCc
Q 001778 288 LNLKVIDLSANNLTGAIPNDFGK-----LENLLNLSLMFNQLSG----EIPEGIGLLPSLKDVRLFNNMLSGA----LPP 354 (1014)
Q Consensus 288 ~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 354 (1014)
.+|++|++++|.+++.....+.. .+.|+.|++++|.++. .+...+..+++|+++++++|.+... ...
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 24666666666665432222222 2567777777777651 2333445557788888888887743 333
Q ss_pred cccCC-CCCceeecccccc
Q 001778 355 DFGRY-SPLEYFEVSVNNL 372 (1014)
Q Consensus 355 ~~~~l-~~L~~L~Ls~N~l 372 (1014)
.+... +.|++|++.+|.+
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 44444 6777888777753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=161.48 Aligned_cols=137 Identities=17% Similarity=0.238 Sum_probs=105.3
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-----CCCccceEEEEEEcCC---
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-----RHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpniv~l~~~~~~~~--- 760 (1014)
+...+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||++++|+++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 45567899999999996 5555554 699884422 23456799999999999 5799999999998863
Q ss_pred c-eEEEEEc--ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEeccCCCCCeeecC
Q 001778 761 L-KLLVYEY--MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL-CYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 761 ~-~~lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~s~~ivH~Dlk~~NIll~~ 836 (1014)
. +.+|+|| +++|+|.+++.+.. +++. ..++.+++.++ +|||+. +|+||||||+||+++.
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~~------------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~ 140 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQCR------------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQR 140 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHccc------------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEec
Confidence 3 3378999 56899999996531 3433 35677888777 999966 9999999999999974
Q ss_pred ----CCcEEEeecccc
Q 001778 837 ----NFNAKIADFGVA 848 (1014)
Q Consensus 837 ----~~~~kl~Dfgla 848 (1014)
++.++|+||+-+
T Consensus 141 ~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 141 ISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCCcEEEEECCCC
Confidence 347999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=160.04 Aligned_cols=144 Identities=17% Similarity=0.146 Sum_probs=109.4
Q ss_pred CCCCceeccCCcEEEEEee-ecCCCeEEEEEEecccchh-------------------h--HHhHHHHHHHHHHHHcCCC
Q 001778 689 LTESNVIGSGGSGKVYRVP-INHTAEVVAVKKIWNDRKL-------------------D--QKHEKEFLAEVQILSTIRH 746 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~-------------------~--~~~~~~~~~Ei~~l~~l~h 746 (1014)
|++.+.||+|++|.||+|. +..+|+.||+|++...... . ......+.+|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5677889999999999998 6678999999998643210 0 0112346789999999975
Q ss_pred C--ccceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eE
Q 001778 747 L--NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPT-IV 823 (1014)
Q Consensus 747 p--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~-iv 823 (1014)
. .+.+.+++ . ..++||||++++++....... ..........++.|++.++++||.. + |+
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---g~ii 171 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-----------VEPEEEEEFELYDDILEEMRKLYKE---GELV 171 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCccccccccc-----------CCcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence 3 34445543 2 358999999998887654222 1244556778999999999999966 8 99
Q ss_pred eccCCCCCeeecCCCcEEEeeccccccc
Q 001778 824 HRDLKSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 824 H~Dlk~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
|||+||+||+++ ++.++++|||.|...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=158.55 Aligned_cols=137 Identities=19% Similarity=0.298 Sum_probs=113.2
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchh-----hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-----DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
+.||+|++|.||+|.+ .+..|++|+....... .......+.+|+.++..++|+++.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999976 5667899986432221 12234568899999999999998877777777778899999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++|++|.+++... .+ .+..++.+++.++.++|.. +++|||++|.||+++ ++.++++|||.
T Consensus 80 ~~~G~~L~~~~~~~--------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 80 YIEGEPLKDLINSN--------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EeCCcCHHHHHHhc--------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 99999999998653 12 7889999999999999965 999999999999999 78999999999
Q ss_pred ccc
Q 001778 848 AKI 850 (1014)
Q Consensus 848 a~~ 850 (1014)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.6e-16 Score=183.03 Aligned_cols=151 Identities=30% Similarity=0.435 Sum_probs=125.1
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCC---CCCCCceEeCC------CceeEEeeccccCCccCCCCCCCCCCcc
Q 001778 28 QLYDREHAVLLKLKQHWQNPPPISHWATTNSS---HCTWPEIACTD------GSVTELHLTNMNMNGTFPPFICDLRNLT 98 (1014)
Q Consensus 28 ~~~~~~~~~ll~~k~~~~~~~~~~~w~~~~~~---~c~w~gv~c~~------~~v~~L~l~~~~l~~~~~~~l~~l~~L~ 98 (1014)
...+.|..||+++|+++.++.. .+|... .| +|.|.||.|+. ..|+.|+|+++++.|.+|+.++++++|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~-~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR-FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc-CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 4566799999999999976543 479643 21 13799999952 1488999999999999999999999999
Q ss_pred EEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhccc-CccceEecccc
Q 001778 99 ILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRL-TELRQLNLVVN 177 (1014)
Q Consensus 99 ~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N 177 (1014)
.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.+|
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999888764 46777888877
Q ss_pred ccC
Q 001778 178 QFN 180 (1014)
Q Consensus 178 ~l~ 180 (1014)
...
T Consensus 526 ~~l 528 (623)
T PLN03150 526 AGL 528 (623)
T ss_pred ccc
Confidence 643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=171.25 Aligned_cols=179 Identities=31% Similarity=0.408 Sum_probs=133.8
Q ss_pred CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCc
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~ 839 (1014)
...|+.|++|...+|.+|+.... ....-+|.....++.|++.|+.| . +.+|+|+||.||++..+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~--------~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR--------TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC--------cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence 35689999999999999997543 23446888999999999999999 3 8999999999999999999
Q ss_pred EEEeeccccccccccc---CccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhc-CCCCCCCCCchhHHHH
Q 001778 840 AKIADFGVAKILIKEE---GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQW 915 (1014)
Q Consensus 840 ~kl~Dfgla~~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ellt-g~~p~~~~~~~~~~~~ 915 (1014)
+||.|||+........ ..........||..||+||.+.+..|+.++||||+|++++|++. -..++...
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------- 466 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------- 466 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------
Confidence 9999999998765432 12335667899999999999999999999999999999999997 22222100
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
..+.++.+..+. +.+..+...=..+..+++.+.|.+||++.++..
T Consensus 467 --------~t~~d~r~g~ip-~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 467 --------ATLTDIRDGIIP-PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred --------HhhhhhhcCCCC-hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhh
Confidence 001112222222 112222223346788899999999997666654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-14 Score=170.81 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=111.4
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccch-----hhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCC
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK-----LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 760 (1014)
...|...+.||+|+||+||+|.+.... +++|+...+.. ......+.+.+|+++++.++|++++....++..+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344567889999999999999775443 44443321111 11223467889999999999999998887777777
Q ss_pred ceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 761 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..++||||+++++|.+++. ....++.++++++.+||+. +++|||+||+||++ .++.+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence 7899999999999998874 2357899999999999965 99999999999999 57799
Q ss_pred EEeecccccc
Q 001778 841 KIADFGVAKI 850 (1014)
Q Consensus 841 kl~Dfgla~~ 850 (1014)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.4e-15 Score=151.69 Aligned_cols=133 Identities=21% Similarity=0.289 Sum_probs=105.6
Q ss_pred eeccCCcEEEEEeeecCCCeEEEEEEecccchh-----hHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEc
Q 001778 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL-----DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 768 (1014)
.||+|+||.||+|.+ .+..|++|........ .......+.+|+.++..++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999974 4677999986432211 122346788999999999888765544455556667899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+++++|.+++.... . .++.+++.++.++|.. +++|||++|.||+++ ++.++++|||++
T Consensus 79 ~~g~~l~~~~~~~~--------------~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--------------D----ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred ECCccHHHHHhhcH--------------H----HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 99999998875420 0 7899999999999965 999999999999999 789999999998
Q ss_pred cc
Q 001778 849 KI 850 (1014)
Q Consensus 849 ~~ 850 (1014)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.3e-15 Score=150.00 Aligned_cols=139 Identities=20% Similarity=0.117 Sum_probs=106.6
Q ss_pred CCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhh-------------------HHhHHHHHHHHHHHHcCCCC--
Q 001778 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD-------------------QKHEKEFLAEVQILSTIRHL-- 747 (1014)
Q Consensus 689 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~Ei~~l~~l~hp-- 747 (1014)
|...+.||+|+||.||++.+. +++.||||++....... ......+..|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 666788999999999999875 68999999875422100 01123467889999988777
Q ss_pred ccceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC
Q 001778 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL 827 (1014)
Q Consensus 748 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl 827 (1014)
.+...++. ...++||||+++++|.+.... .....++.+++.++.++|+. +|+||||
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-----------------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 44444442 345899999999998765321 23457888999999999965 9999999
Q ss_pred CCCCeeecCCCcEEEeecccccccc
Q 001778 828 KSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 828 k~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
||+||++++++.++|+|||.+....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-14 Score=173.56 Aligned_cols=93 Identities=33% Similarity=0.574 Sum_probs=65.9
Q ss_pred ceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceeccccccccccCcccccccccceeecCC
Q 001778 480 LVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSE 559 (1014)
Q Consensus 480 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 559 (1014)
++.|+|++|.+.|.+|..++.+++|+.|+|++|.|+|.+|..+..+++|+.|+|++|+|+|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CccccCCchhhhh
Q 001778 560 NQFSGKIPPQIGR 572 (1014)
Q Consensus 560 N~l~g~ip~~~~~ 572 (1014)
|+++|.+|..++.
T Consensus 500 N~l~g~iP~~l~~ 512 (623)
T PLN03150 500 NSLSGRVPAALGG 512 (623)
T ss_pred CcccccCChHHhh
Confidence 7777777766554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.8e-15 Score=176.02 Aligned_cols=265 Identities=22% Similarity=0.213 Sum_probs=195.5
Q ss_pred CCCCCCceeccCCcEEEEEeeecCC-CeEEEEEEecccchhhHHhHHHHHHHHHHHHcCC-CCccceEEEEEEcCCceEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~l 764 (1014)
..|...+.||+|+|+.|-....... ...+|+|.+.... ........+..|..+-..+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4577778899999999988765333 4457777663322 33445566667887777775 9999999999999999999
Q ss_pred EEEcccCCCHHHHh-hhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEeccCCCCCeeecCCC-cEE
Q 001778 765 VYEYMEKRSLDQWL-HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH-HDCSPTIVHRDLKSSNILLDYNF-NAK 841 (1014)
Q Consensus 765 V~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~s~~ivH~Dlk~~NIll~~~~-~~k 841 (1014)
+.+|..++++.+.+ +... ...+......++.|+..++.|+| +. ++.|+|+||+|.+++..+ ..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~----------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS----------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred ccCcccccccccccccCCc----------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 99999999999887 3321 12344556678999999999999 66 999999999999999999 999
Q ss_pred EeecccccccccccCcccccccccc-CcccccccccccC-CCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVG-SCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 842 l~Dfgla~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
++|||+|..+....+.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+........... .
T Consensus 166 ~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---~ 242 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---S 242 (601)
T ss_pred CCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---e
Confidence 9999999988763444445556778 9999999999885 456789999999999999999999975543221100 0
Q ss_pred HhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 979 (1014)
+.+.. .......+........++..+++..+|..|.+.+++ +.++|+..
T Consensus 243 ~~~~~-------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~----~~d~~~~~ 291 (601)
T KOG0590|consen 243 WKSNK-------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL----KLDNWLSS 291 (601)
T ss_pred ecccc-------cccccCccccCChhhhhcccccccCCchhccccccc----cccccccc
Confidence 00000 000111222333345677778999999999995554 55999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.2e-14 Score=141.49 Aligned_cols=139 Identities=23% Similarity=0.216 Sum_probs=97.1
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHH---------------------HHHHHHHHHHcCCCC--c
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK---------------------EFLAEVQILSTIRHL--N 748 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~hp--n 748 (1014)
.+.||+|+||.||+|.+. +++.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7889999998543221111111 113566666666433 2
Q ss_pred cceEEEEEEcCCceEEEEEcccCCCHHHH-hhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC
Q 001778 749 IVKLLCCISSENLKLLVYEYMEKRSLDQW-LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL 827 (1014)
Q Consensus 749 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl 827 (1014)
+.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|.. .+|+|+|+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl 141 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------------LL-EDPEELYDQILELMRKLYRE--AGLVHGDL 141 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh------------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCC
Confidence 4444443 235899999998654221 11110 01 55778999999999999961 49999999
Q ss_pred CCCCeeecCCCcEEEeeccccccc
Q 001778 828 KSSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 828 k~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
||+||+++ ++.++++|||.+...
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccc
Confidence 99999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.9e-13 Score=132.71 Aligned_cols=135 Identities=26% Similarity=0.276 Sum_probs=112.0
Q ss_pred CCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC--CccceEEEEEEcCCceEEEEEc
Q 001778 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH--LNIVKLLCCISSENLKLLVYEY 768 (1014)
Q Consensus 691 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~ 768 (1014)
+.+.||+|.++.||++.... ..+++|....... ...+.+|+..++.++| .++.+++++...++..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35679999999999997644 6799998843221 5678899999999976 5899999998888889999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 769 MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 769 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
++++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+
T Consensus 75 ~~g~~~~~~------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 75 IEGETLDEV------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred cCCeecccC------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 988666432 34566788999999999999764468999999999999999899999999988
Q ss_pred cc
Q 001778 849 KI 850 (1014)
Q Consensus 849 ~~ 850 (1014)
..
T Consensus 137 ~~ 138 (155)
T cd05120 137 GY 138 (155)
T ss_pred cC
Confidence 64
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.1e-15 Score=162.42 Aligned_cols=194 Identities=27% Similarity=0.424 Sum_probs=149.0
Q ss_pred CCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCccccccccccccc
Q 001778 359 YSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVL 438 (1014)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~ 438 (1014)
++.-...||+.|++. .+|..+|.+..|+.+.|..|.+. .+|..+.++..|++|||+.|+++ .+|..++.+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l------- 143 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL------- 143 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-------
Confidence 444556677777777 67777777777777777777776 67777777777777777777777 455554443
Q ss_pred ccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCC
Q 001778 439 ISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSL 518 (1014)
Q Consensus 439 l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 518 (1014)
-|+.|-+++|+++ .+|..++....|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+
T Consensus 144 ----------------pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 144 ----------------PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred ----------------cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 3777888888888 77888888888888888888887 67888888999999999999887 67
Q ss_pred cccccccccccceeccccccccccCcccccccccceeecCCCccccCCchhhhhh----cccccccCCCc
Q 001778 519 PLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL----MLTSLNLSSNR 584 (1014)
Q Consensus 519 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~----~l~~l~ls~N~ 584 (1014)
|+++.. -.|..||+|+|+++ .||..|.+|..|++|-|.+|.|. ..|+.+... ..++|+..-+.
T Consensus 205 p~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 205 PEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred CHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 888774 56888999999998 78999999999999999999987 667776543 25666666553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.3e-15 Score=158.75 Aligned_cols=214 Identities=30% Similarity=0.395 Sum_probs=179.1
Q ss_pred EEeeccccCCccCCCCC-CCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeecCc
Q 001778 75 ELHLTNMNMNGTFPPFI-CDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTAN 153 (1014)
Q Consensus 75 ~L~l~~~~l~~~~~~~l-~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 153 (1014)
+|.|++..+....-+.. -.|+.-...||+.|++ ..+|..+..+..|+.|.|++|.+. .+|..+.+|..|++|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~-~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRF-SELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhcccccc-ccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 35556655553221211 4677778899999999 468889999999999999999998 89999999999999999999
Q ss_pred cCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCcc
Q 001778 154 NMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEI 233 (1014)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 233 (1014)
+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..|+.+.|. +..+|..++.+.+|+.|.+..|++. .+
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne---i~slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE---IQSLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhh---hhhchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 999 8899999988 999999999998 899999999999999999997 5678999999999999999999987 45
Q ss_pred ccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCcccccc---ccceeeccccc
Q 001778 234 PETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL---NLKVIDLSANN 299 (1014)
Q Consensus 234 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~---~L~~L~Ls~N~ 299 (1014)
|+.++.| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|.+...+...+..- -.++|+..-++
T Consensus 205 p~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 205 PEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred CHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhcc
Confidence 6667744 6999999999999 899999999999999999999985444433221 24677766664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.1e-13 Score=139.09 Aligned_cols=138 Identities=20% Similarity=0.264 Sum_probs=103.7
Q ss_pred Cceec-cCCcEEEEEeeecCCCeEEEEEEecccch----------hhHHhHHHHHHHHHHHHcCCCCcc--ceEEEEEEc
Q 001778 692 SNVIG-SGGSGKVYRVPINHTAEVVAVKKIWNDRK----------LDQKHEKEFLAEVQILSTIRHLNI--VKLLCCISS 758 (1014)
Q Consensus 692 ~~~LG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~hpni--v~l~~~~~~ 758 (1014)
..+|| .|+.|+||.+... +..++||.+..... ........+.+|+.++..++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45687 8999999988653 67789998743211 112334668899999999988774 667766443
Q ss_pred C-Cc---eEEEEEcccC-CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 001778 759 E-NL---KLLVYEYMEK-RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 759 ~-~~---~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIl 833 (1014)
. .. .++|+||+++ .+|.+++... .++. ..+.+++.++.+||+. ||+||||||+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------------~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NIL 174 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------------PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNIL 174 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------------CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEE
Confidence 2 22 2599999997 6999887542 1333 2356899999999966 9999999999999
Q ss_pred ecCCCcEEEeecccccc
Q 001778 834 LDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~ 850 (1014)
++.++.++|+|||.+..
T Consensus 175 v~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 175 LDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EcCCCCEEEEECCCccc
Confidence 99988999999998875
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.3e-13 Score=153.81 Aligned_cols=214 Identities=33% Similarity=0.427 Sum_probs=134.9
Q ss_pred CCCCceEeCCCcee---EEeeccccCCccCCCCCCCCCCccEEECccCCCCCCCCccccCCC-CcceecccccccCCCCC
Q 001778 61 CTWPEIACTDGSVT---ELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCS-KLEYLDLSQNYFIGPIP 136 (1014)
Q Consensus 61 c~w~gv~c~~~~v~---~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 136 (1014)
+.+.+..+....+. .+++..+.+...+ ..+..++.++.|++.+|+++. +|.....++ +|+.|++++|++. .+|
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~ 156 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLP 156 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCc-hhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhh
Confidence 45555555544444 4666666654332 334555777778887777754 444556664 7778888888777 566
Q ss_pred cccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccc
Q 001778 137 EDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQL 216 (1014)
Q Consensus 137 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l 216 (1014)
..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..++.+..|++|.+++|+ ....+..+.++
T Consensus 157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~---~~~~~~~~~~~ 231 (394)
T COG4886 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS---IIELLSSLSNL 231 (394)
T ss_pred hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc---ceecchhhhhc
Confidence 66777777888888888777 66666667777777788877777 666666666667777777774 23344556666
Q ss_pred cccceeecccccccCccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccc
Q 001778 217 KKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV 285 (1014)
Q Consensus 217 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 285 (1014)
.++..|.+.+|.+... +..++.+++++.|++++|+++ .++. ++.+.+++.|++++|.+...++...
T Consensus 232 ~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 232 KNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccccccCCceeeec-cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 6666666555544322 455566666666666666666 3333 5556666666666666655554443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=146.67 Aligned_cols=264 Identities=21% Similarity=0.229 Sum_probs=189.3
Q ss_pred CCCCCceecc--CCcEEEEEeee--cCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCce
Q 001778 688 KLTESNVIGS--GGSGKVYRVPI--NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 688 ~~~~~~~LG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 762 (1014)
.+...+.+|. |.+|.||.+.. ..++..+|+|.-+.. .........=.+|+...+++ .|++.++.+..++.++..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 3556677999 99999999988 888899999974221 22223334445677777777 499999999999999999
Q ss_pred EEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEeccCCCCCeeecCC-
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ----GLCYMHHDCSPTIVHRDLKSSNILLDYN- 837 (1014)
Q Consensus 763 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~s~~ivH~Dlk~~NIll~~~- 837 (1014)
++-+|++. .++.++.+... ..++....+.+..+..+ |+.++| +.+++|-|+||.||+...+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~----------~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC----------NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred eeeecccc-chhHHhhhccc----------ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccc
Confidence 99999985 68988887642 22555666677777777 999999 5599999999999999999
Q ss_pred CcEEEeeccccccccccc-Cccccccc-cccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHH
Q 001778 838 FNAKIADFGVAKILIKEE-GEFAAMST-VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915 (1014)
Q Consensus 838 ~~~kl~Dfgla~~~~~~~-~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~ 915 (1014)
..++++|||+...+.... ........ ..|...|++||...+ .++...|+|++|.+..+..++..++...... .
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---~- 334 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS---S- 334 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC---C-
Confidence 889999999998886644 11112122 378899999998775 6789999999999999999988776543110 0
Q ss_pred HHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 001778 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGR 985 (1014)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~ 985 (1014)
|....... +...+...-..++...+..|++.||-.|++.+++.. ++++......+.
T Consensus 335 -W~~~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~----l~~i~s~~~~~~ 390 (524)
T KOG0601|consen 335 -WSQLRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA----LNVIHSKLFVHL 390 (524)
T ss_pred -cccccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc----cccccchhhhcc
Confidence 11111111 111111111223334777899999999999777666 888875444433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.2e-12 Score=147.95 Aligned_cols=200 Identities=34% Similarity=0.452 Sum_probs=99.3
Q ss_pred EEEccCCCCCCCCCccccccccceeeccccccCCCCCCcccccc-cccccccccceecccCCcccCCCCCCCcccccCCc
Q 001778 269 KVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLE-NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNM 347 (1014)
Q Consensus 269 ~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 347 (1014)
.+.+..|.+...+........++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 355555555333333333334555555555555 3444444443 6666666666665 444555666666666666666
Q ss_pred ccccCCccccCCCCCceeeccccccccCCChhhhcCCCccEEEccccccCCCCCcccccCCcccEEEeecceeecCCCcc
Q 001778 348 LSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAG 427 (1014)
Q Consensus 348 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 427 (1014)
++ .+|...+.++.|+.|++++|++. .+|........|+.|.+++|.+. ..+..+.++.++..+
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l-------------- 237 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGL-------------- 237 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccccc--------------
Confidence 65 44444445555666666666655 33333322333344444433211 122223333333333
Q ss_pred cccccccccccccCCcccCCCCCcCCCCCceeccccccccCcCCCcccCCCcceEEEccCCcccccccccccccccccee
Q 001778 428 LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTL 507 (1014)
Q Consensus 428 ~~~~~~L~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 507 (1014)
.+++|++. ..+..+..+.+++.|++++|+++...+ ++.+.+++.|
T Consensus 238 --------------------------------~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L 282 (394)
T COG4886 238 --------------------------------ELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLREL 282 (394)
T ss_pred --------------------------------ccCCceee-eccchhccccccceecccccccccccc--ccccCccCEE
Confidence 33333333 124445555556666666666653322 6666666666
Q ss_pred cccccccCCCCcccc
Q 001778 508 LLDQNQLSGSLPLDI 522 (1014)
Q Consensus 508 ~Ls~N~l~~~~p~~~ 522 (1014)
|+++|.++..+|...
T Consensus 283 ~~s~n~~~~~~~~~~ 297 (394)
T COG4886 283 DLSGNSLSNALPLIA 297 (394)
T ss_pred eccCccccccchhhh
Confidence 666666665544443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.3e-12 Score=128.20 Aligned_cols=207 Identities=23% Similarity=0.315 Sum_probs=142.9
Q ss_pred HHcCCCCccceEEEEEEcC-----CceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHh
Q 001778 741 LSTIRHLNIVKLLCCISSE-----NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH 815 (1014)
Q Consensus 741 l~~l~hpniv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 815 (1014)
+-++.|-|+|+++.|+.+. .+..+++|||+.|++.+++++... ....+......+++.||..||.|||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-------~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-------NQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-------hhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 4445699999999887653 456899999999999999997532 3445777888899999999999999
Q ss_pred hcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccC-ccccccccccCcccccccccccCCCCCcCcchhHHHHH
Q 001778 816 HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG-EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894 (1014)
Q Consensus 816 ~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll 894 (1014)
.. .+.|+|+++.-+-|++..++-+|++--.-......... .........+-++|.|||+-.....+-++|||+||+..
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 76 89999999999999999998888843211111111000 00112234567899999988877778899999999999
Q ss_pred HHHhcCCCCC-CCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhc
Q 001778 895 LELTTGKEAN-NGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 895 ~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 973 (1014)
.||.-+..-- .+.........+...+ ..+..+ .-..++..|++..|..||+|.+.+.
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~~i-----------~~len~-------lqr~~i~kcl~~eP~~rp~ar~llf---- 330 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIANVI-----------IGLENG-------LQRGSITKCLEGEPNGRPDARLLLF---- 330 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhhhe-----------eeccCc-------cccCcCcccccCCCCCCcchhhhhc----
Confidence 9999887542 2222111111111100 001110 0124667899999999999998876
Q ss_pred CCCC
Q 001778 974 NPIF 977 (1014)
Q Consensus 974 ~~~~ 977 (1014)
||..
T Consensus 331 Hpll 334 (458)
T KOG1266|consen 331 HPLL 334 (458)
T ss_pred Ccee
Confidence 6543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=130.77 Aligned_cols=170 Identities=17% Similarity=0.179 Sum_probs=128.5
Q ss_pred EeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCC
Q 001778 705 RVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS 784 (1014)
Q Consensus 705 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 784 (1014)
.|..+.++..|.|+...... ......+.+-++-++.++||+|+++++.++.++..|+|+|-+. -|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 35556778888888873321 2445667788888999999999999999999999999999875 477777663
Q ss_pred CCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCcccccccc
Q 001778 785 SLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864 (1014)
Q Consensus 785 ~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 864 (1014)
......-.+.||+.||.|||+.+ +++|+++....|+|+..|..||++|.++........ .....
T Consensus 102 -----------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~ 165 (690)
T KOG1243|consen 102 -----------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSL 165 (690)
T ss_pred -----------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccc
Confidence 34455667899999999999754 999999999999999999999999998865432111 11122
Q ss_pred ccCcccccccccccCCCCCcCcchhHHHHHHHHhcC
Q 001778 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900 (1014)
Q Consensus 865 ~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg 900 (1014)
.--..|..|+.+.... -..|.|.||+++||++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 2334566666544322 356999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=133.56 Aligned_cols=145 Identities=19% Similarity=0.188 Sum_probs=97.6
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhH-------------------------------------HhHHHH
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ-------------------------------------KHEKEF 734 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~~ 734 (1014)
.+.||.|++|.||+|... +|+.||||+.+......- ..+-++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999875 688999999854311100 001134
Q ss_pred HHHHHHHHcC----CCCccceEEEEE-EcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHH
Q 001778 735 LAEVQILSTI----RHLNIVKLLCCI-SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809 (1014)
Q Consensus 735 ~~Ei~~l~~l----~hpniv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 809 (1014)
.+|...+.++ +|.+-+.+-..+ +.....++||||++|+++.++...... .. .+.+++..++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----------~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----------GL---DRKALAENLAR 267 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----------CC---CHHHHHHHHHH
Confidence 5565555554 233223332222 224457999999999999887654210 01 23456666555
Q ss_pred -HHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccccccc
Q 001778 810 -GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK 853 (1014)
Q Consensus 810 -~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 853 (1014)
.+..+|.. |++|+|++|.||+++.++.++++|||++..+.+
T Consensus 268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 36777855 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=143.91 Aligned_cols=274 Identities=20% Similarity=0.185 Sum_probs=187.3
Q ss_pred CCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEE
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 766 (1014)
+.+.+.+-+..|.++.++-+.-...+...+.|.............+....+-.+.-..++|.+++....+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34556667889999999988777777666766653333322333344444444444456677777666666677789999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecc
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfg 846 (1014)
+|..++++...++..+. ....-.......+.++.+|||.. .+.|+|++|.|.+...++..++.|||
T Consensus 884 ~~~~~~~~~Skl~~~~~-----------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC-----------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred HHhccCCchhhhhcCCC-----------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 99999999999987642 22222334455677899999953 68999999999999999999999998
Q ss_pred cccccccc---------------------c-------CccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHh
Q 001778 847 VAKILIKE---------------------E-------GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELT 898 (1014)
Q Consensus 847 la~~~~~~---------------------~-------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~ell 898 (1014)
......-. . ..........||+.|.|||...+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 44322100 0 0011234567999999999999999999999999999999999
Q ss_pred cCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 001778 899 TGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 899 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 978 (1014)
+|.+||.....+...+. +..... +... .......+..+++...+..+|.+|..+.... ....|+||+
T Consensus 1030 ~g~pp~na~tpq~~f~n---i~~~~~-------~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~-e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFEN---ILNRDI-------PWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKGAA-EVKGHPFFQ 1096 (1205)
T ss_pred cCCCCCCCcchhhhhhc---cccCCC-------CCCC--CccccChhhhhhhhhhhccCchhccCccccc-ccccCCccC
Confidence 99999987765433221 111111 1111 1122233455677788899999999987332 355699999
Q ss_pred CCCCCCCcc
Q 001778 979 TEKNGGRKY 987 (1014)
Q Consensus 979 ~~~~~~~~~ 987 (1014)
...+..-+.
T Consensus 1097 ~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1097 DVDWENLAL 1105 (1205)
T ss_pred CCCcccccc
Confidence 887764433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.6e-11 Score=136.91 Aligned_cols=150 Identities=17% Similarity=0.152 Sum_probs=95.0
Q ss_pred CCCCCCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhh-------------------------------HHhHHH-
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD-------------------------------QKHEKE- 733 (1014)
Q Consensus 686 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~~- 733 (1014)
...|.. +.||.|++|.||+|..+.+|+.||||+.++..... ....+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 344555 68999999999999998889999999996431100 011122
Q ss_pred -----HHHHHHHHHcC----CCCccceEEEEEEc-CCceEEEEEcccCCCHHHHhh--hcCCCCCCCCcccccCCHHHHH
Q 001778 734 -----FLAEVQILSTI----RHLNIVKLLCCISS-ENLKLLVYEYMEKRSLDQWLH--KKNRSSLSGRARDEVLSWRRRM 801 (1014)
Q Consensus 734 -----~~~Ei~~l~~l----~hpniv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~l~~~~~~ 801 (1014)
+.+|..-+.++ .+...+.+-..+.+ ....++||||++|+.+.++-. ..+. ....+......
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-------d~~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-------DMKLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-------CHHHHHHHHHH
Confidence 33444434333 23333443333322 455689999999999987532 2110 01112222233
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC----cEEEeeccccccccc
Q 001778 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF----NAKIADFGVAKILIK 853 (1014)
Q Consensus 802 ~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 853 (1014)
.++.|+. ..|++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 271 ~~~~Qif----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3333333 23999999999999999888 999999999987754
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=142.27 Aligned_cols=180 Identities=27% Similarity=0.322 Sum_probs=100.9
Q ss_pred CccEEECccCC--CCCCCCccccCCCCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhcccCccceEe
Q 001778 96 NLTILDLQFNY--IISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLN 173 (1014)
Q Consensus 96 ~L~~L~L~~n~--i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (1014)
.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|..++.|-+|++|+|++..++ .+|..+++|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 56777777765 44444445666777777777776655577777777777777777777777 6777777777777777
Q ss_pred ccccccCCCCcccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCccccccccccccc----eeecc
Q 001778 174 LVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALE----FLDLS 249 (1014)
Q Consensus 174 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~----~L~L~ 249 (1014)
+..+.-...+|..+..+++|++|.+...........-..+.++..|+.+....... .+-..+..++.|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 77766554556666667777777765543111111112223333333333322111 1112222333332 33333
Q ss_pred cccccCcCChhhhCCCCCcEEEccCCCCCC
Q 001778 250 INNFTGSIPSSVFKLKNLSKVYLYSNSLSG 279 (1014)
Q Consensus 250 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 279 (1014)
++... ..+..+..+.+|+.|.+.++.+..
T Consensus 703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 703 GCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred ccccc-eeecccccccCcceEEEEcCCCch
Confidence 33333 345556667777777777777654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.3e-10 Score=111.77 Aligned_cols=131 Identities=21% Similarity=0.134 Sum_probs=93.8
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccc-eEEEEEEcCCceEEEEEccc
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV-KLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv-~l~~~~~~~~~~~lV~e~~~ 770 (1014)
.+.++.|.++.||++... ++.|++|...... .....+.+|+.+++.+.+..++ +++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356889999999998754 7789999874321 1233467888888888654444 4554433 33589999999
Q ss_pred CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeccCCCCCeeecCCCcEEEeecccc
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDC--SPTIVHRDLKSSNILLDYNFNAKIADFGVA 848 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla 848 (1014)
+.++.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+
T Consensus 75 G~~l~~~--~-----------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 75 GSELLTE--D-----------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred CCccccc--c-----------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 9876542 0 011245678999999999652 22369999999999999 668999999988
Q ss_pred cc
Q 001778 849 KI 850 (1014)
Q Consensus 849 ~~ 850 (1014)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 63
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-09 Score=105.88 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=97.2
Q ss_pred ceeccCCcEEEEEeeecC------CCeEEEEEEecccch-------h---h---------HHhHHH----HHHHHHHHHc
Q 001778 693 NVIGSGGSGKVYRVPINH------TAEVVAVKKIWNDRK-------L---D---------QKHEKE----FLAEVQILST 743 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~-------~---~---------~~~~~~----~~~Ei~~l~~ 743 (1014)
..||.|--+.||.|.... .+..+|||+.+.... + + ....+. ..+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999996543 347899998742100 0 0 011222 3489999998
Q ss_pred CCC--CccceEEEEEEcCCceEEEEEcccCCCHHH-HhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHH-hhcCC
Q 001778 744 IRH--LNIVKLLCCISSENLKLLVYEYMEKRSLDQ-WLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM-HHDCS 819 (1014)
Q Consensus 744 l~h--pniv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~s 819 (1014)
+.. -++.+.+++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|..+ |+.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------------~~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------------AKLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------------cccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 843 456666654 34689999997654321 1221 1234455667889999999999 654
Q ss_pred CCeEeccCCCCCeeecCCCcEEEeecccccccc
Q 001778 820 PTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852 (1014)
Q Consensus 820 ~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 852 (1014)
++||||+++.||++++ +.++++|||.|....
T Consensus 145 -glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 -NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred -CeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999999999974 689999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-11 Score=137.12 Aligned_cols=130 Identities=28% Similarity=0.346 Sum_probs=65.1
Q ss_pred cCCCCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhh
Q 001778 116 YNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEA 195 (1014)
Q Consensus 116 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 195 (1014)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|.|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 34455555556666655 23334555666666666666666 3333355566666666666666532 22344455666
Q ss_pred hhcccccCCCCCCCCcccccccccceeecccccccCccc-cccccccccceeeccccccc
Q 001778 196 LELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFT 254 (1014)
Q Consensus 196 L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 254 (1014)
|++++|.+..+.. +..++.|+.+++++|.+...-+ . ...+.+++.+++.+|.+.
T Consensus 145 L~l~~N~i~~~~~----~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 145 LNLSGNLISDISG----LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred heeccCcchhccC----CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 6666665433322 2224444444444444433222 1 234445555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.7e-11 Score=120.06 Aligned_cols=107 Identities=31% Similarity=0.395 Sum_probs=64.8
Q ss_pred CCCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceec
Q 001778 454 GNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNL 533 (1014)
Q Consensus 454 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (1014)
+.++.|++|+|.|. .+.. +..+.+|+.||||+|.++ .+-++-..|.+.++|.|++|.+. --..+.+|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh--hhhhhHhhhhheeccc
Confidence 45666666666665 2222 555666777777777666 33444455666777777777664 2234556667777777
Q ss_pred ccccccccc-CcccccccccceeecCCCccccC
Q 001778 534 SRNQLSGEI-PEKIGFLPVLQDLDLSENQFSGK 565 (1014)
Q Consensus 534 s~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~ 565 (1014)
++|+|.... -..+|+||-|+.|.|-+|.+.+.
T Consensus 382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred cccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 777775321 23567777777777777766643
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.4e-11 Score=135.85 Aligned_cols=238 Identities=26% Similarity=0.283 Sum_probs=145.5
Q ss_pred CcceecccccccCCCCCcccccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcc
Q 001778 120 KLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELA 199 (1014)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 199 (1014)
.++.++..++.+.+.--. ...+..++.+++..|.+. .+-..+..+.+|+.|++.+|+|. .+...+..+++|++|+++
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecc
Confidence 344555555544321111 156778888889999988 34455788899999999999998 444447889999999999
Q ss_pred cccCCCCCCCCcccccccccceeecccccccCccccccccccccceeecccccccCcCChh-hhCCCCCcEEEccCCCCC
Q 001778 200 YNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSS-VFKLKNLSKVYLYSNSLS 278 (1014)
Q Consensus 200 ~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~ 278 (1014)
+|++.++. .+..++.|+.|++++|.+... +.+..+.+|+.+++++|.++..-+ . ...+.+++.+++.+|.+.
T Consensus 127 ~N~I~~i~----~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 127 FNKITKLE----GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR 199 (414)
T ss_pred cccccccc----chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh
Confidence 99876654 355566688888887777543 334456777788888887773322 2 456677777777777765
Q ss_pred CCCCccccccccceeeccccccCCCCCCcccccc--cccccccccceecccCCcccCCCCCCCcccccCCcccccCCccc
Q 001778 279 GEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLE--NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDF 356 (1014)
Q Consensus 279 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 356 (1014)
..... -....+..+++..|.++..-+ +..+. .|+.+++++|.+. .++..+..+.++..|++.+|++... ..+
T Consensus 200 ~i~~~-~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~ 273 (414)
T KOG0531|consen 200 EIEGL-DLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGL 273 (414)
T ss_pred cccch-HHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccc
Confidence 32211 111234444666666663322 11222 2666667777665 3334555566666666666666522 123
Q ss_pred cCCCCCceeeccccccc
Q 001778 357 GRYSPLEYFEVSVNNLT 373 (1014)
Q Consensus 357 ~~l~~L~~L~Ls~N~l~ 373 (1014)
.....+..+.++.|.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLA 290 (414)
T ss_pred cccchHHHhccCcchhc
Confidence 33444445555555544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.9e-10 Score=125.46 Aligned_cols=247 Identities=21% Similarity=0.195 Sum_probs=171.0
Q ss_pred ccCCCCCCCceeccCCcEEEEEeeec-CCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEEEcCCc
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPIN-HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENL 761 (1014)
Q Consensus 684 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 761 (1014)
....+|..+..||.|.|+.|+.+... .++..|++|...+... .......-..|+.+...+ .|.++++.+..+...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 44567888899999999999997765 5677899998754322 222223334566666665 58899988877777777
Q ss_pred eEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCC-CcE
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNA 840 (1014)
Q Consensus 762 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~-~~~ 840 (1014)
.|+--||+++++........ ..+....++++..|++.++.++| ++.++|+|+||+||++..+ +..
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~-----------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS-----------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred ccCchhhhcCcchhhhhHHH-----------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhh
Confidence 78999999999887766322 23666778899999999999999 4599999999999999886 788
Q ss_pred EEeecccccccccccCccccccccccCccc-ccccccccCCCCCcCcchhHHHHHHHHhcCCCCCCCCCchhHHHHHHHH
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGY-IAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
+++|||++..+.- .......++..| .+|+......+..+.|+||||.-+.+.+++...-.... +|
T Consensus 407 ~~~~~~~~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~---- 472 (524)
T KOG0601|consen 407 KLGDFGCWTRLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QS---- 472 (524)
T ss_pred hccccccccccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----cc----
Confidence 9999999864211 111122233334 35666677788899999999999999999875332211 11
Q ss_pred HhcCCcchhcccccc-CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 001778 920 IQEGKPIVDALDKEI-DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 969 (1014)
........ ..+... .++..+...+...||..||.+.+...
T Consensus 473 -------~~i~~~~~p~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 473 -------LTIRSGDTPNLPGLK---LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -------eeeecccccCCCchH---HhhhhhhhhhcCCccccchhhhhhcc
Confidence 11111101 111111 34445566788999999999877655
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=113.46 Aligned_cols=107 Identities=31% Similarity=0.325 Sum_probs=28.9
Q ss_pred CCCCCCccEEECccCCCCCCCCcccc-CCCCcceecccccccCCCCCcccccccccceeeecCccCCCCCchhh-cccCc
Q 001778 91 ICDLRNLTILDLQFNYIISQFPRVLY-NCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTE 168 (1014)
Q Consensus 91 l~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 168 (1014)
+.+...+++|+|++|.|+.+. .++ .+.+|+.|||++|.|+. +. .+..+++|+.|++++|+|+ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 445556777777777776532 344 46677777777777773 32 4666777777777777777 343333 35677
Q ss_pred cceEeccccccCCCC-cccccCccchhhhhccccc
Q 001778 169 LRQLNLVVNQFNGSI-PAEIGNLQNLEALELAYNT 202 (1014)
Q Consensus 169 L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~ 202 (1014)
|++|+|++|+|...- -..++.+++|+.|+|.+|.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP 124 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP 124 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence 777777777775321 1233444445555555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.4e-09 Score=99.95 Aligned_cols=134 Identities=23% Similarity=0.297 Sum_probs=102.4
Q ss_pred ceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHH-----hHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEEEE
Q 001778 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-----HEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYE 767 (1014)
Q Consensus 693 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 767 (1014)
..+++|+-+.||.+.+. |..+++|.-.++....+. ....-.+|..++.+++--.|..-+-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998664 444777765443333322 34556789999998865555554555666777889999
Q ss_pred cccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccc
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgl 847 (1014)
|++|..|.+.+... ...++..+..-+.-||.. ||+|+|+.++||++..+. +.++|||+
T Consensus 80 ~I~G~~lkd~l~~~------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 80 YIEGELLKDALEEA------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred EeCChhHHHHHHhc------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCc
Confidence 99998988888653 246778888889999966 999999999999998764 99999999
Q ss_pred ccc
Q 001778 848 AKI 850 (1014)
Q Consensus 848 a~~ 850 (1014)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 975
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.1e-10 Score=123.98 Aligned_cols=209 Identities=24% Similarity=0.220 Sum_probs=113.1
Q ss_pred CCCCCccEEECccCCCCCCCC-ccccCCCCcceecccccccCCC--CCcccccccccceeeecCccCCCCCchhh-cccC
Q 001778 92 CDLRNLTILDLQFNYIISQFP-RVLYNCSKLEYLDLSQNYFIGP--IPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLT 167 (1014)
Q Consensus 92 ~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~ 167 (1014)
.++.+|+...|++..+....- .....|++++.||||+|-|..- +-.....|++|+.|+|+.|++........ ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 456777778887776633221 3456678888888888877642 22345567788888888887764332222 2467
Q ss_pred ccceEeccccccCCCCc-ccccCccchhhhhcccccCCCCCCCCcccccccccceeecccccccCcc-ccccccccccce
Q 001778 168 ELRQLNLVVNQFNGSIP-AEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEI-PETIGDMLALEF 245 (1014)
Q Consensus 168 ~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~-p~~l~~l~~L~~ 245 (1014)
+|+.|.|+.|.|+..-- ..+...++|+.|+|..|.. +..-......+..|++|+|++|++...- -...+.++.|+.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~--~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEI--ILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccc--cceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 78888888887763222 2234566777777776631 1111122233344455555544443221 112344444444
Q ss_pred eecccccccCcCChhhhCCCCCcEEEccCCCCCCCC-Ccc------ccccccceeeccccccCCCC-CCccccccccccc
Q 001778 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEI-PQA------VESLNLKVIDLSANNLTGAI-PNDFGKLENLLNL 317 (1014)
Q Consensus 246 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~------~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L 317 (1014)
|+++.+.++ ..- |+. -...+|++|+++.|++...- -..+..+.+|+.|
T Consensus 276 Lnls~tgi~------------------------si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l 331 (505)
T KOG3207|consen 276 LNLSSTGIA------------------------SIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL 331 (505)
T ss_pred hhccccCcc------------------------hhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence 444444443 221 111 11125777777777765321 1234456677777
Q ss_pred ccccceecc
Q 001778 318 SLMFNQLSG 326 (1014)
Q Consensus 318 ~L~~N~l~~ 326 (1014)
.+..|.++.
T Consensus 332 ~~~~n~ln~ 340 (505)
T KOG3207|consen 332 RITLNYLNK 340 (505)
T ss_pred hcccccccc
Confidence 777777763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.8e-11 Score=126.57 Aligned_cols=220 Identities=24% Similarity=0.319 Sum_probs=109.0
Q ss_pred CceeEEeeccccCCc----cCCCCCCCCCCccEEECccC---CCCCCCCcc-------ccCCCCcceecccccccCCCCC
Q 001778 71 GSVTELHLTNMNMNG----TFPPFICDLRNLTILDLQFN---YIISQFPRV-------LYNCSKLEYLDLSQNYFIGPIP 136 (1014)
Q Consensus 71 ~~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~n---~i~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~p 136 (1014)
..++.|+|++|.+.- .+.+.+.+.++|+..++++= +....+|.. +..+++|++||||.|-|.-.-+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 367777777777643 34455666677777777652 222233332 3344567777777776664433
Q ss_pred cc----cccccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCC--CCC
Q 001778 137 ED----IDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPS--SLP 210 (1014)
Q Consensus 137 ~~----l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~--~lp 210 (1014)
.. +.+.+.|++|+|.+|.+.-.--..++. .|.+|. .|+ -.+.-+.|+.+..++|+..+.+ .+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A 178 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALA 178 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHH
Confidence 33 334456666666666655221111111 011111 000 0112233444444444433222 122
Q ss_pred cccccccccceeecccccccCc----cccccccccccceeecccccccCc----CChhhhCCCCCcEEEccCCCCCCCCC
Q 001778 211 SNFTQLKKLKKLWMASTNLIGE----IPETIGDMLALEFLDLSINNFTGS----IPSSVFKLKNLSKVYLYSNSLSGEIP 282 (1014)
Q Consensus 211 ~~~~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~ 282 (1014)
..|...+.|+++.+..|.+... +...+..+++|+.|||..|-++.. +...+..+++|+.|++++|.+.....
T Consensus 179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga 258 (382)
T KOG1909|consen 179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA 258 (382)
T ss_pred HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence 3344455555555555554321 234566677777777777776532 22344456667777777766654433
Q ss_pred ccccc------cccceeeccccccC
Q 001778 283 QAVES------LNLKVIDLSANNLT 301 (1014)
Q Consensus 283 ~~~~~------~~L~~L~Ls~N~l~ 301 (1014)
..+.. ++|++|.|.+|.++
T Consensus 259 ~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 259 IAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHHHHHHhccCCCCceeccCcchhH
Confidence 32211 14555555555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.1e-10 Score=112.20 Aligned_cols=127 Identities=27% Similarity=0.353 Sum_probs=42.9
Q ss_pred ccCCCCcceecccccccCCCCCcccc-cccccceeeecCccCCCCCchhhcccCccceEeccccccCCCCcccc-cCccc
Q 001778 115 LYNCSKLEYLDLSQNYFIGPIPEDID-RLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQN 192 (1014)
Q Consensus 115 ~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~ 192 (1014)
+.+..++++|+|++|.|+. + +.++ .+.+|+.|+|++|.|+. ++ .+..++.|++|++++|+|+. +.+.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4556678999999999883 3 3465 57889999999999984 43 47788999999999999984 44444 46788
Q ss_pred hhhhhcccccCCCCCCCCcccccccccceeecccccccCccccccccccccceeecccccccCcCC---hhhhCCCCCcE
Q 001778 193 LEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIP---SSVFKLKNLSK 269 (1014)
Q Consensus 193 L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~ 269 (1014)
|++|+|++|++.++..+ . .++.+++|+.|+|.+|.++..-- ..+..+++|+.
T Consensus 90 L~~L~L~~N~I~~l~~l-~------------------------~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~ 144 (175)
T PF14580_consen 90 LQELYLSNNKISDLNEL-E------------------------PLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKV 144 (175)
T ss_dssp --EEE-TTS---SCCCC-G------------------------GGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SE
T ss_pred CCEEECcCCcCCChHHh-H------------------------HHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhe
Confidence 88888888876554332 2 24445566666666666652211 13445666666
Q ss_pred EE
Q 001778 270 VY 271 (1014)
Q Consensus 270 L~ 271 (1014)
||
T Consensus 145 LD 146 (175)
T PF14580_consen 145 LD 146 (175)
T ss_dssp ET
T ss_pred eC
Confidence 65
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.7e-10 Score=137.73 Aligned_cols=266 Identities=25% Similarity=0.298 Sum_probs=166.8
Q ss_pred ceeEEeecccc--CCccCCCCCCCCCCccEEECccCCCCCCCCccccCCCCcceecccccccCCCCCcccccccccceee
Q 001778 72 SVTELHLTNMN--MNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLY 149 (1014)
Q Consensus 72 ~v~~L~l~~~~--l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (1014)
.+++|-+.++. +....++.|..++.|++|||++|.-.+.+|..+++|-+||+|+|++..++ .+|..+++|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 57788888876 44333445888999999999999888999999999999999999999999 8999999999999999
Q ss_pred ecCccCCCCCchhhcccCccceEeccccccC--CCCcccccCccchhhhhcccccCCCCCCCCcccccccccc----eee
Q 001778 150 LTANNMSGKIPASIGRLTELRQLNLVVNQFN--GSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLK----KLW 223 (1014)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~----~L~ 223 (1014)
+..+.-...+|..+..|++|++|.+..-... ...-..+.++.+|+.+..... +. .+-..+..++.|. .+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~---s~-~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS---SV-LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc---hh-HhHhhhhhhHHHHHHhHhhh
Confidence 9999876677888888999999999876532 222334445555555544322 11 1111222333333 222
Q ss_pred cccccccCccccccccccccceeecccccccCcCChhhhCC------CCCcEEEccCCCCCCCCCccccccccceeeccc
Q 001778 224 MASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKL------KNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSA 297 (1014)
Q Consensus 224 l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~ 297 (1014)
+.. ......+.+++.+.+|+.|.+.++.+........... +++..+...++..-..+......++|+.|++..
T Consensus 701 ~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~ 779 (889)
T KOG4658|consen 701 IEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVS 779 (889)
T ss_pred hcc-cccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEec
Confidence 222 2223445567888899999999988864333222211 122222222222111121222334777777777
Q ss_pred cccCCCCCCcccccccccccccccceeccc-CCcccCCCCCCCcccc
Q 001778 298 NNLTGAIPNDFGKLENLLNLSLMFNQLSGE-IPEGIGLLPSLKDVRL 343 (1014)
Q Consensus 298 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L 343 (1014)
+.....+......+..+..+-+..+.+.+. .-...++++++..+.+
T Consensus 780 ~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 780 CRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 766555555555555566555666666544 2333444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.9e-10 Score=122.14 Aligned_cols=207 Identities=21% Similarity=0.218 Sum_probs=100.3
Q ss_pred cccccceeeecCccCCCCCc--hhhcccCccceEeccccccCCCCc--ccccCccchhhhhcccccCCCCCCCCcccccc
Q 001778 141 RLSRLKFLYLTANNMSGKIP--ASIGRLTELRQLNLVVNQFNGSIP--AEIGNLQNLEALELAYNTEFSPSSLPSNFTQL 216 (1014)
Q Consensus 141 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l 216 (1014)
++++|+...|.+..+. ..+ .....+++++.|||+.|-+....| .-...|++|+.|+|+.|+......
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~-------- 189 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS-------- 189 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc--------
Confidence 3455555555555554 222 244555666666666665552211 223445555555555554322110
Q ss_pred cccceeecccccccCccccccccccccceeecccccccCcC-ChhhhCCCCCcEEEccCCCCCCCCCccccc-cccceee
Q 001778 217 KKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSI-PSSVFKLKNLSKVYLYSNSLSGEIPQAVES-LNLKVID 294 (1014)
Q Consensus 217 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~ 294 (1014)
++. -..++.|+.|.|+.|.++-.. -.....+++|+.|+|..|...........- ..|+.||
T Consensus 190 ----------s~~-------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 190 ----------SNT-------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred ----------ccc-------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 000 012344555555555554211 112233556666666666421111111111 1466666
Q ss_pred ccccccCCCC-CCcccccccccccccccceeccc-CCcc-----cCCCCCCCcccccCCcccccCC--ccccCCCCCcee
Q 001778 295 LSANNLTGAI-PNDFGKLENLLNLSLMFNQLSGE-IPEG-----IGLLPSLKDVRLFNNMLSGALP--PDFGRYSPLEYF 365 (1014)
Q Consensus 295 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L 365 (1014)
|++|++-... -...+.++.|+.|+++.+.+... .|+. ...+++|++|++..|++.. .+ ..+..+.+|+.|
T Consensus 253 Ls~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l 331 (505)
T KOG3207|consen 253 LSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHL 331 (505)
T ss_pred ccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhh
Confidence 6666655322 12445566777777777766531 2222 2456677777777777741 11 223445566666
Q ss_pred ecccccccc
Q 001778 366 EVSVNNLTG 374 (1014)
Q Consensus 366 ~Ls~N~l~~ 374 (1014)
.+..|.++.
T Consensus 332 ~~~~n~ln~ 340 (505)
T KOG3207|consen 332 RITLNYLNK 340 (505)
T ss_pred hcccccccc
Confidence 666676663
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.1e-11 Score=123.21 Aligned_cols=252 Identities=23% Similarity=0.226 Sum_probs=130.7
Q ss_pred CCCCCCCCccEEECccCCCCCC----CCccccCCCCcceecccccccCC----CCCcccccccccceeeecCccCCCCCc
Q 001778 89 PFICDLRNLTILDLQFNYIISQ----FPRVLYNCSKLEYLDLSQNYFIG----PIPEDIDRLSRLKFLYLTANNMSGKIP 160 (1014)
Q Consensus 89 ~~l~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p 160 (1014)
+.+.....++.++|++|.|... +.+.+.+.++|+..++|+=. +| .+|+.+..| -
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~f-tGR~~~Ei~e~L~~l-----------------~ 85 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMF-TGRLKDEIPEALKML-----------------S 85 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhh-cCCcHHHHHHHHHHH-----------------H
Confidence 4455667788888888887543 44455666777777776432 33 333322211 1
Q ss_pred hhhcccCccceEeccccccCCCCcc----cccCccchhhhhcccccCCCCCCCCcccccc-cccceeecccccccCcccc
Q 001778 161 ASIGRLTELRQLNLVVNQFNGSIPA----EIGNLQNLEALELAYNTEFSPSSLPSNFTQL-KKLKKLWMASTNLIGEIPE 235 (1014)
Q Consensus 161 ~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l-~~L~~L~l~~n~l~~~~p~ 235 (1014)
.++-..++|++||||+|-|.-.-+. .+..+.+|++|.|.+|.+... .=+.+ ..|.+|. .++
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~-----ag~~l~~al~~l~--~~k------- 151 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPE-----AGGRLGRALFELA--VNK------- 151 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChh-----HHHHHHHHHHHHH--HHh-------
Confidence 2233334555555555555422222 223445555555555532110 00000 0122221 111
Q ss_pred ccccccccceeecccccccCc----CChhhhCCCCCcEEEccCCCCCCCCCcc----c-cccccceeeccccccCCC---
Q 001778 236 TIGDMLALEFLDLSINNFTGS----IPSSVFKLKNLSKVYLYSNSLSGEIPQA----V-ESLNLKVIDLSANNLTGA--- 303 (1014)
Q Consensus 236 ~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~----~-~~~~L~~L~Ls~N~l~~~--- 303 (1014)
..++-+.|+++..++|++... +...|...+.|+.+.++.|.|....-.. + ..++|++|||.+|-++..
T Consensus 152 k~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~ 231 (382)
T KOG1909|consen 152 KAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV 231 (382)
T ss_pred ccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH
Confidence 123345677888888877522 1233445677788888888775332211 1 123677777777766532
Q ss_pred -CCCcccccccccccccccceecccCCccc-----CCCCCCCcccccCCcccc----cCCccccCCCCCceeecccccc
Q 001778 304 -IPNDFGKLENLLNLSLMFNQLSGEIPEGI-----GLLPSLKDVRLFNNMLSG----ALPPDFGRYSPLEYFEVSVNNL 372 (1014)
Q Consensus 304 -~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 372 (1014)
+...+..+++|+.|+++++.+.......| ...++|+.|.|.+|.++. .+...+...+.|+.|+|++|++
T Consensus 232 ~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 232 ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 23445566777777777777764333222 235667777777777653 1222334456666666666666
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.1e-10 Score=114.30 Aligned_cols=115 Identities=30% Similarity=0.353 Sum_probs=67.3
Q ss_pred ccccccccccccceeecccccccCcCChhhhCCCCCcEEEccCCCCCCCCCccccccccceeeccccccCCCCCCccccc
Q 001778 232 EIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311 (1014)
Q Consensus 232 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 311 (1014)
.+.++..-++.++.|++|+|.+.. + ..+..+++|+.|+|++|.++....-....-++++|.|+.|.|... ..+..+
T Consensus 298 ~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KL 373 (490)
T KOG1259|consen 298 QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIETL--SGLRKL 373 (490)
T ss_pred hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhhh--hhhHhh
Confidence 344455555666666666666662 2 225556666666666666653322111222566666666666522 345566
Q ss_pred ccccccccccceecc-cCCcccCCCCCCCcccccCCcccc
Q 001778 312 ENLLNLSLMFNQLSG-EIPEGIGLLPSLKDVRLFNNMLSG 350 (1014)
Q Consensus 312 ~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~ 350 (1014)
-+|..||+++|+|.. .-...++++|.|++|.|.+|.+.+
T Consensus 374 YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 374 YSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 667777777777753 122356777777777777777764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=107.02 Aligned_cols=144 Identities=19% Similarity=0.255 Sum_probs=104.2
Q ss_pred CceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCC--CccceEEEEEEcC---CceEEEE
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH--LNIVKLLCCISSE---NLKLLVY 766 (1014)
Q Consensus 692 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~---~~~~lV~ 766 (1014)
.+.|+.|..+.||++.... |+.+++|+...... ......+.+|+++++.+++ ..+.+++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGAL--LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCccc--CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3568999999999987643 57899998743221 1235678899999999965 3456777776654 3668999
Q ss_pred EcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhc-----------------------------
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD----------------------------- 817 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------- 817 (1014)
||+++.++.+.+.. ..++..+...++.++++++++||+.
T Consensus 80 e~i~G~~l~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 80 ERVDGRVLRDRLLR------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred EEeCCEecCCCCCC------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 99999877664421 1245556666677777777777632
Q ss_pred ------------------------CCCCeEeccCCCCCeeecC--CCcEEEeecccccc
Q 001778 818 ------------------------CSPTIVHRDLKSSNILLDY--NFNAKIADFGVAKI 850 (1014)
Q Consensus 818 ------------------------~s~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~ 850 (1014)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4e-08 Score=93.33 Aligned_cols=146 Identities=19% Similarity=0.274 Sum_probs=104.4
Q ss_pred CCceeccCCcEEEEEeeecCCCeEEEEEEecccchhh-----HHhHHHHHHHHHHHHcCCCCccceEEEEEEcCCceEEE
Q 001778 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD-----QKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 691 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 765 (1014)
....+-+|+-+.|+++.+ .|+...||.-..++... +-...+..+|+..+.+++--.|.--.-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 456788999999999965 47777888654433332 23456778899999887544443333344455556799
Q ss_pred EEcccC-CCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCC---cEE
Q 001778 766 YEYMEK-RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF---NAK 841 (1014)
Q Consensus 766 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~---~~k 841 (1014)
|||+++ .++.+++...-.. ..........+..|.+.+.-||.. +|+|||+..+||++.+++ .+.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~---------~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMED---------ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EEeccchhHHHHHHHHHccC---------cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 999976 4888888765221 112222367888999999999966 999999999999997655 358
Q ss_pred Eeecccccc
Q 001778 842 IADFGVAKI 850 (1014)
Q Consensus 842 l~Dfgla~~ 850 (1014)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999865
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-09 Score=84.69 Aligned_cols=60 Identities=35% Similarity=0.479 Sum_probs=39.7
Q ss_pred ccceecccccccCCCCcccccccccccceeccccccccccCcccccccccceeecCCCcc
Q 001778 503 SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562 (1014)
Q Consensus 503 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 562 (1014)
+|++|++++|+|+...+..|.++++|++|++++|+++...|.+|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 466666666666644445666667777777777777666666677777777777777764
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.9e-09 Score=82.98 Aligned_cols=60 Identities=35% Similarity=0.446 Sum_probs=31.2
Q ss_pred cceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceecccccc
Q 001778 479 NLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQL 538 (1014)
Q Consensus 479 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 538 (1014)
+|+.|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 344555555555544444555555555555555555544444555555555555555543
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.4e-07 Score=91.30 Aligned_cols=128 Identities=26% Similarity=0.219 Sum_probs=80.9
Q ss_pred EEEEeeecCCCeEEEEEEecccc-----------------------hhhHHhHHHHHHHHHHHHcCCCC--ccceEEEEE
Q 001778 702 KVYRVPINHTAEVVAVKKIWNDR-----------------------KLDQKHEKEFLAEVQILSTIRHL--NIVKLLCCI 756 (1014)
Q Consensus 702 ~Vy~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~~ 756 (1014)
.||.|.. ..++.+|||+.+... ...........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888765 457789999874210 11122356678899999999765 455666442
Q ss_pred EcCCceEEEEEccc--CCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeccCCCCCee
Q 001778 757 SSENLKLLVYEYME--KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM-HHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 757 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~s~~ivH~Dlk~~NIl 833 (1014)
..++||||++ |..+..+.... +.......++.+++..+..+ |. .||+|||+.+.||+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-------------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIl 139 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-------------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNIL 139 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-------------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-------------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEE
Confidence 2479999998 54554433321 11233456777777755554 54 49999999999999
Q ss_pred ecCCCcEEEeeccccccc
Q 001778 834 LDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 834 l~~~~~~kl~Dfgla~~~ 851 (1014)
++++ .+.++|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9988 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.1e-06 Score=91.56 Aligned_cols=196 Identities=14% Similarity=0.201 Sum_probs=127.8
Q ss_pred CCCceeccCCcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcC-CCCccceEEEEE------Ec-CCc
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCI------SS-ENL 761 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~------~~-~~~ 761 (1014)
...+.||+|+-+.+|...-. +. -+.|+++........ +.+..|... .||-+-.=+.|= .+ +..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 45678999999999975322 22 245777543321111 122334444 566543312221 11 223
Q ss_pred eEEEEEcccCCC-HHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcE
Q 001778 762 KLLVYEYMEKRS-LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840 (1014)
Q Consensus 762 ~~lV~e~~~~gs-L~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~ 840 (1014)
..+.|..+++.. ...+.....+ ...-....|...+++++.+|.+.+.||+. |.+-||+.++|+|+++++.|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tR-----Rqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATR-----RQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred eEEecccCCCccchhhhcCchhh-----cccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceE
Confidence 567777776641 2222211110 11233478999999999999999999976 99999999999999999999
Q ss_pred EEeecccccccccccCccccccccccCcccccccccc-----cCCCCCcCcchhHHHHHHHHhcC-CCCCCC
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTG-KEANNG 906 (1014)
Q Consensus 841 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwSlGvll~elltg-~~p~~~ 906 (1014)
.+.|-..-..... + ...-..+|...|.+||.-. +..-+...|-|.+||++++++.| ++||.+
T Consensus 157 ~LVdsDsfqi~~n-g---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 157 VLVDSDSFQINAN-G---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred EEEcccceeeccC-C---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 9998665443211 1 2223467899999999754 33456789999999999999987 889875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-08 Score=113.82 Aligned_cols=161 Identities=16% Similarity=0.194 Sum_probs=109.0
Q ss_pred HHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeecccccccccccCcccc-------ccccccCcccccccccc
Q 001778 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA-------MSTVVGSCGYIAPEYAR 877 (1014)
Q Consensus 805 ~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~ 877 (1014)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+........ +.. .........|.|||++.
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhc
Confidence 3455999999974 5999999999999999999999999998865543211 111 11123456899999999
Q ss_pred cCCCCCcCcchhHHHHHHHHh-cCCCCCCCCCchhHHHHHHHHHhcCCcchhccccccCCcccHHHHHHHHHHHhHccCC
Q 001778 878 TRKVNEKTDIYSFGVILLELT-TGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSM 956 (1014)
Q Consensus 878 ~~~~~~~~DvwSlGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 956 (1014)
....+.++|+||+||++|.+. .|+..+............... +..-...+..+...++.+=+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-----------~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-----------LNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-----------cccccccccccCcHHHHHHHHHHhcC
Confidence 988899999999999999999 565555544332211111000 00000111223334555666689999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001778 957 LPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 957 dP~~RPt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
|+..||++.++.. .|||......
T Consensus 252 ~~~~rp~~~~l~~----~~ff~D~~~~ 274 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS----IPFFSDPGLK 274 (700)
T ss_pred CcccCcchhhhhc----ccccCCchhh
Confidence 9999998666655 8888775543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.7e-08 Score=70.19 Aligned_cols=39 Identities=28% Similarity=0.802 Sum_probs=29.4
Q ss_pred HHHHHHHHHHHHhcCC-C-CCCCCCCCCC-CCCCCCCceEeC
Q 001778 31 DREHAVLLKLKQHWQN-P-PPISHWATTN-SSHCTWPEIACT 69 (1014)
Q Consensus 31 ~~~~~~ll~~k~~~~~-~-~~~~~w~~~~-~~~c~w~gv~c~ 69 (1014)
+.|++||++||+++.+ + ..+.+|+... +++|+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999985 4 3689998874 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.6e-06 Score=91.98 Aligned_cols=143 Identities=14% Similarity=0.104 Sum_probs=97.0
Q ss_pred eeccCCcEEEEEeeecCCCeEEEEEEecccchhh---H-----HhHHHHHHHHHHHHcCCCC--ccceEEEEEEc-----
Q 001778 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD---Q-----KHEKEFLAEVQILSTIRHL--NIVKLLCCISS----- 758 (1014)
Q Consensus 694 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~~~Ei~~l~~l~hp--niv~l~~~~~~----- 758 (1014)
.+-+.....|+++.+ .|+.|.||......... . .....+.+|...+..+... .+...+++.+.
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 344444445666644 46789999763321100 0 1112478898888887432 23344555543
Q ss_pred CCceEEEEEcccCC-CHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecC-
Q 001778 759 ENLKLLVYEYMEKR-SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY- 836 (1014)
Q Consensus 759 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~- 836 (1014)
...-++|+|++++. +|.+++.... ....+...+..++.+++..+..||.. ||+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLP 174 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecc
Confidence 23468999999986 8999885421 11234566778999999999999976 9999999999999975
Q ss_pred ------CCcEEEeecccccc
Q 001778 837 ------NFNAKIADFGVAKI 850 (1014)
Q Consensus 837 ------~~~~kl~Dfgla~~ 850 (1014)
+..+.++||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.7e-09 Score=117.19 Aligned_cols=126 Identities=30% Similarity=0.310 Sum_probs=82.9
Q ss_pred CCceeccccccccCcCCCcccCCCcceEEEccCCccccccccccccccccceecccccccCCCCcc-cccccccccceec
Q 001778 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPL-DIISWKSLTALNL 533 (1014)
Q Consensus 455 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 533 (1014)
.|...+.+.|++. .....+.-++.|+.|||++|+++... .+..++.|..|||++|.|. .+|. ...++ +|+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 5666677777777 55666666677777777777776543 6777777788888888777 4443 33333 3777888
Q ss_pred cccccccccCcccccccccceeecCCCccccCCc-hhhhhh-cccccccCCCcccc
Q 001778 534 SRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIP-PQIGRL-MLTSLNLSSNRLTG 587 (1014)
Q Consensus 534 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~~-~l~~l~ls~N~l~~ 587 (1014)
++|.++.. ..+.+|.+|+-||||.|-|++--- ..+..+ .|..|+|.+|++..
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 88877622 235677777777888877764211 112333 57777888887765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-06 Score=95.11 Aligned_cols=179 Identities=18% Similarity=0.239 Sum_probs=132.4
Q ss_pred CcEEEEEeeecCCCeEEEEEEecccchhhHHhHHHHHHHHHHHHcCCCCccceEEEEEE----cCCceEEEEEcccC-CC
Q 001778 699 GSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCIS----SENLKLLVYEYMEK-RS 773 (1014)
Q Consensus 699 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~----~~~~~~lV~e~~~~-gs 773 (1014)
-..+-|++....+|..|++|+++.++.... .....-+++++++.|+|||++.+++. .+-..++||+|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999899999999999965544333 22334567889999999999998876 24567999999886 57
Q ss_pred HHHHhhhcCCCC----CCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeecCCCcEEEeeccccc
Q 001778 774 LDQWLHKKNRSS----LSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 774 L~~~l~~~~~~~----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~ 849 (1014)
|.++-....... ..-.......++...|.++.|+..||.++|.. |..-+-+.+.+|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 777655432211 11123344578899999999999999999955 99999999999999999999999888776
Q ss_pred ccccccCccccccccccCcccccccccccCCCCCcCcchhHHHHHHHHhcCCCC
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA 903 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwSlGvll~elltg~~p 903 (1014)
....+. . |-+. -..+-|.=.+|.+++.+.||..-
T Consensus 442 vl~~d~---------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDP---------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCC---------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 654422 0 1111 12467888999999999999653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.4e-09 Score=92.10 Aligned_cols=134 Identities=28% Similarity=0.361 Sum_probs=96.5
Q ss_pred CceeccccccccCcCCCc---ccCCCcceEEEccCCcccccccccccc-ccccceecccccccCCCCcccccccccccce
Q 001778 456 LSRLEISNNRFSGKIPTG---VSSSKNLVVFQASNNLFNGTIPGELTA-LPSLTTLLLDQNQLSGSLPLDIISWKSLTAL 531 (1014)
Q Consensus 456 L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 531 (1014)
+..++|+.|.+- -+++. +.....|+..+|++|.+. ..|+.|.. .+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 556777777665 34443 344556777788888888 45555554 457888888999888 788888888899999
Q ss_pred eccccccccccCcccccccccceeecCCCccccCCchhhhhh-cccccccCCCcccccCChhhh
Q 001778 532 NLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFE 594 (1014)
Q Consensus 532 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~l~~l~ls~N~l~~~~p~~~~ 594 (1014)
|++.|.|. ..|..+..|.+|..||..+|.+. +||-.+-.- .....++.+++|.+.-|...|
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 99999887 67777777888888888888886 565543222 355566777788877775443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.6e-08 Score=98.45 Aligned_cols=106 Identities=23% Similarity=0.249 Sum_probs=58.2
Q ss_pred CccEEECccCCCCCCCC-cccc-CCCCcceecccccccCC--CCCcccccccccceeeecCccCCCCCchhhcccCccce
Q 001778 96 NLTILDLQFNYIISQFP-RVLY-NCSKLEYLDLSQNYFIG--PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQ 171 (1014)
Q Consensus 96 ~L~~L~L~~n~i~~~~p-~~~~-~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (1014)
.++.|.|.++.|..+-. ..|+ .++.++.|||.+|.|+. .+-.-+.+|+.|+.|+|+.|.+...|-..-..+.+|++
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 34444454444432211 1222 35667777777777763 34444566777777777777776433211134557777
Q ss_pred EeccccccCCCC-cccccCccchhhhhcccc
Q 001778 172 LNLVVNQFNGSI-PAEIGNLQNLEALELAYN 201 (1014)
Q Consensus 172 L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N 201 (1014)
|-|.+..+...- -..+..++.++.|.++.|
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N 156 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDN 156 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccc
Confidence 777776665322 233455666666666666
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-06 Score=88.90 Aligned_cols=138 Identities=22% Similarity=0.157 Sum_probs=95.8
Q ss_pred CCCceeccCCcEEEEEeeecCCCeEEEEEEecccc-------------------hhhHHhHHHHHHHHHHHHcCCCC--c
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDR-------------------KLDQKHEKEFLAEVQILSTIRHL--N 748 (1014)
Q Consensus 690 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~~~~~Ei~~l~~l~hp--n 748 (1014)
.++..||-|--+.||.|... .|..+|||.=...+ .+-.......++|.++|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34578999999999999765 67889999642111 11123456678999999998644 5
Q ss_pred cceEEEEEEcCCceEEEEEcccCCCHHHHhhhcCCCCCCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCC
Q 001778 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLK 828 (1014)
Q Consensus 749 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk 828 (1014)
|.+.+++ +...+||||++|.-|...- +.......++..|++-+.-.-.. ||||||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------------~~~en~~~il~~il~~~~~~~~~---GiVHGDlS 229 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------------LDVENPDEILDKILEEVRKAYRR---GIVHGDLS 229 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------------CcccCHHHHHHHHHHHHHHHHHc---CccccCCc
Confidence 6555543 4568999999985554332 11223334455555544444433 99999999
Q ss_pred CCCeeecCCCcEEEeeccccccc
Q 001778 829 SSNILLDYNFNAKIADFGVAKIL 851 (1014)
Q Consensus 829 ~~NIll~~~~~~kl~Dfgla~~~ 851 (1014)
+-||+++++|.++++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999877543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.7e-09 Score=116.18 Aligned_cols=178 Identities=25% Similarity=0.275 Sum_probs=118.3
Q ss_pred ccccccccccceeecccccccCcCChhhhCC-CCCcEEEccCCCCC----------CCCCccccccccceeeccccccCC
Q 001778 234 PETIGDMLALEFLDLSINNFTGSIPSSVFKL-KNLSKVYLYSNSLS----------GEIPQAVESLNLKVIDLSANNLTG 302 (1014)
Q Consensus 234 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~~~~~~~~~L~~L~Ls~N~l~~ 302 (1014)
|-.+..+.+|++|.|.++.|.. ...+..+ ..|+.|- .+|.+. |.+...+.-..|.+.+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4456677778888888777762 1111111 2333332 223221 22333333336888888999888
Q ss_pred CCCCcccccccccccccccceecccCCcccCCCCCCCcccccCCcccccCCcc-ccCCCCCceeeccccccccCCChhhh
Q 001778 303 AIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLC 381 (1014)
Q Consensus 303 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~ 381 (1014)
.+...+.-++.|+.|+|++|+++... .+..++.|++|||+.|.+. .+|.. ...+ .|+.|.+++|.++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHH
Confidence 66667778888999999999987432 6788889999999999988 44432 3333 388889998888742 3466
Q ss_pred cCCCccEEEccccccCCCCC-cccccCCcccEEEeecceee
Q 001778 382 AGGKLAGIAAQDNNLSGELP-ESLGNCSSLLMVKIYNNSFT 421 (1014)
Q Consensus 382 ~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~ 421 (1014)
++++|+.||++.|-|.+.-- ..+..+..|+.|.|.+|++-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77888888888888775332 34566777888888888876
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-08 Score=90.56 Aligned_cols=115 Identities=23% Similarity=0.347 Sum_probs=84.7
Q ss_pred CCceeccccccccCcCCCcc-cCCCcceEEEccCCccccccccccccccccceecccccccCCCCcccccccccccceec
Q 001778 455 NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNL 533 (1014)
Q Consensus 455 ~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (1014)
.|...+|++|.+.. +|..| ...+.++.|++++|.|+ .+|.++..++.|+.|+++.|.|. ..|.-+..|.+|..|+.
T Consensus 54 el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 35556677777763 44434 34567888888888888 67888999999999999999998 78888888999999999
Q ss_pred cccccccccCcccccccccceeecCCCccccCCchhhhhh
Q 001778 534 SRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL 573 (1014)
Q Consensus 534 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~ 573 (1014)
.+|.+. .||..+-.-+.....++.++.+.+.-|..+..+
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 999986 777664433344455668888887766655443
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.2e-09 Score=105.20 Aligned_cols=88 Identities=20% Similarity=0.288 Sum_probs=44.7
Q ss_pred ccceeeecCccCCC-CCchhhcccCccceEeccccccCCCCcccccCccchhhhhcccccCCCCCCCCccccccccccee
Q 001778 144 RLKFLYLTANNMSG-KIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKL 222 (1014)
Q Consensus 144 ~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~~~~~~~lp~~~~~l~~L~~L 222 (1014)
+|++||||+..|+. ..-.-+..+.+|+.|.|.++++.+.+...+..-.+|+.|+|+....++-..+.--+.+++.|++|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 35555555554442 12233445556666666666666555566666666666666655322211222224455555555
Q ss_pred ecccccccC
Q 001778 223 WMASTNLIG 231 (1014)
Q Consensus 223 ~l~~n~l~~ 231 (1014)
+++.|.+..
T Consensus 266 NlsWc~l~~ 274 (419)
T KOG2120|consen 266 NLSWCFLFT 274 (419)
T ss_pred CchHhhccc
Confidence 555555543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1014 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-53 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-42 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-27 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-27 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 4e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 5e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 4e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 7e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 483 bits (1245), Expect = e-157
Identities = 177/550 (32%), Positives = 279/550 (50%), Gaps = 21/550 (3%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
++ L +++ N + P F+ D L LD+ N + F R + C++L+ L++S N F
Sbjct: 201 NLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEIGNL 190
+GPIP L L++L L N +G+IP + G L L+L N F G++P G+
Sbjct: 260 VGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLS 249
LE+L L+ N FS +++ LK L ++ GE+PE++ ++ A L LDLS
Sbjct: 318 SLLESLALSSN-NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 250 INNFTGSIPSSVFK--LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPN 306
NNF+G I ++ + L ++YL +N +G+IP + + L + LS N L+G IP+
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
Query: 307 DFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFE 366
G L L +L L N L GEIP+ + + +L+ + L N L+G +P + L +
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496
Query: 367 VSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPA 426
+S N LTG +P+ + LA + +N+ SG +P LG+C SL+ + + N F G IPA
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Query: 427 GLWTGFNLSMVLISDNLFTGELPDKMSGNLS----RLEISNNRFSGKIPTGVSSSKNLVV 482
+ F S I+ N G+ + + + F G ++
Sbjct: 557 AM---FKQSG-KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
Query: 483 FQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEI 542
++ ++ G S+ L + N LSG +P +I S L LNL N +SG I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 543 PEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLTGEIPS--QFENRAYA 599
P+++G L L LDLS N+ G+IP + L LT ++LS+N L+G IP QFE
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET-FPP 731
Query: 600 SSFLNNPGLC 609
+ FLNNPGLC
Sbjct: 732 AKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-151
Identities = 173/583 (29%), Positives = 267/583 (45%), Gaps = 51/583 (8%)
Query: 31 DREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMN---GTF 87
RE L+ K + + W ++N + CT+ + C D VT + L++ +N
Sbjct: 11 YREIHQLISFKDVLPDKNLLPDW-SSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAV 69
Query: 88 PPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPED--IDRLSRL 145
+ L L L L ++I + L LDLS+N GP+ + S L
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 146 KFLYLTANNMSGKIPASIG-RLTELRQLNLVVNQFNGSIPAEI---GNLQNLEALELAYN 201
KFL +++N + S G +L L L+L N +G+ L+ L ++ N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 202 TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSV 261
+ S + ++ L+ L ++S N IP +GD AL+ LD+S N +G ++
Sbjct: 189 -KIS-GDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 243
Query: 262 FKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPND-FGKLENLLNLSL 319
L + + SN G IP L +L+ + L+ N TG IP+ G + L L L
Sbjct: 244 STCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 320 MFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPE 378
N G +P G L+ + L +N SG LP D + L+ ++S
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS---------- 351
Query: 379 HLCAGGKLAGIAAQDNNLSGELPESLGNCS-SLLMVKIYNNSFTGNIPAGLWTGF--NLS 435
N SGELPESL N S SLL + + +N+F+G I L L
Sbjct: 352 --------------FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397
Query: 436 MVLISDNLFTGELPDKMS--GNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGT 493
+ + +N FTG++P +S L L +S N SG IP+ + S L + N+ G
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 494 IPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ 553
IP EL + +L TL+LD N L+G +P + + +L ++LS N+L+GEIP+ IG L L
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517
Query: 554 DLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFEN 595
L LS N FSG IP ++G L L+L++N G IP+
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-15
Identities = 25/100 (25%), Positives = 42/100 (42%), Gaps = 7/100 (7%)
Query: 503 SLTTLLLDQNQLS---GSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSE 559
+T++ L L+ ++ ++S L +L LS + ++G + L LDLS
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109
Query: 560 NQFSGKIPP--QIGRL-MLTSLNLSSNRLTGEIPSQFENR 596
N SG + +G L LN+SSN L +
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 13/113 (11%)
Query: 494 IPGELTALPSLTTLLLDQNQLSG-SLPLDIISWK-------SLTALNLSRNQLS---GEI 542
+ E+ L S +L D+N L S + ++ +T+++LS L+ +
Sbjct: 10 LYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAV 69
Query: 543 PEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFE 594
+ L L+ L LS + +G + LTSL+LS N L+G + +
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = 3e-98
Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 22/288 (7%)
Query: 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
N++G GG GKVY+ + +VAVK++ +R Q E +F EV+++S H N++
Sbjct: 34 NKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLL 90
Query: 751 KLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
+L C++ +LLVY YM S+ L ++ S L W +R +IA+G+A+
Sbjct: 91 RLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQP-------PLDWPKRQRIALGSAR 142
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST-VVGSC 868
GL Y+H C P I+HRD+K++NILLD F A + DFG+AK++ + + ++T V G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTI 199
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANN-----GDEHTCLAQWAWRHIQEG 923
G+IAPEY T K +EKTD++ +GV+LLEL TG+ A + D+ L W ++E
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
K + +D ++ EE+ ++ ++ ++CT P ERP M V+++L
Sbjct: 260 K-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 2e-95
Identities = 94/621 (15%), Positives = 193/621 (31%), Gaps = 86/621 (13%)
Query: 46 NPPPISHWATTNSSHCTW---PEIAC-TDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
P ++W N W P ++ ++G VT L L +G P I L L +L
Sbjct: 53 GTQPGANW-NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLA 111
Query: 102 LQFNYI----ISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRL--SRLKFLYLTANNM 155
L + P+ + E + ++ + R S L + ++
Sbjct: 112 LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171
Query: 156 SGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQ 215
I S + Q+ + N + + L L + + F ++ + +
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNS-PFVAENICEAW-E 228
Query: 216 LKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSN 275
+ + ++ L +++ +P+ + L + + + N
Sbjct: 229 NENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 276 SLSG---------EIPQAVESLNLKVIDLSANNL-TGAIPNDFGKLENLLNLSLMFNQLS 325
+ A +++I + NNL T + K++ L L ++NQL
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 326 GEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP-LEYFEVSVNNLTGSLPEHLCAGG 384
G++P G L + L N ++ +P +F ++ +E + N L +P
Sbjct: 344 GKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIF---- 396
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTG-------NIPAGLWTGFNLSMV 437
+ S + + N + + G N+S +
Sbjct: 397 ------------------DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 438 LISDNLFTGELPDKMSG--NLSRLEISNNRFSG-------KIPTGVSSSKNLVVFQASNN 488
+S+N + + S LS + + N + ++ L N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 489 LFNGTIPGELTA--LPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRN------QLSG 540
+ + A LP L + L N S P ++ +L + +
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556
Query: 541 EIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYAS 600
E PE I P L L + N + +I ++ L++ N S A
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIRK-VNEKITPN-ISVLDIKDNPNISIDLSYVCPYIEAG 614
Query: 601 S---FLNNPGLCASSSNVNLK 618
F + +++K
Sbjct: 615 MYMLFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 21/121 (17%), Positives = 34/121 (28%), Gaps = 5/121 (4%)
Query: 480 LVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLS 539
L + N N + G T + + + + + S +T L+L S
Sbjct: 35 LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94
Query: 540 GEIPEKIGFLPVLQDLDLSENQFSG----KIPPQIGRLM-LTSLNLSSNRLTGEIPSQFE 594
G +P+ IG L L+ L L + P I M
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 595 N 595
Sbjct: 155 R 155
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 1e-92
Identities = 96/298 (32%), Positives = 155/298 (52%), Gaps = 27/298 (9%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKH-EKEFLAE 737
NF + P N +G GG G VY+ +N+T VAVKK+ + + +++F E
Sbjct: 26 NFDER---PISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQE 80
Query: 738 VQILSTIRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
+++++ +H N+V+LL ++ LVY YM SL L LS
Sbjct: 81 IKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRLS--------CLDGTPPLS 131
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
W R +IA GAA G+ ++H + +HRD+KS+NILLD F AKI+DFG+A+ E+
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS--EKF 186
Query: 857 EFAAMST-VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA--NNGDEHTCLA 913
M++ +VG+ Y+APE ++ K+DIYSFGV+LLE+ TG A + + L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244
Query: 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
E K I D +DK++++ + ++ + C +RP+++ V Q+L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-90
Identities = 101/292 (34%), Positives = 154/292 (52%), Gaps = 35/292 (11%)
Query: 691 ESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKH---EKEFLAEVQILSTIRHL 747
+IG G GKVY+ + VA+K+ + +EF E++ LS RH
Sbjct: 43 HKFLIGHGVFGKVYKGVLR-DGAKVALKR------RTPESSQGIEEFETEIETLSFCRHP 95
Query: 748 NIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
++V L+ C + +L+Y+YME +L + L+ + ++S +SW +R++I +G
Sbjct: 96 HLVSLIGFCDERNEM-ILIYKYMENGNLKRHLYGSDLPTMS-------MSWEQRLEICIG 147
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV- 865
AA+GL Y+H I+HRD+KS NILLD NF KI DFG++K E + +STVV
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT--ELDQTHLSTVVK 202
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA---NNGDEHTCLAQWAWRHIQE 922
G+ GYI PEY ++ EK+D+YSFGV+L E+ + A + E LA+WA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 923 GK--PIVD-ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
G+ IVD L +I E + + V C ++ +RP+M VL L
Sbjct: 263 GQLEQIVDPNLADKIRP----ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 8e-87
Identities = 91/333 (27%), Positives = 148/333 (44%), Gaps = 39/333 (11%)
Query: 33 EHAVLLKLKQHWQNPPPISHW-ATTNSSHCTWPEIACTD----GSVTELHLTNMNMNGTF 87
+ LL++K+ NP +S W TT+ + TW + C V L L+ +N+ +
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 88 --PPFICDLRNLTILDLQ-FNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSR 144
P + +L L L + N ++ P + ++L YL ++ G IP+ + ++
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 145 LKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL-EALELAYNTE 203
L L + N +SG +P SI L L + N+ +G+IP G+ L ++ ++ N
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN-- 184
Query: 204 FSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK 263
L G+IP T + L L F+DLS N G
Sbjct: 185 ------------------------RLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGS 219
Query: 264 LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
KN K++L NSL+ ++ + S NL +DL N + G +P +L+ L +L++ FN
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 324 LSGEIPEGIGLLPSLKDVRLF-NNMLSGA-LPP 354
L GEIP+G G L N L G+ LP
Sbjct: 280 LCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 5e-67
Identities = 85/379 (22%), Positives = 136/379 (35%), Gaps = 101/379 (26%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIP 305
D + G + + + ++ + L +L IP
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK---------------------PYPIP 69
Query: 306 NDFGKLENLLNLSLM-FNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
+ L L L + N L G IP I L L + + + +SGA+P + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 365 FEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNI 424
+ S N LSG LP S+ + +L+ + N +G I
Sbjct: 130 LDFS------------------------YNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 425 PAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQ 484
P + S + S + IS NR +GKIP + NL
Sbjct: 166 PDSY---GSFSKLFTS------------------MTISRNRLTGKIPPTFA---NL---- 197
Query: 485 ASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPE 544
+L + L +N L G + S K+ ++L++N L+ ++ +
Sbjct: 198 ------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 545 KIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPS--QFENRAYASS 601
+G L LDL N+ G +P + +L L SLN+S N L GEIP + S+
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR-FDVSA 297
Query: 602 FLNNPGLCASSSNVNLKSC 620
+ NN LC S L +C
Sbjct: 298 YANNKCLCGSP----LPAC 312
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 4e-86
Identities = 118/540 (21%), Positives = 195/540 (36%), Gaps = 35/540 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
+ LDL FN + ++ +L+ LDLS+ LS L L LT N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
+ + L+ L++L V IG+L+ L+ L +A+N LP F+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN-LIQSFKLPEYFS 146
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLALEF----LDLSINNFTGSIPSSVFKLKNLSKV 270
L L+ L ++S + + + + LDLS+N I FK L K+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 271 YLYSNSLSGEIPQAV--ESLNLKVIDLSANNLTGAI---PNDFGKLENLLNLSLMFNQLS 325
L +N S + + L+V L D LE L NL++ +L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 326 ------GEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEH 379
+I + L ++ L + + DF ++ E+
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNN--SFTGNIPAGLWTGFNLSMV 437
L + +L + G S + SL + + N SF G + +L +
Sbjct: 324 LKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 438 LISDNLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTI 494
+S N + G L L+ ++ V S +NL+ S+
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPVLQ 553
G L SL L + N + DI + ++LT L+LS+ QL P L LQ
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 554 DLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFENRAYASSFLN---NPGLC 609
L++S N F L L L+ S N + + ++ + +FLN N C
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-66
Identities = 103/529 (19%), Positives = 182/529 (34%), Gaps = 48/529 (9%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIIS-QFPRVLYNCSKLEYLDLSQNY 130
S+ +L N+ I L+ L L++ N I S + P N + LE+LDLS N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 131 FIGPIPEDIDRLSRLKF----LYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAE 186
D+ L ++ L L+ N M+ I + L +L L N + ++
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 187 -IGNLQNLEALELAYNTEFSPSSLPS-NFTQLKKLKKLWMASTNL------IGEIPETIG 238
I L LE L + +L + + L+ L L + L + +I +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 239 DMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSAN 298
+ + L S + L + ++SL L+
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLK----RLTFT 333
Query: 299 NLTGAIPNDFGKLENL--LNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDF 356
+ G L +L L+LS G + SLK + L N + + +F
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 357 GRYSPLEYFEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKI 415
LE+ + +NL + L + + SSL ++K+
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 416 YNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS 475
NSF N ++T NL+ L++S + PT +
Sbjct: 453 AGNSFQENFLPDIFTELR---------------------NLTFLDLSQCQLEQLSPTAFN 491
Query: 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLS 534
S +L V S+N F L SL L N + S ++ + SL LNL+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 535 RNQLSGEIPEK--IGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLS 581
+N + + + ++ + L + + P + + SLN++
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 50/328 (15%), Positives = 95/328 (28%), Gaps = 22/328 (6%)
Query: 285 VESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLF 344
VE + N IP++ + NL L FN L P L+ + L
Sbjct: 4 VEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 345 NNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESL 404
+ + S L ++ N + L + A + NL+ +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 405 GNCSSLLMVKIYNNSFTG-NIPAGLWTGFNLSMVLISDNLFTGELPD------KMSGNLS 457
G+ +L + + +N +P NL + +S N +M
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 458 RLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGE-LTALPSLTTLLLDQNQLSG 516
L++S N + I G L NN + + + L L L +
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 517 S---LPLDIISWKSLTALNLSRNQLS------GEIPEKIGFLPVLQDLDLSENQFSGKIP 567
D + + L L + +L+ +I + L + L +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VK 298
Query: 568 PQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
L L + + + ++
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKS 326
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 36/226 (15%), Positives = 62/226 (27%), Gaps = 27/226 (11%)
Query: 394 NNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS 453
N L S + L ++ + +LS
Sbjct: 38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ---SLS------------------ 76
Query: 454 GNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
+LS L ++ N S +L A + L +L L + N
Sbjct: 77 -HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 514 L-SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ----DLDLSENQFSGKIPP 568
+ S LP + +L L+LS N++ + L + LDLS N + P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 569 QIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSN 614
+ L L L +N + + +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-81
Identities = 103/542 (19%), Positives = 187/542 (34%), Gaps = 62/542 (11%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
S +++ + P + N+T+L+L N + S+L LD+ N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
PE +L LK L L N +S + T L +L+L+ N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDM--LALEFLD 247
NL L+L++N + + QL+ L++L +++ + E + +L+ L+
Sbjct: 122 NLITLDLSHNGLSSTKLGT----QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 248 LSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES----LNLKVIDLSANNLTGA 303
LS N P + L ++L + L + + + +++ + LS + L+
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 304 IPNDFGKLE--NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
F L+ NL L L +N L+ + LP L+ L N +
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 362 LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT 421
+ Y + + S+ +L S L + + +N
Sbjct: 298 VRYLNLKRSFTKQSIS---------------LASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS----SS 477
G I + ++TG NL L +SN+ S + T + +
Sbjct: 343 G-IKSNMFTGLI---------------------NLKYLSLSNSFTSLRTLTNETFVSLAH 380
Query: 478 KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRN 536
L + + N + + L L L L N++ L +++ + LS N
Sbjct: 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440
Query: 537 QLSGEIPEKIGFLPVLQDLDLSENQFSG--KIPPQIGRL-MLTSLNLSSNRLTGEIPSQF 593
+ +P LQ L L P L LT L+LS+N +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 594 EN 595
E
Sbjct: 501 EG 502
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-66
Identities = 93/544 (17%), Positives = 171/544 (31%), Gaps = 84/544 (15%)
Query: 72 SVTELHLTNMNMNGTFPPFI--CDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQN 129
++ EL L+N + + +L L+L N I P + +L L L+
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 130 YFIGPIPEDI---DRLSRLKFLYLTANNMSGKIPASIG--RLTELRQLNLVVNQFNGSIP 184
+ E + + ++ L L+ + +S + + T L L+L N N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 185 AEIGNLQNLEALELAYN--TEFSPSSLPSNFTQLKKL------KKLWMASTNLIGEIPET 236
L LE L YN SL ++ L K ++ +L +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSL-HGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 237 IGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS-----GEIPQAVESLNLK 291
+ LE L++ N+ G + L NL + L ++ S E ++ L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 292 VIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEG-IGLLPSLKDVRLFNNMLSG 350
+++L+ N ++ + F L +L L L N++ E+ L ++ ++ L N
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 351 ALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSL 410
F L+ + L P +L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNV----------------------DSSPSPFQPLRNL 482
Query: 411 LMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKI 470
++ + NN+ I+D++ G L L L++ +N +
Sbjct: 483 TILDLSNNNIAN----------------INDDMLEG-LE-----KLEILDLQHNNLA--- 517
Query: 471 PTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTA 530
+ + G L L L L L+ N L
Sbjct: 518 -------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 531 LNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRLTGE 588
++L N L+ L+ L+L +N + G LT L++ N
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 589 IPSQ 592
S
Sbjct: 625 CESI 628
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-73
Identities = 88/594 (14%), Positives = 172/594 (28%), Gaps = 94/594 (15%)
Query: 39 KLKQHWQNPPPISHWATTNSSHCTW---PEIACTD-GSVTELHLTNMNMNGTFPPFICDL 94
+ N S N W P + + G VT L L G P I L
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPED-IDRLSRLKFLYLTAN 153
L +L + + + ++ + +D RL L +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 154 NMSGKIPASIGRLTELRQLNLVVNQFNG------SIPAEIGNLQNLEALELAYNTEFSPS 207
++ + + + +++L Q I I L L+ + A +
Sbjct: 407 AINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS------ 458
Query: 208 SLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNL 267
+ + + ++ L ++L +P ++ L L
Sbjct: 459 PFTYDNIAVDWEDANS-DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 268 SKVYLYSNSLSG---------EIPQAVESL-NLKVIDLSANNLTGAIPN-DFGKLENLLN 316
+ + N + ++ +++ + NNL + K+ L
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
Query: 317 LSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP-LEYFEVSVNNLTGS 375
L + N++ + G L D++L N + +P DF ++ +E S N L
Sbjct: 578 LDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-Y 633
Query: 376 LPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLS 435
+P + + + V N
Sbjct: 634 IPNIF----------------------NAKSVYVMGSVDFSYNKIGS------------- 658
Query: 436 MVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLF----- 490
N+ + D N S + +S N ++ + SNNL
Sbjct: 659 ---EGRNISCS-MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE 714
Query: 491 --NGTIPGELTALPSLTTLLLDQNQLSGSLPLDII--SWKSLTALNLSRNQLSGEIPEKI 546
G LTT+ L N+L+ SL D + L+ +++S N S P +
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772
Query: 547 GFLPVLQDLDLSE------NQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQF 593
L+ + N+ + P I L L + SN + ++ +
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-64
Identities = 93/540 (17%), Positives = 177/540 (32%), Gaps = 97/540 (17%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYI------ISQFPRVLYNCSKLEYLD 125
+ L +N P + ++ + + L+ I I+ + + +KL+ +
Sbjct: 397 RLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIY 454
Query: 126 LSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPA 185
+ + F + S L +L + L +P
Sbjct: 455 FANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509
Query: 186 EIGNLQNLEALELAYN-------TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE--T 236
+ +L L++L +A N + + L + K++ +M N + E P +
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM-GYNNLEEFPASAS 568
Query: 237 IGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL--NLKVID 294
+ M+ L LD N + L+ + L N + EIP+ + ++ +
Sbjct: 569 LQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 295 LSANNLTGAIPNDF--GKLENLLNLSLMFNQLSGEIPEGIGLLP-----SLKDVRLFNNM 347
S N L IPN F + + ++ +N++ E + + V L N
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 348 LSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNC 407
+ F SP+ +S N +T S+PE N + N
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMT-SIPE----------------NSLKPKDGNYKNT 727
Query: 408 SSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFS 467
L + + N T +SD+ LP LS +++S N FS
Sbjct: 728 YLLTTIDLRFNKLTS----------------LSDDFRATTLP-----YLSNMDVSYNCFS 766
Query: 468 GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKS 527
PT +S L F + + N++ P I + S
Sbjct: 767 S-FPTQPLNSSQLKAFGIRHQRD------------------AEGNRILRQWPTGITTCPS 807
Query: 528 LTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF-SGKIPPQIGRLMLTSLNLSSNRLT 586
L L + N + ++ EK+ P L LD+++N S + + L ++
Sbjct: 808 LIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-48
Identities = 65/473 (13%), Positives = 136/473 (28%), Gaps = 112/473 (23%)
Query: 139 IDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALEL 198
+D R+ L L G++P +IG+LTEL+ L+ + S + E
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 199 AYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLS------INN 252
+ F + L + I PE + + + L + N
Sbjct: 379 RKHR--IRMHYKKMFLDYDQRLNLSDLLQDAINRNPE-MKPIKKDSRISLKDTQIGNLTN 435
Query: 253 FTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLE 312
I ++ +L L +Y ++ + + +++ + + + L+
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNLK 491
Query: 313 NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNL 372
+L ++ L ++P+ + LP L+ + + N
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN-------------------------- 525
Query: 373 TGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF 432
+ A + + L + + + + N+
Sbjct: 526 ------------RGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEE---------- 562
Query: 433 NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNG 492
+ ++ L L+ +N+
Sbjct: 563 ------FPASASLQKMV-----KLGLLDCVHNKVR------------------------- 586
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--L 549
+ LT L LD NQ+ +P D ++ + L S N+L IP +
Sbjct: 587 HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643
Query: 550 PVLQDLDLSENQFSGKIPPQIGRLM-------LTSLNLSSNRLTGEIPSQFEN 595
V+ +D S N+ I M +++ LS N + F
Sbjct: 644 YVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 53/426 (12%), Positives = 119/426 (27%), Gaps = 50/426 (11%)
Query: 188 GNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLD 247
L+ +++ Y + P N K + +A+ + +P ++A
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNAN--DKYMDIGVATCDSAVWLPAGTYQVVAYTTYS 225
Query: 248 ----LSINNFTGSIPSSVFKLKN-----LSKVYLYSNSLSGEIPQAVESLNL-KVIDLSA 297
T S+ F + + + V + + I + + +D
Sbjct: 226 QSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKN 285
Query: 298 NNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFG 357
N+ N N + + + + + + L G +P G
Sbjct: 286 WRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 358 RYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYN 417
+ + L+ ++ T S + + + + + L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL------ 398
Query: 418 NSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEI--SNNRFSGKIPTGVS 475
+L I+ N + +L +I NR + I +
Sbjct: 399 ------------NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ 445
Query: 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSR 535
L + +N+ F D + + L + K LT + L
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSENQFSG---------KIPPQIGRL-MLTSLNLSSNRL 585
++P+ + LP LQ L+++ N+ ++ + + N L
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 586 TGEIPS 591
E P+
Sbjct: 561 E-EFPA 565
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 51/404 (12%), Positives = 111/404 (27%), Gaps = 32/404 (7%)
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYS 274
+LK + + E + ++ + +P+ +++ YS
Sbjct: 169 VTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAY---TTYS 225
Query: 275 NSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGL 334
S +S+ + + N LT N+ + + + I + L
Sbjct: 226 QSGIKRSELETQSVRGESFTVIDNKLTKDA-----------NVPIQLKETAEYIKDYKAL 274
Query: 335 LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDN 394
+ + N + F ++ L G++ G++
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 395 NLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG 454
G +P+++G + L ++ +S T + M +
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 455 NLSRLEIS---------NNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT 505
RL +S N S K+ + +N + I + L L
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQRLTKLQ 451
Query: 506 TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGK 565
+ + + N + L L D++L +
Sbjct: 452 IIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 566 IPPQIGRL-MLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGL 608
+P + L L SLN++ NR + + A P +
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 47/355 (13%), Positives = 109/355 (30%), Gaps = 37/355 (10%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
N++ +D++ N L + + + + S E D+ +
Sbjct: 154 NIRYVDVTVMNS------FNRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVAT--C 205
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
A+ G Y + Y S + + S E G+ + +P L +
Sbjct: 206 DSAVWLPAGTYQVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETA 265
Query: 409 SLL-----MVKIY------NNSFTGNI----PAGLWTGFNLSMVLISDNLFTGELPDKMS 453
+ + I+ N + L FN + + D +L + +
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV-DLDN--N 322
Query: 454 GNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
G ++ L ++ G++P + L V + + + +++
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 514 LSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG------KI 566
+ + + + L +L ++ ++ PE + + + L + Q I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPE-MKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 567 PPQIGRL-MLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSN-VNLKS 619
I RL L + +++ T + + A + S SN +L
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-70
Identities = 100/538 (18%), Positives = 172/538 (31%), Gaps = 40/538 (7%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
S L + + L NLT LDL I + +L+ L L+ N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
I + LK L+ +S + L L L N + + +
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLS 249
L+ L+ N S + S+ Q L L + + N I I D + L+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDM-SSLQQATNL-SLNL-NGNDIAGIEPGAFDSAVFQSLNFG 210
Query: 250 INNFTGSIP-----SSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAI 304
I S++ L + + +S + + + ++++ I+L +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
N F L L L LS E+P G+ L +LK + L N + L +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 365 FEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNL--SGELPESLGNCSSLLMVKIYNNSFT 421
+ N L L + +++ S L N S L + + N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNL 480
++ + L L+++ R K + L
Sbjct: 390 -SLKTEAFKECP---------------------QLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 481 VVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGS--LPLDIISW-KSLTALNLSRNQ 537
V S++L + + LP+L L L N + + L L LS
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 538 LSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
LS L ++ +DLS N+ + + L LNL+SN ++ +PS
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPI 545
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-59
Identities = 85/508 (16%), Positives = 162/508 (31%), Gaps = 25/508 (4%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
++ L ++ + + + L L L N+I S + KL+ LD N
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 132 IGPIPEDIDRLSRLKFLYL-TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGN- 189
ED+ L + L L N I + LN Q I + N
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 190 -LQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDL 248
+Q+L + S ++ + + T L+ LDL
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 249 SINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAI-PN 306
+ + + +PS + L L K+ L +N + + +L + + N +
Sbjct: 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
Query: 307 DFGKLENLLNLSLMFNQL--SGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
LENL L L + + S + L L+ + L N F LE
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 365 FEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGN 423
+++ L + L + + L + +L + + N F
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 424 IPAGLWTGF----NLSMVLISDNLFTGELPDKMSGNLSRLE---ISNNRFSGKIPTGVSS 476
L ++++S + + +L + +S+NR + +S
Sbjct: 465 NI-QKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 477 SKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPL-DIISWKSLTALNLSR 535
K + + ++N + +P L L T+ L QN L + + W +
Sbjct: 523 LKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW-----YKENM 576
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSENQFS 563
+L P+L+ + LS+ S
Sbjct: 577 QKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-17
Identities = 38/195 (19%), Positives = 65/195 (33%), Gaps = 10/195 (5%)
Query: 417 NNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGV 474
N IP L + + S N+ S NL+ L+++ +
Sbjct: 21 NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 475 SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLS 534
S L + N L+ +L L Q +S + + + K+L +L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 535 RNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQI----GRLMLTSLNLSSNRLTGEIP 590
N +S K L+ LD N + + + SLNL+ N + G P
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
Query: 591 SQFENRAYASSFLNN 605
F++ + S
Sbjct: 197 GAFDSAVFQSLNFGG 211
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-70
Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 43/308 (13%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
L V G G V++ + + E VAVK + K + EV L ++H
Sbjct: 25 PLQLLEVKARGRFGCVWKAQLLN--EYVAVKIF----PIQDKQSWQNEYEVYSLPGMKHE 78
Query: 748 NIVKLL-CCISSENLK---LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
NI++ + ++ L+ + EK SL +L V+SW I
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------------NVVSWNELCHI 126
Query: 804 AVGAAQGLCYMHHD-------CSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
A A+GL Y+H D P I HRD+KS N+LL N A IADFG+A +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-EAGK 185
Query: 857 EFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNG---DE 908
VG+ Y+APE R + D+Y+ G++L EL + A +G +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 909 HTCLAQWAWRH--IQEGKPIVDA--LDKEIDEPCFLEEMIRVF-KLGVICTSMLPTERPN 963
+ +H +++ + +V + + + + + C R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 964 MRMVLQIL 971
V + +
Sbjct: 306 AGCVGERI 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-65
Identities = 104/524 (19%), Positives = 173/524 (33%), Gaps = 35/524 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
+ +DL FN + N S+L++LDLS+ + L L L LT N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
+ P S LT L L V + IG L L+ L +A+N LP+ F+
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN-FIHSCKLPAYFS 150
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLA-----LEFLDLSINNFTGSIPSSVFKLKNLSK 269
L L + ++ N I I L LD+S+N I F+ L +
Sbjct: 151 NLTNLVHVDLSY-NYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHE 208
Query: 270 VYLYSNSLSGEIPQAVES--LNLKVIDLSAN------NLTGAIPNDFGKLENL--LNLSL 319
+ L N S I + L V L NL P+ L ++ L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 320 MFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEH 379
+ + L ++ + L + D ++ + + L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLD 326
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVL- 438
L L + N S + SL + + N+ + ++ + +
Sbjct: 327 L---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRH 380
Query: 439 --ISDNLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGT 493
+S N + G L L+ ++ S + L+ S
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 494 IPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPVL 552
G L SL TL + N + ++ + +LT L+LS+ QL L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 553 QDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFEN 595
Q L++S N +L L++L+ S NR+
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 47/334 (14%), Positives = 90/334 (26%), Gaps = 23/334 (6%)
Query: 279 GEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
G + +E + L+ +P+D + N+ L FN L L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ + L + + L ++ N + P L + A + L+
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISDNLFTGELPDKMSGNLS 457
+G +L + + +N ++ NL V +S N + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLR 177
Query: 458 -------RLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGE-LTALPSLTTLLL 509
L++S N I L N + I L L L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 510 DQNQLSGSLPLDIIS--------WKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQ 561
+ L+I ++ L+ + K L + + L+
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 562 FSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
+ SL++ +L
Sbjct: 297 IK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-19
Identities = 42/227 (18%), Positives = 63/227 (27%), Gaps = 29/227 (12%)
Query: 394 NNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS 453
N L S N S L + + I D + G L
Sbjct: 42 NPLKILKSYSFSNFSELQWLDLSRCEIET----------------IEDKAWHG-LH---- 80
Query: 454 GNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
+LS L ++ N P S +L A + L +L L + N
Sbjct: 81 -HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 514 LSG-SLPLDIISWKSLTALNLSRNQLSGEIPEKIGFL----PVLQDLDLSENQFSGKIPP 568
+ LP + +L ++LS N + + FL V LD+S N I
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQD 198
Query: 569 QIGRLM-LTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSN 614
Q + + L L L N + I
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-17
Identities = 29/131 (22%), Positives = 47/131 (35%), Gaps = 1/131 (0%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPR-VLYNCSKLEYLDLSQNY 130
+ L ++ N F L +L L + N V N + L +LDLS+
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 131 FIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNL 190
D L RL+ L ++ NN+ + +L L L+ N+ S
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
Query: 191 QNLEALELAYN 201
++L L N
Sbjct: 545 KSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-12
Identities = 20/108 (18%), Positives = 33/108 (30%), Gaps = 1/108 (0%)
Query: 74 TELHLTNMNMNGTFPP-FICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L + + + NLT LDL + V +L+ L++S N +
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 133 GPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
++L L L + N + L NL N
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 91/298 (30%), Positives = 145/298 (48%), Gaps = 35/298 (11%)
Query: 678 LNFRDSDILP-KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA 736
++ D DI L IG+G G V+R + + VAVK + ++ + EFL
Sbjct: 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGS--DVAVKIL-MEQDFHAERVNEFLR 83
Query: 737 EVQILSTIRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
EV I+ +RH NIV + NL +V EY+ + SL + LHK E L
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAR--------EQL 134
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
RRR+ +A A+G+ Y+H+ +P IVHR+LKS N+L+D + K+ DFG++++ +
Sbjct: 135 DERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KA 190
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915
F + + G+ ++APE R NEK+D+YSFGVIL EL T ++ AQ
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQV 247
Query: 916 AWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ K I L+ + + +I C + P +RP+ ++ +L
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQ------VAAIIEG------CWTNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-61
Identities = 75/298 (25%), Positives = 134/298 (44%), Gaps = 47/298 (15%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
L V+G G G+ +V T EV+ +K++ + D++ ++ FL EV+++ + H N
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 749 IVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
++K + + L + EY++ +L + + W +R+ A
Sbjct: 69 VLKFIGVLYKDKRL-NFITEYIKGGTLRGIIKSMDSQ----------YPWSQRVSFAKDI 117
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE-----------G 856
A G+ Y+H S I+HRDL S N L+ N N +ADFG+A++++ E+
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916
+ TVVG+ ++APE R +EK D++SFG++L E+ A+ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------YL 226
Query: 917 WRHIQEGKPIVDALDKEIDEPC---FLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
R + G + LD+ C F +R C + P +RP+ + L
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVR-------CCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-60
Identities = 82/331 (24%), Positives = 134/331 (40%), Gaps = 54/331 (16%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
++ V+G G G V + A+ VA+K+I + K F+ E++ LS + H
Sbjct: 9 EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI-----ESESERKAFIVELRQLSRVNHP 61
Query: 748 NIVKLL------CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
NIVKL C+ V EY E SL LH + M
Sbjct: 62 NIVKLYGACLNPVCL--------VMEYAEGGSLYNVLHGAEPLP--------YYTAAHAM 105
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN-AKIADFGVAKILIKEEGEFAA 860
+ +QG+ Y+H ++HRDLK N+LL KI DFG A +
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159
Query: 861 MSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920
M+ GS ++APE +EK D++S+G+IL E+ T ++ + A +
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAV 217
Query: 921 QEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL--LNNPI 976
G P++ L K +E ++ C S P++RP+M +++I+ L
Sbjct: 218 HNGTRPPLIKNLPKP------IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 977 FPTEKNGGRKYDHVTPLLTDSKREKMSESDD 1007
++ H P D + E + +
Sbjct: 266 PGADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-59
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 47/298 (15%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI----WNDRKLDQKHEKEFLAEVQILST 743
++ IG GG G V++ + VVA+K + + +EF EV I+S
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 744 IRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
+ H NIVKL + + V E++ L L K + W +++
Sbjct: 80 LNHPNIVKLYGLMHNPPRM---VMEFVPCGDLYHRLLDKAHP----------IKWSVKLR 126
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD-----YNFNAKIADFGVAKILIKEEGE 857
+ + A G+ YM + +P IVHRDL+S NI L AK+ADFG+++ +
Sbjct: 127 LMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182
Query: 858 FAAMSTVVGSCGYIAPE--YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915
+S ++G+ ++APE A EK D YSF +IL + TG+ + + ++
Sbjct: 183 ---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKF 238
Query: 916 AWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+EG I + + + +C S P +RP+ +++ L
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRN------------VIELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-58
Identities = 58/299 (19%), Positives = 116/299 (38%), Gaps = 44/299 (14%)
Query: 681 RDSDILPK-LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
+ S I K L + SG++++ + VK + R + ++F E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGN--DIVVKVL-KVRDWSTRKSRDFNEECP 59
Query: 740 ILSTIRHLNIVKLL-CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
L H N++ +L C S L+ +M SL LH+ + V+
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG---------TNFVVDQ 110
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
+ ++ A+ A+G+ ++H P I L S ++++D + A+I+ V
Sbjct: 111 SQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------ 163
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVN---EKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ + ++APE + + + D++SF V+L EL T + + +
Sbjct: 164 --QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---ME 218
Query: 915 WAWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ EG I + + ++++ IC + P +RP M++ IL
Sbjct: 219 IGMKVALEGLRPTIPPGISPH------VSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-58
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI-WNDRKLDQKHEKEFLAEVQILSTIRH 746
+LT +IG GG GKVYR VAVK + + + + E ++ + ++H
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 747 LNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
NI+ L C+ NL LV E+ L++ L K + + AV
Sbjct: 66 PNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSGKR------------IPPDILVNWAV 112
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLD--------YNFNAKIADFGVAKILIKEEGE 857
A+G+ Y+H + I+HRDLKSSNIL+ N KI DFG+A+ +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-- 170
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917
+ G+ ++APE R ++ +D++S+GV+L EL TG+ G + A+
Sbjct: 171 ---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAY 224
Query: 918 RHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
PI + +++ C + P RP+ +L L
Sbjct: 225 GVAMNKLALPIPSTCPEP------FAKLMED------CWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 9e-56
Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 45/294 (15%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
++T IGSG G VY+ + VAVK + N + + F EV +L RH+
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NI+ + ++ L +V ++ E SL LH ++ + IA
Sbjct: 81 NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETK----------FEMKKLIDIARQT 129
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
A+G+ Y+H + +I+HRDLKS+NI L + KI DFG+A + G + GS
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQLSGS 185
Query: 868 CGYIAPE---YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
++APE + + ++D+Y+FG++L EL TG Q + +I
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-------------QLPYSNINNRD 232
Query: 925 PIVDALDKEIDEPCFLE-------EMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
I++ + + P + M R+ C ERP+ +L +
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRILAEI 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-55
Identities = 66/322 (20%), Positives = 112/322 (34%), Gaps = 56/322 (17%)
Query: 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI--LST 743
L L +IG G G VY+ ++ VAVK + + F+ E I +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKV------FSFANRQNFINEKNIYRVPL 63
Query: 744 IRHLNIVKLL-CCI----SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+ H NI + + LLV EY SL ++L W
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------------TSDWV 111
Query: 799 RRMQIAVGAAQGLCYMHHD------CSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI-- 850
++A +GL Y+H + P I HRDL S N+L+ + I+DFG++
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 851 ---LIKEEGEFAAMSTVVGSCGYIAPEYAR-------TRKVNEKTDIYSFGVILLELTTG 900
L++ E A + VG+ Y+APE ++ D+Y+ G+I E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 901 KEANNGDEHTCLAQWAWRHIQEGKPIVDALDK---------EIDEPCFLEE--MIRVFKL 949
E Q A++ P + + + E + + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 950 GVICTSMLPTERPNMRMVLQIL 971
C R + + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERM 313
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-53
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 32/239 (13%)
Query: 677 RLNFRDSDILP-KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL 735
+ ++ DI +L +IG G G+VY + VA++ I + + ++ K F
Sbjct: 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFK 77
Query: 736 AEVQILSTIRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV 794
EV RH N+V + C+S +L ++ + R+L +
Sbjct: 78 REVMAYRQTRHENVVLFMGACMSPPHL-AIITSLCKGRTLYSVVRDAKIV---------- 126
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI--LI 852
L + QIA +G+ Y+H + I+H+DLKS N+ D N I DFG+ I ++
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKV---------NEKTDIYSFGVILLELTTGKE 902
+ + G ++APE R ++ +D+++ G I EL +
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-51
Identities = 73/339 (21%), Positives = 118/339 (34%), Gaps = 55/339 (16%)
Query: 664 KDELTSTETT-SFHRLNFRDSDILPK-LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIW 721
+D + ++++ S L + K + IG G G+V+ E VAVK +
Sbjct: 12 RDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFF 69
Query: 722 NDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLK---LLVYEYMEKRSLDQW 777
+ E E + +RH NI+ + I L+ +Y E SL +
Sbjct: 70 TTEEASWFRETE----IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125
Query: 778 LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMH-----HDCSPTIVHRDLKSSNI 832
L L + +++A + GLC++H P I HRDLKS NI
Sbjct: 126 LKST------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 833 LLDYNFNAKIADFGVAKILIKEEGE-FAAMSTVVGSCGYIAPE------YARTRKVNEKT 885
L+ N IAD G+A I + E +T VG+ Y+ PE +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 886 DIYSFGVILLELTTGKEANNGDE------------HTCLAQWAWRHIQEGK-PIVDALDK 932
D+YSFG+IL E+ + E + P
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293
Query: 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + +++ C + P R V + L
Sbjct: 294 SDECLRQMGKLMTE------CWAHNPASRLTALRVKKTL 326
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-50
Identities = 111/521 (21%), Positives = 183/521 (35%), Gaps = 34/521 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
+ LDL FN + ++ +L+ LDLS+ LS L L LT N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
+ + L+ L++L V IG+L+ L+ L +A+N LP F+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN-LIQSFKLPEYFS 146
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLALEF----LDLSINNFTGSIPSSVFKLKNLSKV 270
L L+ L ++S + + + + LDLS+N I FK L K+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 271 YLYSNSLSGEIPQAVES--LNLKVIDL------SANNLTGAIPNDFGKLENLLNLSLMFN 322
L +N S + + L+V L + NL + L NL
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 323 QLSGEIPEGIGL---LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEH 379
L + + I L L ++ L + + DF ++ E+ P
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL 322
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTG-NIPAGLWTGF-NLSMV 437
L + N E + SL + + N + + G +L +
Sbjct: 323 KL--KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 438 LISDNLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTI 494
+S N + G L L+ ++ V S +NL+ S+
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGEIPEKIGFLPVLQ 553
G L SL L + N + DI + ++LT L+LS+ QL P L LQ
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 554 DLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRLTGEIPSQ 592
L+++ NQ +P I + L + L +N P
Sbjct: 498 VLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-40
Identities = 92/510 (18%), Positives = 170/510 (33%), Gaps = 77/510 (15%)
Query: 74 TELHLTNMNMNGTFPPFI-CDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF- 131
+ L LT N + L +L L + S + + L+ L+++ N
Sbjct: 79 STLILTG-NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELR----QLNLVVNQFNGSIPAEI 187
+PE L+ L+ L L++N + + L ++ L+L +N N I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 188 GNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLW-----MASTNLIGEIPETIGDMLA 242
L L L N S + + + L L+ + + + ++ + L
Sbjct: 197 FKEIRLHKLTLRNN-FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 243 ---LEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSAN 298
+E L+ ++ +F L N+S L S ++ + + + ++L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNC 314
Query: 299 NLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS--GALPPDF 356
KL++L L+ N+ + LPSL+ + L N LS G
Sbjct: 315 KFGQ---FPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 357 GRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIY 416
+ L+Y ++S N + + + L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-------------------------TMSSNFLGLEQLEHLDFQ 404
Query: 417 NNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGV-S 475
+++ ++ NL L+IS+ G+ +
Sbjct: 405 HSNLKQMSEFSVFLSLR---------------------NLIYLDISHTHTRV-AFNGIFN 442
Query: 476 SSKNLVVFQASNN-LFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNL 533
+L V + + N +P T L +LT L L Q QL L + SL LN+
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 501
Query: 534 SRNQLSGEIPEKIGFLPVLQDLDLSENQFS 563
+ NQL L LQ + L N +
Sbjct: 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 67/374 (17%), Positives = 124/374 (33%), Gaps = 51/374 (13%)
Query: 72 SVTELHLTNMNMNGTFPP-FICDLRNLTILDLQFNYIISQ------FPRVLYNCSKLEYL 124
+ +L L N + I L L + L ++ L L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 125 DLSQNY---FIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNG 181
+ Y ++ I + + L+ + L + + ++ + L LV +F
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKFG- 317
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNL--IGEIPETIGD 239
P L++L+ L N + S L L+ L ++ L G ++
Sbjct: 318 QFPT--LKLKSLKRLTFTSN---KGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 240 MLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL--NLKVIDLSA 297
+L++LDLS N ++ S+ L+ L + ++L +V NL +D+S
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 298 NNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPD- 355
+ A F L +L L + N I L +L + L L L P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 489
Query: 356 FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKI 415
F S L+ ++ N L S+P +SL + +
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVP-----------------------DGIFDRLTSLQKIWL 525
Query: 416 YNNSFTGNIPAGLW 429
+ N + + P +
Sbjct: 526 HTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-16
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 4/152 (2%)
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506
++PD + + L++S N S L V S G +L L+T
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80
Query: 507 LLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF-SG 564
L+L N + SL L S SL L L+ IG L L++L+++ N S
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 565 KIPPQIGRLM-LTSLNLSSNRLTGEIPSQFEN 595
K+P L L L+LSSN++ +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 42/235 (17%), Positives = 71/235 (30%), Gaps = 32/235 (13%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
N L S + L ++ + I D + L
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQT----------------IEDGAYQS-LS-- 76
Query: 452 MSGNLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLD 510
+LS L ++ N + G S +L A + L +L L +
Sbjct: 77 ---HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 511 QNQL-SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ----DLDLSENQFSGK 565
N + S LP + +L L+LS N++ + L + LDLS N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 566 IPPQIGRLM-LTSLNLSSNRLTGEIPSQFENRAYASSFLNNPGLCASSSNVNLKS 619
I P + + L L L +N + + L + NL+
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV-LGEFRNEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-14
Identities = 45/273 (16%), Positives = 86/273 (31%), Gaps = 41/273 (15%)
Query: 327 EIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG-GK 385
+IP+ + S K++ L N L F + L+ ++S + ++ +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 386 LAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFT 445
L+ + N + + SSL + + + +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS----------------LENFPIG 121
Query: 446 GELPDKMSGNLSRLEISNNRF-SGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSL 504
L L +++N S K+P S+ NL S+N +L L +
Sbjct: 122 H------LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 505 T----TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEK-IGFLPVLQDLDLSE 559
+L L N ++ + L L L N S + + I L L+ L
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 560 NQFSGKIPPQIGRLM------LTSLNLSSNRLT 586
+F + + L +L + RL
Sbjct: 235 GEFRN--EGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 30/136 (22%), Positives = 45/136 (33%), Gaps = 5/136 (3%)
Query: 462 SNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLD 521
F KIP + + S N + P L L L + ++
Sbjct: 15 MELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 522 IISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNL 580
S L+ L L+ N + L LQ L E + IG L L LN+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 581 SSNRLT-GEIPSQFEN 595
+ N + ++P F N
Sbjct: 132 AHNLIQSFKLPEYFSN 147
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-50
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 38/238 (15%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI--RH 746
+T +G G G+V+R E VAVK + EK + E ++ +T+ RH
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQG--ENVAVKI------FSSRDEKSWFRETELYNTVMLRH 61
Query: 747 LNIVKLL-CCISSENLK---LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
NI+ + ++S + L+ Y E SL +L L ++
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------------TLDTVSCLR 109
Query: 803 IAVGAAQGLCYMHHD-----CSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
I + A GL ++H + P I HRDLKS NIL+ N IAD G+A + + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 858 F-AAMSTVVGSCGYIAPE------YARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
+ VG+ Y+APE ++ DI++FG++L E+ +N E
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-49
Identities = 105/478 (21%), Positives = 173/478 (36%), Gaps = 80/478 (16%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
I + L+ ++N++ ++P + + +++ + P G + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
L L +L+ + + +PE LE L S N+ T
Sbjct: 62 VSRL-------RDCLDRQAHELEL-------NNLGLSSLPELPPH---LESLVASCNSLT 104
Query: 255 GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENL 314
+P LK+L +LS P L+ + +S N L +P + L
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 315 LNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTG 374
+ + N L ++P+ L PSL+ + NN L P+ L N+L
Sbjct: 156 KIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK- 208
Query: 375 SLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNL 434
LP+ L I A +N L ELPE L N L + NN +P +L
Sbjct: 209 KLPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLP---PSL 259
Query: 435 SMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTI 494
+ + DN T +LP+ +L+ L++S N FS + NL AS+N ++
Sbjct: 260 EALNVRDNYLT-DLPELP-QSLTFLDVSENIFS-GLS---ELPPNLYYLNASSNEIR-SL 312
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQD 554
PSL L + N+L LP L L S N L+ E+PE L+
Sbjct: 313 CDL---PPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQN---LKQ 361
Query: 555 LDLSENQFSGKIPPQIGRLM-----------------LTSLNLSSNRLTGEIPSQFEN 595
L + N + P + L L++ +N L E P E+
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-44
Identities = 94/502 (18%), Positives = 179/502 (35%), Gaps = 75/502 (14%)
Query: 75 ELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYN-------------CSKL 121
+ L + + P ++++ T ++ P +
Sbjct: 14 QEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQA 73
Query: 122 EYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNG 181
L+L+ + +PE L+ L + N+++ ++P L L N + +
Sbjct: 74 HELELNNLG-LSSLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD 128
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML 241
P LE L ++ N LP LK + + N + ++P+
Sbjct: 129 LPP-------LLEYLGVSNN---QLEKLPE-LQNSSFLKIIDV-DNNSLKKLPDLPP--- 173
Query: 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT 301
+LEF+ N +P + L L+ +Y +NSL ++P L+L+ I N L
Sbjct: 174 SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPD--LPLSLESIVAGNNILE 228
Query: 302 GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
+ L L + N L +P+ L PSL+ + + +N L+ LP
Sbjct: 229 --ELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQS--- 278
Query: 362 LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT 421
L + +VS N + L E L + A N + L + + L + NN
Sbjct: 279 LTFLDVSENIFS-GLSELP---PNLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI 330
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLV 481
+PA L ++ S N E+P+ NL +L + N + P S ++L
Sbjct: 331 -ELPALP---PRLERLIASFNHLA-EVPELP-QNLKQLHVEYNPLR-EFPDIPESVEDL- 382
Query: 482 VFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGE 541
+ +++L +P +L L ++ N L P +S+ L ++ ++
Sbjct: 383 --RMNSHL--AEVPELPQ---NLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDP 431
Query: 542 IPEKIGFLPVLQDLDLSENQFS 563
L+D +
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-49
Identities = 70/341 (20%), Positives = 123/341 (36%), Gaps = 59/341 (17%)
Query: 664 KDELTSTETT-SFHRLNFRDSDILPK-LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIW 721
KD + T+ S L + + + IG G G+V+R E VAVK
Sbjct: 17 KDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKI-- 72
Query: 722 NDRKLDQKHEKEFLAEVQI--LSTIRHLNIVKLL-CCISSENLK---LLVYEYMEKRSLD 775
+ E+ + E +I +RH NI+ + LV +Y E SL
Sbjct: 73 ----FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 776 QWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD-----CSPTIVHRDLKSS 830
+L++ ++ +++A+ A GL ++H + P I HRDLKS
Sbjct: 129 DYLNRY------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 831 NILLDYNFNAKIADFGVAKILIKEEGE-FAAMSTVVGSCGYIAPE------YARTRKVNE 883
NIL+ N IAD G+A A + VG+ Y+APE + + +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 884 KTDIYSFGVILLELTTGKEANNGDE------------HTCLAQWAWRHIQEGK-PIVDAL 930
+ DIY+ G++ E+ E + + ++ P +
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 931 DKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + + +++R C R + + L
Sbjct: 297 WQSCEALRVMAKIMRE------CWYANGAARLTALRIKKTL 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-47
Identities = 97/501 (19%), Positives = 185/501 (36%), Gaps = 46/501 (9%)
Query: 94 LRNLTIL-DLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
L + TI D N I + ++ L + + L ++ L
Sbjct: 3 LGSATITQDTPINQIFT-----DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADR 55
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN--TEFSPSSLP 210
K + L L Q+N NQ P + NL L + + N + +P
Sbjct: 56 LG--IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---- 107
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKV 270
L L L + N I +I + ++ L L+LS N + S++ L +L ++
Sbjct: 108 --LANLTNLTGLTL-FNNQITDID-PLKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161
Query: 271 YLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
N ++ P + +L L+ +D+S+N ++ + KL NL +L NQ+S P
Sbjct: 162 SF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216
Query: 330 EGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGI 389
+G+L +L ++ L N L + L +++ N ++ P L KL +
Sbjct: 217 --LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 390 AAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELP 449
N +S L ++L +++ N P + NL+ + + N + P
Sbjct: 271 KLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 450 DKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLL 509
L RL NN+ S + +++ N+ A +N + P L L +T L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382
Query: 510 DQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQ 569
+ + + P++ + S+ + P I + D++ N S
Sbjct: 383 NDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVS 440
Query: 570 IGRLMLTSLNLSSNRLTGEIP 590
++ + +G +
Sbjct: 441 YTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-44
Identities = 96/491 (19%), Positives = 170/491 (34%), Gaps = 86/491 (17%)
Query: 121 LEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
L ++Q+ I I L+ L N++ + L ++ L
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 181 GSIPAEIGNLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIG 238
+ L NL + + N T+ +P L KL + M + N I +I +
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP------LKNLTKLVDILM-NNNQIADITP-LA 109
Query: 239 DMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSA 297
++ L L L N T P L NL+++ L SN++S A+ L +L+ +
Sbjct: 110 NLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG- 164
Query: 298 NNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFG 357
N +T P L L L + N++S + L +L+ + NN +S + P G
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITP-LG 218
Query: 358 RYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYN 417
+ L+ ++ N L +L + ++L + + N
Sbjct: 219 ILTNLDELSLNGNQLKD--------------------------IGTLASLTNLTDLDLAN 252
Query: 418 NSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSS 477
N + P T L+ L++ N+ S P ++
Sbjct: 253 NQISNLAPLSGLT------------------------KLTELKLGANQISNISP--LAGL 286
Query: 478 KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQ 537
L + + N P ++ L +LT L L N +S P+ S L L N+
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNK 342
Query: 538 LSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRA 597
+S + L + L NQ S + P +T L L+ T + N +
Sbjct: 343 VSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 598 YASSFLNNPGL 608
++ N G
Sbjct: 400 IPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-43
Identities = 90/477 (18%), Positives = 166/477 (34%), Gaps = 61/477 (12%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
VT L + + + L NLT ++ N + P L N +KL + ++ N
Sbjct: 47 QVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
P + L+ L L L N ++ P + LT L +L L N + + + L
Sbjct: 103 ADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLT 156
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN 251
+L+ L + L L++L ++S + + + LE L + N
Sbjct: 157 SLQQLSFGNQ-----VTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN 209
Query: 252 NFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGK 310
+ P L NL ++ L N L + SL NL +DL+ N ++ P
Sbjct: 210 QISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSG 263
Query: 311 LENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVN 370
L L L L NQ+S P + L +L ++ L N L L Y + N
Sbjct: 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFN 319
Query: 371 NLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWT 430
N++ P + + + L + YNN + T
Sbjct: 320 NISDISP--------------------------VSSLTKLQRLFFYNNKVSDVSSLANLT 353
Query: 431 GFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLF 490
N++ + N + P +++L +++ ++ + N+ + N+
Sbjct: 354 --NINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPV---NYKANVSIPNTVKNVT 408
Query: 491 NGTI-PGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI 546
I P ++ S T + N S ++ + SG + + +
Sbjct: 409 GALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 49/236 (20%), Positives = 87/236 (36%), Gaps = 37/236 (15%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
T+L L N ++ + L LT L L N I + P L + L L+L++N
Sbjct: 246 TDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301
Query: 134 PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
P I L L +L L NN+S P + LT+L++L N+ + + + NL N+
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNI 355
Query: 194 EALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEI-------------------- 233
L +N S + L ++ +L +
Sbjct: 356 NWLSAGHN----QISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
Query: 234 --PETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES 287
P TI D + D++ N + + + + + SG + Q +++
Sbjct: 412 IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-45
Identities = 102/513 (19%), Positives = 187/513 (36%), Gaps = 36/513 (7%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLT 151
L L L FNYI + +L+ L+L Y I ++ L L+ L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNGSI--PAEIGNLQNLEALELAYNTEFSPSSL 209
++ + P + L L +L L + ++ NL+ L L+L+ N + L
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN-QIRSLYL 140
Query: 210 PSNFTQLKKLKKLWMASTNLIGEIPETIGD---MLALEFLDLSINNFTGSIPSSVFKLKN 266
+F +L LK + S+N I + E + L F L+ N+ + K N
Sbjct: 141 HPSFGKLNSLKSIDF-SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 267 LSK-VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ + L +SG + + +N ++ + +++ F+ +
Sbjct: 200 PFRNMVLEILDVSG------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 326 GEIPEGI--GL-LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCA 382
+ + GL S++ + L + + F L+ ++ N + E
Sbjct: 254 -DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312
Query: 383 GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISD 441
L + N L + + + + N I + L + + D
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRD 371
Query: 442 NLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTAL 501
N T ++ + +S N+ +P ++ + + + N L N I L +
Sbjct: 372 NALTT---IHFIPSIPDIFLSGNKLV-TLPKINLTANLIHL--SENRLENLDILYFLLRV 425
Query: 502 PSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-----GFLPVLQDL 555
P L L+L+QN+ S S SL L L N L ++ L LQ L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485
Query: 556 DLSENQFSGKIPPQIGRLM--LTSLNLSSNRLT 586
L+ N + +PP + + L L+L+SNRLT
Sbjct: 486 YLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-39
Identities = 115/627 (18%), Positives = 206/627 (32%), Gaps = 97/627 (15%)
Query: 74 TELHLTNMNMNGTFPPFI-CDLRNLTILDLQFNYIISQF--PRVLYNCSKLEYLDLSQNY 130
L L + + P L +L L L F + N L LDLS+N
Sbjct: 76 RILDLGS-SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 131 FIG-PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLT--ELRQLNLVVNQFNGSIPAEI 187
+ +L+ LK + ++N + + L L +L N + +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 188 GNLQN------LEALELAYN----------TEFSPSSLPSNFTQLKKLKKLWMASTNLIG 231
G N LE L+++ N + S + + + I
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF-GFHNIK 253
Query: 232 EIPETIGDMLA---LEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVES 287
+ + LA + LDLS S+ S VF+ LK+L + L N ++ +A
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312
Query: 288 L-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNN 346
L NL+V++LS N L ++F L + + L N ++ + L L+ + L +N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 347 MLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPES-LG 405
L+ + +S N L +LP+ + +N L L
Sbjct: 373 ALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIH---LSENRLENLDILYFLL 423
Query: 406 NCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNR 465
L ++ + N F+ S + E P +L +L + N
Sbjct: 424 RVPHLQILILNQNRFSS----------------CSGDQTPSENP-----SLEQLFLGENM 462
Query: 466 FSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS- 524
T + L L L L+ N L+ SLP + S
Sbjct: 463 LQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLN-SLPPGVFSH 502
Query: 525 WKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNR 584
+L L+L+ N+L+ + L+ LD+S NQ P + L+ L+++ N+
Sbjct: 503 LTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL--APNPDVFVSLSVLDITHNK 558
Query: 585 LTGEIPSQ-FEN--RAYASSFLNNPGLCASSSNVNLK--------SCFFVPRKSRKGSSQ 633
E F N + P + + + K
Sbjct: 559 FICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKF 618
Query: 634 HVAVIIVSVIAVFLVALLSFFYMIRIY 660
+ ++ + +FL+ +L+
Sbjct: 619 SLFIVCTVTLTLFLMTILTVTKFRGFC 645
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-34
Identities = 75/395 (18%), Positives = 150/395 (37%), Gaps = 32/395 (8%)
Query: 207 SSLPSNFTQLKKLKKLWMASTNLIGEIPETI-GDMLALEFLDLSINNFTGSIPSSVFK-L 264
+ +P L ++L + S N I + + + L+ L+L +I F+ L
Sbjct: 17 TQVPQV---LNTTERLLL-SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNL 72
Query: 265 KNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAI--PNDFGKLENLLNLSLMF 321
NL + L S+ + P A + L +L + L L+ A+ F L+ L L L
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 322 NQLSG-EIPEGIGLLPSLKDVRLFNNMLSGALPPDFG--RYSPLEYFEVSVNNLTGSLPE 378
NQ+ + G L SLK + +N + + + L +F ++ N+L +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 379 HLCA-GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMV 437
+ + ++SG N ++ + ++N+ + + L ++
Sbjct: 193 DWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 438 LISDNLFTGELPDKMSG----NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNG 492
+ + +G ++ L++S+ + + V + K+L V + N N
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINK 304
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVL 552
L +L L L N L + + ++L +N ++ + FL L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 553 QDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLT 586
Q LDL +N + I + + + LS N+L
Sbjct: 365 QTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-24
Identities = 60/308 (19%), Positives = 111/308 (36%), Gaps = 46/308 (14%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
+ L+L +N L NL +L+L +N + + Y K+ Y+DL +N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
+ L +L+ L L N ++ I +
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----------------------------TIHFIP 381
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN 251
++ + L+ N +LP + NL +I + + L+ L L+ N
Sbjct: 382 SIPDIFLSGN---KLVTLPKINLTANLIHLSENRLENL--DILYFLLRVPHLQILILNQN 436
Query: 252 NFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESL------NLKVIDLSANNLTGAI 304
F+ + +L +++L N L + +L+V+ L+ N L
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
P F L L LSL N+L+ + L +L+ + + N L A PD + L
Sbjct: 497 PGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDV--FVSLSV 551
Query: 365 FEVSVNNL 372
+++ N
Sbjct: 552 LDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 64/337 (18%), Positives = 117/337 (34%), Gaps = 35/337 (10%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYN--CSKLEYLDLSQN 129
+V + ++ + + ++ F+ I S + +LDLS
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276
Query: 130 YFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGN 189
+ + L LK L L N ++ + L L+ LNL N +
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 190 LQNLEALELAYNT-EFSPSSLPSNFTQLKKL----------------KKLWMASTNLIGE 232
L + ++L N +L+ L +++ S N +
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFL-SGNKLVT 395
Query: 233 IPETIGDMLALEFLDLSINNFTG-SIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL--N 289
+P+ L + LS N I + ++ +L + L N S S +
Sbjct: 396 LPKIN---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 290 LKVIDLSANNLTGAI-----PNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRL 343
L+ + L N L A + F L +L L L N L+ +P G+ L +L+ + L
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSL 511
Query: 344 FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHL 380
+N L+ L + + LE ++S N L P+
Sbjct: 512 NSNRLT-VLSHNDLPAN-LEILDISRNQLLAPNPDVF 546
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-45
Identities = 88/511 (17%), Positives = 176/511 (34%), Gaps = 34/511 (6%)
Query: 97 LTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMS 156
+ D + + P L + ++ LDLS N D+ + L+ L L ++ ++
Sbjct: 7 SGVCDGRSRSF-TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 157 GKIPASIGRLTELRQLNLVVNQFNGSIPAE-IGNLQNLEALELAYNTEFSPSSLPSNFTQ 215
+ L L L+L N + S+ + G L +L+ L L N + + S F
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGN-PYQTLGVTSLFPN 121
Query: 216 LKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLY 273
L L+ L + + EI + +L L++ + + S K ++++ + L+
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLH 180
Query: 274 SNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI 332
+ + + + L +++ ++L NL + E + + + S E
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 333 GLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQ 392
L L L + + F + + + + + +
Sbjct: 241 NELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 393 DNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF------NLSMVLISDNLFTG 446
L +L + + + N+ +P +LS L+ +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 447 ELPDKMSGNLSRLEISNNRFS--GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSL 504
+L L +S N K + + KNL S N F+ +P +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 505 TTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
L L + + I +L L++S N L FLP LQ+L +S N+
Sbjct: 413 RFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK- 464
Query: 565 KIPPQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
+P +L + +S N+L F+
Sbjct: 465 TLPDASLFPVLLVMKISRNQLKSVPDGIFDR 495
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 57/283 (20%), Positives = 99/283 (34%), Gaps = 16/283 (5%)
Query: 69 TDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQ 128
TD S EL + D + D + + L + Q
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 129 NYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGR-LTELRQLNLVVNQFNGSI---P 184
Y + L ++K + + + + +P S + L L L+L N
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 185 AEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALE 244
A G +L+ L L+ N S LK L L + S N +P++ +
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI-SRNTFHPMPDSCQWPEKMR 413
Query: 245 FLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAI 304
FL+LS + + + + L + + +N+L + L+ + +S N L
Sbjct: 414 FLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFS--LFLPRLQELYISRNKLKTLP 467
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
LL + + NQL +P+GI L SL+ + L N
Sbjct: 468 DASL--FPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 64/381 (16%), Positives = 135/381 (35%), Gaps = 28/381 (7%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
S+ EL + +++ + +R++ L L + S + YL+L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
+ + A S S L +L + L +++ + L
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----FDDCTLN 264
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN 251
L + + S + +++L + L ++ + ++ + + +
Sbjct: 265 GLGDFNPSESDVVSELG----KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 252 NFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL----NLKVIDLSANNLT--GAI 304
+P S + LK+L + L N + E + +L+ + LS N+L
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
L+NL +L + N +P+ ++ + L + + + LE
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEV 435
Query: 365 FEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNI 424
+VS NNL S L +L + N L LP++ LL++KI N ++
Sbjct: 436 LDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SV 488
Query: 425 PAGLWTGF-NLSMVLISDNLF 444
P G++ +L + + N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 43/287 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG+G G+ ++ +++ K++ + + + ++ ++EV +L ++H NIV+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 754 CCISSENLKLL--VYEYMEKRSLDQWL--HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
I L V EY E L + K R L + VL Q+
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD---EEFVLRVMT--QLT----L 122
Query: 810 GLCYMH--HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
L H D T++HRDLK +N+ LD N K+ DFG+A+IL + FA T VG+
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFA--KTFVGT 179
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK--P 925
Y++PE NEK+DI+S G +L EL LA I+EGK
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKFRR 235
Query: 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
I E L E+I ML RP++ +L+
Sbjct: 236 IPYRYSDE------LNEIIT---------RMLNLKDYHRPSVEEILE 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 61/319 (19%), Positives = 114/319 (35%), Gaps = 41/319 (12%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPI------------------ 135
L Q + + + VL + D ++ +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 136 -PEDIDRLSR--LKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQN 192
+ ++ ++ L L + + + P RL+ L+ + + +P +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 193 LEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA---------L 243
LE L LA N +LP++ L +L++L + + + E+PE + A L
Sbjct: 129 LETLTLARN---PLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 244 EFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTG 302
+ L L S+P+S+ L+NL + + ++ LS + A+ L L+ +DL
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 303 AIPNDFGKLENLLNLSLM-FNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
P FG L L L + L +P I L L+ + L + LP +
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 362 LEYFEVSVNNLTGSLPEHL 380
V +L L +H
Sbjct: 303 NCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 53/294 (18%), Positives = 106/294 (36%), Gaps = 20/294 (6%)
Query: 57 NSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLR--NLTILDLQFNYIISQFPRV 114
+ + + T + D L+L+ + QFP
Sbjct: 42 DRNRWHSAWRQANSNNPQIETRTG-RALKATADLLEDATQPGRVALELRSVPL-PQFPDQ 99
Query: 115 LYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNL 174
+ S L+++ + + +P+ + + + L+ L L N + +PASI L LR+L++
Sbjct: 100 AFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157
Query: 175 VVNQFNGSIPAEIGN---------LQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMA 225
+P + + L NL++L L + SLP++ L+ LK L +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT---GIRSLPASIANLQNLKSLKI- 213
Query: 226 STNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV 285
+ + + I + LE LDL + P L ++ L S +P +
Sbjct: 214 RNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273
Query: 286 ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
L L+ +DL +P+ +L + + + + P+
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-40
Identities = 54/290 (18%), Positives = 102/290 (35%), Gaps = 20/290 (6%)
Query: 31 DREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNG----T 86
R + ++ + A T+ + +
Sbjct: 36 QRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ 95
Query: 87 FPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLK 146
FP L +L + + ++ P + + LE L L++N +P I L+RL+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLR 153
Query: 147 FLYLTANNMSGKIPASIGR---------LTELRQLNLVVNQFNGSIPAEIGNLQNLEALE 197
L + A ++P + L L+ L L S+PA I NLQNL++L+
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 198 LAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSI 257
+ + S+L L KL++L + + P G L+ L L + ++
Sbjct: 213 IRNS---PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269
Query: 258 PSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPN 306
P + +L L K+ L +P + L +I + + +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 47/324 (14%), Positives = 105/324 (32%), Gaps = 24/324 (7%)
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
+G S + LY + + + + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-------NRWHSAWRQA 53
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLK--KLKKLWMASTNLIGEIPETIGDMLALEFLDLS 249
N ++ T + + L + + + + P+ + L+ + +
Sbjct: 54 NSNNPQIETRTGRALKATADLLEDATQPGRVALEL-RSVPLPQFPDQAFRLSHLQHMTID 112
Query: 250 INNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDF 308
+P ++ + L + L N L +P ++ SL L+ + + A +P
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 309 GK---------LENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRY 359
L NL +L L + + +P I L +LK +++ N+ LS AL P
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 360 SPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNS 419
LE ++ + P L + +D + LP + + L + +
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 420 FTGNIPAGLWTGFNLSMVLISDNL 443
+P+ + ++L+ +L
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 56/389 (14%), Positives = 109/389 (28%), Gaps = 85/389 (21%)
Query: 207 SSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKN 266
S + + L+ + + + + D + S ++ N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNR-------WHSAWRQAN 54
Query: 267 LSKVYLYSNSLSG--EIPQAVESL---NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMF 321
+ + + + +E ++L + L P+ +L +L ++++
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 322 NQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLC 381
L E+P+ + L+ + L N L ALP + L + LPE L
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 382 AGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISD 441
S + +L +++
Sbjct: 172 ---------------STDASGEHQGLVNLQSLRLEWTGIR-------------------- 196
Query: 442 NLFTGELPDKMSG--NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELT 499
LP ++ NL L+I N+ S + +
Sbjct: 197 -----SLPASIANLQNLKSLKIRNSPLS-------------------------ALGPAIH 226
Query: 500 ALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLS-RNQLSGEIPEKIGFLPVLQDLDLS 558
LP L L L + P L L L + L +P I L L+ LDL
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 559 ENQFSGKIPPQIGRLM-LTSLNLSSNRLT 586
++P I +L + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 38/259 (14%), Positives = 71/259 (27%), Gaps = 22/259 (8%)
Query: 350 GALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSS 409
G+ S E + + L + D N N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRW-HSAWRQANSNN 57
Query: 410 LLMVKIYNNSFTGNIPA-GLWTGFNLSMVLISDNLFTGELPDKMSG--NLSRLEISNNRF 466
+ + T + + + PD+ +L + I
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 467 SGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTL-LLDQNQL--------SGS 517
++P + L + N +P + +L L L + +L S
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 518 LPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLT 576
+ +L +L L + +P I L L+ L + + S + P I L L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 577 SLNLSSNRLTGEIPSQFEN 595
L+L P F
Sbjct: 233 ELDLRGCTALRNYPPIFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 25/175 (14%), Positives = 48/175 (27%), Gaps = 9/175 (5%)
Query: 433 NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNG 492
+ + D + R ++ ++S N + +
Sbjct: 13 GRENLYFQGSTALRPYHDVL-SQWQRHYNADRNRW-HSAWRQANSNNPQIETRTGRALK- 69
Query: 493 TIPGELTAL--PSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLP 550
L P L L L P L + + L E+P+ +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 551 VLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFENRAYASSFLN 604
L+ L L+ N +P I L L L++ + E+P + +
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 64/310 (20%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G GG G V+ A+K+I + ++ + EV+ L+ + H IV+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 754 CCISSEN---------LKLLVY---EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
+N K+ +Y + K +L W++ + R+ + +
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE----RERSVCLHIFL 125
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL---------I 852
QIA + + ++H S ++HRDLK SNI + K+ DFG+ + +
Sbjct: 126 QIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912
+A + VG+ Y++PE + K DI+S G+IL EL E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQM--ERVRT 236
Query: 913 AQWAWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMV 967
++ K P+ M++ ML P ERP
Sbjct: 237 ----LTDVRNLKFPPLFTQKYPC------EYVMVQ---------DMLSPSPMERPEAIN- 276
Query: 968 LQILLNNPIF 977
++ N +F
Sbjct: 277 ---IIENAVF 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 74/316 (23%), Positives = 123/316 (38%), Gaps = 65/316 (20%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G+V + + A+KKI + ++ L+EV +L+++ H +V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 754 CCISSENLKL-------------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
+ + EY E +L +H +N + WR
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ------QRDEYWRLF 122
Query: 801 MQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL--------- 851
QI + L Y+H S I+HRDLK NI +D + N KI DFG+AK +
Sbjct: 123 RQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 852 --IKEEGEFAAMSTVVGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
G +++ +G+ Y+A E T NEK D+YS G+I E+
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMR 965
+ + ++ P F + ++V K I ++ P +RP R
Sbjct: 236 NI------LKKLRSVSIEFP--------PDFDDNKMKVEKK--IIRLLIDHDPNKRPGAR 279
Query: 966 MVLQILLNNPIFPTEK 981
LLN+ P +
Sbjct: 280 T----LLNSGWLPVKH 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-43
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 40/281 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G GK V +K+I N ++ K +E EV +L+ ++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+V +Y E L + ++ + D++L W QI L +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---EDQILDWFV--QIC----LALKH 140
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H I+HRD+KS NI L + ++ DFG+A++L E A +G+ Y++P
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELA--RACIGTPYYLSP 194
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK--PIVDALD 931
E + N K+DI++ G +L EL T K A L I G P+
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSFPPVSLHYS 250
Query: 932 KEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
++ + + + P +RP++ +L+
Sbjct: 251 YDLRS---------------LVSQLFKRNPRDRPSVNSILE 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 61/301 (20%), Positives = 118/301 (39%), Gaps = 34/301 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G +VYR VA+KK+ +D K + + E+ +L + H N++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 754 CCISSENLKLLVYEYMEKRSLDQWL--HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+N +V E + L + + KK + + V + Q+ L
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP---ERTVWKYFV--QL----CSAL 149
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
+MH S ++HRD+K +N+ + K+ D G+ + + A ++VG+ Y+
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYM 203
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
+PE N K+DI+S G +L E+ + GD+ + + I++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LCKKIEQCDY------ 255
Query: 932 KEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQILLNNPIFPTEKNGGRKYD 988
+ + EE+ + + + P +RP++ V + +
Sbjct: 256 PPLPSDHYSEELRQ------LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
Query: 989 H 989
H
Sbjct: 310 H 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 9e-42
Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 64/296 (21%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+IGSGG G+V++ + +K++ + + ++ EV+ L+ + H+NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVNIVHY 69
Query: 753 LCCISSENLKL----------------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
C + + E+ +K +L+QW+ K+ L + L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD---KVLALE 126
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEG 856
QI +G+ Y+H S +++RDLK SNI L KI DFG+ L +
Sbjct: 127 LFE--QIT----KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG- 176
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916
+ G+ Y++PE ++ ++ D+Y+ G+IL EL
Sbjct: 177 ---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC--------------- 218
Query: 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
E L I F ++ + +L P +RPN +L+
Sbjct: 219 -DTAFETSKFFTDLRDGIISDIFDKKEKT------LLQKLLSKKPEDRPNTSEILR 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-42
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G VY+ T VA ++ DRKL + + F E ++L ++H NIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 754 -CCISSENLKLLVY---EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
S+ K + E M +L +L + + + SW R QI +
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK-----VLRSWCR--QIL----K 140
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLD-YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
GL ++H +P I+HRDLK NI + + KI D G+A + + V+G+
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTP 194
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
++APE K +E D+Y+FG+ +LE+ T + + E AQ +R + G
Sbjct: 195 EFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQI-YRRVTSGVKP-A 249
Query: 929 ALDKEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
+ DK +E C ER +++ LLN+ F
Sbjct: 250 SFDKVAIPEVKEIIEG----------CIRQNKDERYSIKD----LLNHAFF 286
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 72/495 (14%), Positives = 161/495 (32%), Gaps = 37/495 (7%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
+ I + + + + + ++ LDLS N D+ ++L+ L L++
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN--TEFSPSSLP 210
N + + L+ LR L+L N E+ ++E L A N + S S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVF--KLKNLS 268
K +++A+ + G +++LDL +N ++ + L
Sbjct: 121 G-------KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLE 172
Query: 269 KVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ L N + ++ V LK +DLS+N L + +F + +SL N+L I
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 329 PEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAG 388
+ + +L+ L N DF +S + + L +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 389 IAAQDNNLSGELPES-LGNCSSLLMVKIYNNSFTGN----IPAGLWTGFNLSMVLISDNL 443
+ +LP +L + S G+ + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 444 FTGELPDKMSGNLSRLE---ISNNRFSGKIPTGVSSSKNL--VVFQASNNLFNGTIPGEL 498
+ + D+++ ++ G + L + QA + E
Sbjct: 348 YR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
Query: 499 TALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558
+ L L ++ ++ ++ ++ +++ + E + + DL+
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSV--QNNAIRDWDMYQHKETQLAEENARLKKLNGEADLA 464
Query: 559 ENQFSGKIPPQIGRL 573
+ + + R
Sbjct: 465 LASANATLQELVVRE 479
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-38
Identities = 64/464 (13%), Positives = 149/464 (32%), Gaps = 32/464 (6%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
I E +R K +T +++ + + +++L+L N + A++ LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
L L+ N L L+ L + + N + E+ ++E L + NN +
Sbjct: 62 LLNLSSN---VLYETLD-LESLSTLRTLDL-NNNYVQELLVGP----SIETLHAANNNIS 112
Query: 255 GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTG-AIPNDFGKLE 312
+ S + +YL +N ++ ++ +DL N + +
Sbjct: 113 -RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 313 NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNL 372
L +L+L +N + ++ + + LK + L +N L+ + P+F + + + + N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 373 TGSLPEHLCAGGKLAGIAAQDNNLS-GELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTG 431
+ + L L + N G L + + + + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVK-KLTGQNEEE 282
Query: 432 FNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRF-------SGKIPTGVSSSKNLVVFQ 484
+ + +LP + L L+ + + ++ +
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 485 ASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPE 544
A + I + TL + L + + L E+
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQH 401
Query: 545 KIGFLPVLQDLDLSENQFSGK-IPPQIGRLM-LTSLNLSSNRLT 586
LQ L ++ + Q + + ++ ++ T
Sbjct: 402 ATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 56/421 (13%), Positives = 122/421 (28%), Gaps = 23/421 (5%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDM 240
+I N + ++ + S ++ +K+L ++ L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDS---SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF 57
Query: 241 LALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNL 300
LE L+LS N + L L + L +N + E+ +++ + + NN+
Sbjct: 58 TKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNI 111
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYS 360
+ + + + N+ L N+++ G ++ + L N + + S
Sbjct: 112 S-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 361 P-LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNS 419
LE+ + N + + + KL + N L+ + + + + + + NN
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 420 FTGNIPAGLWTGFNLSMVLISDN-LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSK 478
I L NL + N G L D S N ++
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 479 NLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGS----LPLDIISWKSLTALNLS 534
+ L +L GS L + + ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 535 RNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFE 594
+ Q I + L+ + ++ L E+ E
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 595 N 595
Sbjct: 405 E 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 52/355 (14%), Positives = 98/355 (27%), Gaps = 35/355 (9%)
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFL 148
+ L L LDL NY+ L +E L + N I + K +
Sbjct: 74 LDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNN-ISRVSCSR--GQGKKNI 125
Query: 149 YLTANNMSGKIPASIGRLTELRQLNLVVNQFNG-SIPAEIGNLQNLEALELAYNTEFSPS 207
YL N ++ G + ++ L+L +N+ + + + LE L L YN
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN---FIY 182
Query: 208 SLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNL 267
+ KLK L + S+N + + + ++ L N I ++ +NL
Sbjct: 183 DVKGQ-VVFAKLKTLDL-SSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 268 SKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGE 327
L N + S N +V ++ + + +
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 328 IPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
L +LK + T L +
Sbjct: 300 PAPFADRLIALKRKEHALLSGQ--------------------GSETERLECERENQARQR 339
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442
I A + + + + ++ + + G L L
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-28
Identities = 55/333 (16%), Positives = 106/333 (31%), Gaps = 44/333 (13%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
K+ ++ ++L A+ + N+ L L N LS + L+ + L +N+L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
D S L +++ N + L
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----------------------------ELLVGP 99
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLE---ISNNR 465
S+ + NN+ + + + +++N T L D G SR++ + N
Sbjct: 100 SIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNE 155
Query: 466 FSG-KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS 524
+SS L N + G++ L TL L N+L+ + + S
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS 212
Query: 525 WKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNR 584
+T ++L N+L I + + F L+ DL N F ++
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 585 LTGEIPSQFENRAYASSFLNNPGLCASSSNVNL 617
+ ++ Q E + + C
Sbjct: 272 VK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-21
Identities = 40/310 (12%), Positives = 89/310 (28%), Gaps = 21/310 (6%)
Query: 74 TELHLTNMNMNG-TFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L L ++ F L L+LQ+N+ I + +KL+ LDLS N +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF-IYDVKGQV-VFAKLKTLDLSSNK-L 203
Query: 133 GPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN-GSIPAEIGNLQ 191
+ + + + ++ L N + I ++ L +L N F+ G++ Q
Sbjct: 204 AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML------ALEF 245
++ + + L + + L ++P D L
Sbjct: 263 RVQTVAKQ-----TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAI 304
L + + ++ I Q ++ L +
Sbjct: 318 LSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVR-LFNNMLSGALPPDFGRYSPLE 363
N L E+ L+ +R + + + + +
Sbjct: 377 SNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIR 435
Query: 364 YFEVSVNNLT 373
+++ + T
Sbjct: 436 DWDMYQHKET 445
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 59/317 (18%), Positives = 113/317 (35%), Gaps = 24/317 (7%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
+ I + + + + + ++ LDLS N D+ ++L+ L L++
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN--TEFSPSSLP 210
N + + L+ LR L+L N E+ ++E L A N + S S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSINNFTG-SIPSSVFKLKNLS 268
K +++A+ N I + + G +++LDL +N + L
Sbjct: 121 G-------KKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 269 KVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ L N + ++ V LK +DLS+N L + +F + +SL N+L I
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 329 PEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAG 388
+ + +L+ L N DF +S + + L +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 389 IAAQDNNLSGELPESLG 405
+ +LP
Sbjct: 288 LGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 56/314 (17%), Positives = 94/314 (29%), Gaps = 26/314 (8%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
+T+ ++ N+ LDL N + L +KLE L+LS N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
D++ LS L+ L L N + + + L+ N + + Q
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQ 120
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP--ETIGDMLALEFLD 247
+ + LA N T +++ L + N I + E LE L+
Sbjct: 121 GKKNIYLANNKITMLRDLD----EGCRSRVQYLDL-KLNEIDTVNFAELAASSDTLEHLN 175
Query: 248 LSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPN 306
L N + V L + L SN L+ + +S + I L N L I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 307 DFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFE 366
+NL + L N + + + + L +
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLG 289
Query: 367 VSVNNLTGSLPEHL 380
LP
Sbjct: 290 HYGAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 52/329 (15%), Positives = 116/329 (35%), Gaps = 22/329 (6%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
I E +R K +T +++ + + +++L+L N + A++ LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
L L+ N L L+ L + + N + E+ ++E L + NN +
Sbjct: 62 LLNLSSN---VLYETLD-LESLSTLRTLDL-NNNYVQELLV----GPSIETLHAANNNIS 112
Query: 255 GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTG-AIPNDFGKLE 312
+ S + +YL +N ++ ++ +DL N + +
Sbjct: 113 -RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 313 NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNL 372
L +L+L +N + ++ + + LK + L +N L+ + P+F + + + + N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 373 TGSLPEHLCAGGKLAGIAAQDNNLS-GELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTG 431
+ + L L + N G L + + + + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVK-KLTGQNEEE 282
Query: 432 FNLSMVLISDNLFTGELPDKMSGNLSRLE 460
+ + +LP + L L
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 54/330 (16%), Positives = 102/330 (30%), Gaps = 43/330 (13%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
K+ ++ ++L A+ + N+ L L N LS + L+ + L +N+L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
D S L +++ N + L
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----------------------------ELLVGP 99
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLE---ISNNR 465
S+ + NN+ + + + +++N T L D G SR++ + N
Sbjct: 100 SIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNE 155
Query: 466 FSG-KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS 524
+SS L N + G++ L TL L N+L+ + + S
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS 212
Query: 525 WKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNR 584
+T ++L N+L I + + F L+ DL N F ++
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 585 LTGEIPSQFENRAYASSFLNNPGLCASSSN 614
+ E + C
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 49/311 (15%), Positives = 104/311 (33%), Gaps = 20/311 (6%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP-ETIGDM 240
+I N + ++ + +L S +K+L + S N + +I +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDS--SLKQALASLRQSAWNVKELDL-SGNPLSQISAADLAPF 57
Query: 241 LALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNL 300
LE L+LS N + L L + L +N + E+ +++ + + NN+
Sbjct: 58 TKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNI 111
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYS 360
+ + + + N+ L N+++ G ++ + L N + + S
Sbjct: 112 S-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 361 P-LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNS 419
LE+ + N + + + KL + N L+ + + + + + + NN
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 420 FTGNIPAGLWTGFNLSMVLISDN-LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSK 478
I L NL + N G L D S N ++ K+
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEEC 283
Query: 479 NLVVFQASNNL 489
+
Sbjct: 284 TVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 501 LPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSEN 560
+ + L +L S ++ L+LS N LS + L+ L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 561 QFSGKIPPQIGRL-MLTSLNLSSNRLT 586
+ L L +L+L++N +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-38
Identities = 68/353 (19%), Positives = 127/353 (35%), Gaps = 28/353 (7%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
L +N FP DL LQ + + L ++ +
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK-VA 57
Query: 134 PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
I I+ L+ L++L L N ++ P + L +L L + N+ + + + NL NL
Sbjct: 58 SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNL 112
Query: 194 EALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNF 253
L L + + S + L K+ L + N + +M L +L ++ +
Sbjct: 113 RELYLNED---NISDIS-PLANLTKMYSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 254 TGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLE 312
P + L +L + L N + P + SL +L N +T P +
Sbjct: 168 KDVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 313 NLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNL 372
L +L + N+++ + L L + + N +S + L+ V N +
Sbjct: 222 RLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 373 TGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIP 425
+ L +L + +N L E E +G ++L + + N T P
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 77/420 (18%), Positives = 147/420 (35%), Gaps = 77/420 (18%)
Query: 169 LRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTN 228
L + N P +L L + + +L+ + KL +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKAS----VTDVVTQEELESITKLV-VAGE 54
Query: 229 LIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL 288
+ I I + LE+L+L+ N T P + L L+ +Y+ +N ++ A+++L
Sbjct: 55 KVASIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNL 109
Query: 289 -NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNM 347
NL+ + L+ +N++ P L + +L+L N + + L + + +
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 348 LSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNC 407
+ + L ++ N + L +
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDI--------------------------SPLASL 198
Query: 408 SSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFS 467
+SL Y N T P N++ L+ L+I NN+ +
Sbjct: 199 TSLHYFTAYVNQITDITPVA-----NMT-------------------RLNSLKIGNNKIT 234
Query: 468 GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKS 527
P +++ L + N + + L L L + NQ+S L+ +
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDISVLN--NLSQ 288
Query: 528 LTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLT 586
L +L L+ NQL E E IG L L L LS+N + P + L + S + ++ +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-25
Identities = 59/362 (16%), Positives = 120/362 (33%), Gaps = 94/362 (25%)
Query: 228 NLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES 287
I +I D+ L + T + +L++++K+ + ++ Q +E
Sbjct: 10 APINQI-FPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEY 64
Query: 288 L-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNN 346
L NL+ ++L+ N +T P L L NL + N+++ + L +L+++ L +
Sbjct: 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNED 120
Query: 347 MLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGN 406
+S + + + N + L N
Sbjct: 121 NISD--ISPLANLTKMYSLNLG-------------------------ANHNLSDLSPLSN 153
Query: 407 CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRF 466
+ L + + + P NL+ +L L ++ N+
Sbjct: 154 MTGLNYLTVTESKVKDVTPIA-----NLT-------------------DLYSLSLNYNQI 189
Query: 467 SGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWK 526
P L +L SL NQ++ P+ +
Sbjct: 190 EDISP--------------------------LASLTSLHYFTAYVNQITDITPVA--NMT 221
Query: 527 SLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRL 585
L +L + N+++ P + L L L++ NQ S + L L LN+ SN++
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 586 TG 587
+
Sbjct: 278 SD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 29/223 (13%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
L+L N N + + ++ L L + + + P + N + L L L+ N
Sbjct: 135 YSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191
Query: 134 PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
P + L+ L + N ++ P + +T L L + N+ P + NL L
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQL 245
Query: 194 EALELAYN--TEFSP-SSLP---------------SNFTQLKKLKKLWMASTNLIGEIPE 235
LE+ N ++ + L S L +L L++ + L E E
Sbjct: 246 TWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 236 TIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS 278
IG + L L LS N+ T P + L + + +
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-18
Identities = 47/302 (15%), Positives = 93/302 (30%), Gaps = 66/302 (21%)
Query: 290 LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS 349
+ + P L + L ++ + L S+ + + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 350 GALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSS 409
+ LEY ++ N +T L N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--------------------------ISPLSNLVK 89
Query: 410 LLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGK 469
L + I N T +I A L NL L ++ + S
Sbjct: 90 LTNLYIGTNKIT-DISAL------------------QNLT-----NLRELYLNEDNISDI 125
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLT 529
P +++ + N N + L+ + L L + ++++ P+ + L
Sbjct: 126 SP--LANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLY 180
Query: 530 ALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGE 588
+L+L+ NQ+ P + L L NQ + P + + L SL + +N++T
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236
Query: 589 IP 590
P
Sbjct: 237 SP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 30/154 (19%), Positives = 58/154 (37%), Gaps = 11/154 (7%)
Query: 439 ISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEL 498
PD R + + + +++ + +I G +
Sbjct: 7 TLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-I 62
Query: 499 TALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558
L +L L L+ NQ++ PL + LT L + N+++ + L L++L L+
Sbjct: 63 EYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTNLRELYLN 118
Query: 559 ENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPS 591
E+ S P + L + SLNL +N ++
Sbjct: 119 EDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-38
Identities = 77/335 (22%), Positives = 119/335 (35%), Gaps = 44/335 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G+GG G V R T E VA+K+ ++L K+ + + E+QI+ + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 754 CCISSEN------LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
L LL EY E L ++L++ G + + I+
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLLS--DIS--- 131
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA---KIADFGVAKILIKEEGEFAAMSTV 864
L Y+H I+HRDLK NI+L KI D G AK L ++GE +
Sbjct: 132 -SALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGEL--CTEF 183
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
VG+ Y+APE +K D +SFG + E TG + W K
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ----WHGKVREK 239
Query: 925 PIVDALD-----------KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973
+ + P L ++ KL ML R N
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG-KLERWLQCMLMWH-QRQRGTDPQNPN 297
Query: 974 NPIF-PTEKNGGRKYDHVTPLLTDSKREKMSESDD 1007
F + K V +++ ++
Sbjct: 298 VGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENE 332
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN--IV 750
IGSGGS KV++V +N ++ A+K + N + D + + E+ L+ ++ + I+
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS-WRRRMQIAVGAAQ 809
+L ++ +V E L+ WL KK E S W+ + +
Sbjct: 92 RLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDP-----WERKSYWK---NML----E 138
Query: 810 GLCYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+ +H H IVH DLK +N L+ + K+ DFG+A ++ + + VG+
Sbjct: 139 AVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTV 192
Query: 869 GYIAPE-----------YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+ PE K++ K+D++S G IL +T GK
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 70/335 (20%), Positives = 114/335 (34%), Gaps = 53/335 (15%)
Query: 652 SFFYMIRIYQKRKDELTSTETTSFHRLNFRDSDILPKLTES----NVIGSGGSGKVYRVP 707
+F + Q R+ + + + S +S + +G G G+V++V
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR 77
Query: 708 INHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVY 766
+ AVK+ K LAEV + +H V+L + L
Sbjct: 78 SKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
Query: 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRD 826
E SL Q + +SL E W L ++H S +VH D
Sbjct: 137 ELCG-PSLQQHC-EAWGASLP-----EAQVWGYLRDTL----LALAHLH---SQGLVHLD 182
Query: 827 LKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTD 886
+K +NI L K+ DFG+ L G A G Y+APE + D
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAPELLQ-GSYGTAAD 237
Query: 887 IYSFGVILLELTTGKE-ANNGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIR 945
++S G+ +LE+ E + G+ W+ +++G P F +
Sbjct: 238 VFSLGLTILEVACNMELPHGGEG--------WQQLRQG----------YLPPEFTAGLSS 279
Query: 946 VFKLGVICTSML---PTERPNMRMVLQILLNNPIF 977
+ + ML P R LL P+
Sbjct: 280 ELRS--VLVMMLEPDPKLRATAEA----LLALPVL 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH--LNIV 750
IGSGGS KV++V +N ++ A+K + N + D + + E+ L+ ++ I+
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS-WRRRMQIAVGAAQ 809
+L ++ +V E L+ WL KK E S W+ + +
Sbjct: 73 RLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDP-----WERKSYWK---NML----E 119
Query: 810 GLCYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+ +H H IVH DLK +N L+ + K+ DFG+A ++ + + VG+
Sbjct: 120 AVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTV 173
Query: 869 GYIAPE-----------YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+ PE K++ K+D++S G IL +T GK
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 5e-37
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH--LNIV 750
IGSGGS KV++V +N ++ A+K + N + D + + E+ L+ ++ I+
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS-WRRRMQIAVGAAQ 809
+L ++ +V E L+ WL KK E S W+ + +
Sbjct: 120 RLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDP-----WERKSYWK---NML----E 166
Query: 810 GLCYMH-HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+ +H H IVH DLK +N L+ + K+ DFG+A ++ + + VG+
Sbjct: 167 AVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGAV 220
Query: 869 GYIAPE-----------YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+ PE K++ K+D++S G IL +T GK
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 31/222 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G + V+R T ++ A+K + + + E ++L + H NIVKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 754 CCISSENLKL--LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ L+ E+ SL L + + + G E L R + G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLR--DV----VGGM 125
Query: 812 CYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
++ IVHR++K NI+ D K+ DFG A+ L E+ E ++ G+
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQ--FVSLYGT 178
Query: 868 CGYIAPE--------YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+ P+ +K D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 66/331 (19%), Positives = 116/331 (35%), Gaps = 67/331 (20%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+G GG V V H A+K+I +Q+ +E E + H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHP 86
Query: 748 NIVKLLCCISSENLK----LLVYEYMEKRSLDQWL--HKKNRSSLSGRARDEVLSWRRRM 801
NI++L+ E L+ + ++ +L + K + L+ D++L
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT---EDQIL------ 137
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL---IKEEGEF 858
+ +G +GL +H + HRDLK +NILL + D G ++ +
Sbjct: 138 WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 859 AAMSTVVGSCG---YIAPE---YARTRKVNEKTDIYSFGVILLELTTGK----EANNGDE 908
+ Y APE ++E+TD++S G +L + G+ +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 909 HTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMR 965
LA I P L +++ SM+ P +RP++
Sbjct: 255 SVALAVQNQLSI----PQSPRHSSA------LWQLLN---------SMMTVDPHQRPHIP 295
Query: 966 MVLQIL--LNNPIFPTEKNGGRKYDHVTPLL 994
++L L L P H T +L
Sbjct: 296 LLLSQLEALQPPAPGQ---------HTTQIL 317
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 82/286 (28%), Positives = 127/286 (44%), Gaps = 32/286 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG VY VA+K I+ + ++ K F EV S + H NIV ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
++ LV EY+E +L +++ LS + G+ +
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP-----------LSVDTAINFTNQILDGIKHA 127
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H IVHRD+K NIL+D N KI DFG+AK L E + V+G+ Y +PE
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPE 182
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV-DALDKE 933
A+ +E TDIYS G++L E+ G+ NG+ T ++ A +HIQ+ P V + K+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE--TAVSI-AIKHIQDSVPNVTTDVRKD 239
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTERPN----MRMVLQILLNNP 975
I + L +I + T R M+ L +L+
Sbjct: 240 IPQS--LSNVI------LRATEKDKANRYKTIQEMKDDLSSVLHEN 277
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 73/387 (18%), Positives = 144/387 (37%), Gaps = 50/387 (12%)
Query: 64 PEIACTDGSV------TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYN 117
PE C D ++ ++H+ + F L N I+ + + + +L +
Sbjct: 8 PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDS 67
Query: 118 CSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGR-LTELRQLNLV 175
++E L+L+ I I ++ LY+ N + +P + + + L L L
Sbjct: 68 FRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 176 VNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEI 233
N + S+P I N L L ++ N + + + F L+ L ++S N + +
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNN---NLERIEDDTFQATTSLQNLQLSS-NRLTHV 180
Query: 234 P-----------------ETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNS 276
T+ +A+E LD S N+ + V L+ + L N+
Sbjct: 181 DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNN 237
Query: 277 LSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLP 336
L+ + + L +DLS N L + + F K++ L L + N+L + +P
Sbjct: 238 LT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 337 SLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396
+LK + L +N L + + ++ LE + N++ +L L + N+
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT--LKNLTLSHNDW 351
Query: 397 SGELPESLGNCSSLLMVKIYNNSFTGN 423
N L + +
Sbjct: 352 D-------CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 67/378 (17%), Positives = 125/378 (33%), Gaps = 24/378 (6%)
Query: 243 LEFLDLSINNFTGSIPSSV--FKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANN 299
F D+ I+ T + L N V ++++ ++S +++++L+
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 300 LTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGL-LPSLKDVRLFNNMLSGALPPD-FG 357
+ F + L + FN + +P + +P L + L N LS +LP F
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
Query: 358 RYSPLEYFEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIY 416
L +S NNL + + L + N L+ + L SL +
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 417 NNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSS 476
N + L + + S N + ++ L+ L++ +N + + +
Sbjct: 195 YNLLST-----LAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTAW-LLN 246
Query: 477 SKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRN 536
LV S N + + L L + N+L +L L +L L+LS N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 537 QLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENR 596
L + L++L L N + L +L LS N
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDWDCNSLRALFRN 362
Query: 597 AYASSFLNNPGLCASSSN 614
+ + C
Sbjct: 363 VARPAVDDADQHCKIDYQ 380
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 23/126 (18%), Positives = 45/126 (35%), Gaps = 8/126 (6%)
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSL 528
I + + + E L + + + + LP ++ + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 529 TALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRL 585
LNL+ Q+ EI + +Q L + N +PP + + + LT L L N L
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 586 TGEIPS 591
+ +P
Sbjct: 130 S-SLPR 134
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 11/97 (11%), Positives = 31/97 (31%), Gaps = 5/97 (5%)
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI-GFLPV 551
I L + +D + I+ + + + + ++P +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 552 LQDLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRLT 586
++ L+L++ Q +I + L + N +
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 71/288 (24%), Positives = 108/288 (37%), Gaps = 47/288 (16%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G G + VAVK+I + EVQ+L H N+++
Sbjct: 31 VLGHGAEGTIVYR-GMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHPNVIRY 83
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C + + E +L +++ +K+ + L + Q GL
Sbjct: 84 FCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQ------QTT----SGLA 132
Query: 813 YMHHDCSPTIVHRDLKSSNILL-----DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
++H S IVHRDLK NIL+ A I+DFG+ K L F+ S V G+
Sbjct: 133 HLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 868 CGYIAPEY---ARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
G+IAPE DI+S G + + + G A I G
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-----ILLGA 244
Query: 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQ 969
+D L E E E+I M+ P +RP+ + VL+
Sbjct: 245 CSLDCLHPEKHEDVIARELIE---------KMIAMDPQKRPSAKHVLK 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 31/222 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G + V+R T ++ A+K N+ + + + E ++L + H NIVKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDV-QMREFEVLKKLNHKNIVKLF 73
Query: 754 CCISSENLKL--LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ L+ E+ SL L + + + G E L R + G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLR--DV----VGGM 125
Query: 812 CYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
++ IVHR++K NI+ D K+ DFG A+ L E+ E ++ G+
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQ--FVSLYGT 178
Query: 868 CGYIAPE--------YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+ P+ +K D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 28/251 (11%)
Query: 656 MIRIYQKRKDELTSTETTSFHRLNFRDSDILP--KLTESNVIGSGGSGKVYRVPINHTAE 713
+I + LT HR +D +L L IG G G+V+ +
Sbjct: 81 LIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 714 VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRS 773
+VAVK D K +FL E +IL H NIV+L+ + + +V E ++
Sbjct: 141 LVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198
Query: 774 LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833
+L R L + +Q+ AA G+ Y+ S +HRDL + N L
Sbjct: 199 FLTFL----------RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCL 245
Query: 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIY 888
+ KI+DFG+++ +G +AA G + APE + + ++D++
Sbjct: 246 VTEKNVLKISDFGMSREE--ADGVYAAS----GGLRQVPVKWTAPEALNYGRYSSESDVW 299
Query: 889 SFGVILLELTT 899
SFG++L E +
Sbjct: 300 SFGILLWETFS 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 63/242 (26%), Positives = 116/242 (47%), Gaps = 28/242 (11%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
Q+++ E T+ L D + + +G+G G V++V + V+A K I
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDD------FEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 721 WNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHK 780
++ + + E+Q+L IV S+ + E+M+ SLDQ L K
Sbjct: 67 --HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 781 KNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840
+GR +++L ++++ +GL Y+ I+HRD+K SNIL++
Sbjct: 125 ------AGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEI 171
Query: 841 KIADFGVAKILIKEEGEFAAMS-TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
K+ DFGV+ LI +M+ + VG+ Y++PE + + ++DI+S G+ L+E+
Sbjct: 172 KLCDFGVSGQLI------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 900 GK 901
G+
Sbjct: 226 GR 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 62/312 (19%), Positives = 111/312 (35%), Gaps = 62/312 (19%)
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL 741
S + E IGSG G V++ + A+K+ E+ L EV
Sbjct: 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAH 64
Query: 742 STI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
+ + +H ++V+ + ++ L+ EY SL + + R E
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI---MSYFKEAELKDLL 121
Query: 801 MQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-------------------FNAK 841
+Q+ +GL Y+H S ++VH D+K SNI + K
Sbjct: 122 LQVG----RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKV-NEKTDIYSFGVILLELTTG 900
I D G + ++ G ++A E + K DI++ + ++
Sbjct: 175 IGDLGHVTRI-------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
Query: 901 KEA-NNGDEHTCLAQWAWRHIQEGK--PIVDALDKEIDEPCFLEEMIRVFKLGVICTSML 957
+ NGD+ W I++G+ I L +E E L+ MI
Sbjct: 228 EPLPRNGDQ--------WHEIRQGRLPRIPQVLSQEFTE--LLKVMIHP----------D 267
Query: 958 PTERPNMRMVLQ 969
P RP+ +++
Sbjct: 268 PERRPSAMALVK 279
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 95/476 (19%), Positives = 171/476 (35%), Gaps = 47/476 (9%)
Query: 119 SKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQ 178
K L++SQNY DI LS+L+ L ++ N + + EL L+L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 179 FNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIG 238
I NL+ L+L++N F + F + +LK L +++T+L I
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 239 DMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSAN 298
+ + L + + L++ + L+ + + + +D+S
Sbjct: 137 HLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFI-------LDVSVK 187
Query: 299 NLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGR 358
+ ++ + S + L+ +L ++ N L
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ--LVW 245
Query: 359 YSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNN 418
++ + YF +S L G L + S + +L + ++ ++
Sbjct: 246 HTTVWYFSISNVKLQGQLD-------------------FRDFDYSGTSLKALSIHQVVSD 286
Query: 419 SFTGNIPAGLWTGF---NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS 475
F + ++ F N+ +S L L+ SNN +
Sbjct: 287 VFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENC 344
Query: 476 SS-KNLVVFQASNNLFN--GTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTAL 531
L N I T + SL L + QN +S SW KSL +L
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 532 NLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLT 586
N+S N L+ I P ++ LDL N+ IP Q+ +L L LN++SN+L
Sbjct: 405 NMSSNILTDTIFRC--LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 92/464 (19%), Positives = 161/464 (34%), Gaps = 56/464 (12%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
+P+D+ + L ++ N +S + I L++LR L + N+ +Q L+
Sbjct: 15 VPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNR-----------IQYLD 61
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
S F ++L+ L + S N + +I + L+ LDLS N F
Sbjct: 62 ---------------ISVFKFNQELEYLDL-SHNKLVKIS--CHPTVNLKHLDLSFNAFD 103
Query: 255 GSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLEN 313
F + L + L + L + LN+ + L G D L++
Sbjct: 104 ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQD 162
Query: 314 LLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLT 373
SL + + I + L + + L + Y ++ N
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL 222
Query: 374 GSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFN 433
+L L I N+ L L +++ I N G + +
Sbjct: 223 SNLT--------LNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 434 LSMVLIS----DNLFTGELPDKMSGNLSRLEISNNRFSGK--IPTGVSSS-KNLVVFQAS 486
S+ +S + G + S + I N SG + S + S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 487 NNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDI---ISWKSLTALNLSRNQLSGEIP 543
NNL T+ L L TL+L NQL L KSL L++S+N +S +
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 544 EKI-GFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLT 586
+ + L L++S N + I + + L+L SN++
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-IKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 93/483 (19%), Positives = 165/483 (34%), Gaps = 38/483 (7%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
+ TIL++ NYI + + + SKL L +S N I + + L++L L+ N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHN 79
Query: 154 NMSGKIPASIGRLTELRQLNLVVNQFNGSIP--AEIGNLQNLEALELAYNTEFSPSSLPS 211
+ S L+ L+L N F+ ++P E GN+ L+ L L+ S
Sbjct: 80 KLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL--EKSSVL 133
Query: 212 NFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVY 271
L K L + + + L I T + + +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 272 LYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEG 331
L +++ L + L N L N+ +N I +
Sbjct: 192 LELSNIKC-------VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQL 243
Query: 332 IGLLP----SLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
+ S+ +V+L + L +V + +
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISDNLFT- 445
+ S L + NN T + L +++ N
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLKE 362
Query: 446 ----GELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTA 500
E+ +M +L +L+IS N S G S +K+L+ S+N+ TI L
Sbjct: 363 LSKIAEMTTQMK-SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420
Query: 501 LPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSE 559
P + L L N++ S+P ++ ++L LN++ NQL +P+ I L LQ + L
Sbjct: 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 560 NQF 562
N +
Sbjct: 478 NPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 76/466 (16%), Positives = 144/466 (30%), Gaps = 95/466 (20%)
Query: 94 LRNLTILDLQFNYIIS-QFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
NL LDL FN + + N S+L++L LS + I L+ K L +
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 153 NNMSGKIPA---SIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTE----FS 205
K L + +F+ + + + NLE + E
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML---ALEFLDLSINNFTGSIPSSVF 262
S+ + KL L + + I ++ + + +S G + F
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESL------NLKVIDLSANNLTGAIPNDFGKLENLLN 316
S L + + ++ +S N+ + + + + K+ L+
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 317 LSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD---FGRYSPLEYFEVSVNNLT 373
L N L+ + E G L L+ + L N L L + L+ ++S N+++
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 374 GSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFN 433
+ G+CS +
Sbjct: 388 YDEKK--------------------------GDCSWTK---------------------S 400
Query: 434 LSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGT 493
L + +S N+ T + + + L++ +N+ +
Sbjct: 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-------------------------S 435
Query: 494 IPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRNQL 538
IP ++ L +L L + NQL S+P I SL + L N
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 62/308 (20%), Positives = 112/308 (36%), Gaps = 37/308 (12%)
Query: 49 PISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFI------CDLRNLTILDL 102
S + T+ ++ L L N+ I + +I ++
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 103 QFNYII--SQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIP 160
+ + F + L + + F P + S + T +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 161 ASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLK 220
+++ L+ N ++ G+L LE L L N QLK+L
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN-------------QLKELS 364
Query: 221 KLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSG 279
K+ +T + +L+ LD+S N+ + K+L + + SN L+
Sbjct: 365 KIAEMTTQMK-----------SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 280 EIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSL 338
I + + +KV+DL +N + +IP KLE L L++ NQL +P+GI L SL
Sbjct: 414 TIFRCLPP-RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSL 470
Query: 339 KDVRLFNN 346
+ + L N
Sbjct: 471 QKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 8e-19
Identities = 55/365 (15%), Positives = 105/365 (28%), Gaps = 53/365 (14%)
Query: 243 LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNL 300
L++S N + + +S L L + + N + + L+ +DLS N L
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEG--IGLLPSLKDVRLFNNMLSGALPPDFGR 358
I NL +L L FN +P G + LK + L L +
Sbjct: 82 V-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKS---SVLP 134
Query: 359 YSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNC--SSLLMVKIY 416
+ L +V + + E PE L + SL +V
Sbjct: 135 IAHLNISKVLLVLG--------------------ETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 417 NNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSS 476
N F + + T NL + I L + +S +
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 477 SKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-----KSLTAL 531
+ + + Q L ++ + +L G L + K+L+
Sbjct: 235 NSFIRILQ-------------LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 532 NLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-LTSLNLSSNRLTGEIP 590
+ + + + + + ++ L+ S+N LT +
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 591 SQFEN 595
+
Sbjct: 342 ENCGH 346
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 33/147 (22%), Positives = 58/147 (39%), Gaps = 10/147 (6%)
Query: 462 SNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLD 521
S N +P +S + S N + ++ +L L L++ N++ L +
Sbjct: 8 SKNGLI-HVPKDLSQK--TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDIS 63
Query: 522 IISW-KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF-SGKIPPQIGRLM-LTSL 578
+ + + L L+LS N+L +I L+ LDLS N F + I + G + L L
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 579 NLSSNRLTGEIPSQFENRAYASSFLNN 605
LS+ L + + L
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVL 147
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-35
Identities = 65/310 (20%), Positives = 118/310 (38%), Gaps = 19/310 (6%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
L L + +L L+L N + + P N L L L N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN-R 91
Query: 132 IGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-G 188
+ IP + LS L L ++ N + + + L L+ L + N I
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
Query: 189 NLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFL 246
L +LE L L + +S+P+ + L L L + I I + + + L+ L
Sbjct: 150 GLNSLEQLTLEKC---NLTSIPTEALSHLHGLIVLRLRH-LNINAIRDYSFKRLYRLKVL 205
Query: 247 DLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIP-QAVESL-NLKVIDLSANNLTGAI 304
++S + ++ + NL+ + + +L+ +P AV L L+ ++LS N ++
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIE 264
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPL 362
+ +L L + L+ QL+ + L L+ + + N L+ L F L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNL 322
Query: 363 EYFEVSVNNL 372
E + N L
Sbjct: 323 ETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 21/313 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
+LDL N I + + LE L+L++N + + + L L+ L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSN 90
Query: 154 NMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPS 211
+ IP + L+ L +L++ N+ + + +L NL++LE+ N +
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN---DLVYISH 145
Query: 212 N-FTQLKKLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLS 268
F+ L L++L + + IP E + + L L L N +I FK L L
Sbjct: 146 RAFSGLNSLEQLTLEK-CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLK 203
Query: 269 KVYLYSNSLSGEI-PQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGE 327
+ + + P + LNL + ++ NLT L L L+L +N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 328 IPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG-G 384
I + L L++++L L+ + P F + L VS N LT +L E + G
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
Query: 385 KLAGIAAQDNNLS 397
L + N L+
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 21/286 (7%)
Query: 74 TELHLTNMNM----NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQN 129
EL L + G F +L NL L L+ N + V S L LD+S+N
Sbjct: 59 EELELNENIVSAVEPGAFN----NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 130 YFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI- 187
I + + + L LK L + N++ + L L QL L SIP E
Sbjct: 115 -KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEAL 172
Query: 188 GNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFL 246
+L L L L + + +++ F +L +LK L ++ + + L L L
Sbjct: 173 SHLHGLIVLRLRHL---NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 247 DLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAI 304
++ N T ++P + L L + L N +S + L L+ I L L
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 305 PNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLS 349
P F L L L++ NQL+ + E + + +L+ + L +N L+
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-29
Identities = 75/369 (20%), Positives = 128/369 (34%), Gaps = 73/369 (19%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETI-GDMLALEFLDLSINNFTGSIPSSVFK- 263
P +P+ + L + N I + + LE L+L+ N + ++ F
Sbjct: 27 PEGIPTE------TRLLDL-GKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNN 78
Query: 264 LKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMF 321
L NL + L SN L IP V L NL +D+S N + + F L NL +L +
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 322 NQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEH 379
N L I L SL+ + L L+ ++P + L + N+ ++
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIR-- 192
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLI 439
S L +++I + + + G NL+ + I
Sbjct: 193 ---------------------DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
Query: 440 SDNLFTGELPDKMSGNLSRLE---ISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPG 496
+ T +P +L L +S N S I ++ +
Sbjct: 232 THCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE---------------GSMLHE---- 270
Query: 497 ELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQD 554
L L + L QL+ + L LN+S NQL+ + E + + L+
Sbjct: 271 ----LLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 555 LDLSENQFS 563
L L N +
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 71/365 (19%), Positives = 131/365 (35%), Gaps = 63/365 (17%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGD 239
++P I L+L N +L + F L++L + + N++ + +
Sbjct: 25 AVPEGI--PTETRLLDLGKN---RIKTLNQDEFASFPHLEELEL-NENIVSAVEPGAFNN 78
Query: 240 MLALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSA 297
+ L L L N IP VF L NL+K+ + N + + + L NLK +++
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 298 NNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPDF 356
N+L F L +L L+L L+ IP L L +RL + ++ F
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196
Query: 357 GRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPE-SLGNCSSLLMVKI 415
R L+ E+S ++ + G L ++ NL+ +P ++ + L + +
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNL 255
Query: 416 YNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS 475
N + I ++ L L +++ + + +
Sbjct: 256 SYNPIS----------------TIEGSMLHE-LL-----RLQEIQLVGGQLA-VVEPYA- 291
Query: 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLS 534
F G L L L + NQL+ +L + S +L L L
Sbjct: 292 --------------FRG--------LNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILD 328
Query: 535 RNQLS 539
N L+
Sbjct: 329 SNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 64/318 (20%), Positives = 119/318 (37%), Gaps = 19/318 (5%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
+PE I + + L L N + L +L L N ++ NL NL
Sbjct: 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNL 82
Query: 194 EALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETI-GDMLALEFLDLSIN 251
L L N +P FT L L KL + S N I + + + D+ L+ L++ N
Sbjct: 83 RTLGLRSN---RLKLIPLGVFTGLSNLTKLDI-SENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 252 NFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFG 309
+ I F L +L ++ L +L+ +A+ L L V+ L N+ F
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 310 KLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVS 368
+L L L + + +L + + + L+ A+P L + +S
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 369 VNNLTGSLPEHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAG 427
N ++ ++ + +L I L+ P + + L ++ + N T +
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEES 314
Query: 428 LWTGF-NLSMVLISDNLF 444
++ NL +++ N
Sbjct: 315 VFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 67/326 (20%), Positives = 121/326 (37%), Gaps = 41/326 (12%)
Query: 270 VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
V + +P+ + +++DL N + ++F +L L L N +S +
Sbjct: 16 VLCHRKRFV-AVPEGI-PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE 72
Query: 330 EGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG-GKL 386
G L +L+ + L +N L +P F S L ++S N + L +++ L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL 130
Query: 387 AGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTG 446
+ DN+L + +SL + + + T I +
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT----------------SIPTEALSH 174
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLT 505
L L L + + + I L V + S+ + T+ +LT
Sbjct: 175 -LH-----GLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 506 TLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQF 562
+L + L+ ++P + L LNLS N +S I + L LQ++ L Q
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSM-LHELLRLQEIQLVGGQL 284
Query: 563 SGKIPPQI--GRLMLTSLNLSSNRLT 586
+ + P G L LN+S N+LT
Sbjct: 285 A-VVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 41/215 (19%), Positives = 80/215 (37%), Gaps = 42/215 (19%)
Query: 72 SVTELHLTNMNM----NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
S+ +L L N+ L L +L L+ I + +L+ L++S
Sbjct: 153 SLEQLTLEKCNLTSIPTEAL----SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPA-SIGRLTELRQLNLVVNQFNGSIPAE 186
++ + + L L +T N++ +P ++ L LR LNL N
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI------- 260
Query: 187 IGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLALE 244
S++ + +L +L+++ + + + + L
Sbjct: 261 --------------------STIEGSMLHELLRLQEIQLVG-GQLAVVEPYAFRGLNYLR 299
Query: 245 FLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLS 278
L++S N T ++ SVF + NL + L SN L+
Sbjct: 300 VLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 42/211 (19%), Positives = 71/211 (33%), Gaps = 18/211 (8%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISDNLFTGELPD 450
+PE + + ++ + N + + F +L + +++N+ + +
Sbjct: 19 HRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-AVEP 73
Query: 451 KMSGNLSRLEI---SNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506
NL L +NR IP GV + NL S N + L +L +
Sbjct: 74 GAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132
Query: 507 LLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSG 564
L + N L + S SL L L + L+ IP + L L L L +
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 565 KIPPQI-GRL-MLTSLNLSSNRLTGEIPSQF 593
I RL L L +S +
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 45/294 (15%)
Query: 695 IGSGGSGKVYRVPINHTAE------VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
+G GG +V+ A VAVK + D D F E Q + + H
Sbjct: 20 LGFGGMSEVHL------ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 749 IVKLL----CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
IV + + L +V EY++ +L +H + ++ +R +++
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----------MTPKRAIEVI 122
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
A Q L + H + I+HRD+K +NI++ K+ DFG+A+ + + V
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
+G+ Y++PE AR V+ ++D+YS G +L E+ TG+ GD + ++ A++H++E
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSV-AYQHVREDP 236
Query: 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN----MRMVLQILLNN 974
A + + L+ ++ + + P R MR L + N
Sbjct: 237 IPPSARHEGLSAD--LDAVV------LKALAKNPENRYQTAAEMRADLVRVHNG 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G VYR HT VA+K I + EV+I ++H +I++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
N LV E ++++L + + E + QI G+ Y+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR------VKPFSENEARHFMHQI----ITGMLYL 128
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H S I+HRDL SN+LL N N KIADFG+A +K E T+ G+ YI+PE
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEK--HYTLCGTPNYISPE 182
Query: 875 YARTRKVNEKTDIYSFGVILLELTTGK 901
A ++D++S G + L G+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 6e-34
Identities = 84/595 (14%), Positives = 186/595 (31%), Gaps = 79/595 (13%)
Query: 49 PISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYII 108
+ + D ++H+ + F L N I+ + + +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 109 SQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGR-L 166
+L + ++E L+L+ I I ++ LY+ N + +P + + +
Sbjct: 65 KLPAALLDSFRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 122
Query: 167 TELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWM 224
L L L N + S+P I N L L ++ N + + + F L+ L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN---NLERIEDDTFQATTSLQNLQL 178
Query: 225 ASTNLIGEIP-----------------ETIGDMLALEFLDLSINNFTGSIPSSVFKLKNL 267
+S N + + T+ +A+E LD S N+ + V L
Sbjct: 179 SS-NRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVN--VEL 234
Query: 268 SKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGE 327
+ + L N+L+ + + L +DLS N L + + F K++ L L + N+L
Sbjct: 235 TILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 328 IPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
+ +P+LK + L +N L + + ++ LE + N++ +L L
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT--LK 348
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGN-----------------IPAGLWT 430
+ N+ N L + + +
Sbjct: 349 NLTLSHNDWD-------CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYL 401
Query: 431 GFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLF 490
L + ++ + + + + G + +A N
Sbjct: 402 DRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461
Query: 491 NGTIPGELTALPSLTTLLLDQNQ-LSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGF- 548
+ LL + + +L + L + + N++ + E+ F
Sbjct: 462 RAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFK 521
Query: 549 --------------LPVLQDLDLSENQFSGKIPPQIGRL--MLTSLNLSSNRLTG 587
+DL+ ++ + + + +L ++
Sbjct: 522 LRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG K + + T EV A K + L ++ E+ I ++ H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAVGAAQGLCY 813
+ +V E +RSL + ++ + E R + QI G Y
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEA---RYYLRQI----VLGCQY 130
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H ++HRDLK N+ L+ + KI DFG+A ++ +GE + G+ YIAP
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGER--KKVLCGTPNYIAP 184
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E + + + D++S G I+ L GK
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 59/311 (18%), Positives = 111/311 (35%), Gaps = 48/311 (15%)
Query: 681 RDSDILPKLTESNVIGSGGSG--KVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEV 738
R+ L KL ++ + E+ + + ++
Sbjct: 53 REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+ + N V L S + + + K +L W++++ R+ +
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED----REHGVCLH 168
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE--- 855
+QIA + + ++H S ++HRDLK SNI + K+ DFG+ + ++E
Sbjct: 169 IFIQIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 856 ------GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
+A + VG+ Y++PE + K DI+S G+IL EL E
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMER 279
Query: 910 TCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRM 966
+ ++ K ++ + M++ ML PTERP
Sbjct: 280 VRI----ITDVRNLK-FPLLFTQKYPQ---EHMMVQ---------DMLSPSPTERPEA-- 320
Query: 967 VLQILLNNPIF 977
++ N IF
Sbjct: 321 --TDIIENAIF 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G GG K + + T EV A K + L ++ E+ I ++ H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAVGAAQGLCY 813
+ +V E +RSL + ++ + E R + QI G Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEA---RYYLRQI----VLGCQY 156
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H + ++HRDLK N+ L+ + KI DFG+A ++ +GE + G+ YIAP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGER--KKVLCGTPNYIAP 210
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK 901
E + + + D++S G I+ L GK
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 65/308 (21%), Positives = 109/308 (35%), Gaps = 57/308 (18%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-H 746
+L V+ GG VY + A+K++ +++ + + EV + + H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 747 LNIVKLLCCISSENLK--------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
NIV+ S + LL+ E + + ++ ++R LS D VL
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS---CDTVL--- 139
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI------ 852
+I + + +MH P I+HRDLK N+LL K+ DFG A +
Sbjct: 140 ---KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 853 KEEGEFAAMSTVVGSCG---YIAPE---YARTRKVNEKTDIYSFGVILLELTTGKEANNG 906
A + + Y PE + EK DI++ G IL L +
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-- 253
Query: 907 DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML---PTERPN 963
++ L I GK + + +ML P ER +
Sbjct: 254 EDGAKLR------IVNGKY------SIPPHDTQYTVFHSLIR------AMLQVNPEERLS 295
Query: 964 MRMVLQIL 971
+ V+ L
Sbjct: 296 IAEVVHQL 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI-LSTIRHL 747
L +G G G V ++ + +++AVK+I ++ + +K L ++ I + T+
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
V + E + E M+ SLD++ K +++L +IAV
Sbjct: 67 FTVTFYGALFREGDVWICMELMDT-SLDKFY--KQVIDKGQTIPEDILG-----KIAVSI 118
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ L ++H S ++HRD+K SN+L++ K+ DFG++ L+ + A G
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGC 172
Query: 868 CGYIAPE----YARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE + + K+DI+S G+ ++EL +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKI--------------WNDRKLDQKHEKEFLAEVQ 739
+ G K+ + A+KK ND+ + +F E+Q
Sbjct: 38 TLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 740 ILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
I++ I++ + I++ + ++YEYME S+ ++ + + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 800 RM-QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
+ + Y+H++ + I HRD+K SNIL+D N K++DFG ++ ++ ++
Sbjct: 156 IIKSVL----NSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--- 206
Query: 859 AAMSTVVGSCGYIAPEYARTRKV--NEKTDIYSFGVILLELTTGK 901
+ G+ ++ PE+ K DI+S G+ L +
Sbjct: 207 --IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 74/362 (20%), Positives = 130/362 (35%), Gaps = 72/362 (19%)
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
C +L++ + + + P L + + L + N + +P L+ L +
Sbjct: 36 ACLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDN-NLTSLPALP---PELRTLEV 88
Query: 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLP 210
+ N ++ +P L EL + + +PA L L
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLW---------------- 127
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKV 270
N + +P L+ L +S N S+P+ +L L
Sbjct: 128 --------------IFGNQLTSLPVLPP---GLQELSVSDNQLA-SLPALPSELCKL--- 166
Query: 271 YLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPE 330
+ Y+N L+ +P L+ + +S N L ++P +L L N+L+ +P
Sbjct: 167 WAYNNQLT-SLPMLPS--GLQELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPA 218
Query: 331 GIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIA 390
L LK++ + N L+ +LP L+ VS N LT SLP L ++
Sbjct: 219 ---LPSGLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLP---SGLLSLS 267
Query: 391 AQDNNLSGELPESLGNCSSLLMVKIYNN---SFTGNIPAGLWTGFNLSMVLISDNLFTGE 447
N L+ LPESL + SS V + N T + + S +I ++
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
Query: 448 LP 449
P
Sbjct: 327 AP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 75/349 (21%), Positives = 119/349 (34%), Gaps = 70/349 (20%)
Query: 190 LQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLS 249
L + + ++LP + L + N + +P + L L++S
Sbjct: 39 NNGNAVLNVGES---GLTTLPDCL--PAHITTLVI-PDNNLTSLPALPPE---LRTLEVS 89
Query: 250 INNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
N T S+P L LS L L + + N LT ++P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLT-SLPVLPP 141
Query: 310 KLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSV 369
L+ L S+ NQL+ +P L L +NN L+ +LP L+ VS
Sbjct: 142 GLQEL---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG---LQELSVSD 190
Query: 370 NNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLW 429
N L SLP +L + A +N L+ LP L + N T ++P
Sbjct: 191 NQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLT-SLPVLP- 240
Query: 430 TGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNL 489
L +++S N T LP L L + N+ +
Sbjct: 241 --SELKELMVSGNRLT-SLPMLP-SGLLSLSVYRNQLT---------------------- 274
Query: 490 FNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQL 538
+P L L S TT+ L+ N LS L + +T+ +
Sbjct: 275 ---RLPESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 63/325 (19%), Positives = 112/325 (34%), Gaps = 40/325 (12%)
Query: 71 GSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNY 130
+ L ++ + + P L L+I P + S L L + N
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALP---SGLCKLWIFGNQ 132
Query: 131 FIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNL 190
+P L+ L ++ N ++ +PA L +L N NQ S+P L
Sbjct: 133 LTS-LPVLP---PGLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGL 183
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSI 250
Q L ++ N +SLP+ ++L KL A N + +P L+ L +S
Sbjct: 184 QE---LSVSDN---QLASLPTLPSELYKLW----AYNNRLTSLPALPS---GLKELIVSG 230
Query: 251 NNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGK 310
N T S+P +LK L + N L+ +P L + + N LT +P
Sbjct: 231 NRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPS--GLLSLSVYRNQLT-RLPESLIH 282
Query: 311 LENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVN 370
L + ++L N LS + + + S ++ + + +
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPG--YSGPIIRFDMAGASAPRETRALHLAAAD 340
Query: 371 NLTGSLPEHLCAGGKLAGIAAQDNN 395
L + + +DN
Sbjct: 341 WLVPAREGEPAPADRWHMFGQEDNA 365
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 40/299 (13%)
Query: 689 LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
L +G G GKV ++T E VAVK + + H + E++IL +
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNL 80
Query: 745 RHLNIVKLLCCISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
H NIVK + + L+ E++ SL ++L ++ +++++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----------PKNKNKINLKQQLK 130
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
AV +G+ Y+ S VHRDL + N+L++ KI DFG+ K + ++ +
Sbjct: 131 YAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY---- 183
Query: 863 TVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWA 916
V APE K +D++SFGV L EL T ++
Sbjct: 184 -TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 917 WRHIQEGKPIVDALDK----EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+V+ L + C E V++L C P+ R + + +++
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 64/271 (23%), Positives = 96/271 (35%), Gaps = 41/271 (15%)
Query: 668 TSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL- 726
S+ + + ++ K IG G G V N T + A+K + N K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM-NKNKIR 65
Query: 727 --DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS 784
+ K + EV+++ + H NI +L E LV E L L+
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 785 SLSGRARDEVLSWRRRMQIAVGAA-----------------------------QGLCYMH 815
S A D V + A L Y+H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 816 HDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIK-EEGEFAAMSTVVGSCGYIA 872
+ I HRD+K N L N + K+ DFG++K K GE+ M+T G+ ++A
Sbjct: 186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 873 PE--YARTRKVNEKTDIYSFGVILLELTTGK 901
PE K D +S GV+L L G
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI-LSTIRHLNIVKL 752
IG G G V ++ + +++AVK+I +D+K +K+ L ++ + + + IV+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ E + E M S D++ K S L +E+L +I + + L
Sbjct: 87 YGALFREGDCWICMELMST-SFDKFY-KYVYSVLDDVIPEEILG-----KITLATVKALN 139
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++ + I+HRD+K SNILLD + N K+ DFG++ L+ A + G Y+A
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKTRDAGCRPYMA 193
Query: 873 PE----YARTRKVNEKTDIYSFGVILLELTTGK 901
PE A + + ++D++S G+ L EL TG+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 52/251 (20%), Positives = 88/251 (35%), Gaps = 22/251 (8%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G GG G VY +VA+K + D E + ++ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ + + L L ++ L+ R + I L
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----------LAPPRAVAIVRQIGSALDA 149
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H HRD+K NIL+ + A + DFG+A + + + VG+ Y+AP
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
E + DIY+ +L E TG GD+ HI + P +
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LSVMGAHINQAIPRPSTVRPG 260
Query: 934 IDEPCFLEEMI 944
I P + +I
Sbjct: 261 I--PVAFDAVI 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+T + +G G G+VY + VAVK + K D +EFL E ++ I+H
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
N+V+LL + E ++ E+M +L +L + NR +S + +A
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------VSAVVLLYMATQI 327
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ + Y+ +HR+L + N L+ N K+ADFG+++++ + A +
Sbjct: 328 SSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFP 382
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE K + K+D+++FGV+L E+ T
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ + VIG G G VY + + AVK + +R D +FL E I+
Sbjct: 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 83
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H N++ LL C+ SE L+V YM+ L ++ R + + +
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----------RNETHNPTVKDLIGF 133
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ A+G+ Y+ S VHRDL + N +LD F K+ADFG+A+ + ++ ++ +
Sbjct: 134 GLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNK 189
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + A E +T+K K+D++SFGV+L EL T
Sbjct: 190 ---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 689 LTESNVIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ V+GSG G VY+ +P ++ VA+K++ K KE L E +++++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV 74
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
+ ++ +LL + + L+ + M L ++ R + + + +
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYV----------REHKDNIGSQYLLNWC 123
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
V A+G+ Y+ +VHRDL + N+L+ + KI DFG+AK+L EE E+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---- 176
Query: 865 VGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G + A E R ++D++S+GV + EL T
Sbjct: 177 --EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 56/304 (18%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVK 751
++G G SG V + VAVK++ L E+++L+ H N+++
Sbjct: 21 KILGYGSSGTVVFQ-GSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
C +++ + E +L + KN S + + + E QIA G+
Sbjct: 74 YYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA----SGV 128
Query: 812 CYMHHDCSPTIVHRDLKSSNILLD-------------YNFNAKIADFGVAKILIKEEGEF 858
++H S I+HRDLK NIL+ N I+DFG+ K L + F
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 859 AA-MSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT 910
++ G+ G+ APE R++ DI+S G + + + + GD+++
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 911 CLAQWAWRHIQEGKPIVDALDKEIDEPCFLE--EMIRVFKLGVICTSML---PTERPNMR 965
+ I G +D + D E ++I M+ P +RP
Sbjct: 246 RESN-----IIRGIFSLDEMKCLHDRSLIAEATDLIS---------QMIDHDPLKRPTAM 291
Query: 966 MVLQ 969
VL+
Sbjct: 292 KVLR 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 34/253 (13%)
Query: 660 YQKRKDELTSTETTSFHRLNFRDSDILPK--LTESNVIGSGGSGKVYR----VPINHTAE 713
Y E + RD + L +G G G V ++T E
Sbjct: 12 YDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71
Query: 714 VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKL-LVYEYMEK 771
VVAVKK+ + ++H ++F E++IL +++H NIVK C S+ L L+ EY+
Sbjct: 72 VVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831
SL +L + E + + +Q +G+ Y+ + +HRDL + N
Sbjct: 129 GSLRDYL----------QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRN 175
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTD 886
IL++ KI DFG+ K+L +++ + V G APE K + +D
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYY-----KVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 887 IYSFGVILLELTT 899
++SFGV+L EL T
Sbjct: 231 VWSFGVVLYELFT 243
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 31/250 (12%)
Query: 658 RIYQKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAV 717
R+ + +D T +++ + + +T +G G G+V+R+ T AV
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88
Query: 718 KKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQW 777
KK+ +L+ + E+ + + IV L + + E +E SL Q
Sbjct: 89 KKV----RLEVFRVE----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 778 LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ---GLCYMHHDCSPTIVHRDLKSSNILL 834
+ + E + Q GL Y+H + I+H D+K+ N+LL
Sbjct: 141 IKQ-------MGCLPE-------DRALYYLGQALEGLEYLH---TRRILHGDVKADNVLL 183
Query: 835 DYN-FNAKIADFGVAKIL--IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFG 891
+ A + DFG A L + G+ ++APE + + K DI+S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 892 VILLELTTGK 901
++L + G
Sbjct: 244 CMMLHMLNGC 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 68/226 (30%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK--EFLAEVQILSTIRHLNIVK 751
VIGSG + V E VA+K+I L++ E L E+Q +S H NIV
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRI----NLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 752 LLCCISSENLKL-LVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---G 806
++ +L LV + + S+ D H + DE IA
Sbjct: 78 YYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES-------TIATILRE 129
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS--TV 864
+GL Y+H +HRD+K+ NILL + + +IADFGV+ L T
Sbjct: 130 VLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 865 VGSCGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEH 909
VG+ ++APE + R + K DI+SFG+ +EL TG A
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG-AAPYHKYP 231
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 76/416 (18%), Positives = 134/416 (32%), Gaps = 41/416 (9%)
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSI 250
N + A + ++ QL L L + I ++ I + L L +
Sbjct: 18 DNFASEVAAAFEMQATDTIS--EEQLATLTSLD-CHNSSITDMTG-IEKLTGLTKLICTS 73
Query: 251 NNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFG 309
NN T ++ + + NL+ + SN L+ + V L L ++ N LT D
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 310 KLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSV 369
+ L L+ N L+ EI + L ++ N D + L + S
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSF 179
Query: 370 NNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLW 429
N +T L L + NN++ +L L L + +N T I
Sbjct: 180 NKIT-ELDVSQNK--LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPL 232
Query: 430 TGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNL 489
T L+ S N T EL L+ L +I ++ + L+ FQA
Sbjct: 233 T--QLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC- 285
Query: 490 FNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFL 549
++T L L ++ LD+ L L L+ +L+ E+ +
Sbjct: 286 -RKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 550 PVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNN 605
L+ L L + + + N + + +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 78/421 (18%), Positives = 150/421 (35%), Gaps = 42/421 (9%)
Query: 119 SKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQ 178
+ ++L+ L L ++++ + I +LT L +L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 179 FNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIG 238
++ + NL L N ++L T L KL L TN + ++ +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSN---KLTNLD--VTPLTKLTYLNC-DTNKLTKLD--VS 124
Query: 239 DMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSAN 298
L +L+ + N T I S L+++ + N L +D S N
Sbjct: 125 QNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFN 180
Query: 299 NLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGR 358
+T D + + L L+ N ++ ++ + L + +N L+ D
Sbjct: 181 KITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTP 231
Query: 359 YSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNN 418
+ L YF+ SVN LT L + KL + +L E+ L + + L+ +
Sbjct: 232 LTQLTYFDCSVNPLT-ELDVSTLS--KLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC 285
Query: 419 SFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSK 478
+ T L ++ T EL + L L ++N + ++ VS +
Sbjct: 286 RKIKELDVTHNT--QLYLLDCQAAGIT-ELDLSQNPKLVYLYLNNTELT-ELD--VSHNT 339
Query: 479 NLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQL 538
L N + +P+L + Q ++P + ++ SLT + +S + L
Sbjct: 340 KLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVSPDLL 395
Query: 539 S 539
Sbjct: 396 D 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 78/441 (17%), Positives = 145/441 (32%), Gaps = 55/441 (12%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
++T L N ++ T I L LT L N I+ L + L YL N
Sbjct: 43 TLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN-ITTLD--LSQNTNLTYLACDSNKL 97
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
D+ L++L +L N ++ + + L LN N I + +
Sbjct: 98 TNL---DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNT 148
Query: 192 NLEALELAYNTEFSPSSLPSN-----------------FTQLKKLKKLWMASTNLIGEIP 234
L L+ N + + + +Q K L +L TN I ++
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNC-DTNNITKLD 207
Query: 235 ETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVID 294
+ + L FLD S N T I + L L+ N L+ E+ + S L +
Sbjct: 208 --LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELDVSTLS-KLTTLH 260
Query: 295 LSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPP 354
+L D L+ + E+ + L + ++
Sbjct: 261 CIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---EL 312
Query: 355 DFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVK 414
D + L Y ++ LT L KL ++ + ++ + +G +L
Sbjct: 313 DLSQNPKLVYLYLNNTELT-ELDVSHNT--KLKSLSCVNAHIQ-DFSS-VGKIPALNNNF 367
Query: 415 IYNNSFTGNIPAGLWTGFNLSMVLISDNL-FTGELPDKMSGNLSRLEISNNRFSGKIPTG 473
+P T +L++ + D L G + G+ + + N + + +
Sbjct: 368 EAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
Query: 474 VSSSKNLVVFQASNNLFNGTI 494
+ + F + N GT+
Sbjct: 427 DNPAVTY-TFTSENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 56/316 (17%), Positives = 98/316 (31%), Gaps = 72/316 (22%)
Query: 281 IPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKD 340
N +A + +L L +L + ++ ++ GI L L
Sbjct: 11 FNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTK 68
Query: 341 VRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGEL 400
+ +N ++ D + + L Y N LT +L
Sbjct: 69 LICTSNNITT---LDLSQNTNLTYLACDSNKLT-NLD----------------------- 101
Query: 401 PESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLE 460
+ + L + N T +L + L+ L
Sbjct: 102 ---VTPLTKLTYLNCDTNKLT-------------------------KLDVSQNPLLTYLN 133
Query: 461 ISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPL 520
+ N + +I VS + L N ++T LTTL N+++ L
Sbjct: 134 CARNTLT-EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKITE---L 185
Query: 521 DIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLN 579
D+ K L LN N ++ ++ + L LD S N+ + +I + L LT +
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 580 LSSNRLTGEIPSQFEN 595
S N LT S
Sbjct: 240 CSVNPLTELDVSTLSK 255
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 18/104 (17%), Positives = 39/104 (37%), Gaps = 11/104 (10%)
Query: 484 QASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIP 543
FN P + + + ++ + + +LT+L+ + ++ ++
Sbjct: 5 AGQTQSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT 58
Query: 544 EKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLT 586
I L L L + N + + + + LT L SN+LT
Sbjct: 59 G-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT 98
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
+ +LDLQ N I N L L L N I I L +L+ LYL+ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKN 110
Query: 154 NMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN 212
+ ++P + L++L + N+ + + L + +EL N S + +
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN-PLKSSGIENG 165
Query: 213 -FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSKV 270
F +KKL + +A I IP+ G +L L L N T + ++ K L NL+K+
Sbjct: 166 AFQGMKKLSYIRIAD-TNITTIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 271 YLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
L NS+S ++ + +L+ + L+ N L +P + + + L N +S I
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG 279
Query: 330 EG-------IGLLPSLKDVRLFNNMLS-GALPPD 355
S V LF+N + + P
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 38/295 (12%)
Query: 72 SVTELHLTNMNM----NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
L L N + +G F +L+NL L L N I P KLE L LS
Sbjct: 53 DTALLDLQNNKITEIKDGDFK----NLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQF-NGSIPA 185
+N + +PE + L+ L + N ++ K+ S+ L ++ + L N + I
Sbjct: 109 KNQ-LKELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 186 EI-GNLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE-TIGDML 241
++ L + +A T PS L +L + N I ++ ++ +
Sbjct: 165 GAFQGMKKLSYIRIADTNITTIPQGLPPS-------LTELHL-DGNKITKVDAASLKGLN 216
Query: 242 ALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANN 299
L L LS N+ + ++ + +L +++L +N L ++P + ++V+ L NN
Sbjct: 217 NLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274
Query: 300 LTG------AIPNDFGKLENLLNLSLMFNQLS-GEIPEGI-GLLPSLKDVRLFNN 346
++ P K + +SL N + EI + V+L N
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 66/332 (19%), Positives = 119/332 (35%), Gaps = 68/332 (20%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+L V L ++P+ + + ++DL N +T DF L+NL L L+ N++S
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 326 GEIPEGIGL-LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
+I G L L+ + L N L LP L+ V N +T +
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVR------- 137
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT-GNIPAGLWTGF-NLSMVLISDN 442
+ +++V++ N I G + G LS + I+D
Sbjct: 138 ----------------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 443 LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALP 502
T +P + +L+ L + N+ + K+ G L
Sbjct: 182 NIT-TIPQGLPPSLTELHLDGNKIT-KVDAAS---------------LKG--------LN 216
Query: 503 SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
+L L L N +S + + L L+L+ N+L ++P + +Q + L N
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 563 SGKIPPQI--------GRLMLTSLNLSSNRLT 586
S I + + ++L SN +
Sbjct: 276 S-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/246 (23%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 660 YQKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKK 719
+ +T + + R+ D L IG G +G V H+ VAVK
Sbjct: 18 LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKM 77
Query: 720 IWNDRKLDQKHEKEFL-AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL 778
+ L ++ +E L EV I+ +H N+V++ ++ E+++ +L +
Sbjct: 78 M----DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133
Query: 779 HKKNRSSLSGRARDEVLSWRRRMQIAV---GAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835
+ +E QIA Q L Y+H + ++HRD+KS +ILL
Sbjct: 134 SQVRL--------NE-------EQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT 175
Query: 836 YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILL 895
+ K++DFG + K + ++VG+ ++APE + DI+S G++++
Sbjct: 176 LDGRVKLSDFGFCAQISK---DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 896 ELTTGK 901
E+ G+
Sbjct: 233 EMVDGE 238
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
VIG G G VY + A+K + + + + FL E ++ +
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL 79
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H N++ L+ + E L ++ YM L Q++ R+ + + +
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----------RSPQRNPTVKDLISF 129
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ A+G+ Y+ VHRDL + N +LD +F K+ADFG+A+ I + ++
Sbjct: 130 GLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQ- 184
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ A E +T + K+D++SFGV+L EL T
Sbjct: 185 --HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 27/244 (11%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
+ + + +G G G VY+ T ++VA+K++
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 721 WNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHK 780
++ +E + E+ I+ ++VK +V EY S+ + +
Sbjct: 63 ----PVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIR 116
Query: 781 KNRSSLSGRARDEVLSWRRRMQIAV---GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837
+L E +IA +GL Y+H +HRD+K+ NILL+
Sbjct: 117 LRNKTL-----TED-------EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTE 161
Query: 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLEL 897
+AK+ADFGVA L + +TV+G+ ++APE + N DI+S G+ +E+
Sbjct: 162 GHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
Query: 898 TTGK 901
GK
Sbjct: 219 AEGK 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 688 KLTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
L +G G G V ++T EVVAVKK+ + ++H ++F E++IL +
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKS 67
Query: 744 IRHLNIVKLL-CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
++H NIVK C S+ L L+ EY+ SL +L + E + + +
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----------QKHKERIDHIKLL 117
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
Q +G+ Y+ + +HRDL + NIL++ KI DFG+ K+L +++ F
Sbjct: 118 QYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF--- 171
Query: 862 STVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
V G APE K + +D++SFGV+L EL T
Sbjct: 172 --KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK--EFLAEVQILSTIRHLNIVK 751
IG G G+V++ N T +VVA+K I L++ ++ + E+ +LS + K
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GAA 808
+ ++ EY+ S L DE QIA
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPG--------PLDET-------QIATILREIL 129
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+GL Y+H S +HRD+K++N+LL + K+ADFGVA L +T VG+
Sbjct: 130 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTP 183
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
++APE + + K DI+S G+ +EL G+
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 681 RDSDILPK--LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEF 734
+D I + L + +G G G V ++T +VAVK++ + +++F
Sbjct: 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDF 71
Query: 735 LAEVQILSTIRHLNIVKLL-CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
E+QIL + IVK L LV EY+ L +L +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----------QRHR 121
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
L R + + +G+ Y+ S VHRDL + NIL++ + KIADFG+AK+L
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 853 KEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
++ + VV G APE + ++D++SFGV+L EL T
Sbjct: 179 LDKDYY-----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 681 RDSDILPK--LTESNVIGSGGSGKVYR----VPINHTAEVVAVKKIWNDRKLDQKHEKEF 734
D + K L + +G G GKV + T E+VAVK + D +H +
Sbjct: 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGW 80
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARD 792
E+ IL T+ H +I+K C LV EY+ SL +L + +
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---------- 130
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
+ + + A +G+ Y+H + +HRDL + N+LLD + KI DFG+AK +
Sbjct: 131 --IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 853 KEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + V G APE + K +D++SFGV L EL T
Sbjct: 186 EGHEYY-----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G G VY + ++A+K ++ + E + EV+I S +RH NI++L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L+ EY ++ + L K ++ DE + ++ A L
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYITEL----ANALS 123
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y H S ++HRD+K N+LL KIADFG + + + + G+ Y+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-----PSSRRTDLCGTLDYLP 175
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK 901
PE R +EK D++S GV+ E GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQI 740
D K T IG G SG VY T + VA++++ L Q+ +KE + E+ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILV 70
Query: 741 LSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
+ ++ NIV L + +V EY+ SL + + DE
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--------CMDEG------ 116
Query: 801 MQIAV---GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
QIA Q L ++H S ++HRD+KS NILL + + K+ DFG + E+ +
Sbjct: 117 -QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
ST+VG+ ++APE + K DI+S G++ +E+ G+
Sbjct: 173 ---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ + VIG G G VY + + AVK + D +FL E I+
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF 147
Query: 745 RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
H N++ LL C+ SE L+V YM+ L ++ R + + +
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----------RNETHNPTVKDLIGF 197
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ A+G+ ++ S VHRDL + N +LD F K+ADFG+A+ + +E + S
Sbjct: 198 GLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD----SV 250
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + A E +T+K K+D++SFGV+L EL T
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 37/344 (10%), Positives = 78/344 (22%), Gaps = 53/344 (15%)
Query: 664 KDELTSTETTSFHRLNFRDSDILPK---LTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
E + + DS + L + G V+ V E A+K
Sbjct: 36 MVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVF 95
Query: 721 WNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL-----------------------LCCIS 757
+ + + + + + + L
Sbjct: 96 TMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155
Query: 758 SENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD 817
+ M S+D L + + + +
Sbjct: 156 DDYAVANYLLLMPAASVD--LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 818 CSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEY-- 875
+VH N+ + + + D + G Y E+
Sbjct: 214 G---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGT--RGPASSVPVTYAPREFLN 264
Query: 876 ARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEID 935
A T + + G+ + + T + +W+ P D+L
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPF--GLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322
Query: 936 E--PCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
P F++ +I L R++ + P F
Sbjct: 323 TPLPDFVKTLIG---------RFL-NFDRRRRLLPLEAMETPEF 356
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+T + +G G G+VY + VAVK + K D +EFL E ++ I+H
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
N+V+LL + E ++ E+M +L +L + NR + +S + +A
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---------QEVSAVVLLYMATQI 120
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ + Y+ +HRDL + N L+ N K+ADFG+++++ + A +
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA-----HA 170
Query: 868 CGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
APE K + K+D+++FGV+L E+ T
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 29/242 (11%)
Query: 666 ELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK 725
+ T T R +D L +GSG G+V+++ T V+AVK++ R
Sbjct: 8 KQTGYLTIGGQRYQAEIND----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRS 61
Query: 726 LDQKHEKEFLAEVQIL-STIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRS 784
+++ K L ++ ++ + IV+ + + E M ++ +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQ-- 118
Query: 785 SLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
G + +L ++ V + L Y+ ++HRD+K SNILLD K+ D
Sbjct: 119 ---GPIPERILG-----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCD 168
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPE-----YARTRKVNEKTDIYSFGVILLELTT 899
FG++ L+ + A G Y+APE + + D++S G+ L+EL T
Sbjct: 169 FGISGRLVDD----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 900 GK 901
G+
Sbjct: 225 GQ 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IG G KV T VA+K I + +L+ ++ EV+I+ + H NIVKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
I +E L+ EY + +L R E + + QI + Y
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMK-------EKEARSKFRQIV----SAVQYC 130
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H IVHRDLK+ N+LLD + N KIADFG + G + G+ Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGK--LDAFCGAPPYAAPE 183
Query: 875 YARTRKVN-EKTDIYSFGVILLELTTGK 901
+ +K + + D++S GVIL L +G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G G G VY +A+K+I + D ++ + E+ + ++H NIV+ L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 754 CCISSENLKLLVY-EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ--- 809
S + ++ E + SL L K G +D I Q
Sbjct: 86 GSFSENG-FIKIFMEQVPGGSLSALLRSKW-----GPLKD------NEQTIGFYTKQILE 133
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLD-YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
GL Y+H + IVHRD+K N+L++ Y+ KI+DFG +K L G T G+
Sbjct: 134 GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTL 187
Query: 869 GYIAPEYAR--TRKVNEKTDIYSFGVILLELTTGK 901
Y+APE R + DI+S G ++E+ TGK
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 24/269 (8%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
+ LDL N I L C L+ L L+ N I I ED L L+ L L+ N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNY 111
Query: 155 MSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN 212
+S + +S L+ L LNL+ N + + +L L+ L + F + +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF--TKIQRK 168
Query: 213 -FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-KLKNLSK 269
F L L++L + + + + + L L + + ++
Sbjct: 169 DFAGLTFLEELEI-DASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
Query: 270 VYLYSNSLSGEIPQAVES---------LNLKVIDLSANNLTGAIPNDFGKLENLLNLSLM 320
+ L L + + + + ++ +L + ++ LL L
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 321 FNQLSGEIPEGI-GLLPSLKDVRLFNNML 348
NQL +P+GI L SL+ + L N
Sbjct: 286 RNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 59/284 (20%), Positives = 105/284 (36%), Gaps = 25/284 (8%)
Query: 270 VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
S SL+ IP + + +K +DLS N +T +D + NL L L N ++ I
Sbjct: 36 CKGSSGSLN-SIPSGL-TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 330 EGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGG--K 385
E L SL+ + L N LS L F S L + + N +L E K
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK 150
Query: 386 LAGIAAQDNNLSGELPE-SLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISDNL 443
L + + + ++ + L ++I + + N+S +++
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQ 209
Query: 444 FTGELPD---KMSGNLSRLEISNNRFSG----KIPTGVSSS-KNLVVFQASNNLFNG--T 493
L + ++ ++ LE+ + ++ TG ++S F+
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268
Query: 494 IPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRN 536
+ L + L L +NQL S+P I SL + L N
Sbjct: 269 VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 37/221 (16%), Positives = 65/221 (29%), Gaps = 38/221 (17%)
Query: 407 CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLE---ISN 463
C + K + S +IP+GL + + +S+N T + + L+ +++
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTS 85
Query: 464 NRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDI 522
N + I SS +L S N + L SLT L L N +
Sbjct: 86 NGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 523 ISW--------------------------KSLTALNLSRNQLSGEIPEKIGFLPVLQDLD 556
S L L + + L P+ + + + L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 557 LSENQFSGKIPPQIGRLM--LTSLNLSSNRLTGEIPSQFEN 595
L Q + + + L L L S+
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-30
Identities = 34/242 (14%), Positives = 64/242 (26%), Gaps = 36/242 (14%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR--- 745
L V+G T E V + + K+ EV L +R
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 746 -------------------HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSL 786
K++ E ++ + + L L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 787 SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846
S + + L R+Q+ + + L +HH +VH L+ +I+LD + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 847 VAKILIKEEGEFAAMST--VVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTT 899
+G A A + D ++ G+ + +
Sbjct: 257 HL----VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 900 GK 901
Sbjct: 313 AD 314
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G VY +EVVA+KK+ K + ++ + EV+ L +RH N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GAAQ 809
C E+ LV EY + D L + ++ L EV +IA GA Q
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD--LLEVHKKPL-----QEV-------EIAAVTHGALQ 165
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL Y+H S ++HRD+K+ NILL K+ DFG A I+ ++ VG+
Sbjct: 166 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPY 215
Query: 870 YIAPEYARTRKV---NEKTDIYSFGVILLELTTGK 901
++APE + K D++S G+ +EL K
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 668 TSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD 727
T+ + D DI +G G G VY ++A+K ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIG------RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK 54
Query: 728 QKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS 787
+ E + E++I S +RH NI+++ L+ E+ + L + L K R
Sbjct: 55 EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-- 112
Query: 788 GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847
E S ++ A L Y H ++HRD+K N+L+ Y KIADFG
Sbjct: 113 -----EQRSATFMEEL----ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW 160
Query: 848 AKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ T+ G+ Y+ PE + +EK D++ GV+ E G
Sbjct: 161 SVH---APSLR--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G V R T A K I N +KL + ++ E +I ++H NIV+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQGLC 812
I E+ LV++ + L + + + S A + QI + +
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQ------QIL----ESIA 119
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
Y H S IVHR+LK N+LL K+ADFG+A + + E G+ G
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEA--WHGFAGTPG 172
Query: 870 YIAPEYARTRKVNEKTDIYSFGVIL 894
Y++PE + ++ DI++ GVIL
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 72/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 660 YQKRKDELTSTETTSFHRLNFRDSDILPKLTE--------SNVIGSGGSGKVYRVPINHT 711
Y K D L TT + + E +G G G+V+ N T
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208
Query: 712 AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771
V A+K + K + FL E Q++ +RH +V+L +S E + +V EYM K
Sbjct: 209 TRV-AIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSK 262
Query: 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831
SL +L + + L + + +A A G+ Y+ VHRDL+++N
Sbjct: 263 GSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN 310
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFG 891
IL+ N K+ADFG+A+++ E+ E+ A + APE A + K+D++SFG
Sbjct: 311 ILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368
Query: 892 VILLELTT 899
++L ELTT
Sbjct: 369 ILLTELTT 376
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 29/220 (13%)
Query: 689 LTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
L +G G G V R + VAVK + D + +F+ EV + ++
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H N+++L + + + +V E SL L R + AV
Sbjct: 80 HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRL----------RKHQGHFLLGTLSRYAV 128
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A+G+ Y+ S +HRDL + N+LL KI DFG+ + L + + +
Sbjct: 129 QVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM----- 180
Query: 866 GSCG------YIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE +TR + +D + FGV L E+ T
Sbjct: 181 -QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
+ ++G G G+V + T + AVK I N K L EV++
Sbjct: 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVEL 74
Query: 741 LSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
L + H NI+KL + + +V E L + K+ R S D +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----EHDAARIIK-- 128
Query: 801 MQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGE 857
Q+ G+ YMH IVHRDLK NILL + + + KI DFG++ ++
Sbjct: 129 -QVF----SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNT 178
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
M +G+ YIAPE R +EK D++S GVIL
Sbjct: 179 K--MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 689 LTESNVIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ V+GSG G VY+ +P ++ VA+K++ K KE L E +++++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV 74
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
+ ++ +LL + + L+ + M L ++ R + + + +
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYV----------REHKDNIGSQYLLNWC 123
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
V A+G+ Y+ +VHRDL + N+L+ + KI DFG+AK+L EE E+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---- 176
Query: 865 VGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G + A E R ++D++S+GV + EL T
Sbjct: 177 --EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 15/239 (6%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQN--YFIGPIPEDIDRLSRLKFLYLTAN 153
+ T L+L+ N + S V ++L L LS N F G + + LK+L L+ N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 154 NMSGKIPASIGRLTELRQLNLVVNQFNGSIPAE--IGNLQNLEALELAYNTEFSPSSLPS 211
+ + ++ L +L L+ + + +L+NL L++++ +
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT---HTRVAFN 143
Query: 212 N-FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVFK-LKNLS 268
F L L+ L MA + I L L FLDLS + + F L +L
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 269 KVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKL-ENLLNLSLMFNQLS 325
+ + N+ + L +L+V+D S N++ + + +L L+L N +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 67/326 (20%), Positives = 102/326 (31%), Gaps = 79/326 (24%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ +++ S L+ +P + + ++L +N L F KL L LSL N LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI-PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 326 -GEIPEGIGL-LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
SLK + L N + + +F LE+ + +NL + E
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE----- 118
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
+ +L+ + I + + + +
Sbjct: 119 -----------------FSVFLSLRNLIYLDISHTHTR----------------VAFNGI 145
Query: 444 FTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPS 503
F G L +L L+++ N F P T L +
Sbjct: 146 FNG-LS-----SLEVLKMAGNSFQENFL-----------------------PDIFTELRN 176
Query: 504 LTTLLLDQNQLSGSLPLDI-ISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
LT L L Q QL L S SL LN+S N L LQ LD S N
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
Query: 563 SGKIPPQIGRLM---LTSLNLSSNRL 585
Q + L LNL+ N
Sbjct: 236 M-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 56/280 (20%), Positives = 87/280 (31%), Gaps = 34/280 (12%)
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
+ + ++ +P I + +L L N+ L L L L+ N
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLK 265
+ LK L + S N + + + LE LD +N SVF
Sbjct: 67 KGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL-- 123
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+L NL +D+S + A F L +L L + N
Sbjct: 124 SLR--------------------NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 326 GEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
I L +L + L L L P F S L+ +S NN SL
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKC 221
Query: 384 -GKLAGIAAQDNNLSGELPESL--GNCSSLLMVKIYNNSF 420
L + N++ + SSL + + N F
Sbjct: 222 LNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 62/331 (18%), Positives = 111/331 (33%), Gaps = 86/331 (25%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNM 347
+ I ++ LT ++P + L L N+L +P G+ L L + L +N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNG 63
Query: 348 LS--GALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLG 405
LS G + L+Y ++S N + + +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFL 98
Query: 406 NCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNR 465
L + +++ + ++F L NL L+IS+
Sbjct: 99 GLEQLEHLDFQHSNLK---------------QMSEFSVFLS-LR-----NLIYLDISHTH 137
Query: 466 FSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW 525
G+ FNG L SL L + N + DI +
Sbjct: 138 TR-VAFNGI---------------FNG--------LSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 526 -KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSGKIPPQIGRLM--LTSLNLS 581
++LT L+LS+ QL ++ L LQ L++S N F + + + L L+ S
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYS 231
Query: 582 SNRLTGEIPSQFENRAYASSFL---NNPGLC 609
N + + ++ + +FL N C
Sbjct: 232 LNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 11/148 (7%)
Query: 77 HLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIP 136
+L M+ F LRNL LD+ + F + S LE L ++ N F
Sbjct: 112 NLKQMSEFSVFL----SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 137 EDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
DI L L FL L+ + ++ + L+ L+ LN+ N F S+ L +L
Sbjct: 168 PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSL 225
Query: 194 EALELAYN--TEFSPSSLPSNFTQLKKL 219
+ L+ + N L + L L
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFL 253
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
L +G+G G+V+ N +V AVK + K + FLAE ++ T++H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM----KPGSMSVEAFLAEANVMKTLQHD 243
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+VKL ++ E + ++ E+M K SL +L + + +
Sbjct: 244 KLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQI 293
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
A+G+ ++ +HRDL+++NIL+ + KIADFG+A+++ E+ E+ A G+
Sbjct: 294 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTARE---GA 345
Query: 868 CGYI---APEYARTRKVNEKTDIYSFGVILLELTT 899
I APE K+D++SFG++L+E+ T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 689 LTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR 745
+ +IGSG SG+V VA+K + ++ ++FL+E I+
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD 108
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H NI++L ++ L ++V EYME SLD +L R D + + + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL----------RTHDGQFTIMQLVGMLR 158
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
G G+ Y+ VHRDL + N+L+D N K++DFG+++ +++++ + A +T
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTG- 213
Query: 866 GSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G I APE R + +D++SFGV++ E+
Sbjct: 214 ---GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 68/234 (29%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 674 SFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE 733
S + RD I+ K +GSG G+V T + VA+K I + RK +E
Sbjct: 2 SVYPKALRDEYIMSK-----TLGSGACGEVKLAFERKTCKKVAIKII-SKRKFAIGSARE 55
Query: 734 ------FLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS 787
E++IL + H I+K+ +E+ +V E ME L + R L
Sbjct: 56 ADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LK 112
Query: 788 GR-ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIA 843
+ Q+ + Y+H I+HRDLK N+LL + + KI
Sbjct: 113 EATCKLYFY------QML----LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPE---YARTRKVNEKTDIYSFGVIL 894
DFG +KIL E M T+ G+ Y+APE T N D +S GVIL
Sbjct: 160 DFGHSKIL--GETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 68/257 (26%), Positives = 111/257 (43%), Gaps = 40/257 (15%)
Query: 656 MIRIYQKRKDELTST--------ETTSFHRLNFRDSDILPK--LTESNVIGSGGSGKVYR 705
++ Y D L + T + +R L L IG G G V
Sbjct: 152 LVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVML 211
Query: 706 VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKLL 764
VAVK I ND + FLAE +++ +RH N+V+LL + + +
Sbjct: 212 GDYRGN--KVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264
Query: 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVH 824
V EYM K SL +L + RS L ++ ++ + + Y+ VH
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLG---------GDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 825 RDLKSSNILLDYNFNAKIADFGVAKIL--IKEEGEFAAMSTVVGSCGYIAPEYARTRKVN 882
RDL + N+L+ + AK++DFG+ K ++ G+ T APE R +K +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------APEALREKKFS 364
Query: 883 EKTDIYSFGVILLELTT 899
K+D++SFG++L E+ +
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 76/410 (18%), Positives = 143/410 (34%), Gaps = 46/410 (11%)
Query: 167 TELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMA 225
+ ++L +N LQ+L+ L++ T + +N F L L L +
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTP--GLVIRNNTFRGLSSLIILKL- 86
Query: 226 STNLIGEIPETIGDML-ALEFLDLSINNFTGS-IPSSVF-KLKNLSKVYLYSNSLSGEIP 282
N ++ + L LE L L+ N G+ + + F L +L + L N++ P
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 283 QAV-ESL-NLKVIDLSANNLTGAIPNDFGKLE--NLLNLSLMFNQLSGEIPEGIGLLPSL 338
+ ++ V+DL+ N + D + + L L L
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ------------- 193
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ L + + + + ++S N S+ + I + + S
Sbjct: 194 ---DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLS---MVLISDNLFTGELPDKMSGN 455
+ S G+ + N +F G +G+ +LS + + ++F+ +
Sbjct: 251 NMGSSFGHTN---FKDPDNFTFKGLEASGV-KTCDLSKSKIFALLKSVFSH-FT-----D 300
Query: 456 LSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQL 514
L +L ++ N + KI +L+ S N L L L L N +
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 515 SGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQF 562
+L +L L L NQL +P+ I L LQ + L N +
Sbjct: 360 R-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 61/384 (15%), Positives = 123/384 (32%), Gaps = 46/384 (11%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
++ +DL N I L++L + Q I + LS L L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 155 MSGKIPASI-GRLTELRQLNLVVNQFNGS-IPAEI-GNLQNLEALELAYN--TEFSPSSL 209
++ L L L L +G+ + L +LE L L N + P+S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 210 PSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFL-----------DLSINNFTGSIP 258
F +++ L + + N + I E + D++
Sbjct: 150 ---FLNMRRFHVLDL-TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 259 SSVFKLKNLSKVYLYSNSLSGEIPQAVESL--------------NLKVIDLSANNLTGAI 304
+ FK +++ + L N + + N
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 305 PNDFGKLE--NLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYS 360
F LE + L +++ + + + L+ + L N ++ + + F +
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT 323
Query: 361 PLEYFEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNS 419
L +S N L S+ + KL + N++ +S +L + + N
Sbjct: 324 HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ 382
Query: 420 FTGNIPAGLWTGF-NLSMVLISDN 442
++P G++ +L + + N
Sbjct: 383 LK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 65/337 (19%), Positives = 113/337 (33%), Gaps = 37/337 (10%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L + L +L IL L +N + + LE L L+Q
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116
Query: 133 G-PIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-- 187
G + + L+ L+ L L NN+ PAS + L+L N+ SI E
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLL 175
Query: 188 -GNLQNLEALELAYNTEFS------PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDM 240
++ L L+ T N + + L ++ + + D
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 241 LALEFL-------------DLSINNFTGSIPSSVFKLK--NLSKVYLYSNSLSGEIPQAV 285
+A + NF + L+ + L + + + ++V
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV 294
Query: 286 -ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVR 342
+L+ + L+ N + N F L +LL L+L N L I + L L+ +
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLD 353
Query: 343 LFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPE 378
L N + AL F L+ + N L S+P+
Sbjct: 354 LSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 67/372 (18%), Positives = 134/372 (36%), Gaps = 51/372 (13%)
Query: 230 IGEIPETIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ES 287
+ E+P + ++DLS+N+ + + F +L++L + + + I
Sbjct: 25 VPELPAHV------NYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 288 L-NLKVIDLSANNLTGAIPND-FGKLENLLNLSLMFNQL-SGEIPEGI-GLLPSLKDVRL 343
L +L ++ L N + F L NL L+L L + L SL+ + L
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 344 FNNMLSGALPPD--FGRYSPLEYFEVSVNNLTGSLPEHLCAG--GKLAGIAAQDNNLSGE 399
+N + + P F +++ N + +C G LS
Sbjct: 137 RDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK-----SICEEDLLNFQGKHFTLLRLS-- 188
Query: 400 LPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRL 459
S+ + + + +++ + +S N F + + ++
Sbjct: 189 ---------SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 460 EISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLP 519
+I + S G S + N T G + T L ++++ +L
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNF-----KDPDNFTFKG--LEASGVKTCDLSKSKIF-ALL 291
Query: 520 LDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQI-GRLM- 574
+ S L L L++N+++ +I + F L L L+LS+N I ++ L
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNA-FWGLTHLLKLNLSQNFLG-SIDSRMFENLDK 348
Query: 575 LTSLNLSSNRLT 586
L L+LS N +
Sbjct: 349 LEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-18
Identities = 50/262 (19%), Positives = 93/262 (35%), Gaps = 38/262 (14%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLE----------YLDLSQNYFIGPIPEDIDRLS 143
+R +LDL FN + S L N D+++ + + + +
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 144 RLKFLYLTANNMSGKIPASIGRLTELRQL-------------NLVVNQFNGSIPAEIGNL 190
+ L L+ N + ++ + F L
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL 272
Query: 191 Q--NLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFL 246
+ ++ +L+ + +L + F+ L++L + + N I +I + L L L
Sbjct: 273 EASGVKTCDLSKS---KIFALLKSVFSHFTDLEQLTL-AQNEINKIDDNAFWGLTHLLKL 328
Query: 247 DLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGA 303
+LS N SI S +F L L + L N + + L NLK + L N L +
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 304 IPND-FGKLENLLNLSLMFNQL 324
+P+ F +L +L + L N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 34/200 (17%), Positives = 72/200 (36%), Gaps = 25/200 (12%)
Query: 415 IYNNSFTGNIPAGLWTGF-NLSMVLISDNLFTGELPD---KMSGNLSRLEISNNRFSGKI 470
+ NS + ++ +L + + + + + +L L++ N+F ++
Sbjct: 37 LSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QL 94
Query: 471 PTGV-SSSKNLVVFQ-ASNNLFNGTIP-GELTALPSLTTLLLDQNQLSGSLPLDII--SW 525
TG + NL V NL + L SL L+L N + + +
Sbjct: 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNM 153
Query: 526 KSLTALNLSRNQLSGEIPEKI-----------GFLPVLQDLDLSENQFSGKIPPQIGRLM 574
+ L+L+ N++ I E+ L + D++E + +
Sbjct: 154 RRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 575 -LTSLNLSSNRLTGEIPSQF 593
+T+L+LS N + +F
Sbjct: 213 SITTLDLSGNGFKESMAKRF 232
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 20/96 (20%), Positives = 30/96 (31%), Gaps = 8/96 (8%)
Query: 498 LTALPSL----TTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI-GFLPVL 552
L +P L + L N ++ + L L + + I L L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 553 QDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
L L NQF ++ L L L L+ L
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLD 116
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 72/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 660 YQKRKDELTSTETTSFHRLNFRDSDILPKLTE--------SNVIGSGGSGKVYRVPINHT 711
Y K D L TT + + E +G G G+V+ N T
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 291
Query: 712 AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEK 771
V A+K + K + FL E Q++ +RH +V+L +S E + +V EYM K
Sbjct: 292 TRV-AIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSK 345
Query: 772 RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831
SL +L + + L + + +A A G+ Y+ VHRDL+++N
Sbjct: 346 GSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN 393
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFG 891
IL+ N K+ADFG+A+++ E+ E+ A + APE A + K+D++SFG
Sbjct: 394 ILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 451
Query: 892 VILLELTT 899
++L ELTT
Sbjct: 452 ILLTELTT 459
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 58/281 (20%), Positives = 98/281 (34%), Gaps = 66/281 (23%)
Query: 694 VIGSGGSGKVYRVPINHTAE-------VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH 746
I GG G +Y A V +K + + D + + +AE Q L+ + H
Sbjct: 87 CIAHGGLGWIYL------ALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVH 138
Query: 747 LNIVKLL-----CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM 801
+IV++ + + +V EY+ +SL + ++ + L +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR-------------SKGQKLPVAEAI 185
Query: 802 QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAM 861
+ L Y+H S +V+ DLK NI+L K+ D G + +
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-------NSF 234
Query: 862 STVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921
+ G+ G+ APE RT TDIY+ G L LT NG +
Sbjct: 235 GYLYGTPGFQAPEIVRTGPT-VATDIYTVGRTLAALTLDLPTRNGR--------YVDGLP 285
Query: 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP 962
E P++ ++R P +R
Sbjct: 286 EDDPVLKT-------YDSYGRLLR------RAIDPDPRQRF 313
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
K+T S +G G G VY V + VA+K + + EFL E ++
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMK 83
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
++V+LL +S L++ E M + L +L + R +++ S + +Q
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQ 142
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+A A G+ Y++ + VHRDL + N ++ +F KI DFG+ + + + +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------Y 193
Query: 863 TVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G G + +PE + +D++SFGV+L E+ T
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE------FLAEVQILSTIRHL 747
+GSG G+V T + VA++ I + RK +E E++IL + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRII-SKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVG 806
I+K+ +E+ +V E ME L + R L + Q+
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFY------QML-- 249
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ Y+H I+HRDLK N+LL + + KI DFG +KIL E M T
Sbjct: 250 --LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL--MRT 300
Query: 864 VVGSCGYIAPE---YARTRKVNEKTDIYSFGVIL 894
+ G+ Y+APE T N D +S GVIL
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEV 738
RD+ ++ + +G G G V + + VA+K + ++ +E + E
Sbjct: 8 RDNLLIADI----ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREA 61
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
QI+ + + IV+L+ +E L +LV E L ++L + E +
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL----------VGKREEIPVS 110
Query: 799 RRMQIAVGAAQGLCY---MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
++ + G+ Y + VHRDL + N+LL AKI+DFG++K L ++
Sbjct: 111 NVAELLHQVSMGMKYLEEKN------FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 856 GEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ A S G APE RK + ++D++S+GV + E +
Sbjct: 165 SYYTARSA-----GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
L +G+G G+V+ N +V AVK + K FLAE ++ ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL----KQGSMSPDAFLAEANLMKQLQHQ 68
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+V+L ++ E + ++ EYME SL +L + L+ + + +A
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLT---------INKLLDMAAQI 118
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
A+G+ ++ +HRDL+++NIL+ + KIADFG+A+++ E+ E+ A
Sbjct: 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREG---- 169
Query: 868 CGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
APE K+D++SFG++L E+ T
Sbjct: 170 -AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 53/223 (23%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVK- 751
++G+G G+VY+ T ++ A+K + + E+E E+ +L H NI
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 752 ----LLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV- 805
+ + +L LV E+ S+ + ++L E IA
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-----KEE-------WIAYI 134
Query: 806 --GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+GL ++H ++HRD+K N+LL N K+ DFGV+ L + G +T
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNT 188
Query: 864 VVGSCGYIAPEYARTRKV-----NEKTDIYSFGVILLELTTGK 901
+G+ ++APE + + K+D++S G+ +E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 38/234 (16%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-FLAEV 738
RD D +G G GKVY+ T + A K I + + E E ++ E+
Sbjct: 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYIVEI 67
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+IL+T H IVKLL + ++ E+ ++D +L
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----------------AIMLELD 111
Query: 799 RRM---QIAV---GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
R + QI V + L ++H S I+HRDLK+ N+L+ + ++ADFGV+ +
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168
Query: 853 KEEGEFAAMSTVVGSCGYIAPE-----YARTRKVNEKTDIYSFGVILLELTTGK 901
K + +G+ ++APE + + K DI+S G+ L+E+ +
Sbjct: 169 K---TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
LT IGSG G V+ + +V A+K I + E++F+ E +++ + H
Sbjct: 10 LTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI----REGAMSEEDFIEEAEVMMKLSHPK 64
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V+L + LV E+ME L +L R + + + + + +
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVC 114
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+G+ Y+ ++HRDL + N L+ N K++DFG+ + ++ ++ ++ G+
Sbjct: 115 EGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-----YTSSTGTK 166
Query: 869 GYI---APEYARTRKVNEKTDIYSFGVILLELTT 899
+ +PE + + K+D++SFGV++ E+ +
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 50/229 (21%), Positives = 97/229 (42%), Gaps = 30/229 (13%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+ +G GKVY+ + VA+K + + + + +EF E + +
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRA 67
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEVLSW 797
++H N+V LL ++ + +++ Y L ++L H S+ R L
Sbjct: 68 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 798 RRRMQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + A G+ Y+ HH +VH+DL + N+L+ N KI+D G+ + + +
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 856 GEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + APE K + +DI+S+GV+L E+ +
Sbjct: 183 ------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 21/205 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL-NIVKL 752
+G G V + T + A K + R+ Q E L E+ +L + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ + +L+ EY + + +S ++ QI +G+
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI-----KQIL----EGVY 145
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
Y+H IVH DLK NILL + KI DFG+++ + + ++G+
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACE--LREIMGTPE 198
Query: 870 YIAPEYARTRKVNEKTDIYSFGVIL 894
Y+APE + TD+++ G+I
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIA 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
++T +GSG G V +V AVK I K E EF E Q + + H
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI----KEGSMSEDEFFQEAQTMMKLSHP 63
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+VK S E +V EY+ L +L R+ + L + +++
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL----------RSHGKGLEPSQLLEMCYDV 113
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS----- 862
+G+ ++ S +HRDL + N L+D + K++DFG+ + + + ++ +
Sbjct: 114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFP 168
Query: 863 ---TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE K + K+D+++FG+++ E+ +
Sbjct: 169 VKWS--------APEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G V R T A K I N +KL + ++ E +I ++H NIV+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQGLC 812
I E+ LV++ + L + + R S A + QI + +
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCI------QQIL----ESIA 142
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
Y H S IVHR+LK N+LL K+ADFG+A + + E G+ G
Sbjct: 143 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEA--WHGFAGTPG 195
Query: 870 YIAPEYARTRKVNEKTDIYSFGVIL 894
Y++PE + ++ DI++ GVIL
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 47/220 (21%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
LT +G+G G V +V A+K I K E EF+ E +++ + H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI----KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+V+L + + ++ EYM L +L R ++ +++
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDV 129
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS----- 862
+ + Y+ S +HRDL + N L++ K++DFG+++ + + E+ +
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFP 184
Query: 863 ---TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ PE K + K+DI++FGV++ E+ +
Sbjct: 185 VRWS--------PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILST 743
+L + V+GSG G V++ +P + ++ V +K I + ++ + + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGS 71
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
+ H +IV+LL +L LV +Y+ SL + R L + +
Sbjct: 72 LDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHV----------RQHRGALGPQLLLNW 120
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
V A+G+ Y+ +VHR+L + N+LL ++ADFGVA +L ++ +
Sbjct: 121 GVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--- 174
Query: 864 VVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
S A E K ++D++S+GV + EL T
Sbjct: 175 ---SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+ +G G GKV+ + +VAVK + + K+F E ++L+
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 72
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEVLSW 797
++H +IVK + ++V+EYM+ L+++L R L
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 798 RRRMQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + IA A G+ Y+ H VHRDL + N L+ N KI DFG+++ + +
Sbjct: 133 SQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 856 GEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
VG + PE RK ++D++SFGVIL E+ T
Sbjct: 188 ------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 672 TTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE 731
+S + I +GSG G V+ V + +K I ++ Q
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPM 64
Query: 732 KEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRS-SLSGR 789
++ AE+++L ++ H NI+K+ + +V E E L ++ + + R +LS
Sbjct: 65 EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 790 ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFG 846
E++ Q+ L Y H S +VH+DLK NIL + KI DFG
Sbjct: 125 YVAELMK-----QMM----NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172
Query: 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+A++ + E + G+ Y+APE + R V K DI+S GV++
Sbjct: 173 LAELF--KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 46/223 (20%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+L IG G G V VAVK I ND + FLAE +++ +RH
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKND-----ATAQAFLAEASVMTQLRHS 74
Query: 748 NIVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
N+V+LL + + +V EYM K SL +L + RS L ++ ++
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---------GDCLLKFSLD 125
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA----------KILIKEEG 856
+ + Y+ VHRDL + N+L+ + AK++DFG+ K+ +K
Sbjct: 126 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--- 179
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE R +K + K+D++SFG++L E+ +
Sbjct: 180 -------------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
L ++G G G V + T+ VAVK + Q+ +EFL+E +
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF 93
Query: 745 RHLNIVKLL-CCISSE----NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
H N+++LL CI +++ +M+ L +L +R + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKH----IPLQT 148
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA 859
++ V A G+ Y+ + +HRDL + N +L + +ADFG++K + +
Sbjct: 149 LLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---- 201
Query: 860 AMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G + A E R K+D+++FGV + E+ T
Sbjct: 202 --YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 694 VIGSGGSGKVY----RVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
VIG+G G+VY + VA+K + +K +FL E I+ H NI
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
++L IS +++ EYME +LD++L R +D S + + + G A
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL----------REKDGEFSVLQLVGMLRGIAA 158
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIK-EEGEFAAMSTVVGSC 868
G+ Y+ + VHRDL + NIL++ N K++DFG++++L E +
Sbjct: 159 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG------ 209
Query: 869 GYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G I APE RK +D++SFG+++ E+ T
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-28
Identities = 47/220 (21%), Positives = 78/220 (35%), Gaps = 27/220 (12%)
Query: 693 NVIGSGGS--GKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
VIG G V T E V V++I N + E+ + H NIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV---GA 807
++N +V +M S + + +E+ IA G
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-----NEL-------AIAYILQGV 137
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA----KILIKEEGEFAAMST 863
+ L Y+HH VHR +K+S+IL+ + ++ ++
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 864 VVGSCGYIAPEYARTRKV--NEKTDIYSFGVILLELTTGK 901
V +++PE + + K+DIYS G+ EL G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/247 (27%), Positives = 104/247 (42%), Gaps = 44/247 (17%)
Query: 663 RKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI-- 720
R L + +T F ++ + ++G G S V R T + AVK I
Sbjct: 2 RDAALPGSHSTH----GFYENYEPKE-----ILGRGVSSVVRRCIHKPTCKEYAVKIIDV 52
Query: 721 ----WNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSL- 774
+ Q+ + L EV IL + H NI++L + LV++ M+K L
Sbjct: 53 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112
Query: 775 DQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833
D K +LS + R + + + +C +H IVHRDLK NIL
Sbjct: 113 DYLTEKV---TLSEKETRKIMR------ALL----EVICALH---KLNIVHRDLKPENIL 156
Query: 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE------YARTRKVNEKTDI 887
LD + N K+ DFG + L + GE + V G+ Y+APE ++ D+
Sbjct: 157 LDDDMNIKLTDFGFSCQL--DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 888 YSFGVIL 894
+S GVI+
Sbjct: 213 WSTGVIM 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 694 VIGSGGSGKVYR--VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVK 751
+GSG G V + + + VAVK + N+ D + E LAE ++ + + IV+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVR 82
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
++ +E+ +LV E E L+++L ++NR + + +++ + G+
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYL-QQNRH----------VKDKNIIELVHQVSMGM 130
Query: 812 CY---MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
Y + VHRDL + N+LL AKI+DFG++K L +E + A +
Sbjct: 131 KYLEESN------FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-----QTH 179
Query: 869 GYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G APE K + K+D++SFGV++ E +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+T +G G G+VY +P + + VAVK + + +FL E I+S
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIIS 88
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
H NIV+ + + ++ E M L +L R + ++ L+ +
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLH 144
Query: 803 IAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDY---NFNAKIADFGVAKILIKEEGE 857
+A A G Y+ +H +HRD+ + N LL AKI DFG+A+ + +
Sbjct: 145 VARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-- 197
Query: 858 FAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G C + PE KTD +SFGV+L E+ +
Sbjct: 198 ----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 35/241 (14%), Positives = 68/241 (28%), Gaps = 43/241 (17%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G T E V + + K+ EV L +R + K
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSS----------------------LSGRAR 791
+ + +K+ + + + LS +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
+ L R+Q+ + + L +HH +VH L+ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEY-----------ARTRKVNEKTDIYSFGVILLELTTG 900
A S G+ PE R + D ++ G+++ +
Sbjct: 255 -----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 901 K 901
Sbjct: 310 D 310
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEV 738
+ + ++I V+GSG +V+ V T ++ A+K I +K + E+
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI---KKSPAFRDSSLENEI 57
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSW 797
+L I+H NIV L S LV + + L + ++ + + A +
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQ-- 113
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKE 854
Q+ + Y+H IVHRDLK N+L + N I DFG++K+
Sbjct: 114 ----QVL----SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--- 159
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ MST G+ GY+APE + ++ D +S GVI
Sbjct: 160 --QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKH---EKEFLAEVQILSTIRHLNIV 750
VIG G V R T + AVK + + K ++ E I ++H +IV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 751 KLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSS-LSGR-ARDEVLSWRRRMQIAVGA 807
+LL SS+ + +V+E+M+ L + + + + S A + QI
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM------RQIL--- 140
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ L Y H I+HRD+K +LL + + K+ FGVA + E G
Sbjct: 141 -EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGL--VAGGR 193
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
VG+ ++APE + + D++ GVIL
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ T ++G G G V + + VAVK + + +EFL E +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 745 RHLNIVKLL-CCISSENLK-----LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
H ++ KL+ + S +++ +M+ L +L +S L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LAS-RIGENPFNLPLQ 137
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
++ V A G+ Y+ S +HRDL + N +L + +ADFG+++ I +
Sbjct: 138 TLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYY 193
Query: 859 AAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G + A E +D+++FGV + E+ T
Sbjct: 194 -----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 693 NVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
V+G+G G+V + VA+K + +K ++FL E I+ H NI
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNI 108
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
++L ++ ++V EYME SLD +L R D + + + + G A
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL----------RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLCY---MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
G+ Y M VHRDL + NIL++ N K++DFG+ ++L E+ AA +T G
Sbjct: 159 GMKYLSDMG------YVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGG 210
Query: 867 SCGY--IAPEYARTRKVNEKTDIYSFGVILLELTT 899
+PE RK +D++S+G++L E+ +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 74/326 (22%), Positives = 124/326 (38%), Gaps = 50/326 (15%)
Query: 659 IYQKRKDELTSTETTSFHRLNFRDSDILPKLTES--------NVIGSGGSGKVYRVPINH 710
++ L + +GSG G+V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 711 TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYME 770
T A+K I + + L EV +L + H NI+KL + LV E +
Sbjct: 61 THVERAIKII-RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSS 830
L + + + + EV + ++ + + Y+H IVHRDLK
Sbjct: 120 GGELFDEIIHRMKFN-------EVDA-AVIIKQVLSG---VTYLH---KHNIVHRDLKPE 165
Query: 831 NILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDI 887
N+LL + + KI DFG++ + E + M +G+ YIAPE R +K +EK D+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVF--ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDV 220
Query: 888 YSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD-KEIDEPCFLEEMIRV 946
+S GVIL L G G + R +++GK D+ + K + E +++I+
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEI----LRKVEKGKYTFDSPEWKNVSEGA--KDLIK- 273
Query: 947 FKLGVICTSML---PTERPNMRMVLQ 969
ML R + + L+
Sbjct: 274 --------QMLQFDSQRRISAQQALE 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+ +G G GKV+ + +VAVK + ++ + ++F E ++L+
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLT 98
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV-----LSW 797
++H +IV+ + L+V+EYM L+++L + + A E L
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGL 157
Query: 798 RRRMQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + +A A G+ Y+ H VHRDL + N L+ KI DFG+++ + +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 856 GEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
VG + PE RK ++D++SFGV+L E+ T
Sbjct: 213 ------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 658 RIYQKRKDELTST--ETTSFHRLNFRDSDILP----------KLTESNVIGSGGSGKVYR 705
+ QK K ++ E+ + F D LP L +G+G GKV
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 706 -----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL-CCISS 758
+ VAVK + + D+K + ++E++I+S + +H NIV LL C
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHENIVNLLGACTHG 122
Query: 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSG---RARDEVLSWRRRMQIAVGAAQGLCYMH 815
+ L++ EY L +L +K+R + + S R + + AQG+ ++
Sbjct: 123 GPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 816 HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI---- 871
S +HRD+ + N+LL AKI DFG+A+ I + + +V +
Sbjct: 182 ---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNY-----IVKGNARLPVKW 232
Query: 872 -APEYARTRKVNEKTDIYSFGVILLELTT 899
APE ++D++S+G++L E+ +
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 14/231 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
N +L+L N I + LE L LS+N+ I I + L+ L L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDN 122
Query: 154 NMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPS 211
++ IP L++L++L L N SIP+ + +L L+L S +
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL--SYISE 178
Query: 212 N-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSK 269
F L L+ L + + + EIP + ++ L+ LDLS N+ + +I F+ L +L K
Sbjct: 179 GAFEGLSNLRYLNL-AMCNLREIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQK 235
Query: 270 VYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSL 319
+++ + + A ++L +L I+L+ NNLT + F L +L + L
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 71/244 (29%), Positives = 102/244 (41%), Gaps = 16/244 (6%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
+P+ I + + L L N + S L L L L N +I L NL
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 194 EALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSIN 251
LEL N +++P+ F L KLK+LW+ N I IP + +L LDL
Sbjct: 115 NTLELFDN---RLTTIPNGAFVYLSKLKELWL-RNNPIESIPSYAFNRIPSLRRLDLGEL 170
Query: 252 NFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGK 310
I F+ L NL + L +L EIP + L +DLS N+L+ P F
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 311 LENLLNLSLMFNQLSGEIPEG-IGLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVS 368
L +L L ++ +Q+ I L SL ++ L +N L+ LP D F LE +
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287
Query: 369 VNNL 372
N
Sbjct: 288 HNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 71 GSVTELHLTNMN----MNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDL 126
+ L L+ + G F L NL L+L N + + SKL+ L L
Sbjct: 88 RHLEILQLSRNHIRTIEIGAF----NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143
Query: 127 SQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIP 184
N I IP +R+ L+ L L I L+ LR LNL + IP
Sbjct: 144 RNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201
Query: 185 AEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLA 242
+ L L+ L+L+ N S++ F L L+KLWM + I I ++ +
Sbjct: 202 N-LTPLIKLDELDLSGN---HLSAIRPGSFQGLMHLQKLWMIQ-SQIQVIERNAFDNLQS 256
Query: 243 LEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSL 277
L ++L+ NN T +P +F L +L +++L+ N
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-18
Identities = 67/299 (22%), Positives = 109/299 (36%), Gaps = 57/299 (19%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
SKV +L E+P + S N ++++L N + N F L +L L L N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI-STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 326 GEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
I G L +L + LF+N L+ +P F S L+ + N + S+P
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIP------ 152
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
+ SL + + LS IS+
Sbjct: 153 -----------------SYAFNRIPSLRRLDLGEL----K---------RLSY--ISEGA 180
Query: 444 FTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPS 503
F G L NL L ++ +IP ++ L S N + PG L
Sbjct: 181 FEG-LS-----NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 504 LTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSEN 560
L L + Q+Q+ + + +SL +NL+ N L+ +P + L L+ + L N
Sbjct: 233 LQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 60/302 (19%), Positives = 95/302 (31%), Gaps = 81/302 (26%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNM 347
+ NL +P+ N L+L NQ+ I L L+ ++L N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 348 LSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGN 406
+ + F + L E+ N LT ++P +
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIP-----------------------NGAFVY 134
Query: 407 CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRF 466
S L + + NN +IP+ + +P +L RL++ +
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNR----------------IP-----SLRRLDLGELKR 172
Query: 467 SGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWK 526
I G F G L +L L L L +P ++
Sbjct: 173 LSYISEGA---------------FEG--------LSNLRYLNLAMCNLR-EIP-NLTPLI 207
Query: 527 SLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQI--GRLMLTSLNLSSNR 584
L L+LS N LS P L LQ L + ++Q I L +NL+ N
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNN 266
Query: 585 LT 586
LT
Sbjct: 267 LT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 13/103 (12%)
Query: 498 LTALP-----SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGF--LP 550
L +P + L L +NQ+ + L L LSRN + I F L
Sbjct: 55 LREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGA-FNGLA 112
Query: 551 VLQDLDLSENQFSGKIPPQI--GRLMLTSLNLSSNRLTGEIPS 591
L L+L +N+ + IP L L L +N + IPS
Sbjct: 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVK-----KIWNDRKLDQKHEKEFLAEVQILSTIR-HL 747
VIG G S V R T AVK + ++ + E IL + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAV 805
+I+ L+ S + LV++ M K L D K +LS + R + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMR------SLL- 210
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ + ++H + IVHRDLK NILLD N +++DFG + L E GE + +
Sbjct: 211 ---EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEK--LRELC 260
Query: 866 GSCGYIAPE------YARTRKVNEKTDIYSFGVIL 894
G+ GY+APE ++ D+++ GVIL
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
+ + ++G G G+V + T + AVK I N K L EV+
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVE 73
Query: 740 ILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
+L + H NI+KL + + +V E L + K+ R S E + R
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-------EHDA-AR 125
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEG 856
++ + YMH IVHRDLK NILL + + + KI DFG++ ++
Sbjct: 126 IIKQVFSG---ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQN 177
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
M +G+ YIAPE R +EK D++S GVIL L +G
Sbjct: 178 TK--MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+T +G G G+VY +P + + VAVK + ++ E +FL E I+S
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIIS 129
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
H NIV+ + + ++ E M L +L R + ++ L+ +
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLH 185
Query: 803 IAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDY---NFNAKIADFGVAKILIKEEGE 857
+A A G Y+ +H +HRD+ + N LL AKI DFG+A+ + +
Sbjct: 186 VARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-- 238
Query: 858 FAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G C + PE KTD +SFGV+L E+ +
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
R + + + G G G V T VA+KK+ D + E L +Q
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRE---LQIMQD 72
Query: 741 LSTIRHLNIVKLLCCISSENLK-------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDE 793
L+ + H NIV+L + + +V EY+ LH+ R+ +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPP 127
Query: 794 VLSWRRRM-QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKIL 851
+ + + Q+ + + +H S + HRD+K N+L++ + K+ DFG AK L
Sbjct: 128 PILIKVFLFQL----IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 852 IKEEGEFAAMSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
E + S Y APE Y T V DI+S G I E+ G+
Sbjct: 183 SPSE----PNVAYICSRYYRAPELIFGNQHY--TTAV----DIWSVGCIFAEMMLGE 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 689 LTESNVIGSGGSGKVYR-VPINHTAEV-VAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH 746
L +G G G V + V ++ VA+K + ++ +E + E QI+ + +
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDN 395
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
IV+L+ +E L +LV E L ++L + E + ++
Sbjct: 396 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL----------VGKREEIPVSNVAELLHQ 444
Query: 807 AAQGLCY---MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ G+ Y + VHR+L + N+LL AKI+DFG++K L ++ + A
Sbjct: 445 VSMGMKYLEEKN------FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA--- 495
Query: 864 VVGSCG------YIAPEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE RK + ++D++S+GV + E +
Sbjct: 496 ---RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 31/220 (14%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
++ IG G G V++ + + A VA+K N ++FL E +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF 73
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H +IVKL+ I+ + ++ E L +L + R L + A
Sbjct: 74 DHPHIVKLIGVITENPV-WIIMELCTLGELRSFL----------QVRKYSLDLASLILYA 122
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ L Y+ S VHRD+ + N+L+ N K+ DFG+++ +++ + A
Sbjct: 123 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK-- 176
Query: 865 VGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
G + APE R+ +D++ FGV + E+
Sbjct: 177 ----GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
DI T N IG G G+V T A KKI + + F E++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFV--EDVDRFKQEIE 58
Query: 740 ILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
I+ ++ H NI++L LV E L + + K E + R
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR-------ESDA-AR 110
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEG 856
M+ + A + Y H + HRDLK N L + K+ DFG+A + G
Sbjct: 111 IMKDVLSA---VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPG 162
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ M T VG+ Y++P+ + D +S GV++
Sbjct: 163 KM--MRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L +G G G+V + T VAVK + + + ++E++IL
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KE-GATHSEHRALMSELKILI 85
Query: 743 TI-RHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEVL 795
I HLN+V LL C +++ E+ + +L +L + L
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + + A+G M S +HRDL + NILL KI DFG+A+ I ++
Sbjct: 146 TLEHLICYSFQVAKG---MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 201
Query: 856 GEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
++ V + APE R ++D++SFGV+L E+ +
Sbjct: 202 PDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 70/212 (33%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-FLAEVQILSTIRHLNIVK 751
V+G G G+V T + AVK I + R++ QK +KE L EVQ+L + H NI+K
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L + LV E L + + R S EV + R ++ + +
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-------EVDA-ARIIRQVLSG---I 139
Query: 812 CYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
YMH IVHRDLK N+LL + N +I DFG++ E + M +G+
Sbjct: 140 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK--MKDKIGTA 192
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
YIAPE +EK D++S GVIL L +G
Sbjct: 193 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 31/220 (14%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
+ + ++G G G+VY VAVK D ++++F++E I+ +
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNL 70
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H +IVKL+ I E ++ E L +L L + +
Sbjct: 71 DHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYL----------ERNKNSLKVLTLVLYS 119
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ + + Y+ S VHRD+ NIL+ K+ DFG+++ + E+
Sbjct: 120 LQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------YY 169
Query: 865 VGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
S + +PE R+ +D++ F V + E+ +
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G V R + A I N +KL + ++ E +I ++H NIV+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGR-ARDEVLSWRRRMQIAVGAAQGLC 812
IS E L+++ + L + + R S A + QI + +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCI------QQIL----EAVL 124
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
+ H +VHR+LK N+LL K+ADFG+A ++ E + A G+ G
Sbjct: 125 HCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ--AWFGFAGTPG 178
Query: 870 YIAPEYARTRKVNEKTDIYSFGVIL 894
Y++PE R + D+++ GVIL
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 44/235 (18%)
Query: 682 DSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL 741
D T++ VIG+G G VY+ + + E+VA+KK+ D+ + E+QI+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIM 101
Query: 742 STIRHLNIVKLLCCISSENLKL------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
+ H NIV+L S K LV +Y+ + +++ R + V+
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVI 156
Query: 796 SWRRRM-QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAKILIK 853
+ M Q+ + L Y+H S I HRD+K N+LLD + K+ DFG AK L++
Sbjct: 157 YVKLYMYQL----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 854 EEGEFAAMSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
E + + S Y APE Y T + D++S G +L EL G+
Sbjct: 210 GE----PNVSYICSRYYRAPELIFGATDY--TSSI----DVWSAGCVLAELLLGQ 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 73/209 (34%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKLL 753
+G G GKV T VAVK I N +K+ + E+Q L RH +I+KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
IS+ +V EY+ L ++ K R E+ + R QI + Y
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVE-------EMEARRLFQQIL----SAVDY 126
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H +VHRDLK N+LLD + NAKIADFG++ ++ +GEF + T GS Y AP
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEF--LRTSCGSPNYAAP 179
Query: 874 EYARTRKVN-EKTDIYSFGVILLELTTGK 901
E R + DI+S GVIL L G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 14/236 (5%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
N L+L N I + LE L L +N I I + L+ L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDN 133
Query: 154 NMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPS 211
++ IP+ L++LR+L L N SIP+ + +L L+L + +
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL--EYISE 189
Query: 212 N-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSK 269
F L LK L + I ++P + ++ LE L++S N+F I F L +L K
Sbjct: 190 GAFEGLFNLKYLNLGM-CNIKDMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKK 246
Query: 270 VYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
+++ ++ +S A + L +L ++L+ NNL+ + F L L+ L L N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 67/244 (27%), Positives = 102/244 (41%), Gaps = 16/244 (6%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
+P+ I S ++L L NN+ + L L L L N I L +L
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 194 EALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETI-GDMLALEFLDLSIN 251
LEL N + +PS F L KL++LW+ N I IP + +L LDL
Sbjct: 126 NTLELFDN---WLTVIPSGAFEYLSKLRELWL-RNNPIESIPSYAFNRVPSLMRLDLGEL 181
Query: 252 NFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGK 310
I F+ L NL + L ++ ++P + L+ +++S N+ P F
Sbjct: 182 KKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHG 240
Query: 311 LENLLNLSLMFNQLSGEIPEG-IGLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVS 368
L +L L +M +Q+S I L SL ++ L +N LS +LP D F L +
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLH 298
Query: 369 VNNL 372
N
Sbjct: 299 HNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 14/213 (6%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
L +L +L L N I + L L+L N ++ IP + LS+L+ L+L
Sbjct: 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN-WLTVIPSGAFEYLSKLRELWLRN 156
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLP 210
N + IP+ R+ L +L+L + I L NL+ L L + +P
Sbjct: 157 NPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC---NIKDMP 212
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLS 268
+ T L L++L M S N EI + + +L+ L + + + I + F L +L
Sbjct: 213 N-LTPLVGLEELEM-SGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLV 269
Query: 269 KVYLYSNSLSGEIPQAVESL-NLKVIDLSANNL 300
++ L N+LS L L + L N
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 73/303 (24%), Positives = 113/303 (37%), Gaps = 61/303 (20%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
SKV LS E+PQ + N + ++L NN+ + F L +L L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI-PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 326 GEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
+I G L SL + LF+N L+ +P F S L + N + S+P
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIP------ 163
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTG-FNLSMVLISDN 442
+ SL+ + + I G + G FNL + +
Sbjct: 164 -----------------SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 443 LFTGELPD-KMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTAL 501
++P+ L LE+S N F +I G F+G L
Sbjct: 207 NIK-DMPNLTPLVGLEELEMSGNHFP-EIRPGS---------------FHG--------L 241
Query: 502 PSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSE 559
SL L + +Q+S + + SL LNL+ N LS +P + L L +L L
Sbjct: 242 SSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
Query: 560 NQF 562
N +
Sbjct: 300 NPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 74 TELHLTNMNM-----NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQ 128
L L + N +G F L L L L+ N I S L LDL +
Sbjct: 126 NTLELFD-NWLTVIPSGAFE----YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE 180
Query: 129 NYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI 187
+ I E + L LK+L L N+ +P + L L +L + N F
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHF-------- 230
Query: 188 GNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEF 245
+ F L LKKLW+ + + + I + +L
Sbjct: 231 -------------------PEIRPGSFHGLSSLKKLWVMN-SQVSLIERNAFDGLASLVE 270
Query: 246 LDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSL 277
L+L+ NN + S+P +F L+ L +++L+ N
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 56/302 (18%), Positives = 92/302 (30%), Gaps = 81/302 (26%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNM 347
+ + L+ +P N L+LM N + I L L+ ++L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 348 LSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGN 406
+ + F + L E+ N LT +P +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIP-----------------------SGAFEY 145
Query: 407 CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRF 466
S L + + NN +IP+ + +P +L RL++ +
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNR----------------VP-----SLMRLDLGELKK 183
Query: 467 SGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWK 526
I G F G L +L L L + +P ++
Sbjct: 184 LEYISEGA---------------FEG--------LFNLKYLNLGMCNIK-DMP-NLTPLV 218
Query: 527 SLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQI--GRLMLTSLNLSSNR 584
L L +S N P L L+ L + +Q S I G L LNL+ N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277
Query: 585 LT 586
L+
Sbjct: 278 LS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/146 (23%), Positives = 50/146 (34%), Gaps = 14/146 (9%)
Query: 453 SGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQN 512
S S++ + S ++P G+ S N N L L L L +N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 513 QLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQ 569
+ + + + SL L L N L+ IP F L L++L L N IP
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGA-FEYLSKLRELWLRNNPIE-SIPSY 165
Query: 570 I--GRLMLTSLNLSS-NRLTGEIPSQ 592
L L+L +L I
Sbjct: 166 AFNRVPSLMRLDLGELKKLE-YISEG 190
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 31/225 (13%), Positives = 70/225 (31%), Gaps = 29/225 (12%)
Query: 693 NVIGSGGSGKVYRV-----PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+++G G +VY + +K + + ++ L
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ---LMERLKPSMQH 127
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+K +N +LV E +L ++ ++V+ + A+
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY------KNTPEKVMPQGLVISFAMRM 181
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILL-----------DYNFNAKIADFGVAKILIKEEG 856
+ +H I+H D+K N +L D + + D G + I +K
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS-IDMKLFP 237
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ + + G+ E + N + D + + + G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 31/220 (14%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI 744
++ IG G G V++ + + A VA+K N ++FL E +
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQF 448
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
H +IVKL+ I+ + ++ E L +L + R L + A
Sbjct: 449 DHPHIVKLIGVITENPV-WIIMELCTLGELRSFL----------QVRKFSLDLASLILYA 497
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
+ L Y+ S VHRD+ + N+L+ N K+ DFG+++ +
Sbjct: 498 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YY 547
Query: 865 VGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
S G + APE R+ +D++ FGV + E+
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTI- 744
+ +VIG G G+V + I A+K++ + ++F E+++L +
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLG 83
Query: 745 RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK-----NRSSLSGRARDEVLSWRR 799
H NI+ LL L EY +L +L K + + + LS ++
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA 859
+ A A+G M + +HRDL + NIL+ N+ AKIADFG++ + + +
Sbjct: 144 LLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVY- 195
Query: 860 AMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
V + G + A E +D++S+GV+L E+ +
Sbjct: 196 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 32/236 (13%)
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI----------WNDRKLD 727
+ ++ I + +GSG G+V + A+K I +D K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 728 QKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS 787
+K +E E+ +L ++ H NI+KL + LV E+ E L + + +++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 788 GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIAD 844
++ QI G+CY+H IVHRD+K NILL + N KI D
Sbjct: 145 ECDAANIMK-----QIL----SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
FG++ + + +G+ YIAPE + +K NEK D++S GVI+ L G
Sbjct: 193 FGLSSFF--SKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 99/509 (19%), Positives = 171/509 (33%), Gaps = 93/509 (18%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
L L N I + S+L L LS N I + + L++L ++ N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
+ I + LR L+L N F+ +P + F
Sbjct: 112 LQ-NISC--CPMASLRHLDLSFNDFD-VLP------------------------VCKEFG 143
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYS 274
L KL L + S ++ L L + L L S
Sbjct: 144 NLTKLTFLGL-SAAKFRQLDLLPVAHLHLSCILLD----------------------LVS 180
Query: 275 NSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSG-------E 327
+ G ++++ N V+ L + + + L +L L +L+
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 328 IPEGIGLLPSLKDVRLFNNMLSGALPPDFGRY---SPLEYFEVSVNNLTGSLPEHLCAGG 384
+ P+L +V L + + ++ P+EY + +T +
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREE---- 296
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF---NLSMVLISD 441
S SL++ + N F L++ F N+ M+ ISD
Sbjct: 297 ---------------FTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISD 340
Query: 442 NLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFN--GTIPGELT 499
F + + + L + N F+ + G S+ K L N +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 500 ALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558
+ SL TL + N L+ +W +S+ LNLS N L+G + + P ++ LDL
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 559 ENQFSGKIPPQIGRL-MLTSLNLSSNRLT 586
N+ IP + L L LN++SN+L
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 74/466 (15%), Positives = 151/466 (32%), Gaps = 56/466 (12%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTAN 153
L L +L L N I S V LEYLD+S N + I ++ L+ L L+ N
Sbjct: 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR-LQNIS--CCPMASLRHLDLSFN 131
Query: 154 NM-SGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN 212
+ + G LT+L L L +F + +L + L + +
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETES 190
Query: 213 FTQLKKLKKLWMASTNLIGEIPETIG----DMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
+ N + + + L L + L+ N + + +
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 269 KVYLYSNSLSG------EIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322
+ + + ++ Q ++ +++ +T I + SLM
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 323 QLSGE----IPEGIG-LLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLP 377
+ + E + + + L + S + + N T
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSV 369
Query: 378 EHLCAG-GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF---- 432
C+ +L + Q N L + ++ ++ + S ++ + +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWA 427
Query: 433 -NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFN 491
++ ++ +S N+ TG + + + L++ NNR
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM------------------------ 463
Query: 492 GTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRN 536
+IP ++T L +L L + NQL S+P + SL + L N
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 40/217 (18%), Positives = 79/217 (36%), Gaps = 19/217 (8%)
Query: 69 TDGSVTELHLTNMNMNG--TFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLD 125
++ ++ L + ++ + + I L + + S +L+
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 126 LSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN----G 181
+QN F + + L RL+ L L N + + L + N
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 182 SIPAEIGNLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGD 239
+ +++ L L+ N T LP +K L + N I IP+ +
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK------VKVLDL-HNNRIMSIPKDVTH 471
Query: 240 MLALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSN 275
+ AL+ L+++ N S+P VF L +L ++L+ N
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 63/364 (17%), Positives = 124/364 (34%), Gaps = 47/364 (12%)
Query: 75 ELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF--- 131
L L + ++ G + N T+L L F+ +V + + L +L LS
Sbjct: 175 LLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 132 ----IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRL---TELRQLNLVVNQFNGSIP 184
+ ++ R L + L + K + + + LN+ I
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 185 AEIGNLQN--LEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDML 241
E L++L + + ++ ++ ++ ++
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 242 ALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN---SLSGEIPQAVESLNLKVIDLSA 297
+ FL+ + N FT LK L + L N + +L+ +D+S
Sbjct: 354 SFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412
Query: 298 NNLT-GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDF 356
N+L A E++L L+L N L+G + L P +K + L NN + ++P D
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--CLPPKVKVLDLHNNRIM-SIPKDV 469
Query: 357 GRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIY 416
L+ V+ N L S+P+ +SL + ++
Sbjct: 470 THLQALQELNVASNQLK-SVPD-----------------------GVFDRLTSLQYIWLH 505
Query: 417 NNSF 420
+N +
Sbjct: 506 DNPW 509
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST-IRHLNIV 750
IG G R T AVK I + K D E ++IL +H NI+
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTEE------IEILLRYGQHPNII 79
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
L +V E M+ L + + + S R VL I +
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLF-----TIT----KT 128
Query: 811 LCYMHHDCSPTIVHRDLKSSNILL-DYNFNA---KIADFGVAKILIKEEGEFAAMSTVVG 866
+ Y+H + +VHRDLK SNIL D + N +I DFG AK ++ E + T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGL--LMTPCY 182
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ ++APE + + DI+S GV+L
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVK-----KIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+GSG G V+ + V VK K+ D ++ + E+ ILS + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 750 VKLLCCISSENLKLLVYEY----MEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+K+L ++ LV E ++ L ++ + R DE L+ Q+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRL-------DEPLASYIFRQLV- 140
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ Y+ I+HRD+K NI++ +F K+ DFG A L E G+ T
Sbjct: 141 ---SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKL--FYTFC 190
Query: 866 GSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTG 900
G+ Y APE + +++S GV L L
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L+ +G+G GKV + + A VAVK + + ++E+++LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLS 81
Query: 743 TI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR-------DEV 794
+ H+NIV LL + L++ EY L +L +K S + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
L + + A+G+ ++ S +HRDL + NILL + KI DFG+A+ IK
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR-DIKN 197
Query: 855 EGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + VV + APE ++D++S+G+ L EL +
Sbjct: 198 DSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G V T+ A+K + + + E ++S + H VKL
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 754 CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQ 809
+ KL Y + L +++ K + R E++S
Sbjct: 97 FTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVS------------- 141
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
L Y+H I+HRDLK NILL+ + + +I DFG AK+L E + A ++ VG+
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQ 197
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y++PE + + +D+++ G I+ +L G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVK-----KIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
++G G GKV V + T AVK K+ + +KE +Q+L +RH N
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLRHKN 67
Query: 749 IVKLLCCISSENLK--LLVYEYMEKRS---LDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
+++L+ + +E + +V EY LD K+ + Q+
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR----FP-----VCQAHGYFCQL 118
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE-EGEFAAMS 862
GL Y+H S IVH+D+K N+LL KI+ GVA+ L +
Sbjct: 119 I----DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CR 169
Query: 863 TVVGSCGYIAPEYARTRKVNE--KTDIYSFGVILLELTTGK 901
T GS + PE A K DI+S GV L +TTG
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 27/223 (12%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE----KEFL 735
F+ + +GSG V + T A K I R+ +E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVSREEIE 63
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
EV IL + H N++ L + +L+ E + L +L +K SLS +
Sbjct: 64 REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFI 121
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL-DYNFNA---KIADFGVAKIL 851
QI G+ Y+H + I H DLK NI+L D N K+ DFG+A +
Sbjct: 122 -----KQIL----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
E+G + G+ ++APE + + D++S GVI
Sbjct: 170 --EDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G + VYR T + A+K + + +D +K E+ +L + H NI+KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVD---KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ LV E + L + +K S RD + + QI + + Y
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYS----ERDAADAVK---QIL----EAVAY 163
Query: 814 MHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
+H IVHRDLK N+L + KIADFG++KI+ E M TV G+ GY
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVL--MKTVCGTPGY 216
Query: 871 IAPEYARTRKVNEKTDIYSFGVIL 894
APE R + D++S G+I
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G+V T E VAVK I + ++ E E+ I + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI--AVGAAQGLC 812
N++ L EY L + E + R Q+ V
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMP-------EPDAQRFFHQLMAGVV------ 119
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I HRD+K N+LLD N KI+DFG+A + + ++ + G+ Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVA 175
Query: 873 PEYARTRKVN-EKTDIYSFGVILLELTTG 900
PE + R+ + E D++S G++L + G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 71/273 (26%), Positives = 109/273 (39%), Gaps = 46/273 (16%)
Query: 675 FHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN--DRKLDQKH 730
F+ + DS +L + IGSG G V VA+KK+ + K
Sbjct: 11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 70
Query: 731 EKEFLAEVQILSTIRHLNIVKLLCCISSENLKL------LVYEYMEKRSLDQWLHKKNRS 784
E+ ++ + H NI+ LL + + +V E M+ + L + +
Sbjct: 71 A---YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---N--LCQVIQM 122
Query: 785 SLSGRARDEVLSWRRRMQIAVGAAQGLC---YMHHDCSPTIVHRDLKSSNILLDYNFNAK 841
L E RM + Q LC ++H S I+HRDLK SNI++ + K
Sbjct: 123 ELD----HE------RMSYLL--YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
I DFG+A+ M+ V + Y APE E DI+S G I+ E+ G
Sbjct: 168 ILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
Query: 902 EANNGDEHTCLAQWAWRHIQE--GKPIVDALDK 932
G +H + Q W + E G P + + K
Sbjct: 224 VLFPGTDH--IDQ--WNKVIEQLGTPCPEFMKK 252
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 27/223 (12%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK----EFL 735
F+ + +GSG V + T A K I R+ E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVCREEIE 63
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
EV IL + H NI+ L + +L+ E + L +L +K SLS +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFI 121
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIADFGVAKIL 851
QI G+ Y+H + I H DLK NI+L + K+ DFG+A +
Sbjct: 122 -----KQIL----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
E+G + G+ ++APE + + D++S GVI
Sbjct: 170 --EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 29/206 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKL 752
+G G + + + AVK I + R + E+ L H NIVKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII-SKRMEANTQK-----EITALKLCEGHPNIVKL 71
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHK-KNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ LV E + L + K + S ++ ++ +
Sbjct: 72 HEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIM-----RKLV----SAV 119
Query: 812 CYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+MH +VHRDLK N+L + N KI DFG A++ + + + T +
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQ--PLKTPCFTL 173
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVIL 894
Y APE +E D++S GVIL
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE----KEFLAEVQILSTIRHLNI 749
+GSG V + T + A K I R+L +E EV IL IRH NI
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFI-KKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 750 VKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ L ++ +L+ E + L D K++ + + + QI
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-----DEATQFLK---QIL---- 118
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIADFGVAKILIKEEGEFAAMSTV 864
G+ Y+H S I H DLK NI+L N K+ DFG+A + E G +
Sbjct: 119 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNE--FKNI 171
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
G+ ++APE + + D++S GVI
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 43/270 (15%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPK-------LTESNVIGSGGSGKVYR-----VPI 708
Q + ++T + + ++FR+ + K L V+GSG GKV +
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISK 71
Query: 709 NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL-CCISSENLKLLVY 766
+ VAVK + + K D + ++E+++++ + H NIV LL C S + L++
Sbjct: 72 TGVSIQVAVKML-KE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI-YLIF 128
Query: 767 EYMEKRSLDQWLHKK------------NRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
EY L +L K N+ L VL++ + A A+G M
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG---M 185
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI--- 871
+ VHRDL + N+L+ + KI DFG+A+ I + + VV +
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-DIMSDSNY-----VVRGNARLPVK 239
Query: 872 --APEYARTRKVNEKTDIYSFGVILLELTT 899
APE K+D++S+G++L E+ +
Sbjct: 240 WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
++++ ++G G G+V++ T +A K I R + K +E E+ +++ + H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDK--EEVKNEISVMNQLDHA 146
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVG 806
N+++L S+N +LV EY++ L D+ + + + D +L + QI
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT----ELDTILFMK---QIC-- 197
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEEGEFAAMSTV 864
+G+ +MH I+H DLK NIL KI DFG+A+ E +
Sbjct: 198 --EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVN 248
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
G+ ++APE V+ TD++S GVI
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V + T ++ A KK+ R +K E L E QIL + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-GRAR---DEVLSWRRRMQIAVGAAQ 809
+++ LV M L ++ ++ RA E+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC------------- 297
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL +H IV+RDLK NILLD + + +I+D G+A E + VG+ G
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVG 350
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE + + D ++ G +L E+ G+
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/190 (26%), Positives = 76/190 (40%), Gaps = 13/190 (6%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
RNLTIL L N + + LE LDLS N + + L RL L+L
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLP 210
+ ++ + L L+ L L N ++P + +L NL L L N SS+P
Sbjct: 115 CGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGN---RISSVP 169
Query: 211 SN-FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVFK-LKNL 267
F L L +L + N + + L L L L NN + ++P+ L+ L
Sbjct: 170 ERAFRGLHSLDRLLLHQ-NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRAL 227
Query: 268 SKVYLYSNSL 277
+ L N
Sbjct: 228 QYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 14/213 (6%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTAN 153
+ L N I C L L L N + I L+ L+ L L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLSDN 90
Query: 154 NMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPS 211
+ + L L L+L + + L L+ L L N + +LP
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN---ALQALPD 146
Query: 212 N-FTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLS 268
+ F L L L++ N I +PE + +L+ L L N + F L L
Sbjct: 147 DTFRDLGNLTHLFL-HGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLM 204
Query: 269 KVYLYSNSLSGEIPQAVESL-NLKVIDLSANNL 300
+YL++N+LS +A+ L L+ + L+ N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 15/203 (7%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLK 217
+P I +++ L N+ + A +NL L L N + + + FT L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN---VLARIDAAAFTGLA 80
Query: 218 KLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
L++L ++ + + T + L L L + +F L L +YL N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 276 SLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI- 332
+L +P L NL + L N ++ F L +L L L N+++ +
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 333 GLLPSLKDVRLFNNMLSGALPPD 355
L L + LF N LS ALP +
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 57/297 (19%), Positives = 89/297 (29%), Gaps = 79/297 (26%)
Query: 270 VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
L +P + + I L N ++ F NL L L N L+ I
Sbjct: 16 TSCPQQGLQ-AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RID 72
Query: 330 EGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
L L+ + L +N ++ P F L + L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG---------- 121
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGE 447
P ++L + + +N+ +P +
Sbjct: 122 -------------PGLFRGLAALQYLYLQDNALQ-ALPDDTFRD---------------- 151
Query: 448 LPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTL 507
L NL+ L + NR S +P F G L SL L
Sbjct: 152 LG-----NLTHLFLHGNRIS-SVPERA---------------FRG--------LHSLDRL 182
Query: 508 LLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQF 562
LL QN+++ + L L L N LS +P + L LQ L L++N +
Sbjct: 183 LLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 38/204 (18%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGF-NLSMVLISDNLFTGELPD 450
N +S S C +L ++ +++N I A +TG L + +SDN +
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
Query: 451 KM---SGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTL 507
G L L + ++ G+ F G L +L L
Sbjct: 99 ATFHGLGRLHTLHLDRCGLQ-ELGPGL---------------FRG--------LAALQYL 134
Query: 508 LLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSG 564
L N L +LP D +LT L L N++S +PE+ F L L L L +N+ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERA-FRGLHSLDRLLLHQNRVA- 190
Query: 565 KIPPQI--GRLMLTSLNLSSNRLT 586
+ P L +L L +N L+
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 38/189 (20%), Positives = 61/189 (32%), Gaps = 17/189 (8%)
Query: 407 CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEI---SN 463
+ +P G+ + + N + +P L I +
Sbjct: 10 NEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHS 65
Query: 464 NRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIP-GELTALPSLTTLLLDQNQLSGSLPLD 521
N + +I + L S+N ++ L L TL LD+ L L
Sbjct: 66 NVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
Query: 522 IISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSGKIPPQI--GRLMLTS 577
+ +L L L N L +P+ L L L L N+ S +P + G L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR 181
Query: 578 LNLSSNRLT 586
L L NR+
Sbjct: 182 LLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 27/133 (20%), Positives = 39/133 (29%), Gaps = 8/133 (6%)
Query: 462 SNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLD 521
+P G+ + N + A +LT L L N L+
Sbjct: 19 PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 522 IISWKSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSGKIPPQI--GRLMLTSL 578
L L+LS N + L L L L ++ P + G L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 579 NLSSNRLTGEIPS 591
L N L +P
Sbjct: 135 YLQDNALQ-ALPD 146
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQI 740
KLT +G G G+V + + E VAVK + D +K + ++E+++
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KD-DATEKDLSDLVSEMEM 93
Query: 741 LSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEV 794
+ I +H NI+ LL + + ++ EY K +L ++L S R +E
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
++++ + A+G+ Y+ S +HRDL + N+L+ N KIADFG+A+ I
Sbjct: 154 MTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINN 209
Query: 855 EGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + G + APE R ++D++SFGV++ E+ T
Sbjct: 210 IDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE 737
+ + +L +G+G G V+RV T A K + + ++ E
Sbjct: 148 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKE 204
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLS 796
+Q +S +RH +V L +N +++YE+M L ++ + N+ S + V
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS----EDEAVEY 260
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKE 854
R Q+ +GLC+MH VH DLK NI+ + K+ DFG+ L +
Sbjct: 261 MR---QVC----KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--D 308
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ ++ G+ + APE A + V TD++S GV+
Sbjct: 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 45/227 (19%)
Query: 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
T VIG+G G V++ + + EV A+KK+ D++ + E+QI+ ++H N+
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEV-AIKKV----LQDKRFK---NRELQIMRIVKHPNV 94
Query: 750 VKLLCCISSENLKL------LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-Q 802
V L S K LV EY+ + +++ +R + +L + M Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-KIADFGVAKILIKEEGEFAAM 861
+ + L Y+H S I HRD+K N+LLD K+ DFG AKILI E
Sbjct: 150 LL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PN 198
Query: 862 STVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + S Y APE Y T + DI+S G ++ EL G+
Sbjct: 199 VSYICSRYYRAPELIFGATNY--TTNI----DIWSTGCVMAELMQGQ 239
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 44/204 (21%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G G V+R + + K + + D + E+ IL+ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTD---QVLVKKEISILNIARHRNILHLH 67
Query: 754 CCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
S ++++E++ + ++ + R+ V Q+ + L
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVH---QVC----EALQ 116
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
++H S I H D++ NI+ ++ KI +FG A+ L + G+ + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGD--NFRLLFTAPEY 169
Query: 871 IAPEYARTRKVNEKTDIYSFGVIL 894
APE + V+ TD++S G ++
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 24/204 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+GSG G V+R T V K I + E+ I++ + H ++ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 754 CCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ +L+ E++ L D+ + + S + + R Q +GL
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS----EAEVINYMR---QAC----EGLK 163
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
+MH +IVH D+K NI+ + + KI DFG+A L +E + + +
Sbjct: 164 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEF 216
Query: 871 IAPEYARTRKVNEKTDIYSFGVIL 894
APE V TD+++ GV+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
+G G G+V T E VAVK I + ++ E E+ I + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
N++ L EY L + E + R Q+ G+ Y+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMP-------EPDAQRFFHQLM----AGVVYL 121
Query: 815 HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE 874
H I HRD+K N+LLD N KI+DFG+A + + ++ + G+ Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPE 177
Query: 875 YARTRKVN-EKTDIYSFGVILLELTTG 900
+ R+ + E D++S G++L + G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 39/236 (16%), Positives = 88/236 (37%), Gaps = 55/236 (23%)
Query: 688 KLTESNVIGSGGSGKVYR-------VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
L + +G G K+++ V +K + K + + + F +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASM 65
Query: 741 LSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
+S + H ++V + +LV E+++ SLD +L + ++ +
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----------KKNKNCINILWK 115
Query: 801 MQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLD--------YNFNAKIADFGVAKI 850
+++A A + ++ + ++H ++ + NILL K++D G++
Sbjct: 116 LEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 851 LIKEEGEFAAMSTVVGSCGY------IAPEYARTRKV-NEKTDIYSFGVILLELTT 899
++ ++ + PE K N TD +SFG L E+ +
Sbjct: 171 VLPKD-------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 75/209 (35%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKLL 753
+G G GKV T VAVK I N +K+ + E+Q L RH +I+KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
IS+ + +V EY+ L ++ K R E S R QI G+ Y
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLD-------EKESRRLFQQIL----SGVDY 131
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H +VHRDLK N+LLD + NAKIADFG++ ++ +GEF + T GS Y AP
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEF--LRTSCGSPNYAAP 184
Query: 874 EYARTRKVN-EKTDIYSFGVILLELTTGK 901
E R + DI+S GVIL L G
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 54/224 (24%), Positives = 87/224 (38%), Gaps = 29/224 (12%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK----EFL 735
FR ++ +GSG V + T A K I R+ +
Sbjct: 4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIE 62
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSL-DQWLHKKNRSSLSGRARDEV 794
EV IL I+H N++ L ++ +L+ E + L D K++ + +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-----EEAT 117
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL----DYNFNAKIADFGVAKI 850
+ QI G+ Y+H S I H DLK NI+L KI DFG+A
Sbjct: 118 EFLK---QIL----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 851 LIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ + G + G+ ++APE + + D++S GVI
Sbjct: 168 I--DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 61/331 (18%), Positives = 116/331 (35%), Gaps = 67/331 (20%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+L V L +P+ + S + ++DL N+++ +DF L++L L L+ N++S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI-SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 326 GEIPEGI-GLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGG 384
+I E L L+ + + N L +PP S L + N + +P
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVP------- 139
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT-GNIPAGLWTGFNLSMVLISDNL 443
++ +++ N G + G L+ + IS+
Sbjct: 140 ----------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 444 FTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPS 503
T +P + L+ L + +N+ I
Sbjct: 184 LT-GIPKDLPETLNELHLDHNKIQ-AIELED---------------LLR--------YSK 218
Query: 504 LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFS 563
L L L NQ+ + +L L+L N+LS +P + L +LQ + L N +
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 564 GKIPP--------QIGRLMLTSLNLSSNRLT 586
K+ + R ++L +N +
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 33/292 (11%)
Query: 72 SVTELHLTNMNM----NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
T L L N ++ F L++L L L N I + KL+ L +S
Sbjct: 55 DTTLLDLQNNDISELRKDDFK----GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQF-NGSIPA 185
+N + IP ++ S L L + N + K+P + L + + + N N
Sbjct: 111 KN-HLVEIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 186 EIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE-TIGDMLALE 244
+ L L ++ + +P + + L +L + N I I + L
Sbjct: 167 GAFDGLKLNYLRISEA---KLTGIPKDL--PETLNELHLDH-NKIQAIELEDLLRYSKLY 220
Query: 245 FLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTG 302
L L N I + L L +++L +N LS +P + L L+V+ L NN+T
Sbjct: 221 RLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278
Query: 303 AIPNDF------GKLENLLNLSLMFNQLS-GEIPEGIGL-LPSLKDVRLFNN 346
NDF K +SL N + E+ + ++ N
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 61/337 (18%), Positives = 116/337 (34%), Gaps = 59/337 (17%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
+P++I L L N++S L L L LV N+ + I + L+ L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKL 104
Query: 194 EALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE-TIGDMLALEFLDLSI 250
+ L ++ N E P +LPS+ L +L + N I ++P+ + + +++
Sbjct: 105 QKLYISKNHLVEI-PPNLPSS------LVELRI-HDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 251 NNFT-GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
N F L+ + + L+ IP+ + L + L N + D
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE-TLNELHLDHNKIQAIELEDLL 214
Query: 310 KLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVS 368
+ L L L NQ+ I G LP+L+++ L NN LS +P L+ +
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 369 VNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGL 428
NN+T + + + + ++NN
Sbjct: 273 TNNIT-KVGVNDFCP-----------------VGFGVKRAYYNGISLFNN---------- 304
Query: 429 WTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNR 465
+ + F + + ++ N +
Sbjct: 305 ----PVPYWEVQPATFRC-VT-----DRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 59/334 (17%), Positives = 111/334 (33%), Gaps = 52/334 (15%)
Query: 243 LEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNL 300
L + S ++P + + + + L +N +S E+ + + L +L + L N +
Sbjct: 35 LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD-FGRY 359
+ F L L L + N L EIP L SL ++R+ +N + +P F
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPN--LPSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 360 SPLEYFEVSVNNLT-GSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNN 418
+ E+ N L G KL + + L+ +P+ L +L + + +N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 419 SFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGV-SSS 477
I L RL + +N+ I G S
Sbjct: 204 KIQ----------------AIELEDLLR-YS-----KLYRLGLGHNQIR-MIENGSLSFL 240
Query: 478 KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS-------WKSLTA 530
L NN + +P L L L + L N ++ + ++
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 531 LNLSRNQLS-GEIPEKIGF--LPVLQDLDLSENQ 561
++L N + E+ F + + +
Sbjct: 299 ISLFNNPVPYWEVQPAT-FRCVTDRLAIQFGNYK 331
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL-STIRHLNIVKL 752
V+G G +GKV T + A+K + D ++ EV +IV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQ-------EVDHHWQASGGPHIVCI 87
Query: 753 L----CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
L + L++ E ME L + ++ + + R E++ I
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-----DIG---- 138
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ ++H S I HRD+K N+L + + K+ DFG AK + + T
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNA---LQTPC 190
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ Y+APE K ++ D++S GVI+
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA-EVQILSTIRHLNIVKLL 753
+G G GKV T + VA+K + + L + + E+ L +RH +I+KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
I++ ++V EY D ++ +K R + E R QI + Y
Sbjct: 76 DVITTPTDIVMVIEYAGGELFD-YIVEKKRMT-------EDEGRRFFQQII----CAIEY 123
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H IVHRDLK N+LLD N N KIADFG++ I+ +G F + T GS Y AP
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNF--LKTSCGSPNYAAP 176
Query: 874 EYARTRKVN-EKTDIYSFGVILLELTTGK 901
E + + D++S G++L + G+
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 32/215 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKL 752
V+G G +V T++ AVK I + + EV++L + H N+++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKII-EKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ E+ LV+E M S+ +HK R + V+ +A L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQ-----DVA----SALD 125
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFA-----AMSTV 864
++H + I HRDLK NIL + KI DF + IK G+ + + T
Sbjct: 126 FLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG-IKLNGDCSPISTPELLTP 181
Query: 865 VGSCGYIAPE-----YARTRKVNEKTDIYSFGVIL 894
GS Y+APE +++ D++S GVIL
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 688 KLTESNVIGSGGSGKVYR---VPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQI 740
KLT +G G G+V V I+ VAVK + +K + ++E+++
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEM 139
Query: 741 LSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEV 794
+ I +H NI+ LL + + ++ EY K +L ++L S R +E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
++++ + A+G+ Y+ S +HRDL + N+L+ N KIADFG+A+ I
Sbjct: 200 MTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINN 255
Query: 855 EGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + G + APE R ++D++SFGV++ E+ T
Sbjct: 256 IDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 36/236 (15%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
L +G G GKV + + VAVK + + ++ L+E +L
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLK 81
Query: 743 TIRHLNIVKLL-CCISSENLKLLVYEYMEKRSLDQWL-------------HKKNRSSLSG 788
+ H +++KL C L LL+ EY + SL +L SS
Sbjct: 82 QVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 789 RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848
+ L+ + A +QG M + +VHRDL + NIL+ KI+DFG++
Sbjct: 141 HPDERALTMGDLISFAWQISQG---MQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 849 KILIKEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ + EE + V S G I A E ++D++SFGV+L E+ T
Sbjct: 198 R-DVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 64/328 (19%), Positives = 98/328 (29%), Gaps = 57/328 (17%)
Query: 289 NLKVIDLSANNLTGAIPNDF----GKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLF 344
N + S N D+ K E N+ + E L+ +++L
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFSELQLN 67
Query: 345 NNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESL 404
LS +LP + + E++ N L SLPE L + A DN LS LPE
Sbjct: 68 RLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TLPELP 119
Query: 405 GNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNN 464
+ L + NN T LP+ L + NN
Sbjct: 120 ASLKHL---DVDNNQLT-------------------------MLPELP-ALLEYINADNN 150
Query: 465 RFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS 524
+ + +P +L V NN +P SL L + N L SLP +
Sbjct: 151 QLT-MLP---ELPTSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVR 201
Query: 525 WKSLT----ALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNL 580
N+++ IPE I L + L +N S +I + +
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 581 SSNRLTGEIPSQFENRAYASSFLNNPGL 608
Q +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 73/416 (17%), Positives = 140/416 (33%), Gaps = 55/416 (13%)
Query: 150 LTANNMSGKIPASIGR-LTELRQLNLVVNQFNG--SIPAEIGNLQNLEALELAYNTEFSP 206
+ N A + + L N S+ E + L+L +
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRL---NL 71
Query: 207 SSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKN 266
SSLP N ++ L + + N + +PE LE+LD N + ++P LK+
Sbjct: 72 SSLPDNL--PPQITVLEI-TQNALISLPELPAS---LEYLDACDNRLS-TLPELPASLKH 124
Query: 267 LSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSG 326
L + +N L+ +P+ L+ I+ N LT +P +L LS+ NQL+
Sbjct: 125 L---DVDNNQLT-MLPELPA--LLEYINADNNQLT-MLPE---LPTSLEVLSVRNNQLT- 173
Query: 327 EIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKL 386
+PE L SL+ + + N+L +LP R E E+
Sbjct: 174 FLPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR---------------- 213
Query: 387 AGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTG 446
++N ++ +PE++ + + + +N + I L F+
Sbjct: 214 ----CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506
+ + + + F + VS + + N F+ L+ S
Sbjct: 269 SDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARN 327
Query: 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
+ Q++ L + L ++ + E L +L +
Sbjct: 328 TSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-24
Identities = 52/261 (19%), Positives = 91/261 (34%), Gaps = 46/261 (17%)
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFL 148
C + + L L +S P L ++ L+++QN + +PE + L++L
Sbjct: 53 LKECLINQFSELQLNRLN-LSSLPDNL--PPQITVLEITQNA-LISLPELP---ASLEYL 105
Query: 149 YLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSS 208
N +S +P L L++ NQ +P L+ + N +
Sbjct: 106 DACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPALLEY---INADNN---QLTM 154
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
LP T L+ L N + +PE +LE LD+S N S+P+ + +
Sbjct: 155 LPELPTSLEVLS----VRNNQLTFLPELPE---SLEALDVS-TNLLESLPAVPVRNHHSE 206
Query: 269 KVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ ++ N +T IP + L+ + L N LS I
Sbjct: 207 ETEIF-------------------FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246
Query: 329 PEGIGLLPSLKDVRLFNNMLS 349
E + + D S
Sbjct: 247 RESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 10/153 (6%)
Query: 71 GSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLE----YLDL 126
S+ L + N N P +L LD+ N + P V E +
Sbjct: 160 TSLEVLSVRN-NQLTFLPEL---PESLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRC 214
Query: 127 SQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAE 186
+N I IPE+I L + L N +S +I S+ + T + F+ S +
Sbjct: 215 RENR-ITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 187 IGNLQNLEALELAYNTEFSPSSLPSNFTQLKKL 219
+ L A+ E S + + +
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHE 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 53/237 (22%), Positives = 95/237 (40%), Gaps = 38/237 (16%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+ IG G G+V++ + +VAVK + + + +F E +++
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA 105
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK-------------NRSSLSGR 789
+ NIVKLL + L++EYM L+++L + +
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 790 ARDEVLSWRRRMQIAVGAAQGLCYM--HHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847
LS ++ IA A G+ Y+ VHRDL + N L+ N KIADFG+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGL 220
Query: 848 AKILIKEEGEFAAMSTVVGSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
++ I + I PE + ++D++++GV+L E+ +
Sbjct: 221 SR-NIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
+ LDL FN + ++ +L+ LDLS+ I I + LS L L LT N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNP 87
Query: 155 MSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN 212
+ + L+ L++L V S+ G+L+ L+ L +A+N S
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN---LIQSFKLP 142
Query: 213 --FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEF----LDLSINNFTGSIPSSVFKLK 265
F+ L L+ L + S+N I I T +L + LDLS+N I FK
Sbjct: 143 EYFSNLTNLEHLDL-SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 266 NLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSAN 298
L ++ L +N L + L +L+ I L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 14/190 (7%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
L +LDL I + + S L L L+ N I + LS L+ L
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVE 109
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLP 210
N++ + G L L++LN+ N E NL NLE L+L+ N S+
Sbjct: 110 TNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN---KIQSIY 165
Query: 211 SN-FTQLKKLKKLWMA---STNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK-LK 265
L ++ L ++ S N + I + L+ L L N S+P +F L
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLT 224
Query: 266 NLSKVYLYSN 275
+L K++L++N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 56/295 (18%), Positives = 87/295 (29%), Gaps = 76/295 (25%)
Query: 270 VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
+ +IP + + K +DLS N L F L L L ++ I
Sbjct: 12 YQCMELNFY-KIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 330 EGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLA 387
+G L L + L N + +L F S L+ NL SL
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLE---------- 116
Query: 388 GIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGE 447
+G+ +L + + +N F+
Sbjct: 117 -------------NFPIGHLKTLKELNVAHNLIQ---------------SFKLPEYFSN- 147
Query: 448 LPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT-T 506
L NL L++S+N+ I L +P L +
Sbjct: 148 LT-----NLEHLDLSSNKIQ-SIYCTD---------------LRV-----LHQMPLLNLS 181
Query: 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSEN 560
L L N ++ + L L L NQL +P+ I L LQ + L N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 40/205 (19%), Positives = 65/205 (31%), Gaps = 37/205 (18%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
N L S + L ++ + I G + +L
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAY-----------QSL-------- 75
Query: 452 MSGNLSRLEISNNRFSGKIPTGVSSS-KNLVVFQASNNLFNGTIPGELTALPSLTTLLLD 510
+LS L ++ N + G S +L A + L +L L +
Sbjct: 76 --SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 511 QNQLSGSLPLDII--SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQ----DLDLSENQF 562
N + S L + +L L+LS N++ I L + LDLS N
Sbjct: 133 HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD-LRVLHQMPLLNLSLDLSLNPM 189
Query: 563 SGKIPPQI-GRLMLTSLNLSSNRLT 586
+ I P + L L L +N+L
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 21/103 (20%), Positives = 32/103 (31%), Gaps = 13/103 (12%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGF--LP 550
+P L L N L S+ L L+LSR ++ I + + L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA-YQSLS 76
Query: 551 VLQDLDLSENQFSGKIPPQI-GRL-MLTSLNLSSNRLTGEIPS 591
L L L+ N + L L L L + +
Sbjct: 77 HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLEN 117
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 655 YMIRIYQKRKDELTSTETTSFHRLNFRDSDILP----------KLTESNVIGSGGSGKVY 704
Y + D T+ L LP +L +G G G+V
Sbjct: 27 YYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVV 86
Query: 705 R-----VPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLL-CC 755
+ + V VAVK + +D + ++E++++ I +H NI+ LL C
Sbjct: 87 LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 756 ISSENLKLLVYEYMEKRSLDQWL-----HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
L ++ EY K +L ++L S +E LS + + A A+G
Sbjct: 145 TQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
+ Y+ S +HRDL + N+L+ + KIADFG+A+ I + + G
Sbjct: 204 MEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-DIHHIDYY-----KKTTNGR 254
Query: 871 I-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE R ++D++SFGV+L E+ T
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/246 (20%), Positives = 83/246 (33%), Gaps = 16/246 (6%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
L+ LT+ + I + S L+ L L G P + + L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 153 NNMS-GKIPASIGRL-----TELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN----- 201
N+S A + L L+ L++ ++ L L+L+ N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 202 TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSV 261
+ P F L+ L G + L+ LDLS N+ + +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 262 F-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLM 320
L+ + L L ++P+ + + L V+DLS N L P +L + NLSL
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLPA-KLSVLDLSYNRLDR-NP-SPDELPQVGNLSLK 304
Query: 321 FNQLSG 326
N
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 53/291 (18%), Positives = 93/291 (31%), Gaps = 26/291 (8%)
Query: 318 SLMFNQLSGEIPEGIGLLPSLKDV-RLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSL 376
S FN L E G SL+ + + + D + L+ V + +
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84
Query: 377 PEH---LCAGGKLAGIAAQDNNLSGELPESLGNCS--SLLMVKIYNNSFTGNIPA----G 427
+ L + ++ ++G P L + L ++ + N S+
Sbjct: 85 LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144
Query: 428 LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLE---ISNNRFSGKI-------PTGVSSS 477
W L ++ I+ + L +S+N G+ P +
Sbjct: 145 QWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 478 KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRN 536
+ L + A +G A L L L N L + W L +LNLS
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263
Query: 537 QLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTG 587
L ++P+ + L LDLS N+ P + +L+L N
Sbjct: 264 GLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 62/272 (22%), Positives = 98/272 (36%), Gaps = 22/272 (8%)
Query: 121 LEYLDLSQNYFIGPIP-EDIDRLSRLKFLYLTANNMSGKIPASIGRL---TELRQLNLVV 176
LEYL + DI + LK L + A + +I R+ + L++L L
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 177 NQFNGSIPAEIGNLQ--NLEALELAYNTEFSPSSLPSNFTQLKK--LKKLWMASTNLIGE 232
+ G+ P + +L L L + + + + Q K LK L +A + +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 233 IPETIGDMLALEFLDLSINNFTGSI-------PSSVFKLKNLSKVYLYSNSLSGEIPQAV 285
E + AL LDLS N G P L+ L+ + SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 286 ESL-NLKVIDLSANNLTGAIPN-DFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRL 343
+ L+ +DLS N+L A L +L+L F L ++P+ GL L + L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDL 281
Query: 344 FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGS 375
N L P + + N S
Sbjct: 282 SYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 70/329 (21%), Positives = 112/329 (34%), Gaps = 50/329 (15%)
Query: 252 NFTGSIP--SSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
NF+ P SS F + V LY S E LK +D A+ D
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLE-------YLLKRVDTEADLGQ---FTDII 65
Query: 310 KLENLLNLSLMFNQLSGEIPEGIGLL---PSLKDVRLFNNMLSGALPPDFGRYSPLEYFE 366
K +L L++ ++ I G + L+++ L N ++G PP + +
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 367 VSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPA 426
+++ N++ + + EL + L L ++ I N
Sbjct: 126 LNLRNVSWATR----------------DAWLAELQQWLK--PGLKVLSIAQAHSL-NFSC 166
Query: 427 GLWTGF-NLSMVLISDNLFTGE------LPDKMSGNLSRLEISNNRF---SGKIPTGVSS 476
F LS + +SDN GE L L L + N SG ++
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 477 SKNLVVFQASNNLFNGTIPGELTALP-SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSR 535
L S+N P L +L L L +P + + L+ L+LS
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSY 283
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
N+L P LP + +L L N F
Sbjct: 284 NRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 57/306 (18%), Positives = 96/306 (31%), Gaps = 45/306 (14%)
Query: 181 GSIPAEI-GNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGD 239
G+ E+ G ++LE L +TE L LK+L + + + I
Sbjct: 32 GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILFGALR 90
Query: 240 MLA---LEFLDLSINNFTGSIPSSVFKL--KNLSKVYLYSNSLSGEIP-----QAVESLN 289
+L L+ L L TG+ P + + +L+ + L + S + Q
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 290 LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGL----LPSLKDVRLFN 345
LKV+ ++ + L L L N GE L P+L+ + L N
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 346 NM---LSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPE 402
SG L+ ++S N+L + C
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD-------------------- 250
Query: 403 SLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEIS 462
S L + + +P GL LS++ +S N + L +
Sbjct: 251 ---WPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRNPSPDELPQVGNLSLK 304
Query: 463 NNRFSG 468
N F
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 35/176 (19%), Positives = 52/176 (29%), Gaps = 16/176 (9%)
Query: 433 NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPT--GVSSSKNLVVFQASNNLF 490
+ I + G L L L + N +G P ++ +L + N +
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 491 NG--TIPGELTAL--PSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI 546
EL P L L + Q + + +L+ L+LS N GE
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 547 ----GFLPVLQDLDLSENQFSGKIPPQIGRLM-----LTSLNLSSNRLTGEIPSQF 593
P LQ L L L L L+LS N L +
Sbjct: 194 ALCPLKFPTLQVLALRNAGME-TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 30/168 (17%), Positives = 55/168 (32%), Gaps = 15/168 (8%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNC----SKLEYLDLS 127
+ L + + + L+ LDL N + + + C L+ L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 128 QNYF---IGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSI 183
G +L+ L L+ N++ A ++L LNL +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 184 PAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIG 231
P + L L+L+YN PS +L ++ L + +
Sbjct: 269 PKGL--PAKLSVLDLSYN---RLDRNPS-PDELPQVGNLSLKGNPFLD 310
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
V+G GG G+V+ + T ++ A KK+ R +K + + E +IL+ + IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 754 CCISSENLKLLVYEYME----KRSLDQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVG 806
++ LV M + + RA +++S
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVS---------- 300
Query: 807 AAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVG 866
GL ++H I++RDLK N+LLD + N +I+D G+A L + G
Sbjct: 301 ---GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
+ G++APE + + D ++ GV L E+ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-24
Identities = 65/243 (26%), Positives = 100/243 (41%), Gaps = 34/243 (13%)
Query: 669 STETTSFHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN--DR 724
S F+ + DS +L + IGSG G V VA+KK+
Sbjct: 42 SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 725 KLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI----SSENLK--LLVYEYMEKRSLDQWL 778
+ K E+ ++ + H NI+ LL + E + LV E M+ + L
Sbjct: 102 QTHAKRA---YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N--L 153
Query: 779 HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838
+ + L E +S+ Q+ G + ++H S I+HRDLK SNI++ +
Sbjct: 154 CQVIQMELD----HERMSYLL-YQMLCG----IKHLH---SAGIIHRDLKPSNIVVKSDC 201
Query: 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELT 898
KI DFG+A+ G M+ V + Y APE E DI+S G I+ E+
Sbjct: 202 TLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 899 TGK 901
K
Sbjct: 258 RHK 260
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 18/215 (8%)
Query: 67 ACT---DGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEY 123
C S E++ N+ PP + ++ TIL L N + + L ++L
Sbjct: 3 ICEVSKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 124 LDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSI 183
L+L + + + D L L L L+ N + +P L L L++ N+ S+
Sbjct: 60 LNLDRAE-LTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 184 PAEI-GNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDML 241
P L L+ L L N +LP T KL+KL + + N + E+P + + L
Sbjct: 116 PLGALRGLGELQELYLKGN---ELKTLPPGLLTPTPKLEKLSL-ANNNLTELPAGLLNGL 171
Query: 242 -ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSN 275
L+ L L N+ +IP F L +L+ N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 56/272 (20%), Positives = 89/272 (32%), Gaps = 78/272 (28%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ +V +L+ +P + + ++ LS N L L L+L +L+
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 326 GEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG-G 384
++ LP L + L +N L +LP L +VS N LT SLP G G
Sbjct: 69 -KLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 385 KLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLF 444
+L + + N L +P GL
Sbjct: 125 ELQELYLKGNELK-------------------------TLPPGL---L--------TPT- 147
Query: 445 TGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSL 504
L +L ++NN + ++P G+ NG L +L
Sbjct: 148 ---------PKLEKLSLANNNLT-ELPAGL---------------LNG--------LENL 174
Query: 505 TTLLLDQNQLSGSLPLDIISWKSLTALNLSRN 536
TLLL +N L ++P L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 19/214 (8%)
Query: 406 NCS-SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NLSRLEIS 462
+ S L V + T +P L + +++ +S+NL + L++L +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 463 NNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDI 522
+ K+ + + + N L ++P LP+LT L + N+L+ SLPL
Sbjct: 64 RAELT-KLQVDGTLPVLGTLDLSHNQL--QSLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
Query: 523 I-SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQI-GRL-MLTS 577
+ L L L N+L +P + P L+ L L+ N + ++P + L L +
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGL-LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176
Query: 578 LNLSSNRLTGEIPSQFENRAYASSFL-NNPGLCA 610
L L N L F + +FL NP LC
Sbjct: 177 LLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 32/209 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G +GKV ++ T E A+K + D ++ EV++ + +IV++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR-------EVELHWRASQCPHIVRI 120
Query: 753 LC----CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ + L+V E ++ L + + + + R E++ I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM-----KSIG---- 171
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ + Y+H S I HRD+K N+L N K+ DFG AK ++T
Sbjct: 172 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPC 224
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
+ Y+APE K ++ D++S GVI+
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 48/236 (20%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA------------------ 736
IG G G V + A+K + + +KL ++
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMK-VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 737 ------EVQILSTIRHLNIVKLLCCISSEN-LKL-LVYEYMEKRSLDQWLHKKNRSSLSG 788
E+ IL + H N+VKL+ + N L +V+E + + + + LS
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLS- 135
Query: 789 RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVA 848
E + + +G+ Y+H I+HRD+K SN+L+ + + KIADFGV+
Sbjct: 136 ----EDQARFYFQDLI----KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 849 KILIKEEGEFAAMSTVVGSCGYIAPE--YARTRKVN-EKTDIYSFGVILLELTTGK 901
+ +S VG+ ++APE + + + D+++ GV L G+
Sbjct: 185 NEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 26/248 (10%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
+ + + + D+ P+ T + IG G G V N VA+KKI
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 721 WN-DRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-----LVYEYMEKRSL 774
+ + + L E++IL RH NI+ + I + ++ +V + ME
Sbjct: 61 SPFEHQTYCQRT---LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--- 114
Query: 775 DQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834
D L+K ++ + LS +GL Y+H S ++HRDLK SN+LL
Sbjct: 115 D--LYKLLKT--------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLL 161
Query: 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVI 893
+ + KI DFG+A++ + ++ V + Y APE + + DI+S G I
Sbjct: 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 894 LLELTTGK 901
L E+ + +
Sbjct: 222 LAEMLSNR 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLC 754
IGSG G + T E+VAVK I +D+ ++E + ++RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83
Query: 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYM 814
I + ++ EY L + + R S E + Q+ G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFS-------EDEARFFFQQLL----SGVSYC 132
Query: 815 HHDCSPTIVHRDLKSSNILLDYNF--NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
H S I HRDLK N LLD + KI DFG +K + VG+ YIA
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQ--PKSTVGTPAYIA 185
Query: 873 PEYARTRKVN-EKTDIYSFGVILLELTTG 900
PE ++ + + D++S GV L + G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 37/246 (15%)
Query: 667 LTSTETTSFHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN-- 722
L+ F++ + + ++ +GSG G V + E VA+KK+
Sbjct: 2 LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 723 DRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI----SSENLK--LLVYEYMEKRSLDQ 776
++ K E+ +L ++H N++ LL S N LV +M+ D
Sbjct: 62 QSEIFAKRA---YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D- 114
Query: 777 WLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836
L K S +E + + + +GL Y+H S +VHRDLK N+ ++
Sbjct: 115 -LQKIMGLKFS----EEKIQY-----LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNE 161
Query: 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILL 895
+ KI DFG+A+ A M+ V + Y APE + N+ DI+S G I+
Sbjct: 162 DCELKILDFGLAR------HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 896 ELTTGK 901
E+ TGK
Sbjct: 216 EMLTGK 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA----EVQILSTIRHL-- 747
++GSGG G VY VA+K + ++ E EV +L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 748 NIVKLLCCISSENLKLLVYEYME-KRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAV 805
+++LL + +L+ E E + L ++ ++ L E L+ R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQ-----EELA-RSFFWQVL- 159
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKILIKEEGEFAAMSTV 864
+ + + H+ ++HRD+K NIL+D N K+ DFG +L ++ + +
Sbjct: 160 ---EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVY---TDF 208
Query: 865 VGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTGK 901
G+ Y PE+ R + + ++S G++L ++ G
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 49/227 (21%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF----LAEVQILSTIRHLN 748
+G+G VY+ T VA+K++ KLD E+ + E+ ++ ++H N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV----KLD--SEEGTPSTAIREISLMKELKHEN 64
Query: 749 IVKLLCCISSENLKLLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
IV+L I +EN LV+E+M+ K+ +D L + V ++ ++
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE---LNLVKYFQWQLL--- 118
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AM 861
QGL + H + I+HRDLK N+L++ K+ DFG+A+ F
Sbjct: 119 ---QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-------AFGIPVNTF 165
Query: 862 STVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
S+ V + Y AP+ Y + DI+S G IL E+ TGK
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQILSTIRHL 747
IG G G VY+ N+ E A+KKI +L+ E E + E+ IL ++H
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKI----RLE--KEDEGIPSTTIREISILKELKHS 60
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NIVKL I ++ +LV+E++ DQ L K G S+ Q+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-----DQDLKKLLDVCEGGLESVTAKSFLL--QLL--- 110
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AMST 863
G+ Y H ++HRDLK N+L++ KIADFG+A+ F +
Sbjct: 111 -NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR-------AFGIPVRKYTH 159
Query: 864 VVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + Y AP+ Y + DI+S G I E+ G
Sbjct: 160 EIVTLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 56/255 (21%), Positives = 93/255 (36%), Gaps = 76/255 (29%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G+G G V V + + A+KK+ D + E+ I+ + H+NI+KL+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHVNIIKLV 66
Query: 754 CCISSENLKL--------------------------------------LVYEYMEKRSLD 775
+ + ++ EY+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DT 123
Query: 776 QWLHKKNRSSLSGRARDEVLSWRRRM-QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834
LHK +S + + + Q+ + + ++H S I HRD+K N+L+
Sbjct: 124 --LHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLV 174
Query: 835 DYNFNA-KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE-------YARTRKVNEKTD 886
+ N K+ DFG AK LI E + S Y APE Y T + D
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEY--TPSI----D 224
Query: 887 IYSFGVILLELTTGK 901
++S G + EL GK
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 674 SFHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN--DRKLDQK 729
F+R + ++ + +GSG G V T VA+KK++ +L K
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 69
Query: 730 HEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL------LVYEYMEKRSLDQWLHKKNR 783
E+++L +RH N++ LL + + LV +M D L K +
Sbjct: 70 RA---YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LGKLMK 121
Query: 784 SSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843
E L R + +GL Y+H + I+HRDLK N+ ++ + KI
Sbjct: 122 H--------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGK 901
DFG+A+ + M+ V + Y APE + + DI+S G I+ E+ TGK
Sbjct: 171 DFGLAR------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 60/249 (24%)
Query: 676 HRLNFRDSDILPKLTES----NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE 731
H + R++ L E +G G G VY+ + +VA+K+I +LD E
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRI----RLD--AE 58
Query: 732 KE-----FLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYME---KRSLDQWLHKKNR 783
E + E+ +L + H NIV L+ I SE LV+E+ME K+ LD+ N+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE-----NK 113
Query: 784 SSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843
+ L ++ + Q+ +G+ + H I+HRDLK N+L++ + K+A
Sbjct: 114 TGLQ---DSQIKIYLY--QLL----RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLA 161
Query: 844 DFGVAKILIKEEGEFA----AMSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGV 892
DFG+A+ F + + V + Y AP+ Y + DI+S G
Sbjct: 162 DFGLAR-------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKY------STSVDIWSIGC 208
Query: 893 ILLELTTGK 901
I E+ TGK
Sbjct: 209 IFAEMITGK 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 674 SFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE 733
S + F D+ + + +G GG+G V+ N + VA+KKI KH
Sbjct: 1 SMNIHGF---DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-- 55
Query: 734 FLAEVQILSTIRHLNIVKLLCCISSENLKL--------------LVYEYMEKRSLDQWLH 779
L E++I+ + H NIVK+ + +L +V EYME D L
Sbjct: 56 -LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LA 109
Query: 780 KKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD-YNF 838
+ + Q+ +GL Y+H S ++HRDLK +N+ ++ +
Sbjct: 110 NVLEQGPLLEEHARLFMY----QLL----RGLKYIH---SANVLHRDLKPANLFINTEDL 158
Query: 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLEL 897
KI DFG+A+I+ +S + + Y +P + + D+++ G I E+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 898 TTGK 901
TGK
Sbjct: 219 LTGK 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 47/226 (20%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQILSTIRHL 747
+G G G+VY+ T E VA+K+I +L+ HE+E + EV +L ++H
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI----RLE--HEEEGVPGTAIREVSLLKELQHR 93
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NI++L I + L++EY E L +++ K S+ + S+ Q+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR-----VIKSFLY--QL---- 141
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-----KIADFGVAKILIKEEGEFAAMS 862
G+ + H S +HRDLK N+LL + + KI DFG+A+ +
Sbjct: 142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR---QFT 195
Query: 863 TVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + Y PE Y + DI+S I E+
Sbjct: 196 HEIITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQILSTIRHL 747
IG G G V++ T E+VA+K++ +LD + E L E+ +L ++H
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV----RLD--DDDEGVPSSALREICLLKELKHK 61
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
NIV+L + S+ LV+E+ ++ L ++ N + V S+ Q+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN----GDLDPEIVKSFLF--QLL--- 111
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AMST 863
+GL + H ++HRDLK N+L++ N K+A+FG+A+ F S
Sbjct: 112 -KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-------AFGIPVRCYSA 160
Query: 864 VVGSCGYIAPEY-ARTRKVNEKTDIYSFGVILLELTTGKEA 903
V + Y P+ + + D++S G I EL
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
+ LDLQ N + S + + +KL L L+ N + +P I L L+ L++T N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNK 96
Query: 155 MSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN 212
+ +P + +L L +L L NQ S+P + +L L L L YN SLP
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN---ELQSLPKG 151
Query: 213 -FTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-KLKNLSK 269
F +L LK+L + N + +PE D L L+ L L N +P F L+ L
Sbjct: 152 VFDKLTSLKELRL-YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
Query: 270 VYLYSN 275
+ L N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN-FTQL 216
IP++I + ++L+L N+ + S+P++ L L L L N +LP+ F +L
Sbjct: 31 IPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDN---KLQTLPAGIFKEL 84
Query: 217 KKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYS 274
K L+ LW+ + N + +P + D L L L L N S+P VF L L+ + L
Sbjct: 85 KNLETLWV-TDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 275 NSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI 332
N L +P+ V + L +LK + L N L F KL L L L NQL +PEG
Sbjct: 143 NELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
Query: 333 -GLLPSLKDVRLFNN 346
L LK ++L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L+L + N T P I L+NL L + N + + V L L L +N +
Sbjct: 64 RLLYLND-NKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQ-L 121
Query: 133 GPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GN 189
+P + D L++L +L L N + +P + +LT L++L L NQ +P
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDK 179
Query: 190 LQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLW 223
L L+ L+L N +P F L+KLK L
Sbjct: 180 LTELKTLKLDNN---QLKRVPEGAFDSLEKLKMLQ 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 27/146 (18%)
Query: 455 NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPS--------LT 505
+ +L++ +N+ S +P+ L + ++N +L LP+ L
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDN--------KLQTLPAGIFKELKNLE 88
Query: 506 TLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQF 562
TL + N+L +LP+ + +L L L RNQL +P ++ F L L L L N+
Sbjct: 89 TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV-FDSLTKLTYLSLGYNEL 145
Query: 563 SGKIPPQI-GRLM-LTSLNLSSNRLT 586
+P + +L L L L +N+L
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 12/139 (8%)
Query: 453 SGNLSRLEISNNRFSGKIPTGVSSS-KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQ 511
+ N + ++ S+ + + IP+ + + K L + +N + L L L L+
Sbjct: 15 NNNKNSVDCSSKKLTA-IPSNIPADTKKLDL---QSNKLSSLPSKAFHRLTKLRLLYLND 70
Query: 512 NQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQFSGKIPPQ 569
N+L +LP I K+L L ++ N+L +P + L L +L L NQ +PP+
Sbjct: 71 NKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
Query: 570 I--GRLMLTSLNLSSNRLT 586
+ LT L+L N L
Sbjct: 128 VFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/132 (33%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L +T+ N P + D L NL L L N + S PRV + +KL YL L N +
Sbjct: 88 ETLWVTD-NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE-L 145
Query: 133 GPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GN 189
+P+ + D+L+ LK L L N + ++P +LTEL+ L L NQ +P +
Sbjct: 146 QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDS 203
Query: 190 LQNLEALELAYN 201
L+ L+ L+L N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 394 NNLSGELPESLGNCSSLLM-VKIYNNSFT---GNIPAG---LWTGFNLSMVLISDNLFTG 446
N + + +C++ V + T NIPA L N + + F
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSN-KLSSLPSKAFHR 59
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIP-GELTALPSL 504
L L L +++N+ +P G+ KNL ++N +P G L +L
Sbjct: 60 -LT-----KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNL 111
Query: 505 TTLLLDQNQLSGSLPLDI-ISWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQ 561
L LD+NQL SLP + S LT L+L N+L +P+ + F L L++L L NQ
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKLTSLKELRLYNNQ 168
Query: 562 FSGKIPPQI--GRLMLTSLNLSSNRLTGEIPSQFEN 595
++P L +L L +N+L F++
Sbjct: 169 LK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 66/312 (21%), Positives = 95/312 (30%), Gaps = 99/312 (31%)
Query: 251 NNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
N V N + V S L+ IP + + K +DL +N L+ F
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNI-PADTKKLDLQSNKLSSLPSKAFH 58
Query: 310 KLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSV 369
+L L L L N+L +P GI F LE V+
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGI-----------------------FKELKNLETLWVTD 94
Query: 370 NNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLW 429
N L +LP G+ + L +L +++ N ++P ++
Sbjct: 95 NKLQ-ALP---------IGV-----------FDQL---VNLAELRLDRNQLK-SLPPRVF 129
Query: 430 TGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNL 489
D+L L+ L + N +P GV
Sbjct: 130 -----------DSL----------TKLTYLSLGYNELQ-SLPKGV--------------- 152
Query: 490 FNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF 548
F+ L SL L L NQL +P L L L NQL
Sbjct: 153 FDK--------LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 549 LPVLQDLDLSEN 560
L L+ L L EN
Sbjct: 204 LEKLKMLQLQEN 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 35/233 (15%)
Query: 676 HRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL 735
+NF +IL IG G GKV V N T ++ A+K + + +++ +
Sbjct: 10 EDVNFDHFEIL------RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 736 AEVQILSTIRHLNIVKLLCCI-SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR--- 791
E+QI+ + H +V L E++ +V + + L L + +
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFI 121
Query: 792 DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL 851
E++ L Y+ + I+HRD+K NILLD + + I DF +A +L
Sbjct: 122 CELVM-------------ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 852 IKEEGEFAAMSTVVGSCGYIAPEYARTRKV---NEKTDIYSFGVILLELTTGK 901
+E ++T+ G+ Y+APE +RK + D +S GV EL G+
Sbjct: 166 PRETQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF----LAEVQILSTIRHLN 748
+ +G G VY+ T +VA+K+I +L+ HE+ + EV +L ++H N
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI----RLE--HEEGAPCTAIREVSLLKDLKHAN 61
Query: 749 IVKLLCCISSENLKLLVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
IV L I +E LV+EY++ K+ LD N ++ V + Q+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMH-----NVKLFLF--QLL- 110
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AM 861
+GL Y H ++HRDLK N+L++ K+ADFG+A+ +
Sbjct: 111 ---RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPTKTY 157
Query: 862 STVVGSCGYIAPEY-ARTRKVNEKTDIYSFGVILLELTTGK 901
V + Y P+ + + + D++ G I E+ TG+
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF------LAEVQIL---ST 743
IG G G VY+ H+ VA+K + ++ + EV +L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 744 IRHLNIVKLLCCISSENLKL-----LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
H N+V+L+ ++ LV+E++++ L +L K L + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP---AETIKDLM 126
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
R Q +GL ++H +C IVHRDLK NIL+ K+ADFG+A+I
Sbjct: 127 R--QFL----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQ 173
Query: 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
A++ VV + Y APE D++S G I E+ K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-22
Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 36/250 (14%)
Query: 664 KDELTSTETTSFHRLNFRDSDILPKLTESN-----VIGSGGSGKVYRVPINHTAEVVAVK 718
+ + S + T F +++ ++ LT ++ +IG GG G+VY T ++ A+K
Sbjct: 163 QKFIESDKFTRF--CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 719 KIWNDRKLDQKHEKEFLAEVQILSTIRHLN---IVKLLCCISSENLKLLVYEYMEKRSLD 775
+ R ++ E L E +LS + + IV + + + + + M L
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 776 QWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNI 832
L + S + R E++ GL +MH + +V+RDLK +NI
Sbjct: 281 YHLSQHGVFSEA-DMRFYAAEIIL-------------GLEHMH---NRFVVYRDLKPANI 323
Query: 833 LLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE-YARTRKVNEKTDIYSFG 891
LLD + + +I+D G+A K++ VG+ GY+APE + + D +S G
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 892 VILLELTTGK 901
+L +L G
Sbjct: 379 CMLFKLLRGH 388
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 38/246 (15%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
+ ++D L ET S + D + +G+G G+V V + A+K +
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDRI------KTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 721 WNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHK 780
+ + K + L E +IL + +VKL + +V EY+ + L +
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 781 KNRSSLSGRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837
R S AR +++ Y+H S +++RDLK N+L+D
Sbjct: 135 IGRFSEP-HARFYAAQIVL-------------TFEYLH---SLDLIYRDLKPENLLIDQQ 177
Query: 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCG---YIAPEYARTRKVNEKTDIYSFGVIL 894
++ DFG AK + CG +APE ++ N+ D ++ GV++
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTL---------CGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 895 LELTTG 900
E+ G
Sbjct: 229 YEMAAG 234
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 60/235 (25%), Positives = 86/235 (36%), Gaps = 34/235 (14%)
Query: 676 HRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFL 735
RL D +IL VIG G +V V + T +V A+K + L + F
Sbjct: 56 VRLQRDDFEIL------KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR---D 792
E +L I +L EN LV EY L L K + AR
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 793 EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILI 852
E++ + +H VHRD+K NILLD + ++ADFG L
Sbjct: 170 EIVM-------------AIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIY-------SFGVILLELTTG 900
+ + VG+ Y++PE + T Y + GV E+ G
Sbjct: 214 ADGTVRS--LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 28/241 (11%)
Query: 664 KDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWND 723
+E+ + HR+ + + L ++G G GKV V T A+K + +
Sbjct: 131 AEEMEVSLAKPKHRVTMNEFEYL------KLLGKGTFGKVILVKEKATGRYYAMKILKKE 184
Query: 724 RKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNR 783
+ + L E ++L RH + L + + V EY L L ++
Sbjct: 185 VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV 244
Query: 784 SSLSGRARD---EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840
S RAR E++S L Y+H + + +V+RDLK N++LD + +
Sbjct: 245 FSED-RARFYGAEIVS-------------ALDYLHSEKN--VVYRDLKLENLMLDKDGHI 288
Query: 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
KI DFG+ K IK+ A M T G+ Y+APE D + GV++ E+ G
Sbjct: 289 KITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 901 K 901
+
Sbjct: 346 R 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 62/242 (25%), Positives = 95/242 (39%), Gaps = 34/242 (14%)
Query: 668 TSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD 727
T RL+ D +IL VIG G G+V V + + +V A+K + L
Sbjct: 61 PFTSKVKQMRLHREDFEIL------KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK 114
Query: 728 QKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSL 786
+ F E +L I L +N L LV +Y L L K
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFEDRLP 173
Query: 787 SGRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843
AR E++ + +H VHRD+K NIL+D N + ++A
Sbjct: 174 EEMARFYLAEMVI-------------AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 217
Query: 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKT-----DIYSFGVILLELT 898
DFG L+++ + S VG+ YI+PE + + + D +S GV + E+
Sbjct: 218 DFGSCLKLMEDGTVQS--SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 899 TG 900
G
Sbjct: 276 YG 277
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 693 NVIGSGGSGKVYR-VPINHTAEVVAVKKIWNDRKLDQKHEKE-----FLAEVQIL---ST 743
IG G GKV++ + + VA+K++ ++ +E + EV +L T
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQ--TGEEGMPLSTIREVAVLRHLET 70
Query: 744 IRHLNIVKLLCCISSENLKL-----LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
H N+V+L + LV+E++++ L +L K + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP---TETIKDMM 126
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
Q+ +GL ++H +VHRDLK NIL+ + K+ADFG+A+I
Sbjct: 127 F--QLL----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQ 173
Query: 859 AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
A+++VV + Y APE D++S G I E+ K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 42/258 (16%)
Query: 663 RKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVY---RVPINHTAEVVAVKK 719
++ +T + + ++L V+G G GKV+ ++ + ++ A+K
Sbjct: 6 KEIAITHHVKEGHEKADPSQFELL------KVLGQGSFGKVFLVKKISGSDARQLYAMKV 59
Query: 720 IWNDRK--LDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQ 776
+ +K L + E IL + H IVKL +E KL L+ +++ L
Sbjct: 60 L---KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFT 115
Query: 777 WLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833
L K+ + + E+ L ++H S I++RDLK NIL
Sbjct: 116 RLSKEVMFTEE-DVKFYLAELAL-------------ALDHLH---SLGIIYRDLKPENIL 158
Query: 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVI 893
LD + K+ DFG++K I E + + G+ Y+APE R + D +SFGV+
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL 215
Query: 894 LLELTTGK---EANNGDE 908
+ E+ TG + + E
Sbjct: 216 MFEMLTGTLPFQGKDRKE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 29/215 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF-----LAEVQILSTIRHL 747
IG G G V++ T ++VA+KK + L E+++L ++H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF----LES--EDDPVIKKIALREIRMLKQLKHP 62
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
N+V LL + LV+EY + ++ L + R G V S Q
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSIT--WQTL--- 112
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
Q + + H +HRD+K NIL+ + K+ DFG A++L G V +
Sbjct: 113 -QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVAT 165
Query: 868 CGYIAPEY-ARTRKVNEKTDIYSFGVILLELTTGK 901
Y +PE + D+++ G + EL +G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 42/277 (15%)
Query: 669 STETTSFHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN--DR 724
S E +F+R + ++ + + +GSG G V T VAVKK+
Sbjct: 9 SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 725 KLDQKHEKEFLAEVQILSTIRHLNIVKLLCCI----SSENLK--LLVYEYMEKRSLDQWL 778
+ K E+++L ++H N++ LL S E LV M D L
Sbjct: 69 IIHAKRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--L 120
Query: 779 HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838
+ + + L + QI +GL Y+H S I+HRDLK SN+ ++ +
Sbjct: 121 NNIVKCQKLTDDHVQFLIY----QIL----RGLKYIH---SADIIHRDLKPSNLAVNEDC 169
Query: 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLEL 897
KI DFG+A+ M+ V + Y APE N+ DI+S G I+ EL
Sbjct: 170 ELKILDFGLAR------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 898 TTGKEANNGDEHTCLAQWAWRHIQE--GKPIVDALDK 932
TG+ G +H + Q + I G P + L K
Sbjct: 224 LTGRTLFPGTDH--IDQ--LKLILRLVGTPGAELLKK 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 59/264 (22%), Positives = 97/264 (36%), Gaps = 51/264 (19%)
Query: 656 MIRIYQKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVY--RVPINHTAE 713
M ++ + F + +G G G VY + +
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCK-------------VGRGTYGHVYKAKRKDGKDDK 49
Query: 714 VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL-CCISSENLKL-LVYEYME- 770
A+K+I E+ +L ++H N++ L +S + K+ L+++Y E
Sbjct: 50 DYALKQIEGTGISMSA-----CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104
Query: 771 --KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLK 828
+ K R V S QI G+ Y+H + ++HRDLK
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLY--QIL----DGIHYLHANW---VLHRDLK 155
Query: 829 SSNILLDYNFNA----KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE-------YAR 877
+NIL+ KIAD G A++ A + VV + Y APE Y
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY-- 213
Query: 878 TRKVNEKTDIYSFGVILLELTTGK 901
T+ + DI++ G I EL T +
Sbjct: 214 TKAI----DIWAIGCIFAELLTSE 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 33/219 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLA----EVQILSTIR---- 745
++G GG G V+ VA+K I ++ EV +L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEK-RSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QI 803
H +++LL ++ +LV E + L ++ +K E S R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL-------GEGPS-RCFFGQV 148
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKILIKEEGEFAAMS 862
+ + H +VHRD+K NIL+D AK+ DFG +L + + +
Sbjct: 149 V----AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPY---T 196
Query: 863 TVVGSCGYIAPEYARTRKVN-EKTDIYSFGVILLELTTG 900
G+ Y PE+ + + ++S G++L ++ G
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G G GKV V T A+K + + + + + E ++L RH + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 754 CCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARD---EVLSWRRRMQIAVGAAQ 809
+ + +L V EY L L ++ + RAR E++S
Sbjct: 72 YAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVS------------- 116
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
L Y+H S +V+RD+K N++LD + + KI DFG+ K I + A M T G+
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPE 170
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE D + GV++ E+ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 54/244 (22%), Positives = 85/244 (34%), Gaps = 35/244 (14%)
Query: 674 SFHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL----- 726
+ + T I SG G V ++ VA+K+++N
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 727 ---DQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-----LVYEYMEKRSLDQWL 778
D K L E+++L+ H NI+ L LV E M D L
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---D--L 120
Query: 779 HKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838
+ + V+S + GL +H +VHRDL NILL N
Sbjct: 121 AQVIHD------QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNN 171
Query: 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLEL 897
+ I DF +A+ + + V Y APE + + D++S G ++ E+
Sbjct: 172 DITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 898 TTGK 901
K
Sbjct: 228 FNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-21
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 50/227 (22%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF------LAEVQILSTIRH 746
+ +G G VY+ +T ++VA+KKI KL + E + L E+++L + H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI----KLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 747 LNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAV 805
NI+ LL ++ LV+++ME L+ + K N L+ + ++ M
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLT---PSHIKAY---MLMT-- 121
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA----AM 861
QGL Y+H I+HRDLK +N+LLD N K+ADFG+AK F A
Sbjct: 122 --LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-------SFGSPNRAY 169
Query: 862 STVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ V + Y APE Y V D+++ G IL EL
Sbjct: 170 THQVVTRWYRAPELLFGARMY--GVGV----DMWAVGCILAELLLRV 210
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 46/255 (18%), Positives = 95/255 (37%), Gaps = 23/255 (9%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTAN 153
L N + + + + + L + I E + L+ L L L N
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG-VTTI-EGVQYLNNLIGLELKDN 73
Query: 154 NMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN--TEFSPSSLPS 211
++ + + LT++ +L L N ++ A I LQ+++ L+L T+ +P
Sbjct: 74 QIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP----- 124
Query: 212 NFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVY 271
L L+ L++ N I I + + L++L + + + + + L L+ +
Sbjct: 125 -LAGLSNLQVLYLDL-NQITNISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLK 179
Query: 272 LYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEG 331
N +S +I NL + L N ++ P NL ++L ++ +
Sbjct: 180 ADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236
Query: 332 IGLLPSLKDVRLFNN 346
L V+ +
Sbjct: 237 NNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 50/255 (19%), Positives = 95/255 (37%), Gaps = 23/255 (9%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
+ ++ N+ DL +T L + + + + L L+L N
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQ- 74
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
I + + L+++ L L+ N + + A I L ++ L+L Q P + L
Sbjct: 75 ITDLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLS 129
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLS 249
NL+ L L N T SP L L+ L + + ++ + ++ L L
Sbjct: 130 NLQVLYLDLNQITNISP------LAGLTNLQYLSI-GNAQVSDLTP-LANLSKLTTLKAD 181
Query: 250 INNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
N + I S + L NL +V+L +N +S ++ + NL ++ L+ +T
Sbjct: 182 DNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 310 KLENLLNLSLMFNQL 324
L +
Sbjct: 239 NLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 48/236 (20%), Positives = 90/236 (38%), Gaps = 21/236 (8%)
Query: 115 LYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNL 174
+ + ++ + L + L ++ I + L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 175 VVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP 234
NQ + + NL + LEL+ N P S L+ +K L + ++ I ++
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGN----PLKNVSAIAGLQSIKTLDL-TSTQITDVT 123
Query: 235 ETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVI 293
+ + L+ L L +N T +I S + L NL + + + +S P + +L L +
Sbjct: 124 P-LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 294 DLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS 349
N ++ P L NL+ + L NQ+S + +L V L N ++
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 27/258 (10%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
+T L + T + L NL L+L+ N I P L N +K+ L+LS N
Sbjct: 42 GITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP- 96
Query: 132 IGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ 191
+ + I L +K L LT+ ++ P + L+ L+ L L +NQ +I + L
Sbjct: 97 LKNV-SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLT 151
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLS 249
NL+ L + ++ +P L KL L A N I +I + + L + L
Sbjct: 152 NLQYLSIGNAQVSDLTP------LANLSKLTTLK-ADDNKISDISP-LASLPNLIEVHLK 203
Query: 250 INNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAI--PND 307
N + S + NL V L + +++ + N V+ +GA P
Sbjct: 204 NNQISDV--SPLANTSNLFIVTLTNQTITNQPV---FYNNNLVVPNVVKGPSGAPIAPAT 258
Query: 308 FGKLENLLNLSLMFNQLS 325
+ +L +N S
Sbjct: 259 ISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 66/295 (22%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
N I +N+T + L+ + LS ++ I EG+ L +L + L +N +
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
+ + + E+S N L ++
Sbjct: 76 TD--LAPLKNLTKITELELSGNPLKN--------------------------VSAIAGLQ 107
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSG 468
S+ + + + I+D L NL L + N+ +
Sbjct: 108 SIKTLDLTSTQ-------------------ITDVTPLAGLS-----NLQVLYLDLNQIT- 142
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSL 528
I ++ NL N + P L L LTTL D N++S PL S +L
Sbjct: 143 NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPLA--SLPNL 197
Query: 529 TALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSN 583
++L NQ+S P + L + L+ + P L N+
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN--QPVFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 56/345 (16%), Positives = 113/345 (32%), Gaps = 69/345 (20%)
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322
L N K+ ++++ + QA + + +T I L NL+ L L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 323 QLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCA 382
Q++ + L + ++ L N L ++ +++ +T
Sbjct: 74 QITD--LAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITD-------- 121
Query: 383 GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442
L S+L ++ + N I++
Sbjct: 122 ------------------VTPLAGLSNLQVLYLDLNQ-------------------ITNI 144
Query: 443 LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALP 502
L NL L I N + S + +++ L +A +N + I L +LP
Sbjct: 145 SPLAGLT-----NLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKIS-DISP-LASLP 195
Query: 503 SLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
+L + L NQ+S PL + +L + L+ ++ + + L ++ +
Sbjct: 196 NLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVF---YNNNLVVPNVVKGPS 250
Query: 563 SGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFENRAYASSFLNNPG 607
I P + + +S LT + S N +Y +
Sbjct: 251 GAPIAPAT---ISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 28/134 (20%), Positives = 46/134 (34%), Gaps = 8/134 (5%)
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFL 148
+ +L LT L N I P L + L + L N I + + S L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ-ISDVSP-LANTSNLFIV 222
Query: 149 YLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSI-PAEIGNLQNLEALELAYNTEFSPS 207
LT ++ + + L N+V I PA I + + L +N +
Sbjct: 223 TLTNQTITNQ---PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFIN 279
Query: 208 SLPSNFTQLKKLKK 221
++ F Q K
Sbjct: 280 NVSYTFNQSVTFKN 293
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 53/278 (19%)
Query: 664 KDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN- 722
S+ + + ++ + ++IG G G VY +T + VA+KK+
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM 62
Query: 723 -DRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-----LVYEYMEKRSLDQ 776
+ +D K L E+ IL+ ++ I++L I ++L +V E + D
Sbjct: 63 FEDLIDCKR---ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---D- 115
Query: 777 WLHKKNRSSLSGRARDEVLSWRRRM----QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNI 832
L K ++ L+ + +G ++H I+HRDLK +N
Sbjct: 116 -LKKLFKTP-------IFLTEEHIKTILYNLLLG----ENFIH---ESGIIHRDLKPANC 160
Query: 833 LLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP--------EYARTR----- 879
LL+ + + K+ DFG+A+ + E+ + TR
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 880 -------KVNEKTDIYSFGVILLELTTGKEANNGDEHT 910
+ DI+S G I EL +++ D
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 31/272 (11%), Positives = 64/272 (23%), Gaps = 60/272 (22%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
G + ++ VA+ + L +E L+ LS I + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ + L+V E++ SL + D S ++ A
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-------------DTSPSPVGAIRAMQSLAAAADA 144
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
H + S + + + + +A +
Sbjct: 145 AHRA---GVALSIDHPSRVRVSIDGDVVLAYP-----------------------ATMPD 178
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
+ DI G L L + A R +D++
Sbjct: 179 ANPQ-------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 934 IDEPCFLEEMIRVFKLGVICTSML---PTERP 962
I + + + R
Sbjct: 232 IPFQ-----------ISAVAARSVQGDGGIRS 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-21
Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 53/233 (22%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKE-F----LAEVQILSTIRHL 747
IG G G+V++ T + VA+KK+ ++ +EKE F L E++IL ++H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV----LME--NEKEGFPITALREIKILQLLKHE 76
Query: 748 NIVKLLCCISSENLKL--------LVYEYME---KRSLDQWLHKKNRSSLSGRARDEVLS 796
N+V L+ ++ LV+++ E L + + +LS E+
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLS-----EIKR 128
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL-IKEE 855
+ + GL Y+H + I+HRD+K++N+L+ + K+ADFG+A+ + +
Sbjct: 129 VMQ--MLL----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 856 GEFAAMSTVVGSCGYIAPE-------YARTRKVNEKTDIYSFGVILLELTTGK 901
+ + V + Y PE Y + D++ G I+ E+ T
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDY--GPPI----DLWGAGCIMAEMWTRS 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLAEVQILSTIRHLNI 749
++G G G V + T +VA+KK + K + E+++L +RH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
V LL + LV+E+++ + +G V + QI
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH---T--ILDDLELFPNGLDYQVVQKYLF--QII----N 135
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ + H I+HRD+K NIL+ + K+ DFG A+ L V +
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYDDEVATRW 189
Query: 870 YIAPEY-ARTRKVNEKTDIYSFGVILLELTTGK 901
Y APE K + D+++ G ++ E+ G+
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 9e-21
Identities = 51/299 (17%), Positives = 105/299 (35%), Gaps = 25/299 (8%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
E + + FP +L+ + + ++ + + + I
Sbjct: 2 GETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-DIK 56
Query: 134 PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
+ + I L + L+L N ++ I + L L L L N+ + + + +L+ L
Sbjct: 57 SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LKDLKKL 111
Query: 194 EALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN 251
++L L +N ++ + L +L+ L++ N I +I + + L+ L L N
Sbjct: 112 KSLSLEHNGISDING------LVHLPQLESLYL-GNNKITDI-TVLSRLTKLDTLSLEDN 163
Query: 252 NFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311
+ I + L L +YL N +S ++ NL V++L + N L
Sbjct: 164 QIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 312 ENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVN 370
+ L PE I + + ++ F Y P+ +
Sbjct: 221 VVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 9/154 (5%)
Query: 433 NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNG 492
+ T + ++ ++ +N+ + G+ N+ + N
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD 79
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVL 552
P LT L +L L LD+N++ L K L +L+L N +S +I + LP L
Sbjct: 80 IKP--LTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS-DI-NGLVHLPQL 133
Query: 553 QDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLT 586
+ L L N+ + I L +L+L N+++
Sbjct: 134 ESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 49/297 (16%), Positives = 89/297 (29%), Gaps = 65/297 (21%)
Query: 290 LKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS 349
+ + + I D + +L ++ + L S+ + N+ +
Sbjct: 1 MGETITVSTPIK-QIFPD-DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 350 GALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSS 409
++Y + + N L+ + L N +
Sbjct: 57 --------SVQGIQYLP------------------NVTKLFLNGNKLTDI--KPLTNLKN 88
Query: 410 LLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGK 469
L + + N I D +L L L + +N S
Sbjct: 89 LGWLFLDENK-------------------IKDLSSLKDLK-----KLKSLSLEHNGIS-D 123
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLT 529
I G+ L NN L+ L L TL L+ NQ+S +PL L
Sbjct: 124 I-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQ 178
Query: 530 ALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRL 585
L LS+N +S ++ + L L L+L + K L + ++ + L
Sbjct: 179 NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 13/84 (15%), Positives = 30/84 (35%), Gaps = 7/84 (8%)
Query: 504 LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFS 563
+ + + P D ++ NL + ++ + L + + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 564 GKIPPQIGRLM-LTSLNLSSNRLT 586
+ I L +T L L+ N+LT
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLT 78
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 39/235 (16%), Positives = 73/235 (31%), Gaps = 37/235 (15%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
+ L L ++ + N + + +S + + + LS++ + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAE--IGNLQNLEALELAYNTEFSPSSL 209
I L L+ L + P + + LE+ N +S+
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM--TSI 146
Query: 210 PSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
P N F L L L N FT S+ F L
Sbjct: 147 PVNAFQGLCNE-----------------------TLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 269 KVYLYSNSLSGEIPQAV-ESL--NLKVIDLSANNLTGAIPND-FGKLENLLNLSL 319
VYL N I + + ++D+S ++T A+P+ L+ L+ +
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 33/211 (15%), Positives = 70/211 (33%), Gaps = 36/211 (17%)
Query: 72 SVTELHLTNMNMNGTFPPFI-CDLRNLTILDLQFNYIISQFPR-VLYNCSKLEYLDLSQN 129
+++ ++++ +L +T ++++ ++ L L++L +
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 130 YFIGPIPED--IDRLSRLKFLYLTANNMSGKIPASI--GRLTELRQLNLVVNQFNGSIPA 185
+ P+ + L +T N IP + G E L L N F S+
Sbjct: 116 -GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG 173
Query: 186 EIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLALE 244
N L+A+ L N + + + F +
Sbjct: 174 YAFNGTKLDAVYLNKNKYL--TVIDKDAFGGVYSG-----------------------PS 208
Query: 245 FLDLSINNFTGSIPSSVFK-LKNLSKVYLYS 274
LD+S + T ++PS + LK L ++
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 34/219 (15%), Positives = 74/219 (33%), Gaps = 16/219 (7%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ + IP + + + L +L + F L N+ + + +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68
Query: 326 GEIPEGI-GLLPSLKDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
++ L + + + N + PD L++ + L P+
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 384 G--KLAGIAAQDNNLSGELPESL--GNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLI 439
+ DN +P + G C+ L +K+YNN FT ++ + G L V +
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 440 SDNLFTGELP----DKMSGNLSRLEISNNRFSGKIPTGV 474
+ N + + + S L++S + +P+
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 28/202 (13%)
Query: 408 SSLLMVKIYNNSFTGNIPAG----------LWTGFNLSMVLISDNLFTGELPDKMSGNLS 457
S +K+ IP+ ++ ++++ + + F L ++
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN-LS-----KVT 83
Query: 458 RLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGE--LTALPSLTTLLLDQNQL 514
+EI N R I L N P + + L + N
Sbjct: 84 HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY 142
Query: 515 SGSLPLDIISW--KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQI-- 570
S+P++ L L N + + L + L++N++ I
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
Query: 571 -GRLMLTSLNLSSNRLTGEIPS 591
+ L++S +T +PS
Sbjct: 202 GVYSGPSLLDVSQTSVT-ALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 34/196 (17%), Positives = 61/196 (31%), Gaps = 19/196 (9%)
Query: 407 CSSLLMVKIYNNSFTG--NIPAGLWTGF--NLSMVLISDNLFTGELPDKMSGNLSRLEIS 462
C ++ ++P T + I + F+ LP N+SR+ +S
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSN-LP-----NISRIYVS 63
Query: 463 NNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIP-GELTALPSLTTLLLDQNQLSGSLPL 520
+ ++ + + + + N I L LP L L + L P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 521 D--IISWKSLTALNLSRNQLSGEIPEKI--GFLPVLQDLDLSENQFSGKIPPQI-GRLML 575
+ S L ++ N IP G L L N F+ + L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 576 TSLNLSSNRLTGEIPS 591
++ L+ N+ I
Sbjct: 182 DAVYLNKNKYLTVIDK 197
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 58/267 (21%), Positives = 95/267 (35%), Gaps = 28/267 (10%)
Query: 60 HCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCS 119
HC+ C + VTE P + RN L +
Sbjct: 8 HCSNRVFLCQESKVTE-----------IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 54
Query: 120 KLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVN 177
LE +++SQN + I D+ L +L + + N I L L+ L +
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 178 QFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN-FTQL-KKLKKLWMASTNLIGEIP 234
+P + L++ N ++ N F L + LW+ + N I EI
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINI--HTIERNSFVGLSFESVILWL-NKNGIQEIH 170
Query: 235 ETIGDMLALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGEIPQAV-ESLNLKV 292
+ + L+ L+LS NN +P+ VF + + + +P E+L K+
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLK-KL 228
Query: 293 IDLSANNLTGAIPNDFGKLENLLNLSL 319
S NL +P KL L+ SL
Sbjct: 229 RARSTYNLK-KLPT-LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 53/324 (16%), Positives = 94/324 (29%), Gaps = 81/324 (25%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ + ++ EIP + N + L F +L + + N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 326 GEIPEGI-GLLPSLKDVRLFN-NMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCA 382
I + LP L ++R+ N L + P+ F L+Y +S + LP+
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPD---- 121
Query: 383 GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442
+ L + L N+++ I N
Sbjct: 122 ----------------------VHKIHSLQKVL------------LDIQDNINIHTIERN 147
Query: 443 LFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALP 502
F G +S L ++ N +I FNG
Sbjct: 148 SFVG-----LSFESVILWLNKNGIQ-EIHNSA---------------FNG--------TQ 178
Query: 503 SLTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSEN 560
L D N L LP D+ L++SR ++ +P L L+
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236
Query: 561 QFSGKIPPQIGRLMLTSLNLSSNR 584
+ K+P + L +L+
Sbjct: 237 K---KLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 36/179 (20%), Positives = 58/179 (32%), Gaps = 39/179 (21%)
Query: 439 ISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNLVV--FQASNNLFNGTIP 495
I F+G +L ++EIS N I V S+ L + +NNL I
Sbjct: 45 IQKGAFSG-FG-----DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY--IN 96
Query: 496 -GELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKI--GFLPVL 552
LP+L LL+ + + I L++ N I G
Sbjct: 97 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 553 QDLDLSENQ--------FSG---------------KIPPQI--GRLMLTSLNLSSNRLT 586
L L++N F+G ++P + G L++S R+
Sbjct: 157 VILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 33/240 (13%)
Query: 668 TSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD 727
+ R+ D +++ VIG G G+V V T +V A+K + +
Sbjct: 56 DTINKIRDLRMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK 109
Query: 728 QKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS 787
+ F E I++ +V+L + +V EYM L + +
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--E 167
Query: 788 GRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
AR EV+ L +H S +HRD+K N+LLD + + K+AD
Sbjct: 168 KWARFYTAEVVL-------------ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEK----TDIYSFGVILLELTTG 900
FG + KE T VG+ YI+PE +++ + D +S GV L E+ G
Sbjct: 212 FGTCMKMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 694 VIGSGGSGKVY---RVPINHTAEVVAVKKIWNDRKLDQKHEKEF-LAEVQILSTIRHLNI 749
V+G GG GKV+ +V +T ++ A+K + + + AE IL ++H I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 750 VKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAV 805
V L+ + KL L+ EY+ L L ++ A E+
Sbjct: 84 VDLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISM--------- 132
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
L ++H I++RDLK NI+L++ + K+ DFG+ K I + T
Sbjct: 133 ----ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFC 182
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDE 908
G+ Y+APE N D +S G ++ ++ TG N +
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 5e-20
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 687 PKLTESN-----VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQIL 741
PK + + +G+G G+V+ + H A+K + + + K + E +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 742 STIRHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRAR---DEVLSW 797
S + H I+++ ++ ++ +Y+E L L K R A+ EV
Sbjct: 61 SIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCL- 117
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
L Y+H S I++RDLK NILLD N + KI DFG AK +
Sbjct: 118 ------------ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162
Query: 858 FAAMSTVVGSCG---YIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
CG YIAPE T+ N+ D +SFG+++ E+ G
Sbjct: 163 L---------CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 51/246 (20%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN--DRKLDQKHEKEFLAEVQIL 741
+L K +G G G V++ T EVVAVKKI++ D + E+ IL
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMIL 62
Query: 742 STIR-HLNIVKLLCCISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
+ + H NIV LL + ++N + LV++YME D LH R+ +L
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYMET---D--LHAVIRA--------NILEPV 109
Query: 799 RRM----QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
+ Q+ + + Y+H S ++HRD+K SNILL+ + K+ADFG+++ +
Sbjct: 110 HKQYVVYQLI----KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 855 EGEFAAMSTVVGSCGYIAP-------EYARTR------------KVNEKTDIYSFGVILL 895
+ + +Y TR K + D++S G IL
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 896 ELTTGK 901
E+ GK
Sbjct: 223 EILCGK 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVKL 752
VIG G GKV AVK + L +K EK ++E +L ++H +V L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 753 LCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAA 808
+ + KL V +Y+ L L ++ RAR E+ S
Sbjct: 105 HFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEP-RARFYAAEIAS------------ 150
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L Y+H S IV+RDLK NILLD + + DFG+ K I+ ST G+
Sbjct: 151 -ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTP 203
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
Y+APE + + D + G +L E+ G
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 666 ELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK 725
EL + +L D + ++G G GKV+ T + A+K + D
Sbjct: 2 ELNKERPSLQIKLKIEDFILH------KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 726 LDQKHEKEFLAEVQILST-IRHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWLHKKNR 783
L + + E ++LS H + + C ++ L V EY+ L + ++
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHK 114
Query: 784 SSLSGRARD---EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA 840
LS RA E++ GL ++H S IV+RDLK NILLD + +
Sbjct: 115 FDLS-RATFYAAEIIL-------------GLQFLH---SKGIVYRDLKLDNILLDKDGHI 157
Query: 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTG 900
KIADFG+ K + + +T G+ YIAPE +K N D +SFGV+L E+ G
Sbjct: 158 KIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-19
Identities = 73/327 (22%), Positives = 122/327 (37%), Gaps = 39/327 (11%)
Query: 595 NRAYASSFLNNPGLCASSSNVNLKSCFFVPRKSRKGSSQHVAVIIVSVIAVFLVALLSFF 654
+ + F+ + S +F +G +V V +
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 655 YMIRIYQKRKDELTSTETTSFH------RLNFRDSDILPKLTESNVIGSGGSGKVYRVPI 708
I K +E T+ + F R+ D + L V+G G GKV
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFL------MVLGKGSFGKVMLSER 362
Query: 709 NHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYE 767
T E+ AVK + D + + + E ++L+ + + +L C + + V E
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422
Query: 768 YMEKRSLDQWLHKKNRSSLSGRARD---EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVH 824
Y+ L + + R A E+ GL ++ S I++
Sbjct: 423 YVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAI-------------GLFFLQ---SKGIIY 465
Query: 825 RDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEK 884
RDLK N++LD + KIADFG+ K I + T G+ YIAPE + +
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS 522
Query: 885 TDIYSFGVILLELTTGK---EANNGDE 908
D ++FGV+L E+ G+ E + DE
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDE 549
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 65/283 (22%), Positives = 108/283 (38%), Gaps = 57/283 (20%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
Q+RK +S T S R D I + ++IG+G G V VVA+KKI
Sbjct: 28 QQRKQHHSSKPTASMPR-PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 721 WN--DRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-----LVYEYMEKRS 773
+ +D K L E+ IL+ + H ++VK+L + ++++ +V E +
Sbjct: 87 LRVFEDLIDCKRI---LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--- 140
Query: 774 LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ---GLCYMHHDCSPTIVHRDLKSS 830
D K R+ L+ + I G+ Y+H S I+HRDLK +
Sbjct: 141 SD--FKKLFRTP-------VYLT---ELHIKTLLYNLLVGVKYVH---SAGILHRDLKPA 185
Query: 831 NILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP-------------EYAR 877
N L++ + + K+ DFG+A+ + E + + +
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 878 TR------------KVNEKTDIYSFGVILLELTTGKEANNGDE 908
TR E D++S G I EL + N
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 44/253 (17%), Positives = 92/253 (36%), Gaps = 23/253 (9%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
+E + F +L+ + + ++ + + + I
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-DIK 59
Query: 134 PIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
+ + I L + L+L N ++ I + L L L L N+ + + + +L+ L
Sbjct: 60 SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKL 114
Query: 194 EALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN 251
++L L +N ++ + L +L+ L++ N I +I + + L+ L L N
Sbjct: 115 KSLSLEHNGISDING------LVHLPQLESLYL-GNNKITDI-TVLSRLTKLDTLSLEDN 166
Query: 252 NFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311
+ I + L L +YL N +S ++ NL V++L + N L
Sbjct: 167 QIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 312 ENLLNLSLMFNQL 324
+ L
Sbjct: 224 VVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 50/274 (18%), Positives = 90/274 (32%), Gaps = 62/274 (22%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
+L ++T A+ +L ++ + + + + +GI LP++ + L N L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 80
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
+ PL NL L + +N + +L SL +
Sbjct: 81 T--------DIKPLA-------NLK-----------NLGWLFLDENKVK-DL-SSLKDLK 112
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSG 468
L + + +N + +I L LP L L + NN+ +
Sbjct: 113 KLKSLSLEHNGIS-DIN-------GLV-----------HLP-----QLESLYLGNNKIT- 147
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSL 528
I T +S L +N + I L L L L L +N +S L K+L
Sbjct: 148 DI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALA--GLKNL 202
Query: 529 TALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
L L + + L V + ++
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
VIG G KV V + T + A+K + + D + E + H +V L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 753 LCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARD---EVLSWRRRMQIAVGAA 808
C +E+ +L V EY+ L + ++ + AR E+
Sbjct: 76 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISL------------ 121
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L Y+H I++RDLK N+LLD + K+ D+G+ K ++ ST G+
Sbjct: 122 -ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTP 174
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
YIAPE R D ++ GV++ E+ G+
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 35/256 (13%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKI 720
++ E S +RL + + + V+G G GKV + T ++ AVK +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFI------RVLGKGSFGKVMLARVKETGDLYAVKVL 56
Query: 721 WNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKL-LVYEYMEKRSLDQWL 778
D L + + E +ILS H + +L CC + + +L V E++ L +
Sbjct: 57 KKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHI 115
Query: 779 HKKNRSSLSGRARD---EVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD 835
K R + RAR E++S L ++H I++RDLK N+LLD
Sbjct: 116 QKSRRFDEA-RARFYAAEIIS-------------ALMFLH---DKGIIYRDLKLDNVLLD 158
Query: 836 YNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILL 895
+ + K+ADFG+ K I +T G+ YIAPE + D ++ GV+L
Sbjct: 159 HEGHCKLADFGMCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 896 ELTTGK---EANNGDE 908
E+ G EA N D+
Sbjct: 216 EMLCGHAPFEAENEDD 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G GKV T E+ AVK + D + + + E ++L+ + + +L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 753 LCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARD---EVLSWRRRMQIAVGAA 808
C + + +L V EY+ L + + R A E+
Sbjct: 87 HSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAI------------ 132
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
GL ++ S I++RDLK N++LD + KIADFG+ K I + T G+
Sbjct: 133 -GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTP 185
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDE 908
YIAPE + + D ++FGV+L E+ G+ E + DE
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 61/256 (23%), Positives = 111/256 (43%), Gaps = 45/256 (17%)
Query: 661 QKRKDELTSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVY---RVPINHTAEVVAV 717
+ + T+ T ++ + ++L V+G+G GKV+ ++ + T ++ A+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELL------KVLGTGAYGKVFLVRKISGHDTGKLYAM 87
Query: 718 KKIWNDRKLDQKHEKEF-LAEVQILSTIRHLN-IVKLLCCISSENLKL-LVYEYMEKRSL 774
K + + + E E Q+L IR +V L +E KL L+ +Y+ L
Sbjct: 88 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-KLHLILDYINGGEL 146
Query: 775 DQWLHKKNRSSLSGRAR---DEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSN 831
L ++ R + + E++ L ++H I++RD+K N
Sbjct: 147 FTHLSQRERFTEH-EVQIYVGEIVL-------------ALEHLH---KLGIIYRDIKLEN 189
Query: 832 ILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE------YARTRKVNEKT 885
ILLD N + + DFG++K + +E E A G+ Y+AP+ + V
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAV---- 243
Query: 886 DIYSFGVILLELTTGK 901
D +S GV++ EL TG
Sbjct: 244 DWWSLGVLMYELLTGA 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 46/220 (20%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLL 753
+G G +V+ E V VK + K +K K+ E++IL +R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL----KPVKK--KKIKREIKILENLRGGPNIITLA 97
Query: 754 CCISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRM-QIAVGAAQG 810
+ + LV+E++ Q L+ ++ R M +I +
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTD---YDI---RFYMYEIL----KA 142
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
L Y H S I+HRD+K N+++D+ + ++ D+G+A+ + + V S
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRY 195
Query: 870 YIAPE-------YARTRKVNEKTDIYSFGVILLELTTGKE 902
+ PE Y + D++S G +L + KE
Sbjct: 196 FKGPELLVDYQMY--DYSL----DMWSLGCMLASMIFRKE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 61/256 (23%)
Query: 670 TETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWN-DRKLDQ 728
+ ++ I +++G G G V T E+VA+KKI D+ L
Sbjct: 2 PKRIVYN--------ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA 53
Query: 729 KHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL-----LVYEYMEKRSLDQWLHKKNR 783
L E++IL +H NI+ + ++ + ++ E M+ D LH+
Sbjct: 54 LRT---LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT---D--LHRVIS 105
Query: 784 SSLSGRARDEVLSWRRRM----QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839
+ ++LS Q + + +H ++HRDLK SN+L++ N +
Sbjct: 106 T--------QMLSDDHIQYFIYQTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCD 150
Query: 840 AKIADFGVAKILIKEEGEFAAMSTVVGSC-GYI------APE-------YARTRKVNEKT 885
K+ DFG+A+I+ + + + + ++ APE Y +R +
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY--SRAM---- 204
Query: 886 DIYSFGVILLELTTGK 901
D++S G IL EL +
Sbjct: 205 DVWSCGCILAELFLRR 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
VIG G KV V + T + A++ + + D + E + H +V L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 753 LCCISSENLKL-LVYEYMEKRSLDQWLHKKNRSSLSGRARD---EVLSWRRRMQIAVGAA 808
C +E+ +L V EY+ L + ++ + AR E+
Sbjct: 119 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISL------------ 164
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L Y+H I++RDLK N+LLD + K+ D+G+ K ++ ST G+
Sbjct: 165 -ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTP 217
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
YIAPE R D ++ GV++ E+ G+
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 31/187 (16%), Positives = 67/187 (35%), Gaps = 9/187 (4%)
Query: 69 TDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQ 128
D + + + T + +LT + L + + ++ L ++
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 129 NYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIG 188
+ I LS L+ L + +++ ++ LT L L++ + + SI +I
Sbjct: 76 IH-ATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 189 NLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDL 248
L + +++L+YN + L +LK L + + + + I D L L
Sbjct: 134 TLPKVNSIDLSYNGA---ITDIMPLKTLPELKSLNI-QFDGVHDY-RGIEDFPKLNQLYA 188
Query: 249 SINNFTG 255
G
Sbjct: 189 FSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 28/186 (15%), Positives = 66/186 (35%), Gaps = 14/186 (7%)
Query: 145 LKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN--T 202
K S + ++ L + L + I N++ L + T
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT 79
Query: 203 EFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVF 262
++P + L L++L + ++ + + + +L LD+S + SI + +
Sbjct: 80 NYNP------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMF 321
L ++ + L N +I +++L LK +++ + + L L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 322 NQLSGE 327
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 31/133 (23%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQL 514
+L+ + ++N + + TG+ + N+ +N P ++ L +L L + +
Sbjct: 45 SLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 515 SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM 574
+ ++ SLT L++S + I KI LP + +DLS N I P + L
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 575 -LTSLNLSSNRLT 586
L SLN+ + +
Sbjct: 160 ELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 28/176 (15%), Positives = 60/176 (34%), Gaps = 11/176 (6%)
Query: 201 NTEFSPSSLPSNF--TQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIP 258
T S N + K + + I T M +L ++ L+ N T +
Sbjct: 5 QTGLKASQDNVNIPDSTFKAYLNGLL-GQSSTANI--TEAQMNSLTYITLANINVT-DL- 59
Query: 259 SSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNL 317
+ + N+ + + + + P + L NL+ + + ++T + L +L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 318 SLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLT 373
+ + I I LP + + L N + P L+ + + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 6/135 (4%)
Query: 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQL 514
N+ L I+N + +S NL + L+ L SLT L + +
Sbjct: 67 NIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 515 SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM 574
S+ I + + +++LS N +I + LP L+ L++ + I
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRG-IEDFP 181
Query: 575 -LTSLNLSSNRLTGE 588
L L S + G+
Sbjct: 182 KLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 3/132 (2%)
Query: 433 NLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNG 492
N+ + I++ T P NL RL I + +S +L + S++ +
Sbjct: 67 NIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVL 552
+I ++ LP + ++ L N + + + L +LN+ + + I P L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 553 QDLDLSENQFSG 564
L G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 22/146 (15%), Positives = 50/146 (34%), Gaps = 8/146 (5%)
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506
+PD + + + + +L +N + G + ++
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTG-IEYAHNIKD 70
Query: 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKI 566
L ++ + P+ +L L + ++ + + L L LD+S + I
Sbjct: 71 LTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 567 PPQIGRLM-LTSLNLSSNRLTGEIPS 591
+I L + S++LS N +I
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 18/106 (16%), Positives = 39/106 (36%), Gaps = 5/106 (4%)
Query: 491 NGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLP 550
+ T + SLT + L ++ ++ ++ L ++ + P I L
Sbjct: 33 SSTANITEAQMNSLTYITLANINVTDLTGIEYA--HNIKDLTINNIHATNYNP--ISGLS 88
Query: 551 VLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPSQFEN 595
L+ L + + P + L LT L++S + I ++
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 30/253 (11%), Positives = 72/253 (28%), Gaps = 77/253 (30%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
K + ++ +L ++L ++ ++ GI ++KD+ + N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
+ Y+P+ L+ L + +++ + +L +
Sbjct: 79 TN--------YNPIS-------GLS-----------NLERLRIMGKDVTSDKIPNLSGLT 112
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSG 468
+L+ L+IS++
Sbjct: 113 ----------------------------------------------SLTLLDISHSAHDD 126
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSL 528
I T +++ + S N I L LP L +L + + + ++ L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDF--PKL 183
Query: 529 TALNLSRNQLSGE 541
L + G+
Sbjct: 184 NQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 18/105 (17%), Positives = 38/105 (36%), Gaps = 8/105 (7%)
Query: 491 NGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLP 550
N IP + + LL Q+ + + SLT + L+ ++ ++ I +
Sbjct: 14 NVNIP--DSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL-TGIEYAH 66
Query: 551 VLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFEN 595
++DL ++ + P G L L + +T +
Sbjct: 67 NIKDLTINNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSG 110
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 49/237 (20%), Positives = 78/237 (32%), Gaps = 59/237 (24%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL------ 747
+G G V+ VA+K + D+ + E E+++L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKED 81
Query: 748 -----NIVKLL------------CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRA 790
+I+KLL + E L + + KK
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI----------KKY-------- 123
Query: 791 RDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY------NFNAKIAD 844
+ QI+ GL YMH C I+H D+K N+L++ KIAD
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
G A E + + + Y +PE DI+S ++ EL TG
Sbjct: 182 LGNA-CWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 53/209 (25%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G +GKV ++ T E A+K + D ++ EV++ + +IV++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR-------EVELHWRASQCPHIVRI 76
Query: 753 L----CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ + L+V E ++ L + + + + R E++ I
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIG---- 127
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ + Y+H S I HRD+K N+L N K+ DFG AK E
Sbjct: 128 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE----------- 173
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVIL 894
Y ++ D++S GVI+
Sbjct: 174 ---KY-----------DKSCDMWSLGVIM 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 36/183 (19%)
Query: 98 TILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMS 156
LDLQ + + +KL +L+L N + + + D L+ L L L N ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ-LQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 157 GKIPASI-GRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FT 214
+P + LT+L +L L NQ L+ SLPS F
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQ-----------LK----------------SLPSGVFD 128
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-KLKNLSKVYL 272
+L KLK+L + +TN + IP D L L+ L LS N S+P F +L L + L
Sbjct: 129 RLTKLKELRL-NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL 186
Query: 273 YSN 275
+ N
Sbjct: 187 FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLK 217
+P+ I TE +L+L A L L L L YN +L + F L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYN---QLQTLSAGVFDDLT 83
Query: 218 KLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
+L L + + N + +P + D L L+ L L N S+PS VF +L L ++ L +N
Sbjct: 84 ELGTLGL-ANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN 141
Query: 276 SLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
L IP + L NL+ + LS N L F +L L ++L NQ
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 17/171 (9%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-K 263
PS +P++ +L + + + + L L +L+L N ++ + VF
Sbjct: 30 PSGIPADTEKLD-------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD 81
Query: 264 LKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPND-FGKLENLLNLSLM 320
L L + L +N L+ +P V + L L + L N L ++P+ F +L L L L
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLN 139
Query: 321 FNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVN 370
NQL IP G L +L+ + L N L F R L+ + N
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIG 133
+L L + + L LT L+L +N + + V + ++L L L+ N +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ-LA 96
Query: 134 PIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNL 190
+P + D L++L LYL N + +P+ + RLT+L++L L NQ SIPA L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 191 QNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLW 223
NL+ L L+ N S+P F +L KL+ +
Sbjct: 155 TNLQTLSLSTN---QLQSVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 40/143 (27%), Positives = 58/143 (40%), Gaps = 9/143 (6%)
Query: 458 RLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGS 517
+L++ + + L N G L L TL L NQL+ S
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 518 LPLDI-ISWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQI-GRL 573
LPL + L L L NQL +P + F L L++L L+ NQ IP +L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGV-FDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 574 -MLTSLNLSSNRLTGEIPSQFEN 595
L +L+LS+N+L F+
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDR 177
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 42/132 (31%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
T L+L N T + D L L L L N + S V + ++L+ L L N +
Sbjct: 62 TWLNLDY-NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ-L 119
Query: 133 GPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GN 189
+P + DRL++LK L L N + IPA +LT L+ L+L NQ S+P
Sbjct: 120 KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDR 177
Query: 190 LQNLEALELAYN 201
L L+ + L N
Sbjct: 178 LGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 26/97 (26%), Positives = 36/97 (37%), Gaps = 10/97 (10%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV- 551
L ++PS L L L+ LT LNL NQL + +
Sbjct: 26 LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84
Query: 552 LQDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
L L L+ NQ + +P + L L L L N+L
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK 120
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 4/109 (3%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
L L N N + P + D L L L L N + S V +KL+ L L+ N +
Sbjct: 86 GTLGLAN-NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ-L 143
Query: 133 GPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
IP D+L+ L+ L L+ N + + RL +L+ + L NQF+
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 40/162 (24%), Positives = 60/162 (37%), Gaps = 28/162 (17%)
Query: 416 YNNSFTGNIPAGLWTGF-NLSMVLISDNLFTGELP----DKMSGNLSRLEISNNRFSGKI 470
+ + + G L+ + + N L D ++ L L ++NN+ + +
Sbjct: 43 QSTGLA-TLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLT-ELGTLGLANNQLA-SL 98
Query: 471 PTGV-SSSKNLVVFQASNNLFNGTIPGELTALPS--------LTTLLLDQNQLSGSLPLD 521
P GV L N +L +LPS L L L+ NQL S+P
Sbjct: 99 PLGVFDHLTQLDKLYLGGN--------QLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 522 II-SWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
+L L+LS NQL L LQ + L NQF
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQ--FPRVLYNCSKLEYLDLSQN 129
+ +L +L ++ + + I S + + YL L N
Sbjct: 20 ETIKANL-KKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQGIQYL----PNVRYLALGGN 73
Query: 130 YF--IGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAE 186
I + L+ L +L LT N + +P + +LT L++L LV NQ S+P
Sbjct: 74 KLHDISAL----KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127
Query: 187 IGN-LQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLA-L 243
+ + L NL L LA+N SLP F +L L +L + S N + +PE + D L L
Sbjct: 128 VFDKLTNLTYLNLAHN---QLQSLPKGVFDKLTNLTELDL-SYNQLQSLPEGVFDKLTQL 183
Query: 244 EFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
+ L L N S+P VF +L +L ++L+ N
Sbjct: 184 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKK 218
P E + NL + L +++ + + S+ L
Sbjct: 13 FPDDA--FAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNS---DIKSVQG-IQYLPN 64
Query: 219 LKKLWMASTNLIGEIPETIG--DMLA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYS 274
++ L + L I L L +L L+ N S+P+ VF KL NL ++ L
Sbjct: 65 VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118
Query: 275 NSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI 332
N L +P V + L NL ++L+ N L F KL NL L L +NQL +PEG+
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGV 176
Query: 333 -GLLPSLKDVRLFNNML 348
L LKD+RL+ N L
Sbjct: 177 FDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 501 LPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFLPV-LQDLDLS 558
L +LT L+L NQL SLP + +L L L NQL +P+ + L L+L+
Sbjct: 84 LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 559 ENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
NQ +P + +L LT L+LS N+L
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 40/111 (36%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 455 NLSRLEISNNRFSGKIPTGVSSS-KNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
NL+ L ++ N+ +P GV NL N G L +LT L L NQ
Sbjct: 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 514 LSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQ 561
L SLP + +LT L+LS NQL +PE + F L L+DL L +NQ
Sbjct: 145 LQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGV-FDKLTQLKDLRLYQNQ 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 17/122 (13%)
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLT 529
P + + + L S+ ++ + + + + + ++
Sbjct: 13 FPDDAFAETIKANLK--KKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLP--NVR 66
Query: 530 ALNLSRNQLSGEIPEKIG-F--LPVLQDLDLSENQFSGKIPPQIGRLM--LTSLNLSSNR 584
L L N+L I L L L L+ NQ +P + + L L L N+
Sbjct: 67 YLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 585 LT 586
L
Sbjct: 121 LQ 122
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 55/279 (19%), Positives = 92/279 (32%), Gaps = 78/279 (27%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L +G G G+V + T VAVK + + ++E++IL
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 80
Query: 743 TI-RHLNIVKLL-CCISSENLKLLV---------YEYMEKR------------------- 772
I HLN+V LL C +++ Y+ +
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 773 ---------------------------SLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
++ L + L+ + +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
A+G M S +HRDL + NILL KI DFG+A+ + K+ V
Sbjct: 201 QVAKG---MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVR 251
Query: 866 GSCGYI-----APEYARTRKVNEKTDIYSFGVILLELTT 899
+ APE R ++D++SFGV+L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 17/147 (11%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTGSIPSSVF-K 263
P++LP T+++ L N I IP L +DLS N + + F
Sbjct: 27 PTNLPETITEIR----L---EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78
Query: 264 LKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPND-FGKLENLLNLSLM 320
L++L+ + LY N ++ E+P+++ E L +L+++ L+AN + + D F L NL LSL
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 321 FNQLSGEIPEGI-GLLPSLKDVRLFNN 346
N+L I +G L +++ + L N
Sbjct: 137 DNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 35/135 (25%), Positives = 58/135 (42%), Gaps = 10/135 (7%)
Query: 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANN 154
+T + L+ N I P KL +DLS N I + D L L L L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-QISELAPDAFQGLRSLNSLVLYGNK 91
Query: 155 MSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN 212
++ ++P S+ L L+ L L N+ N + + +L NL L L N ++
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN---KLQTIAKG 146
Query: 213 -FTQLKKLKKLWMAS 226
F+ L+ ++ + +A
Sbjct: 147 TFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 34/134 (25%), Positives = 54/134 (40%), Gaps = 8/134 (5%)
Query: 72 SVTELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNY 130
++TE+ L N PP + L +DL N I P L L L N
Sbjct: 33 TITEIRLEQ-NTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 131 FIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI- 187
I +P+ + + L L+ L L AN ++ + L L L+L N+ +I
Sbjct: 92 -ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 188 GNLQNLEALELAYN 201
L+ ++ + LA N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGF--LPV 551
PG + L + L NQ+S L D +SL +L L N+++ E+P+ + F L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSL-FEGLFS 105
Query: 552 LQDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
LQ L L+ N+ + + L L L+L N+L
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 28/143 (19%), Positives = 52/143 (36%), Gaps = 11/143 (7%)
Query: 281 IPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLK 339
+P+ + + L N + P F + L + L NQ+S E+ L SL
Sbjct: 30 LPETITEI-----RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLN 83
Query: 340 DVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNLS 397
+ L+ N ++ LP F L+ ++ N + L L ++ DN L
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 398 GELPESLGNCSSLLMVKIYNNSF 420
+ ++ + + N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 4/109 (3%)
Query: 74 TELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132
+ L+N N P LR+L L L N I + L+ L L+ N I
Sbjct: 59 RRIDLSN-NQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK-I 116
Query: 133 GPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
+ D L L L L N + + L ++ ++L N F
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 33/135 (24%), Positives = 57/135 (42%), Gaps = 11/135 (8%)
Query: 455 NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
++ + + N IP G S K L SNN + P L SL +L+L N+
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 514 LSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQI 570
++ LP + SL L L+ N+++ + F L L L L +N+ I
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDA-FQDLHNLNLLSLYDNKLQ-TIAKGT 147
Query: 571 GRLM--LTSLNLSSN 583
+ + +++L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 27/110 (24%), Positives = 47/110 (42%), Gaps = 4/110 (3%)
Query: 455 NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
L R+++SNN+ S ++ ++L N L SL LLL+ N+
Sbjct: 57 KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK 115
Query: 514 LSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQF 562
++ L +D +L L+L N+L L +Q + L++N F
Sbjct: 116 IN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDI-ISWKSLTALNLSRNQLSGEIPEKIGF--L 549
LT +P+ +T + L+QN + +P +K L ++LS NQ+S E+ F L
Sbjct: 23 LTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA-FQGL 79
Query: 550 PVLQDLDLSENQFSGKIPPQI-GRL-MLTSLNLSSNRLT 586
L L L N+ + ++P + L L L L++N++
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 43/177 (24%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN--FTQLKKLKKLWMASTNLIGEIPE-TIG 238
++P + + L+L++N + S L + T+L L L + S N + I
Sbjct: 32 NVPQSLPS--YTALLDLSHN---NLSRLRAEWTPTRLTNLHSLLL-SHNHLNFISSEAFV 85
Query: 239 DMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDL 295
+ L +LDLS N+ ++ +F L+ L + LY+N + + + E + L+ + L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYL 143
Query: 296 SANNLTGAIPND----FGKLENLLNLSLMFNQLSGEIPEGIGLLPSLK--DVRLFNN 346
S N ++ P + KL L+ L L N+L + LP+ + L NN
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 17/173 (9%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEI--GNLQNLEALELAYNTEFSPSSLPSN-FTQ 215
+P S+ T L+L N + AE L NL +L L++N + + S F
Sbjct: 33 VPQSLPSYTA--LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHN---HLNFISSEAFVP 86
Query: 216 LKKLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLY 273
+ L+ L + S+N + + D+ ALE L L N+ + + F + L K+YL
Sbjct: 87 VPNLRYLDL-SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 274 SNSLSGEIPQAVESL----NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322
N +S + ++ L ++DLS+N L D KL + L +
Sbjct: 145 QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 10/164 (6%)
Query: 95 RNLTILDLQFNYIISQFPR-VLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
+LDL N + + L L LS N+ + I + + L++L L++
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSS 97
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYN--TEFSPSS 208
N++ + + L L L L N + ++ L+ L L+ N + F
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINN 252
+ + +L KL L ++S L + + A L ++N
Sbjct: 156 I-KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 12/145 (8%)
Query: 243 LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIP-QAVESL-NLKVIDLSANN 299
LDLS NN + +L NL + L N L+ I +A + NL+ +DLS+N+
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 300 LTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLSGALPPD--- 355
L F L+ L L L N + + + L+ + L N +S P +
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 356 -FGRYSPLEYFEVSVNNLTGSLPEH 379
+ L ++S N L LP
Sbjct: 158 DGNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 13/136 (9%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTA 152
L NL L L N++ L YLDLS N + + E + L L+ L L
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN-HLHTLDEFLFSDLQALEVLLLYN 121
Query: 153 NNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI----GNLQNLEALELAYNTEFSPS 207
N++ + + + +L++L L NQ + P E+ L L L+L+ N
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN---KLK 176
Query: 208 SLPSN-FTQLKKLKKL 222
LP +L K
Sbjct: 177 KLPLTDLQKLPAWVKN 192
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSS--KNLVVFQASNNLFNGTIP-GELTALPS 503
+P + + L++S+N S ++ + + NL S+N N I +P+
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 504 LTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKI-GFLPVLQDLDLSENQ 561
L L L N L +L + S ++L L L N + + + LQ L LS+NQ
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 562 FSGKIPPQI----GRL-MLTSLNLSSNRLTGEIPSQFEN 595
S + P ++ +L L L+LSSN+L + +
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 44/177 (24%), Positives = 68/177 (38%), Gaps = 23/177 (12%)
Query: 423 NIPAG---LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGV-SSSK 478
++P+ L N L ++ T L NL L +S+N + I +
Sbjct: 36 SLPSYTALLDLSHNNLSRLRAEWTPTR-LT-----NLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 479 NLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQ 537
NL S+N + + L +L LLL N + + + L L LS+NQ
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 538 LSGEIPEKI----GFLPVLQDLDLSENQFSGKIPPQI----GRLMLTSLNLSSNRLT 586
+S P ++ LP L LDLS N+ K+P + L L +N L
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 7/111 (6%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLT 151
+ NL LDL N++ + + + LE L L N+ I + + + +++L+ LYL+
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYLS 144
Query: 152 ANNMSGKIPA----SIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALEL 198
N +S + P +L +L L+L N+ ++ L L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 26/108 (24%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 72 SVTELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNY 130
++ L L++ N T F+ L+ L +L L N+I+ + ++L+ L LSQN
Sbjct: 89 NLRYLDLSS-NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN- 146
Query: 131 FIGPIPEDI----DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNL 174
I P ++ ++L +L L L++N + + +L + L
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK-LDQKHEKEFLAEVQILSTIRHL----- 747
VIG G G+V + + + VA+K + N+++ Q E++IL +R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEEIRILEHLRKQDKDNT 158
Query: 748 -NIVKLLC--------CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
N++ +L C++ E L + +YE + KKN+ G S
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELI----------KKNK--FQG------FSLP 200
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL-DYNFNA-KIADFGVAKILIKEEG 856
+ A Q L +H I+H DLK NILL + K+ DFG +
Sbjct: 201 LVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY------ 251
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
E + T + S Y APE + D++S G IL EL TG
Sbjct: 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 38/171 (22%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN--FTQLKKLKKLWMASTNLIGEIPETIGD 239
IP I Q L L N + L + F +L +L+K+ S N I +I E +
Sbjct: 25 KIPEHIP--QYTAELRLNNN---EFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFE 78
Query: 240 ML-ALEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSA 297
+ + L+ N ++ +F L++L + L SN ++
Sbjct: 79 GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT------------------- 118
Query: 298 NNLTGAIPND-FGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
+ ND F L ++ LSL NQ++ + G L SL + L N
Sbjct: 119 -----CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 6/108 (5%)
Query: 246 LDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTG 302
L L+ N FT + +F KL L K+ +N ++ +I + E + I L++N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN 95
Query: 303 AIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLS 349
F LE+L L L N+++ + L S++ + L++N ++
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 15/138 (10%)
Query: 72 SVTELHL-----TNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDL 126
EL L T + G F L L ++ N I S + + L
Sbjct: 33 YTAELRLNNNEFTVLEATGIFK----KLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88
Query: 127 SQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIP 184
+ N + + + L LK L L +N ++ + L+ +R L+L NQ ++
Sbjct: 89 TSNR-LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
Query: 185 AEI-GNLQNLEALELAYN 201
L +L L L N
Sbjct: 146 PGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 10/141 (7%)
Query: 449 PDKMSGNLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTL 507
P+ + + L ++NN F+ TG+ L SNN G + +
Sbjct: 27 PEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86
Query: 508 LLDQNQLSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSG 564
LL N+L ++ + +SL L L N+++ + F L ++ L L +NQ +
Sbjct: 87 LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS-FIGLSSVRLLSLYDNQIT- 142
Query: 565 KIPPQI-GRLM-LTSLNLSSN 583
+ P L L++LNL +N
Sbjct: 143 TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/122 (18%), Positives = 45/122 (36%), Gaps = 10/122 (8%)
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSL 528
IP + + +N G LP L + N+++ + +
Sbjct: 26 IPEHIPQYTAELRLN-NNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGV 83
Query: 529 TALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQI--GRLMLTSLNLSSNR 584
+ L+ N+L + K+ F L L+ L L N+ + + G + L+L N+
Sbjct: 84 NEILLTSNRLE-NVQHKM-FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 585 LT 586
+T
Sbjct: 141 IT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 13/99 (13%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGEIPEKIGF--L 549
L +P L L+ N+ + I L +N S N+++ +I E F
Sbjct: 23 LNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGA-FEGA 80
Query: 550 PVLQDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
+ ++ L+ N+ + ++ L L +L L SNR+T
Sbjct: 81 SGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLT 151
+ + L N + + ++ L+ L L N I + D LS ++ L L
Sbjct: 79 GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLY 137
Query: 152 ANNMSGKIPASI-GRLTELRQLNLVVNQFN 180
N ++ + L L LNL+ N FN
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 30/144 (20%), Positives = 54/144 (37%), Gaps = 12/144 (8%)
Query: 281 IPQAVESLNLKVIDLSANNLTGAIPND-FGKLENLLNLSLMFNQLSGEIPEGI-GLLPSL 338
IPQ L L+ N T F KL L ++ N+++ +I EG +
Sbjct: 30 IPQYTAEL-----RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGV 83
Query: 339 KDVRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAG-GKLAGIAAQDNNL 396
++ L +N L + F L+ + N +T + G + ++ DN +
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 397 SGELPESLGNCSSLLMVKIYNNSF 420
+ P + SL + + N F
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPF 165
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 3e-14
Identities = 110/763 (14%), Positives = 208/763 (27%), Gaps = 242/763 (31%)
Query: 230 IGEIPETIGDMLALEFLDLSINNF----TGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV 285
GE D+L++ F D ++NF +P S+ + + + AV
Sbjct: 11 TGEHQYQYKDILSV-FEDAFVDNFDCKDVQDMPKSILSKEEIDHII--------MSKDAV 61
Query: 286 ESLNLKVIDLSANNLTGAIPNDFGKLENLL--NLSLMFNQLSGE--IPEGIGLLPSLKDV 341
L + F +E +L N + + + E P + + +
Sbjct: 62 SGTLRLFWTLLSKQEEMV--QKF--VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 342 RLFNNMLSGALPPDFGRYSPLEYFEVS----VNNLTGSLPE---------HLCAG-GK-- 385
RL+N+ F +Y+ VS L +L E G GK
Sbjct: 118 RLYND------NQVFAKYN------VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165
Query: 386 LAGIAAQDNNLSGELPE-----SLGN-CSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLI 439
+A + ++ +L N S ++++ L I
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK---------LLY-------QI 209
Query: 440 SDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELT 499
N D S R+ + L+ + N
Sbjct: 210 DPNW--TSRSDHSSNIKLRIHSIQAEL-----------RRLLKSKPYEN----------- 245
Query: 500 ALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSE 559
L L+L ++ + K+ A NLS
Sbjct: 246 ---CL--LVLL----------NVQNAKAWNAFNLS------------------------- 265
Query: 560 NQFSGKIPPQIGRLMLTSLNLS-SNRLTGEIPSQFENRAYASSFL--NNPGLCASSSNVN 616
+++LT+ ++ L+ + ++ + L +
Sbjct: 266 -----------CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 617 LKSCFFVPRKSRKGSSQHVAVIIVSVIAVFL---VALLSFFYMIRIYQKRK------DEL 667
+ +PR+ + + + S+IA + +A + + + + L
Sbjct: 315 PQD---LPREVLTTNPRRL-----SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 668 TSTETTSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWND---- 723
E +R F + P I ++++ IW D
Sbjct: 367 EPAE----YRKMFDRLSVFPP----------------SAHI--PTILLSL--IWFDVIKS 402
Query: 724 --RKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL----KLLVYEYMEKRSLDQW 777
+ K K L E Q + + + L + EN + +V Y ++ D
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 778 LHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY-MHHDCSPTIVHRDLKSSNILLDY 836
L D+ + HH + R + LD+
Sbjct: 463 -------DLIPPYLDQYFYS---------------HIGHHLKNIEHPERMTLFRMVFLDF 500
Query: 837 NF-NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA---PEYARTRKVNEKTDIYSFGV 892
F KI A + + YI P+Y R VN I F
Sbjct: 501 RFLEQKIRHDSTA--WNASGSILNTLQQLKFYKPYICDNDPKY--ERLVN---AILDF-- 551
Query: 893 ILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKEID 935
L +E ++T L + A E + I + K++
Sbjct: 552 ----LPKIEENLICSKYTDLLRIALMA--EDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 4e-08
Identities = 58/386 (15%), Positives = 118/386 (30%), Gaps = 110/386 (28%)
Query: 641 SVIAVFLVALLSFFY---MIRI-YQKRKDELTSTETTSFHRLNFRDSDILPKLT------ 690
++ F+ +L Y M I ++R+ + + + D+ + K
Sbjct: 77 EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 691 -------------ESNVI--GSGGSGK-VYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF 734
NV+ G GSGK +V L K + +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWV------ALDVC----------LSYKVQCKM 180
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR-DE 793
++ L +++ N + + E L+ L+Y+ +D ++ S + + R
Sbjct: 181 DFKIFWL-NLKNCNSPETVL----EMLQKLLYQ------IDPNWTSRSDHSSNIKLRIHS 229
Query: 794 VLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI----ADFGVAK 849
+ + RR+ + L +V +++++ +N + KI V
Sbjct: 230 IQAELRRLLKSKPYENCL----------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 850 ILIKEEGEFAAMSTVVGSCGYIAPE-------YARTRKV---NEKTDIYSFGVILLELTT 899
L +S S E Y R E + ++
Sbjct: 280 FLS--AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII---- 333
Query: 900 GKEANNGDEHTCLAQWA-WRHIQEGK------PIVDALDKEIDEPCFLEEMIRVFKLGV- 951
+ +G LA W W+H+ K ++ L+ F + + VF
Sbjct: 334 AESIRDG-----LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DRLSVFPPSAH 386
Query: 952 ICTSMLPTERPNMRMVLQILLNNPIF 977
I PT +L ++ + I
Sbjct: 387 I-----PTI------LLSLIWFDVIK 401
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 9e-07
Identities = 93/610 (15%), Positives = 176/610 (28%), Gaps = 190/610 (31%)
Query: 70 DGSVTELHLTNMNMNGTF-PPFICDLRNLTILDL--------QFNYIISQFPRV-----L 115
D E ++ F F+ + + D+ + ++II V L
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 116 YN--CSKLE-----YLD--LSQNY-FI-GPIPEDIDRLSRLKFLYLTA-----NNMSGKI 159
+ SK E +++ L NY F+ PI + + S + +Y+ N+
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 160 PASIGR----------LTELR-QLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSS 208
++ R L ELR N++++ GS G + AL++ + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-----GK-TWV-ALDVCLSYKVQ-CK 179
Query: 209 LPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSIN-----NFTGSIPSSV- 261
+ F W+ N PET+ +ML + N + + +I +
Sbjct: 180 MDFKIF---------WLNLKNC--NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 262 ---FKLKNLSKVYLYSNSLSGEI-------PQAVESLNL--KVIDLSAN-NLTGAIPNDF 308
+L+ L K Y N L + +A + NL K++ + +T +
Sbjct: 229 SIQAELRRLLKSKPYENCL---LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 309 GKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVS 368
+L + S+ E LL L+Y +
Sbjct: 286 TTHISLDHHSMTLTP-----DEVKSLL--------------------------LKYLDCR 314
Query: 369 VNNLTGSLPEHLCAGG--KLAGIAA---------------QDNNLSGELPESLGNCSSLL 411
LP + +L+ IA + L+ + SL
Sbjct: 315 P----QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 412 MVKIYNNSFT-----GNIPAG----LWTG-------------FNLSMVLISDNLFTGELP 449
K++ + + +IP +W S+V T +P
Sbjct: 371 YRKMF-DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 450 D---KMSGNLSRLEISNNRF--SGKIPTGVSSSKNLVVFQASNNLFN-------GTIPGE 497
++ L + IP S +L+ ++ E
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 498 LTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDL 557
L + LD L + D +W + ++ L LQ L
Sbjct: 489 RMTL--FRMVFLDFRFLEQKIRHDSTAWNASGSI-----------------LNTLQQLKF 529
Query: 558 SENQFSGKIP 567
+ P
Sbjct: 530 YKPYICDNDP 539
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 61/394 (15%), Positives = 122/394 (30%), Gaps = 103/394 (26%)
Query: 10 LQILLSTLLLFFFGRAN--SQLYDREHAVLLKLKQHWQNPP-PIS-----------HWAT 55
LQ LL + + R++ S + R H++ +L++ ++ P W
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 56 TNSSHC----TWPEIACTD--GSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIIS 109
N C T TD + T H++ + + T P ++L +
Sbjct: 262 FNL-SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD----EVKSLLLKYLDCRPQ 316
Query: 110 QFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLK-FLYLTANNMSGKIPASIGRLT 167
PR + + + I E I D L+ + ++ + ++ I +S+ L
Sbjct: 317 DLPREVLTTNPR---------RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 168 --ELRQL--NLVVNQFNGSIPAEI-----GNLQNLEALELAYNTEFSPSSL----PSNFT 214
E R++ L V + IP + ++ + + + + SL P T
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV--NKLHKYSLVEKQPKEST 425
Query: 215 ------QLKKLKKL---------------------------------W-------MASTN 228
L+ KL + + +
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 229 LIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL 288
+ L FL+ I + + + +S L L ++ Y + P+
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK----Y 541
Query: 289 NLKVIDLSANNLTGAIPNDF-GKLENLLNLSLMF 321
V + + L N K +LL ++LM
Sbjct: 542 ERLVNAI-LDFLPKIEENLICSKYTDLLRIALMA 574
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 47/226 (20%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK-LDQKHEKEFLAEVQILSTIRHL---- 747
++IG G G+V + E VA+K I N + L+Q EV++L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEM 114
Query: 748 --NIVKLLC--------CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
IV L C+ E L +Y+ + + G +S
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLL----------RNTN--FRG------VSL 156
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEE 855
+ A L ++ +I+H DLK NILL + KI DFG +
Sbjct: 157 NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----L 211
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK 901
G+ + + S Y +PE + D++S G IL+E+ TG+
Sbjct: 212 GQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 44/239 (18%), Positives = 87/239 (36%), Gaps = 26/239 (10%)
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
L N +L + S ++ + + I + + + LK L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSN-IQSL-AGMQFFTNLKELHL 70
Query: 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQ--NLEALELAYNTEFSPSS 208
+ N +S + + LT+L +L++ N+ + + L L L N S
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS 123
Query: 209 LPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
L LK L+ L + + N + I +G + LE LDL N T + + +LK ++
Sbjct: 124 L----IHLKNLEILSIRN-NKLKSI-VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVN 175
Query: 269 KVYLYSNSLSGEIPQAVESLNL--KVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+ L E + L + V D ++ P + ++ +++
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 10/132 (7%)
Query: 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQL 514
+ N+ + G+ NL S+N + + L L L L +++N+L
Sbjct: 42 GVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL 97
Query: 515 SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM 574
L+ I L+ L L N+L + + L L+ L + N+ I
Sbjct: 98 KN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSK 151
Query: 575 LTSLNLSSNRLT 586
L L+L N +T
Sbjct: 152 LEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 30/199 (15%), Positives = 63/199 (31%), Gaps = 18/199 (9%)
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
+ DL L L + N + + + L L L N + + L L+ L +
Sbjct: 81 LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSI 135
Query: 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLP 210
N + I +G L++L L+L N+ + + L+ + ++L +
Sbjct: 136 RNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVNEPV-- 189
Query: 211 SNFTQLKKLKKLWMASTNLIGEI--PETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
+L + + G P I + + + +K
Sbjct: 190 KYQPELYITNTV----KDPDGRWISPYYISNGGSYVDGCVLWELPV-YTDEVSYKFSEYI 244
Query: 269 KVYLYSNSLSGEIPQAVES 287
V G + Q +++
Sbjct: 245 NVGETEAIFDGTVTQPIKN 263
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 14/140 (10%)
Query: 449 PDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLL 508
PD N + + + + F N+ ++ G + +L L
Sbjct: 14 PDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELH 69
Query: 509 LDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFL--PVLQDLDLSENQFSGKI 566
L NQ+S PL L L+++RN+L + + L L L N+
Sbjct: 70 LSHNQISDLSPLK--DLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR-DT 121
Query: 567 PPQIGRLMLTSLNLSSNRLT 586
I L L++ +N+L
Sbjct: 122 DSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 10/141 (7%)
Query: 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQL 514
NL L +S+N+ S + + + L + N + G L+ L LD N+L
Sbjct: 64 NLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNEL 118
Query: 515 SGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM 574
+ L K+L L++ N+L I +GFL L+ LDL N+ +
Sbjct: 119 RDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGGLTRLKK 173
Query: 575 LTSLNLSSNRLTGEIPSQFEN 595
+ ++L+ + E
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPE 194
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 38/203 (18%), Positives = 77/203 (37%), Gaps = 20/203 (9%)
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMF 321
L N K L S++ + Q + L ++ + +N+ ++ NL L L
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 322 NQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLC 381
NQ+S ++ + L L+++ + N L + L + N L + L
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRD--TDSLI 125
Query: 382 AGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISD 441
L ++ ++N L + LG S L ++ ++ N T N GL ++ + ++
Sbjct: 126 HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTG 181
Query: 442 NLFTGELPDKMSGNLSRLEISNN 464
++ L I+N
Sbjct: 182 QKCV----NEPVKYQPELYITNT 200
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-12
Identities = 78/479 (16%), Positives = 161/479 (33%), Gaps = 86/479 (17%)
Query: 167 TELRQLNLVVNQFNGSIPAEIG-NLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLW 223
+++ L++ + + + AE+ LQ + + L TE + S L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 224 MASTNLIGEIPETIGDMLA-----LEFLDLSINNFT----GSIPSSVFKLKNLSKVYLYS 274
+ S L + L ++ L L T G + S++ L L +++L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 275 NSLSGE----IPQAVESLN--LKVIDLSANNLTGAIPNDFGKL----ENLLNLSLMFNQL 324
N L + + + L+ + L +L+ A + + L++ N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 325 SGEIPEGIGLL--------PSLKDVRLFNNMLS----GALPPDFGRYSPLEYFEVSVNNL 372
+ G+ +L L+ ++L + ++ L + L + N L
Sbjct: 183 N---EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 373 TGSLPEHLCAGGK-----LAGIAAQDNNLSGE----LPESLGNCSSLLMVKIYNNSFTGN 423
LC G L + + ++ + L L SL + + N
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG-- 297
Query: 424 IPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGK----IPTGVSSSKN 479
+ L+ + L + L L + + F+ + ++ ++
Sbjct: 298 ---------DEGARLLCETLL------EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 480 LVVFQASNNLF--NGTIP---GELTALPSLTTLLLDQNQLS----GSLPLDIISWKSLTA 530
L+ Q SNN G G L L L +S SL +++ SL
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402
Query: 531 LNLSRNQLSGEIPEKIGFL-----PVLQDLDLSENQFSGKIPPQIGRLM-----LTSLN 579
L+LS N L ++ +L+ L L + +S ++ ++ L L ++
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 77/460 (16%), Positives = 153/460 (33%), Gaps = 87/460 (18%)
Query: 72 SVTELHLTNMNMNGTFPPFICD-LRNLTILDLQFNYI----ISQFPRVLYNCSKLEYLDL 126
+ L + ++ + L+ ++ L + L L L+L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 127 SQNYFIGPIPEDIDRLS--------RLKFLYLTANNMSGK----IPASIGRLTELRQLNL 174
N +G + + +++ L L ++G + +++ L L++L+L
Sbjct: 64 RSN-ELG--DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 175 VVNQFNGS-----IPAEIGNLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMAST 227
N + + LE L+L Y + S L S K+L +++
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 228 NLIGEIPETIGDMLA-----LEFLDLSINNFT----GSIPSSVFKLKNLSKVYLYSNSLS 278
++ + L LE L L T + V +L ++ L SN L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 279 GE----IPQAVESLN--LKVIDLSANNLT----GAIPNDFGKLENLLNLSLMFNQLSGEI 328
+ + + L+ + + +T G + E+L LSL N+L
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG--- 297
Query: 329 PEGIGLL--------PSLKDVRLFNNMLSGALPPDFG----RYSPLEYFEVSVNNLTGSL 376
EG LL L+ + + + + A F + L ++S N L +
Sbjct: 298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357
Query: 377 PEHLCAGGK-----LAGIAAQDNNLSGE----LPESLGNCSSLLMVKIYNNSFTGNIPAG 427
LC G L + D ++S L +L SL + + NN AG
Sbjct: 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAG 414
Query: 428 LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFS 467
++ + +++ + L +L + + +S
Sbjct: 415 --------ILQLVESV------RQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 64/374 (17%), Positives = 120/374 (32%), Gaps = 70/374 (18%)
Query: 265 KNLSKVYLYSNSLSGE-IPQAVESL-NLKVIDLSANNLT----GAIPNDFGKLENLLNLS 318
++ + + LS + + L +V+ L LT I + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 319 LMFNQLSGEIPEGIGLL--------PSLKDVRLFNNMLS----GALPPDFGRYSPLEYFE 366
L N+L G+ + ++ + L N L+ G L L+
Sbjct: 63 LRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 367 VSVNNLTGSLPEHLCAGG-----KLAGIAAQDNNLSGE----LPESLGNCSSLLMVKIYN 417
+S N L + + LC G +L + + +LS L L + + N
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 418 NSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGK----IPTG 473
N + ++ L L L++ + + +
Sbjct: 180 NDIN-----------EAGVRVLCQGL------KDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 474 VSSSKNLVVFQASNNLFNGT-----IPGELTALPSLTTLLLDQNQLS----GSLPLDIIS 524
V+S +L +N PG L L TL + + ++ G L + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 525 WKSLTALNLSRNQLSGEIPEKIGFL-----PVLQDLDLSENQFSGKIPPQIGRLM----- 574
+SL L+L+ N+L E + L+ L + F+ ++
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 575 LTSLNLSSNRLTGE 588
L L +S+NRL
Sbjct: 343 LLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 54/346 (15%), Positives = 111/346 (32%), Gaps = 63/346 (18%)
Query: 287 SLNLKVIDLSANNLT-GAIPNDFGKLENLLNLSLMFNQLSGE----IPEGIGLLPSLKDV 341
SL+++ +D+ L+ L+ + L L+ I + + P+L ++
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 342 RLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGE-- 399
L +N L +V V+ + L C K+ ++ Q+ L+G
Sbjct: 62 NLRSNELG----------------DVGVHCVLQGLQTPSC---KIQKLSLQNCCLTGAGC 102
Query: 400 --LPESLGNCSSLLMVKIYNNSFTGN-----IPAGLWTGFNLSMVLISDNLFTGE----L 448
L +L +L + + +N L L + + + L
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 449 PDKMSGN--LSRLEISNNRFSGK----IPTGVSSSK-NLVVFQASNNLFN----GTIPGE 497
+ L +SNN + + G+ S L + + + G
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 498 LTALPSLTTLLLDQNQLSGS-----LPLDIISWKSLTALNLSRNQLSGE----IPEKIGF 548
+ + SL L L N+L P + L L + ++ + + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 549 LPVLQDLDLSENQFSGKIPPQIGRLM------LTSLNLSSNRLTGE 588
L++L L+ N+ + + + L SL + S T
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 16/146 (10%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-K 263
P+ +P+N L N I ++ + D L L+ L L N ++P VF
Sbjct: 35 PAGIPTNAQILY-------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS 86
Query: 264 LKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMF 321
L L+ + L +N L+ +P AV + L +LK + + N LT +P +L +L +L+L
Sbjct: 87 LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144
Query: 322 NQLSGEIPEGI-GLLPSLKDVRLFNN 346
NQL IP G L SL LF N
Sbjct: 145 NQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 9/129 (6%)
Query: 98 TILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMS 156
IL L N I P V + L+ L L N +G +P + D L++L L L N ++
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-LGALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 157 GKIPASI-GRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FT 214
+P+++ RL L++L + N+ +P I L +L L L N S+P F
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN---QLKSIPHGAFD 156
Query: 215 QLKKLKKLW 223
+L L +
Sbjct: 157 RLSSLTHAY 165
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 15/144 (10%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI-GNLQNL 193
IP + L YL N ++ P L L++L L NQ ++P + +L L
Sbjct: 38 IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 194 EALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINN 252
L+L N + LPS F +L LK+L+M N + E+P I + L L L N
Sbjct: 91 TVLDLGTN---QLTVLPSAVFDRLVHLKELFM-CCNKLTELPRGIERLTHLTHLALD-QN 145
Query: 253 FTGSIPSSVF-KLKNLSKVYLYSN 275
SIP F +L +L+ YL+ N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 40/108 (37%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 244 EFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNL 300
+ L L N T + VF L NL ++YL SN L +P V +SL L V+DL N L
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
T F +L +L L + N+L+ E+P GI L L + L N L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 470 IPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSL 528
+P G+ ++ ++ +N PG +L +L L L NQL +LP+ + S L
Sbjct: 34 VPAGIPTNAQILYLH--DNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 529 TALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRL 585
T L+L NQL+ +P + F L L++L + N+ + ++P I RL LT L L N+L
Sbjct: 91 TVLDLGTNQLT-VLPSAV-FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 586 TGEIPSQFEN 595
F+
Sbjct: 148 KSIPHGAFDR 157
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/107 (30%), Positives = 48/107 (44%), Gaps = 13/107 (12%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGF--LP 550
++P+ L L NQ++ P S +L L L NQL +P + F L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV-FDSLT 88
Query: 551 VLQDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLTGEIPSQFEN 595
L LDL NQ + +P + RL+ L L + N+LT E+P E
Sbjct: 89 QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 4/112 (3%)
Query: 72 SVTELHLTNMNMNG--TFPPFICD-LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQ 128
S+ L + N P + D L LT+LDL N + V L+ L +
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 129 NYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
N +P I+RL+ L L L N + + RL+ L L N ++
Sbjct: 122 NKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 8/106 (7%)
Query: 246 LDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTG 302
L L+ N +F +L +L K+ L N L+ I E +++ + L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 303 AIPND-FGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
I N F L L L+L NQ+S + G L SL + L +N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 13/123 (10%)
Query: 158 KIPASIGRLTELRQLNLVVNQFNGSIPAE--IGNLQNLEALELAYNTEFSPSSLPSN-FT 214
+IP I T +L L N+ I ++ G L +L LEL N + + N F
Sbjct: 22 EIPRDIPLHTT--ELLLNDNELG-RISSDGLFGRLPHLVKLELKRN---QLTGIEPNAFE 75
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYL 272
+++L + N I EI + L L+ L+L N + + F L +L+ + L
Sbjct: 76 GASHIQELQL-GENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
Query: 273 YSN 275
SN
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 39/123 (31%), Positives = 58/123 (47%), Gaps = 16/123 (13%)
Query: 469 KIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWK 526
+IP + + L++ N L + G LP L L L +NQL+ + +
Sbjct: 22 EIPRDIPLHTTELLL--NDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 527 SLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQFSGKIPPQIG---RLM-LTSLNL 580
+ L L N++ EI K+ F L L+ L+L +NQ S + P G L LTSLNL
Sbjct: 79 HIQELQLGENKIK-EISNKM-FLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLTSLNL 133
Query: 581 SSN 583
+SN
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 36/112 (32%), Positives = 47/112 (41%), Gaps = 5/112 (4%)
Query: 72 SVTELHLTNMNMNGTFPPFIC--DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQN 129
TEL L N N G L +L L+L+ N + P S ++ L L +N
Sbjct: 30 HTTELLL-NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 130 YFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
I I + L +LK L L N +S +P S L L LNL N FN
Sbjct: 89 K-IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 257 IPSSVFKLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPNDFGKLENL 314
IP +L L N L + L +L ++L N LTG PN F ++
Sbjct: 27 IPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 315 LNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNMLS 349
L L N++ EI + L LK + L++N +S
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 7e-12
Identities = 48/260 (18%), Positives = 77/260 (29%), Gaps = 50/260 (19%)
Query: 678 LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD-----QKHEK 732
+ F KL IG G G+V++ +HT VA+K I + QK +
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFE 68
Query: 733 EFLAEVQILSTIRHLNIVKLLCCISSENLK-------------LLVYEYM--EKRSLDQW 777
E L E+ I + L+ L L +++ K S +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 778 LHKKNRSSLSG------------RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHR 825
L + R ++ S I L HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 826 DLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP--EYARTRKVNE 883
DL N+LL K+ K S+ + SCG +Y +R +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK------------SSTIPSCGLQVSIIDYTLSRLERD 234
Query: 884 KTDIYSFGVILLELTTGKEA 903
++ + +L TG
Sbjct: 235 GIVVFCDVSMDEDLFTGDGD 254
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 17/147 (11%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-K 263
P+ +P+ T L TN + +P + D L L L L N S+P+ VF K
Sbjct: 23 PTGIPAQTTYLD-------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNK 74
Query: 264 LKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGAIPND-FGKLENLLNLSLM 320
L +L+ + L +N L +P V + L LK + L+ N L ++P+ F KL L +L L
Sbjct: 75 LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132
Query: 321 FNQLSGEIPEGI-GLLPSLKDVRLFNN 346
NQL +P+G+ L SL+ + L +N
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 16/145 (11%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGN-LQNL 193
IP L L N++ LT L QL L N+ S+P + N L +L
Sbjct: 26 IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 194 EALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSIN 251
L L+ N SLP+ F +L +LK+L + +TN + +P+ + D L L+ L L N
Sbjct: 79 TYLNLSTN---QLQSLPNGVFDKLTQLKELAL-NTNQLQSLPDGVFDKLTQLKDLRLYQN 134
Query: 252 NFTGSIPSSVF-KLKNLSKVYLYSN 275
S+P VF +L +L ++L+ N
Sbjct: 135 QLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 10/130 (7%)
Query: 98 TILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-DRLSRLKFLYLTANNMS 156
T LDL+ N + S V + L L L N + +P + ++L+ L +L L+ N +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 157 GKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-GNLQNLEALELAYNTEFSPSSLPSN-F 213
+P + +LT+L++L L NQ S+P + L L+ L L N S+P F
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN---QLKSVPDGVF 144
Query: 214 TQLKKLKKLW 223
+L L+ +W
Sbjct: 145 DRLTSLQYIW 154
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 41/109 (37%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 244 EFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNL 300
+LDL N+ S+P+ VF +L +L+++YL N L +P V L +L ++LS N L
Sbjct: 31 TYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNNML 348
F KL L L+L NQL +P+G+ L LKD+RL+ N L
Sbjct: 89 QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
T L L ++ +L +LT L L N + S V + L YL+LS N
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ- 87
Query: 132 IGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFNGSIPAEI-G 188
+ +P + D+L++LK L L N + +P + +LT+L+ L L NQ S+P +
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFD 145
Query: 189 NLQNLEALELAYN 201
L +L+ + L N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 10/97 (10%)
Query: 498 LTALPS-----LTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV- 551
T++P+ T L L+ N L SLT L L N+L +P +
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 552 LQDLDLSENQFSGKIPPQI-GRLM-LTSLNLSSNRLT 586
L L+LS NQ +P + +L L L L++N+L
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ 113
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 54/248 (21%), Positives = 84/248 (33%), Gaps = 73/248 (29%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL-----N 748
+G G G+V + AVK + N +K+ + E IL I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 749 IVKLLC--------CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRR 800
IVK C+ E L +YE + + N + + +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRN---------NYNGFH-------IEDIKL 141
Query: 801 M--QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF 858
+I + L Y+ S + H DLK NILLD + K K+ +
Sbjct: 142 YCIEIL----KALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 859 AAMSTVV-----GSC--------GYI------APE------YARTRKVNEKTDIYSFGVI 893
ST + G I APE + + +D++SFG +
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCV 248
Query: 894 LLELTTGK 901
L EL TG
Sbjct: 249 LAELYTGS 256
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 31/249 (12%), Positives = 82/249 (32%), Gaps = 33/249 (13%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
W W + TD + L ++ + + + L L+
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELE 378
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLS---------------------QNYFIGPIPEDID 140
+ + + ++ L Y + ++ F+
Sbjct: 379 PENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKM 438
Query: 141 RLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAY 200
+ ++ L+L +++ + + +L + L+L N+ ++P + L+ LE L+ +
Sbjct: 439 EYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495
Query: 201 NTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE--TIGDMLALEFLDLSINNFTGSIP 258
N + ++ L +L++L + + N + + + L L+L N+
Sbjct: 496 N---ALENVD-GVANLPRLQELLLCN-NRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEE 549
Query: 259 SSVFKLKNL 267
+L +
Sbjct: 550 GIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 43/327 (13%), Positives = 100/327 (30%), Gaps = 35/327 (10%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
L++ + + S+ +L + + P + L L L
Sbjct: 255 ACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV-WLCDLPAASLNDQL 313
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
++ L+ ++ + + L EL+ S +
Sbjct: 314 PQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKSTVLQSELESCK 372
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYS 274
+L++L+ I + + +L + + P ++ L S
Sbjct: 373 ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP-----MRAAYLDDLRS 427
Query: 275 NSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGL 334
L +E +++V+ L+ +LT + + +L + +L L N+L +P +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 335 LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDN 394
L L+ ++ +N L + L+ + N L
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAA---------------- 525
Query: 395 NLSGELPESLGNCSSLLMVKIYNNSFT 421
+ L +C L+++ + NS
Sbjct: 526 ------IQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 42/233 (18%), Positives = 75/233 (32%), Gaps = 9/233 (3%)
Query: 351 ALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSL 410
D L E+SV T L L + +L + ++ + + L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398
Query: 411 LMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKI 470
L K F+ + A L S L + ++ L +++ + +
Sbjct: 399 LYEKETLQYFS-TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456
Query: 471 PTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTA 530
+ + S+N +P L AL L L N L ++ + + L
Sbjct: 457 C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512
Query: 531 LNLSRNQLSG-EIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSS 582
L L N+L + + P L L+L N + RL ++SS
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 42/207 (20%), Positives = 69/207 (33%), Gaps = 32/207 (15%)
Query: 394 NNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMS 453
S L L +C L ++ N L+++L+ L +
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKWCL------------LTIILLMRALDPLLYEKETL 405
Query: 454 GNLSRLE------------ISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTAL 501
S L+ + + + + V+ A +L T+ L L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL---TVLCHLEQL 462
Query: 502 PSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQ 561
+T L L N+L +LP + + + L L S N L + + LP LQ+L L N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519
Query: 562 FSG-KIPPQIGRLM-LTSLNLSSNRLT 586
+ L LNL N L
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 38/200 (19%), Positives = 65/200 (32%), Gaps = 28/200 (14%)
Query: 411 LMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--NLSRLEISNNRFSG 468
L N+ + +WTG + + + L R E+S + S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-ST 362
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDII----- 523
+ + + S K L + N TI + AL L S +D +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 524 ----------------SWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIP 567
+ + L+L+ L+ + + L ++ LDLS N+ +P
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALP 479
Query: 568 PQIGRL-MLTSLNLSSNRLT 586
P + L L L S N L
Sbjct: 480 PALAALRCLEVLQASDNALE 499
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 56/252 (22%), Positives = 89/252 (35%), Gaps = 85/252 (33%)
Query: 694 VIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRK-LDQKHEKEFLAEVQILSTIRHL--- 747
+G G GKV I+H VAVK + N + + +E+Q+L +
Sbjct: 21 TLGEGAFGKVVEC-IDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQVLEHLNTTDPN 74
Query: 748 ---NIVKLLC--------CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
V++L CI E L L Y+++++ L
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKEN---------GFLPFR-------LD 118
Query: 797 WRRRM--QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-------------- 840
R+M QI + + ++H + H DLK NIL +
Sbjct: 119 HIRKMAYQIC----KSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 841 -----KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE------YARTRKVNEKTDIYS 889
K+ DFG A + E ST+V + Y APE + ++ D++S
Sbjct: 172 INPDIKVVDFGSATY----DDEH--HSTLVSTRHYRAPEVILALGW------SQPCDVWS 219
Query: 890 FGVILLELTTGK 901
G IL+E G
Sbjct: 220 IGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 53/252 (21%), Positives = 82/252 (32%), Gaps = 85/252 (33%)
Query: 694 VIGSGGSGKVYRVPINHTA-EVVAVKKIWNDRK-LDQKHEKEFLAEVQILSTIRHL---- 747
+G G GKV + VA+K I N K + E+ +L I+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKEKDKEN 80
Query: 748 --NIVKLLC--------CISSENLKLLVYEYMEKRSLDQWLHKKNR-SSLSGRARDEVLS 796
V + CI+ E L +E++ K+N L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL----------KENNFQPYP-------LP 123
Query: 797 WRRRM--QIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNA-------------- 840
R M Q+ L ++H + + H DLK NIL +
Sbjct: 124 HVRHMAYQLC----HALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 841 -----KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPE------YARTRKVNEKTDIYS 889
++ADFG A + E +T+V + Y PE + + D++S
Sbjct: 177 KNTSIRVADFGSATF----DHEH--HTTIVATRHYRPPEVILELGW------AQPCDVWS 224
Query: 890 FGVILLELTTGK 901
G IL E G
Sbjct: 225 IGCILFEYYRGF 236
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 11/120 (9%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLK 217
+P I R +L L NQF +P E+ N ++L ++L+ N S+L + F+ +
Sbjct: 25 LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNN---RISTLSNQSFSNMT 78
Query: 218 KLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
+L L + S N + IP D L L L L N+ + +P F L LS + + +N
Sbjct: 79 QLLTLIL-SYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 8/105 (7%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV-ESL-NLKVIDLSANNLTGA 303
L L N FT +P + K+L+ + L +N +S + ++ L + LS N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 304 IPND-FGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
IP F L++L LSL N +S +PEG L +L + + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/72 (31%), Positives = 33/72 (45%), Gaps = 6/72 (8%)
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--L 549
+P EL+ LT + L N++S +L + L L LS N+L IP + F L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRT-FDGL 101
Query: 550 PVLQDLDLSENQ 561
L+ L L N
Sbjct: 102 KSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 5/111 (4%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
VTEL+L + N P + + ++LT++DL N I + + N ++L L LS N
Sbjct: 32 DVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR- 89
Query: 132 IGPIPEDI-DRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVVNQFN 180
+ IP D L L+ L L N++S +P L+ L L + N
Sbjct: 90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 23/116 (19%)
Query: 458 RLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPS--------LTTLLL 509
L + N+F+ +P +S+ K+L + SNN ++ L + L TL+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNN--------RISTLSNQSFSNMTQLLTLIL 85
Query: 510 DQNQLSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--LPVLQDLDLSENQF 562
N+L +P KSL L+L N +S +PE F L L L + N
Sbjct: 86 SYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGA-FNDLSALSHLAIGANPL 138
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 17/96 (17%), Positives = 38/96 (39%), Gaps = 3/96 (3%)
Query: 208 SLPSNFTQLKKLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFTGSIPSSVF-KLK 265
+ + L +L++ + + + + + L L + + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT 301
LS++ L N+L + V+ L+L+ + LS N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEI-PETIGD 239
+ +NL L + L L +L+ L + + + + P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHL--QHLELRDLRGLGELRNLTI-VKSGLRFVAPDAFHF 78
Query: 240 MLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSL 277
L L+LS N S+ + +L ++ L N L
Sbjct: 79 TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 24/96 (25%), Positives = 34/96 (35%), Gaps = 3/96 (3%)
Query: 493 TIPGELTALPSLTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGEIPEKI-GFLP 550
L +LT L ++ Q L L + L L + ++ L + F P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 551 VLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLT 586
L L+LS N + L L L LS N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 3/95 (3%)
Query: 256 SIPSSVFKLKNLSKVYLYSNSLSGEIP-QAVESL-NLKVIDLSANNLTGAIPNDFGKLEN 313
+ +NL+++Y+ + + + + L L+ + + + L P+ F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 314 LLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
L L+L FN L + SL+++ L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 5/115 (4%)
Query: 68 CTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPR-VLYNCSKLEYLDL 126
C + L T + NLT L ++ + L +L L +
Sbjct: 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 127 SQNYFIGPIPEDI-DRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
++ + + D RL L L+ N + + + L++L L N +
Sbjct: 64 VKSG-LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 5/112 (4%)
Query: 502 PSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIP-EKIGFLPVLQDLDLSEN 560
P ++ L + + ++LT L + Q + + L L++L + ++
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 561 QFSGKIPPQIGRLM--LTSLNLSSNRLTGEIPSQFENRAYASSFL-NNPGLC 609
+ P L+ LNLS N L + + L NP C
Sbjct: 67 GLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 22/85 (25%), Positives = 28/85 (32%), Gaps = 2/85 (2%)
Query: 455 NLSRLEISNNRFSGKIPTGV-SSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
NL+ L I N + + L + P P L+ L L N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91
Query: 514 LSGSLPLDIISWKSLTALNLSRNQL 538
L SL + SL L LS N L
Sbjct: 92 LE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 3/114 (2%)
Query: 89 PFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIP-EDIDRLSRLKF 147
P C + L + + L L L + + + D+ L L+
Sbjct: 2 PDACCPHGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 148 LYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYN 201
L + + + P + L +LNL N S+ + +L+ L L+ N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 23/117 (19%), Positives = 38/117 (32%), Gaps = 5/117 (4%)
Query: 282 PQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEG-IGLLPSLKD 340
P A + + + + ENL L + Q + + L L++
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 341 VRLFNNMLSGALPPD-FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396
+ + + L + PD F L +S N L SL G L + N L
Sbjct: 61 LTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 1e-08
Identities = 21/156 (13%), Positives = 57/156 (36%), Gaps = 18/156 (11%)
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSS-----KNLVVFQASNNLFNGTIPGELTAL 501
+ K NL LEI + + + S + LV++ + L
Sbjct: 186 SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245
Query: 502 ------PSLTTLLLDQNQLSGSLPLDIIS---WKSLTALNLSRNQLSGE----IPEKIGF 548
P+L L + + + + L +++S L+ E + + +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305
Query: 549 LPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNR 584
+ L+ +++ N S ++ ++ + + +++S ++
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 37/194 (19%), Positives = 65/194 (33%), Gaps = 30/194 (15%)
Query: 109 SQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIG--RL 166
VL L L + + LK L + + + + I L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 167 TELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMAS 226
L +L L V + ++ + L FS P LK L +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPL----------FSKDRFP-------NLKWLGIVD 261
Query: 227 TNLIGEIPETIGD---MLALEFLDLSINNFTGS----IPSSVFKLKNLSKVYLYSNSLSG 279
+ E + + LE +D+S T + V K+K+L + + N LS
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
Query: 280 EIPQAV-ESLNLKV 292
E+ + + +SL +K+
Sbjct: 322 EMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 6e-06
Identities = 35/183 (19%), Positives = 66/183 (36%), Gaps = 25/183 (13%)
Query: 179 FNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIG 238
+ + + L L++ S P LK L + S L + E I
Sbjct: 160 EQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRP-----NLKSLEIISGGLPDSVVEDIL 214
Query: 239 DML--ALEFLDLSI--NNFTGSIPSSVF-------KLKNLSKVYLYSNSLSGEIPQAVES 287
LE L L + ++ +VF + NL + + + +
Sbjct: 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274
Query: 288 L----NLKVIDLSANNLTG----AIPNDFGKLENLLNLSLMFNQLSGEIPEGIG-LLPSL 338
L+ +D+SA LT + + K+++L +++ +N LS E+ + + LP
Sbjct: 275 SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334
Query: 339 KDV 341
DV
Sbjct: 335 IDV 337
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 52/291 (17%), Positives = 94/291 (32%), Gaps = 58/291 (19%)
Query: 91 ICDLRNLTILDLQFNYI----ISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDID------ 140
+ + ++ + L N I + + LE + S F G + ++I
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLL 86
Query: 141 -----RLSRLKFLYLTANNMSGKIPASIGRL----TELRQLNLVVNQF------------ 179
+ +L + L+ N + T L L L N
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 180 -NGSIPAEIGNLQNLEALELAYN--TEFSPSSLPSNFTQLKKLKKLWMASTNLIGE--IP 234
++ + N L ++ N S F + L + M N I I
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM-VQNGIRPEGIE 205
Query: 235 ETIGDMLA----LEFLDLSINNFTG----SIPSSVFKLKNLSKVYLYSNSLS-------G 279
+ + LA L+ LDL N FT ++ ++ NL ++ L LS
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 280 EIPQAVESLNLKVIDLSANNLTGAIPNDFG-----KLENLLNLSLMFNQLS 325
+ +E++ L+ + L N + K+ +LL L L N+ S
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/320 (16%), Positives = 103/320 (32%), Gaps = 68/320 (21%)
Query: 94 LRNLTI--LDLQFNYI----ISQFPRVLYNCSKLEYLDLSQNYF-------IGPIPEDID 140
+ +I L+ + I VL ++ + LS N +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 141 RLSRLKFLYLTANNMSGKIPASIGRLTE-------LRQLNLVVNQFNGSIPAEIGNL--- 190
L +F + + +IP ++ L + L + L N F + + +
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 191 -QNLEALELAYN--------------TEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP- 234
LE L L N E + + N L+ + + N +
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI----ICGRNRLENGSM 176
Query: 235 ETIGDMLA----LEFLDLSINNFT-----GSIPSSVFKLKNLSKVYLYSNSLSGE----I 281
+ L + + N + + + L + L N+ + +
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236
Query: 282 PQAVESL-NLKVIDLSANNLTG----AIPNDFGKLEN--LLNLSLMFNQLSGE----IPE 330
A++S NL+ + L+ L+ A+ + F KLEN L L L +N++ + +
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296
Query: 331 GIGL-LPSLKDVRLFNNMLS 349
I +P L + L N S
Sbjct: 297 VIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 40/255 (15%), Positives = 84/255 (32%), Gaps = 53/255 (20%)
Query: 386 LAGIAAQDNNLSGE----LPESLGNCSSLLMVKIYNNSFTGN----IPAGLWTGFNLSMV 437
+ G + + + ++ E + L S+ + + N+ + + + +L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 438 LISDNLFTGELPD-------------KMSGNLSRLEISNNRFSGK----IPTGVSSSKNL 480
SD FTG + D L + +S+N F + +S L
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 481 VVFQASNN-------------LFNGTIPGELTALPSLTTLLLDQNQLSG----SLPLDII 523
NN L + + P L +++ +N+L
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 524 SWKSLTALNLSRNQLSGE-----IPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM---- 574
S + L + + +N + E + E + + L+ LDL +N F+ + +
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 575 -LTSLNLSSNRLTGE 588
L L L+ L+
Sbjct: 245 NLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 56/338 (16%), Positives = 98/338 (28%), Gaps = 64/338 (18%)
Query: 288 LNLKVIDLSANNLTG----AIPNDFGKLENLLNLSLMFNQLSGE----IPEGIGLLPSLK 339
+++ L + +T ++ + +++ + L N + E + E I L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 340 DVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGE 399
+ GR + L + L KL + DN
Sbjct: 64 IAEFSDIFT--------GRVKDEIPEALR------LLLQALLKCPKLHTVRLSDNAFGPT 109
Query: 400 ----LPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGN 455
L + L + L + ++NN P I+ L + K
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLG---PQA--------GAKIARALQELAVNKKAKNA 158
Query: 456 --LSRLEISNNRFSGK----IPTGVSSSKNLVVFQASNNLFN-----GTIPGELTALPSL 504
L + NR S + L + N + L L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 505 TTLLLDQNQLS--GSLPL--DIISWKSLTALNLSRNQLSGE----IPE--KIGFLPVLQD 554
L L N + GS L + SW +L L L+ LS + + LQ
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 555 LDLSENQFSGKIPPQIGRLM------LTSLNLSSNRLT 586
L L N+ + ++ L L L+ NR +
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 38/259 (14%), Positives = 76/259 (29%), Gaps = 55/259 (21%)
Query: 72 SVTELHLTNMNMNGTFPPF----------ICDLRNLTILDLQFNYI----ISQFPRVLYN 117
+ +++ + L + L N L
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 118 CSKLEYLDLSQNYFIGP--------------IPEDIDRLSRLKFLYLTANNMSGK----I 159
+ LE+L L N +GP + + L+ + N +
Sbjct: 121 HTPLEHLYLHNNG-LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 160 PASIGRLTELRQLNLVVNQFN-----GSIPAEIGNLQNLEALELAYNTEFSP---SSLPS 211
+ L + +V N + + Q L+ L+L NT F+ S+L
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-FTHLGSSALAI 238
Query: 212 NFTQLKKLKKLWMASTNLIGEI-PETIGDMLA------LEFLDLSINNFTG----SIPSS 260
L++L + + L+ + D + L+ L L N ++ +
Sbjct: 239 ALKSWPNLRELGL-NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 261 VF-KLKNLSKVYLYSNSLS 278
+ K+ +L + L N S
Sbjct: 298 IDEKMPDLLFLELNGNRFS 316
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLK 217
+P I + +L L N+ L L L L+ N SLP F +L
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN---QIQSLPDGVFDKLT 76
Query: 218 KLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
KL L++ N + +P + D L L+ L L N S+P +F +L +L K++L++N
Sbjct: 77 KLTILYL-HENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 43/144 (29%), Positives = 62/144 (43%), Gaps = 35/144 (24%)
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA-LEFLDLSINNFTGSIPSSVF-K 263
P+ +PS+ +L + +N + +P + D L L L LS N S+P VF K
Sbjct: 23 PTGIPSS-AT-----RLEL-ESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74
Query: 264 LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
L L+ +YL+ N L +P V F KL L L+L NQ
Sbjct: 75 LTKLTILYLHENKLQ-SLPNGV----------------------FDKLTQLKELALDTNQ 111
Query: 324 LSGEIPEGI-GLLPSLKDVRLFNN 346
L +P+GI L SL+ + L N
Sbjct: 112 LKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 26/70 (37%), Positives = 33/70 (47%), Gaps = 6/70 (8%)
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDII-SWKSLTALNLSRNQLSGEIPEKIGF--LPV 551
G L LT L L QNQ+ SLP + LT L L N+L +P + F L
Sbjct: 45 HGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGV-FDKLTQ 101
Query: 552 LQDLDLSENQ 561
L++L L NQ
Sbjct: 102 LKELALDTNQ 111
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 71/371 (19%), Positives = 121/371 (32%), Gaps = 120/371 (32%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN------ 748
+G G V+ + VA+K + K + + + L E+++L ++R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 749 --IVKLLCC--ISSENLK--LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
+V+LL IS N +V+E + L +W+ ++ + L +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII---------KSNYQGLPLPCVKK 150
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN------------------------- 837
I QGL Y+H C I+H D+K NILL N
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 838 ------------------------FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
KIAD G A + K + + + Y +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL 262
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGK---EANNGDEHTC----LAQ-----------W 915
E N DI+S + EL TG E ++G+E+T +A
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 916 A---------------WRHIQEGKPIVDALDKEIDEPCFL--EEMIRVFKLGVICTSMLP 958
+HI + KP L + + E EE + ++P
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPW--GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 959 TERPNMRMVLQ 969
+R L+
Sbjct: 381 EKRATAAECLR 391
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 23/159 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ-KHEKEFLAEVQILSTIRHLNIVKLL 753
IGSG G++Y T E VA+K K Q +E + +IL I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIY---RILQGGTG--IPNVR 69
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +LV + + SL+ + +R LS + + +A + +
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK----------LSLKTVLMLADQMINRVEF 118
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAK---IADFGVAK 849
+H S + +HRD+K N L+ A I DFG+AK
Sbjct: 119 VH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 23/159 (14%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ-KHEKEFLAEVQILSTIRHLNIVKLL 753
IGSG G +Y E VA+K K Q E + +++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY---KMMQGGVG--IPTIR 71
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
C + + ++V E + SL+ + +R S + + +A + Y
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNFCSRK----------FSLKTVLLLADQMISRIEY 120
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAK---IADFGVAK 849
+H S +HRD+K N L+ I DFG+AK
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 23/105 (21%), Positives = 40/105 (38%), Gaps = 5/105 (4%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
+ LDL+ Y I + + + +D S N I + + L RLK L +
Sbjct: 17 NAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNE-IRKL-DGFPLLRRLKTLLVNN 73
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALE 197
N + L +L +L L N ++ L +L++L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLT 116
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 22/119 (18%), Positives = 45/119 (37%), Gaps = 7/119 (5%)
Query: 185 AEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALE 244
A+ N L+L +L + Q + S N I ++ + + L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQ---FDAIDF-SDNEIRKL-DGFPLLRRLK 67
Query: 245 FLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS--GEIPQAVESLNLKVIDLSANNLT 301
L ++ N L +L+++ L +NSL G++ +L + + N +T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 14/127 (11%)
Query: 226 STNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV 285
+ LI + + + + LDL I + L + N + +
Sbjct: 5 TAELIEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KL 57
Query: 286 ESL----NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS--GEIPEGIGLLPSLK 339
+ LK + ++ N + L +L L L N L G++ + + L SL
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLT 116
Query: 340 DVRLFNN 346
+ + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 5/63 (7%)
Query: 94 LRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLS---RLKFLYL 150
LR L L + N I + L L L+ N + + D+D L+ L +L +
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-SLVEL-GDLDPLASLKSLTYLCI 120
Query: 151 TAN 153
N
Sbjct: 121 LRN 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 28/171 (16%)
Query: 186 EIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEF 245
+ E +EL + + + + LK K L + STN I +I ++ M L
Sbjct: 18 KSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLAL-STNNIEKI-SSLSGMENLRI 74
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSN---SLSGEIPQAVESL-NLKVIDLSANNLT 301
L L N I + L ++++ N SLSG +E L NL+V+ +S N +T
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKIT 128
Query: 302 GAIPNDFGKLE---NLLNLSLMFNQLSGEIPEG----------IGLLPSLK 339
+ KL L +L L N L + E + LP+LK
Sbjct: 129 N--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 35/163 (21%), Positives = 54/163 (33%), Gaps = 35/163 (21%)
Query: 92 CDLRNLTILDLQFNYI-ISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
++L I + L ++L LS N I I + + L+ L L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN-IEKI-SSLSGMENLRILSL 77
Query: 151 TANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLP 210
N + KI L +L + NQ I +L +E
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQ--------IASLSGIE---------------- 112
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPE--TIGDMLALEFLDLSIN 251
+L L+ L+M S N I E + + LE L L+ N
Sbjct: 113 ----KLVNLRVLYM-SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 4/90 (4%)
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYL 150
+ + NL IL L N I + + LE L +S N I + I++L L+ LY+
Sbjct: 66 LSGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQ-IASL-SGIEKLVNLRVLYM 122
Query: 151 TANNMSG-KIPASIGRLTELRQLNLVVNQF 179
+ N ++ + L +L L L N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 494 IPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ 553
+ L+ L + L L N + L + ++L L+L RN + +I L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGM--ENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 554 DLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLT 586
+L +S NQ + + + L L +S+N++T
Sbjct: 97 ELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/108 (22%), Positives = 49/108 (45%), Gaps = 13/108 (12%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL----NLKVIDLSANNLT 301
L I + +++ LK + L +N++ + SL NL+++ L N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK 83
Query: 302 GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS 349
I N + L L + +NQ++ + GI L +L+ + + NN ++
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 32/173 (18%), Positives = 62/173 (35%), Gaps = 31/173 (17%)
Query: 695 IGSGGSGKVY--------RVPINHTAEVVAVK------KIWNDRKLDQKHEKEFLAEV-Q 739
G +Y + ++K +++N++ Q+ K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 740 ILSTIRHLNIVKLLCCISSENL-KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
L + L I + ++ + LV + RSL L + LS R+ VL
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLG-RSLQSALDVSPKHVLSERS---VL--- 162
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI--ADFGVAK 849
Q+A L ++H VH ++ + NI +D +++ A +G A
Sbjct: 163 ---QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 8/110 (7%)
Query: 72 SVTELHLTNMNMN-GTFPPFICDLRNLTILDLQFNYI--ISQFPRVLYNCSKLEYLDLSQ 128
+V EL L N N G + NL L L + +S P KL+ L+LS+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSE 80
Query: 129 NYFIGPIPEDIDRLSRLKFLYLTANNMSG-KIPASIGRLTELRQLNLVVN 177
N G + ++L L L L+ N + + +L L+ L+L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 6/117 (5%)
Query: 447 ELPDKMSGNLSRLEISNNRFS-GKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT 505
EL ++ + L + N + + GKI + NL N ++ L LP L
Sbjct: 17 ELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLK 74
Query: 506 TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLS--GEIPEKIGFLPVLQDLDLSEN 560
L L +N++ G L + +LT LNLS N+L + E + L L+ LDL
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 25/111 (22%), Positives = 48/111 (43%), Gaps = 5/111 (4%)
Query: 92 CDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151
+R L + + + N + + LE+L L + + ++ +L +LK L L+
Sbjct: 24 AAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVG-LISV-SNLPKLPKLKKLELS 79
Query: 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNG-SIPAEIGNLQNLEALELAYN 201
N + G + +L L LNL N+ S + L+ L++L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 7/117 (5%)
Query: 228 NLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES 287
+ G+I + + LEFL L N S+ S++ KL L K+ L N + G + E
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLI-NVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 288 L-NLKVIDLSANNLTG-AIPNDFGKLENLLNLSLMFNQLSGEI---PEGIGLLPSLK 339
L NL ++LS N L + KLE L +L L +++ LLP L
Sbjct: 94 LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLT 150
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 6/99 (6%)
Query: 275 NSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGL 334
L P AV L L D +N G I + NL LSL+ L + +
Sbjct: 16 LELRNRTPAAVRELVL---DNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPK 69
Query: 335 LPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLT 373
LP LK + L N + G L + L + +S N L
Sbjct: 70 LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 245 FLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAI 304
LD +N G I + NL + L + L + + LK ++LS N + G +
Sbjct: 30 VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGL 87
Query: 305 PNDFGKLENLLNLSLMFNQLS--GEIPEGIGLLPSLKDVRLFNN 346
KL NL +L+L N+L + E + L LK + LFN
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 27/99 (27%), Positives = 38/99 (38%), Gaps = 8/99 (8%)
Query: 492 GTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV 551
G I G +L L L L L + L L LS N++ G + LP
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISVSNLPKL--PKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 552 LQDLDLSENQFSGKIPPQIGRL----MLTSLNLSSNRLT 586
L L+LS N+ + L L SL+L + +T
Sbjct: 97 LTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 10/130 (7%)
Query: 154 NMSGKIPASIG--RLTELRQLNLVVNQFN-GSIPAEIGNLQNLEALELAYNTEFSPSSLP 210
+M +I + +R+L L + N G I NLE L L S+
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV---GLISV- 64
Query: 211 SNFTQLKKLKKLWMASTNLIGEIPETIGDML-ALEFLDLSINNFTG-SIPSSVFKLKNLS 268
SN +L KLKKL ++ N I + + + L L L+LS N S + KL+ L
Sbjct: 65 SNLPKLPKLKKLELSE-NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
Query: 269 KVYLYSNSLS 278
+ L++ ++
Sbjct: 124 SLDLFNCEVT 133
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDM 240
S+PA I + + L L N + L F L L++L+ ++N + IP + D
Sbjct: 26 SVPAGI--PTDKQRLWLNNN---QITKLEPGVFDHLVNLQQLYF-NSNKLTAIPTGVFDK 79
Query: 241 LA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
L L LDL+ N+ SIP F LK+L+ +YLY+N
Sbjct: 80 LTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 33/105 (31%), Positives = 41/105 (39%), Gaps = 27/105 (25%)
Query: 244 EFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTG 302
+ L L+ N T + VF L NL ++Y SN L+ IP V
Sbjct: 36 QRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGV----------------- 76
Query: 303 AIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
F KL L L L N L IP G L SL + L+NN
Sbjct: 77 -----FDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 10/97 (10%)
Query: 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSN-FTQLKKLKKLWMASTNLIGEIPETIGDM 240
S+P I + L L N + L F +L +L +L + N + +P + D
Sbjct: 23 SVPTGI--PTTTQVLYLYDN---QITKLEPGVFDRLTQLTRLDL-DNNQLTVLPAGVFDK 76
Query: 241 LA-LEFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSN 275
L L L L+ N SIP F LK+L+ ++L +N
Sbjct: 77 LTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 32/105 (30%), Positives = 42/105 (40%), Gaps = 27/105 (25%)
Query: 244 EFLDLSINNFTGSIPSSVF-KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTG 302
+ L L N T + VF +L L+++ L +N L+ +P V
Sbjct: 33 QVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGV----------------- 73
Query: 303 AIPNDFGKLENLLNLSLMFNQLSGEIPEGI-GLLPSLKDVRLFNN 346
F KL L LSL NQL IP G L SL + L NN
Sbjct: 74 -----FDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 29/161 (18%), Positives = 52/161 (32%), Gaps = 25/161 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH-LNIVKLL 753
IG G G ++ + VA+K Q + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-----EYRTYKLLAGCTGIPNVY 72
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+LV + + SL+ L R S + A +
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQS 121
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAK-----IADFGVAK 849
+H ++V+RD+K N L+ + + DFG+ K
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 35/161 (21%), Positives = 60/161 (37%), Gaps = 25/161 (15%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH-LNIVKLL 753
IG G G++ +T E VA+K + Q H E + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-----EYRFYKQLGSGDGIPQVY 71
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+V E + SL+ +R+ S + + IA+ + Y
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEY 120
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAK-----IADFGVAK 849
+H S +++RD+K N L+ N I DF +AK
Sbjct: 121 VH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 25/111 (22%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 93 DLRNLTILDLQFNYI-ISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151
++ L L + + + +LE+L + I ++ +L++LK L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSI-ANLPKLNKLKKLELS 72
Query: 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNG-SIPAEIGNLQNLEALELAYN 201
N +SG + + L LNL N+ S + L+NL++L+L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 28/114 (24%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 165 RLTELRQLNLVVNQFN-GSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLW 223
+++++L L ++ N G + + LE L +S+ +N +L KLKKL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV---GLTSI-ANLPKLNKLKKLE 70
Query: 224 MASTNLIGEIPETIGDML-ALEFLDLSINNFTG-SIPSSVFKLKNLSKVYLYSN 275
++ N + E + + L L+LS N S + KL+NL + L++
Sbjct: 71 LSD-NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 3/102 (2%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIP 305
LD S +N G + + + L + + L+ I + LK ++LS N ++G +
Sbjct: 24 LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLE 81
Query: 306 NDFGKLENLLNLSLMFNQLSG-EIPEGIGLLPSLKDVRLFNN 346
K NL +L+L N++ E + L +LK + LFN
Sbjct: 82 VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 10/101 (9%)
Query: 491 NGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW-KSLTALNLSRNQLSGEIPEKIGFL 549
G + G L L L+ + + L L LS N++SG +
Sbjct: 31 EGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDNRVSGGLEVLAEKC 87
Query: 550 PVLQDLDLSENQFSGKIPPQIGRL----MLTSLNLSSNRLT 586
P L L+LS N+ I L L SL+L + +T
Sbjct: 88 PNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 35/192 (18%), Positives = 63/192 (32%), Gaps = 11/192 (5%)
Query: 68 CTDGSVTELHLTNMNMN-GTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDL 126
+ V + L+N + T + L L L+ + L S L L+L
Sbjct: 90 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149
Query: 127 SQNYFI--GPIPEDIDRLSRLKFLYL------TANNMSGKIPASIGRLTELRQLNLVVNQ 178
S + + SRL L L T ++ + +T+L N
Sbjct: 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 209
Query: 179 FNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEI-PETI 237
+ + NL L+L+ + F QL L+ L ++ I +
Sbjct: 210 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF-QEFFQLNYLQHLSLSRCYDIIPETLLEL 268
Query: 238 GDMLALEFLDLS 249
G++ L+ L +
Sbjct: 269 GEIPTLKTLQVF 280
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 35/190 (18%), Positives = 78/190 (41%), Gaps = 14/190 (7%)
Query: 142 LSRLKFLYLTANNMSGK-IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAY 200
R++ + L+ + + + + + ++L+ L+L + + I + NL L L+
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 201 NTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA-----LEFLDLS--INNF 253
+ FS +L + + +L +L ++ E + + +A + L+LS N
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTE--KHVQVAVAHVSETITQLNLSGYRKNL 209
Query: 254 T-GSIPSSVFKLKNLSKVYL-YSNSLSGEIPQAVESL-NLKVIDLSA-NNLTGAIPNDFG 309
+ + V + NL + L S L + Q L L+ + LS ++ + G
Sbjct: 210 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269
Query: 310 KLENLLNLSL 319
++ L L +
Sbjct: 270 EIPTLKTLQV 279
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 69/515 (13%), Positives = 155/515 (30%), Gaps = 64/515 (12%)
Query: 95 RNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANN 154
R + I + V+ K+ ++L D + ++ A
Sbjct: 46 RKVFIGNCYA----VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA-- 99
Query: 155 MSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFT 214
+ +S L E+R +VV + + + +N + L L+ FS L +
Sbjct: 100 ----MSSSYTWLEEIRLKRMVVT--DDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAA 153
Query: 215 QLKKLKKLWMASTNLIGEIPETIGDML----ALEFLDLSI--NNFTGSIPSSVFK-LKNL 267
+ LK+L + +++ + +L L++S + + S + NL
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNL 213
Query: 268 SKVYL-YSNSLSGEIPQAVESLNLKVIDLSA------NNLTGAIPNDFGKLENLLNLSLM 320
+ L + L + L+ + ++ + + L LS
Sbjct: 214 KSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGF 273
Query: 321 FNQLSGEIPEGIGLLPSLKDVRL-FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEH 379
++ + +P + L + L + + S L + L+ V + + + E
Sbjct: 274 WDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-DYIEDAGLEV 332
Query: 380 LCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLI 439
L + K ++ + P + +L ++ G L VL
Sbjct: 333 LASTCK----DLRELRVFPSEPFVMEPNVAL------TEQGLVSVSMGCP---KLESVLY 379
Query: 440 SDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELT 499
T ++ N + + + + + +
Sbjct: 380 FCRQMTNAALITIARNRPNMTRFR----------LCIIEPKAPDYLTLEPLDIGFGAIVE 429
Query: 500 ALPSLTTLLLDQNQLSGSLPLDIIS-----WKSLTALNLSRNQLSGEIPEKIG-FLPVLQ 553
L L LSG L + K + L+++ S + L+
Sbjct: 430 HCKDLRRL-----SLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484
Query: 554 DLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRLT 586
L++ + F K + + SL +SS ++
Sbjct: 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 37/235 (15%), Positives = 79/235 (33%), Gaps = 27/235 (11%)
Query: 94 LRNLTILDLQFNYIISQFPRVLY----NCSKLEYLDLSQNYFI---GPIPEDIDRLSRLK 146
RNL LDL+ + + L + L L++S + + R LK
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 147 FLYLTANNMSGKIPASIGRLTELRQLNL------VVNQFNGSIPAEIGNLQNLEALELAY 200
L L K+ + R +L +L V + + + L L+
Sbjct: 215 SLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL--RCLSG 272
Query: 201 NTEFSPSSLPSNFTQLKKLKKLWMASTNLIGE-IPETIGDMLALEFLDLSINNFTGSIPS 259
+ P+ LP+ ++ +L L ++ + + + + L+ L + +
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEV 332
Query: 260 SVFKLKNLSKVYLYSNSLSGEIP------QAVESL-----NLKVIDLSANNLTGA 303
K+L ++ ++ + P Q + S+ L+ + +T A
Sbjct: 333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA 387
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 48/282 (17%), Positives = 95/282 (33%), Gaps = 53/282 (18%)
Query: 95 RNLTILDLQFNYIISQFPRVL-----YNCSKLEYLDLSQNYFIGPIPEDIDRLSR----- 144
+T LDL N + S L + + L+LS N +G ++ D L +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS-LG--FKNSDELVQILAAI 78
Query: 145 ---LKFLYLTANNMSGKIPASIGRL-----TELRQLNLVVNQFNGSIPAEIGNL-----Q 191
+ L L+ N +S K + + + L+L N F+ +E
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 192 NLEALELAYN--TEFSPSSLPSNFTQL-KKLKKLWMASTNLIGEIP-ETIGDMLA----- 242
++ +L L N S L + + L + N + + LA
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNL-RGNNLASKNCAELAKFLASIPAS 197
Query: 243 LEFLDLSINNFT--GSIP-SSVFKLKN--LSKVYLYSNSLSGEIPQAVESL-----NLKV 292
+ LDLS N + +F + + L N L G + ++ L +L+
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 293 IDLSANNLTG-------AIPNDFGKLENLLNLSLMFNQLSGE 327
+ L + + A+ F ++ ++ + ++
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 45/285 (15%), Positives = 92/285 (32%), Gaps = 53/285 (18%)
Query: 114 VLYNCSKLEYLDLSQNYFIGPIPEDIDRLSR--------LKFLYLTANNMSGKIPASIGR 165
+ LDLS N + L + + L L+ N++ K + +
Sbjct: 17 FTSIPHGVTSLDLSLNN-LY--SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73
Query: 166 L-----TELRQLNLVVNQFNGSIPAEIGNL-----QNLEALELAYN--TEFSPSSLPSNF 213
+ + LNL N + E+ + L+L +N + S S F
Sbjct: 74 ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133
Query: 214 TQL-KKLKKLWMASTNLIGEIP-ETIGDMLA-----LEFLDLSINNFT---GSIPSSVFK 263
+ L + L + N +G + + +LA + L+L NN + +
Sbjct: 134 SNLPASITSLNL-RGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 264 LKN--LSKVYLYSNSLSGE----IPQAVESLN--LKVIDLSANNLTG----AIPNDFGKL 311
++ + L +N L + + S+ + ++L N L G + L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 312 ENLLNLSLMFNQLSGEIPEGIGLL-------PSLKDVRLFNNMLS 349
++L + L ++ + E L + V +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 36/172 (20%), Positives = 60/172 (34%), Gaps = 32/172 (18%)
Query: 695 IGSGGSGKVYRVPINHTAEVVAVK--KIWNDRKLDQKHEKEFLAEVQ---------ILST 743
IGSGG G +Y + E A K+ E +F V
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 744 IRHLNIVKLLCC----ISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
+ +L I + + +V E + L + + S VL
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKST-----VL---- 154
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI--ADFGVAK 849
Q+ + L Y+H VH D+K++N+LL Y ++ AD+G++
Sbjct: 155 --QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 75/525 (14%), Positives = 156/525 (29%), Gaps = 77/525 (14%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
D + + Y + R+ L L L P + L +
Sbjct: 48 DSETREHVTMALCYTAT-PDRLSRRFPNLRSLKLKGK----PRAAMFN-LIPENWGGYVT 101
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN 212
++ +I ++ +L + ++V+ +LE L+L + F+ L S
Sbjct: 102 PWVT-EISNNLRQLKSVHFRRMIVSD-LDLDRLAKARADDLETLKLDKCSGFTTDGLLSI 159
Query: 213 FTQLKKLKKLWMASTNLIGEIPETIGDMLA----LEFLDLSINNFTG----SIPSSVFKL 264
T +K+K L M ++ + + + ++ LE L+ + F + +
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219
Query: 265 KNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQL 324
++L V + + + + NL+ + N +P + L L +
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 325 SG--EIPEGIGLLPSLKDVRL-FNNMLSGALPPDFGRYSPLEYFEV-------SVNNLTG 374
G E+P ++ + L + + + + LE E + L
Sbjct: 280 MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQ 339
Query: 375 SLPE----HLCAGGKLAGIAAQDNNLSGELPESLG-NCSSLLMVKIYNNSFTGNIPAGLW 429
+ + G G+ ++ +S +L C L + +Y + T
Sbjct: 340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT-------- 391
Query: 430 TGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNL 489
N S+ I L NL + +I ++
Sbjct: 392 ---NESLESIGTYL----------KNLCDFRLVLLDREERI---------------TDLP 423
Query: 490 FNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIIS-----WKSLTALNLSRNQLSGEIPE 544
+ + L L G L +S ++ + L S E
Sbjct: 424 LDNGVRSLLIGCKKLRRFAFYLR--QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481
Query: 545 KIGF-LPVLQDLDLSENQFSGKIPPQIGRLM--LTSLNLSSNRLT 586
+ P LQ L++ FS + + L L + R +
Sbjct: 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1014 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-62
Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IGSG G VY+ + VAVK + N + + F EV +L RH+NI+
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ ++ L +V ++ E SL LH + + IA AQG+
Sbjct: 70 MGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK----------FEMIKLIDIARQTAQGMD 118
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I+HRDLKS+NI L + KI DFG+A + + G + GS ++A
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMA 174
Query: 873 PEYARTRK---VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929
PE R + + ++D+Y+FG++L EL TG+ + + + G D
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIFMVGRGYLSPDL 231
Query: 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ P ++ ++ C ERP +L +
Sbjct: 232 SKVRSNCPKAMKRLMAE------CLKKKRDERPLFPQILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-60
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 20/251 (7%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+ +G+G G V++V + V+A K I ++ + + E+Q+L IV
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
S+ + E+M+ SLDQ L K R + + ++++ +GL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----------IPEQILGKVSIAVIKGLT 118
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+ I+HRD+K SNIL++ K+ DFGV+ LI ++ VG+ Y++
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE + + ++DI+S G+ L+E+ G+ + L ++ +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 933 EIDEPCFLEEM 943
P M
Sbjct: 232 TPGRPLSSYGM 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG+G G+ ++ +++ K++ + + + ++ ++EV +L ++H NIV+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 753 LCCISSENLKLL--VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
I L V EY E L + K + + L +++
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-------ERQYLDEEFVLRVMTQLTLA 121
Query: 811 LCYMH--HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L H D T++HRDLK +N+ LD N K+ DFG+A+IL + VG+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTP 178
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
Y++PE NEK+DI+S G +L EL + I+EGK
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKF--R 232
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ + L E+I ++ RP++ +L+
Sbjct: 233 RIPYRYSDE--LNEIITR------MLNLKDYHRPSVEEILE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-59
Identities = 66/279 (23%), Positives = 124/279 (44%), Gaps = 33/279 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G+G G+V+ + VAVK + K FLAE ++ ++H +V+L
Sbjct: 19 ERLGAGQFGEVWMG-YYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
++ E + ++ EYME SL +L + L+ + + +A A+G+
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLT---------INKLLDMAAQIAEGMA 123
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++ +HRDL+++NIL+ + KIADFG+A+++ E+ E+ A + A
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 178
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE K+D++SFG++L E+ T ++++ G +V
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMV----- 230
Query: 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
EE+ ++ +L C P +RP + +L
Sbjct: 231 --RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (508), Expect = 5e-58
Identities = 64/305 (20%), Positives = 132/305 (43%), Gaps = 36/305 (11%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFL 735
F + + VIG+G G+V + + VA+K + +K ++FL
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFL 75
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
+E I+ H N++ L ++ +++ E+ME SLD +L + +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF---------- 125
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + + + G A G+ Y+ VHRDL + NIL++ N K++DFG+++ L +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 856 GEFAAMSTV--VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLA 913
+ S + + APE + RK +D++S+G+++ E+ + E D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---- 238
Query: 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL-- 971
+ +++A++++ P ++ + +L + C RP ++ L
Sbjct: 239 ---------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 972 -LNNP 975
+ NP
Sbjct: 290 MIRNP 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 3e-57
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 693 NVIGSGGSGKVYRV-----PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
IG G G+V++ +VAVK + + + +F E +++ +
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNP 76
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSG-------------RARDEV 794
NIVKLL + L++EYM L+++L + ++
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
LS ++ IA A G+ Y+ VHRDL + N L+ N KIADFG+++ I
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR-NIYS 192
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ A ++ PE + ++D++++GV+L E+ + +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HE 249
Query: 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++++G + C + ++ L +C S LP +RP+ + +IL
Sbjct: 250 EVIYYVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 4e-57
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 34/277 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G G VY + ++A+K ++ + E + EV+I S +RH NI++L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L+ EY ++ + L K ++ +R A L
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTATYITELANALS 120
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y H S ++HRD+K N+LL KIADFG + +T+ G+ Y+
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLP 172
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE R +EK D++S GV+ E GK + + Q ++ I +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEF---TFPD 225
Query: 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ E ++I P++RP +R VL+
Sbjct: 226 FVTEGA--RDLISR------LLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 36/282 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G VY+ T VA ++ DRKL + + F E ++L ++H NIV+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 753 L----CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ + +LV E M +L +L + + +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------MKIKVLRSWCRQIL 122
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILL-DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+GL ++H P I+HRDLK NI + + KI D G+A + V+G+
Sbjct: 123 KGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVIGT 176
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
++APE K +E D+Y+FG+ +LE+ T + + ++ A +R + G
Sbjct: 177 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVK-- 230
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ + E+ + + C ER +++ +L
Sbjct: 231 ----PASFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-56
Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 39/280 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G V ++ VAVK I ND + FLAE +++ +RH N+V+L
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQL 65
Query: 753 L-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
L + + +V EYM K SL +L + RS VL ++ ++ + +
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---------VLGGDCLLKFSLDVCEAM 116
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
Y+ VHRDL + N+L+ + AK++DFG+ K T +
Sbjct: 117 EYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWT 167
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
APE R +K + K+D++SFG++L E+ + + +++G +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKM----- 219
Query: 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + C + V K C + RP+ + + L
Sbjct: 220 -DAPDGC-PPAVYEVMKN---CWHLDAAMRPSFLQLREQL 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 2e-56
Identities = 76/330 (23%), Positives = 125/330 (37%), Gaps = 39/330 (11%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQ 739
F D ++ IG G G VY +EVVA+KK+ K + ++ + EV+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 740 ILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRR 799
L +RH N ++ C E+ LV EY + D K L
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVE 116
Query: 800 RMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFA 859
+ GA QGL Y+H S ++HRD+K+ NILL K+ DFG A I+
Sbjct: 117 IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167
Query: 860 AMSTVVGSCGYIAPEYART---RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916
++ VG+ ++APE + + K D++S G+ +EL K
Sbjct: 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSAL 223
Query: 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ--ILLNN 974
+ Q P + + E C +P +RP ++L+ +L
Sbjct: 224 YHIAQNESP-------ALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRE 273
Query: 975 PIFPTEKNGGRKYDHVTPLLTDSKREKMSE 1004
+ ++ L + + KM +
Sbjct: 274 RPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 691 ESNVIGSGGSGKVYRV--PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
E +GSG G V + + + VAVK + + D + E LAE ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 69
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
IV+++ +E+ +LV E E L+++L + + + +++ +
Sbjct: 70 IVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-----------VKDKNIIELVHQVS 117
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
G+ Y+ VHRDL + N+LL AKI+DFG++K L +E + A +
Sbjct: 118 MGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLE-LTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
+ APE K + K+D++SFGV++ E + G++ G + +++G+ +
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERM- 229
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
C EM + L C + RP V L N +
Sbjct: 230 -----GCPAGC-PREMYDLMNL---CWTYDVENRPGFAAVELR-LRNYYY 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-56
Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 33/294 (11%)
Query: 683 SDILP-KLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAE 737
++I P +T VIG+G G+VY+ + ++ VA+K + +K +FL E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGE 59
Query: 738 VQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSW 797
I+ H NI++L IS +++ EYME +LD++L +K+ S
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----------EFSV 109
Query: 798 RRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGE 857
+ + + G A G M + + VHRDL + NIL++ N K++DFG++++L +
Sbjct: 110 LQLVGMLRGIAAG---MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 858 FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917
S + APE RK +D++SFG+++ E+ T E
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-------------RP 213
Query: 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++ A++ P ++ +++L + C RP ++ IL
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 60/278 (21%), Positives = 106/278 (38%), Gaps = 30/278 (10%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G G+V T E VAVK + D K + E+ I + H N+VK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
N++ L EY L + + + G+
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----------MPEPDAQRFFHQLMAGVV 117
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I HRD+K N+LLD N KI+DFG+A + + ++ + G+ Y+A
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVA 173
Query: 873 PEYARTRKVN-EKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
PE + R+ + E D++S G++L + G+ + +C W+ + +D
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
L +++ P+ R + + +
Sbjct: 234 SAPLA--LLHKILVE----------NPSARITIPDIKK 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 47/304 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G G+V+R E VAVK ++ AE+ +RH NI+ +
Sbjct: 10 SIGKGRFGEVWRG--KWRGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 754 CCISSENLKL----LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
+ +N LV +Y E SL +L++ ++ +++A+ A
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------------VTVEGMIKLALSTAS 111
Query: 810 GLCYMHHDC-----SPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEF-AAMST 863
GL ++H + P I HRDLKS NIL+ N IAD G+A A +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 864 VVGSCGYIAPEYARTR------KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917
VG+ Y+APE + ++ DIY+ G++ E+ E Q +
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY---QLPY 228
Query: 918 RHIQEGKPIVDALDKEIDEPCF----------LEEMIRVFKLGVICTSMLPTERPNMRMV 967
+ P V+ + K + E E + + K+ C R +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 968 LQIL 971
+ L
Sbjct: 289 KKTL 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
L +G G G+V+ N T V A+K + K + FL E Q++ +RH
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL----KPGTMSPEAFLQEAQVMKKLRHE 72
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+V+L +S E + +V EYM K SL +L + + L + + +A
Sbjct: 73 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQI 122
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
A G+ Y+ VHRDL+++NIL+ N K+ADFG+A+++ E+ E+ A
Sbjct: 123 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 177
Query: 868 CGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
+ APE A + K+D++SFG++L ELTT + ++
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------REVL 224
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
D +++ PC E + L C P ERP + L
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 36/282 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G GKVY+ T+ + A K I ++ ++++ E+ IL++ H NIVKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L EN ++ E+ ++D + + R L+ + + L
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERP----------LTESQIQVVCKQTLDALN 124
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+H I+HRDLK+ NIL + + K+ADFGV+ + + +G+ ++A
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMA 178
Query: 873 PEYART-----RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIV 927
PE R + K D++S G+ L+E+ + ++ I + +P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRVLLKIAKSEPPT 234
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
A ++ ++ C R +LQ
Sbjct: 235 LAQPSRWSSN--FKDFLKK------CLEKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-55
Identities = 65/280 (23%), Positives = 118/280 (42%), Gaps = 33/280 (11%)
Query: 695 IGSGGSGKVYRV--PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G G G V + + VA+K + + ++ +E + E QI+ + + IV+L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ +E L +LV E L ++L K + ++ + G+
Sbjct: 75 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE----------IPVSNVAELLHQVSMGMK 123
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
Y+ VHRDL + N+LL AKI+DFG++K L ++ + A S + A
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 873 PEYARTRKVNEKTDIYSFGVILLE-LTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
PE RK + ++D++S+GV + E L+ G++ + I++GK +
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQGKRM----- 231
Query: 932 KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
E C E+ + C +RP+ V Q +
Sbjct: 232 -ECPPEC-PPELYALMSD---CWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 9e-55
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 33/285 (11%)
Query: 692 SNVIGSGGSGKVYR---VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
+ VIG G G VY + + AVK + +R D +FL E I+ H N
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 749 IVKLL-CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
++ LL C+ SE L+V YM+ L ++ + + + + + +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----------PTVKDLIGFGLQV 139
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST-VVG 866
A+G+ ++ VHRDL + N +LD F K+ADFG+A+ + +E + T
Sbjct: 140 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 867 SCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926
++A E +T+K K+D++SFGV+L EL T D + +Q +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRL- 253
Query: 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + + V C RP+ ++ +
Sbjct: 254 -------LQPEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRI 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 54/283 (19%), Positives = 114/283 (40%), Gaps = 33/283 (11%)
Query: 689 LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN 748
LT IGSG G V+ + VA+K I + E++F+ E +++ + H
Sbjct: 7 LTFVQEIGSGQFGLVHLG-YWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPK 61
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V+L + LV+E+ME L +L + + + + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG----------LFAAETLLGMCLDVC 111
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+G+ + ++HRDL + N L+ N K++DFG+ + + + ++ + +
Sbjct: 112 EGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPV 166
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
+ +PE + + K+D++SFGV++ E+ + + + I G +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLY- 222
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ ++ C P +RP +L+ L
Sbjct: 223 ------KPRLASTHVYQIMNH---CWKERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 1e-54
Identities = 67/297 (22%), Positives = 127/297 (42%), Gaps = 32/297 (10%)
Query: 676 HRLNFRDSDILPK-LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEF 734
N+ ++ +T + +G G G+VY + VAVK + K D +EF
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEF 60
Query: 735 LAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV 794
L E ++ I+H N+V+LL + E ++ E+M +L +L + NR
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------- 111
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
+S + +A + + Y+ +HRDL + N L+ N K+ADFG+++++
Sbjct: 112 VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--T 166
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ A + + APE K + K+D+++FGV+L E+ T
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG------------- 213
Query: 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ + + + L+K+ +V++L C P++RP+ + Q
Sbjct: 214 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-54
Identities = 59/290 (20%), Positives = 116/290 (40%), Gaps = 34/290 (11%)
Query: 685 ILPK-LTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
I PK LT +G+G G V VA+K I K E EF+ E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMN 55
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
+ H +V+L + + ++ EYM L +L + ++ +++
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----------FQTQQLLEM 105
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+ + Y+ +HRDL + N L++ K++DFG+++ + + E+ +
Sbjct: 106 CKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVG 160
Query: 864 VVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923
+ PE K + K+DI++FGV++ E+ + + HI +G
Sbjct: 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQG 217
Query: 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973
+ E +V+ + C ERP +++L +L+
Sbjct: 218 LRLYR--PHLASE--------KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-54
Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 688 KLTESNVIGSGGSGKVYRV-----PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
+L+ +G+G GKV + A VAVK + + ++E+++LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLS 81
Query: 743 TI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEV------- 794
+ H+NIV LL + L++ EY L +L +K S + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
L + + A+G+ ++ +HRDL + NILL + KI DFG+A+ IK
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-DIKN 197
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ + ++APE ++D++S+G+ L EL + + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMPVDS 255
Query: 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++ I+EG + + EM + K C P +RP + ++Q++
Sbjct: 256 KFYKMIKEGFRM-------LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 63/296 (21%), Positives = 119/296 (40%), Gaps = 36/296 (12%)
Query: 694 VIGSGGSGKVYRV-----PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHL 747
V+GSG GKV + VAVK + K D + ++E+++++ + H
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSHE 101
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKK------------NRSSLSGRARDEVL 795
NIV LL + L++EY L +L K N+ L VL
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
++ + A A+G+ ++ + VHRDL + N+L+ + KI DFG+A+ + +
Sbjct: 162 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-MSD 217
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915
+ ++APE K+D++S+G++L E+ +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--DAN 275
Query: 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++ IQ G +D+ + +++ C + +RP+ + L
Sbjct: 276 FYKLIQNGFK----MDQPFYATEEIYIIMQS------CWAFDSRKRPSFPNLTSFL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-53
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 36/307 (11%)
Query: 673 TSFHRLNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAE--VVAVKKIWNDRKLDQKH 730
T + L++ D + +VIG G G+V + I A+K++ +
Sbjct: 2 TIYPVLDWND------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDD 53
Query: 731 EKEFLAEVQILSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLS-- 787
++F E+++L + H NI+ LL L EY +L +L K
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 788 ---GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844
+ LS ++ + A A+G+ Y+ +HRDL + NIL+ N+ AKIAD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIAD 170
Query: 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEAN 904
FG+++ + + + ++A E +D++S+GV+L E+ +
Sbjct: 171 FGLSRG----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 905 NGDEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNM 964
+ + +G + E C E V+ L C P ERP+
Sbjct: 227 YCGMTC---AELYEKLPQGYRL------EKPLNCDDE----VYDLMRQCWREKPYERPSF 273
Query: 965 RMVLQIL 971
+L L
Sbjct: 274 AQILVSL 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 31/284 (10%)
Query: 693 NVIGSGGSGKVYRV---PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
+G G G V R + VAVK + D + +F+ EV + ++ H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
++L + + +K+ V E SL L K + AV A+
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----------FLLGTLSRYAVQVAE 122
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
G+ Y+ +HRDL + N+LL KI DFG+ + L + + +
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLE-LTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
+ APE +TR + +D + FGV L E T G+E G +Q + +EG+ +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERL-- 234
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972
E C + ++ + V C + P +RP + LL
Sbjct: 235 ----PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-51
Identities = 67/309 (21%), Positives = 124/309 (40%), Gaps = 47/309 (15%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G SG VY T + VA++++ Q ++ + E+ ++ ++ NIV
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L + +V EY+ SL + + + + Q L
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCM------------DEGQIAAVCRECLQALE 130
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
++H + ++HRD+KS NILL + + K+ DFG + E+ + ST+VG+ ++A
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMA 184
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE + K DI+S G++ +E+ G+ + + + G P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTP------- 234
Query: 933 EIDEPCFLEEMIRVFKLGVICTSML---PTERPNMRMVLQILLNNPIFPTEKNGGRKYDH 989
E+ P L + R F L +R + + +LQ + +
Sbjct: 235 ELQNPEKLSAIFRDF-----LNRCLDMDVEKRGSAKELLQ----HQFL----KIAKPLSS 281
Query: 990 VTPLLTDSK 998
+TPL+ +K
Sbjct: 282 LTPLIAAAK 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 51/289 (17%), Positives = 106/289 (36%), Gaps = 36/289 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
++G G V T+ A+K + + + E ++S + H VKL
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ Y + L +++ K A+ +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----------FDET---CTRFYTAEIVS 119
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ + I+HRDLK NILL+ + + +I DFG AK ++ E + A ++ VG+ Y++
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVS 178
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE + + +D+++ G I+ +L G + ++ I + + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI----FQKIIKLEY---DFPE 231
Query: 933 EIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQI--LLNNPIF 977
+ +E+++ + T+R + L +P F
Sbjct: 232 KFFPKARDLVEKLLVL----------DATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 25/289 (8%)
Query: 688 KLTESNVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS 742
K+T S +G G G VY V + VA+K + + + EFL E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMK 78
Query: 743 TIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQ 802
++V+LL +S L++ E M + L +L R +++ S + +Q
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPSLSKMIQ 137
Query: 803 IAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMS 862
+A A G+ Y+ + VHRDL + N ++ +F KI DFG+ + I E +
Sbjct: 138 MAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 193
Query: 863 TVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922
+ +++PE + +D++SFGV+L E+ T E + R + E
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVME 250
Query: 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
G + + + C +F+L +C P RP+ ++ +
Sbjct: 251 GGLL------DKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-50
Identities = 71/334 (21%), Positives = 127/334 (38%), Gaps = 41/334 (12%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHT----AEVVAVKKIWNDRKLDQKHEKEFL 735
++++ + V+GSG G VY+ VA+K++ K KE L
Sbjct: 6 LKETE----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEIL 59
Query: 736 AEVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVL 795
E +++++ + ++ +LL + ++L+ LD K+
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG---------- 109
Query: 796 SWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEE 855
+ + V A+G+ Y+ +VHRDL + N+L+ + KI DFG+AK+L EE
Sbjct: 110 -SQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165
Query: 856 GEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQW 915
E+ ++A E R ++D++S+GV + EL T
Sbjct: 166 KEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ 218
Query: 916 AWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL---L 972
I L+K P I V+ + V C + RP R ++
Sbjct: 219 -------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
Query: 973 NNPIFPTEKNGGRKYDHVTPLLTDSKREKMSESD 1006
+P G + +P ++ R M E D
Sbjct: 272 RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 305
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (446), Expect = 6e-50
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 29/273 (10%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
++G GG +V+ VAVK + D D F E Q + + H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 754 CCISSEN----LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
+E L +V EY++ +L +H + ++ +R +++ A Q
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----------MTPKRAIEVIADACQ 122
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
L + I+HRD+K +NI++ K+ DFG+A+ + + V+G+
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929
Y++PE AR V+ ++D+YS G +L E+ TG+ GD A++H++E A
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPIPPSA 236
Query: 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP 962
+ + L+ ++ + P R
Sbjct: 237 RHEGLSAD--LDAVVLK------ALAKNPENRY 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 2e-49
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 37/295 (12%)
Query: 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEV 738
+ +L +G+G G V+RV T A K + + ++ E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEI 74
Query: 739 QILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWR 798
Q +S +RH +V L +N +++YE+M L + + ++ +S
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----------MSED 124
Query: 799 RRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL--DYNFNAKIADFGVAKILIKEEG 856
++ +GLC+MH + VH DLK NI+ + K+ DFG+ L
Sbjct: 125 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----D 177
Query: 857 EFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916
++ G+ + APE A + V TD++S GV+ L +G G+ +
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL 234
Query: 917 WRHIQEGKPIVDALDKEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ D+ I E F+ +++ P R + L+
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD----------PNTRMTIHQALE 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-49
Identities = 65/297 (21%), Positives = 130/297 (43%), Gaps = 32/297 (10%)
Query: 688 KLTESNVIGSGGSGKVYRV-------PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI 740
+L +G G G+V + VAVK + +K + ++E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEM 71
Query: 741 LSTI-RHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRAR-----DEV 794
+ I +H NI+ LL + + ++ EY K +L ++L + L +E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 795 LSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKE 854
LS + + A A+G+ Y+ S +HRDL + N+L+ + KIADFG+A+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HH 187
Query: 855 EGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914
+ + ++APE R ++D++SFGV+L E+ T + +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 244
Query: 915 WAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
++ ++EG + + C E+ + + C +P++RP + +++ L
Sbjct: 245 ELFKLLKEGHRM------DKPSNC-TNELYMMMRD---CWHAVPSQRPTFKQLVEDL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 36/282 (12%)
Query: 694 VIGSGGSGKVYRV---PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIV 750
IG G G V++ + A VA+K ++FL E + H +IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
KL+ I+ EN ++ E L +L + S L + A +
Sbjct: 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS----------LDLASLILYAYQLSTA 120
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L Y+ S VHRD+ + N+L+ N K+ DFG+++ + E+ + S +
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKW 175
Query: 871 IAPEYARTRKVNEKTDIYSFGVILLE-LTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929
+APE R+ +D++ FGV + E L G + G ++ I+ G+ +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGERL--P 229
Query: 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ L ++ C + P+ RP + L
Sbjct: 230 MPPNCPPT--LYSLMT------KCWAYDPSRRPRFTELKAQL 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-47
Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 30/291 (10%)
Query: 693 NVIGSGGSGKVYR-----VPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHL 747
+G G G+V + T VAVK + + ++E++IL I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHH 76
Query: 748 NIVKLL--CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDE-----VLSWRRR 800
V L C +++ E+ + +L +L K + + E L+
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 801 MQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAA 860
+ + A+G+ ++ S +HRDL + NILL KI DFG+A+ + K+ ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVR 192
Query: 861 MSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920
++APE R ++D++SFGV+L E+ + + + + R +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--IDEEFCRRL 250
Query: 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+EG + + EM + C P++RP +++ L
Sbjct: 251 KEGTRM------RAPDYT-TPEMYQTMLD---CWHGEPSQRPTFSELVEHL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (426), Expect = 8e-47
Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 40/288 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+G+G G+V+ + H A+K + + + K + E +LS + H I+++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
++ +Y+E L L K R AA+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--------------NPVAKFYAAEVCL 115
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ + S I++RDLK NILLD N + KI DFG AK + T+ G+ YIA
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIA 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE T+ N+ D +SFG+++ E+ G + I +
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAEL---RFPP 222
Query: 933 EIDEPC--FLEEMIRVFKLGVICTSMLPTERP-NMRMVLQILLNNPIF 977
+E L +I ++R N++ + + N+P F
Sbjct: 223 FFNEDVKDLLSRLITR----------DLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (421), Expect = 9e-46
Identities = 54/280 (19%), Positives = 103/280 (36%), Gaps = 37/280 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+GSG G V+R T V K I + E+ I++ + H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +L+ E++ L + ++ +S + A +GL +
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYK----------MSEAEVINYMRQACEGLKH 142
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
MH +IVH D+K NI+ + + KI DFG+A L +E + + +
Sbjct: 143 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFA 195
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
APE V TD+++ GV+ L +G G++ Q + +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRCDWEFDEDAF 252
Query: 932 KEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ F++ +++ P +R + L+
Sbjct: 253 SSVSPEAKDFIKNLLQK----------EPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-45
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
+V+G+G +V T ++VA+K I +K + E E+ +L I+H NIV L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
S L+ + + L + +K + R ++ +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF-----------YTERDASRLIFQVLDAVK 121
Query: 813 YMHHDCSPTIVHRDLKSSNILL---DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
Y+H IVHRDLK N+L D + I+DFG++K+ +ST G+ G
Sbjct: 122 YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPG 174
Query: 870 YIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929
Y+APE + ++ D +S GVI L G + A+ + ++
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAEYEFDSP 231
Query: 930 LDKEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+I + F+ ++ P +R LQ
Sbjct: 232 YWDDISDSAKDFIRHLMEK----------DPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 6e-45
Identities = 73/291 (25%), Positives = 111/291 (38%), Gaps = 44/291 (15%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKI------WNDRKLDQKHEKEFLAEVQILSTIR- 745
++G G S V R T + AVK I + Q+ + L EV IL +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
H NI++L + LV++ M+K L +L +K LS + +I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------LSEKETRKIMR 117
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ +C +H IVHRDLK NILLD + N K+ DFG + L E + V
Sbjct: 118 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVC 170
Query: 866 GSCGYIAPEYART------RKVNEKTDIYSFGVILLELTTGKEANNGD-EHTCLAQWAWR 918
G+ Y+APE ++ D++S GVI+ L G + L
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ Q G P D + + + + V P +R L
Sbjct: 231 NYQFGSPEWDDYSDTVKD--LVSRFLVVQ----------PQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 7e-45
Identities = 52/280 (18%), Positives = 102/280 (36%), Gaps = 38/280 (13%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G G V+R + + K + K+ + E+ IL+ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV----KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
S ++++E++ + + ++ L+ R + + L +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFE----------LNEREIVSYVHQVCEALQF 117
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNA--KIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
+H S I H D++ NI+ ++ KI +FG A+ L + + + Y
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYY 170
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
APE + V+ TD++S G ++ L +G + + Q + +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYTFDEEAF 227
Query: 932 KEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
KEI F++ ++ R LQ
Sbjct: 228 KEISIEAMDFVDRLLVK----------ERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 40/288 (13%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVK 751
++G G GKV+ T + A+K + D L + + E ++LS H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 752 LLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGL 811
+ C ++ V EY+ L + ++ R A GL
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----------FDLSRATFYAAEIILGL 116
Query: 812 CYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYI 871
++H IV+RDLK NILLD + + KIADFG+ K + + + +T G+ YI
Sbjct: 117 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYI 170
Query: 872 APEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
APE +K N D +SFGV+L E+ G+ +G + L + I+ P
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPF---YP 223
Query: 932 KEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977
+ +++ L ++ P +R +R + +P+F
Sbjct: 224 RWLEKEAKDLLVKLFVRE----------PEKRLGVR---GDIRQHPLF 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-44
Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 17/294 (5%)
Query: 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILST 743
D+ P+ T + IG G G V N VA+KKI Q + + L E++IL
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 62
Query: 744 IRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
RH NI+ + I + ++ + Y+ + L+K + + LS
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK--------LLKTQHLSNDHICYF 114
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMST 863
+GL Y+H S ++HRDLK SN+LL+ + KI DFG+A++ + ++
Sbjct: 115 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 864 VVGSCGYIAPEYARTRKV-NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922
V + Y APE K + DI+S G IL E+ + + G + +
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-- 229
Query: 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN-NP 975
G P + L+ I+ + K V + P +L +L NP
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (403), Expect = 5e-44
Identities = 40/287 (13%), Positives = 86/287 (29%), Gaps = 34/287 (11%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IG G G ++ + VA+K + + E + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE-----PRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
E L ++ + SL+ L R S + A +
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQS 116
Query: 814 MHHDCSPTIVHRDLKSSNILLD-----YNFNAKIADFGVAKILIKEEGE----FAAMSTV 864
+H +V+RD+K N L+ + DFG+ K + + +
Sbjct: 117 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 865 VGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924
G+ Y++ R+ + + D+ + G + + G G + Q + I E K
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKK 232
Query: 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971
+ P + + ++ P+ + +
Sbjct: 233 QSTPLRELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLF 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 1e-42
Identities = 63/290 (21%), Positives = 110/290 (37%), Gaps = 36/290 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEV---QILSTIRHLNI 749
+IG GG G+VY T ++ A+K + R ++ E L E ++ST I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 750 VKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
V + + + + + M L L + S A
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----------SEADMRFYAAEIIL 118
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCG 869
GL +MH + +V+RDLK +NILLD + + +I+D G+A K++ VG+ G
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHG 170
Query: 870 YIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
Y+APE + + D +S G +L +L G + + + + D
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-NMRMVLQILLNNPIF 977
+ E+ LE +++ R + Q + +P F
Sbjct: 231 SFSPELRS--LLEGLLQRD----------VNRRLGCLGRGAQEVKESPFF 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-42
Identities = 55/305 (18%), Positives = 100/305 (32%), Gaps = 39/305 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
IGSG G +Y E VA+K + + E +I ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 754 -CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
C + + ++V E + D + + S + + +A +
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----------FSLKTVLLLADQMISRIE 117
Query: 813 YMHHDCSPTIVHRDLKSSNIL---LDYNFNAKIADFGVAKILIKEEGE----FAAMSTVV 865
Y+H S +HRD+K N L I DFG+AK + +
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925
G+ Y + + + + D+ S G +L+ G G + Q R ++
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGGR 985
E+ + E C S+ ++P+ + Q L N G
Sbjct: 235 T----PIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQ-LFRNLFH----RQGF 282
Query: 986 KYDHV 990
YD+V
Sbjct: 283 SYDYV 287
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 33/293 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKH--EKEFLAEVQILSTIRHLNIV 750
+ +G G VY+ +T ++VA+KKI + + K + L E+++L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 751 KLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQG 810
LL ++ LV+++ME L+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----------LTPSHIKAYM---LMT 109
Query: 811 LCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGY 870
L + + I+HRDLK +N+LLD N K+ADFG+AK A + V + Y
Sbjct: 110 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWY 166
Query: 871 IAPEYARTRKV-NEKTDIYSFGVILLELTTGKEANNGDEH----TCLAQWAWRHIQEGKP 925
APE ++ D+++ G IL EL GD T + + +E P
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 926 IVDALDKEIDEPCFLEEMIRVFKLGV------ICTSML---PTERPNMRMVLQ 969
+ +L + F + + + P R L+
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 9e-42
Identities = 64/298 (21%), Positives = 104/298 (34%), Gaps = 38/298 (12%)
Query: 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE---KEFLA 736
FR ++ +GSG V + T A K I R + ++
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 737 EVQILSTIRHLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLS 796
EV IL I+H N++ L ++ +L+ E + L +L +K L+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----------LT 111
Query: 797 WRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN----FNAKIADFGVAKILI 852
+ G+ Y+H S I H DLK NI+L KI DFG+A +
Sbjct: 112 EEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 853 KEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912
+ G+ ++APE + + D++S GVI L +G GD
Sbjct: 169 FGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--- 221
Query: 913 AQWAWRHIQEGK-PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
Q ++ D ++ IR P +R ++ LQ
Sbjct: 222 -QETLANVSAVNYEFEDEYFSNTSALA--KDFIRR------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-41
Identities = 70/294 (23%), Positives = 109/294 (37%), Gaps = 36/294 (12%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G VY+ T EVVA+KKI D + + + E+ +L + H NIVKL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
L I +EN LV+E++ + + QGL
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTG----------IPLPLIKSYLFQLLQGLA 116
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ S ++HRDLK N+L++ K+ADFG+A+ + V + Y A
Sbjct: 117 FC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRA 170
Query: 873 PE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALD 931
PE + + DI+S G I E+ T + GD + Q G P
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWP 228
Query: 932 KEIDEPCFLEEMIRVFKLGV-------------ICTSML---PTERPNMRMVLQ 969
P + + + + + ML P +R + + L
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 33/286 (11%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
++G G GKV V T A+K + + + + + E ++L RH + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ + V EY L L ++ + R A+ +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERV-----------FTEERARFY---GAEIVS 116
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ + S +V+RD+K N++LD + + KI DFG+ K I + A M T G+ Y+A
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLA 173
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDK 932
PE D + GV++ E+ G+ +H + + E L
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFPRTLSP 230
Query: 933 EIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMV-LQILLNNPIF 977
E L +++ P +R + ++ + F
Sbjct: 231 EAKS--LLAGLLKK----------DPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 46/283 (16%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ---KHEKEFLAEVQILSTIR--HLN 748
++GSGG G VY VA+K + DR D + EV +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+++LL + +L+ E E + + L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----------LQEELARSFFWQVL 120
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ + + H+ ++HRD+K NIL+D N K+ DFG +L + + G+
Sbjct: 121 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDGT 172
Query: 868 CGYIAPEYARTRKV-NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926
Y PE+ R + ++S G++L ++ G DE Q +R
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------- 224
Query: 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ + C + +IR C ++ P++RP +
Sbjct: 225 -----QRVSSEC--QHLIR------WCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 9e-40
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 32/291 (10%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G VY+ N+ E A+KKI K D+ + E+ IL ++H NIVKL
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
I ++ +LV+E++++ + L + Q L
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LES---VTAKSFLLQLLN 111
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ + ++HRDLK N+L++ KIADFG+A+ +V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK----EANNGDEHTCLAQWAWRHIQEGKPIVD 928
++K + DI+S G I E+ G + D+ + + + P V
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 929 ALDKE-----IDEPCFLEEMIRVFKLGVI--CTSML---PTERPNMRMVLQ 969
L K + EP E ++ I + ML P +R + L+
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-40
Identities = 58/287 (20%), Positives = 112/287 (39%), Gaps = 45/287 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKL 752
V+G G +GKV ++ T E A+K + + + EV++ + +IV++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRI 70
Query: 753 LCCI----SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+ + L+V E ++ L + + D+ + R +I
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG---------DQAFTEREASEIMKSIG 121
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLD---YNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ + Y+H S I HRD+K N+L N K+ DFG AK +++T
Sbjct: 122 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPC 174
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925
+ Y+APE K ++ D++S GVI+ L G + ++ I+ G+
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 926 -IVDALDKEIDEPC--FLEEMIRVFKLGVICTSMLPTERPNMRMVLQ 969
+ E+ E + +++ PT+R + +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKT----------EPTQRMTITEFMN 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-39
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 29/293 (9%)
Query: 693 NVIGSGGSGKVYRV-PINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQI---LSTIRHLN 748
IG G GKV++ + + VA+K++ + ++ + EV + L T H N
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 749 IVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
+V+L + + +DQ L + + + + +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-----TYLDKVPEPGVPTETIKDMMFQLL 126
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
+GL ++H +VHRDLK NIL+ + K+ADFG+A+I A+++VV +
Sbjct: 127 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTL 179
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928
Y APE D++S G I E+ K G I
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 929 ALDKEIDEPCFLEEMIRVFKLGVICTS---------ML---PTERPNMRMVLQ 969
D + F + + + V L P +R + L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 53/305 (17%), Positives = 117/305 (38%), Gaps = 44/305 (14%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G+V++ T + VA+KK+ + L E++IL ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 753 LCCISS--------ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIA 804
+ + + LV+++ E + + +LS +R+
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS---------EIKRV--- 122
Query: 805 VGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKIL-IKEEGEFAAMST 863
L +++ I+HRD+K++N+L+ + K+ADFG+A+ + + + +
Sbjct: 123 --MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 864 VVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGKEANNGDEHT-----------C 911
V + Y PE + D++ G I+ E+ T G+
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSML-------PTERPNM 964
+ W ++ + + L+ + +++ ++ + ++ P +R +
Sbjct: 241 ITPEVWPNVDN-YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 965 RMVLQ 969
L
Sbjct: 300 DDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 8e-39
Identities = 56/285 (19%), Positives = 106/285 (37%), Gaps = 36/285 (12%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G+G G+V V + A+K + + + K + L E +IL + +VKL
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 754 CCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCY 813
+ +V EY+ + L + R S A Y
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----------FSEPHARFYAAQIVLTFEY 156
Query: 814 MHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAP 873
+H S +++RDLK N+L+D ++ DFG AK T+ G+ +AP
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------VKGRTWTLCGTPEALAP 207
Query: 874 EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVDALDKE 933
E ++ N+ D ++ GV++ E+ G D+ + + +
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---RFPSHFSSD 264
Query: 934 IDEPCFLEEMIRVFKLGVICTSMLPTER-PNMRMVLQILLNNPIF 977
+ L +++V T+R N++ + + N+ F
Sbjct: 265 L--KDLLRNLLQV----------DLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 73/302 (24%), Positives = 115/302 (38%), Gaps = 44/302 (14%)
Query: 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNI 749
T++ VIG+G G VY+ + + E+VA+KK+ D++ + E+QI+ + H NI
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNI 75
Query: 750 VKLLCCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQI 803
V+L S K LV +Y+ + H + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--------AKQTLPVIYVKLY 127
Query: 804 AVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-FNAKIADFGVAKILIKEEGEFAAMS 862
+ L Y+H S I HRD+K N+LLD + K+ DFG AK L++ E
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV 180
Query: 863 TVVGSCGYIAP-EYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHT--------CLA 913
+ + S Y AP D++S G +L EL G+ GD L
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240
Query: 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVF---KLGVICTSML---PTERPNMRMV 967
I+E P + ++ R + +C+ +L PT R
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 968 LQ 969
Sbjct: 301 CA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 59/292 (20%), Positives = 108/292 (36%), Gaps = 32/292 (10%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKL 752
IG G G V++ T E+VA+K++ D+ L E+ +L ++H NIV+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 753 LCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLC 812
+ S+ LV+E+ ++ + + Q L
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--------------DLDPEIVKSFLFQLLK 112
Query: 813 YMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIA 872
+ S ++HRDLK N+L++ N K+A+FG+A+ ++A VV
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPP 170
Query: 873 PEYARTRKVNEKTDIYSFGVILLELTTGK-----EANNGDEHTCLAQWAWRHIQEGKPIV 927
+ + D++S G I EL + D+ + + +E P +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 928 DALDKEIDEPCFLEEMIRVFKLGVI-------CTSML---PTERPNMRMVLQ 969
L P + V + + ++L P +R + LQ
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 46/299 (15%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+GSG G V T VA+KK+ + K E+++L +RH N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 754 CCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+ + LV +M + L K + L R +
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMG--TDLGKLMKHEK-----------LGEDRIQFLVYQM 130
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+GL Y+H + I+HRDLK N+ ++ + KI DFG+A+ E M+ V +
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVT 181
Query: 868 CGYIAPE-YARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926
Y APE + + DI+S G I+ E+ TGK G +H + +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 927 VDALDKEIDEPCFLEEMIRVFKLGV-------------ICTSML---PTERPNMRMVLQ 969
+ + +++ + + K + ML +R L
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-34
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 23/240 (9%)
Query: 693 NVIGSGGSGKVYRV---PINHTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILSTIRHL- 747
V+G+G GKV+ V + T ++ A+K + + K + E Q+L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 748 NIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGA 807
+V L +E L+ +Y+ L L ++ R + ++ +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--------------EVQIYV 135
Query: 808 AQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGS 867
+ + + H I++RD+K NILLD N + + DFG++K + +E E A G+
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC--GT 193
Query: 868 CGYIAPEYART--RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925
Y+AP+ R ++ D +S GV++ EL TG D R I + +P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-31
Identities = 61/259 (23%), Positives = 96/259 (37%), Gaps = 30/259 (11%)
Query: 675 FHRLNFRDS--DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEK 732
F+ + DS +L + IGSG G V VA+KK+ + +Q H K
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAK 61
Query: 733 EFLAEVQILSTIRHLNIVKLLCCISSENLK------LLVYEYMEKRSLDQWLHKKNRSSL 786
E+ ++ + H NI+ LL + + LV E M+ +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116
Query: 787 SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846
R + G+ ++H I+HRDLK SNI++ + KI DFG
Sbjct: 117 ---------DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNG 906
+A+ M+ V + Y APE E DI+S G I+ E+ K G
Sbjct: 165 LARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 907 DEHTCLAQWAWRHIQEGKP 925
++ + P
Sbjct: 221 RDYIDQWNKVIEQLGTPCP 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-30
Identities = 64/319 (20%), Positives = 117/319 (36%), Gaps = 44/319 (13%)
Query: 674 SFHR--LNFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHE 731
+F+R LN ++ + + +GSG G V T VAVKK+ + H
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHA 61
Query: 732 KEFLAEVQILSTIRHLNIVKLLCCISS-----ENLKLLVYEYMEKRSLDQWLHKKNRSSL 786
K E+++L ++H N++ LL + E + + ++ L+ + +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---- 117
Query: 787 SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846
L+ + +GL Y+H S I+HRDLK SN+ ++ + KI DFG
Sbjct: 118 --------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNG 906
+A+ + V N+ DI+S G I+ EL TG+ G
Sbjct: 167 LARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 907 DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGV-------------IC 953
+H + R + + +++ + ++ K+ +
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 954 TSML---PTERPNMRMVLQ 969
ML +R L
Sbjct: 282 EKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 3e-29
Identities = 52/305 (17%), Positives = 103/305 (33%), Gaps = 55/305 (18%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVK 751
+G G +V+ E V VK + +K+ E++IL +R NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL------KPVKKKKIKREIKILENLRGGPNIIT 94
Query: 752 LLCCISSENLKL--LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQ 809
L + + LV+E++ Q L+ +
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------------LTDYDIRFYMYEILK 140
Query: 810 GLCYMHHDCSPTIVHRDLKSSNILLDY-NFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
L Y H I+HRD+K N+++D+ + ++ D+G+A+ + + V S
Sbjct: 141 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASR 193
Query: 869 GYIAPE-YARTRKVNEKTDIYSFGVILLELTTGK-----EANNGDEHTCLAQ-----WAW 917
+ PE + + D++S G +L + K +N D+ +A+ +
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGV----------ICTSML---PTERPNM 964
+I + +D +I + R +L R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 965 RMVLQ 969
R ++
Sbjct: 314 REAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 8e-29
Identities = 43/220 (19%), Positives = 82/220 (37%), Gaps = 11/220 (5%)
Query: 694 VIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLL 753
+G G V+ VA+K + + D+ + + E+++L + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 754 CCISSENLKLLVYEYMEKRS-----LDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAA 808
++ LKLL + + + + + +N +L + + QI+
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 809 QGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSC 868
GL YMH C I+H D+K N+L++ + + L + + +
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 869 GYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE 908
Y +PE DI+S ++ EL TG DE
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 108 bits (269), Expect = 3e-26
Identities = 66/304 (21%), Positives = 116/304 (38%), Gaps = 29/304 (9%)
Query: 31 DREHAVLLKLKQHWQNPPPISHW-ATTNSSHCTWPEIACTDGS----VTELHLTNMNMNG 85
++ LL++K+ NP +S W TT+ + TW + C + V L L+ +N+
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 86 TF--PPFICDLRNLTILDLQFNY-IISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRL 142
+ P + +L L L + ++ P + ++L YL ++ G IP+ + ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 143 SRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNT 202
L L + N +SG +P SI L L + N+ +G+IP G+ L
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 203 EFSPSSLPSNFTQLKKLK---------------------KLWMASTNLIGEIPETIGDML 241
+ P+ + + N + +G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT 301
L LDL N G++P + +LK L + + N+L GEIPQ V + N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 302 GAIP 305
P
Sbjct: 305 CGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.7 bits (213), Expect = 5e-19
Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 5/271 (1%)
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSG--EIPEGIGLLPSLKDVRLFNNM-LSGALPPDFG 357
G + + + + NL L L IP + LP L + + L G +PP
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 358 RYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYN 417
+ + L Y ++ N++G++P+ L L + N LSG LP S+ + +L+ +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 418 NSFTGNIPAGLWTGFNLSM-VLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSS 476
N +G IP + L + IS N TG++P + + + +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 477 SKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRN 536
S G++ +L L L N++ G+LP + K L +LN+S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 537 QLSGEIPEKIGFLPVLQDLDLSENQFSGKIP 567
L GEIP+ G L + N+ P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 2e-15
Identities = 65/262 (24%), Positives = 100/262 (38%), Gaps = 29/262 (11%)
Query: 287 SLNLKVIDLSANNLTGA--IPNDFGKLENLLNLSLMFN-QLSGEIPEGIGLLPSLKDVRL 343
+ + +DLS NL IP+ L L L + L G IP I L L + +
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108
Query: 344 FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPES 403
+ +SGA+P + L + S N L+G+LP + + L GI N +SG +P+S
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 404 LGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSG--------- 454
G+ S L + + + NL+ V +S N+ G+
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 455 ----------------NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEL 498
NL+ L++ NNR G +P G++ K L S N G IP +
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287
Query: 499 TALPSLTTLLLDQNQLSGSLPL 520
L N+ PL
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 1e-12
Identities = 67/268 (25%), Positives = 100/268 (37%), Gaps = 36/268 (13%)
Query: 384 GKLAGIAAQDNNLSG--ELPESLGNCSSLLMVKIYNN-SFTGNIPAGLWTGFNLSMVLIS 440
++ + NL +P SL N L + I + G IP + L + I+
Sbjct: 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 441 DNLFTGELPD--KMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGEL 498
+G +PD L L+ S N SG +P +SS NLV N +G IP
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 499 TALPSLTT-LLLDQNQLSGSLPLDIISWKSLTALNLS----------------------R 535
+ L T + + +N+L+G +P +
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNRLTGEIPS--Q 592
K+G L LDL N+ G +P + +L L SLN+S N L GEIP
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 593 FENRAYASSFLNNPGLCASSSNVNLKSC 620
+ S++ NN LC S L +C
Sbjct: 290 LQR-FDVSAYANNKCLCGSP----LPAC 312
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 62/375 (16%), Positives = 114/375 (30%), Gaps = 62/375 (16%)
Query: 259 SSVFKLKNLSKV---YLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLL 315
+ +F L++ L +++ + Q + + + + +I L NL
Sbjct: 13 NQIFTDTALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGIK-SIDG-VEYLNNLT 69
Query: 316 NLSLMFNQLSGEIPEGIGLLPSLKDVR-------------------LFNNMLSGALPPDF 356
++ NQL+ P + L L D+ + D
Sbjct: 70 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 127
Query: 357 GRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIY 416
+ +N + L +
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE---RLDISS 184
Query: 417 NNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSS 476
N ++ A L +L ++N + P + NL L ++ N+ ++S
Sbjct: 185 NKVSDISVLAKLTNLESLIA---TNNQISDITPLGILTNLDELSLNGNQLKD--IGTLAS 239
Query: 477 SKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKS--------- 527
NL +NN + P L+ L LT L L NQ+S PL ++ +
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 528 -----------LTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-ML 575
LT L L N +S P + L LQ L + N+ S + L +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 576 TSLNLSSNRLTGEIP 590
L+ N+++ P
Sbjct: 354 NWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 72/403 (17%), Positives = 130/403 (32%), Gaps = 31/403 (7%)
Query: 184 PAEIGNLQNLEALELAYNTEFSPSSLPSNFTQ--LKKLKKLWMASTNLIGEIPETIGDML 241
I + AL T +++ +Q L ++ L I I + + +
Sbjct: 9 DTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLG-IKSI-DGVEYLN 66
Query: 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLT 301
L ++ S N T P LKNL+K+ + + + + L+ N
Sbjct: 67 NLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121
Query: 302 GAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSP 361
+ L NL L L N +S L
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 362 LEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFT 421
+ +VS ++ L + A +N +S P ++L + + N
Sbjct: 182 ISSNKVSDISVLAKLTNLES-------LIATNNQISDITPLG--ILTNLDELSLNGNQLK 232
Query: 422 GNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLV 481
L + NL+ + +++N + P L+ L++ N+ S P ++ +
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 482 VFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGE 541
+ I L +LT L L N +S P+ S L L + N++S
Sbjct: 291 ELNENQLEDISPISN----LKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD- 343
Query: 542 IPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSN 583
+ L + L NQ S P + L +T L L+
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.8 bits (198), Expect = 1e-16
Identities = 68/445 (15%), Positives = 136/445 (30%), Gaps = 82/445 (18%)
Query: 117 NCSKLEYLDLSQNYFIGPIP-EDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLV 175
++ L + + D+D+++ L+ L ++ G + L L Q+N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 176 VNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPE 235
NQ P + NL L + + N + L + + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 236 TIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDL 295
+ + I+ +G N +L+ +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI---------- 182
Query: 296 SANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPD 355
++ + + KL NL +L NQ+S P GI +L ++ L N L
Sbjct: 183 --SSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGT 236
Query: 356 FGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKI 415
+ L +++ N ++ P L + L +K+
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--------------------------LSGLTKLTELKL 270
Query: 416 YNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVS 475
N + P L L+ + +++N P NL+ L + N S P
Sbjct: 271 GANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---- 324
Query: 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSR 535
+++L L L N++S + + ++ L+
Sbjct: 325 ----------------------VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 536 NQLSGEIPEKIGFLPVLQDLDLSEN 560
NQ+S P + L + L L++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.9 bits (193), Expect = 5e-16
Identities = 77/397 (19%), Positives = 141/397 (35%), Gaps = 31/397 (7%)
Query: 69 TDGSVTELHLTNMNMNG-TFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
TD ++ E T + T DL +T L I S + + L ++ S
Sbjct: 17 TDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 74
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEI 187
N P + L++L + + N ++ P + N ++
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLT-----------NLTGLTLFNNQ 121
Query: 188 GNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLD 247
+ N S+ S+ + L L L S + + ++ LE LD
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 248 LSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPND 307
+S N + S + KL NL + +N +S P + + NL + L+ N L
Sbjct: 182 ISSNKVS--DISVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGT 236
Query: 308 FGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEV 367
L NL +L L NQ+S P + L L +++L N +S + P G +
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELN 293
Query: 368 SVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAG 427
S +L L + NN+S P + + + L + NN + +
Sbjct: 294 ENQLEDISPISNLK---NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSS 346
Query: 428 LWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNN 464
L N++ + N + P +++L +++
Sbjct: 347 LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 2e-15
Identities = 55/259 (21%), Positives = 91/259 (35%), Gaps = 20/259 (7%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICD-LRNLTIL 100
+ S ++T L +++ N + L NL L
Sbjct: 143 TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 202
Query: 101 DLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIP 160
N I P + L+ L L+ N + L+ L L L N +S P
Sbjct: 203 IATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 258
Query: 161 ASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLK 220
+ LT+L +L L NQ + P + L L LEL N S + LK L
Sbjct: 259 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS----PISNLKNLT 310
Query: 221 KLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGE 280
L + N+ P + + L+ L + N + SS+ L N++ + N +S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 281 IPQAVESL-NLKVIDLSAN 298
P + +L + + L+
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.2 bits (186), Expect = 4e-15
Identities = 54/305 (17%), Positives = 94/305 (30%), Gaps = 41/305 (13%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
+ P+ + N + I+ L ++ T+
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPA 161
L + VL + LE L + N P I + L L L N +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 162 SIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKK 221
++ LT L L+L NQ + P + L L L+L N + S L
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT----- 288
Query: 222 LWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEI 281
+ E I ++ L +L L NN + P + +L+
Sbjct: 289 -NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-----VSSLT------------- 329
Query: 282 PQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDV 341
L+ + + N ++ + L N+ LS NQ+S P + L + +
Sbjct: 330 -------KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 342 RLFNN 346
L +
Sbjct: 379 GLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.3 bits (233), Expect = 2e-21
Identities = 62/324 (19%), Positives = 106/324 (32%), Gaps = 38/324 (11%)
Query: 266 NLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLS 325
+L V L ++P+ + + ++DL N +T DF L+NL L L+ N++S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 326 GEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGK 385
P L L+ + L N L L E + + S+ L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL----- 123
Query: 386 LAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFT 445
N ++ + +G LS + I+D T
Sbjct: 124 --------------------NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
Query: 446 GELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT 505
+P + +L+ L + N+ + + NL S N + G L P L
Sbjct: 164 -TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 506 TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSG------EIPEKIGFLPVLQDLDLSE 559
L L+ N+L P + K + + L N +S P + L
Sbjct: 223 ELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 560 NQFS-GKIPPQIGRLM--LTSLNL 580
N +I P R + ++ L
Sbjct: 282 NPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 5e-21
Identities = 67/297 (22%), Positives = 107/297 (36%), Gaps = 27/297 (9%)
Query: 60 HCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCS 119
C + C+D + ++ P + + +LDLQ N I N
Sbjct: 9 QCHLRVVQCSDLGLEKV-----------PKDL--PPDTALLDLQNNKITEIKDGDFKNLK 55
Query: 120 KLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQF 179
L L L N P L +L+ LYL+ N + L ELR N+
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE---NEI 112
Query: 180 NGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGD 239
+ L + +EL N S F +KKL + I IP+ +
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL-SYIRIADTNITTIPQGLPP 171
Query: 240 MLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSAN 298
+L L L N T +S+ L NL+K+ L NS+S ++ + +L+ + L+ N
Sbjct: 172 --SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 299 NLTGAIPNDFGKLENLLNLSLMFNQLSG------EIPEGIGLLPSLKDVRLFNNMLS 349
L +P + + + L N +S P S V LF+N +
Sbjct: 230 KLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 49/259 (18%), Positives = 89/259 (34%), Gaps = 12/259 (4%)
Query: 121 LEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
LDL N D L L L L N +S P + L +L +L L NQ
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 181 GSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDM 240
+P ++ + L + N N + +L G M
Sbjct: 93 -ELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 241 LALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNL 300
L ++ ++ N T +IP + +L++++L N ++ +++ LN + N
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSG------ALPP 354
A+ N L + N ++P G+ ++ V L NN +S P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 355 DFGRYSPLEYFEVSVNNLT 373
+ + + N +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 1e-14
Identities = 47/269 (17%), Positives = 87/269 (32%), Gaps = 7/269 (2%)
Query: 337 SLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396
L+ V+ + L +P D ++ N +T L + +N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 397 SGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSM-VLISDNLFTGELPDKMSGN 455
S P + L + + N T L + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 456 LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLS 515
+ L + + SG K L + ++ TIP L PSLT L LD N+++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 516 GSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLML 575
+ +L L LS N +S + P L++L L+ N+ +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
Query: 576 TSLNLSSNRLTGEIPSQFENRAYASSFLN 604
+ L +N ++ + F Y + +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKAS 273
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 7e-07
Identities = 27/185 (14%), Positives = 49/185 (26%), Gaps = 7/185 (3%)
Query: 44 WQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQ 103
+ + + + + +L + +LT L L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 179
Query: 104 FNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASI 163
N I L + L L LS N + L+ L+ NN K+P +
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNKLVKVPGGL 238
Query: 164 GRLTELRQLNLVVNQFNG------SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLK 217
++ + L N + P + + L N PS F +
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 218 KLKKL 222
+
Sbjct: 299 VRAAV 303
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 7e-18
Identities = 31/211 (14%), Positives = 58/211 (27%), Gaps = 32/211 (15%)
Query: 693 NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQK-------HEKEFLAEVQILSTIR 745
++G G V+ + VK +K + F +
Sbjct: 6 KLMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 746 HLNIVKLLCCISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAV 805
+ KL + Y + L + + K + ++
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELY---------RVRVENPDEVLD 110
Query: 806 GAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVV 865
+ + +H IVH DL N+L+ I DF + + +E V
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVR 166
Query: 866 GSCGYIAPEYARTRKVNEKTDIYSFGVILLE 896
Y + R + DI S +L+
Sbjct: 167 NIITYFS------RTYRTEKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 58/256 (22%), Positives = 88/256 (34%), Gaps = 6/256 (2%)
Query: 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF 131
+ + L ++ RNLTIL L N + + LE LDLS N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 132 IGPI-PEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNL 190
+ + P L RL L+L + P L L+ L L N +L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSI 250
NL L L N S F L L +L + + P D+ L L L
Sbjct: 153 GNLTHLFLHGNRIS--SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 251 NNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGK 310
NN + ++ L+ L + L N + L+ S++ + ++P
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 311 LENLLNLSLMFNQLSG 326
+L L+ N L G
Sbjct: 271 R-DLKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (194), Expect = 1e-16
Identities = 47/296 (15%), Positives = 84/296 (28%), Gaps = 29/296 (9%)
Query: 270 VYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIP 329
L +P + + I L N ++ F NL L L N L+
Sbjct: 16 TSCPQQGLQ-AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 330 EGIGLLPSLKDVRLFNNMLSGALPP-DFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAG 388
L L+ + L +N ++ P F L + L P L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 389 IAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGEL 448
+ QDN L ++ + +L + ++ N + +L +L+ N
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 449 PDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLL 508
P L+ N + L L +L L
Sbjct: 194 PHAFRDL----------------------GRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 509 LDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSG 564
L+ N W L S +++ +P+++ + L+ N G
Sbjct: 232 LNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 4e-13
Identities = 49/270 (18%), Positives = 78/270 (28%), Gaps = 23/270 (8%)
Query: 327 EIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKL 386
+P GI + + + L N +S F L + N L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 387 AGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTG 446
+ DN + + + L + + GL+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF----------------- 125
Query: 447 ELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTT 506
+ L L + +N NL N + L SL
Sbjct: 126 ----RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 507 LLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKI 566
LLL QN+++ P L L L N LS E + L LQ L L++N +
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 567 PPQIGRLMLTSLNLSSNRLTGEIPSQFENR 596
+ L SS+ + +P + R
Sbjct: 242 RARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 1e-12
Identities = 49/288 (17%), Positives = 86/288 (29%), Gaps = 30/288 (10%)
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKK 218
+P I +++ L N+ + A +NL + ++ + +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLT-ILWLHSNVLARIDAAAFTGLALL 82
Query: 219 LKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLS 278
+ + L P T + L L L P L L +YL N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN--- 139
Query: 279 GEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
L + F L NL +L L N++S L SL
Sbjct: 140 --------------------ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 339 KDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
+ L N ++ P F L + NNL+ E L L + DN
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTG 446
+ + + L + ++ ++P L + ++ N G
Sbjct: 240 D-CRARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (133), Expect = 7e-09
Identities = 41/196 (20%), Positives = 63/196 (32%), Gaps = 30/196 (15%)
Query: 60 HCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCS 119
P + ++ L+L + + DL NLT L L N I S R
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 120 KLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQF 179
L+ L L QN P L RL LYL ANN+S ++ L L+ L L N +
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 180 NGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGD 239
A L+ + + + +P+ +
Sbjct: 238 VCDCRA-RPLWAWLQKFRGSSS--------------------------EVPCSLPQRLAG 270
Query: 240 MLALEFLDLSINNFTG 255
+ L+ N+ G
Sbjct: 271 ---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 41/221 (18%), Positives = 64/221 (28%), Gaps = 24/221 (10%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
N +S S C +L ++ +++N A L + +SDN +
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99
Query: 452 MSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQ 511
L RL PG L +L L L
Sbjct: 100 TFHGLGRLH---------------------TLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 512 NQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIG 571
N L +LT L L N++S L L L L +N+ + P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 572 RLMLTSLNLSSNRLTGEIPSQFENRAYASSFL---NNPGLC 609
L +P++ A +L +NP +C
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 25/175 (14%), Positives = 45/175 (25%), Gaps = 28/175 (16%)
Query: 31 DREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPF 90
DR L + N+ + G++T L L ++
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 91 ICDLRNLTILDLQFNYIISQFPRVLY------------------------NCSKLEYLDL 126
L +L L L N + P L+YL L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 127 SQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNG 181
+ N ++ + L+ +++ + +P L L N G
Sbjct: 233 NDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 41/207 (19%), Positives = 70/207 (33%), Gaps = 9/207 (4%)
Query: 71 GSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNY 130
S E++ N+ PP + ++ TIL L N + + L ++L L+L +
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 131 FIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNL 190
+ L L + + + T L V+ +
Sbjct: 67 LTKLQVDG-----TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSI 250
E EL + P T KL+KL +A+ NL + + L+ L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 251 NNFTGSIPSSVFKLKNLSKVYLYSNSL 277
N+ +IP F L +L+ N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 33/209 (15%), Positives = 59/209 (28%), Gaps = 8/209 (3%)
Query: 138 DIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALE 197
++ +++ + N++ +P + + L+L N A + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 198 LAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSI 257
L L L L ++ L + +
Sbjct: 62 LDRAELTK----LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 258 PSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNL 317
+ + + + + L+ + L+ NNLT LENL L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 318 SLMFNQLSGEIPEGIGLLPSLKDVRLFNN 346
L N L IP+G L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 44/206 (21%), Positives = 74/206 (35%), Gaps = 8/206 (3%)
Query: 263 KLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFN 322
K+ + +V +L+ +P + + ++ LS N L L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL-PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 323 QLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCA 382
+L+ +G LP L ++ +LP L +VS N LT L
Sbjct: 66 ELTKLQVDGT--LPVL-GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 383 GGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDN 442
G+L + + N L P L L + + NN+ T L NL +L+ +N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 443 LFTGELPDKMSG--NLSRLEISNNRF 466
+P G L + N +
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 35/179 (19%), Positives = 57/179 (31%), Gaps = 7/179 (3%)
Query: 8 TSLQIL------LSTLLLFFFGRANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHC 61
IL L T L L Q P + +++
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 62 TWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKL 121
+ P + T ++T L ++ + + L L L L+ N + + P +L KL
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 122 EYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180
E L L+ N ++ L L L L N++ IP L L N +
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 44/195 (22%), Positives = 65/195 (33%), Gaps = 6/195 (3%)
Query: 392 QDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDK 451
NL+ LP L ++ + N A L L+ + + T D
Sbjct: 18 DKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 452 MSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQ 511
L L++S+N+ G + V+ + N L G L L L L L
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKG 133
Query: 512 NQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIG 571
N+L P + L L+L+ N L+ + L L L L EN IP
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 572 RL-MLTSLNLSSNRL 585
+L L N
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 5/189 (2%)
Query: 232 EIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLK 291
+P + L LS N +++ L+++ L + Q +L +
Sbjct: 24 ALPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVL 79
Query: 292 VIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGA 351
++N ++P L L L + FN+L+ + L L+++ L N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 352 LPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLL 411
P LE ++ NNLT L L + Q+N+L +P+ L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 412 MVKIYNNSF 420
++ N +
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 6/209 (2%)
Query: 403 SLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEIS 462
+ +S L V + T +P L + +++ +S+NL +RL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYT-FSLATLMPYTRLTQL 60
Query: 463 NNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDI 522
N + V + ++ ++ ++P LP+LT L + N+L+ +
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 523 ISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLS 581
L L L N+L P + P L+ L L+ N + + L L +L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 582 SNRLTGEIPSQFENRAYASSFL-NNPGLC 609
N L F + +FL NP LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 24/89 (26%), Positives = 36/89 (40%), Gaps = 9/89 (10%)
Query: 509 LDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPP 568
N S + SL LN+S N+L E+P P L+ L S N + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPE 321
Query: 569 QIGRLMLTSLNLSSNRLTG--EIPSQFEN 595
L L++ N L +IP E+
Sbjct: 322 LPQN--LKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 23/155 (14%), Positives = 51/155 (32%), Gaps = 10/155 (6%)
Query: 39 KLKQHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLT 98
L + + + S + EL + ++ + F
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 99 ILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGK 158
N ++ + LE L++S N I +P RL+ L + N+++ +
Sbjct: 265 N-LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-E 318
Query: 159 IPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193
+P L + L++ N P ++++L
Sbjct: 319 VPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 8/92 (8%)
Query: 223 WMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIP 282
EI +LE L++S N +P+ +L+ L N L+ E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320
Query: 283 QAVESLNLKVIDLSANNLTGAIPNDFGKLENL 314
+ + NLK + + N L P+ +E+L
Sbjct: 321 ELPQ--NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 27/180 (15%), Positives = 50/180 (27%), Gaps = 12/180 (6%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
++ ++ P + L + D + +
Sbjct: 182 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPE 241
Query: 102 L-QFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIP 160
L Q + + S+L N I D L+ L ++ N + ++P
Sbjct: 242 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP 300
Query: 161 ASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLK 220
A RL L N +P NL+ L + YN P ++ L+
Sbjct: 301 ALPPRLERL---IASFNHLA-EVPELPQNLKQL---HVEYN---PLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 51/337 (15%), Positives = 100/337 (29%), Gaps = 24/337 (7%)
Query: 217 KKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNS 276
++ +L + + L +PE LE L S N+ T +P ++L + + +N+
Sbjct: 38 RQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPEL---PQSLKSLLVDNNN 89
Query: 277 LSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLP 336
L L V + L + F K+ ++ N SL E I
Sbjct: 90 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149
Query: 337 SLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNL 396
+ + L ++ L+ + L
Sbjct: 150 NQLEELPELQNLP---FLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206
Query: 397 SGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNL 456
+ ++ + + + S+ + + ++ NL
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266
Query: 457 SRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSG 516
L S+N +L SNN +P P L L+ N L+
Sbjct: 267 YYLNASSNEIRSLCDLP----PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA- 317
Query: 517 SLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ 553
+P ++L L++ N L E P+ + L+
Sbjct: 318 EVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 3e-04
Identities = 19/64 (29%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 532 NLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPS 591
N S EI P L++L++S N+ ++P R L L S N L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR--LERLIASFNHLA-EVPE 321
Query: 592 QFEN 595
+N
Sbjct: 322 LPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 8e-04
Identities = 13/54 (24%), Positives = 22/54 (40%), Gaps = 5/54 (9%)
Query: 526 KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLN 579
+ L L+ LS +PE P L+ L S N + ++P L ++
Sbjct: 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVD 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 10/81 (12%)
Query: 524 SWKSLTALNLSRNQLSGE----IPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM----- 574
L L L+ +S + + L++LDLS N Q+ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 575 -LTSLNLSSNRLTGEIPSQFE 594
L L L + E+ + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 13/92 (14%), Positives = 34/92 (36%), Gaps = 11/92 (11%)
Query: 503 SLTTLLLDQNQLSGSLPLDIIS-WKSLTALNLSRNQLSGE----IPEKIGFLPVLQDLDL 557
+ +L + +LS + +++ + + L L+ I + P L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 558 SENQFSGKIPPQIGRLM------LTSLNLSSN 583
N+ + + + + L+L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 2e-06
Identities = 14/92 (15%), Positives = 31/92 (33%), Gaps = 6/92 (6%)
Query: 241 LALEFLDLSINNFTGSIPSSVFK-LKNLSKVYLYSNSLSGE----IPQAVESL-NLKVID 294
L ++ LD+ + + + + L+ V L L+ I A+ L ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 295 LSANNLTGAIPNDFGKLENLLNLSLMFNQLSG 326
L +N L + + + + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 15/73 (20%), Positives = 25/73 (34%), Gaps = 6/73 (8%)
Query: 527 SLTALNLSRNQLSGE-IPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLM-----LTSLNL 580
+ +L++ +LS E + L Q + L + + I + L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 581 SSNRLTGEIPSQF 593
SN L
Sbjct: 63 RSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 3e-06
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 502 PSLTTLLLDQNQLSG----SLPLDIISWKSLTALNLSRNQLSGEIPEKIG-----FLPVL 552
L L L +S SL +++ SL L+LS N L ++ +L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 553 QDLDLSENQFSGKIPPQIGRLMLTSLNLS 581
+ L L + +S ++ ++ L +L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 14/77 (18%), Positives = 31/77 (40%), Gaps = 5/77 (6%)
Query: 287 SLNLKVIDLSANNLTGAIPND-FGKLENLLNLSLMFNQLSGE----IPEGIGLLPSLKDV 341
SL+++ +D+ L+ A + L+ + L L+ I + + P+L ++
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 342 RLFNNMLSGALPPDFGR 358
L +N L +
Sbjct: 61 NLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 16/159 (10%), Positives = 36/159 (22%), Gaps = 9/159 (5%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
+ T E + + ++
Sbjct: 292 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 351
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLSQNYF----IGPIPEDIDRLSRLKFLYLTANNMSG 157
L+ + + S L L L+ + + L+ L L+ N +
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 158 KIPASIGR-----LTELRQLNLVVNQFNGSIPAEIGNLQ 191
+ L QL L ++ + + L+
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 14/92 (15%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 192 NLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLA----LEFLD 247
++++L++ E S + L++ + + + L + I L L L+
Sbjct: 3 DIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 248 LSINNFTGSIPSSVFKLKNLSKVYLYSNSLSG 279
L N V + + SL
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 19/138 (13%), Positives = 36/138 (26%), Gaps = 9/138 (6%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
W + ++ S + ++ L + + L +L
Sbjct: 316 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 375
Query: 102 LQFNYI----ISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDI-----DRLSRLKFLYLTA 152
L + S L L LDLS N + L+ L L
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435
Query: 153 NNMSGKIPASIGRLTELR 170
S ++ + L + +
Sbjct: 436 IYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 6/91 (6%)
Query: 266 NLSKVYLYSNSLSGE-IPQAVESL-NLKVIDLSANNLTG----AIPNDFGKLENLLNLSL 319
++ + + LS + + L +V+ L LT I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 320 MFNQLSGEIPEGIGLLPSLKDVRLFNNMLSG 350
N+L + ++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 15/80 (18%), Positives = 32/80 (40%), Gaps = 10/80 (12%)
Query: 243 LEFLDLSINNFTG----SIPSSVFKLKNLSKVYLYSNSLSGEIPQA-VESL-----NLKV 292
L L L+ + + S+ +++ +L ++ L +N L VES+ L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 293 IDLSANNLTGAIPNDFGKLE 312
+ L + + + LE
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 14/91 (15%)
Query: 217 KKLKKLWMASTNLIGEIPETIGDMLA----LEFLDLSINNFTGSIPSSVFK-----LKNL 267
L+ LW+A ++ ++ L L LDLS N + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 268 SKVYLYSNSLSGEIPQAVESL-----NLKVI 293
++ LY S E+ +++L +L+VI
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 8/91 (8%), Positives = 25/91 (27%), Gaps = 5/91 (5%)
Query: 72 SVTELHLTNMNMNGT-FPPFICDLRNLTILDLQFNYI----ISQFPRVLYNCSKLEYLDL 126
+ L + ++ + + L+ ++ L + L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 127 SQNYFIGPIPEDIDRLSRLKFLYLTANNMSG 157
N + + + + ++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 12/89 (13%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 96 NLTILDLQFNYII-SQFPRVLYNCSKLEYLDLSQNYF----IGPIPEDIDRLSRLKFLYL 150
++ LD+Q + +++ +L + + + L I + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 151 TANNMSGKIPASIGRL-----TELRQLNL 174
+N + + + ++++L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 10/88 (11%)
Query: 121 LEYLDLSQNYFI-GPIPEDIDRLSRLKFLYLTANNMSGK----IPASIGRLTELRQLNLV 175
++ LD+ E + L + + + L ++ I +++ L +LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 176 VNQFNGSIPAEIG-----NLQNLEALEL 198
N+ + ++ L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 14/93 (15%), Positives = 28/93 (30%), Gaps = 5/93 (5%)
Query: 453 SGNLSRLEISNNRFSGKIPTGVSSS-KNLVVFQASNNLFNG----TIPGELTALPSLTTL 507
S ++ L+I S + + V + + I L P+L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 508 LLDQNQLSGSLPLDIISWKSLTALNLSRNQLSG 540
L N+L ++ + + + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 11/74 (14%), Positives = 26/74 (35%), Gaps = 9/74 (12%)
Query: 289 NLKVIDLSANNLTG----AIPNDFGKLENLLNLSLMFNQLSGEIPEGIG-----LLPSLK 339
L+V+ L+ +++ ++ +L L L N L + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 340 DVRLFNNMLSGALP 353
+ L++ S +
Sbjct: 430 QLVLYDIYWSEEME 443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 42/268 (15%), Positives = 89/268 (33%), Gaps = 18/268 (6%)
Query: 317 LSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTG-S 375
L L L ++ + L + R + + L F + +++ ++S + + +
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 376 LPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSL--LMVKIYNNSFTGNIPAGLWTGFN 433
L L KL ++ + LS + +L S+L L + + + L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 434 LSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQAS------- 486
L + +S E +++ I+ SG S + +V +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 487 --NNLFNGTIPGELTALPSLTTLLLDQ-NQLSGSLPLDIISWKSLTALNLSRNQLSGEIP 543
+ + E L L L L + + L++ +L L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 544 EKIGFLPVLQDLDLSENQFSGKIPPQIG 571
L L ++ + F+ P IG
Sbjct: 243 L---LKEALPHLQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 5e-07
Identities = 36/275 (13%), Positives = 89/275 (32%), Gaps = 15/275 (5%)
Query: 74 TELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYF-I 132
L LT N++ + + + + Q ++ +++++DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL-SQGVIAFRC-PRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 133 GPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLV--VNQFNGSIPAEIGNL 190
+ + + S+L+ L L +S I ++ + + L +LNL ++ + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 191 QNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGD-----MLALEF 245
L+ L L++ +F+ + + + S + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYL-YSNSLSGEIPQAVESL-NLKVIDLSANNLTGA 303
F+L L + L + E + + LK + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 304 IPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338
+ E L +L + + + IG +
Sbjct: 241 LQL---LKEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 12/101 (11%), Positives = 33/101 (32%), Gaps = 8/101 (7%)
Query: 529 TALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGE 588
L+L+ L ++ ++ V+ + + + ++LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 589 IPSQF-------ENRAYASSFLNNPGLCASSSNVNLKSCFF 622
+N + L++P + + N NL
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 4e-06
Identities = 47/333 (14%), Positives = 98/333 (29%), Gaps = 29/333 (8%)
Query: 262 FKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTG----AIPNDFGKLENLLNL 317
+ K+L + + +E ++K I LS N + + + ++L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 318 SLMFNQ---LSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTG 374
+ EIPE + LL + + + +S +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 375 SLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNL 434
L H G AG + + N L + N F
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 435 SMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTI 494
+L + + + + +L ++ + + +L + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL---------QDNTFTHLGSSAL 235
Query: 495 PGELTALPSLTTLLLDQNQLSGSLPLDIISW------KSLTALNLSRNQLSGEIPEKI-- 546
L + P+L L L+ LS ++ L L L N++ + +
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295
Query: 547 ---GFLPVLQDLDLSENQFS--GKIPPQIGRLM 574
+P L L+L+ N+FS + +I +
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 40/318 (12%), Positives = 91/318 (28%), Gaps = 20/318 (6%)
Query: 241 LALEFLDLSINNFTG----SIPSSVFKLKNLSKVYLYSNSLSGE----IPQAVESL-NLK 291
++E L ++ T S+ + + + ++ ++ L N++ E + + + S +L+
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 292 VIDLSAN---NLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
+ + S + IP L L + + L +
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
L P +++ ++ + L I N L +
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSG 468
+ I L + L +L D +L ++ S
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW--- 525
+ + L+ + + + + L TL L N++ + +
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVD---AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 526 --KSLTALNLSRNQLSGE 541
L L L+ N+ S E
Sbjct: 300 KMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 39/325 (12%), Positives = 86/325 (26%), Gaps = 29/325 (8%)
Query: 286 ESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGE----IPEGIGLLPSLKDV 341
E +LK+ ++ + ++ + +++ + L N + E + E I L+
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 342 RL---FNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSG 398
F + +P ++ + S + +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 399 ELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSR 458
L KI + L ++ N + +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 459 LEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSL 518
+ + +N + + +L + + S +L
Sbjct: 185 HRLLHTV---------KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235
Query: 519 PLDIISWKSLTALNLSRNQLSGEIPEKIGF------LPVLQDLDLSENQFSGKIPPQIGR 572
+ + SW +L L L+ LS + LQ L L N+ +
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295
Query: 573 LM------LTSLNLSSNRLTGEIPS 591
++ L L L+ NR + E
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDV 320
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 53/306 (17%), Positives = 97/306 (31%), Gaps = 31/306 (10%)
Query: 72 SVTELHLTNMNMNG----TFPPFICDLRNLTILDLQFNYIIS----------QFPRVLYN 117
SV E+ L+ + I ++L I + + + L
Sbjct: 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLK 91
Query: 118 CSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVN 177
C KL + LS N F E + + + G L VN
Sbjct: 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 151
Query: 178 QFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETI 237
+ + P + LE E++ + K+ + + + + E +
Sbjct: 152 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 211
Query: 238 GDMLALEFLDLSINNFT----GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAV-------E 286
L+ LDL N FT ++ ++ NL ++ L LS AV E
Sbjct: 212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271
Query: 287 SLNLKVIDLSANNLTGAIPND-----FGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDV 341
++ L+ + L N + K+ +LL L L N+ S E + + + +
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVFST 330
Query: 342 RLFNNM 347
R +
Sbjct: 331 RGRGEL 336
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 22/106 (20%), Positives = 36/106 (33%), Gaps = 5/106 (4%)
Query: 246 LDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIP 305
L L+ + T + + +L ++ + L N L P L+V+ S N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 306 NDFGKLENLLNLSLMFNQL-SGEIPEGIGLLPSLKDVRLFNNMLSG 350
L L N+L + + P L + L N L
Sbjct: 61 VANLPRLQELLLC--NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 19/122 (15%), Positives = 45/122 (36%), Gaps = 10/122 (8%)
Query: 146 KFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFS 205
+ L+L +++ + + +L + L+L N+ P + L+ LE +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV----LQASDN 53
Query: 206 PSSLPSNFTQLKKLKKLWMASTNLIG-EIPETIGDMLALEFLDLSINNFTG--SIPSSVF 262
L +L++L + + L + + L L+L N+ I +
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 263 KL 264
++
Sbjct: 114 EM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 23/125 (18%), Positives = 41/125 (32%), Gaps = 7/125 (5%)
Query: 459 LEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSL 518
L +++ + + + + S+N P L AL L L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALEN 57
Query: 519 PLDIISWKSLTALNLSRNQL-SGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTS 577
+ + L L L N+L + + P L L+L N RL
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
Query: 578 LNLSS 582
++SS
Sbjct: 117 PSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 8e-05
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 9/125 (7%)
Query: 76 LHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPI 135
LHL + ++ T + L +T LDL N + + P L LE L +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 136 PEDIDRLSRLKFLYLTANNM-SGKIPASIGRLTELRQLNLVVNQF---NGSIPAEIGNLQ 191
+ + L RL+ L L N + + L LNL N G L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 192 NLEAL 196
++ ++
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 7e-04
Identities = 30/106 (28%), Positives = 42/106 (39%), Gaps = 8/106 (7%)
Query: 485 ASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPE 544
A +L T+ L L +T L L N+L P + + + L L S N E +
Sbjct: 6 AHKDL---TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVD 59
Query: 545 KIGFLPVLQDLDLSENQF-SGKIPPQIGRLM-LTSLNLSSNRLTGE 588
+ LP LQ+L L N+ + L LNL N L E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 3/100 (3%)
Query: 274 SNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIG 333
+ L + Q ++ + +DL + I N L+ + N++ +G
Sbjct: 4 TAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFP 60
Query: 334 LLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLT 373
LL LK + + NN + L ++ N+L
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 22/132 (16%), Positives = 43/132 (32%), Gaps = 5/132 (3%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
+ LDL+ I + + + +D S N + L RLK L +
Sbjct: 16 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNG-SIPAEIGNLQNLEALELAY-NTEFSPSSLP 210
N + L +L +L L N + +L++L L +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 211 SNFTQLKKLKKL 222
++ +++ L
Sbjct: 133 YVIYKVPQVRVL 144
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 30/175 (17%), Positives = 52/175 (29%), Gaps = 6/175 (3%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
IP DI L L N + + + I +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
+ F L +LK L + + +P + + +L L+L+ N F
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 255 GSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFG 309
+ + F + L K L + P V + +K DL + + N G
Sbjct: 140 CNCHLAWF-AEWLRKKSLNGGAARCGAPSKVRDVQIK--DLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.003
Identities = 30/151 (19%), Positives = 53/151 (35%), Gaps = 1/151 (0%)
Query: 447 ELPDKMSGNLSRLEISNNRFSGKI-PTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLT 505
E+P + + + L +++N +LV + N G P +
Sbjct: 22 EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81
Query: 506 TLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGK 565
L L +N++ + L LNL NQ+S +P L L L+L+ N F+
Sbjct: 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141
Query: 566 IPPQIGRLMLTSLNLSSNRLTGEIPSQFENR 596
L +L+ PS+ +
Sbjct: 142 CHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 31/224 (13%), Positives = 64/224 (28%), Gaps = 15/224 (6%)
Query: 264 LKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQ 323
L N K+ ++++ + QA + + + +T L NL+ L L NQ
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 324 LSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAG 383
++ P L S + + S
Sbjct: 75 ITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 384 GKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNL 443
++ + + + + L L+ + DN
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 444 FTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASN 487
+ P NL + + NN+ S P ++++ NL + +N
Sbjct: 185 ISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 32/227 (14%), Positives = 73/227 (32%), Gaps = 17/227 (7%)
Query: 311 LENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVN 370
L N + ++ + ++ + + L + + F ++ + L E+ N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 371 NLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWT 430
+T P ++ + + L + + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 431 GFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLF 490
+ + + + G + +S T +++ L +A +N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQY--------LSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 491 NGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQ 537
+ P L +LP+L + L NQ+S PL + +L + L+ NQ
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 30/229 (13%), Positives = 69/229 (30%), Gaps = 19/229 (8%)
Query: 117 NCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVV 176
+ + ++ + + L + L ++ I + L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 177 NQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPET 236
NQ ++ L+NL + + ++ + ++
Sbjct: 73 NQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 237 IGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLS 296
+ ++ L I N + + + ++ + + + L +
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS------KLTTLKAD 181
Query: 297 ANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFN 345
N ++ P L NL+ + L NQ+S P + +L V L N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 40/225 (17%), Positives = 75/225 (33%), Gaps = 17/225 (7%)
Query: 289 NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNML 348
N I +N+T + L+ + LS ++ EG+ L +L + L +N +
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI 75
Query: 349 SGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCS 408
D L + AG + + ++ G +
Sbjct: 76 -----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 409 SLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSG 468
+ +Y + + L NL + I + + P L+ L+ +N+ S
Sbjct: 131 ---LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 469 KIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQ 513
P ++S NL+ NN + P L +L + L NQ
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 29/205 (14%), Positives = 60/205 (29%), Gaps = 19/205 (9%)
Query: 93 DLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTA 152
DL +T L + + + + L L+L N P L
Sbjct: 39 DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNP 96
Query: 153 NNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSN 212
I T + + + + + L + + +
Sbjct: 97 LKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY------------LDLNQITNI 144
Query: 213 FTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYL 272
+++ N + ++ L L N + P + L NL +V+L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202
Query: 273 YSNSLSGEIPQAVESL-NLKVIDLS 296
+N +S P + + NL ++ L+
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 43 HWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNG-TFPPFICDLRNLTILD 101
+P S ++++L + N + + L NL +
Sbjct: 142 TNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVH 201
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLS 127
L+ N I P L N S L + L+
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 26/167 (15%), Positives = 42/167 (25%), Gaps = 5/167 (2%)
Query: 8 TSLQILLSTLLLFFFGRANSQLYDREHAVLLKLKQHWQNPPPISHWATTNSSHCTWPEIA 67
+L L L L + T T
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 68 CTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLS 127
++ L + +++N N +S L N SKL L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKAD 181
Query: 128 QNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNL 174
N P + L L ++L N +S P + + L + L
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 21/109 (19%), Positives = 33/109 (30%), Gaps = 4/109 (3%)
Query: 43 HWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDL 102
+S+ I+ G +L+ N + + +L LT L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 103 QFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151
N I P L + L + L N P + S L + LT
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 15/119 (12%), Positives = 29/119 (24%), Gaps = 3/119 (2%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
H + N L L + + +
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIP 160
N + V + S LD+S+ ++ L +L+ N+ K+P
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 36/245 (14%), Positives = 63/245 (25%), Gaps = 18/245 (7%)
Query: 60 HCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCS 119
HC+ C + VTE+ P + RN L +
Sbjct: 7 HCSNRVFLCQESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 120 KLEYLDLSQNYFIGPI--PEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVN 177
LE +++SQN + I + + ANN+ P + L L+ L +
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 178 QFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETI 237
+ L++ N S + LW+ +
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 238 GDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLS 296
E NN + + + +E+L L+
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST- 232
Query: 297 ANNLT 301
NL
Sbjct: 233 -YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 30/251 (11%), Positives = 57/251 (22%), Gaps = 19/251 (7%)
Query: 92 CDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLT 151
C R + + I S PR L L+ + ++
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPR------NAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 61
Query: 152 ANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPS 211
N++ I A + + N L +
Sbjct: 62 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121
Query: 212 NFTQLKKLKKLWMAS--TNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSK 269
+ + L + E +G L L+ N + +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 270 VYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEI 328
+N+L ++D+S + L+ L S L
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-- 237
Query: 329 PEGIGLLPSLK 339
LP+L+
Sbjct: 238 ------LPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 17/133 (12%), Positives = 31/133 (23%)
Query: 42 QHWQNPPPISHWATTNSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILD 101
Q+ N + T +I + ++ F+ IL
Sbjct: 100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 159
Query: 102 LQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPA 161
L N I E N + S L ++ +
Sbjct: 160 LNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 219
Query: 162 SIGRLTELRQLNL 174
+ L +LR +
Sbjct: 220 GLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 33/223 (14%), Positives = 65/223 (29%), Gaps = 8/223 (3%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
IP D+ L + + +L ++ + N I A++ +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
P F L L+ L +++T + L LD+ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 255 GSIPSSVFKLKNLSKVYLY---SNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKL 311
+I + F + V L+ + + ++ NNL + F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 312 ENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPP 354
+ L + ++ G+ L L+ +N LP
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 20/125 (16%), Positives = 40/125 (32%), Gaps = 3/125 (2%)
Query: 135 IPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLE 194
+ + + L + + + LN + ++ N+ L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68
Query: 195 ALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFT 254
+L L+ N + + S + LK L ++ L E L LE L L N+ +
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 255 GSIPS 259
+
Sbjct: 129 DTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 8e-04
Identities = 25/121 (20%), Positives = 46/121 (38%), Gaps = 4/121 (3%)
Query: 488 NLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSG--EIPEK 545
+L +L A L ++ ++ +L + + L +LNLS N+L ++
Sbjct: 28 DLKGLRSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 546 IGFLPVLQDLDLSENQFSGKIPPQIGR-LMLTSLNLSSNRLTGEIPSQFENRAYASSFLN 604
+ P L+ L+LS N+ + + L L L L N L+ Q +
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFP 146
Query: 605 N 605
Sbjct: 147 K 147
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 9e-04
Identities = 24/135 (17%), Positives = 52/135 (38%), Gaps = 5/135 (3%)
Query: 247 DLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPN 306
+L + + K + S+ L L + + N+ V+ +++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRI 59
Query: 307 DFGKLENLLNLSLMFNQLSG--EIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEY 364
+ LL+L+L N+L ++ + P+LK + L N L D + LE
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 365 FEVSVNNLTGSLPEH 379
+ N+L+ + +
Sbjct: 120 LWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 19/118 (16%), Positives = 42/118 (35%), Gaps = 3/118 (2%)
Query: 57 NSSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYI--ISQFPRV 114
+ L+ + +M T ++ L L+L N + + +
Sbjct: 28 DLKGLRSDPDLVAQNIDVVLNRRS-SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 115 LYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQL 172
+ L+ L+LS N D + +L+ L+L N++S ++ +R+
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 31/191 (16%), Positives = 66/191 (34%), Gaps = 16/191 (8%)
Query: 84 NGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLS 143
+ T +L ++ + + I S + + L L+ N P L+
Sbjct: 35 SVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP-----LA 87
Query: 144 RLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTE 203
LK L + + S + + + + + I + Q
Sbjct: 88 NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES-----LYLG 142
Query: 204 FSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFK 263
+ + + ++L KL L + + +P + + L+ L LS N+ + ++
Sbjct: 143 NNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAG 198
Query: 264 LKNLSKVYLYS 274
LKNL + L+S
Sbjct: 199 LKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 21/141 (14%), Positives = 42/141 (29%), Gaps = 3/141 (2%)
Query: 243 LEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVES--LNLKVIDLSANNL 300
L + + + +NL+++Y+ + + L+ + + + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 301 TGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYS 360
P+ F L L+L FN L + + L + V N + R+
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 361 PLEYFEVSVNNLTGSLPEHLC 381
V L L
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLA 149
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 23/153 (15%), Positives = 43/153 (28%), Gaps = 6/153 (3%)
Query: 118 CSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASI-GRLTELRQLNLVV 176
L +++ + + L LY+ + L ELR L +V
Sbjct: 7 PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 177 NQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLI-GEIPE 235
+ P L L L++N + SL Q L++L ++ L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFN---ALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122
Query: 236 TIGDMLALEFLDLSINNFTGSIPSSVFKLKNLS 268
+ + + + N S
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1014 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.97 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.94 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.87 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.85 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.7 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.7 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.67 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.48 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.83 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.41 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.21 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=216.1
Q ss_pred CCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 53789997740065794899996544997089999850431113786999999999998079996105999997399159
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
+..++|...+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 9510538878981285829999999899989999998430---1727999999999998679998805857798899989
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399968990
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~ 843 (1014)
+||||+++|+|.+++... .+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+
T Consensus 94 ivmEy~~gg~L~~~~~~~------------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~ 158 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (293)
T ss_dssp EEEECCTTCBHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEC
T ss_conf 999703798089886415------------999999999999999999999987---97226776888688789968642
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 01464013234574211235545755245210156887975750448799999862997899997102899999997519
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 844 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
|||+|+.+.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.... .......+
T Consensus 159 DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~ 232 (293)
T d1yhwa1 159 DFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATNG 232 (293)
T ss_dssp CCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHHC
T ss_pred CCHHHEEECCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHCC
T ss_conf 515641321366---644444447773682664479988012031372999998048899899799999---99998579
Q ss_pred CCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 96011012223882129999999999967139999999999999999724999999
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
.+.. ..+......+.+++.+||+.||++|||++|+++ ||||+.
T Consensus 233 ~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----Hp~~~~ 275 (293)
T d1yhwa1 233 TPEL---------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ----HQFLKI 275 (293)
T ss_dssp SCCC---------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT----CGGGGG
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCC
T ss_conf 9988---------885537999999999986699668909999964----996577
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.39 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=214.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 78999774006579489999654499708999985043111378699999999999807999610599999739915999
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 765 (1014)
.++|+..+.||+|+||+||+|.++.+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 746089989721748099999999999799999984566--412799999999999857998884696540467436798
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539996899001
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Df 845 (1014)
|||+++|+|.+++... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+||
T Consensus 82 mEy~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp EECCTTEEGGGGSBTT-----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred EECCCCCCHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCC
T ss_conf 8645898089997537-----------9999999999999999999999975---9835754689978878998798323
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 464013234574211235545755245210156887-9757504487999998629978999971028999999975199
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKV-NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|+|+....... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||........... ......
T Consensus 148 G~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~ 223 (271)
T d1nvra_ 148 GLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKK 223 (271)
T ss_dssp TTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTC
T ss_pred HHHEEECCCCC-CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHCCC
T ss_conf 14224046886-53111325574742872861899999710161737999999829978888985999999---986388
Q ss_pred CCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 6011012223882129999999999967139999999999999999724999999879
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
... ..+......+.+++.+||+.||++|||++|+++ ||||+..-.
T Consensus 224 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~----hpwf~~~l~ 268 (271)
T d1nvra_ 224 TYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK----DRWYNKPLK 268 (271)
T ss_dssp TTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT----CTTTTCCCC
T ss_pred CCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCCC
T ss_conf 878---------864469999999999976799668909999961----984585988
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=377.42 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=219.4
Q ss_pred CCCCCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 43453789997740065794899996544997089999850431113786999999999998079996105999997399
Q 001778 681 RDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 681 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 760 (1014)
....+.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 20 ~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 9887865758988984076819999998899989999998452---4316999999999998679979992999999899
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CC
Q ss_conf 1599998266899889951038998777755666899999999999999998873159998495067998754539--99
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY--NF 838 (1014)
Q Consensus 761 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~--~~ 838 (1014)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++. ++
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT----------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSC
T ss_pred EEEEEEECCCCCCHHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCC
T ss_conf 9999998579988999997623----------7899999999999999999999756---97600015467364168898
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 68990014640132345742112355457552452101568879757504487999998629978999971028999999
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+||+|||+|+.+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .
T Consensus 164 ~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~ 236 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---N 236 (350)
T ss_dssp CEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H
T ss_pred EEEEEECCHHEECCCCC----CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---H
T ss_conf 69995452104425654----3200068624218899758998726765546599999985989989979999999---9
Q ss_pred HHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 97519960110122238821299999999999671399999999999999997249999998799
Q 001778 919 HIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+......... .........+.+++.+||+.||++|||++|+++ ||||......
T Consensus 237 i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~----hp~~~~~~~~ 289 (350)
T d1koaa2 237 VKSCDWNMDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE----HPWLTPGNAP 289 (350)
T ss_dssp HHHTCCCSCC--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH----STTTSCTTCC
T ss_pred HHHCCCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCCCCCCC
T ss_conf 9847889894--------223589999999999975689667908999862----9132889888
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=375.03 Aligned_cols=269 Identities=20% Similarity=0.253 Sum_probs=220.0
Q ss_pred CCCCCCCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
Q ss_conf 44434537899977400657948999965449970899998504311137869999999999980799961059999973
Q 001778 679 NFRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS 758 (1014)
Q Consensus 679 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 758 (1014)
..+.....++|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 5789985403599899931778299999998999799999988726---4679999999999986799798919999998
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--C
Q ss_conf 99159999826689988995103899877775566689999999999999999887315999849506799875453--9
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD--Y 836 (1014)
Q Consensus 759 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~--~ 836 (1014)
++..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++ .
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~ 164 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAED----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 164 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTT----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTT
T ss_pred CCEEEEEEECCCCCHHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCC
T ss_conf 999999998289980888898638----------9989999999999999999999977---926513144553113467
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99689900146401323457421123554575524521015688797575044879999986299789999710289999
Q 001778 837 NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 837 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 916 (1014)
++.+||+|||+|....... ......|++.|+|||++.+..++.++||||+||++|||+||+.||.+.+.......
T Consensus 165 ~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~- 239 (352)
T d1koba_ 165 ASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN- 239 (352)
T ss_dssp CCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-
T ss_pred CCEEEEEECCCCEECCCCC----CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-
T ss_conf 8848995256303437887----20100476453489997479989763338989999999968899899799999999-
Q ss_pred HHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 999751996011012223882129999999999967139999999999999999724999999879
Q 001778 917 WRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
+......... ..+.....++.+++.+||+.||++|||++|+++ ||||+....
T Consensus 240 --i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~----Hp~~~~~~~ 291 (352)
T d1koba_ 240 --VKRCDWEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE----HPWLKGDHS 291 (352)
T ss_dssp --HHHCCCCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT----STTTSSCCT
T ss_pred --HHHCCCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCCC
T ss_conf --9847889893--------002479999999999975699668918999960----973488820
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.29 Aligned_cols=270 Identities=20% Similarity=0.275 Sum_probs=223.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||+||+|.+..+++.||||++.+.........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 88 Ey~~gg~L~~~~~~~~-----------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ECCCCCCHHHHHHCCC-----------CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCC
T ss_conf 7048987777653159-----------999999999999999999762165---08847677412366888538860321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .+..+..
T Consensus 154 ~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~~- 227 (288)
T d1uu3a_ 154 TAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----KIIKLEY- 227 (288)
T ss_dssp TCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHTTCC-
T ss_pred CCEECCCCCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHCCCC-
T ss_conf 0242256776-433355567755258440026898966623045699999803889989959999999----9971899-
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHH--HHHHCCCCCCCCCCCCCC
Q ss_conf 110122238821299999999999671399999999999999--997249999998799976
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVL--QILLNNPIFPTEKNGGRK 986 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~--~~L~~~~~~~~~~~~~~~ 986 (1014)
.+. .....++.+++.+||+.||++|||++|+. ..+++||||....+.+-.
T Consensus 228 ------~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 228 ------DFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp ------CCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred ------CCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHH
T ss_conf ------998----5479999999999855797689197897377898769764789988961
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.83 Aligned_cols=267 Identities=24% Similarity=0.276 Sum_probs=218.6
Q ss_pred CCCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 45378999774006579489999654499708999985043111378699999999999807999610599999739915
Q 001778 683 SDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 683 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 762 (1014)
+++.+.|...+.||+|+||+||+|.++.+++.||||++..... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 8776666998899406583999999999998999999815773--12899999999999867998999198999989988
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCC
Q ss_conf 9999826689988995103899877775566689999999999999999887315999849506799875453---9996
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD---YNFN 839 (1014)
Q Consensus 763 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~---~~~~ 839 (1014)
|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||.. +|+||||||+||++. .++.
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG-----------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEECCCCCCHHHHHHCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCE
T ss_conf 89885268984888653036-----------788789999999999998752413---0556870463001104688824
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89900146401323457421123554575524521015688797575044879999986299789999710289999999
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 840 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
+||+|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+......... .
T Consensus 149 vkl~DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~---i 221 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ---I 221 (307)
T ss_dssp EEECCC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H
T ss_pred EEEECCCEEEECCCCC----EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---H
T ss_conf 9983154358725897----04400328422591887379998078734515999999859799999899999999---8
Q ss_pred HHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75199601101222388212999999999996713999999999999999972499999987999
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNGG 984 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~~~ 984 (1014)
........ .+........+.+++.+|++.||++|||++|+++ ||||+......
T Consensus 222 ~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----hp~~~~~~~~~ 274 (307)
T d1a06a_ 222 LKAEYEFD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ----HPWIAGDTALD 274 (307)
T ss_dssp HTTCCCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH----STTTTSSCCCC
T ss_pred HCCCCCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCCCCC
T ss_conf 61687778--------7666678999999999976089757918999862----98447997545
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.46 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=214.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||+||+|.+..+++.||+|++... ........+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC--CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 6888978971277809999999899969999998754--09789999999999998679999994999999899999999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||
T Consensus 84 Ey~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp ECCTTEEHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCCCCCHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECC
T ss_conf 7679986899874249-----------999999999999999999999985--999714457799468789989995487
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC-
Q ss_conf 6401323457421123554575524521015688797575044879999986299789999710289999999751996-
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP- 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 925 (1014)
+|...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.................
T Consensus 151 la~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 151 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 76256788-----6211137714119468758998948889989999999998889989988789999998875177545
Q ss_pred ------------------------CHHCCC-------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf ------------------------011012-------2238821299999999999671399999999999999997249
Q 001778 926 ------------------------IVDALD-------KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 926 ------------------------~~~~~~-------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 974 (1014)
..+..+ +...... ...++.+++.+|++.||++|||++|+++ |
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~~L~~dP~~R~ta~e~L~----H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV---FSLEFQDFVNKCLIKNPAERADLKQLMV----H 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTT---BCHHHHHHHHHHTCSSTTTSCCHHHHHT----S
T ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHH----C
T ss_conf 77421233322111122235413477887665026876676444---8999999999986899467908999960----9
Q ss_pred CCCCCCCC
Q ss_conf 99999879
Q 001778 975 PIFPTEKN 982 (1014)
Q Consensus 975 ~~~~~~~~ 982 (1014)
|||++..+
T Consensus 299 pf~~~~~~ 306 (322)
T d1s9ja_ 299 AFIKRSDA 306 (322)
T ss_dssp HHHHHHHH
T ss_pred HHHCCCCC
T ss_conf 86476982
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.80 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=215.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 86 Ey~~~g~L~~~l~~~~-----------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EECCCCCHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCC
T ss_conf 5047985898875048-----------999999999999999999999988---94652202344146689987115556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..... ..+......
T Consensus 152 ~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~ 222 (263)
T d2j4za1 152 WSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----KRISRVEFT 222 (263)
T ss_dssp SCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCC
T ss_pred EEEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHCCCCC
T ss_conf 33544888-----523557887634999975899893144046759999983299998889999999----999718999
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 11012223882129999999999967139999999999999999724999999
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
+ +.....++.+++.+||+.||++|||++|+++ ||||.+
T Consensus 223 -------~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~----hp~~~~ 260 (263)
T d2j4za1 223 -------F----PDFVTEGARDLISRLLKHNPSQRPMLREVLE----HPWITA 260 (263)
T ss_dssp -------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT----CHHHHH
T ss_pred -------C----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCCC
T ss_conf -------9----8668999999999976479768909999971----907078
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.27 Aligned_cols=271 Identities=23% Similarity=0.271 Sum_probs=220.9
Q ss_pred CCCCCCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 443453789997740065794899996544997089999850431113---78699999999999807999610599999
Q 001778 680 FRDSDILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLD---QKHEKEFLAEVQILSTIRHLNIVKLLCCI 756 (1014)
Q Consensus 680 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 756 (1014)
|+...+.++|...+.||+|+||+||+|.++.+++.||||++.+..... ....+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp CBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE
T ss_conf 65788556779827981178959999999999989999998756632134068999999999999867998999388999
Q ss_pred ECCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC
Q ss_conf 73991599998266899889951038998777755666899999999999999998873159998495067998754539
Q 001778 757 SSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 757 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~ 836 (1014)
.+++..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||.. +|+||||||+||+++.
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~-----------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKE-----------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD 148 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred EECCEEEEEEECCCCCCCCCHHCCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEEC
T ss_conf 97998999998677864310010356-----------421557899999999998766625---4221133301279825
Q ss_pred CC----CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 99----68990014640132345742112355457552452101568879757504487999998629978999971028
Q 001778 837 NF----NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 837 ~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 912 (1014)
++ .+|++|||+|....... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+......
T Consensus 149 ~~~~~~~vkl~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 224 (293)
T d1jksa_ 149 RNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224 (293)
T ss_dssp SSSSSCCEEECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCCCCEEECCHHHHHHCCCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 89866646964334421057776----31224777743099998189999766522140999999708899889999999
Q ss_pred HHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99999997519960110122238821299999999999671399999999999999997249999998799
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.. ........... ..+......+.+++.+||+.||++|||++|+++ ||||+....+
T Consensus 225 ~~---~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----hp~~~~~~~~ 280 (293)
T d1jksa_ 225 LA---NVSAVNYEFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ----HPWIKPKDTQ 280 (293)
T ss_dssp HH---HHHTTCCCCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH----STTTCC----
T ss_pred HH---HHHHCCCCCCC--------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCCCCCHH
T ss_conf 99---99816888870--------104788999999999986389668919999961----9041888705
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.68 Aligned_cols=259 Identities=23% Similarity=0.297 Sum_probs=217.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|...+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++...+ .+++.....++.|++.||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 85 ey~~gg~L~~~~~~~~-----------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ECCCCCCHHHHHHCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECC
T ss_conf 0357986055553256-----------775999999999996521134315---96224647778476589988882056
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+....... .......+
T Consensus 151 ~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---i~~~~~~~ 224 (337)
T d1o6la_ 151 LCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---ILMEEIRF 224 (337)
T ss_dssp TCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCCCCC
T ss_pred CCCCCCCCC---CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH---HHCCCCCC
T ss_conf 520035678---620551008899666650489888333102230678899878999999699999999---85289989
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHHCCCCCCCCC
Q ss_conf 1101222388212999999999996713999999999-----999999972499999987
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev~~~L~~~~~~~~~~ 981 (1014)
+.....++.+++..|+++||++|++ ++|+++ ||||....
T Consensus 225 ------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~----Hp~f~~i~ 268 (337)
T d1o6la_ 225 ------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----HRFFLSIN 268 (337)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----SGGGTTCC
T ss_pred ------------CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC----CCCCCCCC
T ss_conf ------------866899999999866638934422565234999972----91503699
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.94 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=213.5
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 78999774006579489999654499708999985043111378699999999999807999610599999739915999
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 765 (1014)
.+.|+..+.||+|+||+||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 03759847993077819999999999939999998728---999999999999999867999988498898009958999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539996899001
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Df 845 (1014)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 88 mEy~~~g~L~~~~~~~~----------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELE----------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EECCTTEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EECCCCCCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEEC
T ss_conf 96279981889998628----------9999999999999999999999988---9887140700314878999899716
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 46401323457421123554575524521015-----6887975750448799999862997899997102899999997
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYAR-----TRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 846 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 920 (1014)
|+|....... .......||+.|+|||++. +..|+.++||||+||++|||+||+.||.+........ ...
T Consensus 155 G~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i~ 228 (288)
T d2jfla1 155 GVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIA 228 (288)
T ss_dssp TTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHH
T ss_pred HHHHCCCCCC---CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH
T ss_conf 1230357786---4100102562647999983202578888806657878999999820889999989999999---997
Q ss_pred HCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 5199601101222388212999999999996713999999999999999972499999987
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 981 (1014)
....+.. ..+......+.+++.+||+.||++|||++|+++ ||||+.+.
T Consensus 229 ~~~~~~~---------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~----hp~~~~~~ 276 (288)
T d2jfla1 229 KSEPPTL---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ----HPFVTVDS 276 (288)
T ss_dssp HSCCCCC---------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT----SGGGCCCC
T ss_pred CCCCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCCCCC
T ss_conf 0799877---------765669999999999976699668919999962----92318898
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=371.90 Aligned_cols=262 Identities=23% Similarity=0.246 Sum_probs=209.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHH---HHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 899977400657948999965449970899998504311137869999999---99998079996105999997399159
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAE---VQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
++|...+.||+|+||.||+|.+..+++.||+|++.+...........+.+| +.+++.++||||+++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399968990
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~ 843 (1014)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEECCCCCHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEE
T ss_conf 9999148983899987325-----------532789999999999999999977---96220444221678588967982
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 01464013234574211235545755245210156-88797575044879999986299789999710289999999751
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+|+..... ......||+.|+|||++.. ..++.++||||+||++|||+||+.||.+................
T Consensus 150 DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~ 224 (364)
T d1omwa3 150 DLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224 (364)
T ss_dssp CCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC
T ss_pred EECEEEECCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 20102333788-----6433113455421687603899984410467789999998599988889989999999860468
Q ss_pred CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHHCCCCCCCCCCC
Q ss_conf 99601101222388212999999999996713999999999-----99999997249999998799
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev~~~L~~~~~~~~~~~~ 983 (1014)
... . +.....++.+++.+||+.||++||| ++|+++ ||||+...+.
T Consensus 225 ~~~--------~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~----Hp~f~~i~~~ 274 (364)
T d1omwa3 225 AVE--------L----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----SPFFRSLDWQ 274 (364)
T ss_dssp CCC--------C----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT----SGGGTTCCHH
T ss_pred CCC--------C----CCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC----CCCCCCCCHH
T ss_conf 887--------8----877899999999998566988808874357999974----9102378987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=376.06 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=214.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
+.|+..+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
|||++|++..+.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 95 E~~~~g~l~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp ECCSEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EECCCCCHHHHHHHC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECC
T ss_conf 806999457899737-----------9999999999999999999999868---97666788421798799978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 64013234574211235545755245210156---887975750448799999862997899997102899999997519
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYART---RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
+|..... .....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+..... .........
T Consensus 161 ~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~~~~i~~~~ 230 (309)
T d1u5ra_ 161 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNE 230 (309)
T ss_dssp TCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSC
T ss_pred CCCCCCC-------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHCC
T ss_conf 5334677-------873134766368899834678886721454558999999987889999979999---999998289
Q ss_pred CCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 96011012223882129999999999967139999999999999999724999999879
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
.+. ...... ...+.+++..||+.||++|||++|+++ ||||..+..
T Consensus 231 ~~~-------~~~~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~----Hp~~~~~~~ 275 (309)
T d1u5ra_ 231 SPA-------LQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK----HRFVLRERP 275 (309)
T ss_dssp CCC-------CSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT----CHHHHSCCC
T ss_pred CCC-------CCCCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHH----CHHHCCCCC
T ss_conf 998-------887888---999999999977379657918999971----997537899
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=370.58 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=216.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|.+.+.||+|+||.||+|.++.+++.||||++.+.........+.+.+|+.+++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+.+|+|.+++...+ .+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 121 e~~~~g~l~~~l~~~~-----------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCCCCCCHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECE
T ss_conf 2334662266675158-----------989999999999999989999859---98617679999360778978861010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+...... .+.......
T Consensus 187 ~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~~~~ 257 (350)
T d1rdqe_ 187 FAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---KIVSGKVRF 257 (350)
T ss_dssp TCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHCCCCC
T ss_pred EEEECCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHH---HHHCCCCCC
T ss_conf 33322566------643367635678899717998853311450078999975889989959999999---986179889
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHHCCCCCCCCCCC
Q ss_conf 110122238821299999999999671399999999-----999999997249999998799
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
+.....++.+++..||+.||.+|+ |++|+++ ||||+...+.
T Consensus 258 ------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----Hp~f~~~~~~ 303 (350)
T d1rdqe_ 258 ------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----HKWFATTDWI 303 (350)
T ss_dssp ------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----SGGGTTCCHH
T ss_pred ------------CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC----CCCCCCCCHH
T ss_conf ------------766899999999998340998606553454999971----9051589989
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.22 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=213.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CCCEE
Q ss_conf 7899977400657948999965449970899998504311137869999999999980799961059999973--99159
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS--ENLKL 763 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 763 (1014)
.++|+..+.||+|+||+||+|.++.+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+ .+..|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT-SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 333799679830889199999999999799999987465-7979999999999999977899982489999917899899
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEE
Q ss_conf 9998266899889951038998777755666899999999999999998873159--99849506799875453999689
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDC--SPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--s~~ivH~Dlk~~NILl~~~~~~k 841 (1014)
+||||+++|+|.+++.... .....+++..++.++.|++.||.|||... ..+|+||||||+|||++.++.+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~-------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 82 IVMEYCEGGDLASVITKGT-------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp EEEECCTTEEHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred EEEECCCCCCHHHHHHHCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEE
T ss_conf 9995689993899998515-------457899999999999999999999997167788788586765425747888579
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 90014640132345742112355457552452101568879757504487999998629978999971028999999975
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 842 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
|+|||+|+...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+....... +.
T Consensus 155 l~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~----i~ 227 (269)
T d2java1 155 LGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----IR 227 (269)
T ss_dssp ECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HH
T ss_pred EEECCCEEECCCCC---CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH----HH
T ss_conf 80010003224577---755667788232799998399999389887527899998018899899899999999----97
Q ss_pred CCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 19960110122238821299999999999671399999999999999997249999
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 977 (1014)
.+.. . .+.. ....++.+++.+||+.||++|||++|+++ |||+
T Consensus 228 ~~~~-~-----~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~----hp~i 269 (269)
T d2java1 228 EGKF-R-----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE----NPLI 269 (269)
T ss_dssp HTCC-C-----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT----STTC
T ss_pred CCCC-C-----CCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHH----CCCC
T ss_conf 1899-8-----8974----35999999999976799557918999972----9819
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=371.00 Aligned_cols=259 Identities=22% Similarity=0.383 Sum_probs=211.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCE---EEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 7899977400657948999965449970---8999985043111378699999999999807999610599999739915
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAE---VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 762 (1014)
...|...+.||+|+||+||+|.+..+++ .||||++.. .......+.|.+|+.++++++||||+++++++..++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 0042785698027882999999957997889999999784--45989999999999999857998886189999628877
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 99998266899889951038998777755666899999999999999998873159998495067998754539996899
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl 842 (1014)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~----------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl 169 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKV 169 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEEECCCCCCEEEECCCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEE
T ss_conf 99997227985300210456----------7999999999999999988988527---9835761504489889991998
Q ss_pred EECCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHH
Q ss_conf 0014640132345742--11235545755245210156887975750448799999862-99789999710289999999
Q 001778 843 ADFGVAKILIKEEGEF--AAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 843 ~Dfg~a~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 919 (1014)
+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i--- 246 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI--- 246 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---
T ss_pred CCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH---
T ss_conf 88443157567777653650256668830038788836997861214453578999986799999999999999999---
Q ss_pred HHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 751996011012223882129999999999967139999999999999999724
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
..+.. .+.+......+.+++.+||+.||++|||+.|+++.|++
T Consensus 247 -~~~~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 247 -EQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp -HTTCC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -HCCCC----------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -73788----------99974226999999999758797689299999999999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=368.18 Aligned_cols=258 Identities=24% Similarity=0.274 Sum_probs=215.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|...+.||+|+||+||+|.++.+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|++.+++.... .+++.....++.|++.|+.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 84 E~~~gg~l~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EECCCCCCCCCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCC
T ss_conf 5037863223432222-----------111007999999998765541247---67705568105038689988983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... .........
T Consensus 150 ~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~~~~ 220 (316)
T d1fota_ 150 FAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---KILNAELRF 220 (316)
T ss_dssp SCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHHCCCCC
T ss_pred CCEEECCC------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH---HHHCCCCCC
T ss_conf 21671245------643457634359999838999804304653336899975989999969999999---997089889
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHHCCCCCCCCCCC
Q ss_conf 110122238821299999999999671399999999-----999999997249999998799
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-----NMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. ......+.+++.+|++.||.+|+ |++|+++ ||||+...+.
T Consensus 221 p------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~----Hp~f~~i~~~ 266 (316)
T d1fota_ 221 P------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----HPWFKEVVWE 266 (316)
T ss_dssp C------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----SGGGSSCCHH
T ss_pred C------------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC----CCCCCCCCHH
T ss_conf 9------------77899999999999544997666431021999981----9351467989
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.59 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=203.8
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC----CCCEEEE
Q ss_conf 977400657948999965449970899998504311137869999999999980799961059999973----9915999
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS----ENLKLLV 765 (1014)
Q Consensus 690 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 765 (1014)
...+.||+|+||+||+|.+..++..||+|++.... ......+.+.+|++++++++||||+++++++.. ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 85169700828499999999999599999985122-79899999999999998579998506999984033458889999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEE
Q ss_conf 9826689988995103899877775566689999999999999999887315999849506799875453-999689900
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLD-YNFNAKIAD 844 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~-~~~~~kl~D 844 (1014)
|||+++|+|.+++.... .+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|
T Consensus 91 mE~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-----------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EECCCSCBHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EECCCCCCHHHHHHCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEE
T ss_conf 95789894899975135-----------546999999999999999999978-997996876743511667999889800
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 14640132345742112355457552452101568879757504487999998629978999971028999999975199
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 845 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
||+|+..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.... ......+..+.
T Consensus 159 FGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~~~i~~~~ 229 (270)
T d1t4ha_ 159 LGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGV 229 (270)
T ss_dssp TTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHHHTTTC
T ss_pred CCCCEECCCC-----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHCCC
T ss_conf 5765423687-----6677553813008988478-9998671100799999998788999876559---99999997389
Q ss_pred CCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 601101222388212999999999996713999999999999999972499999
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~ 978 (1014)
.... .+. ....++.+++.+||+.||++|||++|+++ ||||+
T Consensus 230 ~~~~-~~~--------~~~~~~~~li~~~l~~dp~~R~s~~ell~----Hp~fk 270 (270)
T d1t4ha_ 230 KPAS-FDK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN----HAFFQ 270 (270)
T ss_dssp CCGG-GGG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT----SGGGC
T ss_pred CCCC-CCC--------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCC
T ss_conf 9865-675--------57899999999976379758929999967----75409
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.26 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=212.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCC-----EEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCC
Q ss_conf 89997740065794899996544997-----08999985043111378699999999999807-9996105999997399
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA-----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 760 (1014)
++|...+.||+|+||+||+|.+...+ ..||+|.+... ........+.+|+.++.++ +||||+++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 993970198307881999999857885542049999996633--587899999999999997158996868778886299
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCC------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 15999982668998899510389987------------777556668999999999999999988731599984950679
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSL------------SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLK 828 (1014)
Q Consensus 761 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk 828 (1014)
..++||||+++|+|.++++....... ........+++..++.++.|++.||+|||.. +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 98754539996899001464013234574211235545755245210156887975750448799999862-99789999
Q 001778 829 SSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGD 907 (1014)
Q Consensus 829 ~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~ 907 (1014)
|+||+++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCC-EEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 3214434598289851422220457786-156234357876578388727999963303000399999983899999998
Q ss_pred CCHHHHHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 71028999999975199601101222388212999999999996713999999999999999972
Q 001778 908 EHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILL 972 (1014)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~ 972 (1014)
..... +...+..+.. .+.+.....++.+++..||+.||++|||++||++.|.
T Consensus 271 ~~~~~---~~~~~~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN---FYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH---HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH---HHHHHHCCCC----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 98999---9999856998----------9988767899999999975889668939999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.41 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=210.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|...+.||+|+||+||+|.+..+++.||||++..+ ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 9939865982088808999999999969999997776----103999999999998679998826775274578547876
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 93 E~~~~g~l~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN---------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp ECCTTCBHHHHHHHSC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ECCCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCC
T ss_conf 3146760677753035---------54157999999999999978889878---93057604576899899928983244
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
+|+....... .......|++.|+|||++.+..++.++|||||||++|||++++.||...... ..+...+..+..
T Consensus 161 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~~~~i~~~~~- 234 (287)
T d1opja_ 161 LSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYR- 234 (287)
T ss_dssp CTTTCCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCC-
T ss_pred CEEECCCCCC--EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHCCCC-
T ss_conf 5465378872--2103556654666927872799981043021789999998679988774259---999999855888-
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 11012223882129999999999967139999999999999999724
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
.+.+......+.+++..||+.||++|||++|+++.|+.
T Consensus 235 ---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 235 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ---------88874330999999999757797689399999999999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.27 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=208.9
Q ss_pred CCCCCC-EECCCCCEEEEEEEECC--CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 999774-00657948999965449--970899998504311137869999999999980799961059999973991599
Q 001778 688 KLTESN-VIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 688 ~~~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 764 (1014)
++...+ .||+|+||+||+|.+.. ++..||||++... ......+.+.+|+.++++++||||+++++++..+ ..++
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC-EEEE
T ss_conf 718878487306080999999960897689999998820--3978999999999999867998880686560368-0799
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 99826689988995103899877775566689999999999999999887315999849506799875453999689900
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIAD 844 (1014)
Q Consensus 765 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~D 844 (1014)
||||+++|+|.+++...+ ..+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+|
T Consensus 86 vmE~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp EEECCTTEEHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred EEEECCCCCHHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECC
T ss_conf 998078996899752125----------6999999999999999987899868---810576764660454688542033
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 1464013234574211235545755245210156887975750448799999862-997899997102899999997519
Q 001778 845 FGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEG 923 (1014)
Q Consensus 845 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 923 (1014)
||+|+................||+.|+|||++.+..++.++|||||||++|||+| |+.||.+........ .+..+
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~ 228 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQG 228 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTT
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHH----HHHCC
T ss_conf 13421155434321135621137433586887279999541232201789999938999999979999999----99818
Q ss_pred CCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 960110122238821299999999999671399999999999999997249999
Q 001778 924 KPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 977 (1014)
... +.+.....++.+++..||+.||++|||+.+|.+.|+. +|+
T Consensus 229 ~~~----------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~-~~~ 271 (285)
T d1u59a_ 229 KRM----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA-CYY 271 (285)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH-HHH
T ss_pred CCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH-HHH
T ss_conf 999----------9997678999999999757797689099999999999-999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.91 Aligned_cols=259 Identities=28% Similarity=0.381 Sum_probs=213.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHH-CCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998-07999610599999739915999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILS-TIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 765 (1014)
++|...+.||+|+||+||+|.+..+++.||||++.+...........+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539996899001
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Df 845 (1014)
|||+++|+|.+++.... .+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+||
T Consensus 82 mEy~~~g~L~~~i~~~~-----------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEECCCCCHHHHHHCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCC
T ss_conf 75037980899864047-----------899999999999999999999868---9340347654044448996301555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 46401323457421123554575524521015688797575044879999986299789999710289999999751996
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 846 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
|+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..... ..+..+.+
T Consensus 148 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~ 220 (320)
T d1xjda_ 148 GMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNP 220 (320)
T ss_dssp TTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCC
T ss_pred CHHHHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHCCCC
T ss_conf 3023235665---3345457877768999982799883232011227898987388999998999999----99971899
Q ss_pred CHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHHHHHCCCCCCCCC
Q ss_conf 0110122238821299999999999671399999999999-9999972499999987
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMR-MVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~~~L~~~~~~~~~~ 981 (1014)
.. +......+.+++.+||+.||++||++. |+++ ||||....
T Consensus 221 ~~-----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~----hpff~~~~ 262 (320)
T d1xjda_ 221 FY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ----HPLFREIN 262 (320)
T ss_dssp CC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG----SGGGTTCC
T ss_pred CC-----------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH----CCHHCCCC
T ss_conf 89-----------75679999999999654489878388999980----90131589
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.46 Aligned_cols=260 Identities=28% Similarity=0.372 Sum_probs=205.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 78999774006579489999654499708999985043111378699999999999807999610599999739915999
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 765 (1014)
.++|...+.||+|+||+||+|+.. ..||||++... .......+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCS-SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECC-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEE
T ss_conf 451899889830788589999999---98999999734-6998999999999999984799878645679715-589999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539996899001
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Df 845 (1014)
|||+++|+|.++++... ..+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+||
T Consensus 82 ~Ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE----------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EECCCEEEHHHHHHTSC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCC
T ss_pred EECCCCCCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCC
T ss_conf 96589988899985235----------7899999999999999998887509---9951614789979818997887500
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 464013234574211235545755245210156---88797575044879999986299789999710289999999751
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYART---RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 846 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+....... ......
T Consensus 149 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~ 224 (276)
T d1uwha_ 149 GLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGR 224 (276)
T ss_dssp CCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHH
T ss_pred CCEEECCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHC
T ss_conf 22133355677-63125665574317999995056899995315163599999999788998998969999---999965
Q ss_pred CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 996011012223882129999999999967139999999999999999724
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+...... ... .......+.+++.+||+.||++|||++|+++.|+.
T Consensus 225 ~~~~p~~--~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 225 GYLSPDL--SKV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp TSCCCCG--GGS----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC--HHC----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 8889860--003----65554999999999758897689299999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.69 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=209.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCC----EEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 89997740065794899996544997----08999985043111378699999999999807999610599999739915
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA----EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLK 762 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 762 (1014)
..|+..++||+|+||+||+|.+..++ ..||||++.. .........+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT--TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 9968615981177909999999689987879999999884--45968999999999999856898783236778338803
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 99998266899889951038998777755666899999999999999998873159998495067998754539996899
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKI 842 (1014)
Q Consensus 763 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl 842 (1014)
++|+||+.+|++.+++.... ..+++..+..++.|++.|+.|||.. +|+||||||+|||++.++.+||
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl 151 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV 151 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEEECCCCCCHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEE
T ss_conf 89997213574022210234----------5420899999999999854121212---3425765644278889984998
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 001464013234574211235545755245210156887975750448799999862997899997-1028999999975
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDE-HTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~ 921 (1014)
+|||+|+................||+.|+|||++.+..++.++|||||||++|||++++.|+.... .... ...+.
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~----~~~i~ 227 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAIN 227 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH
T ss_pred CCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH----HHHHH
T ss_conf 45510300357876526742677773434888870499997355634489899999679886556899999----99986
Q ss_pred CCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 1996011012223882129999999999967139999999999999999724
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
.+.. .+.+......+.+++.+||+.||++|||+.||++.|++
T Consensus 228 ~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 228 DGFR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp TTCC----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCC----------CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 3578----------99850457999999999776797689399999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.94 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=205.7
Q ss_pred CEECCCCCEEEEEEEECC--CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEECCC
Q ss_conf 400657948999965449--970899998504311137869999999999980799961059999973991599998266
Q 001778 693 NVIGSGGSGKVYRVPINH--TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 693 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 770 (1014)
+.||+|+||+||+|.+.. +++.||||++... ..+....+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHH-HCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCC
T ss_conf 783458782999999816973859999998801-08989999999999999867998985277775059-7799997478
Q ss_pred CCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89988995103899877775566689999999999999999887315999849506799875453999689900146401
Q 001778 771 KRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 771 ~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~~ 850 (1014)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 91 ~g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 91 LGPLNKYLQQNR-----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp TEEHHHHHHHCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHH
T ss_conf 896899975225-----------789999999999999997668747---955677761131023567512341345331
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHCCCCCHHC
Q ss_conf 3234574211235545755245210156887975750448799999862-997899997102899999997519960110
Q 001778 851 LIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKPIVDA 929 (1014)
Q Consensus 851 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1014)
...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+........ .+..+...
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~----~i~~~~~~--- 229 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGERM--- 229 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTCCC---
T ss_pred CCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHH----HHHCCCCC---
T ss_conf 34323443224456778420391665379998434430340313289658999999989999999----99828999---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 12223882129999999999967139999999999999999724
Q 001778 930 LDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+.+.....++.+++.+||+.||++|||+++|.+.|+.
T Consensus 230 -------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf -------9986567999999999758897689098999998528
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.90 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=214.9
Q ss_pred CCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 53789997740065794899996544997089999850431113786999999999998079996105999997399159
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 684 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
++.++|.+.+.||+|+||+||+|.++.+++.||+|++... ......+.+|+.+++.++||||+++++++++++..|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 8701058878983177839999999899969999997578----665999999999998579979890989998899889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399--9689
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN--FNAK 841 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~--~~~k 841 (1014)
+|||||++|+|.+++...+ ..+++..+..++.|++.||.|||.. +|+||||||+|||++.+ ..+|
T Consensus 78 lvmE~~~gg~L~~~i~~~~----------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEECCCCCCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEE
T ss_conf 9995389980889987538----------9999999999999999999999876---99751355444344378851899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 90014640132345742112355457552452101568879757504487999998629978999971028999999975
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 842 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
|+|||++....... ......+++.|+|||...+..++.++||||+||++|+|++|..||.+........ .+..
T Consensus 145 l~DFG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~---~i~~ 217 (321)
T d1tkia_ 145 IIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMN 217 (321)
T ss_dssp ECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHH
T ss_pred ECCCCHHHCCCCCC----CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHH---HHHH
T ss_conf 76441110034677----5321223322234021048777840113027999999982899999989999999---9983
Q ss_pred CCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 19960110122238821299999999999671399999999999999997249999998
Q 001778 922 EGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~ 980 (1014)
....+.... +.....++.+++..|++.||++|||++|+++ ||||.+.
T Consensus 218 ~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~----hp~~~~~ 264 (321)
T d1tkia_ 218 AEYTFDEEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQ----HPWLKQK 264 (321)
T ss_dssp TCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH----SHHHHSC
T ss_pred CCCCCCHHH--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCC
T ss_conf 899988022--------3678999999999986699668909999963----9965667
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.96 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=210.9
Q ss_pred CCCCCCCCCCCC-CEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 434537899977-4006579489999654499708999985043111378699999999999807-99961059999973
Q 001778 681 RDSDILPKLTES-NVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 681 ~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 758 (1014)
....+.++|.+. ++||+|+||.||+|.+..+++.||||++.. ...+.+|+.++.++ +||||+++++++++
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC--------CHHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 8997014879810796545486999999889998999999897--------47799999999986699997829899950
Q ss_pred ----CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf ----9915999982668998899510389987777556668999999999999999988731599984950679987545
Q 001778 759 ----ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 759 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl 834 (1014)
+...|+|||||++|+|.+++...+ ...+++..+..++.|++.|+.|||.. +|+||||||+|||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~---------~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll 144 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRG---------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLY 144 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCS---------CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCC
T ss_conf 3468978999997789984999998627---------87757999999999999999999976---98644410022011
Q ss_pred CC---CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 39---996899001464013234574211235545755245210156887975750448799999862997899997102
Q 001778 835 DY---NFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTC 911 (1014)
Q Consensus 835 ~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 911 (1014)
+. ++.+||+|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+.....
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred CCCCCCCCCCCCCCCEEEECCCCC----CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH
T ss_conf 355556631135455123336888----6432267756379277748988888888764516778865889988988778
Q ss_pred HHHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 89999999751996011012223882129999999999967139999999999999999724999999879
Q 001778 912 LAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
...........+.. ....+.......++.+++.+|++.||++|||+.|+++ ||||.....
T Consensus 221 ~~~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----hp~~~~~~~ 280 (335)
T d2ozaa1 221 ISPGMKTRIRMGQY-------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN----HPWIMQSTK 280 (335)
T ss_dssp -------CCCSCSS-------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH----SHHHHTTTS
T ss_pred HHHHHHHHHHCCCC-------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHHCCCC
T ss_conf 89999999853888-------8898543469999999999975699657909999970----987617887
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=355.16 Aligned_cols=261 Identities=28% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHH------HHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEC
Q ss_conf 78999774006579489999654499708999985043111------3786999999999998079-9961059999973
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKL------DQKHEKEFLAEVQILSTIR-HLNIVKLLCCISS 758 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 758 (1014)
.++|+..+.||+|+||+||+|.+..+++.||||++...... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 99159999826689988995103899877775566689999999999999999887315999849506799875453999
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 759 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~ 838 (1014)
++..|+||||+++|+|.++++..+ .+++..+..++.|+++||+|||.. +|+||||||+||+++.++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-----------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-----------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCC
T ss_conf 760599997689866899998659-----------999999999999999999999875---994323462548986899
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 6899001464013234574211235545755245210156------8879757504487999998629978999971028
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART------RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCL 912 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 912 (1014)
.+||+|||+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......
T Consensus 148 ~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp CEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CEEECCCHHEEECCCCC----CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH
T ss_conf 83871240316726887----21345246788898886053445678899233185656023103228889889999999
Q ss_pred HHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 9999999751996011012223882129999999999967139999999999999999724999999
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
... ........ ..+.......++.+++.+||+.||++|||++|+++ ||||++
T Consensus 224 ~~~---i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~----h~~~~~ 275 (277)
T d1phka_ 224 LRM---IMSGNYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA----HPFFQQ 275 (277)
T ss_dssp HHH---HHHTCCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT----SGGGCT
T ss_pred HHH---HHHCCCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHHH
T ss_conf 999---98189888--------98543468999999999976589668919999973----978797
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.08 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=204.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
.+|+..+.||+|+||.||+|.+. ++..||||++... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEE
T ss_conf 99588889820888299999988-9999999998788----676899999999999668997565352431599337999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 80 E~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp ECCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred EECCCCCHHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCC
T ss_conf 8369991899752013----------4788999999999999987765316---43104431532666688776865532
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC-CCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 640132345742112355457552452101568879757504487999998629978-9999710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEA-NNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
+|+....... .......||+.|+|||++.+..++.++|||||||++|||+|++.| |........... +..+..
T Consensus 147 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~~~ 220 (263)
T d1sm2a_ 147 MTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGFR 220 (263)
T ss_dssp --------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH----HHHTCC
T ss_pred HHEECCCCCC--EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHHCCC
T ss_conf 1002368873--3504300176667857860799984033210599999998789888778999999999----980688
Q ss_pred CHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 011012223882129999999999967139999999999999999724
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
. ..+.....++.+++..||+.||++|||++|+++.|++
T Consensus 221 ~----------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 221 L----------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 8----------9954367999999999765797689199999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.50 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=202.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||+||+|.+. ++..||||++... ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf 99388679810798289999999-9999999998647----6888999999999986799988578731045-9769999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|.+++... ....+++..+.+|+.||++||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 87 Ey~~~g~L~~~~~~~---------~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp ECCTTCBHHHHTTSH---------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EECCCCCHHHHHHHC---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCC
T ss_conf 957898288887514---------789887889999999999999999748---95467564225156202440423410
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCCHHHHHHHHHHHHCCCC
Q ss_conf 640132345742112355457552452101568879757504487999998629978999-9710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNG-DEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~ 925 (1014)
+|+...... ........|++.|+|||++.+..++.++|||||||++|||+||+.|+.. ....... ..+..+..
T Consensus 155 la~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~----~~i~~~~~ 228 (272)
T d1qpca_ 155 LARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLERGYR 228 (272)
T ss_dssp TCEECSSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTTCC
T ss_pred CEEECCCCC--CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHHCCC
T ss_conf 147735886--442035677444458289837999824564525799999996898888888999999----99970688
Q ss_pred CHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 011012223882129999999999967139999999999999999724
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
. ..+......+.+++.+||+.||++|||++|+++.|+.
T Consensus 229 ~----------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 M----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 8----------8965571999999999758897689399999998611
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.57 Aligned_cols=269 Identities=25% Similarity=0.270 Sum_probs=210.5
Q ss_pred CCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEECC
Q ss_conf 7400657948999965449970899998504311137--86999999999998079996105999997399159999826
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ--KHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVYEYM 769 (1014)
Q Consensus 692 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 769 (1014)
.++||+|+||+||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 68998899510389987777556668999999999999999988731599984950679987545399968990014640
Q 001778 770 EKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAK 849 (1014)
Q Consensus 770 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~ 849 (1014)
+++++..+.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||.|.
T Consensus 83 ~~~~~~~~~~~~-----------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp SEEHHHHHTTCC-----------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CCHHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCC
T ss_conf 450776554126-----------6778999999999999999886316---35503577625885377841146576100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCCHH
Q ss_conf 13234574211235545755245210156-88797575044879999986299789999710289999999751996011
Q 001778 850 ILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPIVD 928 (1014)
Q Consensus 850 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1014)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|..||.+....+....+..... .+..+
T Consensus 149 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~--~~~~~ 223 (299)
T d1ua2a_ 149 SFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG--TPTEE 223 (299)
T ss_dssp TTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCCTT
T ss_pred CCCCCC---CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC--CCCHH
T ss_conf 057875---5433020473336399972677888056436304289999859699999999999999998518--99725
Q ss_pred CCCCCC----------CCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 012223----------88212-----99999999999671399999999999999997249999998799
Q 001778 929 ALDKEI----------DEPCF-----LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 929 ~~~~~~----------~~~~~-----~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
...... ..... ......+.+++.+|++.||++|||++|+++ ||||+.++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~----Hp~f~~~p~p 289 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK----MKYFSNRPGP 289 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT----SGGGTSSSCC
T ss_pred HCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCCCC
T ss_conf 45210002134430347898867856568999999999976389456908999967----9965789999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=350.68 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=218.8
Q ss_pred CCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 53789997740065794899996544997089999850431113786999999999998079996105999997399---
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 684 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 760 (1014)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf 70620698689960899299999999999899999985566469899999999999998569998873114354326887
Q ss_pred -CEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf -1599998266899889951038998777755666899999999999999998873159998495067998754539996
Q 001778 761 -LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 761 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~ 839 (1014)
..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||.. +|+||||||+|||++.++.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~-----------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~ 149 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG-----------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 149 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC-----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSC
T ss_pred CEEEEEEECCCCCEEHHHHCCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCC
T ss_conf 66999997788987101120358-----------999999999999999999999857---9527634675566575432
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89900146401323457421123554575524521015688797575044879999986299789999710289999999
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 840 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
.+++|||.+.................||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ......
T Consensus 150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~ 226 (277)
T d1o6ya_ 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQH 226 (277)
T ss_dssp EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH
T ss_pred CEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH---HHHHHH
T ss_conf 01003444322123544333346425762436999983999996632026528999997697998996999---999999
Q ss_pred HHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHC
Q ss_conf 7519960110122238821299999999999671399999999-99999999724
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERP-NMRMVLQILLN 973 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-t~~ev~~~L~~ 973 (1014)
............+ ....++.+++.+|++.||++|| |++++.+.|.+
T Consensus 227 ~~~~~~~~~~~~~--------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 227 VREDPIPPSARHE--------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHCCCCCGGGTSS--------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHCCCCCCCHHCC--------CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 8469999710034--------7899999999998667976777399999999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.50 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=209.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||+||+|+++ ++..||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
T ss_conf 99799689820788399999988-99899999987475----77899999999999668986015889985078169999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|++.+++.... ..+++..+.+++.|+++||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 79 Ey~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp ECCTTEEHHHHHHSGG----------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred ECCCCCCHHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCH
T ss_conf 7048993888641024----------6776899999999999999987546---84346654135887699847988614
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 64013234574211235545755245210156887975750448799999862-99789999710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+......... +..+..
T Consensus 146 ~a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----i~~~~~ 219 (258)
T d1k2pa_ 146 LSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLR 219 (258)
T ss_dssp SCCBCSSSS--CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHTTCC
T ss_pred HHEECCCCC--CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHH----HHHCCC
T ss_conf 420235787--22524657887757807863799885210336432467397559999889999999999----980797
Q ss_pred CHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 011012223882129999999999967139999999999999999724
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
. ..+......+.+++.+||+.||++|||++|+++.|.+
T Consensus 220 ~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 L----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp C----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred C----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 8----------9965465999999999766897689399999987418
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.63 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=207.1
Q ss_pred CCCCCCEECCCCCEEEEEEEECCCCE----EEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 99977400657948999965449970----89999850431113786999999999998079996105999997399159
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAE----VVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 688 ~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
+|+..+.||+|+||+||+|.+..+++ .||+|++.. .......+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 997831982089929999999589988989999999651--34979999999999999867998881589999619-836
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399968990
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~ 843 (1014)
+++||+.+|+|.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~ 153 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 153 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEEECCCCCCCCCCCCCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEE
T ss_conf 9998426874010111334----------5799999999999999999999876---95047621203116799875860
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 01464013234574211235545755245210156887975750448799999862-99789999710289999999751
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.....+...+. .
T Consensus 154 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~----~ 228 (317)
T d1xkka_ 154 DFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----K 228 (317)
T ss_dssp CCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH----H
T ss_pred CCCCCEECCCCCCC-CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----C
T ss_conf 25522233544453-223651058644670887469998356544079999999977999999999899999997----5
Q ss_pred CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 996011012223882129999999999967139999999999999999724
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+... +.+......+.+++.+||+.||++|||+.|+++.|.+
T Consensus 229 ~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 229 GERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp TCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 9989----------9985568999999998478993469199999999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.75 Aligned_cols=269 Identities=24% Similarity=0.410 Sum_probs=215.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-----CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 7899977400657948999965449-----97089999850431113786999999999998079996105999997399
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN 760 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 760 (1014)
.++|...+.||+|+||+||+|++.. +++.||||++.. .......+.+.+|+.+++.++||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~--~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT--TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECH--HCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCC
T ss_conf 889388679820788399999988876577882999999882--108579999999999999668997655246660598
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCC-------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 159999826689988995103899877-------------7755666899999999999999998873159998495067
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLS-------------GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDL 827 (1014)
Q Consensus 761 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dl 827 (1014)
..++++||+++|+|.++++........ .......+++..+..++.|++.||+|||.. +++||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEE
T ss_conf 0389998158992999998527554210000111001210346788989999999999999985541357---8685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCC
Q ss_conf 99875453999689900146401323457421123554575524521015688797575044879999986299-78999
Q 001778 828 KSSNILLDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK-EANNG 906 (1014)
Q Consensus 828 k~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~ 906 (1014)
||+|||++.++.+||+|||+|+....... ........|++.|+|||++.+..++.++|||||||++|||+++. +||.+
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCC
T ss_conf 40116898999289833144211367764-11157777676767989972688980563025236299998068999999
Q ss_pred CCCHHHHHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 97102899999997519960110122238821299999999999671399999999999999997249
Q 001778 907 DEHTCLAQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 974 (1014)
......... +..+... +.+.....++.+++..||+.||++||||.||++.|++.
T Consensus 246 ~~~~e~~~~----v~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 246 MAHEEVIYY----VRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp SCHHHHHHH----HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCHHHHHHH----HHCCCCC----------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 899999999----9739978----------88732529999999997488965793999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.38 Aligned_cols=272 Identities=26% Similarity=0.317 Sum_probs=211.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|.+.+.||+|+||+||+|.+..+++.||+|++... .......+.+.+|+.++++++||||+++++++.++...++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHH-HCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 9977651772376809999999999979999998022-257589999999999998679983887445332243203788
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+.+ ++.+++... ....+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||
T Consensus 81 e~~~~-~~~~~~~~~---------~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDAS---------ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp ECCSE-EHHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EECCC-CHHHHHHHH---------CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCC
T ss_conf 62377-445554420---------256888899999999999999986528---89921357114011346762103578
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 6401323457421123554575524521015688-797575044879999986299789999710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.|+...... .......|++.|+|||++.... ++.++||||+||++|+|++|+.||.+.+.......+..... .+
T Consensus 148 ~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~--~~ 222 (298)
T d1gz8a_ 148 LARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG--TP 222 (298)
T ss_dssp HHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--CC
T ss_pred CCEECCCCC---CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC--CC
T ss_conf 613436886---4100103652154112213665777422103333134279668799898899999999998328--98
Q ss_pred CHHCCCCC------------CCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 01101222------------38821----2999999999996713999999999999999972499999987
Q 001778 926 IVDALDKE------------IDEPC----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 926 ~~~~~~~~------------~~~~~----~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 981 (1014)
........ ..... ......++.+++.+|++.||++|||++|+++ ||||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~----H~ff~~~~ 290 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA----HPFFQDVT 290 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT----SGGGTTCC
T ss_pred CHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCC
T ss_conf 333144422242124345432222044416678999999999976399557918999967----87014699
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.29 Aligned_cols=277 Identities=24% Similarity=0.283 Sum_probs=214.2
Q ss_pred CCCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 53789997740065794899996544997089999850431113786999999999998079996105999997399---
Q 001778 684 DILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN--- 760 (1014)
Q Consensus 684 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 760 (1014)
++.++|...+.||+|+||+||+|.+..+++.||||++.+. ......+.+++|+.+++.++|||++++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH--CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 7389859978994064809999999999949999998031--09589999999999999768989885888995056455
Q ss_pred -CEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf -1599998266899889951038998777755666899999999999999998873159998495067998754539996
Q 001778 761 -LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 761 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~ 839 (1014)
..+++++|+.+|+|.+++... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~------------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~ 147 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ------------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCD 147 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred CCEEEEEEEECCCCHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCC
T ss_conf 4149999962598656644058------------999999999999999999999978---9867778764378879997
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 899001464013234574211235545755245210156-8879757504487999998629978999971028999999
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+||+|||+|.................|++.|+|||++.. ..++.++||||+||++|||++|+.||.+.+..........
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~ 227 (345)
T d1pmea_ 148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227 (345)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 78754570565047776410101102652000387860478887410100467013377669799788888999998765
Q ss_pred HHHCCCCCHHCCCCCC-------------CCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 9751996011012223-------------88212-----99999999999671399999999999999997249999998
Q 001778 919 HIQEGKPIVDALDKEI-------------DEPCF-----LEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~~-------------~~~~~-----~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~ 980 (1014)
...... ........ ..... .....++.+++.+|++.||++|||+.|+++ ||||+..
T Consensus 228 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~----hpf~~~~ 301 (345)
T d1pmea_ 228 ILGSPS--QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA----HPYLEQY 301 (345)
T ss_dssp HHCSCC--HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT----SGGGTTT
T ss_pred HCCCCC--HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCC
T ss_conf 206997--5664234332222024467755778777837899999999999976489567908999861----9865558
Q ss_pred CCC
Q ss_conf 799
Q 001778 981 KNG 983 (1014)
Q Consensus 981 ~~~ 983 (1014)
...
T Consensus 302 ~~~ 304 (345)
T d1pmea_ 302 YDP 304 (345)
T ss_dssp CCG
T ss_pred CCC
T ss_conf 897
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.65 Aligned_cols=257 Identities=29% Similarity=0.440 Sum_probs=206.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|+..+.||+|+||.||+|.+..+ ..||||++... ....+.|.+|+.++++++||||+++++++.+ +..++||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
T ss_conf 9979846993079809999999999-99999998804----4888999999999986666788689999823-9759999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+++|+|..++.... ...++|..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 91 Ey~~~g~l~~~~~~~~---------~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp CCCTTCBHHHHHSHHH---------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EECCCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCC
T ss_conf 9447994354200003---------55305999999999999999987541---14335312307999899929984425
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-CCHHHHHHHHHHHHCCCC
Q ss_conf 6401323457421123554575524521015688797575044879999986299789999-710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD-EHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~ 925 (1014)
+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....... .+..+..
T Consensus 159 la~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~----~i~~~~~ 232 (285)
T d1fmka3 159 LARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVERGYR 232 (285)
T ss_dssp TTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTCC
T ss_pred HHHHCCCCC--CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHH----HHHHCCC
T ss_conf 554256887--3352454556654580898379989177413235899999868999998888999999----9982689
Q ss_pred CHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 011012223882129999999999967139999999999999999724999999
Q 001778 926 IVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
.+.......++.+++.+||+.||++||++++|++.|+. ||..
T Consensus 233 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~--~~~~ 274 (285)
T d1fmka3 233 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED--YFTS 274 (285)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT--TTSC
T ss_pred ----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH--HHCC
T ss_conf ----------99983237999999999756697589199999998766--6238
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.55 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=211.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC---CEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 8999774006579489999654499---7089999850431113786999999999998079996105999997399159
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
++|+..+.||+|+||.||+|..... ...||||++...........+.|.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399968990
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~ 843 (1014)
+|+||+++|++.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+
T Consensus 87 lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred EEEEEECCCCHHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEEC
T ss_conf 1465423861254442126----------8999999999999999999875217---87520566888156556543325
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 01464013234574211235545755245210156887975750448799999862-99789999710289999999751
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+++................|+..|+|||++.+..++.++||||||+++|||+| |+.||.+.+......+ ....
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~---i~~~ 230 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDKE 230 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHTS
T ss_pred CCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHHC
T ss_conf 6115553035887526547632573107999983799994215661489999999689999999699999999---9847
Q ss_pred CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 996011012223882129999999999967139999999999999999724
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+... +........+.+++..||+.||++|||+.||.+.|++
T Consensus 231 ~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 GERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 9999----------9854453999999999768896679299999999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.08 Aligned_cols=271 Identities=23% Similarity=0.370 Sum_probs=214.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-----CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 899977400657948999965449-----970899998504311137869999999999980799961059999973991
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 761 (1014)
++|...+.||+|+||+||+|.+.. ++..||||++.. .........+.+|+.++++++||||+++++++..++.
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~--~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT--TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 99188359820788189999987864477896899999870--1286899999999999997699988412547842881
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 59999826689988995103899877775566689999999999999999887315999849506799875453999689
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~k 841 (1014)
.++||||+++|+|.+++....... ........+++..+.+++.|+++||.|||.. +|+||||||+|||++.++.+|
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAM-ANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHH-HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEE
T ss_conf 067776048998899987503321-1344468879999999999999999987647---965432867754035996499
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHH
Q ss_conf 900146401323457421123554575524521015688797575044879999986299-7899997102899999997
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK-EANNGDEHTCLAQWAWRHI 920 (1014)
Q Consensus 842 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~ 920 (1014)
|+|||+|+....... ........|++.|+|||.+.+..++.++||||||+++|||+|++ .||.+........ .+
T Consensus 174 l~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~----~i 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FV 248 (308)
T ss_dssp ECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HH
T ss_pred EEECCCCEECCCCCC-EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH----HH
T ss_conf 942454202357763-0313402316323788887369988333444378999999968999999989999999----99
Q ss_pred HCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC--CCCCC
Q ss_conf 51996011012223882129999999999967139999999999999999724--99999
Q 001778 921 QEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN--NPIFP 978 (1014)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~--~~~~~ 978 (1014)
..+.. . +.+......+.+++.+||+.||++|||+.+|++.|++ +|+|.
T Consensus 249 ~~~~~-~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 249 MEGGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHCCC-C---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCC
T ss_conf 80888-8---------88633539999999997577965893999999997876177875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.49 Aligned_cols=279 Identities=20% Similarity=0.259 Sum_probs=214.2
Q ss_pred CCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC------
Q ss_conf 37899977400657948999965449970899998504311137869999999999980799961059999973------
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS------ 758 (1014)
Q Consensus 685 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 758 (1014)
..++|++.+.||+|+||+||+|.+..+++.||||++.... .......++.+|+.+++.++|||++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 6279889999722748299999998999799999984222-463789999999999998359996606765402465444
Q ss_pred --CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC
Q ss_conf --991599998266899889951038998777755666899999999999999998873159998495067998754539
Q 001778 759 --ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY 836 (1014)
Q Consensus 759 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~ 836 (1014)
.+..++||||++++.+....... ..++...+..++.|++.||.|||.. +|+||||||+|||++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~-----------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~ 152 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITR 152 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred CCCCEEEEEEECCCCCCCCHHHHCC-----------CCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECC
T ss_conf 4576389998535787410122203-----------4433089999999999999885229---9885676722203668
Q ss_pred CCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 996899001464013234574-2112355457552452101568-87975750448799999862997899997102899
Q 001778 837 NFNAKIADFGVAKILIKEEGE-FAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQ 914 (1014)
Q Consensus 837 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 914 (1014)
++.+|++|||++..+...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+........
T Consensus 153 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 232 (318)
T d3blha1 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232 (318)
T ss_dssp TSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCEEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHH
T ss_conf 99687631350022355444321135660249787428997079998917870067864661744879989989999999
Q ss_pred HHHHHHHCCCC-CHHC---------CCCCCCCCC-CHH------HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99999751996-0110---------122238821-299------999999999671399999999999999997249999
Q 001778 915 WAWRHIQEGKP-IVDA---------LDKEIDEPC-FLE------EMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 915 ~~~~~~~~~~~-~~~~---------~~~~~~~~~-~~~------~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 977 (1014)
.+........+ .... ......... ... ....+.+++.+|++.||++|||++|+++ ||||
T Consensus 233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~----Hpff 308 (318)
T d3blha1 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN----HDFF 308 (318)
T ss_dssp HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH----SGGG
T ss_pred HHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHH
T ss_conf 999841899825534432034443320133445550334044459989999999987389658909999974----9501
Q ss_pred CCCCC
Q ss_conf 99879
Q 001778 978 PTEKN 982 (1014)
Q Consensus 978 ~~~~~ 982 (1014)
+.++.
T Consensus 309 ~~~p~ 313 (318)
T d3blha1 309 WSDPM 313 (318)
T ss_dssp SSSSC
T ss_pred CCCCC
T ss_conf 56999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.23 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=208.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEE--EEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCEE
Q ss_conf 8999774006579489999654499708--999985043111378699999999999807-9996105999997399159
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEV--VAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 763 (1014)
++|+..+.||+|+||+||+|.+..++.. ||||++.. .......+.+.+|+.++.++ +||||+++++++.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC--C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf 99688779820788289999998999699999999782--3385799999999999986228998836788884187369
Q ss_pred EEEECCCCCCHHHHHHHCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 99982668998899510389987-----7775566689999999999999999887315999849506799875453999
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~ 838 (1014)
+||||+++|+|.++++....... ........+++..+..++.|++.|+.|+|.. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf 99980289869999864035555512310123457899999999999999998766308---954555052048986887
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC-CCCCCCCHHHHHHHH
Q ss_conf 6899001464013234574211235545755245210156887975750448799999862997-899997102899999
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKE-ANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|.. ||.+........
T Consensus 165 ~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~--- 237 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--- 237 (309)
T ss_dssp CEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---
T ss_pred CEEECCCCCCCCCCCC----CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHH---
T ss_conf 6387434432244422----345530137755553875269999622153138899999836899999999999999---
Q ss_pred HHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 997519960110122238821299999999999671399999999999999997249
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 974 (1014)
.+..+.. ...+.....++.+++.+||+.||++||||.||++.|++.
T Consensus 238 -~i~~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 238 -KLPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp -HGGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHCCC----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -9982688----------888766789999999997678966894999999999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.57 Aligned_cols=272 Identities=23% Similarity=0.293 Sum_probs=205.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC-CEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC---CCCCCCEEEEEEEC----
Q ss_conf 8999774006579489999654499-708999985043111378699999999999807---99961059999973----
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT-AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI---RHLNIVKLLCCISS---- 758 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 758 (1014)
++|++.+.||+|+||+||+|.+..+ ++.||||++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 8979888992155869999999888998999999802324-516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf -9915999982668998899510389987777556668999999999999999988731599984950679987545399
Q 001778 759 -ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 759 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~ 837 (1014)
....++++||+++|.+....... ...+++..+..++.|++.||+|||.. +|+||||||+|||++.+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 152 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCEEEEEEEECCCCCHHHHHHCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCC
T ss_conf 674699999740587144444303----------78999899999999999999999758---89835798627898589
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 96899001464013234574211235545755245210156887975750448799999862997899997102899999
Q 001778 838 FNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 838 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
+.+||+|||.+...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.........+.
T Consensus 153 ~~~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp CCEEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCEEECCHHHHHHHCCC----CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 97542100010110023----45777654851148310017988811100032899999987879989989899999999
Q ss_pred HHHHCCCCCHHCCCCCC--------------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 99751996011012223--------------882129999999999967139999999999999999724999999879
Q 001778 918 RHIQEGKPIVDALDKEI--------------DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..... +......... ...........+.+++.+|++.||++|||++|+++ ||||+...+
T Consensus 229 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~----Hpff~~i~~ 301 (305)
T d1blxa_ 229 DVIGL--PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS----HPYFQDLER 301 (305)
T ss_dssp HHHCC--CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT----SGGGTTCCC
T ss_pred HHHCC--CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCHH
T ss_conf 84079--96110532111103330223456454404458999999999987489667918999966----963407521
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.35 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-----CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEECC-
Q ss_conf 899977400657948999965449-----9708999985043111378699999999999807-999610599999739-
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINH-----TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSE- 759 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 759 (1014)
++|...+.||+|+||.||+|.+.. +++.||||++.. .......+.+.+|...+.++ +|+||+.+++++..+
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 99798449841678399999986777555783999999860--0171789999999999886149984997411540479
Q ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 9159999826689988995103899877-----77556668999999999999999988731599984950679987545
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLS-----GRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 760 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl 834 (1014)
...++||||+++|+|.++++........ .......+++..+..++.|++.||.|||.. +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEE
T ss_conf 757999984589929999985366666532220233214689999999999999999988737---97178677310657
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCCHHHH
Q ss_conf 3999689900146401323457421123554575524521015688797575044879999986299-789999710289
Q 001778 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK-EANNGDEHTCLA 913 (1014)
Q Consensus 835 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~ 913 (1014)
+.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+|+. .||.+.....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp CGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred CCCCCEEECCCCCHHHCCCCCC-CCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf 7998289845752001135665-2224751667210203686468899663221367899999868899998999899--
Q ss_pred HHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 999999751996011012223882129999999999967139999999999999999724
Q 001778 914 QWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
.+...+..+... +.+.....++.+++.+||+.||++|||++|+++.|++
T Consensus 245 -~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 245 -EFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp -HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -999999638988----------8886578999999999767796679199999999979
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.12 Aligned_cols=268 Identities=23% Similarity=0.363 Sum_probs=211.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-----CCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCC
Q ss_conf 89997740065794899996544-----99708999985043111378699999999999807-9996105999997399
Q 001778 687 PKLTESNVIGSGGSGKVYRVPIN-----HTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISSEN 760 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 760 (1014)
++|...+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.++..+ +||||+++++++.++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 996985498206882999999806644778869999998742--487799999999999876269998878998983199
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 1599998266899889951038998777-------755666899999999999999998873159998495067998754
Q 001778 761 LKLLVYEYMEKRSLDQWLHKKNRSSLSG-------RARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 761 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIL 833 (1014)
..++||||+++|+|.++++......... ......+++..+.+++.||+.|++|||.. +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCCHHH
Q ss_conf 53999689900146401323457421123554575524521015688797575044879999986299-78999971028
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGK-EANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~ 912 (1014)
++.++.+|++|||.++...... .........||+.|+|||++.+..++.++|||||||++|||+|++ ++|.+......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred CCCCCCCCCCCCCHHEECCCCC-CCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 0025752102340102336788-615862013596876778861799997400102589999998589988778998999
Q ss_pred HHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 9999999751996011012223882129999999999967139999999999999999724
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+...+..+.. ..........+.+++.+||+.||++|||++++++.|++
T Consensus 257 ---~~~~i~~~~~----------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 ---FYKMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ---HHHHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHCCCC----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ---9999866898----------89854365999999999757796579299999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.21 Aligned_cols=270 Identities=24% Similarity=0.340 Sum_probs=212.1
Q ss_pred CCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----
Q ss_conf 3789997740065794899996544997089999850431113786999999999998079996105999997399----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN---- 760 (1014)
Q Consensus 685 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 760 (1014)
+.++|...+.||+|+||+||+|.+..+++.||||++... .......+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 477189988980177819999999999989999998522-2596999999999999986689875479998635765555
Q ss_pred --CEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf --159999826689988995103899877775566689999999999999999887315999849506799875453999
Q 001778 761 --LKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 761 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~ 838 (1014)
..++||||+ +++|..+.+.. .+++..+..++.|++.||.|||.. +|+||||||+|||++.++
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~ 158 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHE------------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDC 158 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred CCEEEEEEECC-CCCHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCC
T ss_conf 41599998405-52189998740------------226999999999999999998737---876456685111121001
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 6899001464013234574211235545755245210156-887975750448799999862997899997102899999
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.+|++|||.|+.... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.........
T Consensus 159 ~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 159 ELKILDFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp CEEECCCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCCCCCEECCCC------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 221134310220687------63102455333588998178789965010300389999997869988897689999998
Q ss_pred HHHHCCCCCHHCCCCC--------------CC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 9975199601101222--------------38----82129999999999967139999999999999999724999999
Q 001778 918 RHIQEGKPIVDALDKE--------------ID----EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~--------------~~----~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
... +.+..+..... .. ..........+.+++.+|++.||++|||+.|+++ ||||+.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~----Hp~f~~ 306 (346)
T d1cm8a_ 233 KVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA----HPYFES 306 (346)
T ss_dssp HHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH----SGGGTT
T ss_pred HCC--CCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCC
T ss_conf 503--78848888653000344331157866655667755689999999999977299557929999963----962375
Q ss_pred CCCC
Q ss_conf 8799
Q 001778 980 EKNG 983 (1014)
Q Consensus 980 ~~~~ 983 (1014)
....
T Consensus 307 ~~~~ 310 (346)
T d1cm8a_ 307 LHDT 310 (346)
T ss_dssp TC--
T ss_pred CCCC
T ss_conf 8776
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.45 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=203.1
Q ss_pred CCEECCCCCEEEEEEEECCCC---EEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEEEE
Q ss_conf 740065794899996544997---0899998504311137869999999999980799961059999973-991599998
Q 001778 692 SNVIGSGGSGKVYRVPINHTA---EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-ENLKLLVYE 767 (1014)
Q Consensus 692 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 767 (1014)
.++||+|+||+||+|.+..++ ..||||++.. .......+++.+|+.++++++||||+++++++.. ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 6698136880999999977998799999999884--36978999999999999867899986786789806994389998
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 26689988995103899877775566689999999999999999887315999849506799875453999689900146
Q 001778 768 YMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFGV 847 (1014)
Q Consensus 768 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~ 847 (1014)
|+++|+|.+++.... ...++..+.+++.|++.||.|+|.. +|+||||||+|||+++++.+||+|||+
T Consensus 110 ~~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp CCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred EEECCCHHHHHCCCC----------CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCC
T ss_conf 740674144210134----------5404899999999988765200336---762577668757677999889910652
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 4013234574-211235545755245210156887975750448799999862997899997102899999997519960
Q 001778 848 AKILIKEEGE-FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKPI 926 (1014)
Q Consensus 848 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 926 (1014)
++........ ........||+.|+|||++.+..++.++||||||+++|||+|++.||...... .++... +..+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~-i~~g~~~ 253 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY-LLQGRRL 253 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH-HHTTCCC
T ss_pred HHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHH-HHCCCCC
T ss_conf 3225566555310025655564556768874379997457466199999999789999888999--999999-9808988
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 110122238821299999999999671399999999999999997249
Q 001778 927 VDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNN 974 (1014)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 974 (1014)
. . +......+.+++.+||+.||++||++.||++.|++.
T Consensus 254 ~---~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 L---Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp C---C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---C-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9---9-------644759999999997688976893999999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.29 Aligned_cols=264 Identities=26% Similarity=0.303 Sum_probs=198.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----CE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399----15
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSEN----LK 762 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 762 (1014)
..|...+.||+|+||.||+|++ +++.||||++... .........|+..+..++||||+++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC----CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
T ss_conf 6899988982078819999999--9989999998720----046799999999996279986832688998379860489
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCC
Q ss_conf 9999826689988995103899877775566689999999999999999887315-----99984950679987545399
Q 001778 763 LLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD-----CSPTIVHRDLKSSNILLDYN 837 (1014)
Q Consensus 763 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~s~~ivH~Dlk~~NILl~~~ 837 (1014)
++||||+++|+|.+++++. .++|..+.+++.|++.|+.|+|.. .+++|+||||||+|||++.+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~ 144 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred EEEEECCCCCCHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCC
T ss_conf 9999646698989998658------------9998999999999999999988766520468986615317313578688
Q ss_pred CCEEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 968990014640132345742-112355457552452101568------8797575044879999986299789999710
Q 001778 838 FNAKIADFGVAKILIKEEGEF-AAMSTVVGSCGYIAPEYARTR------KVNEKTDIYSFGVILLELTTGKEANNGDEHT 910 (1014)
Q Consensus 838 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 910 (1014)
+.+||+|||++.......... .......||+.|+|||++.+. .++.++|||||||++|||+||..||......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 77688763866234677762001355250354767822105654546777675012201599999996289988766311
Q ss_pred -----------HHHHHHHHHHHCCCCCHHCCCCCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf -----------289999999751996011012223882-129999999999967139999999999999999724
Q 001778 911 -----------CLAQWAWRHIQEGKPIVDALDKEIDEP-CFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 911 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
............+. .++.+... ...+....+.+++.+||+.||++|||+.||++.|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHCCCCCCHHHHHHHHHHCCC-----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 2410122556430999999875024-----688877655776899999999999760698589599999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.44 Aligned_cols=268 Identities=26% Similarity=0.323 Sum_probs=201.3
Q ss_pred CCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC------CC
Q ss_conf 999774006579489999654499708999985043111378699999999999807999610599999739------91
Q 001778 688 KLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE------NL 761 (1014)
Q Consensus 688 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 761 (1014)
+|+..++||+|+||+||+|.+..+++.||||++..+.. ...+|+.++++++||||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 76751698217683999999999997999999881606-------89999999986689898738789974476577318
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CE
Q ss_conf 59999826689988995103899877775566689999999999999999887315999849506799875453999-68
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NA 840 (1014)
Q Consensus 762 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~-~~ 840 (1014)
.++||||+++|.+..+.+.. .....+++..+..++.|++.||+|||. .+|+||||||+|||++.++ .+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~--------~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~ 162 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYS--------RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVL 162 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCE
T ss_pred EEEEEECCCCCCHHHHHHHH--------HCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCE
T ss_conf 99998416886078888631--------036899999999999999999999986---6876457886037873589711
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99001464013234574211235545755245210156-88797575044879999986299789999710289999999
Q 001778 841 KIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYART-RKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 841 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
||+|||++....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+...
T Consensus 163 kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 163 KLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp EECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EEECCCCHHHCCCCC----CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf 673366054404776----5320025555568277640468882100024652778550287998987999999999997
Q ss_pred HHCCCCCHHCCC-----------CCCC-----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 751996011012-----------2238-----821299999999999671399999999999999997249999998799
Q 001778 920 IQEGKPIVDALD-----------KEID-----EPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 920 ~~~~~~~~~~~~-----------~~~~-----~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~~~ 983 (1014)
. +.+..+... +... ..........+.+|+.+|++.||++|||+.|+++ ||||+..+..
T Consensus 239 ~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~----Hp~f~~~~~~ 312 (350)
T d1q5ka_ 239 L--GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA----HSFFDELRDP 312 (350)
T ss_dssp H--CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT----SGGGGGGGCT
T ss_pred H--CCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCCCC
T ss_conf 4--898177654306210110355445674444315689999999999976589557929999966----9845246677
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=342.36 Aligned_cols=268 Identities=24% Similarity=0.295 Sum_probs=210.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|...+.||+|+||+||+|.++ +++.||||++.... ......+.+.+|+.++++++||||+++++++..++..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEE
T ss_conf 99634318722778189999968-99999999981232-68589999999999998679986876601204677315899
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
||+.++.+..+.... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+|++|||
T Consensus 80 e~~~~~~~~~~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE-----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp ECCSEEHHHHHHTST-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred EEEHHHHHHHHHHHC-----------CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCC
T ss_conf 740045678998604-----------7751445689999999999986057---48826787750568689978732366
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 640132345742112355457552452101568-8797575044879999986299789999710289999999751996
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQEGKP 925 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 925 (1014)
.|....... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.........+..... .+
T Consensus 146 ~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~--~~ 220 (286)
T d1ob3a_ 146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG--TP 220 (286)
T ss_dssp HHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--CC
T ss_pred CCEECCCCC---CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHC--CC
T ss_conf 430114676---5410102431101378871788888410021117589999779799898898999999998638--99
Q ss_pred CHHCCCCC---------C-------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 01101222---------3-------882129999999999967139999999999999999724999999
Q 001778 926 IVDALDKE---------I-------DEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 926 ~~~~~~~~---------~-------~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
........ . ...........+.+++.+|++.||++|||++|+++ ||||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~----Hp~f~~ 286 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE----HAYFKE 286 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT----SGGGGC
T ss_pred CHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCCC
T ss_conf 711042123332214333335676466651258999999999986689668909999856----922074
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.24 Aligned_cols=267 Identities=25% Similarity=0.398 Sum_probs=212.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCC-------EEEEEEEECCCCHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 89997740065794899996544997-------08999985043111378699999999999807-99961059999973
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTA-------EVVAVKKIWNDRKLDQKHEKEFLAEVQILSTI-RHLNIVKLLCCISS 758 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 758 (1014)
++|...+.||+|+||.||+|+...++ ..||||++..+ ........+.+|...+.++ +||||+++++++.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 99697009851678289999985787555667549999998811--2868899999999999981399969734652201
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 9915999982668998899510389987-----77755666899999999999999998873159998495067998754
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSL-----SGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 759 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIL 833 (1014)
++..++||||+++|+|.+++........ ........+++..+++++.|++.||+|||.. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHH
Q ss_conf 539996899001464013234574211235545755245210156887975750448799999862-9978999971028
Q 001778 834 LDYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCL 912 (1014)
Q Consensus 834 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 912 (1014)
++.++.+||+|||.++....... ........+++.|+|||++.++.|+.++||||||+++|||++ |..||.+......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ECCCCCEEECCCHHHCCCCCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 54789767622111011355555-43146678884663266751798882555477588888740179898999999999
Q ss_pred HHHHHHHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 9999999751996011012223882129999999999967139999999999999999724
Q 001778 913 AQWAWRHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
...+..+... .. +......+.+++.+||+.||++|||+.||++.|++
T Consensus 247 ----~~~i~~~~~~------~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 247 ----FKLLKEGHRM------DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp ----HHHHHTTCCC------CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHCCCCC------CC----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ----9999728888------98----74352999999999766797679399999999988
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.30 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=207.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC---CEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 8999774006579489999654499---7089999850431113786999999999998079996105999997399159
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHT---AEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 763 (1014)
++|...+.||+|+||.||+|.+..+ +..||+|.+.. .......+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf 996987799307882999999936996449999999365--6687999999999999986899998569889953-7479
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 99982668998899510389987777556668999999999999999988731599984950679987545399968990
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIA 843 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~ 843 (1014)
+||||+++|++.+++.... ..+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+
T Consensus 84 iv~E~~~~g~l~~~~~~~~----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~ 150 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 150 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEECCCCCHHHHHHCCC----------CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEEC
T ss_conf 9998406980776542247----------8999999999999998775230226---74414102655320678967876
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 01464013234574211235545755245210156887975750448799999862-99789999710289999999751
Q 001778 844 DFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQE 922 (1014)
Q Consensus 844 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 922 (1014)
|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+. .
T Consensus 151 DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~----~ 224 (273)
T d1mp8a_ 151 DFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----N 224 (273)
T ss_dssp C---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T
T ss_pred CCHHHEECCCCCC--EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH----C
T ss_conf 5034213367762--330540058310326675169988745244424789999826999988899999999998----1
Q ss_pred CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 996011012223882129999999999967139999999999999999724
Q 001778 923 GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
+... +.+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 225 ~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 225 GERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 8999----------8987779999999999768797689299999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.73 Aligned_cols=270 Identities=25% Similarity=0.254 Sum_probs=213.5
Q ss_pred CCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC------
Q ss_conf 37899977400657948999965449970899998504311137869999999999980799961059999973------
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS------ 758 (1014)
Q Consensus 685 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 758 (1014)
+.++|.+.++||+|+||+||+|.+..+++.||||++.... .+......+.+|+.+++.++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 3377599889621758599999999999899999988233-697999999999999986489876489989702564345
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 99159999826689988995103899877775566689999999999999999887315999849506799875453999
Q 001778 759 ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF 838 (1014)
Q Consensus 759 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~ 838 (1014)
....|+||||+.++ +.+.+.. .+++..++.++.|++.||.|||.. ||+||||||+|||++.++
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~~-------------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~ 156 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQM-------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred CCEEEEEEECCCHH-HHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCC
T ss_conf 76269998414467-7876503-------------899999999999999999886522---112456776321136544
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 68990014640132345742112355457552452101568879757504487999998629978999971028999999
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
.+|++|||.++..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..
T Consensus 157 ~~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~ 232 (355)
T d2b1pa1 157 TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_dssp CEEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CEEEECHHHHHCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 3132010232114666----553322146555581331477778774333566257898659899888977889999997
Q ss_pred HHHCC-------------------CC-----CHHCCCCC---CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 97519-------------------96-----01101222---38821299999999999671399999999999999997
Q 001778 919 HIQEG-------------------KP-----IVDALDKE---IDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQIL 971 (1014)
Q Consensus 919 ~~~~~-------------------~~-----~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 971 (1014)
..... .. ........ ............+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~-- 310 (355)
T d2b1pa1 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ-- 310 (355)
T ss_dssp HHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--
T ss_pred HCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC--
T ss_conf 205898799987656677776417543566642126433354321013337999999999987699457908999966--
Q ss_pred HCCCCCCCC
Q ss_conf 249999998
Q 001778 972 LNNPIFPTE 980 (1014)
Q Consensus 972 ~~~~~~~~~ 980 (1014)
||||+..
T Consensus 311 --Hpw~~~~ 317 (355)
T d2b1pa1 311 --HPYINVW 317 (355)
T ss_dssp --STTTGGG
T ss_pred --CCCCCCC
T ss_conf --9420878
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.78 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=202.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEE
Q ss_conf 899977400657948999965449970899998504311137869999999999980799961059999973-9915999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISS-ENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 765 (1014)
++|+..+.||+|+||.||+|.++ +..||||++.++ ...+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 99488579820798089999999--909999998857-----77999999999998678989854987887238928999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539996899001
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADF 845 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Df 845 (1014)
|||+++|+|.+++...+ ...+++..+++++.|++.||.|||.. +|+||||||+||+++.++.+|++||
T Consensus 80 ~ey~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp ECCCTTEEHHHHHHHHH---------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EECCCCCCHHHHHHHCC---------CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCC
T ss_conf 96369998999987457---------88889999999999998523211337---6553666567601468997763245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 464013234574211235545755245210156887975750448799999862-9978999971028999999975199
Q 001778 846 GVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTT-GKEANNGDEHTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 846 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 924 (1014)
|+++..... .....++..|+|||++.+..++.++|||||||++|||+| |+.||..........++. .+.
T Consensus 148 g~s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~----~~~ 217 (262)
T d1byga_ 148 GLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----KGY 217 (262)
T ss_dssp CC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT----TTC
T ss_pred CCCEECCCC------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----CCC
T ss_conf 600344787------7655666467781787279888588777579999999978999999999999999998----089
Q ss_pred CCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 6011012223882129999999999967139999999999999999724
Q 001778 925 PIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
. + +.+.....++.+++.+||+.||++|||+.++++.|++
T Consensus 218 ~------~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 K------M----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp C------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 9------9----9976579999999999756697689399999999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.38 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHH---HHHHHHHHHHHHHHCCC--CCCCCEEEEEEECCC
Q ss_conf 7899977400657948999965449970899998504311137---86999999999998079--996105999997399
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQ---KHEKEFLAEVQILSTIR--HLNIVKLLCCISSEN 760 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 760 (1014)
..+|++.+.||+|+||+||+|.+..+++.||||++........ .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEECCCC-CCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-C
Q ss_conf 15999982668-998899510389987777556668999999999999999988731599984950679987545399-9
Q 001778 761 LKLLVYEYMEK-RSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYN-F 838 (1014)
Q Consensus 761 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~-~ 838 (1014)
..++||||+.+ +++.+++... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.+ +
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred EEEEEEEECCCCCHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCC
T ss_conf 6899998336862289998615-----------8999999999999999999999877---9755667611147744788
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 6899001464013234574211235545755245210156887-975750448799999862997899997102899999
Q 001778 839 NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKV-NEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 839 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
.+||+|||+|...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+.
T Consensus 149 ~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------- 215 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 215 (273)
T ss_dssp EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred EEEECCCCCCEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH--------
T ss_conf 4897754653532444-----556656587747999984899788653325540345367568899887367--------
Q ss_pred HHHHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 9975199601101222388212999999999996713999999999999999972499999987
Q 001778 918 RHIQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTEK 981 (1014)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 981 (1014)
....... +.... ..++.+++.+||+.||++|||++|+++ ||||+...
T Consensus 216 -i~~~~~~--------~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~----hp~~~~~~ 262 (273)
T d1xwsa_ 216 -IIRGQVF--------FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN----HPWMQDVL 262 (273)
T ss_dssp -HHHCCCC--------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT----SGGGSSCC
T ss_pred -HHHCCCC--------CCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCCC
T ss_conf -7615447--------78779----999999999976089758939999853----98667887
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=330.80 Aligned_cols=265 Identities=19% Similarity=0.204 Sum_probs=203.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEC--CCCEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079-9961059999973--99159
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISS--ENLKL 763 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~ 763 (1014)
++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf 6718978983174819999998899979999998889------9999999999998515799876799999816877126
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEE
Q ss_conf 999826689988995103899877775566689999999999999999887315999849506799875453999-6899
Q 001778 764 LVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNF-NAKI 842 (1014)
Q Consensus 764 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~-~~kl 842 (1014)
+||||+++|+|.++.+ .+++..+..++.|++.||.|||.. +|+||||||+|||++.++ .+||
T Consensus 109 ~v~e~~~~~~L~~~~~--------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl 171 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ--------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 171 (328)
T ss_dssp EEEECCCSCBGGGTTT--------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEECCCCCHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEE
T ss_conf 8886317985899746--------------899999999999999999887643---34434564412377489983664
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 0014640132345742112355457552452101568-879757504487999998629978999971028999999975
Q 001778 843 ADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRHIQ 921 (1014)
Q Consensus 843 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 921 (1014)
+|||+|....... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.................
T Consensus 172 ~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 172 IDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred CCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 1565426646887----444322486424761026888888452323354555876048899988760189999999987
Q ss_pred --------------CCC-CCHHCCC--------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf --------------199-6011012--------22388212999999999996713999999999999999972499999
Q 001778 922 --------------EGK-PIVDALD--------KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFP 978 (1014)
Q Consensus 922 --------------~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~ 978 (1014)
... ....... .............++.+|+.+|++.||++|||++|+++ ||||+
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~----Hp~F~ 323 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----HPYFY 323 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT----SGGGT
T ss_pred CCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CCCCC
T ss_conf 88415555542254447430000033343311211552112448999999999986699568908999964----93558
Q ss_pred CCCC
Q ss_conf 9879
Q 001778 979 TEKN 982 (1014)
Q Consensus 979 ~~~~ 982 (1014)
...+
T Consensus 324 ~v~~ 327 (328)
T d3bqca1 324 TVVK 327 (328)
T ss_dssp TSCC
T ss_pred CCCC
T ss_conf 8797
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.61 Aligned_cols=266 Identities=24% Similarity=0.286 Sum_probs=213.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEE---CCCCEEEEEEEECCCCHH-HHHHHHHHHHHHHHHHCCCC-CCCCEEEEEEECCCC
Q ss_conf 8999774006579489999654---499708999985043111-37869999999999980799-961059999973991
Q 001778 687 PKLTESNVIGSGGSGKVYRVPI---NHTAEVVAVKKIWNDRKL-DQKHEKEFLAEVQILSTIRH-LNIVKLLCCISSENL 761 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 761 (1014)
++|+..+.||+|+||+||+|.+ ..+++.||+|++...... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 59999826689988995103899877775566689999999999999999887315999849506799875453999689
Q 001778 762 KLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAK 841 (1014)
Q Consensus 762 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~k 841 (1014)
.++++||+.+|+|.+++...+ .+.......++.|++.|+.|+|.. +|+||||||+||+++.++.+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEECCCCCHHHHHHHHCC-----------CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEE
T ss_conf 001231234117999987304-----------543788888899999999885149---989654773201246999888
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 90014640132345742112355457552452101568--8797575044879999986299789999710289999999
Q 001778 842 IADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR--KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWRH 919 (1014)
Q Consensus 842 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 919 (1014)
|+|||+|..+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.........+...
T Consensus 170 L~DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~ 247 (322)
T d1vzoa_ 170 LTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247 (322)
T ss_dssp ESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred EEECCCHHHHCCCCC--CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf 741320222034444--322122233333106876057768871325177779999997689998888777799999983
Q ss_pred HHCCCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHHCCCCCCCCCCC
Q ss_conf 75199601101222388212999999999996713999999999-----99999997249999998799
Q 001778 920 IQEGKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPN-----MRMVLQILLNNPIFPTEKNG 983 (1014)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev~~~L~~~~~~~~~~~~ 983 (1014)
.....+ +.+.....++.+++.+||++||++||| ++|+++ ||||+...+.
T Consensus 248 ~~~~~~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~----Hpff~~i~~~ 301 (322)
T d1vzoa_ 248 ILKSEP-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE----HLFFQKINWD 301 (322)
T ss_dssp HHHCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT----SGGGTTCCHH
T ss_pred CCCCCC-----------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC----CHHHCCCCHH
T ss_conf 356899-----------88654799999999997445898819997450999974----9723489988
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.43 Aligned_cols=271 Identities=23% Similarity=0.259 Sum_probs=211.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079996105999997399159999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSENLKLLVY 766 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 766 (1014)
++|.+.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99786269712868199999999999699999980321-78689999999999998567578882135444443115886
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 82668998899510389987777556668999999999999999988731599984950679987545399968990014
Q 001778 767 EYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFNAKIADFG 846 (1014)
Q Consensus 767 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg 846 (1014)
+++.++++..+....+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+|++|||
T Consensus 81 ~~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG-----------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp ECCSEEHHHHHHHTTT-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EECCCCCCCCCCCCCC-----------CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECC
T ss_conf 3023322211212356-----------540367899999999998774339---98600146761211337826652046
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHCCC
Q ss_conf 6401323457421123554575524521015688-7975750448799999862997899997-1028999999975199
Q 001778 847 VAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRK-VNEKTDIYSFGVILLELTTGKEANNGDE-HTCLAQWAWRHIQEGK 924 (1014)
Q Consensus 847 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~ 924 (1014)
.|....... .......++..|+|||++.+.. ++.++||||+||++|||++|+.||.... .......+........
T Consensus 147 ~a~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred HHHCCCCCC---CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 011046887---51001034431014667506988880444026541889985189999889999999999986118997
Q ss_pred C-C----HHCCC---------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 6-0----11012---------223882129999999999967139999999999999999724999999
Q 001778 925 P-I----VDALD---------KEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPT 979 (1014)
Q Consensus 925 ~-~----~~~~~---------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 979 (1014)
. . ....+ ..............+.+++.+|++.||.+|||++|+++ ||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~----Hp~f~~ 288 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ----HPYFSD 288 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT----SGGGSS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCC
T ss_conf 35513443222113344454431043306568999999999986499668909999964----953407
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.56 Aligned_cols=270 Identities=24% Similarity=0.295 Sum_probs=211.9
Q ss_pred CCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-----
Q ss_conf 378999774006579489999654499708999985043111378699999999999807999610599999739-----
Q 001778 685 ILPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLNIVKLLCCISSE----- 759 (1014)
Q Consensus 685 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 759 (1014)
+.++|...+.||+|+||+||+|.+..+++.||||++.+. ..+....+.+.+|+.+++.++|||++++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 898718888983178839999999999979999998820-0286899999999999986689874259999963464566
Q ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 91599998266899889951038998777755666899999999999999998873159998495067998754539996
Q 001778 760 NLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDYNFN 839 (1014)
Q Consensus 760 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~~~~ 839 (1014)
...+++++|+.+|+|.+++... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~------------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~ 159 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 159 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred CCEEEEEEEECCCCHHHHCCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCC
T ss_conf 8649999962588623200224------------530999999999999999999738---8765166776334554322
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8990014640132345742112355457552452101568-879757504487999998629978999971028999999
Q 001778 840 AKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTR-KVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAWR 918 (1014)
Q Consensus 840 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 918 (1014)
+|++|||.|..... ......|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 160 LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp EEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCCCCHHCCCCC------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 00132100012575------444434543555835533775678551243205899999768899788988999999997
Q ss_pred HHHCCCCCHHCCCCC--------------CCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 975199601101222--------------38821----299999999999671399999999999999997249999998
Q 001778 919 HIQEGKPIVDALDKE--------------IDEPC----FLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIFPTE 980 (1014)
Q Consensus 919 ~~~~~~~~~~~~~~~--------------~~~~~----~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~ 980 (1014)
...... .+..... ..... .......+.+++.+|++.||++|||+.|+++ ||||++.
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~----Hp~f~~~ 307 (348)
T d2gfsa1 234 LVGTPG--AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA----HAYFAQY 307 (348)
T ss_dssp HHCCCC--HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT----SGGGTTT
T ss_pred HCCCCC--HHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC----CHHHCCC
T ss_conf 307997--5773200102445444303557875556626789999999999977588345938999855----9954879
Q ss_pred CC
Q ss_conf 79
Q 001778 981 KN 982 (1014)
Q Consensus 981 ~~ 982 (1014)
..
T Consensus 308 ~~ 309 (348)
T d2gfsa1 308 HD 309 (348)
T ss_dssp CC
T ss_pred CC
T ss_conf 99
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=310.40 Aligned_cols=263 Identities=19% Similarity=0.249 Sum_probs=200.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCCCC-CCEEEEEEECCCCEEE
Q ss_conf 789997740065794899996544997089999850431113786999999999998079996-1059999973991599
Q 001778 686 LPKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRHLN-IVKLLCCISSENLKLL 764 (1014)
Q Consensus 686 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 764 (1014)
-++|+..+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|++ |+.+.++..+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC-----CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf 888999689850788099999998899899999972100-----588899999999970389960179999951987789
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEE
Q ss_conf 998266899889951038998777755666899999999999999998873159998495067998754539---99689
Q 001778 765 VYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY---NFNAK 841 (1014)
Q Consensus 765 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~---~~~~k 841 (1014)
||||++ |++.+.+.... ..+++..+..++.|++.||+|||.. +|+||||||+|||++. +..+|
T Consensus 81 vme~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEECCC-CBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEECC-CCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEE
T ss_conf 998738-71333244306----------8876899999999999999999979---944266787660643357776156
Q ss_pred EEECCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 9001464013234574----211235545755245210156887975750448799999862997899997102899999
Q 001778 842 IADFGVAKILIKEEGE----FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWAW 917 (1014)
Q Consensus 842 l~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 917 (1014)
++|||+|+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred EECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 50467513425544554100013577678735329999918998983218861778999984987665530577999999
Q ss_pred HHHHC--CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99751--9960110122238821299999999999671399999999999999997249999
Q 001778 918 RHIQE--GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLNNPIF 977 (1014)
Q Consensus 918 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 977 (1014)
..... ..+ .. ... .....++.+++..||+.||++||+++++.+.|+. +|.
T Consensus 227 ~~~~~~~~~~-~~----~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~-~~~ 278 (299)
T d1ckia_ 227 RISEKKMSTP-IE----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN-LFH 278 (299)
T ss_dssp HHHHHHHHSC-HH----HHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH-HHH
T ss_pred HHHCCCCCCC-HH----HHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH-HHH
T ss_conf 8523567898-35----753----4788999999999843995579199999999999-999
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=311.70 Aligned_cols=296 Identities=29% Similarity=0.491 Sum_probs=229.8
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--CCCCEEECC----CCEEEEEECCCCCCC--CCCCCCCCCCCCCE
Q ss_conf 8997799999999984589999999889999999--999368399----964488310546775--58977889998529
Q 001778 28 QLYDREHAVLLKLKQHWQNPPPISHWATTNSSHC--TWPEIACTD----GSVTELHLTNMNMNG--TFPPFICDLRNLTI 99 (1014)
Q Consensus 28 ~~~~~~~~~l~~~~~~~~~~~~~~~w~~~~~~~c--~w~gv~c~~----~~v~~L~l~~~~l~~--~~~~~l~~l~~L~~ 99 (1014)
-|.++|++||++||+++.++..+++|... +||| .|.||+|+. .+|+.|+|.++++.| .+|+++++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 98989999999999977999867788999-99988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf 98746-97799987122277876361244533589999210034655565501766789884212056766657403433
Q 001778 100 LDLQF-NYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQ 178 (1014)
Q Consensus 100 L~L~~-n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 178 (1014)
|+|++ |++++.+|..|+++++|++|+|++|++.+..+..+..+..|+++++++|.+.+.+|..+..++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 47987611367530023520135688999999100012333300033666657542111366455534402564468689
Q 001778 179 FNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIP 258 (1014)
Q Consensus 179 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 258 (1014)
+.+.+|..+..+..+ ++.+.++.|++.+..|..+..+.. ..++++.+...+.+|
T Consensus 161 l~~~ip~~~~~l~~l-------------------------~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~ 214 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKL-------------------------FTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDAS 214 (313)
T ss_dssp CEEECCGGGGCCCTT-------------------------CCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCG
T ss_pred CCCCCCCCCCCCCCC-------------------------CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC
T ss_conf 356203121443112-------------------------323102246435332433222222-233333343322222
Q ss_pred HHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCC
Q ss_conf 00107999867983589888888920013653554423664678899764342223420021432014688646898899
Q 001778 259 SSVFKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSL 338 (1014)
Q Consensus 259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 338 (1014)
..+..+++++.+++++|.+.+.++......+++.|+|++|++++.+|..|+.+++|+.|+|++|+++|.+|. ++.+++|
T Consensus 215 ~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L 293 (313)
T d1ogqa_ 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293 (313)
T ss_dssp GGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCC
T ss_conf 222222221112222222222222222455444444765706660876884799999897958835166898-6667998
Q ss_pred CCCCCCCCC-CCCC
Q ss_conf 720244873-3224
Q 001778 339 KDVRLFNNM-LSGA 351 (1014)
Q Consensus 339 ~~L~L~~N~-l~~~ 351 (1014)
+.+++++|+ ++|.
T Consensus 294 ~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 294 DVSAYANNKCLCGS 307 (313)
T ss_dssp CGGGTCSSSEEEST
T ss_pred CHHHHCCCCCCCCC
T ss_conf 97886889500198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=310.65 Aligned_cols=259 Identities=15% Similarity=0.172 Sum_probs=204.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079-99610599999739915999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 765 (1014)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|++.++.++ |++++.+++++..+...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 80699799841788299999998899799999975025-----8299999999999964899987799996018811799
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCE
Q ss_conf 98266899889951038998777755666899999999999999998873159998495067998754539-----9968
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILLDY-----NFNA 840 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl~~-----~~~~ 840 (1014)
|||+ +|+|.+++...+ ..+++..+..++.|++.||+|||.. +|+||||||+||+++. ++.+
T Consensus 80 me~~-~~~l~~~~~~~~----------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~v 145 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI 145 (293)
T ss_dssp EECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCE
T ss_pred EEEC-CCCHHHHHHHHC----------CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCE
T ss_conf 9964-888799997520----------3110689999999999999999977---9662667713152347543447956
Q ss_pred EEEECCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99001464013234574----21123554575524521015688797575044879999986299789999710289999
Q 001778 841 KIADFGVAKILIKEEGE----FAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGDEHTCLAQWA 916 (1014)
Q Consensus 841 kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 916 (1014)
||+|||+|+........ ........||+.|+|||++.+..++.++||||+|+++|||+||+.||.+..........
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 87236605771467665411102467627751026798964888886999898319999998698767885302199999
Q ss_pred HHHHHC--CCCCHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 999751--996011012223882129999999999967139999999999999999724
Q 001778 917 WRHIQE--GKPIVDALDKEIDEPCFLEEMIRVFKLGVICTSMLPTERPNMRMVLQILLN 973 (1014)
Q Consensus 917 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~ 973 (1014)
...... ..+..+ +... .+.++.+++..|++.+|++||+++.+.+.+++
T Consensus 226 ~~i~~~~~~~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 226 ERIGEKKQSTPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHHHHHSCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHCCCCCCHHH-----HCCC----CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 99970567999589-----6579----98999999999843993008599999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=295.37 Aligned_cols=272 Identities=21% Similarity=0.159 Sum_probs=199.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC-----------CCCCCEEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079-----------9961059999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-----------HLNIVKLLCC 755 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 755 (1014)
.+|++.+.||+|+||.||+|++..+++.||||++.++ ....+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 8579989975077818999999999979999998343----133689999999999840145555542276764789987
Q ss_pred EEC--CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 973--991599998266899889951038998777755666899999999999999998873159998495067998754
Q 001778 756 ISS--ENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNIL 833 (1014)
Q Consensus 756 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NIL 833 (1014)
+.. ....+.+++++..+......... .....+++..+..++.|++.|+.|||+. .+|+||||||+|||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL 158 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred EEECCCCCEEEEEEECCCCCCCCCCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEE
T ss_conf 6312565202343200035420000012--------2346786899999999999998887640--58646567705705
Q ss_pred ECCCC------CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 53999------689900146401323457421123554575524521015688797575044879999986299789999
Q 001778 834 LDYNF------NAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILLELTTGKEANNGD 907 (1014)
Q Consensus 834 l~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~ 907 (1014)
++.++ .++++|||.|..... ......|++.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EECCCCCCCCCEEEEEECCCCCCCCC------CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 63057656443056753144212344------542236652105713214667776432012378999998788998987
Q ss_pred CCHH----HHHHHHHHHHCCCCCHHCCCC---------------C--------------CCCCCCHHHHHHHHHHHHHCC
Q ss_conf 7102----899999997519960110122---------------2--------------388212999999999996713
Q 001778 908 EHTC----LAQWAWRHIQEGKPIVDALDK---------------E--------------IDEPCFLEEMIRVFKLGVICT 954 (1014)
Q Consensus 908 ~~~~----~~~~~~~~~~~~~~~~~~~~~---------------~--------------~~~~~~~~~~~~~~~l~~~cl 954 (1014)
+... ..........-+....+.... . ............+.+++.+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 55432102689999999837998788624532200013201220243235776444210001567435899999999987
Q ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 9999999999999999724999999879
Q 001778 955 SMLPTERPNMRMVLQILLNNPIFPTEKN 982 (1014)
Q Consensus 955 ~~dP~~Rpt~~ev~~~L~~~~~~~~~~~ 982 (1014)
..||.+|||++|+++ ||||+....
T Consensus 313 ~~dP~~Rpta~e~L~----Hp~f~~~~~ 336 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVN----HPWLKDTLG 336 (362)
T ss_dssp CSSTTTCBCHHHHHT----CGGGTTCTT
T ss_pred CCCHHHCCCHHHHHC----CCCCCCCCC
T ss_conf 799457908999966----934078987
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.3e-38 Score=237.81 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=114.0
Q ss_pred CCCEEECCCCCCCC--CCCCCCCCCCCCCCCCCCC-CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 53554423664678--8997643422234200214-32014688646898899720244873322498655389999356
Q 001778 289 NLKVIDLSANNLTG--AIPNDFGKLENLLNLSLMF-NQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYF 365 (1014)
Q Consensus 289 ~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 365 (1014)
+++.|+|++|.+.+ .+|..++.+++|+.|+|++ |++.|.+|..|+.+++|++|++++|++.+..+..+..+..|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 98899898998888887984784675335202026543330024311454200110203564344332222201110011
Q ss_pred ECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 51266456678823221897447971466567999955224786628996366440677765445544450013478556
Q 001778 366 EVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGELPESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFT 445 (1014)
Q Consensus 366 ~L~~N~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~l~~l~l~~n~~~ 445 (1014)
+++.|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+..+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l----------------------------------- 175 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----------------------------------- 175 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------------------
T ss_pred CCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-----------------------------------
T ss_conf 112245555685122067400000023553356203121443112-----------------------------------
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCC
Q ss_conf 78898677887631144561237678765688752699945871254224433364445443154443478886441231
Q 001778 446 GELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISW 525 (1014)
Q Consensus 446 ~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 525 (1014)
++.++++.|++++..+..+.++..+ .++++++...+.+|..+..+++++.+++++|.+.+.+| .+..+
T Consensus 176 ----------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~ 243 (313)
T d1ogqa_ 176 ----------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLS 243 (313)
T ss_dssp ----------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCC
T ss_pred ----------CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCC
T ss_conf ----------3231022464353324332222222-33333343322222222222221112222222222222-22245
Q ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHH-CCCCCCCCCCC
Q ss_conf 122300034661422369665666643311048883656791245430-02201257883
Q 001778 526 KSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRL-MLTSLNLSSNR 584 (1014)
Q Consensus 526 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~l~~l~l~~N~ 584 (1014)
+.|+.|+|++|+++|.+|.++.++++|+.|+|++|+++|.+|. ++.+ .|+.+++++|+
T Consensus 244 ~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf 5444444765706660876884799999897958835166898-6667998978868895
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.6e-35 Score=223.16 Aligned_cols=98 Identities=22% Similarity=0.367 Sum_probs=57.9
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 87631144561237678765688752699945871254224433364445443154443478886441231122300034
Q 001778 455 NLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLS 534 (1014)
Q Consensus 455 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (1014)
.++.+.++.|++++. ..+..+.+++.|++++|.+.+.. .+..+++|+.|++++|++++ ++ .+..+++|++|+++
T Consensus 286 ~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 286 ALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAG 359 (384)
T ss_dssp TCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECC
T ss_pred CCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECC
T ss_conf 222233232333332--21000024676777788778984--53668988989898998999-74-67089999989897
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 66142236966566664331104888
Q 001778 535 RNQLSGEIPEKIGFLPVLQDLDLSEN 560 (1014)
Q Consensus 535 ~N~l~~~~p~~~~~l~~L~~L~ls~N 560 (1014)
+|++++..| +.++++|+.|+|++|
T Consensus 360 ~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 995899800--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.3e-34 Score=217.85 Aligned_cols=59 Identities=27% Similarity=0.337 Sum_probs=24.2
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf 568875269994587125422443336444544315444347888644123112230003466
Q 001778 474 VSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRN 536 (1014)
Q Consensus 474 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 536 (1014)
+..+++|+.|++++|.+++ ++ .+..+++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 325 l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 325 VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 3668988989898998999-74-67089999989897995899800--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-33 Score=210.90 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=130.6
Q ss_pred CCCCCCCCEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC
Q ss_conf 99999993683999644883105467755897788999852998746977999871222778763612445335899992
Q 001778 58 SSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPE 137 (1014)
Q Consensus 58 ~~~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 137 (1014)
.|.|.|++|.|+..+++ .+|+.+. +.+++|+|++|+|+...+..|.++++|++|++++|.+....|.
T Consensus 7 ~c~c~~~~~~C~~~~L~-----------~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 7 RCQCHLRVVQCSDLGLE-----------KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp TCEEETTEEECTTSCCC-----------SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred CCEECCCEEEECCCCCC-----------CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf 88955999985599988-----------5198889--9979897849918986965760465652311234434452356
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf 10034655565501766789884212056766657403433479876113675300235201356889999991000123
Q 001778 138 DIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLK 217 (1014)
Q Consensus 138 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~lp~~~~~l~ 217 (1014)
.|.++++|++|++++|+++ .+|..+ ...++.|++.+|.+.+..+..+.....+..++...|...
T Consensus 74 ~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~------------- 137 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK------------- 137 (305)
T ss_dssp TTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC-------------
T ss_pred HHHCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC-------------
T ss_conf 6527985578315687567-676400--111323210246102344445401331100001233333-------------
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCC-CCCEEECC
Q ss_conf 33300033666657542111366455534402564468689001079998679835898888889200136-53554423
Q 001778 218 KLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLS 296 (1014)
Q Consensus 218 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls 296 (1014)
.....+..+..+++|+.+++++|.++ .++..+ .++|+.|++++|.+....+..+... .++.|+++
T Consensus 138 -----------~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 138 -----------SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp -----------GGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred -----------CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCC
T ss_conf -----------46777642234565671203467745-167101--7766789897886778882676413413301544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 66467889976434222342002143201468864689889972024487332
Q 001778 297 ANNLTGAIPNDFGKLENLLNLSLMFNQLSGEIPEGIGLLPSLKDVRLFNNMLS 349 (1014)
Q Consensus 297 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 349 (1014)
+|.+.+..+..|..+++|+.|+|++|.++ .+|.++..+++|+.|++++|+|+
T Consensus 204 ~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp SSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC
T ss_conf 55332223454334433224302554002-46311033467898989898657
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-31 Score=200.23 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=136.3
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 55534402564468689001079998679835898888889200136-53554423664678899764342223420021
Q 001778 242 ALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNSLSGEIPQAVESL-NLKVIDLSANNLTGAIPNDFGKLENLLNLSLM 320 (1014)
Q Consensus 242 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 320 (1014)
.++.+|.++++++ .+|..+. ++++.|++++|+|+...+..+... +|++|++++|.+....|..|..+++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf 5999985599988-5198889--997989784991898696576046565231123443445235665279855783156
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCC
Q ss_conf 43201468864689889972024487332249865538999935651266456678823221897447971466567999
Q 001778 321 FNQLSGEIPEGIGLLPSLKDVRLFNNMLSGALPPDFGRYSPLEYFEVSVNNLTGSLPEHLCAGGKLAGIAAQDNNLSGEL 400 (1014)
Q Consensus 321 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~ 400 (1014)
+|+++ .+|..+ ...+..|.+.+|.+....+..+.....+..++...|... .....
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~----------------------~~~~~ 142 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK----------------------SSGIE 142 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC----------------------GGGBC
T ss_pred CCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC----------------------CCCCC
T ss_conf 87567-676400--111323210246102344445401331100001233333----------------------46777
Q ss_pred CCCCCCCCCCCEEEEECCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 95522478662899636644067776544554445001347855678898677887631144561237678765688752
Q 001778 401 PESLGNCSSLLMVKIYNNSFTGNIPAGLWTGFNLSMVLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNL 480 (1014)
Q Consensus 401 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~l~~l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L 480 (1014)
+..+..+++|+.+++++|.+. .+|...+++++.|++++|.+....+..+.+++.+
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-------------------------~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l 197 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-------------------------TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-------------------------SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTC
T ss_pred CCCCCCCCCCCCCCCCCCCCC-------------------------CCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCC
T ss_conf 642234565671203467745-------------------------1671017766789897886778882676413413
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC------CCCCCCCCE
Q ss_conf 69994587125422443336444544315444347888644123112230003466142236966------566664331
Q 001778 481 VVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEK------IGFLPVLQD 554 (1014)
Q Consensus 481 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L~~ 554 (1014)
+.|++++|.+.+..+.+|..+++|++|+|++|+|+ .+|.++..+++|++|+|++|+++...... ...++.|+.
T Consensus 198 ~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~ 276 (305)
T d1xkua_ 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276 (305)
T ss_dssp CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCE
T ss_conf 30154455332223454334433224302554002-46311033467898989898657638100267210021588897
Q ss_pred EECCCCCCC
Q ss_conf 104888365
Q 001778 555 LDLSENQFS 563 (1014)
Q Consensus 555 L~ls~N~l~ 563 (1014)
|+|++|.+.
T Consensus 277 L~L~~N~~~ 285 (305)
T d1xkua_ 277 VSLFSNPVQ 285 (305)
T ss_dssp EECCSSSSC
T ss_pred EECCCCCCC
T ss_conf 889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-30 Score=194.19 Aligned_cols=65 Identities=23% Similarity=0.198 Sum_probs=21.6
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCC
Q ss_conf 56887526999458712542244333644454431544434788864412311223000346614
Q 001778 474 VSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQL 538 (1014)
Q Consensus 474 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 538 (1014)
|.++++|+.+++++|.+.+..|..|..+++|++||+++|.+.+..|..|..+..|++|++++|.+
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred HCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 54656341314211434662816766532000233333522100000235546568898119988
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-29 Score=188.72 Aligned_cols=90 Identities=28% Similarity=0.277 Sum_probs=31.8
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 56887526999458712542244333644454431544434788864412311223000346614223696656666433
Q 001778 474 VSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQ 553 (1014)
Q Consensus 474 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 553 (1014)
|.+.++|+.|++++|.+....+.+|..+++|+.+++++|++++..|..|..+++|++|++++|++++..+..+..++.|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred HCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 40434050223141765662566654656341314211434662816766532000233333522100000235546568
Q ss_pred EEECCCCCCC
Q ss_conf 1104888365
Q 001778 554 DLDLSENQFS 563 (1014)
Q Consensus 554 ~L~ls~N~l~ 563 (1014)
.|++++|.+.
T Consensus 229 ~L~l~~N~l~ 238 (284)
T d1ozna_ 229 YLRLNDNPWV 238 (284)
T ss_dssp EEECCSSCEE
T ss_pred EEEECCCCCC
T ss_conf 8981199887
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.1e-27 Score=171.97 Aligned_cols=91 Identities=24% Similarity=0.186 Sum_probs=40.6
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCC
Q ss_conf 76568875269994587125422443336444544315444347888644123112230003466142236966566664
Q 001778 472 TGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPV 551 (1014)
Q Consensus 472 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 551 (1014)
..+..+.++..|++++|.+....+..+..+++++.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..++.
T Consensus 118 ~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~ 196 (266)
T d1p9ag_ 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196 (266)
T ss_dssp STTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCC
T ss_pred CCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCC
T ss_conf 11222211112212434210221233322111000000015652237200134212423430139785-56866777888
Q ss_pred CCEEECCCCCCC
Q ss_conf 331104888365
Q 001778 552 LQDLDLSENQFS 563 (1014)
Q Consensus 552 L~~L~ls~N~l~ 563 (1014)
|+.|+|++|.+.
T Consensus 197 L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 197 LPFAFLHGNPWL 208 (266)
T ss_dssp CSEEECCSCCBC
T ss_pred CCEEEECCCCCC
T ss_conf 999983699987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.6e-26 Score=167.19 Aligned_cols=110 Identities=26% Similarity=0.220 Sum_probs=37.7
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 88752699945871254224433364445443154443478886441231122300034661422369665666643311
Q 001778 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDL 555 (1014)
Q Consensus 476 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 555 (1014)
++++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..++.|+.+++++|++++..+..+..+++|+.|
T Consensus 98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L 177 (266)
T d1p9ag_ 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (266)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 22222222222231101100112222111122124342102212333221110000000156522372001342124234
Q ss_pred ECCCCCCCCCCCHHHHHH-CCCCCCCCCCCCC
Q ss_conf 048883656791245430-0220125788343
Q 001778 556 DLSENQFSGKIPPQIGRL-MLTSLNLSSNRLT 586 (1014)
Q Consensus 556 ~ls~N~l~~~~p~~~~~~-~l~~l~l~~N~l~ 586 (1014)
+|++|+|+ .+|+.+..+ .|+.|++++|++.
T Consensus 178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf 30139785-56866777888999983699987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.94 E-value=5.6e-24 Score=154.81 Aligned_cols=53 Identities=23% Similarity=0.360 Sum_probs=21.4
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 6448831054677558977889998529987469779998712227787636124453358
Q 001778 72 SVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFI 132 (1014)
Q Consensus 72 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~ 132 (1014)
+++.|+|++++++ .+|+. .++|++|+|++|+|+. +|.. +.+|+.|++++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK 91 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCCC-CCCC---HHHHHHHHHHHCCCC
T ss_conf 9989993799988-78898---7898889899997963-3620---332033266551432
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.93 E-value=3.3e-23 Score=150.24 Aligned_cols=92 Identities=26% Similarity=0.317 Sum_probs=49.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf 85299874697799987122277876361244533589999210034655565501766789884212056766657403
Q 001778 96 NLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLV 175 (1014)
Q Consensus 96 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 175 (1014)
++++|||++++++. +|+. .++|++|++++|+++ .+|..+ .+|+.|++++|.++ .++. + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCCCC
T ss_conf 99899937999887-8898---789888989999796-336203---32033266551432-0321-0--2211111334
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCC
Q ss_conf 43347987611367530023520135
Q 001778 176 VNQFNGSIPAEIGNLQNLEALELAYN 201 (1014)
Q Consensus 176 ~n~l~~~~p~~~~~l~~L~~L~l~~n 201 (1014)
+|.+. .+|. ++.+++|+.|+++++
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNN 130 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSS
T ss_pred CCCCC-CCCC-HHHHCCCEEECCCCC
T ss_conf 55432-2210-011013123113565
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.5e-25 Score=161.96 Aligned_cols=173 Identities=17% Similarity=0.148 Sum_probs=120.0
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCH---------------HHHHHHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf 977400657948999965449970899998504311---------------13786999999999998079996105999
Q 001778 690 TESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRK---------------LDQKHEKEFLAEVQILSTIRHLNIVKLLC 754 (1014)
Q Consensus 690 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 754 (1014)
...+.||+|+||.||+|.+. +++.||||++..... ...........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 99739915999982668998899510389987777556668999999999999999988731599984950679987545
Q 001778 755 CISSENLKLLVYEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHDCSPTIVHRDLKSSNILL 834 (1014)
Q Consensus 755 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~s~~ivH~Dlk~~NILl 834 (1014)
+.. .+++|||++++.+.+ ++.....+++.|++.+++|||.. +|+||||||+|||+
T Consensus 82 ~~~----~~lvme~~~~~~~~~------------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR------------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp EET----TEEEEECCCCEEGGG------------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ECC----CEEEEEEECCCCCCC------------------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEE
T ss_conf 628----889999504565420------------------01578999999999999998268---88983689036114
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 3999689900146401323457421123554575524521015688797575044879999
Q 001778 835 DYNFNAKIADFGVAKILIKEEGEFAAMSTVVGSCGYIAPEYARTRKVNEKTDIYSFGVILL 895 (1014)
Q Consensus 835 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 895 (1014)
+++ .++++|||.|............ .. .... ..+.+ ...|+.++|+||..--+.
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~~l-~r---d~~~-~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWREIL-ER---DVRN-IITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHHHH-HH---HHHH-HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECC-CEEEEECCCCCCCCCCCCHHHH-HH---HHHH-HHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 289-8999877884308998709999-87---7999-99997-578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.3e-27 Score=174.87 Aligned_cols=37 Identities=35% Similarity=0.428 Sum_probs=14.4
Q ss_pred CCCEECCCCCCCCCC----CCCCCCCCCCCCCEECCCCCCC
Q ss_conf 454431544434788----8644123112230003466142
Q 001778 503 SLTTLLLDQNQLSGS----LPLDIISWKSLTALNLSRNQLS 539 (1014)
Q Consensus 503 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 539 (1014)
.|+.|+|++|.|+.. ++..+...+.|++|+|++|+++
T Consensus 370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 77889897997975999999999962998898989999698
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=3.3e-22 Score=144.32 Aligned_cols=157 Identities=20% Similarity=0.237 Sum_probs=91.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 0134785567889867788763114456123767-876568875269994587125422443336444544315444347
Q 001778 437 VLISDNLFTGELPDKMSGNLSRLEISNNRFSGKI-PTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLS 515 (1014)
Q Consensus 437 l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 515 (1014)
++.++++++ .+|..++.++++|+|++|+|++.+ +..|.++++|+.|++++|.+....++.|..+++|+.|+|++|+|+
T Consensus 13 v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~ 91 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91 (192)
T ss_dssp EECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred EEEECCCCC-CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 997089967-0298989787889848987755302002578762721301363221212122211222210100355344
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 8886441231122300034661422369665666643311048883656791245430022012578834366890444
Q 001778 516 GSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLSENQFSGKIPPQIGRLMLTSLNLSSNRLTGEIPSQFE 594 (1014)
Q Consensus 516 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~l~~N~l~~~~p~~~~ 594 (1014)
...|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+....+...-...+....+..|.+.+..|..+.
T Consensus 92 ~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~ 170 (192)
T d1w8aa_ 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170 (192)
T ss_dssp EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTT
T ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCEEECCCHHHC
T ss_conf 3497998079746552457745353597785687533420003644343530277764235403568982768984336
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.9e-27 Score=173.51 Aligned_cols=116 Identities=20% Similarity=0.159 Sum_probs=66.8
Q ss_pred CCCEEEECCCCCCCCCCC----CCCCCCCCCCEECCCCCCCCCC----CCCCCC-CCCCCCCEECCCCCCCCC----CCC
Q ss_conf 752699945871254224----4333644454431544434788----864412-311223000346614223----696
Q 001778 478 KNLVVFQASNNLFNGTIP----GELTALPSLTTLLLDQNQLSGS----LPLDII-SWKSLTALNLSRNQLSGE----IPE 544 (1014)
Q Consensus 478 ~~L~~L~ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~ 544 (1014)
..|+.+++++|.+..... ..+...++|++|+|++|.++.. ++..+. ..+.|++|+|++|.++.. ++.
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHH
T ss_conf 44333323334102334432133221101111320121013576640011122045677788989799797599999999
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCHHHHH-H-----CCCCCCCCCCCCCCCCCHHH
Q ss_conf 6566664331104888365679124543-0-----02201257883436689044
Q 001778 545 KIGFLPVLQDLDLSENQFSGKIPPQIGR-L-----MLTSLNLSSNRLTGEIPSQF 593 (1014)
Q Consensus 545 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~-~-----~l~~l~l~~N~l~~~~p~~~ 593 (1014)
.+...+.|+.|||++|+++......+.. + .|+.+++++|.+..+....+
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHH
T ss_conf 9962998898989999698799999999997478866789898987898999999
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.6e-22 Score=143.52 Aligned_cols=109 Identities=19% Similarity=0.283 Sum_probs=71.2
Q ss_pred CCCCCCCEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CC
Q ss_conf 99999936839996448831054677558977889998529987469779998712227787636124453358999-92
Q 001778 59 SHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPI-PE 137 (1014)
Q Consensus 59 ~~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~ 137 (1014)
|-|.++.|.|.... ++ .+|+.+. +.+++|+|++|.|+...+..|.++++|++|++++|.+...+ +.
T Consensus 6 C~C~~~~i~c~~~~----------l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~ 72 (242)
T d1xwdc1 6 CHCSNRVFLCQESK----------VT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72 (242)
T ss_dssp EEECSSEEEEESCS----------CS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred CCCCCCEEEEECCC----------CC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECC
T ss_conf 88739999981899----------88-7688889--98899987699189649668614643232110221124201001
Q ss_pred CCCCCCCCCEEEECC-CCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf 100346555655017-6678988421205676665740343347
Q 001778 138 DIDRLSRLKFLYLTA-NNMSGKIPASIGRLTELRQLNLVVNQFN 180 (1014)
Q Consensus 138 ~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 180 (1014)
.|.++++++++.+.. |.+....+..|.++++|+.+++++|.+.
T Consensus 73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 12222222221111123432222221222222222234211112
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.2e-21 Score=139.46 Aligned_cols=81 Identities=14% Similarity=0.005 Sum_probs=36.3
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 52699945871254224433364445443154443478886441231122300034661422369665666643311048
Q 001778 479 NLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDLDLS 558 (1014)
Q Consensus 479 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 558 (1014)
.++.+++++|.++...+..|......+.+++++|.++...+..|.++++|++|++++|+++...+..|.+++.|+.+++.
T Consensus 154 ~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp SCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred CCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCCC
T ss_conf 10012200123333222222201110121235432464247886689999989897992894597797377134147678
Q ss_pred C
Q ss_conf 8
Q 001778 559 E 559 (1014)
Q Consensus 559 ~ 559 (1014)
+
T Consensus 234 ~ 234 (242)
T d1xwdc1 234 N 234 (242)
T ss_dssp S
T ss_pred C
T ss_conf 8
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.1e-21 Score=141.26 Aligned_cols=77 Identities=26% Similarity=0.322 Sum_probs=31.0
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 88752699945871254224433364445443154443478886441231122300034661422369665666643311
Q 001778 476 SSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQLSGEIPEKIGFLPVLQDL 555 (1014)
Q Consensus 476 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 555 (1014)
+..+|+.|++++|.+.+.. .+..+++|+.|+|++|++++ ++ .+..+++|++|+|++|++++ ++ .+.++++|+.|
T Consensus 149 ~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L 222 (227)
T d1h6ua2 149 GLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIV 222 (227)
T ss_dssp GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCC-CH-HHCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCEE
T ss_conf 0211100233333333100--10564633564458884177-85-34479999989795996899-80-20369998989
Q ss_pred ECC
Q ss_conf 048
Q 001778 556 DLS 558 (1014)
Q Consensus 556 ~ls 558 (1014)
+++
T Consensus 223 ~ls 225 (227)
T d1h6ua2 223 TLT 225 (227)
T ss_dssp EEE
T ss_pred EEE
T ss_conf 712
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=2.3e-21 Score=139.37 Aligned_cols=17 Identities=35% Similarity=0.356 Sum_probs=5.9
Q ss_pred HCCCCCCCEEECCCCCC
Q ss_conf 20567666574034334
Q 001778 163 IGRLTELRQLNLVVNQF 179 (1014)
Q Consensus 163 l~~l~~L~~L~L~~n~l 179 (1014)
+..+++|++|++++|.+
T Consensus 59 l~~l~~L~~L~ls~n~i 75 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQI 75 (227)
T ss_dssp GGGCTTCCEEECCSSCC
T ss_pred HHCCCCCCEEECCCCEE
T ss_conf 74488883763578532
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.85 E-value=9.2e-22 Score=141.73 Aligned_cols=131 Identities=26% Similarity=0.307 Sum_probs=77.5
Q ss_pred CCCCCCCEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEECCCCCCCCCCCCC
Q ss_conf 999999368399964488310546775589778899985299874697799-9871222778763612445335899992
Q 001778 59 SHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFNYIIS-QFPRVLYNCSKLEYLDLSQNYFIGPIPE 137 (1014)
Q Consensus 59 ~~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 137 (1014)
+.|.|..|.|+..+++ .+|..+. +.+++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+.
T Consensus 6 C~C~~~~v~Cs~~~L~-----------~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 72 (192)
T d1w8aa_ 6 CHCEGTTVDCTGRGLK-----------EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp SEEETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred CEECCCEEEEECCCCC-----------CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCC
T ss_conf 8976999997089967-----------0298989--78788984898775530200257876272130136322121212
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 10034655565501766789884212056766657403433479876113675300235201356
Q 001778 138 DIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEALELAYNT 202 (1014)
Q Consensus 138 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 202 (1014)
.+..+++|++|+|++|+++...|.+|.++++|++|+|++|+|++..+..|..+++|++|++++|.
T Consensus 73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~ 137 (192)
T d1w8aa_ 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred CCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 22112222101003553443497998079746552457745353597785687533420003644
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=7.3e-19 Score=124.54 Aligned_cols=179 Identities=20% Similarity=0.327 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCC
Q ss_conf 74697799987122277876361244533589999210034655565501766789884212056766657403433479
Q 001778 102 LQFNYIISQFPRVLYNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNG 181 (1014)
Q Consensus 102 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 181 (1014)
+..+.+++.++. ..+.+|+.|++++|.+....+ +..+++|++|++++|.+++..+ ++.+++|+.|++++|+++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~- 103 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK- 103 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-
T ss_conf 575765775188--795484589782798887444--7648998987698960258601--135862120143333321-
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHH
Q ss_conf 87611367530023520135688999999100012333300033666657542111366455534402564468689001
Q 001778 182 SIPAEIGNLQNLEALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSV 261 (1014)
Q Consensus 182 ~~p~~~~~l~~L~~L~l~~n~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 261 (1014)
.++ .+.++++|+.|++++|. ..-...+..++.++.++++.|.+.. +..+..+++|+.+++++|++++..+ +
T Consensus 104 ~l~-~l~~l~~L~~L~l~~~~----~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l 174 (210)
T d1h6ta2 104 DLS-SLKDLKKLKSLSLEHNG----ISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--L 174 (210)
T ss_dssp CGG-GGTTCTTCCEEECTTSC----CCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCC-CCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC--C
T ss_conf 222-12122211122345653----2211220111112221122233345--4310001332100134643025645--3
Q ss_pred HCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 079998679835898888889200136535544236
Q 001778 262 FKLKNLSKVYLYSNSLSGEIPQAVESLNLKVIDLSA 297 (1014)
Q Consensus 262 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~ 297 (1014)
..+++|+.|++++|+++ .++......+|++|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~-~l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCC-BCGGGTTCTTCSEEEEEE
T ss_pred CCCCCCCEEECCCCCCC-CCHHHCCCCCCCEEECCC
T ss_conf 67898999989799899-872116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8.5e-19 Score=124.16 Aligned_cols=184 Identities=21% Similarity=0.295 Sum_probs=0.0
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 77876361244533589999210034655565501766789884212056766657403433479876113675300235
Q 001778 117 NCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNLEAL 196 (1014)
Q Consensus 117 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 196 (1014)
.+.+...+.++.+.+++.++. ..+.++++|++++|.++ .++. +..+++|++|++++|++++..+ ++++++|++|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~-~l~~-l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCC-CCCC-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 999999999677877885598--79468789989999997-7520-2137886757545655667640--1677522311
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC
Q ss_conf 20135688999999100012333300033666657542111366455534402564468689001079998679835898
Q 001778 197 ELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIPETIGDMLALEFLDLSINNFTGSIPSSVFKLKNLSKVYLYSNS 276 (1014)
Q Consensus 197 ~l~~n~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 276 (1014)
++++|. ...++. +..++.|+.|++++|......+ +..+++|+.|++++|++. ....+..+++++.|++.+|+
T Consensus 90 ~l~~n~---~~~~~~-l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~--~~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 90 LMNNNQ---IADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp ECCSSC---CCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC--CCGGGTTCTTCSEEECCSSC
T ss_pred CCCCCC---CCCCCC-CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHC--CCCCCCCCCCCCCCCCCCCC
T ss_conf 112222---222211-1112232221112222223210--001223677643111100--23433321111112234555
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 88888920013653554423664678899764342223420
Q 001778 277 LSGEIPQAVESLNLKVIDLSANNLTGAIPNDFGKLENLLNL 317 (1014)
Q Consensus 277 l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 317 (1014)
++ ..+......+|+.|++++|++++. ..+..+++|+.|
T Consensus 162 l~-~l~~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 162 VT-DLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp CC-CCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CC-CCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCC
T ss_conf 56-770116799899997879979988--101278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=3.5e-19 Score=126.47 Aligned_cols=60 Identities=25% Similarity=0.312 Sum_probs=23.2
Q ss_pred CCCCCEECCCCC-CCCCCCCCCCCCCCCCCCEECCC-CCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 444544315444-34788864412311223000346-6142236966566664331104888
Q 001778 501 LPSLTTLLLDQN-QLSGSLPLDIISWKSLTALNLSR-NQLSGEIPEKIGFLPVLQDLDLSEN 560 (1014)
Q Consensus 501 l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls~N 560 (1014)
+++|+.|++++| .+++..+..+..+++|++|++++ +.+++.....+..+++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 22212355322347783033332135768779899999787378999726999898964488
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.6e-19 Score=127.20 Aligned_cols=37 Identities=14% Similarity=0.262 Sum_probs=13.5
Q ss_pred CCCEEEECCCCCCCC-CCHHHCCCCCCCEEECCCCCCC
Q ss_conf 555655017667898-8421205676665740343347
Q 001778 144 RLKFLYLTANNMSGK-IPASIGRLTELRQLNLVVNQFN 180 (1014)
Q Consensus 144 ~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~ 180 (1014)
+|++|++++|.++.. ++..+..+++|++|+++++.++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~ 84 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 84 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCC
T ss_pred CCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 78878898984577799999974877651452346798
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.67 E-value=1.7e-19 Score=128.28 Aligned_cols=38 Identities=32% Similarity=0.425 Sum_probs=17.9
Q ss_pred CCCCCEECCCCCCCCC----CCCCCC-CCCCCCEEECCCCCCC
Q ss_conf 1223000346614223----696656-6664331104888365
Q 001778 526 KSLTALNLSRNQLSGE----IPEKIG-FLPVLQDLDLSENQFS 563 (1014)
Q Consensus 526 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~ 563 (1014)
..|+.|++++|+++.. +...+. +.+.|+.|+|++|++.
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 8889898989869808999999999703899998978798089
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.64 E-value=5e-18 Score=119.61 Aligned_cols=12 Identities=42% Similarity=0.451 Sum_probs=4.1
Q ss_pred CCCEEECCCCCC
Q ss_conf 555344025644
Q 001778 242 ALEFLDLSINNF 253 (1014)
Q Consensus 242 ~L~~L~L~~N~l 253 (1014)
+|+.|++++|.+
T Consensus 94 ~L~~L~L~~n~i 105 (344)
T d2ca6a1 94 KLHTVRLSDNAF 105 (344)
T ss_dssp TCCEEECCSCCC
T ss_pred CCCCCCCCCCCC
T ss_conf 756330000134
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=8.1e-16 Score=106.53 Aligned_cols=140 Identities=18% Similarity=0.119 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCC
Q ss_conf 01347855678898677887631144561237678765688752699945871254224433364445443154443478
Q 001778 437 VLISDNLFTGELPDKMSGNLSRLEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSG 516 (1014)
Q Consensus 437 l~l~~n~~~~~~p~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 516 (1014)
+-++.+.+.......-...+++|+|++|+|+ .++..+..+.+|+.|++++|.+... +.|..+++|+.|++++|+++.
T Consensus 1 ~rLt~~~i~~~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 1 VKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp CCCCHHHHHTSCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE
T ss_pred CCCCHHHHHHHHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCC
T ss_conf 9888999961175168574848978899788-6576200414599898979978764--774457613064310213457
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CHHHHHH-CCCCCC
Q ss_conf 886441231122300034661422369-66566664331104888365679---1245430-022012
Q 001778 517 SLPLDIISWKSLTALNLSRNQLSGEIP-EKIGFLPVLQDLDLSENQFSGKI---PPQIGRL-MLTSLN 579 (1014)
Q Consensus 517 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~---p~~~~~~-~l~~l~ 579 (1014)
..+..+..++.|+.|++++|+++.... ..+..+++|+.|++++|.++... +..++.+ .|+.||
T Consensus 78 l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 78 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 77632233453443420300016654211001365320664079963456106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=5.1e-15 Score=101.79 Aligned_cols=40 Identities=25% Similarity=0.310 Sum_probs=13.0
Q ss_pred CCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 27787636124453358999921003465556550176678
Q 001778 116 YNCSKLEYLDLSQNYFIGPIPEDIDRLSRLKFLYLTANNMS 156 (1014)
Q Consensus 116 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 156 (1014)
..+.+|++|++++|+++ .+|..++.+++|++|++++|.++
T Consensus 17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 05898898979787168-65215655431354532432112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.2e-14 Score=99.55 Aligned_cols=100 Identities=21% Similarity=0.269 Sum_probs=37.1
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECCCCCC
Q ss_conf 11445612376787656887526999458712542244333644454431544434788864412311223000346614
Q 001778 459 LEISNNRFSGKIPTGVSSSKNLVVFQASNNLFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLSRNQL 538 (1014)
Q Consensus 459 L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 538 (1014)
|+|++|+|+. ++ .+..+.+|++|++++|.++ .+|..|..+++|+.|++++|+|+. +| .+..+++|+.|++++|++
T Consensus 3 L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred EECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCC
T ss_conf 9868998988-71-0105898898979787168-652156554313545324321123-57-412335557688889865
Q ss_pred CCCC-CCCCCCCCCCCEEECCCCCCC
Q ss_conf 2236-966566664331104888365
Q 001778 539 SGEI-PEKIGFLPVLQDLDLSENQFS 563 (1014)
Q Consensus 539 ~~~~-p~~~~~l~~L~~L~ls~N~l~ 563 (1014)
+... ...+..+++|+.|++++|+++
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 88888256537999999989799688
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.1e-14 Score=95.90 Aligned_cols=111 Identities=18% Similarity=0.110 Sum_probs=64.5
Q ss_pred CCCCCCCCEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEECCCCCCCCCCCC
Q ss_conf 999999936839996448831054677558977889998529987469-7799987122277876361244533589999
Q 001778 58 SSHCTWPEIACTDGSVTELHLTNMNMNGTFPPFICDLRNLTILDLQFN-YIISQFPRVLYNCSKLEYLDLSQNYFIGPIP 136 (1014)
Q Consensus 58 ~~~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n-~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 136 (1014)
+.|+.+.+|.|.....+ ..|..+..+++|++|++++| .++.+.+.+|.++++|+.|++++|+++.+.+
T Consensus 5 C~c~~~~~l~c~~~~~~-----------~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 73 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-----------DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (156)
T ss_dssp SCCSSSSCEECCSSCCC-----------TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred CCCCCCCEEEECCCCCC-----------CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCC
T ss_conf 88699996985289976-----------5860025765657431689866443692122566666721620212477420
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf 21003465556550176678988421205676665740343347
Q 001778 137 EDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFN 180 (1014)
Q Consensus 137 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 180 (1014)
.+|..+++|++|+|++|+++...+..+. ..+|+.|+|++|.+.
T Consensus 74 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 74 DAFHFTPRLSRLNLSFNALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred CCCCCCCCCCCEECCCCCCCCCCHHHHC-CCCCCCCCCCCCCCC
T ss_conf 1112455433332267878515745633-532124335798633
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.2e-13 Score=93.62 Aligned_cols=106 Identities=24% Similarity=0.144 Sum_probs=69.7
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCEEEECCCC-CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 763114456123767876568875269994587-1254224433364445443154443478886441231122300034
Q 001778 456 LSRLEISNNRFSGKIPTGVSSSKNLVVFQASNN-LFNGTIPGELTALPSLTTLLLDQNQLSGSLPLDIISWKSLTALNLS 534 (1014)
Q Consensus 456 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (1014)
...++.+++.+. ..|..+.++++|+.|++++| .++.+.+..|.++++|+.|+|++|+|+...|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECC
T ss_conf 996985289976-5860025765657431689866443692122566666721620212477420111245543333226
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 66142236966566664331104888365
Q 001778 535 RNQLSGEIPEKIGFLPVLQDLDLSENQFS 563 (1014)
Q Consensus 535 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 563 (1014)
+|+++ .+|........|+.|+|++|.+.
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 78785-15745633532124335798633
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.47 E-value=7.2e-16 Score=106.82 Aligned_cols=148 Identities=26% Similarity=0.292 Sum_probs=0.0
Q ss_pred CCCCCCCEECCCCC--CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCH
Q ss_conf 27787636124453--3589999210034655565501766789884212056766657403433479876113675300
Q 001778 116 YNCSKLEYLDLSQN--YFIGPIPEDIDRLSRLKFLYLTANNMSGKIPASIGRLTELRQLNLVVNQFNGSIPAEIGNLQNL 193 (1014)
Q Consensus 116 ~~l~~L~~L~L~~n--~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 193 (1014)
.....++.++++++ .+. .++..+..+++|++|+|++|.++ .++ .+..+++|+.|++++|.++ .++..+..+++|
T Consensus 20 ~~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L 95 (198)
T d1m9la_ 20 VVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHC
T ss_pred CCCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCC
T ss_conf 8545331002555568520-02467762604615199446899-864-4247825357341353432-100003322123
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCHH----------HH
Q ss_conf 23520135688999999100012333300033666657542-11136645553440256446868900----------10
Q 001778 194 EALELAYNTEFSPSSLPSNFTQLKKLKKLWMASTNLIGEIP-ETIGDMLALEFLDLSINNFTGSIPSS----------VF 262 (1014)
Q Consensus 194 ~~L~l~~n~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~ 262 (1014)
+.|++++|+ +..++. +..+++|+.|++++|.+..... ..+..+++|+.|++++|++....+.. +.
T Consensus 96 ~~L~l~~N~---i~~l~~-~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~ 171 (198)
T d1m9la_ 96 EELWISYNQ---IASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp CEEECSEEE---CCCHHH-HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHH
T ss_pred CCCCCCCCC---CCCCCC-CCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 333333322---222222-2222234111234102125542212367776302342798434676322220558999998
Q ss_pred CCCCCCEEE
Q ss_conf 799986798
Q 001778 263 KLKNLSKVY 271 (1014)
Q Consensus 263 ~l~~L~~L~ 271 (1014)
.+++|+.|+
T Consensus 172 ~lp~L~~LD 180 (198)
T d1m9la_ 172 RLPNLKKLD 180 (198)
T ss_dssp HCSSCCEES
T ss_pred HCCCCCEEC
T ss_conf 788958769
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.83 E-value=1.5e-08 Score=63.56 Aligned_cols=143 Identities=15% Similarity=0.092 Sum_probs=88.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEE
Q ss_conf 89997740065794899996544997089999850431113786999999999998079-99610599999739915999
Q 001778 687 PKLTESNVIGSGGSGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLLV 765 (1014)
Q Consensus 687 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 765 (1014)
++|...+..+.++.+.||+.. .++..+.+|+.... .......+.+|...+..+. +--+.+++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~---~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSR---YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGG---GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCC---CCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 352799767899877189999--08986999984887---6532556999999999876069987289997508964999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------
Q ss_conf 9826689988995103899877775566689999999999999999887315----------------------------
Q 001778 766 YEYMEKRSLDQWLHKKNRSSLSGRARDEVLSWRRRMQIAVGAAQGLCYMHHD---------------------------- 817 (1014)
Q Consensus 766 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------- 817 (1014)
|++.++..+.+...... ....++.+++..++.||..
T Consensus 89 ~~~l~G~~~~~~~~~~~----------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ----------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EECCSSEEHHHHTTTCS----------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEECCCCCCCCCCCCCC----------------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 98604334354334402----------------69999998999999985568421435764465655577899877655
Q ss_pred -------------------------C---CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------------9---99849506799875453999689900146401
Q 001778 818 -------------------------C---SPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 818 -------------------------~---s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~~ 850 (1014)
. ...++|+|+.+.||+++++..+.++||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 5543033232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=1.6e-09 Score=69.27 Aligned_cols=11 Identities=45% Similarity=0.597 Sum_probs=3.4
Q ss_pred CCEECCCCCCC
Q ss_conf 54431544434
Q 001778 504 LTTLLLDQNQL 514 (1014)
Q Consensus 504 L~~L~Ls~N~l 514 (1014)
|++|+|++|+|
T Consensus 67 L~~L~Ls~N~i 77 (162)
T d1koha1 67 LLSLNLSNNRL 77 (162)
T ss_dssp CCCCCCCSSCC
T ss_pred CCEEECCCCCC
T ss_conf 78863777666
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.40 E-value=2.3e-06 Score=50.56 Aligned_cols=81 Identities=12% Similarity=0.140 Sum_probs=50.2
Q ss_pred CCEECCCCCEEEEEEEECCCCEEEEEEEECCC-CHHH---HHHHHHHHHHHHHHHCC-CC--CCCCEEEEEEECCCCEEE
Q ss_conf 74006579489999654499708999985043-1113---78699999999999807-99--961059999973991599
Q 001778 692 SNVIGSGGSGKVYRVPINHTAEVVAVKKIWND-RKLD---QKHEKEFLAEVQILSTI-RH--LNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 692 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~---~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l 764 (1014)
.+.||.|....||++....+++.+++|..... +... .....+...|...++.+ .+ ..+.+++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred EEECCCCCCH
Q ss_conf 9982668998
Q 001778 765 VYEYMEKRSL 774 (1014)
Q Consensus 765 v~e~~~~gsL 774 (1014)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=1e-06 Score=52.66 Aligned_cols=148 Identities=16% Similarity=0.121 Sum_probs=80.2
Q ss_pred EECCCCC-EEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC--CCCCCEEEEEEECCCCEEEEEECCC
Q ss_conf 0065794-899996544997089999850431113786999999999998079--9961059999973991599998266
Q 001778 694 VIGSGGS-GKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR--HLNIVKLLCCISSENLKLLVYEYME 770 (1014)
Q Consensus 694 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~ 770 (1014)
.+..|.. +.||+... .++..+.+|...... ...+..|...++.+. .-.+.+++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 7678654775899993-898789999589667------768999999999998659998861322245661599987441
Q ss_pred CCCHHH--------------HHHHCCCCCCCCCCCCCCCCHHHHHHHHH--------------------HHHHHHHHHHH
Q ss_conf 899889--------------95103899877775566689999999999--------------------99999988731
Q 001778 771 KRSLDQ--------------WLHKKNRSSLSGRARDEVLSWRRRMQIAV--------------------GAAQGLCYMHH 816 (1014)
Q Consensus 771 ~gsL~~--------------~l~~~~~~~~~~~~~~~~l~~~~~~~i~~--------------------~i~~~L~~LH~ 816 (1014)
|.++.+ .+.+-.......... .-.+.....-.. .....+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPF--DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCC--BCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 35543221268999999999999873688544887--5541246889999998754110113401121379999999987
Q ss_pred C----CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 5----999849506799875453999689900146401
Q 001778 817 D----CSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 817 ~----~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~~ 850 (1014)
. ....++|+|+.+.||+++.+..+-|+||+.+..
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 18765795678678887635773796589998533265
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.72 E-value=3.4e-06 Score=49.54 Aligned_cols=110 Identities=11% Similarity=0.157 Sum_probs=0.0
Q ss_pred CCCCEEEEEECC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEECCCCCCCCC----CC
Q ss_conf 999644883105-467755----8977889998529987469779----9987122277876361244533589----99
Q 001778 69 TDGSVTELHLTN-MNMNGT----FPPFICDLRNLTILDLQFNYII----SQFPRVLYNCSKLEYLDLSQNYFIG----PI 135 (1014)
Q Consensus 69 ~~~~v~~L~l~~-~~l~~~----~~~~l~~l~~L~~L~L~~n~i~----~~~p~~~~~l~~L~~L~L~~n~l~~----~~ 135 (1014)
+...+++|+|++ ..+... +..++...+.|++|+|++|.++ ..+...+...+.|+.|+|++|.++. .+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHH
T ss_conf 89998197827999989899999999976377645401201562156798875310002343300330102145999999
Q ss_pred CCCCCCCCCCCEEEECCCCCCCC-------CCHHHCCCCCCCEEECCCCC
Q ss_conf 92100346555655017667898-------84212056766657403433
Q 001778 136 PEDIDRLSRLKFLYLTANNMSGK-------IPASIGRLTELRQLNLVVNQ 178 (1014)
Q Consensus 136 p~~l~~l~~L~~L~L~~n~l~~~-------~p~~l~~l~~L~~L~L~~n~ 178 (1014)
...+...+.|++|++++|.+... +...+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99998489389877887768886579999999999729985386486888
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.42 E-value=0.00023 Score=38.74 Aligned_cols=142 Identities=15% Similarity=0.154 Sum_probs=71.8
Q ss_pred CEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCCC---C--CCCEEE--EEEECCCCEEEEEECCCCC
Q ss_conf 48999965449970899998504311137869999999999980799---9--610599--9997399159999826689
Q 001778 700 SGKVYRVPINHTAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIRH---L--NIVKLL--CCISSENLKLLVYEYMEKR 772 (1014)
Q Consensus 700 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~--niv~l~--~~~~~~~~~~lv~e~~~~g 772 (1014)
--.||++.. .+|..+++|+.... ......+..|...+..+.. | ..+..- ......+..+.++++.+|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCEEEEEEC-CCCCEEEEEEECCC----CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCC
T ss_conf 202699983-89997999984787----7889999999999999985599878752068980566534799998652776
Q ss_pred CH--------------HHHHHHCCCCCCCCCCCCCCCC----------------------HHHHHHHHHHHHHHHHHH-H
Q ss_conf 98--------------8995103899877775566689----------------------999999999999999887-3
Q 001778 773 SL--------------DQWLHKKNRSSLSGRARDEVLS----------------------WRRRMQIAVGAAQGLCYM-H 815 (1014)
Q Consensus 773 sL--------------~~~l~~~~~~~~~~~~~~~~l~----------------------~~~~~~i~~~i~~~L~~L-H 815 (1014)
.+ ...++........ ....... .......+..+...+... .
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~--~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLF--IHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCC--SSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCC--CCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 88999999999989999998863035786--5567789788766568999874769988989999999999999998454
Q ss_pred HCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 15999849506799875453999689900146401
Q 001778 816 HDCSPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 816 ~~~s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~~ 850 (1014)
.....+++|+|+.+.|||++.+ ..++||+.+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 5687120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.41 E-value=0.001 Score=34.88 Aligned_cols=73 Identities=22% Similarity=0.269 Sum_probs=45.7
Q ss_pred CEECCCCCEEEEEEEECC-------CCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEE
Q ss_conf 400657948999965449-------97089999850431113786999999999998079-9961059999973991599
Q 001778 693 NVIGSGGSGKVYRVPINH-------TAEVVAVKKIWNDRKLDQKHEKEFLAEVQILSTIR-HLNIVKLLCCISSENLKLL 764 (1014)
Q Consensus 693 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 764 (1014)
+.|+.|-.-.+|++.... ..+.|.+++.-. ........+|..+++.+. +.-..++++++.. +.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-----PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-----CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CE
T ss_conf 9917853343489996887754457898179996599-----61165899999999999757999808998189----56
Q ss_pred EEECCCCCCH
Q ss_conf 9982668998
Q 001778 765 VYEYMEKRSL 774 (1014)
Q Consensus 765 v~e~~~~gsL 774 (1014)
|+||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEECCCCC
T ss_conf 9997345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.83 E-value=2.4e-05 Score=44.59 Aligned_cols=111 Identities=13% Similarity=0.083 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCCCCCCCC----CCCCCCEECCCCCCCCC----CCCCCCCCCCCCCEEEECCCCCCCCCC--
Q ss_conf 8999852998746-977999871222----77876361244533589----999210034655565501766789884--
Q 001778 92 CDLRNLTILDLQF-NYIISQFPRVLY----NCSKLEYLDLSQNYFIG----PIPEDIDRLSRLKFLYLTANNMSGKIP-- 160 (1014)
Q Consensus 92 ~~l~~L~~L~L~~-n~i~~~~p~~~~----~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p-- 160 (1014)
.+.+.|++|+|++ +.++...-..+. ..++|+.|++++|.++. .+...+...+.++.+++++|.+....-
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCHHHHHCCCCC
Q ss_conf --21205676665--7403433479----876113675300235201356
Q 001778 161 --ASIGRLTELRQ--LNLVVNQFNG----SIPAEIGNLQNLEALELAYNT 202 (1014)
Q Consensus 161 --~~l~~l~~L~~--L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~n~ 202 (1014)
..+...++|+. |+++.|.+.. .+...+...++|+.|++..+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.0028 Score=32.36 Aligned_cols=32 Identities=22% Similarity=0.232 Sum_probs=28.3
Q ss_pred CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99849506799875453999689900146401
Q 001778 819 SPTIVHRDLKSSNILLDYNFNAKIADFGVAKI 850 (1014)
Q Consensus 819 s~~ivH~Dlk~~NILl~~~~~~kl~Dfg~a~~ 850 (1014)
..|++|+|+.++||+++.+...-+.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 45033378636564020454126742221236
|